,gene-symbol,GO_ID,GO_term,gene-score
0,ABAT,GO:0001666,response to hypoxia,2.0
1,ABAT,GO:0003867,4-aminobutyrate transaminase activity,2.0
2,ABAT,GO:0005739,mitochondrion,2.0
5,ABAT,GO:0005759,mitochondrial matrix,2.0
6,ABAT,GO:0007568,aging,2.0
7,ABAT,GO:0007620,copulation,2.0
8,ABAT,GO:0007626,locomotory behavior,2.0
9,ABAT,GO:0009410,response to xenobiotic stimulus,2.0
10,ABAT,GO:0009448,gamma-aminobutyric acid metabolic process,2.0
11,ABAT,GO:0009449,gamma-aminobutyric acid biosynthetic process,2.0
12,ABAT,GO:0009450,gamma-aminobutyric acid catabolic process,2.0
13,ABAT,GO:0010039,response to iron ion,2.0
14,ABAT,GO:0014053,negative regulation of gamma-aminobutyric acid secretion,2.0
15,ABAT,GO:0021549,cerebellum development,2.0
16,ABAT,GO:0030170,pyridoxal phosphate binding,2.0
18,ABAT,GO:0031652,positive regulation of heat generation,2.0
19,ABAT,GO:0032024,positive regulation of insulin secretion,2.0
20,ABAT,GO:0032144,4-aminobutyrate transaminase complex,2.0
21,ABAT,GO:0032145,succinate-semialdehyde dehydrogenase binding,2.0
22,ABAT,GO:0033602,negative regulation of dopamine secretion,2.0
23,ABAT,GO:0034386,4-aminobutyrate:2-oxoglutarate transaminase activity,2.0
24,ABAT,GO:0035094,response to nicotine,2.0
25,ABAT,GO:0035640,exploration behavior,2.0
26,ABAT,GO:0042135,neurotransmitter catabolic process,2.0
27,ABAT,GO:0042802,identical protein binding,2.0
28,ABAT,GO:0043005,neuron projection,2.0
29,ABAT,GO:0045471,response to ethanol,2.0
30,ABAT,GO:0045776,negative regulation of blood pressure,2.0
31,ABAT,GO:0045964,positive regulation of dopamine metabolic process,2.0
32,ABAT,GO:0046872,metal ion binding,2.0
33,ABAT,GO:0047298,(S)-3-amino-2-methylpropionate transaminase activity,2.0
34,ABAT,GO:0048148,behavioral response to cocaine,2.0
35,ABAT,GO:0051536,iron-sulfur cluster binding,2.0
36,ABAT,GO:0070474,positive regulation of uterine smooth muscle contraction,2.0
37,ABAT,GO:0090331,negative regulation of platelet aggregation,2.0
38,ABAT,GO:0097151,positive regulation of inhibitory postsynaptic potential,2.0
39,ABAT,GO:1902722,positive regulation of prolactin secretion,2.0
40,ABAT,GO:1904450,positive regulation of aspartate secretion,2.0
41,ABCA10,GO:0005319,lipid transporter activity,2.0
42,ABCA10,GO:0005524,ATP binding,2.0
43,ABCA10,GO:0006869,lipid transport,2.0
44,ABCA10,GO:0016020,membrane,2.0
45,ABCA10,GO:0042626,ATPase-coupled transmembrane transporter activity,2.0
46,ABCA10,GO:0043231,intracellular membrane-bounded organelle,2.0
47,ABCA10,GO:0055085,transmembrane transport,2.0
48,ABCA10,GO:0140359,ABC-type transporter activity,2.0
49,ABCA13,GO:0005319,lipid transporter activity,2.0
50,ABCA13,GO:0005524,ATP binding,2.0
51,ABCA13,GO:0005886,plasma membrane,2.0
52,ABCA13,GO:0006869,lipid transport,2.0
53,ABCA13,GO:0030667,secretory granule membrane,2.0
54,ABCA13,GO:0032376,positive regulation of cholesterol transport,2.0
55,ABCA13,GO:0035577,azurophil granule membrane,2.0
56,ABCA13,GO:0035627,ceramide transport,2.0
57,ABCA13,GO:0042626,ATPase-coupled transmembrane transporter activity,2.0
58,ABCA13,GO:0043231,intracellular membrane-bounded organelle,2.0
59,ABCA13,GO:0055085,transmembrane transport,2.0
60,ABCA13,GO:0097708,intracellular vesicle,2.0
61,ABCA13,GO:0140359,ABC-type transporter activity,2.0
62,ABCA13,GO:1900244,positive regulation of synaptic vesicle endocytosis,2.0
63,ABCA7,GO:0000139,Golgi membrane,2.0
64,ABCA7,GO:0001891,phagocytic cup,2.0
65,ABCA7,GO:0005319,lipid transporter activity,2.0
66,ABCA7,GO:0005524,ATP binding,2.0
67,ABCA7,GO:0005548,phospholipid transporter activity,2.0
68,ABCA7,GO:0005783,endoplasmic reticulum,2.0
69,ABCA7,GO:0005794,Golgi apparatus,2.0
70,ABCA7,GO:0005886,plasma membrane,2.0
72,ABCA7,GO:0006869,lipid transport,2.0
73,ABCA7,GO:0006909,phagocytosis,2.0
74,ABCA7,GO:0007613,memory,2.0
75,ABCA7,GO:0008542,visual learning,2.0
76,ABCA7,GO:0009986,cell surface,2.0
77,ABCA7,GO:0010875,positive regulation of cholesterol efflux,2.0
78,ABCA7,GO:0018149,peptide cross-linking,2.0
79,ABCA7,GO:0019216,regulation of lipid metabolic process,2.0
80,ABCA7,GO:0030054,cell junction,2.0
81,ABCA7,GO:0031901,early endosome membrane,2.0
82,ABCA7,GO:0032587,ruffle membrane,2.0
83,ABCA7,GO:0033344,cholesterol efflux,2.0
85,ABCA7,GO:0033700,phospholipid efflux,2.0
88,ABCA7,GO:0034188,apolipoprotein A-I receptor activity,2.0
90,ABCA7,GO:0034205,amyloid-beta formation,2.0
91,ABCA7,GO:0034380,high-density lipoprotein particle assembly,2.0
92,ABCA7,GO:0034504,protein localization to nucleus,2.0
93,ABCA7,GO:0038027,apolipoprotein A-I-mediated signaling pathway,2.0
94,ABCA7,GO:0042626,ATPase-coupled transmembrane transporter activity,2.0
95,ABCA7,GO:0042985,negative regulation of amyloid precursor protein biosynthetic process,2.0
96,ABCA7,GO:0043231,intracellular membrane-bounded organelle,2.0
97,ABCA7,GO:0043409,negative regulation of MAPK cascade,2.0
98,ABCA7,GO:0044857,plasma membrane raft organization,2.0
99,ABCA7,GO:0045332,phospholipid translocation,2.0
100,ABCA7,GO:0045806,negative regulation of endocytosis,2.0
101,ABCA7,GO:0050766,positive regulation of phagocytosis,2.0
102,ABCA7,GO:0055085,transmembrane transport,2.0
103,ABCA7,GO:0070374,positive regulation of ERK1 and ERK2 cascade,2.0
104,ABCA7,GO:0090554,phosphatidylcholine floppase activity,2.0
106,ABCA7,GO:0090556,phosphatidylserine floppase activity,2.0
108,ABCA7,GO:0097386,glial cell projection,2.0
109,ABCA7,GO:0140328,floppase activity,2.0
110,ABCA7,GO:0140359,ABC-type transporter activity,2.0
111,ABCA7,GO:0150094,amyloid-beta clearance by cellular catabolic process,2.0
112,ABCA7,GO:1900223,positive regulation of amyloid-beta clearance,2.0
113,ABCA7,GO:1901076,positive regulation of engulfment of apoptotic cell,2.0
114,ABCA7,GO:1902430,negative regulation of amyloid-beta formation,2.0
115,ABCA7,GO:1902991,regulation of amyloid precursor protein catabolic process,2.0
116,ABCA7,GO:1902995,positive regulation of phospholipid efflux,2.0
117,ABCA7,GO:1903898,negative regulation of PERK-mediated unfolded protein response,2.0
118,ABCA7,GO:2000010,positive regulation of protein localization to cell surface,2.0
152,ACE,GO:0001666,response to hypoxia,2.0
153,ACE,GO:0001822,kidney development,2.0
155,ACE,GO:0001974,blood vessel remodeling,2.0
156,ACE,GO:0002003,angiotensin maturation,2.0
159,ACE,GO:0002019,regulation of renal output by angiotensin,2.0
160,ACE,GO:0002446,neutrophil mediated immunity,2.0
161,ACE,GO:0002474,antigen processing and presentation of peptide antigen via MHC class I,2.0
162,ACE,GO:0003081,regulation of systemic arterial blood pressure by renin-angiotensin,2.0
165,ACE,GO:0003084,positive regulation of systemic arterial blood pressure,2.0
166,ACE,GO:0004175,endopeptidase activity,2.0
167,ACE,GO:0004180,carboxypeptidase activity,2.0
168,ACE,GO:0004222,metalloendopeptidase activity,2.0
169,ACE,GO:0005516,calmodulin binding,2.0
170,ACE,GO:0005576,extracellular region,2.0
171,ACE,GO:0005615,extracellular space,2.0
173,ACE,GO:0005764,lysosome,2.0
174,ACE,GO:0005768,endosome,2.0
175,ACE,GO:0005886,plasma membrane,2.0
178,ACE,GO:0006508,proteolysis,2.0
179,ACE,GO:0007283,spermatogenesis,2.0
180,ACE,GO:0007420,brain development,2.0
181,ACE,GO:0007565,female pregnancy,2.0
182,ACE,GO:0007568,aging,2.0
183,ACE,GO:0008217,regulation of blood pressure,2.0
184,ACE,GO:0008233,peptidase activity,2.0
185,ACE,GO:0008237,metallopeptidase activity,2.0
189,ACE,GO:0008238,exopeptidase activity,2.0
190,ACE,GO:0008240,tripeptidyl-peptidase activity,2.0
191,ACE,GO:0008241,peptidyl-dipeptidase activity,2.0
195,ACE,GO:0008270,zinc ion binding,2.0
196,ACE,GO:0008584,male gonad development,2.0
197,ACE,GO:0009410,response to xenobiotic stimulus,2.0
198,ACE,GO:0009792,embryo development ending in birth or egg hatching,2.0
199,ACE,GO:0009897,external side of plasma membrane,2.0
200,ACE,GO:0009925,basal plasma membrane,2.0
201,ACE,GO:0010608,post-transcriptional regulation of gene expression,2.0
202,ACE,GO:0010629,negative regulation of gene expression,2.0
203,ACE,GO:0010814,substance P catabolic process,2.0
204,ACE,GO:0010815,bradykinin catabolic process,2.0
205,ACE,GO:0014910,regulation of smooth muscle cell migration,2.0
206,ACE,GO:0019229,regulation of vasoconstriction,2.0
207,ACE,GO:0019233,sensory perception of pain,2.0
208,ACE,GO:0031100,animal organ regeneration,2.0
209,ACE,GO:0031404,chloride ion binding,2.0
210,ACE,GO:0031434,mitogen-activated protein kinase kinase binding,2.0
211,ACE,GO:0031526,brush border membrane,2.0
212,ACE,GO:0031667,response to nutrient levels,2.0
213,ACE,GO:0031711,bradykinin receptor binding,2.0
214,ACE,GO:0032091,negative regulation of protein binding,2.0
215,ACE,GO:0032092,positive regulation of protein binding,2.0
216,ACE,GO:0032496,response to lipopolysaccharide,2.0
217,ACE,GO:0032943,mononuclear cell proliferation,2.0
218,ACE,GO:0034616,response to laminar fluid shear stress,2.0
219,ACE,GO:0035814,negative regulation of renal sodium excretion,2.0
220,ACE,GO:0042310,vasoconstriction,2.0
221,ACE,GO:0042445,hormone metabolic process,2.0
222,ACE,GO:0042447,hormone catabolic process,2.0
224,ACE,GO:0042755,eating behavior,2.0
225,ACE,GO:0043065,positive regulation of apoptotic process,2.0
226,ACE,GO:0043171,peptide catabolic process,2.0
227,ACE,GO:0045907,positive regulation of vasoconstriction,2.0
228,ACE,GO:0046325,negative regulation of glucose import,2.0
229,ACE,GO:0048167,regulation of synaptic plasticity,2.0
230,ACE,GO:0048286,lung alveolus development,2.0
231,ACE,GO:0050435,amyloid-beta metabolic process,2.0
232,ACE,GO:0050482,arachidonic acid secretion,2.0
233,ACE,GO:0050729,positive regulation of inflammatory response,2.0
234,ACE,GO:0050769,positive regulation of neurogenesis,2.0
235,ACE,GO:0051019,mitogen-activated protein kinase binding,2.0
236,ACE,GO:0060047,heart contraction,2.0
237,ACE,GO:0060177,regulation of angiotensin metabolic process,2.0
238,ACE,GO:0060218,hematopoietic stem cell differentiation,2.0
239,ACE,GO:0060978,angiogenesis involved in coronary vascular morphogenesis,2.0
240,ACE,GO:0061098,positive regulation of protein tyrosine kinase activity,2.0
241,ACE,GO:0070062,extracellular exosome,2.0
243,ACE,GO:0070573,metallodipeptidase activity,2.0
245,ACE,GO:0071333,cellular response to glucose stimulus,2.0
246,ACE,GO:0071548,response to dexamethasone,2.0
247,ACE,GO:0071838,cell proliferation in bone marrow,2.0
248,ACE,GO:0090281,negative regulation of calcium ion import,2.0
249,ACE,GO:0097066,response to thyroid hormone,2.0
250,ACE,GO:0097225,sperm midpiece,2.0
251,ACE,GO:0097746,blood vessel diameter maintenance,2.0
252,ACE,GO:1900086,positive regulation of peptidyl-tyrosine autophosphorylation,2.0
253,ACE,GO:1901363,heterocyclic compound binding,2.0
254,ACE,GO:1902033,regulation of hematopoietic stem cell proliferation,2.0
256,ACE,GO:1903597,negative regulation of gap junction assembly,2.0
257,ACE,GO:1904045,cellular response to aldosterone,2.0
258,ACE,GO:2000170,positive regulation of peptidyl-cysteine S-nitrosylation,2.0
259,ACHE,GO:0001507,acetylcholine catabolic process in synaptic cleft,2.0
260,ACHE,GO:0001540,amyloid-beta binding,2.0
261,ACHE,GO:0001919,regulation of receptor recycling,2.0
262,ACHE,GO:0002076,osteoblast development,2.0
263,ACHE,GO:0003990,acetylcholinesterase activity,2.0
267,ACHE,GO:0004104,cholinesterase activity,2.0
268,ACHE,GO:0005515,protein binding,2.0
269,ACHE,GO:0005518,collagen binding,2.0
270,ACHE,GO:0005576,extracellular region,2.0
272,ACHE,GO:0005604,basement membrane,2.0
273,ACHE,GO:0005615,extracellular space,2.0
274,ACHE,GO:0005634,nucleus,2.0
275,ACHE,GO:0005794,Golgi apparatus,2.0
276,ACHE,GO:0005886,plasma membrane,2.0
277,ACHE,GO:0006581,acetylcholine catabolic process,2.0
280,ACHE,GO:0007155,cell adhesion,2.0
281,ACHE,GO:0007399,nervous system development,2.0
282,ACHE,GO:0007416,synapse assembly,2.0
283,ACHE,GO:0009986,cell surface,2.0
284,ACHE,GO:0016020,membrane,2.0
285,ACHE,GO:0016787,hydrolase activity,2.0
286,ACHE,GO:0017171,serine hydrolase activity,2.0
287,ACHE,GO:0031594,neuromuscular junction,2.0
288,ACHE,GO:0031623,receptor internalization,2.0
289,ACHE,GO:0032223,"negative regulation of synaptic transmission, cholinergic",2.0
290,ACHE,GO:0042166,acetylcholine binding,2.0
292,ACHE,GO:0042803,protein homodimerization activity,2.0
293,ACHE,GO:0042982,amyloid precursor protein metabolic process,2.0
294,ACHE,GO:0043083,synaptic cleft,2.0
295,ACHE,GO:0043236,laminin binding,2.0
296,ACHE,GO:0043621,protein self-association,2.0
297,ACHE,GO:0045202,synapse,2.0
298,ACHE,GO:0048471,perinuclear region of cytoplasm,2.0
299,ACHE,GO:0050714,positive regulation of protein secretion,2.0
300,ACHE,GO:0060041,retina development in camera-type eye,2.0
301,ACHE,GO:0095500,acetylcholine receptor signaling pathway,2.0
302,ACHE,GO:0120162,positive regulation of cold-induced thermogenesis,2.0
463,ACTN4,GO:0000977,RNA polymerase II transcription regulatory region sequence-specific DNA binding,2.0
464,ACTN4,GO:0001666,response to hypoxia,2.0
465,ACTN4,GO:0001725,stress fiber,2.0
466,ACTN4,GO:0001882,nucleoside binding,2.0
467,ACTN4,GO:0003713,transcription coactivator activity,2.0
468,ACTN4,GO:0003723,RNA binding,2.0
469,ACTN4,GO:0003779,actin binding,2.0
470,ACTN4,GO:0005178,integrin binding,2.0
471,ACTN4,GO:0005509,calcium ion binding,2.0
472,ACTN4,GO:0005515,protein binding,2.0
473,ACTN4,GO:0005576,extracellular region,2.0
474,ACTN4,GO:0005615,extracellular space,2.0
475,ACTN4,GO:0005634,nucleus,2.0
476,ACTN4,GO:0005737,cytoplasm,2.0
478,ACTN4,GO:0005829,cytosol,2.0
479,ACTN4,GO:0005886,plasma membrane,2.0
480,ACTN4,GO:0005925,focal adhesion,2.0
481,ACTN4,GO:0015031,protein transport,2.0
482,ACTN4,GO:0015629,actin cytoskeleton,2.0
484,ACTN4,GO:0016604,nuclear body,2.0
485,ACTN4,GO:0016922,nuclear receptor binding,2.0
486,ACTN4,GO:0030018,Z disc,2.0
487,ACTN4,GO:0030036,actin cytoskeleton organization,2.0
488,ACTN4,GO:0030050,vesicle transport along actin filament,2.0
489,ACTN4,GO:0030054,cell junction,2.0
490,ACTN4,GO:0030335,positive regulation of cell migration,2.0
491,ACTN4,GO:0030374,nuclear receptor coactivator activity,2.0
492,ACTN4,GO:0030864,cortical actin cytoskeleton,2.0
493,ACTN4,GO:0031093,platelet alpha granule lumen,2.0
494,ACTN4,GO:0031143,pseudopodium,2.0
495,ACTN4,GO:0031490,chromatin DNA binding,2.0
496,ACTN4,GO:0032417,positive regulation of sodium:proton antiporter activity,2.0
497,ACTN4,GO:0032991,protein-containing complex,2.0
498,ACTN4,GO:0033209,tumor necrosis factor-mediated signaling pathway,2.0
499,ACTN4,GO:0035357,peroxisome proliferator activated receptor signaling pathway,2.0
500,ACTN4,GO:0042803,protein homodimerization activity,2.0
501,ACTN4,GO:0042974,nuclear retinoic acid receptor binding,2.0
502,ACTN4,GO:0042981,regulation of apoptotic process,2.0
503,ACTN4,GO:0042995,cell projection,2.0
504,ACTN4,GO:0043005,neuron projection,2.0
505,ACTN4,GO:0044325,transmembrane transporter binding,2.0
506,ACTN4,GO:0045893,positive regulation of DNA-templated transcription,2.0
507,ACTN4,GO:0047485,protein N-terminus binding,2.0
508,ACTN4,GO:0048384,retinoic acid receptor signaling pathway,2.0
509,ACTN4,GO:0048471,perinuclear region of cytoplasm,2.0
510,ACTN4,GO:0051015,actin filament binding,2.0
513,ACTN4,GO:0055001,muscle cell development,2.0
514,ACTN4,GO:0070062,extracellular exosome,2.0
515,ACTN4,GO:1900025,negative regulation of substrate adhesion-dependent cell spreading,2.0
516,ACTN4,GO:1901224,positive regulation of NIK/NF-kappaB signaling,2.0
517,ACTN4,GO:1903506,regulation of nucleic acid-templated transcription,2.0
518,ACTN4,GO:1990904,ribonucleoprotein complex,2.0
528,ADA,GO:0000255,allantoin metabolic process,2.0
529,ADA,GO:0001666,response to hypoxia,2.0
530,ADA,GO:0001829,trophectodermal cell differentiation,2.0
531,ADA,GO:0001889,liver development,2.0
532,ADA,GO:0001890,placenta development,2.0
533,ADA,GO:0002314,germinal center B cell differentiation,2.0
534,ADA,GO:0002467,germinal center formation,2.0
535,ADA,GO:0002636,positive regulation of germinal center formation,2.0
536,ADA,GO:0002686,negative regulation of leukocyte migration,2.0
537,ADA,GO:0002901,mature B cell apoptotic process,2.0
538,ADA,GO:0002906,negative regulation of mature B cell apoptotic process,2.0
539,ADA,GO:0004000,adenosine deaminase activity,2.0
543,ADA,GO:0005515,protein binding,2.0
544,ADA,GO:0005764,lysosome,2.0
545,ADA,GO:0005829,cytosol,2.0
548,ADA,GO:0005886,plasma membrane,2.0
549,ADA,GO:0006154,adenosine catabolic process,2.0
553,ADA,GO:0006157,deoxyadenosine catabolic process,2.0
554,ADA,GO:0006196,AMP catabolic process,2.0
555,ADA,GO:0006939,smooth muscle contraction,2.0
556,ADA,GO:0007155,cell adhesion,2.0
557,ADA,GO:0008270,zinc ion binding,2.0
559,ADA,GO:0009897,external side of plasma membrane,2.0
561,ADA,GO:0009986,cell surface,2.0
562,ADA,GO:0010035,response to inorganic substance,2.0
563,ADA,GO:0010460,positive regulation of heart rate,2.0
564,ADA,GO:0014074,response to purine-containing compound,2.0
565,ADA,GO:0016020,membrane,2.0
566,ADA,GO:0019239,deaminase activity,2.0
567,ADA,GO:0019722,calcium-mediated signaling,2.0
568,ADA,GO:0030890,positive regulation of B cell proliferation,2.0
569,ADA,GO:0032261,purine nucleotide salvage,2.0
570,ADA,GO:0032263,GMP salvage,2.0
571,ADA,GO:0033077,T cell differentiation in thymus,2.0
572,ADA,GO:0033089,positive regulation of T cell differentiation in thymus,2.0
573,ADA,GO:0033632,regulation of cell-cell adhesion mediated by integrin,2.0
574,ADA,GO:0042100,B cell proliferation,2.0
575,ADA,GO:0042110,T cell activation,2.0
577,ADA,GO:0043084,penile erection,2.0
578,ADA,GO:0043101,purine-containing compound salvage,2.0
579,ADA,GO:0043103,hypoxanthine salvage,2.0
580,ADA,GO:0044209,AMP salvage,2.0
581,ADA,GO:0045987,positive regulation of smooth muscle contraction,2.0
582,ADA,GO:0046059,dAMP catabolic process,2.0
583,ADA,GO:0046061,dATP catabolic process,2.0
584,ADA,GO:0046085,adenosine metabolic process,2.0
585,ADA,GO:0046103,inosine biosynthetic process,2.0
588,ADA,GO:0046111,xanthine biosynthetic process,2.0
589,ADA,GO:0046632,alpha-beta T cell differentiation,2.0
590,ADA,GO:0046638,positive regulation of alpha-beta T cell differentiation,2.0
591,ADA,GO:0046936,2'-deoxyadenosine deaminase activity,2.0
592,ADA,GO:0048286,lung alveolus development,2.0
593,ADA,GO:0048541,Peyer's patch development,2.0
594,ADA,GO:0048566,embryonic digestive tract development,2.0
595,ADA,GO:0050728,negative regulation of inflammatory response,2.0
596,ADA,GO:0050850,positive regulation of calcium-mediated signaling,2.0
597,ADA,GO:0050852,T cell receptor signaling pathway,2.0
598,ADA,GO:0050862,positive regulation of T cell receptor signaling pathway,2.0
599,ADA,GO:0050900,leukocyte migration,2.0
600,ADA,GO:0060169,negative regulation of adenosine receptor signaling pathway,2.0
602,ADA,GO:0060205,cytoplasmic vesicle lumen,2.0
603,ADA,GO:0060407,negative regulation of penile erection,2.0
604,ADA,GO:0070161,anchoring junction,2.0
605,ADA,GO:0070242,thymocyte apoptotic process,2.0
606,ADA,GO:0070244,negative regulation of thymocyte apoptotic process,2.0
607,ADA,GO:0070254,mucus secretion,2.0
608,ADA,GO:0070256,negative regulation of mucus secretion,2.0
609,ADCY3,GO:0004016,adenylate cyclase activity,2.0
611,ADCY3,GO:0005516,calmodulin binding,2.0
612,ADCY3,GO:0005524,ATP binding,2.0
613,ADCY3,GO:0005737,cytoplasm,2.0
614,ADCY3,GO:0005794,Golgi apparatus,2.0
615,ADCY3,GO:0005886,plasma membrane,2.0
618,ADCY3,GO:0005929,cilium,2.0
619,ADCY3,GO:0006171,cAMP biosynthetic process,2.0
621,ADCY3,GO:0007165,signal transduction,2.0
622,ADCY3,GO:0007189,adenylate cyclase-activating G protein-coupled receptor signaling pathway,2.0
624,ADCY3,GO:0007338,single fertilization,2.0
625,ADCY3,GO:0007340,acrosome reaction,2.0
626,ADCY3,GO:0007608,sensory perception of smell,2.0
627,ADCY3,GO:0008355,olfactory learning,2.0
628,ADCY3,GO:0016020,membrane,2.0
630,ADCY3,GO:0030317,flagellated sperm motility,2.0
631,ADCY3,GO:0035556,intracellular signal transduction,2.0
632,ADCY3,GO:0046872,metal ion binding,2.0
633,ADCY3,GO:0060170,ciliary membrane,2.0
634,ADCY3,GO:1904322,cellular response to forskolin,2.0
635,ADCY5,GO:0001973,G protein-coupled adenosine receptor signaling pathway,2.0
636,ADCY5,GO:0004016,adenylate cyclase activity,2.0
639,ADCY5,GO:0005524,ATP binding,2.0
640,ADCY5,GO:0005886,plasma membrane,2.0
643,ADCY5,GO:0005929,cilium,2.0
644,ADCY5,GO:0006171,cAMP biosynthetic process,2.0
647,ADCY5,GO:0007189,adenylate cyclase-activating G protein-coupled receptor signaling pathway,2.0
649,ADCY5,GO:0007191,adenylate cyclase-activating dopamine receptor signaling pathway,2.0
650,ADCY5,GO:0007193,adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway,2.0
651,ADCY5,GO:0007195,adenylate cyclase-inhibiting dopamine receptor signaling pathway,2.0
652,ADCY5,GO:0007204,positive regulation of cytosolic calcium ion concentration,2.0
653,ADCY5,GO:0007626,locomotory behavior,2.0
654,ADCY5,GO:0008179,adenylate cyclase binding,2.0
655,ADCY5,GO:0016020,membrane,2.0
656,ADCY5,GO:0035556,intracellular signal transduction,2.0
657,ADCY5,GO:0045111,intermediate filament cytoskeleton,2.0
658,ADCY5,GO:0046872,metal ion binding,2.0
659,ADCY5,GO:0050885,neuromuscular process controlling balance,2.0
660,ADCY5,GO:0061178,regulation of insulin secretion involved in cellular response to glucose stimulus,2.0
661,ADCY5,GO:0097110,scaffold protein binding,2.0
662,ADCY5,GO:1904322,cellular response to forskolin,2.0
687,ADK,GO:0003723,RNA binding,2.0
688,ADK,GO:0004001,adenosine kinase activity,2.0
689,ADK,GO:0004136,deoxyadenosine kinase activity,2.0
690,ADK,GO:0005524,ATP binding,2.0
691,ADK,GO:0005634,nucleus,2.0
692,ADK,GO:0005654,nucleoplasm,2.0
693,ADK,GO:0005829,cytosol,2.0
696,ADK,GO:0005886,plasma membrane,2.0
697,ADK,GO:0006144,purine nucleobase metabolic process,2.0
698,ADK,GO:0006166,purine ribonucleoside salvage,2.0
699,ADK,GO:0006175,dATP biosynthetic process,2.0
700,ADK,GO:0009156,ribonucleoside monophosphate biosynthetic process,2.0
701,ADK,GO:0016310,phosphorylation,2.0
702,ADK,GO:0032263,GMP salvage,2.0
703,ADK,GO:0044209,AMP salvage,2.0
704,ADK,GO:0046872,metal ion binding,2.0
705,ADK,GO:0106383,dAMP salvage,2.0
746,ADORA3,GO:0001609,G protein-coupled adenosine receptor activity,2.0
747,ADORA3,GO:0001973,G protein-coupled adenosine receptor signaling pathway,2.0
748,ADORA3,GO:0004930,G protein-coupled receptor activity,2.0
749,ADORA3,GO:0005886,plasma membrane,2.0
751,ADORA3,GO:0006954,inflammatory response,2.0
752,ADORA3,GO:0007165,signal transduction,2.0
753,ADORA3,GO:0007186,G protein-coupled receptor signaling pathway,2.0
754,ADORA3,GO:0007190,activation of adenylate cyclase activity,2.0
755,ADORA3,GO:0008016,regulation of heart contraction,2.0
756,ADORA3,GO:0008285,negative regulation of cell population proliferation,2.0
757,ADORA3,GO:0009611,response to wounding,2.0
758,ADORA3,GO:0014061,regulation of norepinephrine secretion,2.0
759,ADORA3,GO:0030336,negative regulation of cell migration,2.0
760,ADORA3,GO:0032088,negative regulation of NF-kappaB transcription factor activity,2.0
761,ADORA3,GO:0042734,presynaptic membrane,2.0
762,ADORA3,GO:0045202,synapse,2.0
763,ADORA3,GO:0098685,Schaffer collateral - CA1 synapse,2.0
764,ADORA3,GO:0099171,presynaptic modulation of chemical synaptic transmission,2.0
787,ADSS2,GO:0000287,magnesium ion binding,2.0
788,ADSS2,GO:0002376,immune system process,2.0
789,ADSS2,GO:0004019,adenylosuccinate synthase activity,2.0
792,ADSS2,GO:0005515,protein binding,2.0
793,ADSS2,GO:0005525,GTP binding,2.0
794,ADSS2,GO:0005737,cytoplasm,2.0
795,ADSS2,GO:0005739,mitochondrion,2.0
796,ADSS2,GO:0005829,cytosol,2.0
797,ADSS2,GO:0006167,AMP biosynthetic process,2.0
799,ADSS2,GO:0006531,aspartate metabolic process,2.0
800,ADSS2,GO:0014074,response to purine-containing compound,2.0
801,ADSS2,GO:0042301,phosphate ion binding,2.0
802,ADSS2,GO:0044208,'de novo' AMP biosynthetic process,2.0
805,ADSS2,GO:0046040,IMP metabolic process,2.0
806,ADSS2,GO:0060359,response to ammonium ion,2.0
807,ADSS2,GO:0070062,extracellular exosome,2.0
808,ADSS2,GO:0071257,cellular response to electrical stimulus,2.0
825,AGAP1,GO:0003924,GTPase activity,2.0
826,AGAP1,GO:0005096,GTPase activator activity,2.0
827,AGAP1,GO:0005515,protein binding,2.0
828,AGAP1,GO:0005525,GTP binding,2.0
829,AGAP1,GO:0005543,phospholipid binding,2.0
830,AGAP1,GO:0005737,cytoplasm,2.0
831,AGAP1,GO:0015031,protein transport,2.0
832,AGAP1,GO:0046872,metal ion binding,2.0
833,AGAP1,GO:0090630,activation of GTPase activity,2.0
834,AGAP2,GO:0003924,GTPase activity,2.0
837,AGAP2,GO:0005096,GTPase activator activity,2.0
839,AGAP2,GO:0005515,protein binding,2.0
840,AGAP2,GO:0005524,ATP binding,2.0
841,AGAP2,GO:0005525,GTP binding,2.0
842,AGAP2,GO:0005634,nucleus,2.0
846,AGAP2,GO:0005654,nucleoplasm,2.0
847,AGAP2,GO:0005737,cytoplasm,2.0
849,AGAP2,GO:0005768,endosome,2.0
850,AGAP2,GO:0005829,cytosol,2.0
851,AGAP2,GO:0015031,protein transport,2.0
852,AGAP2,GO:0016020,membrane,2.0
853,AGAP2,GO:0016197,endosomal transport,2.0
854,AGAP2,GO:0019901,protein kinase binding,2.0
855,AGAP2,GO:0030036,actin cytoskeleton organization,2.0
856,AGAP2,GO:0030295,protein kinase activator activity,2.0
857,AGAP2,GO:0032147,activation of protein kinase activity,2.0
858,AGAP2,GO:0035014,phosphatidylinositol 3-kinase regulator activity,2.0
859,AGAP2,GO:0042177,negative regulation of protein catabolic process,2.0
860,AGAP2,GO:0043524,negative regulation of neuron apoptotic process,2.0
862,AGAP2,GO:0045860,positive regulation of protein kinase activity,2.0
863,AGAP2,GO:0046872,metal ion binding,2.0
864,AGAP2,GO:0061903,positive regulation of 1-phosphatidylinositol-3-kinase activity,2.0
865,AGAP2,GO:0070062,extracellular exosome,2.0
866,AGAP2,GO:0090543,Flemming body,2.0
867,AGAP2,GO:0090630,activation of GTPase activity,2.0
872,AGBL4,GO:0004181,metallocarboxypeptidase activity,2.0
873,AGBL4,GO:0005794,Golgi apparatus,2.0
874,AGBL4,GO:0005814,centriole,2.0
875,AGBL4,GO:0005829,cytosol,2.0
876,AGBL4,GO:0006508,proteolysis,2.0
877,AGBL4,GO:0008270,zinc ion binding,2.0
878,AGBL4,GO:0008285,negative regulation of cell population proliferation,2.0
879,AGBL4,GO:0015631,tubulin binding,2.0
880,AGBL4,GO:0021954,central nervous system neuron development,2.0
881,AGBL4,GO:0035608,protein deglutamylation,2.0
882,AGBL4,GO:0035609,C-terminal protein deglutamylation,2.0
883,AGBL4,GO:0035610,protein side chain deglutamylation,2.0
884,AGBL4,GO:0036064,ciliary basal body,2.0
885,AGBL4,GO:0051607,defense response to virus,2.0
886,AGBL4,GO:0098957,anterograde axonal transport of mitochondrion,2.0
887,AGBL4,GO:0098958,retrograde axonal transport of mitochondrion,2.0
888,AGBL4,GO:0120222,regulation of blastocyst development,2.0
889,AGBL4,GO:1904115,axon cytoplasm,2.0
890,AGBL4,GO:2000060,positive regulation of ubiquitin-dependent protein catabolic process,2.0
891,AGMO,GO:0005506,iron ion binding,2.0
892,AGMO,GO:0005515,protein binding,2.0
893,AGMO,GO:0005783,endoplasmic reticulum,2.0
895,AGMO,GO:0005789,endoplasmic reticulum membrane,2.0
896,AGMO,GO:0006643,membrane lipid metabolic process,2.0
898,AGMO,GO:0019432,triglyceride biosynthetic process,2.0
899,AGMO,GO:0046485,ether lipid metabolic process,2.0
900,AGMO,GO:0050479,glyceryl-ether monooxygenase activity,2.0
903,AGO1,GO:0000932,P-body,2.0
904,AGO1,GO:0000956,nuclear-transcribed mRNA catabolic process,2.0
905,AGO1,GO:0000993,RNA polymerase II complex binding,2.0
906,AGO1,GO:0001046,core promoter sequence-specific DNA binding,2.0
907,AGO1,GO:0003723,RNA binding,2.0
910,AGO1,GO:0003725,double-stranded RNA binding,2.0
911,AGO1,GO:0003727,single-stranded RNA binding,2.0
913,AGO1,GO:0004521,endoribonuclease activity,2.0
914,AGO1,GO:0005515,protein binding,2.0
915,AGO1,GO:0005634,nucleus,2.0
916,AGO1,GO:0005654,nucleoplasm,2.0
917,AGO1,GO:0005737,cytoplasm,2.0
918,AGO1,GO:0005829,cytosol,2.0
920,AGO1,GO:0005844,polysome,2.0
921,AGO1,GO:0010501,RNA secondary structure unwinding,2.0
923,AGO1,GO:0016442,RISC complex,2.0
924,AGO1,GO:0016525,negative regulation of angiogenesis,2.0
925,AGO1,GO:0031054,pre-miRNA processing,2.0
926,AGO1,GO:0035196,miRNA processing,2.0
927,AGO1,GO:0035198,miRNA binding,2.0
929,AGO1,GO:0035278,miRNA-mediated gene silencing by inhibition of translation,2.0
930,AGO1,GO:0035279,miRNA-mediated gene silencing by mRNA destabilization,2.0
931,AGO1,GO:0036464,cytoplasmic ribonucleoprotein granule,2.0
932,AGO1,GO:0045944,positive regulation of transcription by RNA polymerase II,2.0
933,AGO1,GO:0070578,RISC-loading complex,2.0
934,AGO1,GO:0070922,RISC complex assembly,2.0
935,AGO1,GO:0090625,siRNA-mediated gene silencing by mRNA destabilization,2.0
936,AGO1,GO:1990904,ribonucleoprotein complex,2.0
937,AGO2,GO:0000340,RNA 7-methylguanosine cap binding,2.0
938,AGO2,GO:0000932,P-body,2.0
939,AGO2,GO:0000993,RNA polymerase II complex binding,2.0
940,AGO2,GO:0001046,core promoter sequence-specific DNA binding,2.0
941,AGO2,GO:0003723,RNA binding,2.0
943,AGO2,GO:0003725,double-stranded RNA binding,2.0
944,AGO2,GO:0003727,single-stranded RNA binding,2.0
946,AGO2,GO:0003743,translation initiation factor activity,2.0
947,AGO2,GO:0004521,endoribonuclease activity,2.0
950,AGO2,GO:0005515,protein binding,2.0
951,AGO2,GO:0005634,nucleus,2.0
953,AGO2,GO:0005654,nucleoplasm,2.0
954,AGO2,GO:0005737,cytoplasm,2.0
955,AGO2,GO:0005829,cytosol,2.0
957,AGO2,GO:0005844,polysome,2.0
958,AGO2,GO:0005845,mRNA cap binding complex,2.0
959,AGO2,GO:0006412,translation,2.0
960,AGO2,GO:0006413,translational initiation,2.0
961,AGO2,GO:0008022,protein C-terminus binding,2.0
962,AGO2,GO:0009791,post-embryonic development,2.0
963,AGO2,GO:0010501,RNA secondary structure unwinding,2.0
965,AGO2,GO:0010586,miRNA metabolic process,2.0
966,AGO2,GO:0010628,positive regulation of gene expression,2.0
967,AGO2,GO:0016020,membrane,2.0
968,AGO2,GO:0016442,RISC complex,2.0
971,AGO2,GO:0030422,siRNA processing,2.0
972,AGO2,GO:0030425,dendrite,2.0
973,AGO2,GO:0031047,RNA-mediated gene silencing,2.0
974,AGO2,GO:0031054,pre-miRNA processing,2.0
975,AGO2,GO:0035194,RNA-mediated post-transcriptional gene silencing,2.0
976,AGO2,GO:0035196,miRNA processing,2.0
977,AGO2,GO:0035197,siRNA binding,2.0
979,AGO2,GO:0035198,miRNA binding,2.0
983,AGO2,GO:0035278,miRNA-mediated gene silencing by inhibition of translation,2.0
985,AGO2,GO:0035279,miRNA-mediated gene silencing by mRNA destabilization,2.0
987,AGO2,GO:0036464,cytoplasmic ribonucleoprotein granule,2.0
988,AGO2,GO:0042985,negative regulation of amyloid precursor protein biosynthetic process,2.0
989,AGO2,GO:0045766,positive regulation of angiogenesis,2.0
990,AGO2,GO:0045944,positive regulation of transcription by RNA polymerase II,2.0
991,AGO2,GO:0045947,negative regulation of translational initiation,2.0
992,AGO2,GO:0046872,metal ion binding,2.0
993,AGO2,GO:0060213,positive regulation of nuclear-transcribed mRNA poly(A) tail shortening,2.0
994,AGO2,GO:0070062,extracellular exosome,2.0
995,AGO2,GO:0070551,"endoribonuclease activity, cleaving siRNA-paired mRNA",2.0
996,AGO2,GO:0070578,RISC-loading complex,2.0
998,AGO2,GO:0070922,RISC complex assembly,2.0
999,AGO2,GO:0090502,"RNA phosphodiester bond hydrolysis, endonucleolytic",2.0
1000,AGO2,GO:0090624,"endoribonuclease activity, cleaving miRNA-paired mRNA",2.0
1002,AGO2,GO:0090625,siRNA-mediated gene silencing by mRNA destabilization,2.0
1004,AGO2,GO:0098808,mRNA cap binding,2.0
1005,AGO2,GO:1900153,"positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay",2.0
1006,AGO2,GO:1901165,positive regulation of trophoblast cell migration,2.0
1007,AGO2,GO:1990904,ribonucleoprotein complex,2.0
1008,AGO3,GO:0000794,condensed nuclear chromosome,2.0
1009,AGO3,GO:0000932,P-body,2.0
1010,AGO3,GO:0003723,RNA binding,2.0
1012,AGO3,GO:0003725,double-stranded RNA binding,2.0
1013,AGO3,GO:0003727,single-stranded RNA binding,2.0
1015,AGO3,GO:0004521,endoribonuclease activity,2.0
1017,AGO3,GO:0005515,protein binding,2.0
1018,AGO3,GO:0005654,nucleoplasm,2.0
1019,AGO3,GO:0005737,cytoplasm,2.0
1020,AGO3,GO:0005829,cytosol,2.0
1022,AGO3,GO:0006402,mRNA catabolic process,2.0
1023,AGO3,GO:0010501,RNA secondary structure unwinding,2.0
1025,AGO3,GO:0010628,positive regulation of gene expression,2.0
1026,AGO3,GO:0016020,membrane,2.0
1027,AGO3,GO:0016442,RISC complex,2.0
1028,AGO3,GO:0031054,pre-miRNA processing,2.0
1029,AGO3,GO:0035196,miRNA processing,2.0
1030,AGO3,GO:0035198,miRNA binding,2.0
1032,AGO3,GO:0035278,miRNA-mediated gene silencing by inhibition of translation,2.0
1033,AGO3,GO:0035279,miRNA-mediated gene silencing by mRNA destabilization,2.0
1034,AGO3,GO:0036464,cytoplasmic ribonucleoprotein granule,2.0
1035,AGO3,GO:0046872,metal ion binding,2.0
1036,AGO3,GO:0070578,RISC-loading complex,2.0
1037,AGO3,GO:0070922,RISC complex assembly,2.0
1038,AGO3,GO:0072091,regulation of stem cell proliferation,2.0
1039,AGO3,GO:0090502,"RNA phosphodiester bond hydrolysis, endonucleolytic",2.0
1040,AGO3,GO:0090624,"endoribonuclease activity, cleaving miRNA-paired mRNA",2.0
1041,AGO3,GO:0090625,siRNA-mediated gene silencing by mRNA destabilization,2.0
1042,AGO3,GO:1901224,positive regulation of NIK/NF-kappaB signaling,2.0
1043,AGO4,GO:0000932,P-body,2.0
1044,AGO4,GO:0003723,RNA binding,2.0
1045,AGO4,GO:0003725,double-stranded RNA binding,2.0
1046,AGO4,GO:0003727,single-stranded RNA binding,2.0
1048,AGO4,GO:0004521,endoribonuclease activity,2.0
1049,AGO4,GO:0005515,protein binding,2.0
1050,AGO4,GO:0005634,nucleus,2.0
1051,AGO4,GO:0005737,cytoplasm,2.0
1052,AGO4,GO:0005829,cytosol,2.0
1054,AGO4,GO:0006402,mRNA catabolic process,2.0
1055,AGO4,GO:0007130,synaptonemal complex assembly,2.0
1056,AGO4,GO:0007140,male meiotic nuclear division,2.0
1057,AGO4,GO:0008584,male gonad development,2.0
1058,AGO4,GO:0010501,RNA secondary structure unwinding,2.0
1060,AGO4,GO:0010586,miRNA metabolic process,2.0
1061,AGO4,GO:0016020,membrane,2.0
1062,AGO4,GO:0016442,RISC complex,2.0
1063,AGO4,GO:0022604,regulation of cell morphogenesis,2.0
1064,AGO4,GO:0031054,pre-miRNA processing,2.0
1065,AGO4,GO:0035196,miRNA processing,2.0
1066,AGO4,GO:0035198,miRNA binding,2.0
1068,AGO4,GO:0035278,miRNA-mediated gene silencing by inhibition of translation,2.0
1069,AGO4,GO:0035279,miRNA-mediated gene silencing by mRNA destabilization,2.0
1070,AGO4,GO:0036464,cytoplasmic ribonucleoprotein granule,2.0
1071,AGO4,GO:0043066,negative regulation of apoptotic process,2.0
1072,AGO4,GO:0070578,RISC-loading complex,2.0
1073,AGO4,GO:0070922,RISC complex assembly,2.0
1074,AGO4,GO:0090502,"RNA phosphodiester bond hydrolysis, endonucleolytic",2.0
1075,AGO4,GO:0090625,siRNA-mediated gene silencing by mRNA destabilization,2.0
1076,AGTR2,GO:0001974,blood vessel remodeling,2.0
1077,AGTR2,GO:0001991,regulation of systemic arterial blood pressure by circulatory renin-angiotensin,2.0
1078,AGTR2,GO:0002033,angiotensin-mediated vasodilation involved in regulation of systemic arterial blood pressure,2.0
1079,AGTR2,GO:0002035,brain renin-angiotensin system,2.0
1080,AGTR2,GO:0004930,G protein-coupled receptor activity,2.0
1081,AGTR2,GO:0004945,angiotensin type II receptor activity,2.0
1084,AGTR2,GO:0005515,protein binding,2.0
1085,AGTR2,GO:0005886,plasma membrane,2.0
1088,AGTR2,GO:0006954,inflammatory response,2.0
1089,AGTR2,GO:0007166,cell surface receptor signaling pathway,2.0
1090,AGTR2,GO:0007186,G protein-coupled receptor signaling pathway,2.0
1092,AGTR2,GO:0007199,G protein-coupled receptor signaling pathway coupled to cGMP nucleotide second messenger,2.0
1093,AGTR2,GO:0007263,nitric oxide mediated signal transduction,2.0
1095,AGTR2,GO:0007420,brain development,2.0
1096,AGTR2,GO:0008217,regulation of blood pressure,2.0
1097,AGTR2,GO:0010459,negative regulation of heart rate,2.0
1098,AGTR2,GO:0030308,negative regulation of cell growth,2.0
1099,AGTR2,GO:0032516,positive regulation of phosphoprotein phosphatase activity,2.0
1100,AGTR2,GO:0035556,intracellular signal transduction,2.0
1101,AGTR2,GO:0035566,regulation of metanephros size,2.0
1102,AGTR2,GO:0035640,exploration behavior,2.0
1103,AGTR2,GO:0038166,angiotensin-activated signaling pathway,2.0
1104,AGTR2,GO:0042311,vasodilation,2.0
1105,AGTR2,GO:0043537,negative regulation of blood vessel endothelial cell migration,2.0
1106,AGTR2,GO:0045429,positive regulation of nitric oxide biosynthetic process,2.0
1107,AGTR2,GO:0045893,positive regulation of DNA-templated transcription,2.0
1108,AGTR2,GO:0048019,receptor antagonist activity,2.0
1109,AGTR2,GO:0051000,positive regulation of nitric-oxide synthase activity,2.0
1110,AGTR2,GO:0051387,negative regulation of neurotrophin TRK receptor signaling pathway,2.0
1111,AGTR2,GO:0051402,neuron apoptotic process,2.0
1112,AGTR2,GO:0072300,positive regulation of metanephric glomerulus development,2.0
1113,AGTR2,GO:0090190,positive regulation of branching involved in ureteric bud morphogenesis,2.0
1114,AGTR2,GO:2000272,negative regulation of signaling receptor activity,2.0
1115,AGTR2,GO:2001238,positive regulation of extrinsic apoptotic signaling pathway,2.0
1161,AHNAK,GO:0003723,RNA binding,2.0
1162,AHNAK,GO:0005515,protein binding,2.0
1163,AHNAK,GO:0005634,nucleus,2.0
1166,AHNAK,GO:0005737,cytoplasm,2.0
1168,AHNAK,GO:0005765,lysosomal membrane,2.0
1169,AHNAK,GO:0005829,cytosol,2.0
1171,AHNAK,GO:0005886,plasma membrane,2.0
1172,AHNAK,GO:0005925,focal adhesion,2.0
1173,AHNAK,GO:0015629,actin cytoskeleton,2.0
1174,AHNAK,GO:0016020,membrane,2.0
1175,AHNAK,GO:0030315,T-tubule,2.0
1176,AHNAK,GO:0031982,vesicle,2.0
1177,AHNAK,GO:0042383,sarcolemma,2.0
1179,AHNAK,GO:0043034,costamere,2.0
1181,AHNAK,GO:0043484,regulation of RNA splicing,2.0
1183,AHNAK,GO:0044291,cell-cell contact zone,2.0
1184,AHNAK,GO:0044548,S100 protein binding,2.0
1185,AHNAK,GO:0045121,membrane raft,2.0
1186,AHNAK,GO:0045296,cadherin binding,2.0
1187,AHNAK,GO:0070062,extracellular exosome,2.0
1189,AHNAK,GO:0097493,structural molecule activity conferring elasticity,2.0
1190,AHNAK,GO:0098797,plasma membrane protein complex,2.0
1191,AHNAK,GO:1901385,regulation of voltage-gated calcium channel activity,2.0
1192,AHNAK,GO:1905686,positive regulation of plasma membrane repair,2.0
1193,AKAP9,GO:0003677,DNA binding,2.0
1194,AKAP9,GO:0005102,signaling receptor binding,2.0
1195,AKAP9,GO:0005515,protein binding,2.0
1196,AKAP9,GO:0005794,Golgi apparatus,2.0
1197,AKAP9,GO:0005795,Golgi stack,2.0
1199,AKAP9,GO:0005801,cis-Golgi network,2.0
1201,AKAP9,GO:0005813,centrosome,2.0
1203,AKAP9,GO:0005829,cytosol,2.0
1204,AKAP9,GO:0005856,cytoskeleton,2.0
1205,AKAP9,GO:0007020,microtubule nucleation,2.0
1206,AKAP9,GO:0007165,signal transduction,2.0
1207,AKAP9,GO:0007194,negative regulation of adenylate cyclase activity,2.0
1208,AKAP9,GO:0007268,chemical synaptic transmission,2.0
1209,AKAP9,GO:0008076,voltage-gated potassium channel complex,2.0
1210,AKAP9,GO:0015459,potassium channel regulator activity,2.0
1212,AKAP9,GO:0031116,positive regulation of microtubule polymerization,2.0
1213,AKAP9,GO:0031503,protein-containing complex localization,2.0
1214,AKAP9,GO:0033138,positive regulation of peptidyl-serine phosphorylation,2.0
1216,AKAP9,GO:0034237,protein kinase A regulatory subunit binding,2.0
1219,AKAP9,GO:0034705,potassium channel complex,2.0
1220,AKAP9,GO:0043025,neuronal cell body,2.0
1221,AKAP9,GO:0043231,intracellular membrane-bounded organelle,2.0
1222,AKAP9,GO:0044307,dendritic branch,2.0
1223,AKAP9,GO:0044325,transmembrane transporter binding,2.0
1224,AKAP9,GO:0051602,response to electrical stimulus,2.0
1225,AKAP9,GO:0051661,maintenance of centrosome location,2.0
1227,AKAP9,GO:0060090,molecular adaptor activity,2.0
1229,AKAP9,GO:0060306,regulation of membrane repolarization,2.0
1230,AKAP9,GO:0060307,regulation of ventricular cardiac muscle cell membrane repolarization,2.0
1232,AKAP9,GO:0071320,cellular response to cAMP,2.0
1233,AKAP9,GO:0086091,regulation of heart rate by cardiac conduction,2.0
1234,AKAP9,GO:0097060,synaptic membrane,2.0
1235,AKAP9,GO:0098909,regulation of cardiac muscle cell action potential involved in regulation of contraction,2.0
1236,AKAP9,GO:0098962,regulation of postsynaptic neurotransmitter receptor activity,2.0
1238,AKAP9,GO:0098978,glutamatergic synapse,2.0
1240,AKAP9,GO:0099147,extrinsic component of postsynaptic density membrane,2.0
1241,AKAP9,GO:1901018,positive regulation of potassium ion transmembrane transporter activity,2.0
1243,AKAP9,GO:1903358,regulation of Golgi organization,2.0
1314,AMPD1,GO:0003876,AMP deaminase activity,2.0
1315,AMPD1,GO:0005515,protein binding,2.0
1316,AMPD1,GO:0005829,cytosol,2.0
1318,AMPD1,GO:0006188,IMP biosynthetic process,2.0
1319,AMPD1,GO:0032263,GMP salvage,2.0
1320,AMPD1,GO:0032264,IMP salvage,2.0
1321,AMPD1,GO:0042802,identical protein binding,2.0
1322,AMPD1,GO:0046033,AMP metabolic process,2.0
1323,AMPD1,GO:0046872,metal ion binding,2.0
1324,AMT,GO:0004047,aminomethyltransferase activity,2.0
1327,AMT,GO:0005654,nucleoplasm,2.0
1328,AMT,GO:0005739,mitochondrion,2.0
1331,AMT,GO:0005759,mitochondrial matrix,2.0
1332,AMT,GO:0006546,glycine catabolic process,2.0
1333,AMT,GO:0008483,transaminase activity,2.0
1334,AMT,GO:0019464,glycine decarboxylation via glycine cleavage system,2.0
1492,ANKRD17,GO:0000785,chromatin,2.0
1493,ANKRD17,GO:0001673,male germ cell nucleus,2.0
1494,ANKRD17,GO:0001955,blood vessel maturation,2.0
1495,ANKRD17,GO:0003682,chromatin binding,2.0
1496,ANKRD17,GO:0003723,RNA binding,2.0
1497,ANKRD17,GO:0005515,protein binding,2.0
1498,ANKRD17,GO:0005634,nucleus,2.0
1500,ANKRD17,GO:0005654,nucleoplasm,2.0
1501,ANKRD17,GO:0005737,cytoplasm,2.0
1503,ANKRD17,GO:0006275,regulation of DNA replication,2.0
1504,ANKRD17,GO:0016020,membrane,2.0
1505,ANKRD17,GO:0031965,nuclear membrane,2.0
1506,ANKRD17,GO:0042742,defense response to bacterium,2.0
1507,ANKRD17,GO:0043123,positive regulation of I-kappaB kinase/NF-kappaB signaling,2.0
1508,ANKRD17,GO:0045087,innate immune response,2.0
1510,ANKRD17,GO:0045787,positive regulation of cell cycle,2.0
1511,ANKRD17,GO:0051151,negative regulation of smooth muscle cell differentiation,2.0
1512,ANKRD17,GO:1900087,positive regulation of G1/S transition of mitotic cell cycle,2.0
1513,ANKRD17,GO:1900245,positive regulation of MDA-5 signaling pathway,2.0
1514,ANKRD17,GO:1900246,positive regulation of RIG-I signaling pathway,2.0
1515,ANKS1B,GO:0005654,nucleoplasm,2.0
1516,ANKS1B,GO:0005813,centrosome,2.0
1517,ANKS1B,GO:0005829,cytosol,2.0
1518,ANKS1B,GO:0005886,plasma membrane,2.0
1519,ANKS1B,GO:0014069,postsynaptic density,2.0
1520,ANKS1B,GO:0015030,Cajal body,2.0
1521,ANKS1B,GO:0043197,dendritic spine,2.0
1522,ANKS1B,GO:0046875,ephrin receptor binding,2.0
1524,ANKS1B,GO:0048013,ephrin receptor signaling pathway,2.0
1525,ANKS1B,GO:1900383,regulation of synaptic plasticity by receptor localization to synapse,2.0
1526,ANXA1,GO:0001533,cornified envelope,2.0
1527,ANXA1,GO:0001780,neutrophil homeostasis,2.0
1528,ANXA1,GO:0001891,phagocytic cup,2.0
1529,ANXA1,GO:0002250,adaptive immune response,2.0
1530,ANXA1,GO:0002548,monocyte chemotaxis,2.0
1531,ANXA1,GO:0002685,regulation of leukocyte migration,2.0
1533,ANXA1,GO:0005102,signaling receptor binding,2.0
1534,ANXA1,GO:0005509,calcium ion binding,2.0
1536,ANXA1,GO:0005515,protein binding,2.0
1537,ANXA1,GO:0005543,phospholipid binding,2.0
1538,ANXA1,GO:0005544,calcium-dependent phospholipid binding,2.0
1540,ANXA1,GO:0005576,extracellular region,2.0
1541,ANXA1,GO:0005615,extracellular space,2.0
1544,ANXA1,GO:0005634,nucleus,2.0
1545,ANXA1,GO:0005654,nucleoplasm,2.0
1546,ANXA1,GO:0005737,cytoplasm,2.0
1549,ANXA1,GO:0005768,endosome,2.0
1550,ANXA1,GO:0005829,cytosol,2.0
1551,ANXA1,GO:0005884,actin filament,2.0
1552,ANXA1,GO:0005886,plasma membrane,2.0
1554,ANXA1,GO:0005912,adherens junction,2.0
1555,ANXA1,GO:0005925,focal adhesion,2.0
1556,ANXA1,GO:0006909,phagocytosis,2.0
1557,ANXA1,GO:0006954,inflammatory response,2.0
1559,ANXA1,GO:0007165,signal transduction,2.0
1560,ANXA1,GO:0007166,cell surface receptor signaling pathway,2.0
1561,ANXA1,GO:0007187,"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger",2.0
1563,ANXA1,GO:0008289,lipid binding,2.0
1564,ANXA1,GO:0008360,regulation of cell shape,2.0
1566,ANXA1,GO:0009986,cell surface,2.0
1567,ANXA1,GO:0010165,response to X-ray,2.0
1568,ANXA1,GO:0014839,myoblast migration involved in skeletal muscle regeneration,2.0
1569,ANXA1,GO:0016323,basolateral plasma membrane,2.0
1570,ANXA1,GO:0016324,apical plasma membrane,2.0
1571,ANXA1,GO:0016328,lateral plasma membrane,2.0
1572,ANXA1,GO:0018149,peptide cross-linking,2.0
1573,ANXA1,GO:0019834,phospholipase A2 inhibitor activity,2.0
1575,ANXA1,GO:0019898,extrinsic component of membrane,2.0
1576,ANXA1,GO:0030073,insulin secretion,2.0
1577,ANXA1,GO:0030216,keratinocyte differentiation,2.0
1579,ANXA1,GO:0030850,prostate gland development,2.0
1580,ANXA1,GO:0031018,endocrine pancreas development,2.0
1581,ANXA1,GO:0031232,extrinsic component of external side of plasma membrane,2.0
1582,ANXA1,GO:0031313,extrinsic component of endosome membrane,2.0
1583,ANXA1,GO:0031340,positive regulation of vesicle fusion,2.0
1585,ANXA1,GO:0031394,positive regulation of prostaglandin biosynthetic process,2.0
1586,ANXA1,GO:0031514,motile cilium,2.0
1587,ANXA1,GO:0031532,actin cytoskeleton reorganization,2.0
1589,ANXA1,GO:0031901,early endosome membrane,2.0
1590,ANXA1,GO:0031982,vesicle,2.0
1591,ANXA1,GO:0032355,response to estradiol,2.0
1592,ANXA1,GO:0032508,DNA duplex unwinding,2.0
1593,ANXA1,GO:0032652,regulation of interleukin-1 production,2.0
1595,ANXA1,GO:0032717,negative regulation of interleukin-8 production,2.0
1596,ANXA1,GO:0032743,positive regulation of interleukin-2 production,2.0
1598,ANXA1,GO:0033031,positive regulation of neutrophil apoptotic process,2.0
1599,ANXA1,GO:0035924,cellular response to vascular endothelial growth factor stimulus,2.0
1601,ANXA1,GO:0042063,gliogenesis,2.0
1602,ANXA1,GO:0042102,positive regulation of T cell proliferation,2.0
1604,ANXA1,GO:0042119,neutrophil activation,2.0
1605,ANXA1,GO:0042383,sarcolemma,2.0
1606,ANXA1,GO:0043066,negative regulation of apoptotic process,2.0
1607,ANXA1,GO:0043434,response to peptide hormone,2.0
1608,ANXA1,GO:0044849,estrous cycle,2.0
1609,ANXA1,GO:0045087,innate immune response,2.0
1610,ANXA1,GO:0045627,positive regulation of T-helper 1 cell differentiation,2.0
1612,ANXA1,GO:0045629,negative regulation of T-helper 2 cell differentiation,2.0
1614,ANXA1,GO:0045920,negative regulation of exocytosis,2.0
1616,ANXA1,GO:0046632,alpha-beta T cell differentiation,2.0
1618,ANXA1,GO:0046883,regulation of hormone secretion,2.0
1620,ANXA1,GO:0048306,calcium-dependent protein binding,2.0
1621,ANXA1,GO:0050482,arachidonic acid secretion,2.0
1622,ANXA1,GO:0050727,regulation of inflammatory response,2.0
1624,ANXA1,GO:0051179,localization,2.0
1625,ANXA1,GO:0051238,sequestering of metal ion,2.0
1626,ANXA1,GO:0062023,collagen-containing extracellular matrix,2.0
1627,ANXA1,GO:0070062,extracellular exosome,2.0
1629,ANXA1,GO:0070301,cellular response to hydrogen peroxide,2.0
1630,ANXA1,GO:0070365,hepatocyte differentiation,2.0
1631,ANXA1,GO:0070459,prolactin secretion,2.0
1632,ANXA1,GO:0070555,response to interleukin-1,2.0
1633,ANXA1,GO:0071385,cellular response to glucocorticoid stimulus,2.0
1635,ANXA1,GO:0071621,granulocyte chemotaxis,2.0
1637,ANXA1,GO:0090050,positive regulation of cell migration involved in sprouting angiogenesis,2.0
1639,ANXA1,GO:0090303,positive regulation of wound healing,2.0
1641,ANXA1,GO:0097350,neutrophil clearance,2.0
1643,ANXA1,GO:0098609,cell-cell adhesion,2.0
1644,ANXA1,GO:0098641,cadherin binding involved in cell-cell adhesion,2.0
1645,ANXA1,GO:1900087,positive regulation of G1/S transition of mitotic cell cycle,2.0
1646,ANXA1,GO:1900138,negative regulation of phospholipase A2 activity,2.0
1693,APBA2,GO:0001540,amyloid-beta binding,2.0
1694,APBA2,GO:0001701,in utero embryonic development,2.0
1695,APBA2,GO:0005515,protein binding,2.0
1696,APBA2,GO:0005737,cytoplasm,2.0
1697,APBA2,GO:0005886,plasma membrane,2.0
1698,APBA2,GO:0007268,chemical synaptic transmission,2.0
1699,APBA2,GO:0007399,nervous system development,2.0
1700,APBA2,GO:0007626,locomotory behavior,2.0
1701,APBA2,GO:0008021,synaptic vesicle,2.0
1702,APBA2,GO:0010468,regulation of gene expression,2.0
1703,APBA2,GO:0015031,protein transport,2.0
1704,APBA2,GO:0035264,multicellular organism growth,2.0
1705,APBA2,GO:0042802,identical protein binding,2.0
1706,APBA2,GO:0043197,dendritic spine,2.0
1707,APBA2,GO:0098685,Schaffer collateral - CA1 synapse,2.0
1708,APBA2,GO:0099171,presynaptic modulation of chemical synaptic transmission,2.0
1709,APBB1,GO:0000122,negative regulation of transcription by RNA polymerase II,2.0
1710,APBB1,GO:0001540,amyloid-beta binding,2.0
1711,APBB1,GO:0003682,chromatin binding,2.0
1712,APBB1,GO:0003713,transcription coactivator activity,2.0
1713,APBB1,GO:0005515,protein binding,2.0
1714,APBB1,GO:0005634,nucleus,2.0
1717,APBB1,GO:0005654,nucleoplasm,2.0
1718,APBB1,GO:0005737,cytoplasm,2.0
1720,APBB1,GO:0005783,endoplasmic reticulum,2.0
1721,APBB1,GO:0005886,plasma membrane,2.0
1722,APBB1,GO:0006325,chromatin organization,2.0
1723,APBB1,GO:0006355,regulation of DNA-templated transcription,2.0
1724,APBB1,GO:0006915,apoptotic process,2.0
1725,APBB1,GO:0006939,smooth muscle contraction,2.0
1726,APBB1,GO:0006974,cellular response to DNA damage stimulus,2.0
1727,APBB1,GO:0007165,signal transduction,2.0
1728,APBB1,GO:0007409,axonogenesis,2.0
1729,APBB1,GO:0008134,transcription factor binding,2.0
1730,APBB1,GO:0016607,nuclear speck,2.0
1731,APBB1,GO:0030027,lamellipodium,2.0
1732,APBB1,GO:0030426,growth cone,2.0
1733,APBB1,GO:0031625,ubiquitin protein ligase binding,2.0
1734,APBB1,GO:0042393,histone binding,2.0
1735,APBB1,GO:0043065,positive regulation of apoptotic process,2.0
1736,APBB1,GO:0043967,histone H4 acetylation,2.0
1737,APBB1,GO:0045202,synapse,2.0
1738,APBB1,GO:0045893,positive regulation of DNA-templated transcription,2.0
1739,APBB1,GO:0045944,positive regulation of transcription by RNA polymerase II,2.0
1740,APBB1,GO:0050714,positive regulation of protein secretion,2.0
1741,APBB1,GO:0050750,low-density lipoprotein particle receptor binding,2.0
1742,APBB1,GO:0070064,proline-rich region binding,2.0
1743,APBB1,GO:1902807,negative regulation of cell cycle G1/S phase transition,2.0
1744,APH1A,GO:0001656,metanephros development,2.0
1745,APH1A,GO:0005515,protein binding,2.0
1746,APH1A,GO:0005739,mitochondrion,2.0
1747,APH1A,GO:0005769,early endosome,2.0
1748,APH1A,GO:0005783,endoplasmic reticulum,2.0
1750,APH1A,GO:0005789,endoplasmic reticulum membrane,2.0
1751,APH1A,GO:0005794,Golgi apparatus,2.0
1752,APH1A,GO:0005886,plasma membrane,2.0
1754,APH1A,GO:0006509,membrane protein ectodomain proteolysis,2.0
1755,APH1A,GO:0007219,Notch signaling pathway,2.0
1756,APH1A,GO:0007220,Notch receptor processing,2.0
1761,APH1A,GO:0008021,synaptic vesicle,2.0
1762,APH1A,GO:0010008,endosome membrane,2.0
1763,APH1A,GO:0010950,positive regulation of endopeptidase activity,2.0
1765,APH1A,GO:0016020,membrane,2.0
1768,APH1A,GO:0016485,protein processing,2.0
1772,APH1A,GO:0019899,enzyme binding,2.0
1773,APH1A,GO:0030674,protein-macromolecule adaptor activity,2.0
1775,APH1A,GO:0031293,membrane protein intracellular domain proteolysis,2.0
1778,APH1A,GO:0032580,Golgi cisterna membrane,2.0
1779,APH1A,GO:0034205,amyloid-beta formation,2.0
1782,APH1A,GO:0042734,presynaptic membrane,2.0
1783,APH1A,GO:0042982,amyloid precursor protein metabolic process,2.0
1784,APH1A,GO:0042987,amyloid precursor protein catabolic process,2.0
1789,APH1A,GO:0043085,positive regulation of catalytic activity,2.0
1790,APH1A,GO:0061133,endopeptidase activator activity,2.0
1792,APH1A,GO:0070765,gamma-secretase complex,2.0
1796,ARHGAP11B,GO:0005096,GTPase activator activity,2.0
1798,ARHGAP11B,GO:0005515,protein binding,2.0
1799,ARHGAP11B,GO:0005759,mitochondrial matrix,2.0
1800,ARHGAP11B,GO:0005829,cytosol,2.0
1801,ARHGAP11B,GO:0006543,glutamine catabolic process,2.0
1802,ARHGAP11B,GO:0007165,signal transduction,2.0
1803,ARHGAP11B,GO:0021987,cerebral cortex development,2.0
1804,ARHGAP11B,GO:0035795,negative regulation of mitochondrial membrane permeability,2.0
1805,ARHGAP11B,GO:0043547,positive regulation of GTPase activity,2.0
1806,ARHGAP11B,GO:0051056,regulation of small GTPase mediated signal transduction,2.0
1807,ARHGAP32,GO:0000139,Golgi membrane,2.0
1808,ARHGAP32,GO:0001650,fibrillar center,2.0
1810,ARHGAP32,GO:0005096,GTPase activator activity,2.0
1812,ARHGAP32,GO:0005515,protein binding,2.0
1813,ARHGAP32,GO:0005654,nucleoplasm,2.0
1815,ARHGAP32,GO:0005789,endoplasmic reticulum membrane,2.0
1816,ARHGAP32,GO:0005794,Golgi apparatus,2.0
1818,ARHGAP32,GO:0005829,cytosol,2.0
1819,ARHGAP32,GO:0005938,cell cortex,2.0
1820,ARHGAP32,GO:0007264,small GTPase mediated signal transduction,2.0
1821,ARHGAP32,GO:0010008,endosome membrane,2.0
1822,ARHGAP32,GO:0014069,postsynaptic density,2.0
1823,ARHGAP32,GO:0015629,actin cytoskeleton,2.0
1824,ARHGAP32,GO:0043197,dendritic spine,2.0
1825,ARHGAP32,GO:0050790,regulation of catalytic activity,2.0
1826,ARHGAP32,GO:0051056,regulation of small GTPase mediated signal transduction,2.0
1827,ARHGAP32,GO:1901981,phosphatidylinositol phosphate binding,2.0
1828,ARHGAP5,GO:0003924,GTPase activity,2.0
1829,ARHGAP5,GO:0005096,GTPase activator activity,2.0
1831,ARHGAP5,GO:0005515,protein binding,2.0
1832,ARHGAP5,GO:0005525,GTP binding,2.0
1833,ARHGAP5,GO:0005737,cytoplasm,2.0
1834,ARHGAP5,GO:0005783,endoplasmic reticulum,2.0
1835,ARHGAP5,GO:0005829,cytosol,2.0
1838,ARHGAP5,GO:0005886,plasma membrane,2.0
1839,ARHGAP5,GO:0007155,cell adhesion,2.0
1840,ARHGAP5,GO:0007266,Rho protein signal transduction,2.0
1841,ARHGAP5,GO:0008361,regulation of cell size,2.0
1842,ARHGAP5,GO:0030879,mammary gland development,2.0
1843,ARHGAP5,GO:0042169,SH2 domain binding,2.0
1844,ARHGAP5,GO:0050790,regulation of catalytic activity,2.0
1845,ARHGAP5,GO:0051056,regulation of small GTPase mediated signal transduction,2.0
1846,ARHGEF10,GO:0005085,guanyl-nucleotide exchange factor activity,2.0
1848,ARHGEF10,GO:0005515,protein binding,2.0
1849,ARHGEF10,GO:0005813,centrosome,2.0
1851,ARHGEF10,GO:0005829,cytosol,2.0
1853,ARHGEF10,GO:0019894,kinesin binding,2.0
1854,ARHGEF10,GO:0022011,myelination in peripheral nervous system,2.0
1855,ARHGEF10,GO:0030036,actin cytoskeleton organization,2.0
1856,ARHGEF10,GO:0035023,regulation of Rho protein signal transduction,2.0
1857,ARHGEF10,GO:0051056,regulation of small GTPase mediated signal transduction,2.0
1858,ARHGEF10,GO:0051298,centrosome duplication,2.0
1859,ARHGEF10,GO:0051496,positive regulation of stress fiber assembly,2.0
1861,ARHGEF10,GO:0090307,mitotic spindle assembly,2.0
1863,ARHGEF10,GO:0090630,activation of GTPase activity,2.0
1957,ARID2,GO:0000776,kinetochore,2.0
1958,ARID2,GO:0000785,chromatin,2.0
1959,ARID2,GO:0003007,heart morphogenesis,2.0
1960,ARID2,GO:0003677,DNA binding,2.0
1961,ARID2,GO:0005515,protein binding,2.0
1962,ARID2,GO:0005654,nucleoplasm,2.0
1963,ARID2,GO:0005886,plasma membrane,2.0
1964,ARID2,GO:0006337,nucleosome disassembly,2.0
1965,ARID2,GO:0006338,chromatin remodeling,2.0
1966,ARID2,GO:0006357,regulation of transcription by RNA polymerase II,2.0
1967,ARID2,GO:0008285,negative regulation of cell population proliferation,2.0
1968,ARID2,GO:0016363,nuclear matrix,2.0
1969,ARID2,GO:0016514,SWI/SNF complex,2.0
1970,ARID2,GO:0016586,RSC-type complex,2.0
1971,ARID2,GO:0030071,regulation of mitotic metaphase/anaphase transition,2.0
1972,ARID2,GO:0030336,negative regulation of cell migration,2.0
1973,ARID2,GO:0042592,homeostatic process,2.0
1974,ARID2,GO:0045582,positive regulation of T cell differentiation,2.0
1975,ARID2,GO:0045597,positive regulation of cell differentiation,2.0
1976,ARID2,GO:0045663,positive regulation of myoblast differentiation,2.0
1977,ARID2,GO:0046872,metal ion binding,2.0
1978,ARID2,GO:0048568,embryonic organ development,2.0
1979,ARID2,GO:0060038,cardiac muscle cell proliferation,2.0
1980,ARID2,GO:0060982,coronary artery morphogenesis,2.0
1981,ARID2,GO:0070316,regulation of G0 to G1 transition,2.0
1982,ARID2,GO:0070603,SWI/SNF superfamily-type complex,2.0
1983,ARID2,GO:1905168,positive regulation of double-strand break repair via homologous recombination,2.0
1984,ARID2,GO:2000045,regulation of G1/S transition of mitotic cell cycle,2.0
1985,ARID2,GO:2000781,positive regulation of double-strand break repair,2.0
1986,ARID2,GO:2000819,regulation of nucleotide-excision repair,2.0
1987,ARNT2,GO:0000785,chromatin,2.0
1988,ARNT2,GO:0000978,RNA polymerase II cis-regulatory region sequence-specific DNA binding,2.0
1989,ARNT2,GO:0000981,"DNA-binding transcription factor activity, RNA polymerase II-specific",2.0
1992,ARNT2,GO:0001228,"DNA-binding transcription activator activity, RNA polymerase II-specific",2.0
1993,ARNT2,GO:0001666,response to hypoxia,2.0
1994,ARNT2,GO:0001701,in utero embryonic development,2.0
1995,ARNT2,GO:0003700,DNA-binding transcription factor activity,2.0
1996,ARNT2,GO:0005515,protein binding,2.0
1997,ARNT2,GO:0005634,nucleus,2.0
1999,ARNT2,GO:0005654,nucleoplasm,2.0
2001,ARNT2,GO:0005667,transcription regulator complex,2.0
2002,ARNT2,GO:0005737,cytoplasm,2.0
2003,ARNT2,GO:0006355,regulation of DNA-templated transcription,2.0
2004,ARNT2,GO:0006357,regulation of transcription by RNA polymerase II,2.0
2005,ARNT2,GO:0007417,central nervous system development,2.0
2006,ARNT2,GO:0007420,brain development,2.0
2007,ARNT2,GO:0017162,aryl hydrocarbon receptor binding,2.0
2008,ARNT2,GO:0034751,aryl hydrocarbon receptor complex,2.0
2009,ARNT2,GO:0045893,positive regulation of DNA-templated transcription,2.0
2010,ARNT2,GO:0045944,positive regulation of transcription by RNA polymerase II,2.0
2011,ARNT2,GO:0046982,protein heterodimerization activity,2.0
2014,ARNT2,GO:1990837,sequence-specific double-stranded DNA binding,2.0
2044,ASAP2,GO:0005096,GTPase activator activity,2.0
2045,ASAP2,GO:0005515,protein binding,2.0
2046,ASAP2,GO:0005886,plasma membrane,2.0
2047,ASAP2,GO:0032580,Golgi cisterna membrane,2.0
2048,ASAP2,GO:0043547,positive regulation of GTPase activity,2.0
2049,ASAP2,GO:0046872,metal ion binding,2.0
2050,ASB14,GO:0005829,cytosol,2.0
2051,ASB14,GO:0016567,protein ubiquitination,2.0
2052,ASB14,GO:0035556,intracellular signal transduction,2.0
2088,ASMT,GO:0005829,cytosol,2.0
2089,ASMT,GO:0006412,translation,2.0
2090,ASMT,GO:0006629,lipid metabolic process,2.0
2091,ASMT,GO:0008171,O-methyltransferase activity,2.0
2092,ASMT,GO:0008172,S-methyltransferase activity,2.0
2093,ASMT,GO:0008757,S-adenosylmethionine-dependent methyltransferase activity,2.0
2094,ASMT,GO:0017096,acetylserotonin O-methyltransferase activity,2.0
2096,ASMT,GO:0019438,aromatic compound biosynthetic process,2.0
2097,ASMT,GO:0030187,melatonin biosynthetic process,2.0
2100,ASMT,GO:0032259,methylation,2.0
2101,ASMT,GO:0042802,identical protein binding,2.0
2102,ASMT,GO:0042803,protein homodimerization activity,2.0
2103,ASMT,GO:0046219,indolalkylamine biosynthetic process,2.0
2104,ASPM,GO:0001764,neuron migration,2.0
2105,ASPM,GO:0002052,positive regulation of neuroblast proliferation,2.0
2106,ASPM,GO:0005516,calmodulin binding,2.0
2107,ASPM,GO:0005634,nucleus,2.0
2108,ASPM,GO:0005737,cytoplasm,2.0
2109,ASPM,GO:0005813,centrosome,2.0
2110,ASPM,GO:0007051,spindle organization,2.0
2111,ASPM,GO:0007283,spermatogenesis,2.0
2112,ASPM,GO:0008356,asymmetric cell division,2.0
2113,ASPM,GO:0008584,male gonad development,2.0
2114,ASPM,GO:0016324,apical plasma membrane,2.0
2115,ASPM,GO:0021873,forebrain neuroblast division,2.0
2116,ASPM,GO:0021987,cerebral cortex development,2.0
2117,ASPM,GO:0030496,midbody,2.0
2118,ASPM,GO:0036449,microtubule minus-end,2.0
2119,ASPM,GO:0045665,negative regulation of neuron differentiation,2.0
2120,ASPM,GO:0045769,negative regulation of asymmetric cell division,2.0
2121,ASPM,GO:0048477,oogenesis,2.0
2122,ASPM,GO:0048589,developmental growth,2.0
2123,ASPM,GO:0051445,regulation of meiotic cell cycle,2.0
2124,ASPM,GO:0051653,spindle localization,2.0
2125,ASPM,GO:0051661,maintenance of centrosome location,2.0
2126,ASPM,GO:0072687,meiotic spindle,2.0
2127,ASPM,GO:0090263,positive regulation of canonical Wnt signaling pathway,2.0
2128,ASPM,GO:0090306,meiotic spindle assembly,2.0
2129,ASPM,GO:0097150,neuronal stem cell population maintenance,2.0
2130,ASPM,GO:0097431,mitotic spindle pole,2.0
2131,ASTN2,GO:0001764,neuron migration,2.0
2132,ASTN2,GO:0005509,calcium ion binding,2.0
2133,ASTN2,GO:0005768,endosome,2.0
2134,ASTN2,GO:0005769,early endosome,2.0
2135,ASTN2,GO:0005770,late endosome,2.0
2136,ASTN2,GO:0005938,cell cortex,2.0
2137,ASTN2,GO:0007158,neuron cell-cell adhesion,2.0
2138,ASTN2,GO:0015031,protein transport,2.0
2139,ASTN2,GO:0016020,membrane,2.0
2140,ASTN2,GO:0030136,clathrin-coated vesicle,2.0
2141,ASTN2,GO:0034394,protein localization to cell surface,2.0
2142,ASTN2,GO:0043204,perikaryon,2.0
2143,ASTN2,GO:0043533,"inositol 1,3,4,5 tetrakisphosphate binding",2.0
2145,ASTN2,GO:0048105,establishment of body hair planar orientation,2.0
2146,ASTN2,GO:0060187,cell pole,2.0
2147,ASTN2,GO:2000009,negative regulation of protein localization to cell surface,2.0
2156,ADORA2A,GO:0001609,G protein-coupled adenosine receptor activity,2.0
2158,ADORA2A,GO:0001963,"synaptic transmission, dopaminergic",2.0
2159,ADORA2A,GO:0001973,G protein-coupled adenosine receptor signaling pathway,2.0
2160,ADORA2A,GO:0001975,response to amphetamine,2.0
2161,ADORA2A,GO:0004930,G protein-coupled receptor activity,2.0
2162,ADORA2A,GO:0005515,protein binding,2.0
2163,ADORA2A,GO:0005882,intermediate filament,2.0
2164,ADORA2A,GO:0005886,plasma membrane,2.0
2169,ADORA2A,GO:0006355,regulation of DNA-templated transcription,2.0
2170,ADORA2A,GO:0006469,negative regulation of protein kinase activity,2.0
2171,ADORA2A,GO:0006909,phagocytosis,2.0
2172,ADORA2A,GO:0006915,apoptotic process,2.0
2173,ADORA2A,GO:0006954,inflammatory response,2.0
2174,ADORA2A,GO:0006968,cellular defense response,2.0
2175,ADORA2A,GO:0007186,G protein-coupled receptor signaling pathway,2.0
2176,ADORA2A,GO:0007188,adenylate cyclase-modulating G protein-coupled receptor signaling pathway,2.0
2177,ADORA2A,GO:0007189,adenylate cyclase-activating G protein-coupled receptor signaling pathway,2.0
2179,ADORA2A,GO:0007205,protein kinase C-activating G protein-coupled receptor signaling pathway,2.0
2180,ADORA2A,GO:0007267,cell-cell signaling,2.0
2181,ADORA2A,GO:0007271,"synaptic transmission, cholinergic",2.0
2182,ADORA2A,GO:0007417,central nervous system development,2.0
2183,ADORA2A,GO:0007596,blood coagulation,2.0
2184,ADORA2A,GO:0007600,sensory perception,2.0
2185,ADORA2A,GO:0007626,locomotory behavior,2.0
2186,ADORA2A,GO:0008015,blood circulation,2.0
2187,ADORA2A,GO:0008285,negative regulation of cell population proliferation,2.0
2188,ADORA2A,GO:0008289,lipid binding,2.0
2189,ADORA2A,GO:0009410,response to xenobiotic stimulus,2.0
2190,ADORA2A,GO:0010035,response to inorganic substance,2.0
2191,ADORA2A,GO:0012505,endomembrane system,2.0
2192,ADORA2A,GO:0014049,positive regulation of glutamate secretion,2.0
2193,ADORA2A,GO:0014057,"positive regulation of acetylcholine secretion, neurotransmission",2.0
2194,ADORA2A,GO:0014061,regulation of norepinephrine secretion,2.0
2195,ADORA2A,GO:0014069,postsynaptic density,2.0
2196,ADORA2A,GO:0014074,response to purine-containing compound,2.0
2197,ADORA2A,GO:0016020,membrane,2.0
2198,ADORA2A,GO:0019899,enzyme binding,2.0
2199,ADORA2A,GO:0030425,dendrite,2.0
2200,ADORA2A,GO:0030673,axolemma,2.0
2201,ADORA2A,GO:0031000,response to caffeine,2.0
2202,ADORA2A,GO:0031802,type 5 metabotropic glutamate receptor binding,2.0
2203,ADORA2A,GO:0032230,"positive regulation of synaptic transmission, GABAergic",2.0
2204,ADORA2A,GO:0035249,"synaptic transmission, glutamatergic",2.0
2205,ADORA2A,GO:0035810,positive regulation of urine volume,2.0
2206,ADORA2A,GO:0035815,positive regulation of renal sodium excretion,2.0
2207,ADORA2A,GO:0040013,negative regulation of locomotion,2.0
2208,ADORA2A,GO:0042311,vasodilation,2.0
2209,ADORA2A,GO:0042734,presynaptic membrane,2.0
2210,ADORA2A,GO:0042755,eating behavior,2.0
2211,ADORA2A,GO:0042802,identical protein binding,2.0
2212,ADORA2A,GO:0043025,neuronal cell body,2.0
2213,ADORA2A,GO:0043116,negative regulation of vascular permeability,2.0
2214,ADORA2A,GO:0043154,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process,2.0
2215,ADORA2A,GO:0043524,negative regulation of neuron apoptotic process,2.0
2216,ADORA2A,GO:0044877,protein-containing complex binding,2.0
2217,ADORA2A,GO:0045211,postsynaptic membrane,2.0
2218,ADORA2A,GO:0045938,"positive regulation of circadian sleep/wake cycle, sleep",2.0
2219,ADORA2A,GO:0046636,negative regulation of alpha-beta T cell activation,2.0
2220,ADORA2A,GO:0048143,astrocyte activation,2.0
2221,ADORA2A,GO:0048786,presynaptic active zone,2.0
2222,ADORA2A,GO:0048812,neuron projection morphogenesis,2.0
2223,ADORA2A,GO:0050714,positive regulation of protein secretion,2.0
2224,ADORA2A,GO:0050728,negative regulation of inflammatory response,2.0
2225,ADORA2A,GO:0051393,alpha-actinin binding,2.0
2226,ADORA2A,GO:0051881,regulation of mitochondrial membrane potential,2.0
2227,ADORA2A,GO:0051899,membrane depolarization,2.0
2228,ADORA2A,GO:0051924,regulation of calcium ion transport,2.0
2229,ADORA2A,GO:0051968,"positive regulation of synaptic transmission, glutamatergic",2.0
2230,ADORA2A,GO:0060079,excitatory postsynaptic potential,2.0
2231,ADORA2A,GO:0060080,inhibitory postsynaptic potential,2.0
2232,ADORA2A,GO:0060134,prepulse inhibition,2.0
2233,ADORA2A,GO:0097190,apoptotic signaling pathway,2.0
2234,ADORA2A,GO:0098978,glutamatergic synapse,2.0
2235,ADORA2A,GO:0099171,presynaptic modulation of chemical synaptic transmission,2.0
2236,ADORA2A,GO:1900273,positive regulation of long-term synaptic potentiation,2.0
2237,ADORA2A,GO:2001235,positive regulation of apoptotic signaling pathway,2.0
2238,ADRB2,GO:0001540,amyloid-beta binding,2.0
2239,ADRB2,GO:0002024,diet induced thermogenesis,2.0
2240,ADRB2,GO:0002025,norepinephrine-epinephrine-mediated vasodilation involved in regulation of systemic arterial blood pressure,2.0
2241,ADRB2,GO:0002028,regulation of sodium ion transport,2.0
2242,ADRB2,GO:0002032,desensitization of G protein-coupled receptor signaling pathway by arrestin,2.0
2243,ADRB2,GO:0004930,G protein-coupled receptor activity,2.0
2244,ADRB2,GO:0004941,beta2-adrenergic receptor activity,2.0
2247,ADRB2,GO:0005515,protein binding,2.0
2248,ADRB2,GO:0005634,nucleus,2.0
2249,ADRB2,GO:0005764,lysosome,2.0
2250,ADRB2,GO:0005768,endosome,2.0
2251,ADRB2,GO:0005769,early endosome,2.0
2252,ADRB2,GO:0005794,Golgi apparatus,2.0
2253,ADRB2,GO:0005886,plasma membrane,2.0
2256,ADRB2,GO:0006366,transcription by RNA polymerase II,2.0
2257,ADRB2,GO:0006898,receptor-mediated endocytosis,2.0
2258,ADRB2,GO:0006939,smooth muscle contraction,2.0
2259,ADRB2,GO:0007166,cell surface receptor signaling pathway,2.0
2260,ADRB2,GO:0007171,activation of transmembrane receptor protein tyrosine kinase activity,2.0
2261,ADRB2,GO:0007188,adenylate cyclase-modulating G protein-coupled receptor signaling pathway,2.0
2262,ADRB2,GO:0007190,activation of adenylate cyclase activity,2.0
2263,ADRB2,GO:0008179,adenylate cyclase binding,2.0
2264,ADRB2,GO:0008333,endosome to lysosome transport,2.0
2265,ADRB2,GO:0009409,response to cold,2.0
2266,ADRB2,GO:0010008,endosome membrane,2.0
2267,ADRB2,GO:0010739,positive regulation of protein kinase A signaling,2.0
2268,ADRB2,GO:0015459,potassium channel regulator activity,2.0
2269,ADRB2,GO:0016020,membrane,2.0
2270,ADRB2,GO:0016324,apical plasma membrane,2.0
2271,ADRB2,GO:0030501,positive regulation of bone mineralization,2.0
2272,ADRB2,GO:0030669,clathrin-coated endocytic vesicle membrane,2.0
2273,ADRB2,GO:0031649,heat generation,2.0
2274,ADRB2,GO:0040015,negative regulation of multicellular organism growth,2.0
2275,ADRB2,GO:0042802,identical protein binding,2.0
2276,ADRB2,GO:0042803,protein homodimerization activity,2.0
2277,ADRB2,GO:0043235,receptor complex,2.0
2278,ADRB2,GO:0043410,positive regulation of MAPK cascade,2.0
2279,ADRB2,GO:0044877,protein-containing complex binding,2.0
2280,ADRB2,GO:0045453,bone resorption,2.0
2281,ADRB2,GO:0045944,positive regulation of transcription by RNA polymerase II,2.0
2282,ADRB2,GO:0045986,negative regulation of smooth muscle contraction,2.0
2283,ADRB2,GO:0050873,brown fat cell differentiation,2.0
2284,ADRB2,GO:0051380,norepinephrine binding,2.0
2286,ADRB2,GO:0061885,positive regulation of mini excitatory postsynaptic potential,2.0
2287,ADRB2,GO:0071875,adrenergic receptor signaling pathway,2.0
2288,ADRB2,GO:0071880,adenylate cyclase-activating adrenergic receptor signaling pathway,2.0
2289,ADRB2,GO:0071902,positive regulation of protein serine/threonine kinase activity,2.0
2290,ADRB2,GO:0098992,neuronal dense core vesicle,2.0
2291,ADRB2,GO:0120162,positive regulation of cold-induced thermogenesis,2.0
2292,ADRB2,GO:1901098,positive regulation of autophagosome maturation,2.0
2293,ADRB2,GO:1904504,positive regulation of lipophagy,2.0
2294,ADRB2,GO:1904646,cellular response to amyloid-beta,2.0
2295,ADRB2,GO:1990911,response to psychosocial stress,2.0
2296,ADRB2,GO:2000481,positive regulation of cAMP-dependent protein kinase activity,2.0
2297,ADRB2,GO:2000969,positive regulation of AMPA receptor activity,2.0
2298,AR,GO:0000122,negative regulation of transcription by RNA polymerase II,2.0
2299,AR,GO:0000165,MAPK cascade,2.0
2300,AR,GO:0000785,chromatin,2.0
2302,AR,GO:0000976,transcription cis-regulatory region binding,2.0
2303,AR,GO:0000978,RNA polymerase II cis-regulatory region sequence-specific DNA binding,2.0
2305,AR,GO:0000981,"DNA-binding transcription factor activity, RNA polymerase II-specific",2.0
2306,AR,GO:0001091,RNA polymerase II general transcription initiation factor binding,2.0
2307,AR,GO:0001223,transcription coactivator binding,2.0
2309,AR,GO:0001228,"DNA-binding transcription activator activity, RNA polymerase II-specific",2.0
2310,AR,GO:0001701,in utero embryonic development,2.0
2311,AR,GO:0003073,regulation of systemic arterial blood pressure,2.0
2312,AR,GO:0003382,epithelial cell morphogenesis,2.0
2313,AR,GO:0003682,chromatin binding,2.0
2314,AR,GO:0003700,DNA-binding transcription factor activity,2.0
2315,AR,GO:0004879,nuclear receptor activity,2.0
2319,AR,GO:0005102,signaling receptor binding,2.0
2320,AR,GO:0005496,steroid binding,2.0
2321,AR,GO:0005497,androgen binding,2.0
2322,AR,GO:0005515,protein binding,2.0
2323,AR,GO:0005634,nucleus,2.0
2324,AR,GO:0005654,nucleoplasm,2.0
2325,AR,GO:0005737,cytoplasm,2.0
2326,AR,GO:0005829,cytosol,2.0
2328,AR,GO:0005886,plasma membrane,2.0
2329,AR,GO:0006357,regulation of transcription by RNA polymerase II,2.0
2330,AR,GO:0006366,transcription by RNA polymerase II,2.0
2331,AR,GO:0007165,signal transduction,2.0
2332,AR,GO:0007267,cell-cell signaling,2.0
2333,AR,GO:0007283,spermatogenesis,2.0
2334,AR,GO:0007338,single fertilization,2.0
2335,AR,GO:0008013,beta-catenin binding,2.0
2338,AR,GO:0008270,zinc ion binding,2.0
2339,AR,GO:0008284,positive regulation of cell population proliferation,2.0
2340,AR,GO:0008285,negative regulation of cell population proliferation,2.0
2341,AR,GO:0008584,male gonad development,2.0
2342,AR,GO:0010628,positive regulation of gene expression,2.0
2344,AR,GO:0016607,nuclear speck,2.0
2345,AR,GO:0019102,male somatic sex determination,2.0
2346,AR,GO:0019899,enzyme binding,2.0
2347,AR,GO:0030518,intracellular steroid hormone receptor signaling pathway,2.0
2348,AR,GO:0030520,intracellular estrogen receptor signaling pathway,2.0
2349,AR,GO:0030521,androgen receptor signaling pathway,2.0
2350,AR,GO:0030522,intracellular receptor signaling pathway,2.0
2351,AR,GO:0032991,protein-containing complex,2.0
2352,AR,GO:0033148,positive regulation of intracellular estrogen receptor signaling pathway,2.0
2353,AR,GO:0033327,Leydig cell differentiation,2.0
2354,AR,GO:0035264,multicellular organism growth,2.0
2355,AR,GO:0042327,positive regulation of phosphorylation,2.0
2356,AR,GO:0043410,positive regulation of MAPK cascade,2.0
2357,AR,GO:0043568,positive regulation of insulin-like growth factor receptor signaling pathway,2.0
2358,AR,GO:0045597,positive regulation of cell differentiation,2.0
2359,AR,GO:0045720,negative regulation of integrin biosynthetic process,2.0
2360,AR,GO:0045726,positive regulation of integrin biosynthetic process,2.0
2361,AR,GO:0045893,positive regulation of DNA-templated transcription,2.0
2362,AR,GO:0045944,positive regulation of transcription by RNA polymerase II,2.0
2364,AR,GO:0045945,positive regulation of transcription by RNA polymerase III,2.0
2365,AR,GO:0048009,insulin-like growth factor receptor signaling pathway,2.0
2366,AR,GO:0048638,regulation of developmental growth,2.0
2367,AR,GO:0048645,animal organ formation,2.0
2368,AR,GO:0048808,male genitalia morphogenesis,2.0
2369,AR,GO:0050673,epithelial cell proliferation,2.0
2370,AR,GO:0050680,negative regulation of epithelial cell proliferation,2.0
2371,AR,GO:0051092,positive regulation of NF-kappaB transcription factor activity,2.0
2372,AR,GO:0051117,ATPase binding,2.0
2373,AR,GO:0060090,molecular adaptor activity,2.0
2374,AR,GO:0060520,activation of prostate induction by androgen receptor signaling pathway,2.0
2375,AR,GO:0060571,morphogenesis of an epithelial fold,2.0
2376,AR,GO:0060599,lateral sprouting involved in mammary gland duct morphogenesis,2.0
2377,AR,GO:0060736,prostate gland growth,2.0
2378,AR,GO:0060740,prostate gland epithelium morphogenesis,2.0
2379,AR,GO:0060742,epithelial cell differentiation involved in prostate gland development,2.0
2380,AR,GO:0060748,tertiary branching involved in mammary gland duct morphogenesis,2.0
2381,AR,GO:0060749,mammary gland alveolus development,2.0
2382,AR,GO:0060769,positive regulation of epithelial cell proliferation involved in prostate gland development,2.0
2383,AR,GO:0061629,RNA polymerase II-specific DNA-binding transcription factor binding,2.0
2384,AR,GO:0070974,POU domain binding,2.0
2385,AR,GO:0071383,cellular response to steroid hormone stimulus,2.0
2386,AR,GO:0071391,cellular response to estrogen stimulus,2.0
2387,AR,GO:0071394,cellular response to testosterone stimulus,2.0
2388,AR,GO:0072520,seminiferous tubule development,2.0
2389,AR,GO:1902895,positive regulation of miRNA transcription,2.0
2390,AR,GO:1903076,regulation of protein localization to plasma membrane,2.0
2391,AR,GO:2001237,negative regulation of extrinsic apoptotic signaling pathway,2.0
2392,ATP10A,GO:0000287,magnesium ion binding,2.0
2393,ATP10A,GO:0005515,protein binding,2.0
2394,ATP10A,GO:0005524,ATP binding,2.0
2395,ATP10A,GO:0005783,endoplasmic reticulum,2.0
2396,ATP10A,GO:0005789,endoplasmic reticulum membrane,2.0
2397,ATP10A,GO:0005886,plasma membrane,2.0
2400,ATP10A,GO:0008360,regulation of cell shape,2.0
2401,ATP10A,GO:0016020,membrane,2.0
2402,ATP10A,GO:0016887,ATP hydrolysis activity,2.0
2403,ATP10A,GO:0034220,ion transmembrane transport,2.0
2404,ATP10A,GO:0045332,phospholipid translocation,2.0
2406,ATP10A,GO:0090554,phosphatidylcholine floppase activity,2.0
2407,ATP10A,GO:0140326,ATPase-coupled intramembrane lipid transporter activity,2.0
2410,ATP10A,GO:0140345,phosphatidylcholine flippase activity,2.0
2411,ATP10A,GO:0140351,glycosylceramide flippase activity,2.0
2412,ATP10A,GO:1903527,positive regulation of membrane tubulation,2.0
2413,ATP10A,GO:1990531,phospholipid-translocating ATPase complex,2.0
2415,ATP1A1,GO:0002026,regulation of the force of heart contraction,2.0
2416,ATP1A1,GO:0002028,regulation of sodium ion transport,2.0
2417,ATP1A1,GO:0005391,P-type sodium:potassium-exchanging transporter activity,2.0
2421,ATP1A1,GO:0005515,protein binding,2.0
2422,ATP1A1,GO:0005524,ATP binding,2.0
2423,ATP1A1,GO:0005783,endoplasmic reticulum,2.0
2424,ATP1A1,GO:0005794,Golgi apparatus,2.0
2425,ATP1A1,GO:0005886,plasma membrane,2.0
2430,ATP1A1,GO:0005890,sodium:potassium-exchanging ATPase complex,2.0
2435,ATP1A1,GO:0006883,cellular sodium ion homeostasis,2.0
2438,ATP1A1,GO:0008217,regulation of blood pressure,2.0
2439,ATP1A1,GO:0009410,response to xenobiotic stimulus,2.0
2440,ATP1A1,GO:0010248,establishment or maintenance of transmembrane electrochemical gradient,2.0
2441,ATP1A1,GO:0014069,postsynaptic density,2.0
2442,ATP1A1,GO:0016020,membrane,2.0
2443,ATP1A1,GO:0016323,basolateral plasma membrane,2.0
2444,ATP1A1,GO:0016324,apical plasma membrane,2.0
2445,ATP1A1,GO:0016328,lateral plasma membrane,2.0
2446,ATP1A1,GO:0016791,phosphatase activity,2.0
2447,ATP1A1,GO:0016887,ATP hydrolysis activity,2.0
2448,ATP1A1,GO:0019829,ATPase-coupled cation transmembrane transporter activity,2.0
2449,ATP1A1,GO:0030007,cellular potassium ion homeostasis,2.0
2452,ATP1A1,GO:0030315,T-tubule,2.0
2453,ATP1A1,GO:0030424,axon,2.0
2454,ATP1A1,GO:0030955,potassium ion binding,2.0
2455,ATP1A1,GO:0031090,organelle membrane,2.0
2456,ATP1A1,GO:0031402,sodium ion binding,2.0
2457,ATP1A1,GO:0031947,negative regulation of glucocorticoid biosynthetic process,2.0
2458,ATP1A1,GO:0032991,protein-containing complex,2.0
2459,ATP1A1,GO:0036126,sperm flagellum,2.0
2460,ATP1A1,GO:0036376,sodium ion export across plasma membrane,2.0
2464,ATP1A1,GO:0042383,sarcolemma,2.0
2466,ATP1A1,GO:0042470,melanosome,2.0
2467,ATP1A1,GO:0045121,membrane raft,2.0
2468,ATP1A1,GO:0045822,negative regulation of heart contraction,2.0
2469,ATP1A1,GO:0045823,positive regulation of heart contraction,2.0
2470,ATP1A1,GO:0045989,positive regulation of striated muscle contraction,2.0
2471,ATP1A1,GO:0046982,protein heterodimerization activity,2.0
2472,ATP1A1,GO:0051087,chaperone binding,2.0
2473,ATP1A1,GO:0055119,relaxation of cardiac muscle,2.0
2474,ATP1A1,GO:0060342,photoreceptor inner segment membrane,2.0
2475,ATP1A1,GO:0070062,extracellular exosome,2.0
2476,ATP1A1,GO:0071383,cellular response to steroid hormone stimulus,2.0
2477,ATP1A1,GO:0086002,cardiac muscle cell action potential involved in contraction,2.0
2478,ATP1A1,GO:0086009,membrane repolarization,2.0
2479,ATP1A1,GO:0086013,membrane repolarization during cardiac muscle cell action potential,2.0
2480,ATP1A1,GO:0086064,cell communication by electrical coupling involved in cardiac conduction,2.0
2481,ATP1A1,GO:1902600,proton transmembrane transport,2.0
2483,ATP1A1,GO:1903416,response to glycoside,2.0
2484,ATP1A1,GO:1903561,extracellular vesicle,2.0
2485,ATP1A1,GO:1990239,steroid hormone binding,2.0
2486,ATP1A1,GO:1990573,potassium ion import across plasma membrane,2.0
2490,ATP1A3,GO:0001540,amyloid-beta binding,2.0
2492,ATP1A3,GO:0001917,photoreceptor inner segment,2.0
2493,ATP1A3,GO:0005391,P-type sodium:potassium-exchanging transporter activity,2.0
2497,ATP1A3,GO:0005515,protein binding,2.0
2498,ATP1A3,GO:0005524,ATP binding,2.0
2499,ATP1A3,GO:0005783,endoplasmic reticulum,2.0
2500,ATP1A3,GO:0005794,Golgi apparatus,2.0
2501,ATP1A3,GO:0005886,plasma membrane,2.0
2505,ATP1A3,GO:0005890,sodium:potassium-exchanging ATPase complex,2.0
2508,ATP1A3,GO:0006883,cellular sodium ion homeostasis,2.0
2510,ATP1A3,GO:0010248,establishment or maintenance of transmembrane electrochemical gradient,2.0
2511,ATP1A3,GO:0016020,membrane,2.0
2513,ATP1A3,GO:0016887,ATP hydrolysis activity,2.0
2514,ATP1A3,GO:0019829,ATPase-coupled cation transmembrane transporter activity,2.0
2515,ATP1A3,GO:0021987,cerebral cortex development,2.0
2516,ATP1A3,GO:0030007,cellular potassium ion homeostasis,2.0
2518,ATP1A3,GO:0030424,axon,2.0
2519,ATP1A3,GO:0031090,organelle membrane,2.0
2520,ATP1A3,GO:0031748,D1 dopamine receptor binding,2.0
2521,ATP1A3,GO:0032809,neuronal cell body membrane,2.0
2522,ATP1A3,GO:0036376,sodium ion export across plasma membrane,2.0
2524,ATP1A3,GO:0042734,presynaptic membrane,2.0
2525,ATP1A3,GO:0043025,neuronal cell body,2.0
2526,ATP1A3,GO:0043209,myelin sheath,2.0
2527,ATP1A3,GO:0044305,calyx of Held,2.0
2528,ATP1A3,GO:0044326,dendritic spine neck,2.0
2529,ATP1A3,GO:0044327,dendritic spine head,2.0
2530,ATP1A3,GO:0045202,synapse,2.0
2531,ATP1A3,GO:0046872,metal ion binding,2.0
2532,ATP1A3,GO:0051087,chaperone binding,2.0
2533,ATP1A3,GO:0060075,regulation of resting membrane potential,2.0
2534,ATP1A3,GO:0060342,photoreceptor inner segment membrane,2.0
2535,ATP1A3,GO:0071300,cellular response to retinoic acid,2.0
2536,ATP1A3,GO:0071383,cellular response to steroid hormone stimulus,2.0
2537,ATP1A3,GO:0086064,cell communication by electrical coupling involved in cardiac conduction,2.0
2538,ATP1A3,GO:0097067,cellular response to thyroid hormone stimulus,2.0
2539,ATP1A3,GO:0098984,neuron to neuron synapse,2.0
2540,ATP1A3,GO:1902600,proton transmembrane transport,2.0
2541,ATP1A3,GO:1903416,response to glycoside,2.0
2542,ATP1A3,GO:1903561,extracellular vesicle,2.0
2543,ATP1A3,GO:1904646,cellular response to amyloid-beta,2.0
2544,ATP1A3,GO:1990239,steroid hormone binding,2.0
2545,ATP1A3,GO:1990535,neuron projection maintenance,2.0
2546,ATP1A3,GO:1990573,potassium ion import across plasma membrane,2.0
2599,ATP2B2,GO:0003407,neural retina development,2.0
2600,ATP2B2,GO:0005388,P-type calcium transporter activity,2.0
2603,ATP2B2,GO:0005515,protein binding,2.0
2604,ATP2B2,GO:0005516,calmodulin binding,2.0
2605,ATP2B2,GO:0005524,ATP binding,2.0
2606,ATP2B2,GO:0005737,cytoplasm,2.0
2607,ATP2B2,GO:0005886,plasma membrane,2.0
2610,ATP2B2,GO:0006816,calcium ion transport,2.0
2612,ATP2B2,GO:0006874,cellular calcium ion homeostasis,2.0
2613,ATP2B2,GO:0007420,brain development,2.0
2614,ATP2B2,GO:0007605,sensory perception of sound,2.0
2615,ATP2B2,GO:0016323,basolateral plasma membrane,2.0
2616,ATP2B2,GO:0016324,apical plasma membrane,2.0
2617,ATP2B2,GO:0016887,ATP hydrolysis activity,2.0
2618,ATP2B2,GO:0019829,ATPase-coupled cation transmembrane transporter activity,2.0
2619,ATP2B2,GO:0030165,PDZ domain binding,2.0
2620,ATP2B2,GO:0030182,neuron differentiation,2.0
2621,ATP2B2,GO:0032591,dendritic spine membrane,2.0
2622,ATP2B2,GO:0032809,neuronal cell body membrane,2.0
2623,ATP2B2,GO:0034220,ion transmembrane transport,2.0
2624,ATP2B2,GO:0035254,glutamate receptor binding,2.0
2625,ATP2B2,GO:0043231,intracellular membrane-bounded organelle,2.0
2626,ATP2B2,GO:0045121,membrane raft,2.0
2627,ATP2B2,GO:0046872,metal ion binding,2.0
2628,ATP2B2,GO:0048787,presynaptic active zone membrane,2.0
2629,ATP2B2,GO:0051480,regulation of cytosolic calcium ion concentration,2.0
2631,ATP2B2,GO:0070062,extracellular exosome,2.0
2632,ATP2B2,GO:0070588,calcium ion transmembrane transport,2.0
2633,ATP2B2,GO:0098688,parallel fiber to Purkinje cell synapse,2.0
2634,ATP2B2,GO:0098839,postsynaptic density membrane,2.0
2635,ATP2B2,GO:0098978,glutamatergic synapse,2.0
2638,ATP2B2,GO:0098982,GABA-ergic synapse,2.0
2641,ATP2B2,GO:0099566,regulation of postsynaptic cytosolic calcium ion concentration,2.0
2642,ATP2B2,GO:1903779,regulation of cardiac conduction,2.0
2643,ATP2B2,GO:1905059,P-type calcium transporter activity involved in regulation of postsynaptic cytosolic calcium ion concentration,2.0
2646,ATP6V0A2,GO:0000220,"vacuolar proton-transporting V-type ATPase, V0 domain",2.0
2647,ATP6V0A2,GO:0001669,acrosomal vesicle,2.0
2648,ATP6V0A2,GO:0005515,protein binding,2.0
2649,ATP6V0A2,GO:0005765,lysosomal membrane,2.0
2650,ATP6V0A2,GO:0005886,plasma membrane,2.0
2652,ATP6V0A2,GO:0005925,focal adhesion,2.0
2653,ATP6V0A2,GO:0006879,cellular iron ion homeostasis,2.0
2654,ATP6V0A2,GO:0006955,immune response,2.0
2655,ATP6V0A2,GO:0007035,vacuolar acidification,2.0
2656,ATP6V0A2,GO:0010008,endosome membrane,2.0
2657,ATP6V0A2,GO:0016241,regulation of macroautophagy,2.0
2658,ATP6V0A2,GO:0016471,vacuolar proton-transporting V-type ATPase complex,2.0
2659,ATP6V0A2,GO:0030670,phagocytic vesicle membrane,2.0
2660,ATP6V0A2,GO:0033176,proton-transporting V-type ATPase complex,2.0
2661,ATP6V0A2,GO:0036295,cellular response to increased oxygen levels,2.0
2662,ATP6V0A2,GO:0043231,intracellular membrane-bounded organelle,2.0
2663,ATP6V0A2,GO:0046961,"proton-transporting ATPase activity, rotational mechanism",2.0
2664,ATP6V0A2,GO:0048471,perinuclear region of cytoplasm,2.0
2665,ATP6V0A2,GO:0051117,ATPase binding,2.0
2666,ATP6V0A2,GO:0061795,Golgi lumen acidification,2.0
2667,ATP6V0A2,GO:1902495,transmembrane transporter complex,2.0
2668,ATP6V0A2,GO:1902600,proton transmembrane transport,2.0
2669,ATP6V0A2,GO:1904949,ATPase complex,2.0
2741,AVPR1A,GO:0001992,regulation of systemic arterial blood pressure by vasopressin,2.0
2742,AVPR1A,GO:0002125,maternal aggressive behavior,2.0
2743,AVPR1A,GO:0003084,positive regulation of systemic arterial blood pressure,2.0
2744,AVPR1A,GO:0004930,G protein-coupled receptor activity,2.0
2745,AVPR1A,GO:0005000,vasopressin receptor activity,2.0
2747,AVPR1A,GO:0005080,protein kinase C binding,2.0
2748,AVPR1A,GO:0005515,protein binding,2.0
2749,AVPR1A,GO:0005768,endosome,2.0
2750,AVPR1A,GO:0005886,plasma membrane,2.0
2753,AVPR1A,GO:0006091,generation of precursor metabolites and energy,2.0
2754,AVPR1A,GO:0007186,G protein-coupled receptor signaling pathway,2.0
2755,AVPR1A,GO:0007202,activation of phospholipase C activity,2.0
2756,AVPR1A,GO:0007204,positive regulation of cytosolic calcium ion concentration,2.0
2757,AVPR1A,GO:0007621,negative regulation of female receptivity,2.0
2758,AVPR1A,GO:0007625,grooming behavior,2.0
2759,AVPR1A,GO:0008015,blood circulation,2.0
2760,AVPR1A,GO:0008284,positive regulation of cell population proliferation,2.0
2761,AVPR1A,GO:0010259,multicellular organism aging,2.0
2762,AVPR1A,GO:0010460,positive regulation of heart rate,2.0
2763,AVPR1A,GO:0014049,positive regulation of glutamate secretion,2.0
2764,AVPR1A,GO:0014902,myotube differentiation,2.0
2765,AVPR1A,GO:0017046,peptide hormone binding,2.0
2766,AVPR1A,GO:0019722,calcium-mediated signaling,2.0
2767,AVPR1A,GO:0021537,telencephalon development,2.0
2768,AVPR1A,GO:0030139,endocytic vesicle,2.0
2769,AVPR1A,GO:0030307,positive regulation of cell growth,2.0
2770,AVPR1A,GO:0031394,positive regulation of prostaglandin biosynthetic process,2.0
2771,AVPR1A,GO:0031894,V1A vasopressin receptor binding,2.0
2772,AVPR1A,GO:0032849,positive regulation of cellular pH reduction,2.0
2773,AVPR1A,GO:0035176,social behavior,2.0
2774,AVPR1A,GO:0035815,positive regulation of renal sodium excretion,2.0
2775,AVPR1A,GO:0042277,peptide binding,2.0
2776,AVPR1A,GO:0042631,cellular response to water deprivation,2.0
2777,AVPR1A,GO:0042711,maternal behavior,2.0
2778,AVPR1A,GO:0042713,sperm ejaculation,2.0
2779,AVPR1A,GO:0043084,penile erection,2.0
2780,AVPR1A,GO:0045907,positive regulation of vasoconstriction,2.0
2781,AVPR1A,GO:0051412,response to corticosterone,2.0
2782,AVPR1A,GO:0051970,negative regulation of transmission of nerve impulse,2.0
2783,AVPR1A,GO:0150104,transport across blood-brain barrier,2.0
2784,AZGP1,GO:0001580,detection of chemical stimulus involved in sensory perception of bitter taste,2.0
2785,AZGP1,GO:0001895,retina homeostasis,2.0
2786,AZGP1,GO:0001916,positive regulation of T cell mediated cytotoxicity,2.0
2787,AZGP1,GO:0002476,antigen processing and presentation of endogenous peptide antigen via MHC class Ib,2.0
2788,AZGP1,GO:0002486,"antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent",2.0
2789,AZGP1,GO:0004540,ribonuclease activity,2.0
2790,AZGP1,GO:0005515,protein binding,2.0
2791,AZGP1,GO:0005576,extracellular region,2.0
2794,AZGP1,GO:0005615,extracellular space,2.0
2797,AZGP1,GO:0005634,nucleus,2.0
2798,AZGP1,GO:0006955,immune response,2.0
2799,AZGP1,GO:0007155,cell adhesion,2.0
2800,AZGP1,GO:0008285,negative regulation of cell population proliferation,2.0
2801,AZGP1,GO:0008320,protein transmembrane transporter activity,2.0
2802,AZGP1,GO:0009897,external side of plasma membrane,2.0
2803,AZGP1,GO:0062023,collagen-containing extracellular matrix,2.0
2804,AZGP1,GO:0070062,extracellular exosome,2.0
2805,AZGP1,GO:0071806,protein transmembrane transport,2.0
2806,AZGP1,GO:0090501,RNA phosphodiester bond hydrolysis,2.0
2890,BBS4,GO:0000226,microtubule cytoskeleton organization,2.0
2891,BBS4,GO:0000242,pericentriolar material,2.0
2892,BBS4,GO:0000281,mitotic cytokinesis,2.0
2893,BBS4,GO:0001750,photoreceptor outer segment,2.0
2894,BBS4,GO:0001764,neuron migration,2.0
2895,BBS4,GO:0001843,neural tube closure,2.0
2896,BBS4,GO:0001895,retina homeostasis,2.0
2897,BBS4,GO:0001917,photoreceptor inner segment,2.0
2898,BBS4,GO:0001947,heart looping,2.0
2899,BBS4,GO:0003085,negative regulation of systemic arterial blood pressure,2.0
2900,BBS4,GO:0005515,protein binding,2.0
2901,BBS4,GO:0005634,nucleus,2.0
2902,BBS4,GO:0005813,centrosome,2.0
2903,BBS4,GO:0005814,centriole,2.0
2904,BBS4,GO:0005829,cytosol,2.0
2905,BBS4,GO:0005929,cilium,2.0
2906,BBS4,GO:0007098,centrosome cycle,2.0
2907,BBS4,GO:0007286,spermatid development,2.0
2908,BBS4,GO:0007601,visual perception,2.0
2909,BBS4,GO:0007608,sensory perception of smell,2.0
2910,BBS4,GO:0010467,gene expression,2.0
2911,BBS4,GO:0010629,negative regulation of gene expression,2.0
2912,BBS4,GO:0015031,protein transport,2.0
2913,BBS4,GO:0016358,dendrite development,2.0
2914,BBS4,GO:0019216,regulation of lipid metabolic process,2.0
2915,BBS4,GO:0021591,ventricular system development,2.0
2916,BBS4,GO:0021756,striatum development,2.0
2917,BBS4,GO:0021766,hippocampus development,2.0
2918,BBS4,GO:0021987,cerebral cortex development,2.0
2919,BBS4,GO:0030534,adult behavior,2.0
2920,BBS4,GO:0030674,protein-macromolecule adaptor activity,2.0
2921,BBS4,GO:0030837,negative regulation of actin filament polymerization,2.0
2922,BBS4,GO:0031514,motile cilium,2.0
2923,BBS4,GO:0032391,photoreceptor connecting cilium,2.0
2924,BBS4,GO:0032402,melanosome transport,2.0
2925,BBS4,GO:0032465,regulation of cytokinesis,2.0
2926,BBS4,GO:0033365,protein localization to organelle,2.0
2927,BBS4,GO:0034260,negative regulation of GTPase activity,2.0
2928,BBS4,GO:0034451,centriolar satellite,2.0
2929,BBS4,GO:0034452,dynactin binding,2.0
2930,BBS4,GO:0034454,microtubule anchoring at centrosome,2.0
2931,BBS4,GO:0034464,BBSome,2.0
2933,BBS4,GO:0035176,social behavior,2.0
2934,BBS4,GO:0035845,photoreceptor cell outer segment organization,2.0
2935,BBS4,GO:0035869,ciliary transition zone,2.0
2936,BBS4,GO:0036064,ciliary basal body,2.0
2938,BBS4,GO:0038108,negative regulation of appetite by leptin-mediated signaling pathway,2.0
2939,BBS4,GO:0040018,positive regulation of multicellular organism growth,2.0
2940,BBS4,GO:0043014,alpha-tubulin binding,2.0
2941,BBS4,GO:0045444,fat cell differentiation,2.0
2942,BBS4,GO:0045494,photoreceptor cell maintenance,2.0
2943,BBS4,GO:0045724,positive regulation of cilium assembly,2.0
2944,BBS4,GO:0046548,retinal rod cell development,2.0
2945,BBS4,GO:0046907,intracellular transport,2.0
2946,BBS4,GO:0048487,beta-tubulin binding,2.0
2947,BBS4,GO:0048854,brain morphogenesis,2.0
2948,BBS4,GO:0050893,sensory processing,2.0
2949,BBS4,GO:0051457,maintenance of protein location in nucleus,2.0
2950,BBS4,GO:0051492,regulation of stress fiber assembly,2.0
2951,BBS4,GO:0060170,ciliary membrane,2.0
2952,BBS4,GO:0060271,cilium assembly,2.0
2955,BBS4,GO:0060296,regulation of cilium beat frequency involved in ciliary motility,2.0
2956,BBS4,GO:0060324,face development,2.0
2957,BBS4,GO:0060613,fat pad development,2.0
2958,BBS4,GO:0061512,protein localization to cilium,2.0
2960,BBS4,GO:0061629,RNA polymerase II-specific DNA-binding transcription factor binding,2.0
2961,BBS4,GO:0071539,protein localization to centrosome,2.0
2962,BBS4,GO:0097730,non-motile cilium,2.0
2963,BBS4,GO:1902855,regulation of non-motile cilium assembly,2.0
2964,BBS4,GO:1903546,protein localization to photoreceptor outer segment,2.0
2965,BBS4,GO:1905515,non-motile cilium assembly,2.0
2966,BCAS1,GO:0005737,cytoplasm,2.0
2967,BCAS1,GO:0042552,myelination,2.0
2969,BCAS1,GO:0070062,extracellular exosome,2.0
3018,BICRA,GO:0000785,chromatin,2.0
3019,BICRA,GO:0005515,protein binding,2.0
3020,BICRA,GO:0005634,nucleus,2.0
3021,BICRA,GO:0006338,chromatin remodeling,2.0
3022,BICRA,GO:0006357,regulation of transcription by RNA polymerase II,2.0
3023,BICRA,GO:0008284,positive regulation of cell population proliferation,2.0
3024,BICRA,GO:0016514,SWI/SNF complex,2.0
3026,BICRA,GO:0045596,negative regulation of cell differentiation,2.0
3027,BICRA,GO:0045893,positive regulation of DNA-templated transcription,2.0
3029,BICRA,GO:0140288,GBAF complex,2.0
3030,BICRA,GO:0140537,transcription regulator activator activity,2.0
3031,BICRA,GO:1902459,positive regulation of stem cell population maintenance,2.0
3032,BIRC6,GO:0000922,spindle pole,2.0
3033,BIRC6,GO:0004842,ubiquitin-protein transferase activity,2.0
3034,BIRC6,GO:0004869,cysteine-type endopeptidase inhibitor activity,2.0
3036,BIRC6,GO:0005515,protein binding,2.0
3037,BIRC6,GO:0005634,nucleus,2.0
3038,BIRC6,GO:0005768,endosome,2.0
3039,BIRC6,GO:0005802,trans-Golgi network,2.0
3040,BIRC6,GO:0005815,microtubule organizing center,2.0
3041,BIRC6,GO:0005829,cytosol,2.0
3042,BIRC6,GO:0006468,protein phosphorylation,2.0
3043,BIRC6,GO:0006915,apoptotic process,2.0
3044,BIRC6,GO:0007049,cell cycle,2.0
3045,BIRC6,GO:0008283,cell population proliferation,2.0
3046,BIRC6,GO:0008284,positive regulation of cell population proliferation,2.0
3047,BIRC6,GO:0010951,negative regulation of endopeptidase activity,2.0
3048,BIRC6,GO:0016020,membrane,2.0
3049,BIRC6,GO:0016567,protein ubiquitination,2.0
3050,BIRC6,GO:0030496,midbody,2.0
3051,BIRC6,GO:0032465,regulation of cytokinesis,2.0
3052,BIRC6,GO:0042127,regulation of cell population proliferation,2.0
3053,BIRC6,GO:0043066,negative regulation of apoptotic process,2.0
3056,BIRC6,GO:0051301,cell division,2.0
3057,BIRC6,GO:0060711,labyrinthine layer development,2.0
3058,BIRC6,GO:0061631,ubiquitin conjugating enzyme activity,2.0
3059,BIRC6,GO:0090543,Flemming body,2.0
3060,BIRC6,GO:2001237,negative regulation of extrinsic apoptotic signaling pathway,2.0
3124,BRCA2,GO:0000152,nuclear ubiquitin ligase complex,2.0
3125,BRCA2,GO:0000722,telomere maintenance via recombination,2.0
3126,BRCA2,GO:0000724,double-strand break repair via homologous recombination,2.0
3129,BRCA2,GO:0000781,"chromosome, telomeric region",2.0
3130,BRCA2,GO:0000800,lateral element,2.0
3131,BRCA2,GO:0001556,oocyte maturation,2.0
3132,BRCA2,GO:0001833,inner cell mass cell proliferation,2.0
3133,BRCA2,GO:0002020,protease binding,2.0
3134,BRCA2,GO:0003697,single-stranded DNA binding,2.0
3135,BRCA2,GO:0004402,histone acetyltransferase activity,2.0
3136,BRCA2,GO:0005515,protein binding,2.0
3137,BRCA2,GO:0005634,nucleus,2.0
3140,BRCA2,GO:0005654,nucleoplasm,2.0
3142,BRCA2,GO:0005813,centrosome,2.0
3143,BRCA2,GO:0005829,cytosol,2.0
3145,BRCA2,GO:0006289,nucleotide-excision repair,2.0
3146,BRCA2,GO:0006302,double-strand break repair,2.0
3147,BRCA2,GO:0006355,regulation of DNA-templated transcription,2.0
3148,BRCA2,GO:0006978,"DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator",2.0
3149,BRCA2,GO:0007141,male meiosis I,2.0
3150,BRCA2,GO:0007283,spermatogenesis,2.0
3151,BRCA2,GO:0007420,brain development,2.0
3152,BRCA2,GO:0008022,protein C-terminus binding,2.0
3153,BRCA2,GO:0008585,female gonad development,2.0
3154,BRCA2,GO:0010165,response to X-ray,2.0
3155,BRCA2,GO:0010225,response to UV-C,2.0
3156,BRCA2,GO:0010332,response to gamma radiation,2.0
3157,BRCA2,GO:0010484,histone H3 acetyltransferase activity,2.0
3158,BRCA2,GO:0010485,histone H4 acetyltransferase activity,2.0
3159,BRCA2,GO:0030141,secretory granule,2.0
3160,BRCA2,GO:0032465,regulation of cytokinesis,2.0
3161,BRCA2,GO:0032991,protein-containing complex,2.0
3162,BRCA2,GO:0033593,BRCA2-MAGE-D1 complex,2.0
3163,BRCA2,GO:0033600,negative regulation of mammary gland epithelial cell proliferation,2.0
3164,BRCA2,GO:0035518,histone H2A monoubiquitination,2.0
3165,BRCA2,GO:0042771,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,2.0
3166,BRCA2,GO:0042802,identical protein binding,2.0
3167,BRCA2,GO:0043015,gamma-tubulin binding,2.0
3168,BRCA2,GO:0043966,histone H3 acetylation,2.0
3169,BRCA2,GO:0043967,histone H4 acetylation,2.0
3170,BRCA2,GO:0045893,positive regulation of DNA-templated transcription,2.0
3171,BRCA2,GO:0045931,positive regulation of mitotic cell cycle,2.0
3172,BRCA2,GO:0048478,replication fork protection,2.0
3173,BRCA2,GO:0051298,centrosome duplication,2.0
3174,BRCA2,GO:0051865,protein autoubiquitination,2.0
3175,BRCA2,GO:0070200,establishment of protein localization to telomere,2.0
3176,BRCA2,GO:0071425,hematopoietic stem cell proliferation,2.0
3177,BRCA2,GO:0071479,cellular response to ionizing radiation,2.0
3178,BRCA2,GO:0090398,cellular senescence,2.0
3179,BRCA2,GO:1990391,DNA repair complex,2.0
3180,BRCA2,GO:1990426,mitotic recombination-dependent replication fork processing,2.0
3181,BRCA2,GO:2000001,regulation of DNA damage checkpoint,2.0
3182,BRD4,GO:0000083,regulation of transcription involved in G1/S transition of mitotic cell cycle,2.0
3183,BRD4,GO:0000785,chromatin,2.0
3184,BRD4,GO:0000794,condensed nuclear chromosome,2.0
3185,BRD4,GO:0000976,transcription cis-regulatory region binding,2.0
3186,BRD4,GO:0002039,p53 binding,2.0
3187,BRD4,GO:0003682,chromatin binding,2.0
3188,BRD4,GO:0003712,transcription coregulator activity,2.0
3189,BRD4,GO:0003713,transcription coactivator activity,2.0
3190,BRD4,GO:0005515,protein binding,2.0
3191,BRD4,GO:0005634,nucleus,2.0
3193,BRD4,GO:0005654,nucleoplasm,2.0
3195,BRD4,GO:0006338,chromatin remodeling,2.0
3196,BRD4,GO:0006351,DNA-templated transcription,2.0
3197,BRD4,GO:0006355,regulation of DNA-templated transcription,2.0
3198,BRD4,GO:0006974,cellular response to DNA damage stimulus,2.0
3199,BRD4,GO:0008353,RNA polymerase II CTD heptapeptide repeat kinase activity,2.0
3200,BRD4,GO:0010971,positive regulation of G2/M transition of mitotic cell cycle,2.0
3201,BRD4,GO:0019899,enzyme binding,2.0
3202,BRD4,GO:0032968,positive regulation of transcription elongation by RNA polymerase II,2.0
3205,BRD4,GO:0043123,positive regulation of I-kappaB kinase/NF-kappaB signaling,2.0
3206,BRD4,GO:0045893,positive regulation of DNA-templated transcription,2.0
3207,BRD4,GO:0045944,positive regulation of transcription by RNA polymerase II,2.0
3208,BRD4,GO:0050727,regulation of inflammatory response,2.0
3209,BRD4,GO:0070577,lysine-acetylated histone binding,2.0
3211,BRD4,GO:0099122,RNA polymerase II C-terminal domain binding,2.0
3212,BRD4,GO:0106140,P-TEFb complex binding,2.0
3213,BRD4,GO:0140566,histone reader activity,2.0
3280,BST1,GO:0001931,uropod,2.0
3281,BST1,GO:0001952,regulation of cell-matrix adhesion,2.0
3282,BST1,GO:0002691,regulation of cellular extravasation,2.0
3283,BST1,GO:0003953,NAD+ nucleosidase activity,2.0
3284,BST1,GO:0005576,extracellular region,2.0
3285,BST1,GO:0005886,plasma membrane,2.0
3287,BST1,GO:0006959,humoral immune response,2.0
3288,BST1,GO:0007165,signal transduction,2.0
3289,BST1,GO:0008284,positive regulation of cell population proliferation,2.0
3290,BST1,GO:0016740,transferase activity,2.0
3291,BST1,GO:0016849,phosphorus-oxygen lyase activity,2.0
3292,BST1,GO:0019898,extrinsic component of membrane,2.0
3293,BST1,GO:0030890,positive regulation of B cell proliferation,2.0
3294,BST1,GO:0032956,regulation of actin cytoskeleton organization,2.0
3295,BST1,GO:0035579,specific granule membrane,2.0
3296,BST1,GO:0050135,NAD(P)+ nucleosidase activity,2.0
3297,BST1,GO:0050727,regulation of inflammatory response,2.0
3298,BST1,GO:0050730,regulation of peptidyl-tyrosine phosphorylation,2.0
3299,BST1,GO:0050848,regulation of calcium-mediated signaling,2.0
3301,BST1,GO:0061809,"NAD+ nucleotidase, cyclic ADP-ribose generating",2.0
3302,BST1,GO:0061811,ADP-ribosyl cyclase activity,2.0
3303,BST1,GO:0061812,cyclic ADP-ribose hydrolase,2.0
3304,BST1,GO:0070062,extracellular exosome,2.0
3305,BST1,GO:0090022,regulation of neutrophil chemotaxis,2.0
3306,BST1,GO:0090322,regulation of superoxide metabolic process,2.0
3307,BST1,GO:2001044,regulation of integrin-mediated signaling pathway,2.0
3308,BTAF1,GO:0003677,DNA binding,2.0
3309,BTAF1,GO:0003712,transcription coregulator activity,2.0
3310,BTAF1,GO:0004386,helicase activity,2.0
3311,BTAF1,GO:0005524,ATP binding,2.0
3312,BTAF1,GO:0005654,nucleoplasm,2.0
3313,BTAF1,GO:0006338,chromatin remodeling,2.0
3314,BTAF1,GO:0006351,DNA-templated transcription,2.0
3315,BTAF1,GO:0008094,"ATP-dependent activity, acting on DNA",2.0
3316,BTAF1,GO:0016887,ATP hydrolysis activity,2.0
3317,BTAF1,GO:0017025,TBP-class protein binding,2.0
3318,BTAF1,GO:0035562,negative regulation of chromatin binding,2.0
3319,BTAF1,GO:0043231,intracellular membrane-bounded organelle,2.0
3320,BTAF1,GO:0045892,negative regulation of DNA-templated transcription,2.0
3321,BTAF1,GO:0140658,ATP-dependent chromatin remodeler activity,2.0
3322,BTRC,GO:0000209,protein polyubiquitination,2.0
3324,BTRC,GO:0004842,ubiquitin-protein transferase activity,2.0
3325,BTRC,GO:0005515,protein binding,2.0
3326,BTRC,GO:0005654,nucleoplasm,2.0
3327,BTRC,GO:0005829,cytosol,2.0
3328,BTRC,GO:0006470,protein dephosphorylation,2.0
3329,BTRC,GO:0006511,ubiquitin-dependent protein catabolic process,2.0
3330,BTRC,GO:0007165,signal transduction,2.0
3331,BTRC,GO:0008013,beta-catenin binding,2.0
3332,BTRC,GO:0016055,Wnt signaling pathway,2.0
3333,BTRC,GO:0016567,protein ubiquitination,2.0
3336,BTRC,GO:0016874,ligase activity,2.0
3337,BTRC,GO:0019005,SCF ubiquitin ligase complex,2.0
3339,BTRC,GO:0031146,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process,2.0
3340,BTRC,GO:0031648,protein destabilization,2.0
3341,BTRC,GO:0033598,mammary gland epithelial cell proliferation,2.0
3342,BTRC,GO:0042752,regulation of circadian rhythm,2.0
3343,BTRC,GO:0042753,positive regulation of circadian rhythm,2.0
3344,BTRC,GO:0043122,regulation of I-kappaB kinase/NF-kappaB signaling,2.0
3345,BTRC,GO:0043161,proteasome-mediated ubiquitin-dependent protein catabolic process,2.0
3346,BTRC,GO:0043433,negative regulation of DNA-binding transcription factor activity,2.0
3347,BTRC,GO:0045309,protein phosphorylated amino acid binding,2.0
3348,BTRC,GO:0045862,positive regulation of proteolysis,2.0
3349,BTRC,GO:0045879,negative regulation of smoothened signaling pathway,2.0
3350,BTRC,GO:0045892,negative regulation of DNA-templated transcription,2.0
3351,BTRC,GO:0045893,positive regulation of DNA-templated transcription,2.0
3352,BTRC,GO:0046983,protein dimerization activity,2.0
3353,BTRC,GO:0048511,rhythmic process,2.0
3354,BTRC,GO:0051726,regulation of cell cycle,2.0
3355,BTRC,GO:0060444,branching involved in mammary gland duct morphogenesis,2.0
3356,BTRC,GO:0060828,regulation of canonical Wnt signaling pathway,2.0
3357,BTRC,GO:0061136,regulation of proteasomal protein catabolic process,2.0
3358,BTRC,GO:0061630,ubiquitin protein ligase activity,2.0
3359,BTRC,GO:0070936,protein K48-linked ubiquitination,2.0
3360,BTRC,GO:0071407,cellular response to organic cyclic compound,2.0
3361,BTRC,GO:1904668,positive regulation of ubiquitin protein ligase activity,2.0
3362,BTRC,GO:1990756,ubiquitin ligase-substrate adaptor activity,2.0
3363,BTRC,GO:1990757,ubiquitin ligase activator activity,2.0
3376,C15orf62,GO:0005737,cytoplasm,2.0
3377,C15orf62,GO:0005739,mitochondrion,2.0
3378,C15orf62,GO:0005856,cytoskeleton,2.0
3379,C15orf62,GO:0005886,plasma membrane,2.0
3380,C15orf62,GO:0007266,Rho protein signal transduction,2.0
3381,C15orf62,GO:0008360,regulation of cell shape,2.0
3382,C15orf62,GO:0030838,positive regulation of actin filament polymerization,2.0
3383,C15orf62,GO:0031274,positive regulation of pseudopodium assembly,2.0
3384,C4B,GO:0001848,complement binding,2.0
3385,C4B,GO:0004866,endopeptidase inhibitor activity,2.0
3386,C4B,GO:0005576,extracellular region,2.0
3387,C4B,GO:0005615,extracellular space,2.0
3390,C4B,GO:0005886,plasma membrane,2.0
3391,C4B,GO:0006954,inflammatory response,2.0
3392,C4B,GO:0006956,complement activation,2.0
3394,C4B,GO:0006958,"complement activation, classical pathway",2.0
3395,C4B,GO:0008228,opsonization,2.0
3396,C4B,GO:0010951,negative regulation of endopeptidase activity,2.0
3397,C4B,GO:0030246,carbohydrate binding,2.0
3398,C4B,GO:0030424,axon,2.0
3399,C4B,GO:0030425,dendrite,2.0
3400,C4B,GO:0032490,detection of molecule of bacterial origin,2.0
3401,C4B,GO:0045087,innate immune response,2.0
3402,C4B,GO:0045202,synapse,2.0
3403,C4B,GO:0070062,extracellular exosome,2.0
3404,C4B,GO:0072562,blood microparticle,2.0
3405,C4B,GO:0106139,symbiont cell surface,2.0
3406,C4B,GO:2000427,positive regulation of apoptotic cell clearance,2.0
3407,CA6,GO:0001580,detection of chemical stimulus involved in sensory perception of bitter taste,2.0
3408,CA6,GO:0004089,carbonate dehydratase activity,2.0
3409,CA6,GO:0005576,extracellular region,2.0
3410,CA6,GO:0005615,extracellular space,2.0
3413,CA6,GO:0005829,cytosol,2.0
3414,CA6,GO:0006730,one-carbon metabolic process,2.0
3415,CA6,GO:0008270,zinc ion binding,2.0
3416,CA6,GO:0016836,hydro-lyase activity,2.0
3417,CA6,GO:0070062,extracellular exosome,2.0
3448,CACNA1B,GO:0001540,amyloid-beta binding,2.0
3449,CACNA1B,GO:0005245,voltage-gated calcium channel activity,2.0
3450,CACNA1B,GO:0005509,calcium ion binding,2.0
3451,CACNA1B,GO:0005515,protein binding,2.0
3452,CACNA1B,GO:0005524,ATP binding,2.0
3453,CACNA1B,GO:0005886,plasma membrane,2.0
3454,CACNA1B,GO:0005891,voltage-gated calcium channel complex,2.0
3455,CACNA1B,GO:0007268,chemical synaptic transmission,2.0
3456,CACNA1B,GO:0008022,protein C-terminus binding,2.0
3457,CACNA1B,GO:0008331,high voltage-gated calcium channel activity,2.0
3459,CACNA1B,GO:0034765,regulation of ion transmembrane transport,2.0
3460,CACNA1B,GO:0043025,neuronal cell body,2.0
3461,CACNA1B,GO:0045202,synapse,2.0
3462,CACNA1B,GO:0050804,modulation of chemical synaptic transmission,2.0
3463,CACNA1B,GO:0098703,calcium ion import across plasma membrane,2.0
3464,CACNA1B,GO:1904645,response to amyloid-beta,2.0
3513,CACNA1D,GO:0005245,voltage-gated calcium channel activity,2.0
3514,CACNA1D,GO:0005262,calcium channel activity,2.0
3515,CACNA1D,GO:0005515,protein binding,2.0
3516,CACNA1D,GO:0005886,plasma membrane,2.0
3518,CACNA1D,GO:0005891,voltage-gated calcium channel complex,2.0
3520,CACNA1D,GO:0006816,calcium ion transport,2.0
3521,CACNA1D,GO:0007188,adenylate cyclase-modulating G protein-coupled receptor signaling pathway,2.0
3522,CACNA1D,GO:0007605,sensory perception of sound,2.0
3523,CACNA1D,GO:0008331,high voltage-gated calcium channel activity,2.0
3524,CACNA1D,GO:0030018,Z disc,2.0
3525,CACNA1D,GO:0030506,ankyrin binding,2.0
3526,CACNA1D,GO:0045762,positive regulation of adenylate cyclase activity,2.0
3527,CACNA1D,GO:0046872,metal ion binding,2.0
3528,CACNA1D,GO:0051393,alpha-actinin binding,2.0
3529,CACNA1D,GO:0051928,positive regulation of calcium ion transport,2.0
3530,CACNA1D,GO:0060372,regulation of atrial cardiac muscle cell membrane repolarization,2.0
3531,CACNA1D,GO:0070509,calcium ion import,2.0
3532,CACNA1D,GO:0070588,calcium ion transmembrane transport,2.0
3533,CACNA1D,GO:0086002,cardiac muscle cell action potential involved in contraction,2.0
3534,CACNA1D,GO:0086007,voltage-gated calcium channel activity involved in cardiac muscle cell action potential,2.0
3535,CACNA1D,GO:0086012,membrane depolarization during cardiac muscle cell action potential,2.0
3536,CACNA1D,GO:0086046,membrane depolarization during SA node cell action potential,2.0
3537,CACNA1D,GO:0086059,voltage-gated calcium channel activity involved SA node cell action potential,2.0
3538,CACNA1D,GO:0086091,regulation of heart rate by cardiac conduction,2.0
3539,CACNA1D,GO:0098703,calcium ion import across plasma membrane,2.0
3540,CACNA1D,GO:1901016,regulation of potassium ion transmembrane transporter activity,2.0
3541,CACNA1D,GO:1901379,regulation of potassium ion transmembrane transport,2.0
3542,CACNA1D,GO:1990454,L-type voltage-gated calcium channel complex,2.0
3554,CACNA1F,GO:0001750,photoreceptor outer segment,2.0
3555,CACNA1F,GO:0005245,voltage-gated calcium channel activity,2.0
3556,CACNA1F,GO:0005891,voltage-gated calcium channel complex,2.0
3558,CACNA1F,GO:0007601,visual perception,2.0
3559,CACNA1F,GO:0008331,high voltage-gated calcium channel activity,2.0
3560,CACNA1F,GO:0016020,membrane,2.0
3561,CACNA1F,GO:0034765,regulation of ion transmembrane transport,2.0
3562,CACNA1F,GO:0043204,perikaryon,2.0
3563,CACNA1F,GO:0046872,metal ion binding,2.0
3564,CACNA1F,GO:0050908,detection of light stimulus involved in visual perception,2.0
3565,CACNA1F,GO:0098703,calcium ion import across plasma membrane,2.0
3566,CACNA1G,GO:0001518,voltage-gated sodium channel complex,2.0
3567,CACNA1G,GO:0003163,sinoatrial node development,2.0
3568,CACNA1G,GO:0005248,voltage-gated sodium channel activity,2.0
3569,CACNA1G,GO:0005737,cytoplasm,2.0
3570,CACNA1G,GO:0005886,plasma membrane,2.0
3572,CACNA1G,GO:0005891,voltage-gated calcium channel complex,2.0
3573,CACNA1G,GO:0007268,chemical synaptic transmission,2.0
3574,CACNA1G,GO:0008332,low voltage-gated calcium channel activity,2.0
3576,CACNA1G,GO:0010045,response to nickel cation,2.0
3577,CACNA1G,GO:0019228,neuronal action potential,2.0
3578,CACNA1G,GO:0034765,regulation of ion transmembrane transport,2.0
3579,CACNA1G,GO:0035725,sodium ion transmembrane transport,2.0
3580,CACNA1G,GO:0042391,regulation of membrane potential,2.0
3581,CACNA1G,GO:0043005,neuron projection,2.0
3582,CACNA1G,GO:0045202,synapse,2.0
3583,CACNA1G,GO:0045956,positive regulation of calcium ion-dependent exocytosis,2.0
3584,CACNA1G,GO:0060371,regulation of atrial cardiac muscle cell membrane depolarization,2.0
3585,CACNA1G,GO:0070509,calcium ion import,2.0
3587,CACNA1G,GO:0070588,calcium ion transmembrane transport,2.0
3588,CACNA1G,GO:0086002,cardiac muscle cell action potential involved in contraction,2.0
3589,CACNA1G,GO:0086010,membrane depolarization during action potential,2.0
3590,CACNA1G,GO:0086015,SA node cell action potential,2.0
3591,CACNA1G,GO:0086016,AV node cell action potential,2.0
3592,CACNA1G,GO:0086018,SA node cell to atrial cardiac muscle cell signaling,2.0
3593,CACNA1G,GO:0086027,AV node cell to bundle of His cell signaling,2.0
3594,CACNA1G,GO:0086045,membrane depolarization during AV node cell action potential,2.0
3595,CACNA1G,GO:0086046,membrane depolarization during SA node cell action potential,2.0
3596,CACNA1G,GO:0086056,voltage-gated calcium channel activity involved in AV node cell action potential,2.0
3597,CACNA1G,GO:0086059,voltage-gated calcium channel activity involved SA node cell action potential,2.0
3598,CACNA1G,GO:0086091,regulation of heart rate by cardiac conduction,2.0
3599,CACNA1G,GO:0097110,scaffold protein binding,2.0
3600,CACNA1H,GO:0001518,voltage-gated sodium channel complex,2.0
3601,CACNA1H,GO:0005244,voltage-gated ion channel activity,2.0
3602,CACNA1H,GO:0005248,voltage-gated sodium channel activity,2.0
3603,CACNA1H,GO:0005515,protein binding,2.0
3604,CACNA1H,GO:0005886,plasma membrane,2.0
3606,CACNA1H,GO:0005891,voltage-gated calcium channel complex,2.0
3607,CACNA1H,GO:0006936,muscle contraction,2.0
3608,CACNA1H,GO:0007517,muscle organ development,2.0
3609,CACNA1H,GO:0007520,myoblast fusion,2.0
3610,CACNA1H,GO:0008016,regulation of heart contraction,2.0
3611,CACNA1H,GO:0008332,low voltage-gated calcium channel activity,2.0
3613,CACNA1H,GO:0016020,membrane,2.0
3614,CACNA1H,GO:0019228,neuronal action potential,2.0
3615,CACNA1H,GO:0032342,aldosterone biosynthetic process,2.0
3616,CACNA1H,GO:0032870,cellular response to hormone stimulus,2.0
3617,CACNA1H,GO:0034651,cortisol biosynthetic process,2.0
3618,CACNA1H,GO:0034765,regulation of ion transmembrane transport,2.0
3619,CACNA1H,GO:0035725,sodium ion transmembrane transport,2.0
3620,CACNA1H,GO:0035865,cellular response to potassium ion,2.0
3621,CACNA1H,GO:0042391,regulation of membrane potential,2.0
3622,CACNA1H,GO:0043005,neuron projection,2.0
3623,CACNA1H,GO:0045956,positive regulation of calcium ion-dependent exocytosis,2.0
3624,CACNA1H,GO:0046872,metal ion binding,2.0
3625,CACNA1H,GO:0070509,calcium ion import,2.0
3627,CACNA1H,GO:0070588,calcium ion transmembrane transport,2.0
3628,CACNA1H,GO:0086010,membrane depolarization during action potential,2.0
3629,CACNA1H,GO:0097110,scaffold protein binding,2.0
3630,CACNA1H,GO:0098662,inorganic cation transmembrane transport,2.0
3631,CACNA1H,GO:2000344,positive regulation of acrosome reaction,2.0
3632,CACNA1I,GO:0001518,voltage-gated sodium channel complex,2.0
3633,CACNA1I,GO:0005245,voltage-gated calcium channel activity,2.0
3634,CACNA1I,GO:0005248,voltage-gated sodium channel activity,2.0
3635,CACNA1I,GO:0005515,protein binding,2.0
3636,CACNA1I,GO:0005886,plasma membrane,2.0
3637,CACNA1I,GO:0005891,voltage-gated calcium channel complex,2.0
3638,CACNA1I,GO:0007165,signal transduction,2.0
3639,CACNA1I,GO:0008332,low voltage-gated calcium channel activity,2.0
3640,CACNA1I,GO:0019228,neuronal action potential,2.0
3641,CACNA1I,GO:0030317,flagellated sperm motility,2.0
3642,CACNA1I,GO:0030431,sleep,2.0
3643,CACNA1I,GO:0034765,regulation of ion transmembrane transport,2.0
3644,CACNA1I,GO:0035725,sodium ion transmembrane transport,2.0
3645,CACNA1I,GO:0043005,neuron projection,2.0
3646,CACNA1I,GO:0045956,positive regulation of calcium ion-dependent exocytosis,2.0
3647,CACNA1I,GO:0070509,calcium ion import,2.0
3648,CACNA1I,GO:0070588,calcium ion transmembrane transport,2.0
3649,CACNA1I,GO:0086010,membrane depolarization during action potential,2.0
3650,CACNA2D1,GO:0005245,voltage-gated calcium channel activity,2.0
3654,CACNA2D1,GO:0005891,voltage-gated calcium channel complex,2.0
3656,CACNA2D1,GO:0006816,calcium ion transport,2.0
3657,CACNA2D1,GO:0016529,sarcoplasmic reticulum,2.0
3658,CACNA2D1,GO:0046872,metal ion binding,2.0
3659,CACNA2D1,GO:0051924,regulation of calcium ion transport,2.0
3660,CACNA2D1,GO:0060307,regulation of ventricular cardiac muscle cell membrane repolarization,2.0
3661,CACNA2D1,GO:0060402,calcium ion transport into cytosol,2.0
3662,CACNA2D1,GO:0061577,calcium ion transmembrane transport via high voltage-gated calcium channel,2.0
3663,CACNA2D1,GO:0070062,extracellular exosome,2.0
3664,CACNA2D1,GO:0086002,cardiac muscle cell action potential involved in contraction,2.0
3665,CACNA2D1,GO:0086007,voltage-gated calcium channel activity involved in cardiac muscle cell action potential,2.0
3666,CACNA2D1,GO:0086048,membrane depolarization during bundle of His cell action potential,2.0
3667,CACNA2D1,GO:0086057,voltage-gated calcium channel activity involved in bundle of His cell action potential,2.0
3668,CACNA2D1,GO:0086091,regulation of heart rate by cardiac conduction,2.0
3669,CACNA2D1,GO:0098703,calcium ion import across plasma membrane,2.0
3670,CACNA2D1,GO:0098903,regulation of membrane repolarization during action potential,2.0
3671,CACNA2D1,GO:0098992,neuronal dense core vesicle,2.0
3672,CACNA2D1,GO:1901843,positive regulation of high voltage-gated calcium channel activity,2.0
3673,CACNA2D1,GO:1902514,regulation of calcium ion transmembrane transport via high voltage-gated calcium channel,2.0
3674,CACNA2D1,GO:1904646,cellular response to amyloid-beta,2.0
3675,CACNA2D1,GO:1990454,L-type voltage-gated calcium channel complex,2.0
3682,AVPR1B,GO:0001992,regulation of systemic arterial blood pressure by vasopressin,2.0
3683,AVPR1B,GO:0004930,G protein-coupled receptor activity,2.0
3684,AVPR1B,GO:0005000,vasopressin receptor activity,2.0
3686,AVPR1B,GO:0005080,protein kinase C binding,2.0
3687,AVPR1B,GO:0005768,endosome,2.0
3688,AVPR1B,GO:0005794,Golgi apparatus,2.0
3689,AVPR1B,GO:0005886,plasma membrane,2.0
3692,AVPR1B,GO:0007186,G protein-coupled receptor signaling pathway,2.0
3694,AVPR1B,GO:0007202,activation of phospholipase C activity,2.0
3695,AVPR1B,GO:0007204,positive regulation of cytosolic calcium ion concentration,2.0
3696,AVPR1B,GO:0010259,multicellular organism aging,2.0
3697,AVPR1B,GO:0032430,positive regulation of phospholipase A2 activity,2.0
3698,AVPR1B,GO:0042127,regulation of cell population proliferation,2.0
3699,AVPR1B,GO:0042277,peptide binding,2.0
3700,AVPR1B,GO:0043410,positive regulation of MAPK cascade,2.0
3701,AVPR1B,GO:0045907,positive regulation of vasoconstriction,2.0
3702,AVPR1B,GO:0046718,viral entry into host cell,2.0
3703,AVPR1B,GO:0060732,positive regulation of inositol phosphate biosynthetic process,2.0
3704,AVPR1B,GO:0090238,positive regulation of arachidonic acid secretion,2.0
3705,AVPR1B,GO:0150104,transport across blood-brain barrier,2.0
3706,BICDL1,GO:0005737,cytoplasm,2.0
3707,BICDL1,GO:0005813,centrosome,2.0
3708,BICDL1,GO:0031175,neuron projection development,2.0
3709,BICDL1,GO:0031267,small GTPase binding,2.0
3710,BICDL1,GO:0034452,dynactin binding,2.0
3711,BICDL1,GO:0047496,vesicle transport along microtubule,2.0
3712,BICDL1,GO:0055107,Golgi to secretory granule transport,2.0
3728,CACNB2,GO:0005245,voltage-gated calcium channel activity,2.0
3729,CACNB2,GO:0005262,calcium channel activity,2.0
3730,CACNB2,GO:0005515,protein binding,2.0
3731,CACNB2,GO:0005886,plasma membrane,2.0
3733,CACNB2,GO:0005891,voltage-gated calcium channel complex,2.0
3735,CACNB2,GO:0007268,chemical synaptic transmission,2.0
3736,CACNB2,GO:0007528,neuromuscular junction development,2.0
3737,CACNB2,GO:0007601,visual perception,2.0
3738,CACNB2,GO:0008331,high voltage-gated calcium channel activity,2.0
3739,CACNB2,GO:0051015,actin filament binding,2.0
3740,CACNB2,GO:0051928,positive regulation of calcium ion transport,2.0
3741,CACNB2,GO:0070509,calcium ion import,2.0
3742,CACNB2,GO:0070588,calcium ion transmembrane transport,2.0
3743,CACNB2,GO:0072659,protein localization to plasma membrane,2.0
3744,CACNB2,GO:0086007,voltage-gated calcium channel activity involved in cardiac muscle cell action potential,2.0
3745,CACNB2,GO:0086045,membrane depolarization during AV node cell action potential,2.0
3746,CACNB2,GO:0086056,voltage-gated calcium channel activity involved in AV node cell action potential,2.0
3747,CACNB2,GO:0086091,regulation of heart rate by cardiac conduction,2.0
3748,CACNB2,GO:0098684,photoreceptor ribbon synapse,2.0
3749,CACNB2,GO:0098793,presynapse,2.0
3750,CACNB2,GO:0098912,membrane depolarization during atrial cardiac muscle cell action potential,2.0
3751,CACNB2,GO:0099509,regulation of presynaptic cytosolic calcium ion concentration,2.0
3752,CACNB2,GO:0099626,voltage-gated calcium channel activity involved in regulation of presynaptic cytosolic calcium levels,2.0
3753,CACNB2,GO:1901385,regulation of voltage-gated calcium channel activity,2.0
3754,CACNB2,GO:1901843,positive regulation of high voltage-gated calcium channel activity,2.0
3755,CACNB2,GO:1904879,positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel,2.0
3756,CACNB2,GO:1990454,L-type voltage-gated calcium channel complex,2.0
3757,CADM1,GO:0001819,positive regulation of cytokine production,2.0
3758,CADM1,GO:0001889,liver development,2.0
3759,CADM1,GO:0001913,T cell mediated cytotoxicity,2.0
3760,CADM1,GO:0001933,negative regulation of protein phosphorylation,2.0
3761,CADM1,GO:0005102,signaling receptor binding,2.0
3764,CADM1,GO:0005515,protein binding,2.0
3765,CADM1,GO:0005886,plasma membrane,2.0
3768,CADM1,GO:0005911,cell-cell junction,2.0
3769,CADM1,GO:0006915,apoptotic process,2.0
3770,CADM1,GO:0007156,homophilic cell adhesion via plasma membrane adhesion molecules,2.0
3772,CADM1,GO:0007157,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules,2.0
3773,CADM1,GO:0007283,spermatogenesis,2.0
3774,CADM1,GO:0007420,brain development,2.0
3775,CADM1,GO:0008037,cell recognition,2.0
3778,CADM1,GO:0014069,postsynaptic density,2.0
3779,CADM1,GO:0016323,basolateral plasma membrane,2.0
3780,CADM1,GO:0030154,cell differentiation,2.0
3781,CADM1,GO:0030165,PDZ domain binding,2.0
3782,CADM1,GO:0030425,dendrite,2.0
3783,CADM1,GO:0042271,susceptibility to natural killer cell mediated cytotoxicity,2.0
3786,CADM1,GO:0042803,protein homodimerization activity,2.0
3787,CADM1,GO:0043005,neuron projection,2.0
3788,CADM1,GO:0045202,synapse,2.0
3789,CADM1,GO:0045954,positive regulation of natural killer cell mediated cytotoxicity,2.0
3791,CADM1,GO:0050798,activated T cell proliferation,2.0
3792,CADM1,GO:0050839,cell adhesion molecule binding,2.0
3793,CADM1,GO:0051606,detection of stimulus,2.0
3796,CADM1,GO:0120154,negative regulation of ERBB4 signaling pathway,2.0
3797,CADM2,GO:0005886,plasma membrane,2.0
3798,CADM2,GO:0007156,homophilic cell adhesion via plasma membrane adhesion molecules,2.0
3799,CADM2,GO:0007420,brain development,2.0
3800,CADM2,GO:0030424,axon,2.0
3801,CADM2,GO:0032809,neuronal cell body membrane,2.0
3802,CADM2,GO:0045202,synapse,2.0
3803,CADPS,GO:0005515,protein binding,2.0
3804,CADPS,GO:0005829,cytosol,2.0
3805,CADPS,GO:0006887,exocytosis,2.0
3806,CADPS,GO:0008289,lipid binding,2.0
3807,CADPS,GO:0015031,protein transport,2.0
3808,CADPS,GO:0016079,synaptic vesicle exocytosis,2.0
3809,CADPS,GO:0019901,protein kinase binding,2.0
3810,CADPS,GO:0045921,positive regulation of exocytosis,2.0
3811,CADPS,GO:0046872,metal ion binding,2.0
3812,CADPS,GO:0098793,presynapse,2.0
3813,CADPS,GO:0098978,glutamatergic synapse,2.0
3814,CADPS,GO:0099012,neuronal dense core vesicle membrane,2.0
3815,CADPS,GO:1990504,dense core granule exocytosis,2.0
3816,CADPS2,GO:0005654,nucleoplasm,2.0
3817,CADPS2,GO:0006887,exocytosis,2.0
3818,CADPS2,GO:0008289,lipid binding,2.0
3819,CADPS2,GO:0015031,protein transport,2.0
3820,CADPS2,GO:0016079,synaptic vesicle exocytosis,2.0
3821,CADPS2,GO:0030659,cytoplasmic vesicle membrane,2.0
3822,CADPS2,GO:0043231,intracellular membrane-bounded organelle,2.0
3823,CADPS2,GO:0045921,positive regulation of exocytosis,2.0
3824,CADPS2,GO:0046872,metal ion binding,2.0
3825,CADPS2,GO:0098793,presynapse,2.0
3826,CADPS2,GO:0098978,glutamatergic synapse,2.0
3827,CADPS2,GO:1990504,dense core granule exocytosis,2.0
3828,CAMK2A,GO:0000082,G1/S transition of mitotic cell cycle,2.0
3829,CAMK2A,GO:0002931,response to ischemia,2.0
3830,CAMK2A,GO:0004674,protein serine/threonine kinase activity,2.0
3832,CAMK2A,GO:0004683,calmodulin-dependent protein kinase activity,2.0
3834,CAMK2A,GO:0005515,protein binding,2.0
3835,CAMK2A,GO:0005516,calmodulin binding,2.0
3837,CAMK2A,GO:0005524,ATP binding,2.0
3838,CAMK2A,GO:0005634,nucleus,2.0
3839,CAMK2A,GO:0005654,nucleoplasm,2.0
3840,CAMK2A,GO:0005737,cytoplasm,2.0
3841,CAMK2A,GO:0005739,mitochondrion,2.0
3842,CAMK2A,GO:0005829,cytosol,2.0
3843,CAMK2A,GO:0005954,calcium- and calmodulin-dependent protein kinase complex,2.0
3844,CAMK2A,GO:0006468,protein phosphorylation,2.0
3845,CAMK2A,GO:0006816,calcium ion transport,2.0
3846,CAMK2A,GO:0010666,positive regulation of cardiac muscle cell apoptotic process,2.0
3847,CAMK2A,GO:0014069,postsynaptic density,2.0
3848,CAMK2A,GO:0016301,kinase activity,2.0
3849,CAMK2A,GO:0018105,peptidyl-serine phosphorylation,2.0
3850,CAMK2A,GO:0030666,endocytic vesicle membrane,2.0
3851,CAMK2A,GO:0035254,glutamate receptor binding,2.0
3852,CAMK2A,GO:0035458,cellular response to interferon-beta,2.0
3853,CAMK2A,GO:0038166,angiotensin-activated signaling pathway,2.0
3854,CAMK2A,GO:0042802,identical protein binding,2.0
3855,CAMK2A,GO:0042803,protein homodimerization activity,2.0
3856,CAMK2A,GO:0043005,neuron projection,2.0
3857,CAMK2A,GO:0043197,dendritic spine,2.0
3858,CAMK2A,GO:0046427,positive regulation of receptor signaling pathway via JAK-STAT,2.0
3859,CAMK2A,GO:0046777,protein autophosphorylation,2.0
3860,CAMK2A,GO:0046872,metal ion binding,2.0
3861,CAMK2A,GO:0046928,regulation of neurotransmitter secretion,2.0
3862,CAMK2A,GO:0048168,regulation of neuronal synaptic plasticity,2.0
3863,CAMK2A,GO:0051092,positive regulation of NF-kappaB transcription factor activity,2.0
3864,CAMK2A,GO:0051346,negative regulation of hydrolase activity,2.0
3865,CAMK2A,GO:0051928,positive regulation of calcium ion transport,2.0
3866,CAMK2A,GO:0060996,dendritic spine development,2.0
3867,CAMK2A,GO:0106310,protein serine kinase activity,2.0
3868,CAMK2A,GO:1902108,regulation of mitochondrial membrane permeability involved in apoptotic process,2.0
3869,CAMK2A,GO:1990443,peptidyl-threonine autophosphorylation,2.0
3870,CAMK2A,GO:2000124,regulation of endocannabinoid signaling pathway,2.0
3871,CAMK2A,GO:2001222,regulation of neuron migration,2.0
3905,CAMK4,GO:0001650,fibrillar center,2.0
3906,CAMK4,GO:0002250,adaptive immune response,2.0
3907,CAMK4,GO:0002735,positive regulation of myeloid dendritic cell cytokine production,2.0
3908,CAMK4,GO:0004683,calmodulin-dependent protein kinase activity,2.0
3910,CAMK4,GO:0005516,calmodulin binding,2.0
3911,CAMK4,GO:0005524,ATP binding,2.0
3912,CAMK4,GO:0005634,nucleus,2.0
3913,CAMK4,GO:0005654,nucleoplasm,2.0
3915,CAMK4,GO:0005737,cytoplasm,2.0
3916,CAMK4,GO:0006468,protein phosphorylation,2.0
3917,CAMK4,GO:0006954,inflammatory response,2.0
3918,CAMK4,GO:0007165,signal transduction,2.0
3919,CAMK4,GO:0007616,long-term memory,2.0
3920,CAMK4,GO:0009931,calcium-dependent protein serine/threonine kinase activity,2.0
3921,CAMK4,GO:0018105,peptidyl-serine phosphorylation,2.0
3922,CAMK4,GO:0033081,regulation of T cell differentiation in thymus,2.0
3923,CAMK4,GO:0035556,intracellular signal transduction,2.0
3924,CAMK4,GO:0043011,myeloid dendritic cell differentiation,2.0
3925,CAMK4,GO:0045670,regulation of osteoclast differentiation,2.0
3926,CAMK4,GO:0045893,positive regulation of DNA-templated transcription,2.0
3927,CAMK4,GO:0046777,protein autophosphorylation,2.0
3928,CAMK4,GO:0070062,extracellular exosome,2.0
3929,CAMK4,GO:0098794,postsynapse,2.0
3930,CAMK4,GO:0098978,glutamatergic synapse,2.0
3931,CAMK4,GO:0106310,protein serine kinase activity,2.0
3932,CAPN12,GO:0004198,calcium-dependent cysteine-type endopeptidase activity,2.0
3933,CAPN12,GO:0005509,calcium ion binding,2.0
3934,CAPN12,GO:0005737,cytoplasm,2.0
3935,CAPN12,GO:0006508,proteolysis,2.0
3955,CARD11,GO:0001772,immunological synapse,2.0
3956,CARD11,GO:0004385,guanylate kinase activity,2.0
3957,CARD11,GO:0005515,protein binding,2.0
3958,CARD11,GO:0005737,cytoplasm,2.0
3960,CARD11,GO:0005829,cytosol,2.0
3961,CARD11,GO:0005886,plasma membrane,2.0
3963,CARD11,GO:0007249,I-kappaB kinase/NF-kappaB signaling,2.0
3964,CARD11,GO:0030183,B cell differentiation,2.0
3965,CARD11,GO:0030890,positive regulation of B cell proliferation,2.0
3966,CARD11,GO:0031295,T cell costimulation,2.0
3967,CARD11,GO:0032449,CBM complex,2.0
3968,CARD11,GO:0032743,positive regulation of interleukin-2 production,2.0
3969,CARD11,GO:0035739,"CD4-positive, alpha-beta T cell proliferation",2.0
3970,CARD11,GO:0038202,TORC1 signaling,2.0
3971,CARD11,GO:0042100,B cell proliferation,2.0
3972,CARD11,GO:0042981,regulation of apoptotic process,2.0
3973,CARD11,GO:0043123,positive regulation of I-kappaB kinase/NF-kappaB signaling,2.0
3976,CARD11,GO:0043621,protein self-association,2.0
3977,CARD11,GO:0045061,thymic T cell selection,2.0
3978,CARD11,GO:0045121,membrane raft,2.0
3979,CARD11,GO:0045577,regulation of B cell differentiation,2.0
3980,CARD11,GO:0045580,regulation of T cell differentiation,2.0
3981,CARD11,GO:0046037,GMP metabolic process,2.0
3982,CARD11,GO:0046710,GDP metabolic process,2.0
3983,CARD11,GO:0048872,homeostasis of number of cells,2.0
3984,CARD11,GO:0050700,CARD domain binding,2.0
3986,CARD11,GO:0050862,positive regulation of T cell receptor signaling pathway,2.0
3988,CARD11,GO:0051092,positive regulation of NF-kappaB transcription factor activity,2.0
3990,CARD11,GO:0051260,protein homooligomerization,2.0
3991,CARD11,GO:0070062,extracellular exosome,2.0
3992,CARD11,GO:2000563,"positive regulation of CD4-positive, alpha-beta T cell proliferation",2.0
4033,CASKIN1,GO:0005515,protein binding,2.0
4034,CASKIN1,GO:0005737,cytoplasm,2.0
4036,CASKIN1,GO:0007165,signal transduction,2.0
4037,CASKIN1,GO:0016020,membrane,2.0
4038,CASKIN1,GO:0042802,identical protein binding,2.0
4123,CC2D1A,GO:0000978,RNA polymerase II cis-regulatory region sequence-specific DNA binding,2.0
4125,CC2D1A,GO:0000981,"DNA-binding transcription factor activity, RNA polymerase II-specific",2.0
4126,CC2D1A,GO:0001227,"DNA-binding transcription repressor activity, RNA polymerase II-specific",2.0
4127,CC2D1A,GO:0001650,fibrillar center,2.0
4128,CC2D1A,GO:0005515,protein binding,2.0
4129,CC2D1A,GO:0005634,nucleus,2.0
4130,CC2D1A,GO:0005815,microtubule organizing center,2.0
4131,CC2D1A,GO:0005829,cytosol,2.0
4132,CC2D1A,GO:0005886,plasma membrane,2.0
4133,CC2D1A,GO:0006357,regulation of transcription by RNA polymerase II,2.0
4134,CC2D1A,GO:0016020,membrane,2.0
4135,CC2D1A,GO:0043123,positive regulation of I-kappaB kinase/NF-kappaB signaling,2.0
4136,CC2D1A,GO:0045296,cadherin binding,2.0
4137,CC2D1A,GO:0070062,extracellular exosome,2.0
4138,CC2D1A,GO:1905381,negative regulation of snRNA transcription by RNA polymerase II,2.0
4139,CCDC88C,GO:0001932,regulation of protein phosphorylation,2.0
4140,CCDC88C,GO:0001965,G-protein alpha-subunit binding,2.0
4141,CCDC88C,GO:0003383,apical constriction,2.0
4142,CCDC88C,GO:0005085,guanyl-nucleotide exchange factor activity,2.0
4143,CCDC88C,GO:0005109,frizzled binding,2.0
4144,CCDC88C,GO:0005515,protein binding,2.0
4145,CCDC88C,GO:0005737,cytoplasm,2.0
4147,CCDC88C,GO:0005813,centrosome,2.0
4148,CCDC88C,GO:0007264,small GTPase mediated signal transduction,2.0
4149,CCDC88C,GO:0008017,microtubule binding,2.0
4150,CCDC88C,GO:0030054,cell junction,2.0
4151,CCDC88C,GO:0030165,PDZ domain binding,2.0
4152,CCDC88C,GO:0030705,cytoskeleton-dependent intracellular transport,2.0
4153,CCDC88C,GO:0031098,stress-activated protein kinase signaling cascade,2.0
4154,CCDC88C,GO:0031122,cytoplasmic microtubule organization,2.0
4155,CCDC88C,GO:0031648,protein destabilization,2.0
4156,CCDC88C,GO:0035567,non-canonical Wnt signaling pathway,2.0
4157,CCDC88C,GO:0042802,identical protein binding,2.0
4158,CCDC88C,GO:0043621,protein self-association,2.0
4159,CCDC88C,GO:0050790,regulation of catalytic activity,2.0
4160,CCDC88C,GO:0051959,dynein light intermediate chain binding,2.0
4161,CCDC88C,GO:0070161,anchoring junction,2.0
4162,CCDC88C,GO:0090090,negative regulation of canonical Wnt signaling pathway,2.0
4163,CCDC91,GO:0005654,nucleoplasm,2.0
4164,CCDC91,GO:0005794,Golgi apparatus,2.0
4165,CCDC91,GO:0005802,trans-Golgi network,2.0
4167,CCDC91,GO:0005829,cytosol,2.0
4168,CCDC91,GO:0015031,protein transport,2.0
4169,CCDC91,GO:0016020,membrane,2.0
4170,CCDC91,GO:0090160,Golgi to lysosome transport,2.0
4172,CCIN,GO:0005515,protein binding,2.0
4173,CCIN,GO:0005634,nucleus,2.0
4174,CCIN,GO:0007283,spermatogenesis,2.0
4175,CCIN,GO:0007420,brain development,2.0
4176,CCIN,GO:0015629,actin cytoskeleton,2.0
4177,CCIN,GO:0030036,actin cytoskeleton organization,2.0
4178,CCIN,GO:0030154,cell differentiation,2.0
4179,CCIN,GO:0032839,dendrite cytoplasm,2.0
4180,CCIN,GO:0033150,cytoskeletal calyx,2.0
4181,CCIN,GO:0051015,actin filament binding,2.0
4182,CCNG1,GO:0000079,regulation of cyclin-dependent protein serine/threonine kinase activity,2.0
4183,CCNG1,GO:0000307,cyclin-dependent protein kinase holoenzyme complex,2.0
4184,CCNG1,GO:0005515,protein binding,2.0
4185,CCNG1,GO:0005634,nucleus,2.0
4186,CCNG1,GO:0005654,nucleoplasm,2.0
4187,CCNG1,GO:0005737,cytoplasm,2.0
4188,CCNG1,GO:0006949,syncytium formation,2.0
4189,CCNG1,GO:0007095,mitotic G2 DNA damage checkpoint signaling,2.0
4190,CCNG1,GO:0007420,brain development,2.0
4191,CCNG1,GO:0009629,response to gravity,2.0
4192,CCNG1,GO:0010243,response to organonitrogen compound,2.0
4193,CCNG1,GO:0016538,cyclin-dependent protein serine/threonine kinase regulator activity,2.0
4194,CCNG1,GO:0030425,dendrite,2.0
4195,CCNG1,GO:0043025,neuronal cell body,2.0
4196,CCNG1,GO:0043066,negative regulation of apoptotic process,2.0
4197,CCNG1,GO:0044772,mitotic cell cycle phase transition,2.0
4198,CCNG1,GO:0048471,perinuclear region of cytoplasm,2.0
4199,CCNG1,GO:0051301,cell division,2.0
4225,CCT4,GO:0002199,zona pellucida receptor complex,2.0
4226,CCT4,GO:0003723,RNA binding,2.0
4227,CCT4,GO:0005515,protein binding,2.0
4228,CCT4,GO:0005524,ATP binding,2.0
4229,CCT4,GO:0005654,nucleoplasm,2.0
4230,CCT4,GO:0005813,centrosome,2.0
4231,CCT4,GO:0005829,cytosol,2.0
4233,CCT4,GO:0005832,chaperonin-containing T-complex,2.0
4237,CCT4,GO:0005874,microtubule,2.0
4238,CCT4,GO:0006457,protein folding,2.0
4240,CCT4,GO:0007339,binding of sperm to zona pellucida,2.0
4241,CCT4,GO:0016887,ATP hydrolysis activity,2.0
4242,CCT4,GO:0032212,positive regulation of telomere maintenance via telomerase,2.0
4243,CCT4,GO:0042470,melanosome,2.0
4244,CCT4,GO:0042995,cell projection,2.0
4245,CCT4,GO:0044183,protein folding chaperone,2.0
4246,CCT4,GO:0044297,cell body,2.0
4247,CCT4,GO:0050821,protein stabilization,2.0
4248,CCT4,GO:0051082,unfolded protein binding,2.0
4249,CCT4,GO:0051973,positive regulation of telomerase activity,2.0
4250,CCT4,GO:0061077,chaperone-mediated protein folding,2.0
4251,CCT4,GO:0070062,extracellular exosome,2.0
4252,CCT4,GO:0090666,scaRNA localization to Cajal body,2.0
4253,CCT4,GO:0140662,ATP-dependent protein folding chaperone,2.0
4254,CCT4,GO:1901998,toxin transport,2.0
4255,CCT4,GO:1904851,positive regulation of establishment of protein localization to telomere,2.0
4256,CCT4,GO:1904871,positive regulation of protein localization to Cajal body,2.0
4257,CCT4,GO:1904874,positive regulation of telomerase RNA localization to Cajal body,2.0
4259,CD276,GO:0001817,regulation of cytokine production,2.0
4260,CD276,GO:0005102,signaling receptor binding,2.0
4262,CD276,GO:0005515,protein binding,2.0
4263,CD276,GO:0009897,external side of plasma membrane,2.0
4265,CD276,GO:0016020,membrane,2.0
4266,CD276,GO:0032729,positive regulation of type II interferon production,2.0
4267,CD276,GO:0042102,positive regulation of T cell proliferation,2.0
4268,CD276,GO:0042110,T cell activation,2.0
4269,CD276,GO:0050776,regulation of immune response,2.0
4270,CD276,GO:0050852,T cell receptor signaling pathway,2.0
4271,CD38,GO:0001666,response to hypoxia,2.0
4272,CD38,GO:0003953,NAD+ nucleosidase activity,2.0
4274,CD38,GO:0005634,nucleus,2.0
4275,CD38,GO:0005886,plasma membrane,2.0
4278,CD38,GO:0007165,signal transduction,2.0
4279,CD38,GO:0007204,positive regulation of cytosolic calcium ion concentration,2.0
4280,CD38,GO:0007565,female pregnancy,2.0
4281,CD38,GO:0009410,response to xenobiotic stimulus,2.0
4282,CD38,GO:0009986,cell surface,2.0
4283,CD38,GO:0010977,negative regulation of neuron projection development,2.0
4284,CD38,GO:0014824,artery smooth muscle contraction,2.0
4285,CD38,GO:0016020,membrane,2.0
4286,CD38,GO:0016323,basolateral plasma membrane,2.0
4287,CD38,GO:0016740,transferase activity,2.0
4288,CD38,GO:0016849,phosphorus-oxygen lyase activity,2.0
4289,CD38,GO:0019674,NAD metabolic process,2.0
4290,CD38,GO:0030307,positive regulation of cell growth,2.0
4291,CD38,GO:0030667,secretory granule membrane,2.0
4292,CD38,GO:0030890,positive regulation of B cell proliferation,2.0
4294,CD38,GO:0032024,positive regulation of insulin secretion,2.0
4295,CD38,GO:0032355,response to estradiol,2.0
4296,CD38,GO:0032526,response to retinoic acid,2.0
4297,CD38,GO:0032570,response to progesterone,2.0
4298,CD38,GO:0033194,response to hydroperoxide,2.0
4299,CD38,GO:0042100,B cell proliferation,2.0
4300,CD38,GO:0042802,identical protein binding,2.0
4301,CD38,GO:0043066,negative regulation of apoptotic process,2.0
4302,CD38,GO:0045779,negative regulation of bone resorption,2.0
4303,CD38,GO:0045892,negative regulation of DNA-templated transcription,2.0
4304,CD38,GO:0045893,positive regulation of DNA-templated transcription,2.0
4305,CD38,GO:0045907,positive regulation of vasoconstriction,2.0
4306,CD38,GO:0050135,NAD(P)+ nucleosidase activity,2.0
4307,CD38,GO:0050853,B cell receptor signaling pathway,2.0
4308,CD38,GO:0060292,long-term synaptic depression,2.0
4309,CD38,GO:0061809,"NAD+ nucleotidase, cyclic ADP-ribose generating",2.0
4310,CD38,GO:0070062,extracellular exosome,2.0
4311,CD38,GO:0070555,response to interleukin-1,2.0
4312,CD38,GO:0097190,apoptotic signaling pathway,2.0
4313,CD99L2,GO:0005515,protein binding,2.0
4314,CD99L2,GO:0005886,plasma membrane,2.0
4315,CD99L2,GO:0005912,adherens junction,2.0
4316,CD99L2,GO:0005925,focal adhesion,2.0
4317,CD99L2,GO:0007155,cell adhesion,2.0
4318,CD99L2,GO:0009986,cell surface,2.0
4319,CD99L2,GO:0050904,diapedesis,2.0
4320,CD99L2,GO:2000391,positive regulation of neutrophil extravasation,2.0
4321,CD99L2,GO:2000409,positive regulation of T cell extravasation,2.0
4322,CDC42BPB,GO:0000287,magnesium ion binding,2.0
4323,CDC42BPB,GO:0004672,protein kinase activity,2.0
4324,CDC42BPB,GO:0004674,protein serine/threonine kinase activity,2.0
4326,CDC42BPB,GO:0005524,ATP binding,2.0
4327,CDC42BPB,GO:0005737,cytoplasm,2.0
4328,CDC42BPB,GO:0005829,cytosol,2.0
4329,CDC42BPB,GO:0005856,cytoskeleton,2.0
4330,CDC42BPB,GO:0005886,plasma membrane,2.0
4331,CDC42BPB,GO:0005911,cell-cell junction,2.0
4332,CDC42BPB,GO:0006468,protein phosphorylation,2.0
4334,CDC42BPB,GO:0007010,cytoskeleton organization,2.0
4335,CDC42BPB,GO:0007163,establishment or maintenance of cell polarity,2.0
4336,CDC42BPB,GO:0007165,signal transduction,2.0
4337,CDC42BPB,GO:0016477,cell migration,2.0
4338,CDC42BPB,GO:0018107,peptidyl-threonine phosphorylation,2.0
4339,CDC42BPB,GO:0030027,lamellipodium,2.0
4340,CDC42BPB,GO:0031032,actomyosin structure organization,2.0
4342,CDC42BPB,GO:0031252,cell leading edge,2.0
4343,CDC42BPB,GO:0031267,small GTPase binding,2.0
4344,CDC42BPB,GO:0031532,actin cytoskeleton reorganization,2.0
4345,CDC42BPB,GO:0042641,actomyosin,2.0
4347,CDC42BPB,GO:0044877,protein-containing complex binding,2.0
4348,CDC42BPB,GO:0070062,extracellular exosome,2.0
4349,CDC42BPB,GO:0106310,protein serine kinase activity,2.0
4350,CDH10,GO:0000902,cell morphogenesis,2.0
4351,CDH10,GO:0005509,calcium ion binding,2.0
4352,CDH10,GO:0005886,plasma membrane,2.0
4353,CDH10,GO:0005912,adherens junction,2.0
4354,CDH10,GO:0007043,cell-cell junction assembly,2.0
4355,CDH10,GO:0007156,homophilic cell adhesion via plasma membrane adhesion molecules,2.0
4356,CDH10,GO:0007275,multicellular organism development,2.0
4357,CDH10,GO:0016339,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules,2.0
4358,CDH10,GO:0016342,catenin complex,2.0
4359,CDH10,GO:0034332,adherens junction organization,2.0
4360,CDH10,GO:0045296,cadherin binding,2.0
4361,CDH10,GO:0048787,presynaptic active zone membrane,2.0
4362,CDH10,GO:0098609,cell-cell adhesion,2.0
4363,CDH10,GO:0098742,cell-cell adhesion via plasma-membrane adhesion molecules,2.0
4364,CDH10,GO:0098978,glutamatergic synapse,2.0
4365,CDH10,GO:0098982,GABA-ergic synapse,2.0
4366,CDH10,GO:0099560,synaptic membrane adhesion,2.0
4367,CDH10,GO:0099634,postsynaptic specialization membrane,2.0
4368,CDH11,GO:0000902,cell morphogenesis,2.0
4369,CDH11,GO:0001501,skeletal system development,2.0
4370,CDH11,GO:0001503,ossification,2.0
4371,CDH11,GO:0005509,calcium ion binding,2.0
4372,CDH11,GO:0005737,cytoplasm,2.0
4373,CDH11,GO:0005886,plasma membrane,2.0
4374,CDH11,GO:0005912,adherens junction,2.0
4375,CDH11,GO:0007043,cell-cell junction assembly,2.0
4376,CDH11,GO:0007155,cell adhesion,2.0
4377,CDH11,GO:0007156,homophilic cell adhesion via plasma membrane adhesion molecules,2.0
4378,CDH11,GO:0007275,multicellular organism development,2.0
4379,CDH11,GO:0016339,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules,2.0
4380,CDH11,GO:0016342,catenin complex,2.0
4381,CDH11,GO:0021957,corticospinal tract morphogenesis,2.0
4382,CDH11,GO:0030336,negative regulation of cell migration,2.0
4383,CDH11,GO:0034332,adherens junction organization,2.0
4384,CDH11,GO:0045296,cadherin binding,2.0
4385,CDH11,GO:0048041,focal adhesion assembly,2.0
4386,CDH11,GO:0050804,modulation of chemical synaptic transmission,2.0
4387,CDH11,GO:0070062,extracellular exosome,2.0
4388,CDH11,GO:0098685,Schaffer collateral - CA1 synapse,2.0
4389,CDH11,GO:0098742,cell-cell adhesion via plasma-membrane adhesion molecules,2.0
4390,CDH11,GO:0098978,glutamatergic synapse,2.0
4391,CDH13,GO:0001938,positive regulation of endothelial cell proliferation,2.0
4392,CDH13,GO:0001954,positive regulation of cell-matrix adhesion,2.0
4393,CDH13,GO:0002040,sprouting angiogenesis,2.0
4395,CDH13,GO:0005509,calcium ion binding,2.0
4396,CDH13,GO:0005515,protein binding,2.0
4397,CDH13,GO:0005576,extracellular region,2.0
4398,CDH13,GO:0005615,extracellular space,2.0
4399,CDH13,GO:0005737,cytoplasm,2.0
4400,CDH13,GO:0005886,plasma membrane,2.0
4402,CDH13,GO:0005901,caveola,2.0
4403,CDH13,GO:0005925,focal adhesion,2.0
4404,CDH13,GO:0007156,homophilic cell adhesion via plasma membrane adhesion molecules,2.0
4406,CDH13,GO:0007162,negative regulation of cell adhesion,2.0
4407,CDH13,GO:0007266,Rho protein signal transduction,2.0
4408,CDH13,GO:0008285,negative regulation of cell population proliferation,2.0
4409,CDH13,GO:0009897,external side of plasma membrane,2.0
4410,CDH13,GO:0016339,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules,2.0
4411,CDH13,GO:0016342,catenin complex,2.0
4412,CDH13,GO:0016601,Rac protein signal transduction,2.0
4413,CDH13,GO:0030032,lamellipodium assembly,2.0
4414,CDH13,GO:0030100,regulation of endocytosis,2.0
4415,CDH13,GO:0030169,low-density lipoprotein particle binding,2.0
4416,CDH13,GO:0030335,positive regulation of cell migration,2.0
4417,CDH13,GO:0042058,regulation of epidermal growth factor receptor signaling pathway,2.0
4418,CDH13,GO:0042803,protein homodimerization activity,2.0
4419,CDH13,GO:0043005,neuron projection,2.0
4420,CDH13,GO:0043542,endothelial cell migration,2.0
4421,CDH13,GO:0043616,keratinocyte proliferation,2.0
4422,CDH13,GO:0045296,cadherin binding,2.0
4424,CDH13,GO:0045944,positive regulation of transcription by RNA polymerase II,2.0
4425,CDH13,GO:0048661,positive regulation of smooth muscle cell proliferation,2.0
4426,CDH13,GO:0050850,positive regulation of calcium-mediated signaling,2.0
4427,CDH13,GO:0050927,positive regulation of positive chemotaxis,2.0
4428,CDH13,GO:0051668,localization within membrane,2.0
4429,CDH13,GO:0055096,low-density lipoprotein particle mediated signaling,2.0
4430,CDH13,GO:0055100,adiponectin binding,2.0
4431,CDH13,GO:0062023,collagen-containing extracellular matrix,2.0
4432,CDH13,GO:0070062,extracellular exosome,2.0
4433,CDH13,GO:0071813,lipoprotein particle binding,2.0
4434,CDH13,GO:0098742,cell-cell adhesion via plasma-membrane adhesion molecules,2.0
4435,CDH22,GO:0000902,cell morphogenesis,2.0
4436,CDH22,GO:0005509,calcium ion binding,2.0
4437,CDH22,GO:0005912,adherens junction,2.0
4438,CDH22,GO:0007043,cell-cell junction assembly,2.0
4439,CDH22,GO:0007156,homophilic cell adhesion via plasma membrane adhesion molecules,2.0
4440,CDH22,GO:0007275,multicellular organism development,2.0
4441,CDH22,GO:0007420,brain development,2.0
4442,CDH22,GO:0016339,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules,2.0
4443,CDH22,GO:0016342,catenin complex,2.0
4444,CDH22,GO:0034332,adherens junction organization,2.0
4445,CDH22,GO:0045296,cadherin binding,2.0
4446,CDH22,GO:0098742,cell-cell adhesion via plasma-membrane adhesion molecules,2.0
4447,CDH8,GO:0000902,cell morphogenesis,2.0
4448,CDH8,GO:0005509,calcium ion binding,2.0
4449,CDH8,GO:0005886,plasma membrane,2.0
4451,CDH8,GO:0005912,adherens junction,2.0
4452,CDH8,GO:0007043,cell-cell junction assembly,2.0
4453,CDH8,GO:0007155,cell adhesion,2.0
4454,CDH8,GO:0007156,homophilic cell adhesion via plasma membrane adhesion molecules,2.0
4455,CDH8,GO:0007275,multicellular organism development,2.0
4456,CDH8,GO:0009409,response to cold,2.0
4457,CDH8,GO:0016339,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules,2.0
4458,CDH8,GO:0016342,catenin complex,2.0
4459,CDH8,GO:0034332,adherens junction organization,2.0
4460,CDH8,GO:0035249,"synaptic transmission, glutamatergic",2.0
4461,CDH8,GO:0042802,identical protein binding,2.0
4462,CDH8,GO:0043083,synaptic cleft,2.0
4463,CDH8,GO:0043679,axon terminus,2.0
4464,CDH8,GO:0045296,cadherin binding,2.0
4465,CDH8,GO:0050807,regulation of synapse organization,2.0
4466,CDH8,GO:0097060,synaptic membrane,2.0
4467,CDH8,GO:0098742,cell-cell adhesion via plasma-membrane adhesion molecules,2.0
4468,CDH8,GO:0098978,glutamatergic synapse,2.0
4469,CDH9,GO:0000902,cell morphogenesis,2.0
4470,CDH9,GO:0003674,molecular_function,2.0
4471,CDH9,GO:0005509,calcium ion binding,2.0
4472,CDH9,GO:0005886,plasma membrane,2.0
4473,CDH9,GO:0005912,adherens junction,2.0
4474,CDH9,GO:0007043,cell-cell junction assembly,2.0
4475,CDH9,GO:0007156,homophilic cell adhesion via plasma membrane adhesion molecules,2.0
4476,CDH9,GO:0007275,multicellular organism development,2.0
4477,CDH9,GO:0007416,synapse assembly,2.0
4478,CDH9,GO:0016339,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules,2.0
4479,CDH9,GO:0016342,catenin complex,2.0
4480,CDH9,GO:0034332,adherens junction organization,2.0
4481,CDH9,GO:0042734,presynaptic membrane,2.0
4482,CDH9,GO:0045211,postsynaptic membrane,2.0
4483,CDH9,GO:0045296,cadherin binding,2.0
4484,CDH9,GO:0098609,cell-cell adhesion,2.0
4485,CDH9,GO:0098742,cell-cell adhesion via plasma-membrane adhesion molecules,2.0
4486,CDH9,GO:0099560,synaptic membrane adhesion,2.0
4668,CECR2,GO:0000791,euchromatin,2.0
4669,CECR2,GO:0001842,neural fold formation,2.0
4670,CECR2,GO:0001843,neural tube closure,2.0
4671,CECR2,GO:0005634,nucleus,2.0
4672,CECR2,GO:0006309,apoptotic DNA fragmentation,2.0
4673,CECR2,GO:0006338,chromatin remodeling,2.0
4674,CECR2,GO:0007010,cytoskeleton organization,2.0
4675,CECR2,GO:0007338,single fertilization,2.0
4676,CECR2,GO:0016192,vesicle-mediated transport,2.0
4677,CECR2,GO:0060122,inner ear receptor cell stereocilium organization,2.0
4678,CECR2,GO:0061640,cytoskeleton-dependent cytokinesis,2.0
4679,CECR2,GO:0090102,cochlea development,2.0
4680,CECR2,GO:0090537,CERF complex,2.0
4683,CECR2,GO:0097194,execution phase of apoptosis,2.0
4684,CECR2,GO:0140658,ATP-dependent chromatin remodeler activity,2.0
4685,CELF2,GO:0000381,"regulation of alternative mRNA splicing, via spliceosome",2.0
4686,CELF2,GO:0003723,RNA binding,2.0
4688,CELF2,GO:0003729,mRNA binding,2.0
4689,CELF2,GO:0003730,mRNA 3'-UTR binding,2.0
4690,CELF2,GO:0005634,nucleus,2.0
4693,CELF2,GO:0005654,nucleoplasm,2.0
4694,CELF2,GO:0005737,cytoplasm,2.0
4695,CELF2,GO:0006376,mRNA splice site selection,2.0
4697,CELF2,GO:0006396,RNA processing,2.0
4698,CELF2,GO:0008016,regulation of heart contraction,2.0
4699,CELF2,GO:0036002,pre-mRNA binding,2.0
4700,CELF2,GO:0043231,intracellular membrane-bounded organelle,2.0
4701,CELF2,GO:0090543,Flemming body,2.0
4702,CELF2,GO:1990904,ribonucleoprotein complex,2.0
4728,CELF6,GO:0000381,"regulation of alternative mRNA splicing, via spliceosome",2.0
4730,CELF6,GO:0003723,RNA binding,2.0
4732,CELF6,GO:0003729,mRNA binding,2.0
4733,CELF6,GO:0005634,nucleus,2.0
4735,CELF6,GO:0005737,cytoplasm,2.0
4737,CELF6,GO:0006376,mRNA splice site selection,2.0
4738,CELF6,GO:1990904,ribonucleoprotein complex,2.0
4739,CEP135,GO:0005515,protein binding,2.0
4740,CEP135,GO:0005813,centrosome,2.0
4742,CEP135,GO:0005814,centriole,2.0
4744,CEP135,GO:0005829,cytosol,2.0
4745,CEP135,GO:0007099,centriole replication,2.0
4747,CEP135,GO:0008022,protein C-terminus binding,2.0
4748,CEP135,GO:0010457,centriole-centriole cohesion,2.0
4749,CEP135,GO:1902857,positive regulation of non-motile cilium assembly,2.0
4750,CEP135,GO:1904951,positive regulation of establishment of protein localization,2.0
4751,CEP290,GO:0001822,kidney development,2.0
4752,CEP290,GO:0005515,protein binding,2.0
4753,CEP290,GO:0005576,extracellular region,2.0
4754,CEP290,GO:0005634,nucleus,2.0
4755,CEP290,GO:0005737,cytoplasm,2.0
4756,CEP290,GO:0005813,centrosome,2.0
4758,CEP290,GO:0005814,centriole,2.0
4759,CEP290,GO:0005829,cytosol,2.0
4761,CEP290,GO:0015031,protein transport,2.0
4762,CEP290,GO:0016020,membrane,2.0
4763,CEP290,GO:0030902,hindbrain development,2.0
4764,CEP290,GO:0030916,otic vesicle formation,2.0
4765,CEP290,GO:0032391,photoreceptor connecting cilium,2.0
4766,CEP290,GO:0032991,protein-containing complex,2.0
4767,CEP290,GO:0034451,centriolar satellite,2.0
4769,CEP290,GO:0035580,specific granule lumen,2.0
4770,CEP290,GO:0035869,ciliary transition zone,2.0
4772,CEP290,GO:0036038,MKS complex,2.0
4773,CEP290,GO:0036064,ciliary basal body,2.0
4774,CEP290,GO:0042462,eye photoreceptor cell development,2.0
4775,CEP290,GO:0042802,identical protein binding,2.0
4776,CEP290,GO:0043010,camera-type eye development,2.0
4777,CEP290,GO:0045893,positive regulation of DNA-templated transcription,2.0
4778,CEP290,GO:0048793,pronephros development,2.0
4779,CEP290,GO:0051011,microtubule minus-end binding,2.0
4780,CEP290,GO:0060271,cilium assembly,2.0
4782,CEP290,GO:0070201,regulation of establishment of protein localization,2.0
4783,CEP290,GO:0090316,positive regulation of intracellular protein transport,2.0
4784,CEP290,GO:0097711,ciliary basal body-plasma membrane docking,2.0
4785,CEP290,GO:1905349,ciliary transition zone assembly,2.0
4786,CEP290,GO:1905515,non-motile cilium assembly,2.0
4787,CEP41,GO:0005515,protein binding,2.0
4788,CEP41,GO:0005813,centrosome,2.0
4789,CEP41,GO:0005814,centriole,2.0
4790,CEP41,GO:0005829,cytosol,2.0
4791,CEP41,GO:0005929,cilium,2.0
4792,CEP41,GO:0015031,protein transport,2.0
4793,CEP41,GO:0016020,membrane,2.0
4794,CEP41,GO:0018095,protein polyglutamylation,2.0
4796,CEP41,GO:0036064,ciliary basal body,2.0
4798,CEP41,GO:0060271,cilium assembly,2.0
4800,CGNL1,GO:0005515,protein binding,2.0
4801,CGNL1,GO:0005923,bicellular tight junction,2.0
4802,CGNL1,GO:0007015,actin filament organization,2.0
4803,CGNL1,GO:0016459,myosin complex,2.0
4804,CGNL1,GO:0032991,protein-containing complex,2.0
4805,CGNL1,GO:0051058,negative regulation of small GTPase mediated signal transduction,2.0
4806,CGNL1,GO:0051497,negative regulation of stress fiber assembly,2.0
4807,CGNL1,GO:0150105,protein localization to cell-cell junction,2.0
4829,CHD1,GO:0000228,nuclear chromosome,2.0
4830,CHD1,GO:0000785,chromatin,2.0
4831,CHD1,GO:0003677,DNA binding,2.0
4832,CHD1,GO:0003682,chromatin binding,2.0
4833,CHD1,GO:0004386,helicase activity,2.0
4834,CHD1,GO:0005515,protein binding,2.0
4835,CHD1,GO:0005524,ATP binding,2.0
4836,CHD1,GO:0005634,nucleus,2.0
4838,CHD1,GO:0005654,nucleoplasm,2.0
4839,CHD1,GO:0005737,cytoplasm,2.0
4840,CHD1,GO:0006338,chromatin remodeling,2.0
4842,CHD1,GO:0006357,regulation of transcription by RNA polymerase II,2.0
4843,CHD1,GO:0016887,ATP hydrolysis activity,2.0
4844,CHD1,GO:0034728,nucleosome organization,2.0
4845,CHD1,GO:0035064,methylated histone binding,2.0
4847,CHD1,GO:0042393,histone binding,2.0
4848,CHD1,GO:0043923,positive regulation by host of viral transcription,2.0
4849,CHD1,GO:0140658,ATP-dependent chromatin remodeler activity,2.0
5065,CHMP1A,GO:0000421,autophagosome membrane,2.0
5066,CHMP1A,GO:0000776,kinetochore,2.0
5067,CHMP1A,GO:0000794,condensed nuclear chromosome,2.0
5068,CHMP1A,GO:0000815,ESCRT III complex,2.0
5069,CHMP1A,GO:0001778,plasma membrane repair,2.0
5070,CHMP1A,GO:0005515,protein binding,2.0
5071,CHMP1A,GO:0005643,nuclear pore,2.0
5072,CHMP1A,GO:0005765,lysosomal membrane,2.0
5073,CHMP1A,GO:0005769,early endosome,2.0
5074,CHMP1A,GO:0005771,multivesicular body,2.0
5075,CHMP1A,GO:0005815,microtubule organizing center,2.0
5076,CHMP1A,GO:0005828,kinetochore microtubule,2.0
5077,CHMP1A,GO:0005829,cytosol,2.0
5078,CHMP1A,GO:0005886,plasma membrane,2.0
5079,CHMP1A,GO:0006914,autophagy,2.0
5080,CHMP1A,GO:0006997,nucleus organization,2.0
5081,CHMP1A,GO:0007076,mitotic chromosome condensation,2.0
5082,CHMP1A,GO:0007080,mitotic metaphase plate congression,2.0
5083,CHMP1A,GO:0008237,metallopeptidase activity,2.0
5084,CHMP1A,GO:0008270,zinc ion binding,2.0
5085,CHMP1A,GO:0010629,negative regulation of gene expression,2.0
5086,CHMP1A,GO:0010824,regulation of centrosome duplication,2.0
5087,CHMP1A,GO:0012505,endomembrane system,2.0
5088,CHMP1A,GO:0015031,protein transport,2.0
5089,CHMP1A,GO:0016192,vesicle-mediated transport,2.0
5090,CHMP1A,GO:0016363,nuclear matrix,2.0
5091,CHMP1A,GO:0019904,protein domain specific binding,2.0
5092,CHMP1A,GO:0030496,midbody,2.0
5093,CHMP1A,GO:0031468,nuclear membrane reassembly,2.0
5094,CHMP1A,GO:0032509,endosome transport via multivesicular body sorting pathway,2.0
5095,CHMP1A,GO:0032585,multivesicular body membrane,2.0
5096,CHMP1A,GO:0036258,multivesicular body assembly,2.0
5098,CHMP1A,GO:0039702,viral budding via host ESCRT complex,2.0
5100,CHMP1A,GO:0042802,identical protein binding,2.0
5101,CHMP1A,GO:0042803,protein homodimerization activity,2.0
5102,CHMP1A,GO:0043162,ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway,2.0
5103,CHMP1A,GO:0045324,late endosome to vacuole transport,2.0
5104,CHMP1A,GO:0046761,viral budding from plasma membrane,2.0
5105,CHMP1A,GO:0051301,cell division,2.0
5106,CHMP1A,GO:0051469,vesicle fusion with vacuole,2.0
5107,CHMP1A,GO:0060548,negative regulation of cell death,2.0
5108,CHMP1A,GO:0061763,multivesicular body-lysosome fusion,2.0
5109,CHMP1A,GO:0061952,midbody abscission,2.0
5110,CHMP1A,GO:0070062,extracellular exosome,2.0
5111,CHMP1A,GO:0071985,multivesicular body sorting pathway,2.0
5112,CHMP1A,GO:0090148,membrane fission,2.0
5113,CHMP1A,GO:0097352,autophagosome maturation,2.0
5114,CHMP1A,GO:1901673,regulation of mitotic spindle assembly,2.0
5115,CHMP1A,GO:1902774,late endosome to lysosome transport,2.0
5116,CHMP1A,GO:1904903,ESCRT III complex disassembly,2.0
5117,CHMP1A,GO:1904930,amphisome membrane,2.0
5118,CHRM3,GO:0003056,regulation of vascular associated smooth muscle contraction,2.0
5119,CHRM3,GO:0004435,phosphatidylinositol phospholipase C activity,2.0
5120,CHRM3,GO:0004993,G protein-coupled serotonin receptor activity,2.0
5121,CHRM3,GO:0005515,protein binding,2.0
5122,CHRM3,GO:0005789,endoplasmic reticulum membrane,2.0
5123,CHRM3,GO:0005886,plasma membrane,2.0
5127,CHRM3,GO:0006939,smooth muscle contraction,2.0
5128,CHRM3,GO:0007165,signal transduction,2.0
5129,CHRM3,GO:0007186,G protein-coupled receptor signaling pathway,2.0
5130,CHRM3,GO:0007187,"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger",2.0
5131,CHRM3,GO:0007197,adenylate cyclase-inhibiting G protein-coupled acetylcholine receptor signaling pathway,2.0
5132,CHRM3,GO:0007213,G protein-coupled acetylcholine receptor signaling pathway,2.0
5133,CHRM3,GO:0007268,chemical synaptic transmission,2.0
5134,CHRM3,GO:0007271,"synaptic transmission, cholinergic",2.0
5135,CHRM3,GO:0007399,nervous system development,2.0
5136,CHRM3,GO:0009925,basal plasma membrane,2.0
5137,CHRM3,GO:0016323,basolateral plasma membrane,2.0
5138,CHRM3,GO:0016907,G protein-coupled acetylcholine receptor activity,2.0
5140,CHRM3,GO:0019722,calcium-mediated signaling,2.0
5141,CHRM3,GO:0030425,dendrite,2.0
5142,CHRM3,GO:0030594,neurotransmitter receptor activity,2.0
5143,CHRM3,GO:0032412,regulation of ion transmembrane transporter activity,2.0
5144,CHRM3,GO:0036211,protein modification process,2.0
5145,CHRM3,GO:0038023,signaling receptor activity,2.0
5146,CHRM3,GO:0042166,acetylcholine binding,2.0
5147,CHRM3,GO:0045202,synapse,2.0
5148,CHRM3,GO:0045211,postsynaptic membrane,2.0
5149,CHRM3,GO:0045987,positive regulation of smooth muscle contraction,2.0
5150,CHRM3,GO:0046541,saliva secretion,2.0
5151,CHRM3,GO:0095500,acetylcholine receptor signaling pathway,2.0
5152,CHRM3,GO:0098664,G protein-coupled serotonin receptor signaling pathway,2.0
5153,CHRNA7,GO:0001540,amyloid-beta binding,2.0
5154,CHRNA7,GO:0001666,response to hypoxia,2.0
5155,CHRNA7,GO:0001934,positive regulation of protein phosphorylation,2.0
5156,CHRNA7,GO:0005216,ion channel activity,2.0
5157,CHRNA7,GO:0005231,excitatory extracellular ligand-gated ion channel activity,2.0
5158,CHRNA7,GO:0005262,calcium channel activity,2.0
5159,CHRNA7,GO:0005515,protein binding,2.0
5160,CHRNA7,GO:0005886,plasma membrane,2.0
5163,CHRNA7,GO:0005892,acetylcholine-gated channel complex,2.0
5165,CHRNA7,GO:0006811,ion transport,2.0
5166,CHRNA7,GO:0006816,calcium ion transport,2.0
5168,CHRNA7,GO:0006874,cellular calcium ion homeostasis,2.0
5169,CHRNA7,GO:0007165,signal transduction,2.0
5171,CHRNA7,GO:0007268,chemical synaptic transmission,2.0
5172,CHRNA7,GO:0007271,"synaptic transmission, cholinergic",2.0
5173,CHRNA7,GO:0007611,learning or memory,2.0
5174,CHRNA7,GO:0007613,memory,2.0
5176,CHRNA7,GO:0007614,short-term memory,2.0
5177,CHRNA7,GO:0008284,positive regulation of cell population proliferation,2.0
5178,CHRNA7,GO:0015464,acetylcholine receptor activity,2.0
5179,CHRNA7,GO:0015643,toxic substance binding,2.0
5180,CHRNA7,GO:0016020,membrane,2.0
5181,CHRNA7,GO:0017081,chloride channel regulator activity,2.0
5182,CHRNA7,GO:0022848,acetylcholine-gated cation-selective channel activity,2.0
5185,CHRNA7,GO:0030594,neurotransmitter receptor activity,2.0
5186,CHRNA7,GO:0032720,negative regulation of tumor necrosis factor production,2.0
5188,CHRNA7,GO:0034220,ion transmembrane transport,2.0
5190,CHRNA7,GO:0035094,response to nicotine,2.0
5192,CHRNA7,GO:0042166,acetylcholine binding,2.0
5194,CHRNA7,GO:0042391,regulation of membrane potential,2.0
5195,CHRNA7,GO:0042803,protein homodimerization activity,2.0
5196,CHRNA7,GO:0043005,neuron projection,2.0
5197,CHRNA7,GO:0043410,positive regulation of MAPK cascade,2.0
5198,CHRNA7,GO:0044853,plasma membrane raft,2.0
5199,CHRNA7,GO:0045202,synapse,2.0
5200,CHRNA7,GO:0045211,postsynaptic membrane,2.0
5201,CHRNA7,GO:0045766,positive regulation of angiogenesis,2.0
5202,CHRNA7,GO:0050808,synapse organization,2.0
5203,CHRNA7,GO:0050877,nervous system process,2.0
5204,CHRNA7,GO:0050890,cognition,2.0
5206,CHRNA7,GO:0050893,sensory processing,2.0
5207,CHRNA7,GO:0051247,positive regulation of protein metabolic process,2.0
5208,CHRNA7,GO:0060079,excitatory postsynaptic potential,2.0
5209,CHRNA7,GO:0070374,positive regulation of ERK1 and ERK2 cascade,2.0
5210,CHRNA7,GO:0070588,calcium ion transmembrane transport,2.0
5211,CHRNA7,GO:0095500,acetylcholine receptor signaling pathway,2.0
5212,CHRNA7,GO:0097061,dendritic spine organization,2.0
5213,CHRNA7,GO:0098794,postsynapse,2.0
5214,CHRNA7,GO:0098815,modulation of excitatory postsynaptic potential,2.0
5215,CHRNA7,GO:0140059,dendrite arborization,2.0
5216,CHRNA7,GO:1900273,positive regulation of long-term synaptic potentiation,2.0
5217,CHRNA7,GO:1901214,regulation of neuron death,2.0
5218,CHRNA7,GO:1902004,positive regulation of amyloid-beta formation,2.0
5219,CHRNA7,GO:1902430,negative regulation of amyloid-beta formation,2.0
5220,CHRNA7,GO:1902991,regulation of amyloid precursor protein catabolic process,2.0
5221,CHRNA7,GO:1904315,transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential,2.0
5222,CHRNA7,GO:1904645,response to amyloid-beta,2.0
5223,CHRNA7,GO:1905144,response to acetylcholine,2.0
5225,CHRNA7,GO:1905906,regulation of amyloid fibril formation,2.0
5226,CHRNA7,GO:1905920,positive regulation of CoA-transferase activity,2.0
5227,CHRNA7,GO:2000463,positive regulation of excitatory postsynaptic potential,2.0
5228,CHRNB3,GO:0005231,excitatory extracellular ligand-gated ion channel activity,2.0
5229,CHRNB3,GO:0005886,plasma membrane,2.0
5231,CHRNB3,GO:0005892,acetylcholine-gated channel complex,2.0
5232,CHRNB3,GO:0007165,signal transduction,2.0
5233,CHRNB3,GO:0007268,chemical synaptic transmission,2.0
5234,CHRNB3,GO:0007271,"synaptic transmission, cholinergic",2.0
5235,CHRNB3,GO:0015267,channel activity,2.0
5236,CHRNB3,GO:0015464,acetylcholine receptor activity,2.0
5237,CHRNB3,GO:0016020,membrane,2.0
5238,CHRNB3,GO:0022848,acetylcholine-gated cation-selective channel activity,2.0
5239,CHRNB3,GO:0030594,neurotransmitter receptor activity,2.0
5240,CHRNB3,GO:0034220,ion transmembrane transport,2.0
5241,CHRNB3,GO:0035094,response to nicotine,2.0
5242,CHRNB3,GO:0042166,acetylcholine binding,2.0
5243,CHRNB3,GO:0042391,regulation of membrane potential,2.0
5244,CHRNB3,GO:0043005,neuron projection,2.0
5245,CHRNB3,GO:0045202,synapse,2.0
5246,CHRNB3,GO:0045211,postsynaptic membrane,2.0
5247,CHRNB3,GO:0050877,nervous system process,2.0
5248,CHRNB3,GO:0060079,excitatory postsynaptic potential,2.0
5249,CHRNB3,GO:0098691,dopaminergic synapse,2.0
5250,CHRNB3,GO:0098793,presynapse,2.0
5251,CHRNB3,GO:0099171,presynaptic modulation of chemical synaptic transmission,2.0
5252,CHRNB3,GO:1901363,heterocyclic compound binding,2.0
5253,CHRNB3,GO:1904315,transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential,2.0
5273,CIB2,GO:0000287,magnesium ion binding,2.0
5275,CIB2,GO:0001750,photoreceptor outer segment,2.0
5276,CIB2,GO:0001917,photoreceptor inner segment,2.0
5277,CIB2,GO:0005178,integrin binding,2.0
5278,CIB2,GO:0005509,calcium ion binding,2.0
5280,CIB2,GO:0005515,protein binding,2.0
5281,CIB2,GO:0005737,cytoplasm,2.0
5283,CIB2,GO:0005927,muscle tendon junction,2.0
5284,CIB2,GO:0007204,positive regulation of cytosolic calcium ion concentration,2.0
5285,CIB2,GO:0031594,neuromuscular junction,2.0
5286,CIB2,GO:0032420,stereocilium,2.0
5288,CIB2,GO:0032437,cuticular plate,2.0
5289,CIB2,GO:0042383,sarcolemma,2.0
5290,CIB2,GO:0042803,protein homodimerization activity,2.0
5291,CIB2,GO:0045494,photoreceptor cell maintenance,2.0
5292,CIB2,GO:0055074,calcium ion homeostasis,2.0
5294,CIB2,GO:0071318,cellular response to ATP,2.0
5295,CIB2,GO:0071944,cell periphery,2.0
5296,CIB2,GO:0072562,blood microparticle,2.0
5311,CLASP1,GO:0000226,microtubule cytoskeleton organization,2.0
5314,CLASP1,GO:0000776,kinetochore,2.0
5316,CLASP1,GO:0001578,microtubule bundle formation,2.0
5317,CLASP1,GO:0002162,dystroglycan binding,2.0
5318,CLASP1,GO:0005515,protein binding,2.0
5319,CLASP1,GO:0005794,Golgi apparatus,2.0
5320,CLASP1,GO:0005813,centrosome,2.0
5321,CLASP1,GO:0005815,microtubule organizing center,2.0
5322,CLASP1,GO:0005828,kinetochore microtubule,2.0
5323,CLASP1,GO:0005829,cytosol,2.0
5324,CLASP1,GO:0005876,spindle microtubule,2.0
5326,CLASP1,GO:0005881,cytoplasmic microtubule,2.0
5328,CLASP1,GO:0005925,focal adhesion,2.0
5329,CLASP1,GO:0005938,cell cortex,2.0
5330,CLASP1,GO:0006903,vesicle targeting,2.0
5331,CLASP1,GO:0007020,microtubule nucleation,2.0
5332,CLASP1,GO:0007026,negative regulation of microtubule depolymerization,2.0
5334,CLASP1,GO:0007030,Golgi organization,2.0
5335,CLASP1,GO:0007052,mitotic spindle organization,2.0
5336,CLASP1,GO:0007163,establishment or maintenance of cell polarity,2.0
5337,CLASP1,GO:0008017,microtubule binding,2.0
5340,CLASP1,GO:0010458,exit from mitosis,2.0
5341,CLASP1,GO:0010470,regulation of gastrulation,2.0
5342,CLASP1,GO:0010634,positive regulation of epithelial cell migration,2.0
5343,CLASP1,GO:0010717,regulation of epithelial to mesenchymal transition,2.0
5344,CLASP1,GO:0016020,membrane,2.0
5345,CLASP1,GO:0030953,astral microtubule organization,2.0
5346,CLASP1,GO:0030981,cortical microtubule cytoskeleton,2.0
5347,CLASP1,GO:0031023,microtubule organizing center organization,2.0
5348,CLASP1,GO:0031111,negative regulation of microtubule polymerization or depolymerization,2.0
5349,CLASP1,GO:0031116,positive regulation of microtubule polymerization,2.0
5350,CLASP1,GO:0031592,centrosomal corona,2.0
5351,CLASP1,GO:0034453,microtubule anchoring,2.0
5352,CLASP1,GO:0035371,microtubule plus-end,2.0
5353,CLASP1,GO:0040001,establishment of mitotic spindle localization,2.0
5355,CLASP1,GO:0043515,kinetochore binding,2.0
5357,CLASP1,GO:0045180,basal cortex,2.0
5359,CLASP1,GO:0045921,positive regulation of exocytosis,2.0
5360,CLASP1,GO:0051010,microtubule plus-end binding,2.0
5361,CLASP1,GO:0051294,establishment of spindle orientation,2.0
5364,CLASP1,GO:0051301,cell division,2.0
5365,CLASP1,GO:0051497,negative regulation of stress fiber assembly,2.0
5366,CLASP1,GO:0051893,regulation of focal adhesion assembly,2.0
5367,CLASP1,GO:0070507,regulation of microtubule cytoskeleton organization,2.0
5368,CLASP1,GO:0072686,mitotic spindle,2.0
5369,CLASP1,GO:0090091,positive regulation of extracellular matrix disassembly,2.0
5370,CLASP1,GO:0090162,establishment of epithelial cell polarity,2.0
5371,CLASP1,GO:0090307,mitotic spindle assembly,2.0
5373,CLASP1,GO:1903690,"negative regulation of wound healing, spreading of epidermal cells",2.0
5374,CLASP1,GO:1904261,positive regulation of basement membrane assembly involved in embryonic body morphogenesis,2.0
5376,CLCN4,GO:0005247,voltage-gated chloride channel activity,2.0
5377,CLCN4,GO:0005254,chloride channel activity,2.0
5378,CLCN4,GO:0005515,protein binding,2.0
5379,CLCN4,GO:0005524,ATP binding,2.0
5380,CLCN4,GO:0005765,lysosomal membrane,2.0
5381,CLCN4,GO:0005769,early endosome,2.0
5382,CLCN4,GO:0005789,endoplasmic reticulum membrane,2.0
5383,CLCN4,GO:0005794,Golgi apparatus,2.0
5384,CLCN4,GO:0005886,plasma membrane,2.0
5385,CLCN4,GO:0006821,chloride transport,2.0
5387,CLCN4,GO:0008021,synaptic vesicle,2.0
5388,CLCN4,GO:0010008,endosome membrane,2.0
5390,CLCN4,GO:0015297,antiporter activity,2.0
5393,CLCN4,GO:0015299,solute:proton antiporter activity,2.0
5394,CLCN4,GO:0031901,early endosome membrane,2.0
5395,CLCN4,GO:0031902,late endosome membrane,2.0
5396,CLCN4,GO:0034220,ion transmembrane transport,2.0
5397,CLCN4,GO:0055037,recycling endosome,2.0
5398,CLCN4,GO:0055038,recycling endosome membrane,2.0
5399,CLCN4,GO:0097546,ciliary base,2.0
5400,CLCN4,GO:1902476,chloride transmembrane transport,2.0
5401,CLCN4,GO:1902600,proton transmembrane transport,2.0
5402,CLCN4,GO:1905515,non-motile cilium assembly,2.0
5403,CLN8,GO:0005515,protein binding,2.0
5404,CLN8,GO:0005739,mitochondrion,2.0
5405,CLN8,GO:0005783,endoplasmic reticulum,2.0
5407,CLN8,GO:0005789,endoplasmic reticulum membrane,2.0
5408,CLN8,GO:0005793,endoplasmic reticulum-Golgi intermediate compartment,2.0
5409,CLN8,GO:0006644,phospholipid metabolic process,2.0
5411,CLN8,GO:0006672,ceramide metabolic process,2.0
5412,CLN8,GO:0006869,lipid transport,2.0
5413,CLN8,GO:0007006,mitochondrial membrane organization,2.0
5414,CLN8,GO:0007040,lysosome organization,2.0
5415,CLN8,GO:0007399,nervous system development,2.0
5417,CLN8,GO:0007601,visual perception,2.0
5418,CLN8,GO:0007628,adult walking behavior,2.0
5419,CLN8,GO:0008203,cholesterol metabolic process,2.0
5420,CLN8,GO:0008306,associative learning,2.0
5421,CLN8,GO:0008361,regulation of cell size,2.0
5422,CLN8,GO:0008610,lipid biosynthetic process,2.0
5423,CLN8,GO:0016020,membrane,2.0
5424,CLN8,GO:0021523,somatic motor neuron differentiation,2.0
5425,CLN8,GO:0030163,protein catabolic process,2.0
5426,CLN8,GO:0033116,endoplasmic reticulum-Golgi intermediate compartment membrane,2.0
5427,CLN8,GO:0035176,social behavior,2.0
5428,CLN8,GO:0043524,negative regulation of neuron apoptotic process,2.0
5429,CLN8,GO:0044265,cellular macromolecule catabolic process,2.0
5430,CLN8,GO:0045494,photoreceptor cell maintenance,2.0
5431,CLN8,GO:0045861,negative regulation of proteolysis,2.0
5432,CLN8,GO:0046513,ceramide biosynthetic process,2.0
5433,CLN8,GO:0050881,musculoskeletal movement,2.0
5434,CLN8,GO:0050884,neuromuscular process controlling posture,2.0
5435,CLN8,GO:0050885,neuromuscular process controlling balance,2.0
5436,CLN8,GO:0051935,glutamate reuptake,2.0
5437,CLN8,GO:0055088,lipid homeostasis,2.0
5438,CLN8,GO:0060041,retina development in camera-type eye,2.0
5439,CLN8,GO:0060052,neurofilament cytoskeleton organization,2.0
5440,CLN8,GO:0097001,ceramide binding,2.0
5442,CLN8,GO:0097473,retinal rod cell apoptotic process,2.0
5443,CLN8,GO:0098793,presynapse,2.0
5444,CLTCL1,GO:0000278,mitotic cell cycle,2.0
5446,CLTCL1,GO:0005198,structural molecule activity,2.0
5447,CLTCL1,GO:0005515,protein binding,2.0
5448,CLTCL1,GO:0005769,early endosome,2.0
5449,CLTCL1,GO:0005770,late endosome,2.0
5450,CLTCL1,GO:0005802,trans-Golgi network,2.0
5451,CLTCL1,GO:0005819,spindle,2.0
5452,CLTCL1,GO:0005829,cytosol,2.0
5453,CLTCL1,GO:0005886,plasma membrane,2.0
5454,CLTCL1,GO:0005905,clathrin-coated pit,2.0
5455,CLTCL1,GO:0006886,intracellular protein transport,2.0
5456,CLTCL1,GO:0006898,receptor-mediated endocytosis,2.0
5458,CLTCL1,GO:0009653,anatomical structure morphogenesis,2.0
5459,CLTCL1,GO:0016020,membrane,2.0
5460,CLTCL1,GO:0030130,clathrin coat of trans-Golgi network vesicle,2.0
5461,CLTCL1,GO:0030135,coated vesicle,2.0
5462,CLTCL1,GO:0030136,clathrin-coated vesicle,2.0
5463,CLTCL1,GO:0032051,clathrin light chain binding,2.0
5464,CLTCL1,GO:0042147,"retrograde transport, endosome to Golgi",2.0
5465,CLTCL1,GO:0045334,clathrin-coated endocytic vesicle,2.0
5467,CLTCL1,GO:0046326,positive regulation of glucose import,2.0
5468,CLTCL1,GO:0055037,recycling endosome,2.0
5469,CLTCL1,GO:0070062,extracellular exosome,2.0
5470,CLTCL1,GO:0071439,clathrin complex,2.0
5471,CLTCL1,GO:0097443,sorting endosome,2.0
5472,CMIP,GO:0001701,in utero embryonic development,2.0
5473,CMIP,GO:0005515,protein binding,2.0
5474,CMIP,GO:0005654,nucleoplasm,2.0
5476,CMIP,GO:0005829,cytosol,2.0
5478,CMPK2,GO:0004127,cytidylate kinase activity,2.0
5480,CMPK2,GO:0004550,nucleoside diphosphate kinase activity,2.0
5482,CMPK2,GO:0004798,thymidylate kinase activity,2.0
5483,CMPK2,GO:0005524,ATP binding,2.0
5484,CMPK2,GO:0005654,nucleoplasm,2.0
5485,CMPK2,GO:0005737,cytoplasm,2.0
5486,CMPK2,GO:0005739,mitochondrion,2.0
5488,CMPK2,GO:0006165,nucleoside diphosphate phosphorylation,2.0
5489,CMPK2,GO:0006227,dUDP biosynthetic process,2.0
5490,CMPK2,GO:0006233,dTDP biosynthetic process,2.0
5491,CMPK2,GO:0006235,dTTP biosynthetic process,2.0
5492,CMPK2,GO:0009041,uridylate kinase activity,2.0
5493,CMPK2,GO:0009142,nucleoside triphosphate biosynthetic process,2.0
5494,CMPK2,GO:0033862,UMP kinase activity,2.0
5495,CMPK2,GO:0036430,CMP kinase activity,2.0
5496,CMPK2,GO:0036431,dCMP kinase activity,2.0
5497,CMPK2,GO:0046940,nucleoside monophosphate phosphorylation,2.0
5498,CMPK2,GO:0071222,cellular response to lipopolysaccharide,2.0
5499,CNGB3,GO:0001750,photoreceptor outer segment,2.0
5500,CNGB3,GO:0005222,intracellular cAMP-activated cation channel activity,2.0
5501,CNGB3,GO:0005223,intracellular cGMP-activated cation channel activity,2.0
5503,CNGB3,GO:0005886,plasma membrane,2.0
5504,CNGB3,GO:0006812,cation transport,2.0
5505,CNGB3,GO:0007165,signal transduction,2.0
5506,CNGB3,GO:0007601,visual perception,2.0
5507,CNGB3,GO:0017071,intracellular cyclic nucleotide activated cation channel complex,2.0
5508,CNGB3,GO:0030553,cGMP binding,2.0
5510,CNGB3,GO:0044877,protein-containing complex binding,2.0
5511,CNGB3,GO:0098655,cation transmembrane transport,2.0
5512,CNGB3,GO:1902495,transmembrane transporter complex,2.0
5513,CNKSR2,GO:0005515,protein binding,2.0
5514,CNKSR2,GO:0005737,cytoplasm,2.0
5515,CNKSR2,GO:0005886,plasma membrane,2.0
5516,CNKSR2,GO:0009966,regulation of signal transduction,2.0
5517,CNKSR2,GO:0019901,protein kinase binding,2.0
5518,CNKSR2,GO:0035556,intracellular signal transduction,2.0
5519,CNKSR2,GO:0042802,identical protein binding,2.0
5520,CNKSR2,GO:0043005,neuron projection,2.0
5521,CNKSR2,GO:0043025,neuronal cell body,2.0
5522,CNKSR2,GO:0070062,extracellular exosome,2.0
5523,CNKSR2,GO:0098978,glutamatergic synapse,2.0
5524,CNKSR2,GO:0099147,extrinsic component of postsynaptic density membrane,2.0
5525,CNKSR2,GO:0099173,postsynapse organization,2.0
5526,CNOT1,GO:0000122,negative regulation of transcription by RNA polymerase II,2.0
5527,CNOT1,GO:0000288,"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay",2.0
5528,CNOT1,GO:0000289,nuclear-transcribed mRNA poly(A) tail shortening,2.0
5529,CNOT1,GO:0000932,P-body,2.0
5532,CNOT1,GO:0001829,trophectodermal cell differentiation,2.0
5533,CNOT1,GO:0003723,RNA binding,2.0
5534,CNOT1,GO:0004535,poly(A)-specific ribonuclease activity,2.0
5535,CNOT1,GO:0005515,protein binding,2.0
5536,CNOT1,GO:0005615,extracellular space,2.0
5537,CNOT1,GO:0005634,nucleus,2.0
5538,CNOT1,GO:0005829,cytosol,2.0
5540,CNOT1,GO:0010606,positive regulation of cytoplasmic mRNA processing body assembly,2.0
5541,CNOT1,GO:0016020,membrane,2.0
5542,CNOT1,GO:0017148,negative regulation of translation,2.0
5543,CNOT1,GO:0019904,protein domain specific binding,2.0
5544,CNOT1,GO:0030014,CCR4-NOT complex,2.0
5546,CNOT1,GO:0030015,CCR4-NOT core complex,2.0
5547,CNOT1,GO:0030331,nuclear estrogen receptor binding,2.0
5548,CNOT1,GO:0033147,negative regulation of intracellular estrogen receptor signaling pathway,2.0
5549,CNOT1,GO:0035195,miRNA-mediated gene silencing,2.0
5550,CNOT1,GO:0042974,nuclear retinoic acid receptor binding,2.0
5551,CNOT1,GO:0048387,negative regulation of retinoic acid receptor signaling pathway,2.0
5552,CNOT1,GO:0060090,molecular adaptor activity,2.0
5554,CNOT1,GO:0060213,positive regulation of nuclear-transcribed mRNA poly(A) tail shortening,2.0
5556,CNOT1,GO:0061014,positive regulation of mRNA catabolic process,2.0
5557,CNOT1,GO:0070016,armadillo repeat domain binding,2.0
5558,CNOT1,GO:0090503,"RNA phosphodiester bond hydrolysis, exonucleolytic",2.0
5559,CNOT1,GO:1900153,"positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay",2.0
5560,CNOT1,GO:2000036,regulation of stem cell population maintenance,2.0
5577,CNR1,GO:0002866,positive regulation of acute inflammatory response to antigenic stimulus,2.0
5578,CNR1,GO:0004930,G protein-coupled receptor activity,2.0
5579,CNR1,GO:0004949,cannabinoid receptor activity,2.0
5581,CNR1,GO:0005515,protein binding,2.0
5582,CNR1,GO:0005737,cytoplasm,2.0
5583,CNR1,GO:0005741,mitochondrial outer membrane,2.0
5584,CNR1,GO:0005886,plasma membrane,2.0
5587,CNR1,GO:0007187,"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger",2.0
5588,CNR1,GO:0007188,adenylate cyclase-modulating G protein-coupled receptor signaling pathway,2.0
5589,CNR1,GO:0007189,adenylate cyclase-activating G protein-coupled receptor signaling pathway,2.0
5590,CNR1,GO:0007283,spermatogenesis,2.0
5591,CNR1,GO:0007413,axonal fasciculation,2.0
5592,CNR1,GO:0007568,aging,2.0
5593,CNR1,GO:0007584,response to nutrient,2.0
5594,CNR1,GO:0007613,memory,2.0
5595,CNR1,GO:0010976,positive regulation of neuron projection development,2.0
5596,CNR1,GO:0014063,negative regulation of serotonin secretion,2.0
5597,CNR1,GO:0015629,actin cytoskeleton,2.0
5598,CNR1,GO:0019222,regulation of metabolic process,2.0
5599,CNR1,GO:0019233,sensory perception of pain,2.0
5600,CNR1,GO:0030426,growth cone,2.0
5601,CNR1,GO:0031622,positive regulation of fever generation,2.0
5602,CNR1,GO:0031999,negative regulation of fatty acid beta-oxidation,2.0
5603,CNR1,GO:0032228,"regulation of synaptic transmission, GABAergic",2.0
5604,CNR1,GO:0032496,response to lipopolysaccharide,2.0
5605,CNR1,GO:0033004,negative regulation of mast cell activation,2.0
5606,CNR1,GO:0033602,negative regulation of dopamine secretion,2.0
5607,CNR1,GO:0035094,response to nicotine,2.0
5608,CNR1,GO:0038171,cannabinoid signaling pathway,2.0
5610,CNR1,GO:0042220,response to cocaine,2.0
5611,CNR1,GO:0042593,glucose homeostasis,2.0
5612,CNR1,GO:0042734,presynaptic membrane,2.0
5613,CNR1,GO:0042802,identical protein binding,2.0
5614,CNR1,GO:0043065,positive regulation of apoptotic process,2.0
5615,CNR1,GO:0043278,response to morphine,2.0
5616,CNR1,GO:0045121,membrane raft,2.0
5617,CNR1,GO:0045471,response to ethanol,2.0
5618,CNR1,GO:0045759,negative regulation of action potential,2.0
5619,CNR1,GO:0045776,negative regulation of blood pressure,2.0
5620,CNR1,GO:0045777,positive regulation of blood pressure,2.0
5621,CNR1,GO:0050796,regulation of insulin secretion,2.0
5622,CNR1,GO:0051001,negative regulation of nitric-oxide synthase activity,2.0
5623,CNR1,GO:0051966,"regulation of synaptic transmission, glutamatergic",2.0
5624,CNR1,GO:0060135,maternal process involved in female pregnancy,2.0
5625,CNR1,GO:0060259,regulation of feeding behavior,2.0
5626,CNR1,GO:0060405,regulation of penile erection,2.0
5627,CNR1,GO:0098921,retrograde trans-synaptic signaling by endocannabinoid,2.0
5628,CNR1,GO:0098978,glutamatergic synapse,2.0
5629,CNR1,GO:0098982,GABA-ergic synapse,2.0
5630,CNR1,GO:0099509,regulation of presynaptic cytosolic calcium ion concentration,2.0
5631,CNR1,GO:0099553,"trans-synaptic signaling by endocannabinoid, modulating synaptic transmission",2.0
5632,CNTN3,GO:0005576,extracellular region,2.0
5633,CNTN3,GO:0005886,plasma membrane,2.0
5634,CNTN3,GO:0007155,cell adhesion,2.0
5635,CNTN3,GO:0043005,neuron projection,2.0
5636,CNTN4,GO:0005576,extracellular region,2.0
5637,CNTN4,GO:0005886,plasma membrane,2.0
5640,CNTN4,GO:0007156,homophilic cell adhesion via plasma membrane adhesion molecules,2.0
5641,CNTN4,GO:0007158,neuron cell-cell adhesion,2.0
5642,CNTN4,GO:0007399,nervous system development,2.0
5643,CNTN4,GO:0007409,axonogenesis,2.0
5644,CNTN4,GO:0007411,axon guidance,2.0
5646,CNTN4,GO:0007413,axonal fasciculation,2.0
5647,CNTN4,GO:0007420,brain development,2.0
5648,CNTN4,GO:0030424,axon,2.0
5650,CNTN4,GO:0031175,neuron projection development,2.0
5651,CNTN4,GO:0045665,negative regulation of neuron differentiation,2.0
5652,CNTN4,GO:0048167,regulation of synaptic plasticity,2.0
5653,CNTN4,GO:0070593,dendrite self-avoidance,2.0
5654,CNTN4,GO:0098632,cell-cell adhesion mediator activity,2.0
5655,CNTN5,GO:0005576,extracellular region,2.0
5656,CNTN5,GO:0005886,plasma membrane,2.0
5658,CNTN5,GO:0007411,axon guidance,2.0
5659,CNTN5,GO:0007420,brain development,2.0
5660,CNTN5,GO:0007605,sensory perception of sound,2.0
5661,CNTN5,GO:0030424,axon,2.0
5662,CNTN5,GO:0042734,presynaptic membrane,2.0
5663,CNTN5,GO:0098609,cell-cell adhesion,2.0
5664,CNTN5,GO:0098632,cell-cell adhesion mediator activity,2.0
5665,CNTN5,GO:0098982,GABA-ergic synapse,2.0
5666,CNTN5,GO:0099054,presynapse assembly,2.0
5667,CNTN6,GO:0005886,plasma membrane,2.0
5668,CNTN6,GO:0007155,cell adhesion,2.0
5669,CNTN6,GO:0007156,homophilic cell adhesion via plasma membrane adhesion molecules,2.0
5670,CNTN6,GO:0007219,Notch signaling pathway,2.0
5671,CNTN6,GO:0007411,axon guidance,2.0
5672,CNTN6,GO:0007417,central nervous system development,2.0
5673,CNTN6,GO:0030424,axon,2.0
5674,CNTN6,GO:0042734,presynaptic membrane,2.0
5675,CNTN6,GO:0045747,positive regulation of Notch signaling pathway,2.0
5676,CNTN6,GO:0070593,dendrite self-avoidance,2.0
5677,CNTN6,GO:0098632,cell-cell adhesion mediator activity,2.0
5678,CNTN6,GO:0098688,parallel fiber to Purkinje cell synapse,2.0
5679,CNTNAP2,GO:0005515,protein binding,2.0
5680,CNTNAP2,GO:0005769,early endosome,2.0
5681,CNTNAP2,GO:0005794,Golgi apparatus,2.0
5682,CNTNAP2,GO:0007155,cell adhesion,2.0
5683,CNTNAP2,GO:0007420,brain development,2.0
5684,CNTNAP2,GO:0007612,learning,2.0
5685,CNTNAP2,GO:0008038,neuron recognition,2.0
5686,CNTNAP2,GO:0008076,voltage-gated potassium channel complex,2.0
5688,CNTNAP2,GO:0008283,cell population proliferation,2.0
5689,CNTNAP2,GO:0009986,cell surface,2.0
5690,CNTNAP2,GO:0016020,membrane,2.0
5692,CNTNAP2,GO:0019226,transmission of nerve impulse,2.0
5693,CNTNAP2,GO:0019899,enzyme binding,2.0
5694,CNTNAP2,GO:0021756,striatum development,2.0
5695,CNTNAP2,GO:0021761,limbic system development,2.0
5696,CNTNAP2,GO:0021794,thalamus development,2.0
5697,CNTNAP2,GO:0021987,cerebral cortex development,2.0
5698,CNTNAP2,GO:0030424,axon,2.0
5699,CNTNAP2,GO:0030425,dendrite,2.0
5700,CNTNAP2,GO:0030534,adult behavior,2.0
5701,CNTNAP2,GO:0030673,axolemma,2.0
5702,CNTNAP2,GO:0031175,neuron projection development,2.0
5703,CNTNAP2,GO:0033010,paranodal junction,2.0
5704,CNTNAP2,GO:0035176,social behavior,2.0
5705,CNTNAP2,GO:0042297,vocal learning,2.0
5706,CNTNAP2,GO:0043025,neuronal cell body,2.0
5707,CNTNAP2,GO:0043204,perikaryon,2.0
5708,CNTNAP2,GO:0044224,juxtaparanode region of axon,2.0
5709,CNTNAP2,GO:0045163,clustering of voltage-gated potassium channels,2.0
5710,CNTNAP2,GO:0048812,neuron projection morphogenesis,2.0
5711,CNTNAP2,GO:0071109,superior temporal gyrus development,2.0
5712,CNTNAP2,GO:0071205,protein localization to juxtaparanode region of axon,2.0
5713,CNTNAP2,GO:0071625,vocalization behavior,2.0
5714,CNTNAP2,GO:1903598,positive regulation of gap junction assembly,2.0
5715,CNTNAP3,GO:0005576,extracellular region,2.0
5716,CNTNAP3,GO:0005886,plasma membrane,2.0
5717,CNTNAP3,GO:0007155,cell adhesion,2.0
5718,CNTNAP3,GO:0008037,cell recognition,2.0
5719,CNTNAP3,GO:0016020,membrane,2.0
5720,CNTNAP4,GO:0007155,cell adhesion,2.0
5721,CNTNAP4,GO:0032225,"regulation of synaptic transmission, dopaminergic",2.0
5722,CNTNAP4,GO:0032228,"regulation of synaptic transmission, GABAergic",2.0
5723,CNTNAP4,GO:0042734,presynaptic membrane,2.0
5724,CNTNAP4,GO:0042995,cell projection,2.0
5725,CNTNAP4,GO:2000821,regulation of grooming behavior,2.0
5726,CNTNAP5,GO:0007155,cell adhesion,2.0
5727,CNTNAP5,GO:0016020,membrane,2.0
5728,COL28A1,GO:0004867,serine-type endopeptidase inhibitor activity,2.0
5729,COL28A1,GO:0005201,extracellular matrix structural constituent,2.0
5730,COL28A1,GO:0005576,extracellular region,2.0
5731,COL28A1,GO:0005581,collagen trimer,2.0
5732,COL28A1,GO:0005604,basement membrane,2.0
5733,COL28A1,GO:0005615,extracellular space,2.0
5734,COL28A1,GO:0005788,endoplasmic reticulum lumen,2.0
5735,COL28A1,GO:0007155,cell adhesion,2.0
5736,COL28A1,GO:0010951,negative regulation of endopeptidase activity,2.0
5737,COL28A1,GO:0030020,extracellular matrix structural constituent conferring tensile strength,2.0
5738,COL28A1,GO:0030198,extracellular matrix organization,2.0
5739,COL28A1,GO:0031012,extracellular matrix,2.0
5740,COL28A1,GO:0062023,collagen-containing extracellular matrix,2.0
5804,CPT2,GO:0001676,long-chain fatty acid metabolic process,2.0
5805,CPT2,GO:0001701,in utero embryonic development,2.0
5806,CPT2,GO:0004095,carnitine O-palmitoyltransferase activity,2.0
5810,CPT2,GO:0005515,protein binding,2.0
5811,CPT2,GO:0005654,nucleoplasm,2.0
5812,CPT2,GO:0005730,nucleolus,2.0
5813,CPT2,GO:0005739,mitochondrion,2.0
5815,CPT2,GO:0005743,mitochondrial inner membrane,2.0
5817,CPT2,GO:0006635,fatty acid beta-oxidation,2.0
5820,CPT2,GO:0006853,carnitine shuttle,2.0
5821,CPT2,GO:0008458,carnitine O-octanoyltransferase activity,2.0
5822,CPT2,GO:0009437,carnitine metabolic process,2.0
5823,CPT2,GO:0016746,acyltransferase activity,2.0
5824,CPT2,GO:0120162,positive regulation of cold-induced thermogenesis,2.0
5825,CPZ,GO:0004181,metallocarboxypeptidase activity,2.0
5826,CPZ,GO:0005615,extracellular space,2.0
5827,CPZ,GO:0006508,proteolysis,2.0
5828,CPZ,GO:0006518,peptide metabolic process,2.0
5829,CPZ,GO:0008270,zinc ion binding,2.0
5830,CPZ,GO:0016055,Wnt signaling pathway,2.0
5831,CPZ,GO:0016485,protein processing,2.0
5908,CSMD1,GO:0001964,startle response,2.0
5909,CSMD1,GO:0005515,protein binding,2.0
5910,CSMD1,GO:0007613,memory,2.0
5911,CSMD1,GO:0008584,male gonad development,2.0
5912,CSMD1,GO:0008585,female gonad development,2.0
5913,CSMD1,GO:0016020,membrane,2.0
5914,CSMD1,GO:0035846,oviduct epithelium development,2.0
5915,CSMD1,GO:0042593,glucose homeostasis,2.0
5916,CSMD1,GO:0060745,mammary gland branching involved in pregnancy,2.0
5917,CSMD1,GO:1990708,conditioned place preference,2.0
5922,CSNK1E,GO:0003723,RNA binding,2.0
5923,CSNK1E,GO:0004672,protein kinase activity,2.0
5925,CSNK1E,GO:0004674,protein serine/threonine kinase activity,2.0
5928,CSNK1E,GO:0005515,protein binding,2.0
5929,CSNK1E,GO:0005524,ATP binding,2.0
5930,CSNK1E,GO:0005634,nucleus,2.0
5932,CSNK1E,GO:0005654,nucleoplasm,2.0
5933,CSNK1E,GO:0005737,cytoplasm,2.0
5935,CSNK1E,GO:0005829,cytosol,2.0
5936,CSNK1E,GO:0006281,DNA repair,2.0
5937,CSNK1E,GO:0006468,protein phosphorylation,2.0
5939,CSNK1E,GO:0006897,endocytosis,2.0
5940,CSNK1E,GO:0007165,signal transduction,2.0
5941,CSNK1E,GO:0008104,protein localization,2.0
5942,CSNK1E,GO:0018105,peptidyl-serine phosphorylation,2.0
5944,CSNK1E,GO:0030178,negative regulation of Wnt signaling pathway,2.0
5945,CSNK1E,GO:0030426,growth cone,2.0
5946,CSNK1E,GO:0032091,negative regulation of protein binding,2.0
5947,CSNK1E,GO:0032436,positive regulation of proteasomal ubiquitin-dependent protein catabolic process,2.0
5949,CSNK1E,GO:0032880,regulation of protein localization,2.0
5950,CSNK1E,GO:0032922,circadian regulation of gene expression,2.0
5951,CSNK1E,GO:0042752,regulation of circadian rhythm,2.0
5952,CSNK1E,GO:0043025,neuronal cell body,2.0
5953,CSNK1E,GO:0048512,circadian behavior,2.0
5954,CSNK1E,GO:0060070,canonical Wnt signaling pathway,2.0
5957,CSNK1E,GO:0090263,positive regulation of canonical Wnt signaling pathway,2.0
5958,CSNK1E,GO:0106310,protein serine kinase activity,2.0
5959,CSNK1E,GO:1902004,positive regulation of amyloid-beta formation,2.0
5960,CSNK1E,GO:1905426,positive regulation of Wnt-mediated midbrain dopaminergic neuron differentiation,2.0
5961,CSNK1E,GO:1990090,cellular response to nerve growth factor stimulus,2.0
5962,CSNK1E,GO:1990904,ribonucleoprotein complex,2.0
5963,CSNK1E,GO:2000052,positive regulation of non-canonical Wnt signaling pathway,2.0
6131,CTNNA3,GO:0005515,protein binding,2.0
6132,CTNNA3,GO:0005829,cytosol,2.0
6133,CTNNA3,GO:0005856,cytoskeleton,2.0
6134,CTNNA3,GO:0005912,adherens junction,2.0
6135,CTNNA3,GO:0005916,fascia adherens,2.0
6137,CTNNA3,GO:0007015,actin filament organization,2.0
6138,CTNNA3,GO:0008013,beta-catenin binding,2.0
6140,CTNNA3,GO:0016477,cell migration,2.0
6141,CTNNA3,GO:0030027,lamellipodium,2.0
6142,CTNNA3,GO:0045296,cadherin binding,2.0
6143,CTNNA3,GO:0051015,actin filament binding,2.0
6144,CTNNA3,GO:0086073,bundle of His cell-Purkinje myocyte adhesion involved in cell communication,2.0
6145,CTNNA3,GO:0086091,regulation of heart rate by cardiac conduction,2.0
6146,CTNNA3,GO:0090136,epithelial cell-cell adhesion,2.0
6147,CTNNA3,GO:0098609,cell-cell adhesion,2.0
6149,CTNNA3,GO:0098911,regulation of ventricular cardiac muscle cell action potential,2.0
6401,CTNND2,GO:0005515,protein binding,2.0
6402,CTNND2,GO:0005634,nucleus,2.0
6403,CTNND2,GO:0005737,cytoplasm,2.0
6404,CTNND2,GO:0005886,plasma membrane,2.0
6405,CTNND2,GO:0005912,adherens junction,2.0
6406,CTNND2,GO:0007043,cell-cell junction assembly,2.0
6407,CTNND2,GO:0007155,cell adhesion,2.0
6408,CTNND2,GO:0007165,signal transduction,2.0
6409,CTNND2,GO:0008013,beta-catenin binding,2.0
6410,CTNND2,GO:0014069,postsynaptic density,2.0
6411,CTNND2,GO:0016055,Wnt signaling pathway,2.0
6412,CTNND2,GO:0030425,dendrite,2.0
6413,CTNND2,GO:0043204,perikaryon,2.0
6414,CTNND2,GO:0045296,cadherin binding,2.0
6415,CTNND2,GO:0050808,synapse organization,2.0
6416,CTNND2,GO:0060828,regulation of canonical Wnt signaling pathway,2.0
6417,CTNND2,GO:0060997,dendritic spine morphogenesis,2.0
6419,CTNND2,GO:0098609,cell-cell adhesion,2.0
6450,CTTNBP2,GO:0005515,protein binding,2.0
6451,CTTNBP2,GO:0005938,cell cortex,2.0
6452,CTTNBP2,GO:0007420,brain development,2.0
6453,CTTNBP2,GO:0008021,synaptic vesicle,2.0
6454,CTTNBP2,GO:0017124,SH3 domain binding,2.0
6455,CTTNBP2,GO:0043197,dendritic spine,2.0
6456,CTTNBP2,GO:0050807,regulation of synapse organization,2.0
6457,CTTNBP2,GO:0098871,postsynaptic actin cytoskeleton,2.0
6458,CTTNBP2,GO:0098978,glutamatergic synapse,2.0
6459,CTTNBP2,GO:1905274,regulation of modification of postsynaptic actin cytoskeleton,2.0
6526,CUL7,GO:0000226,microtubule cytoskeleton organization,2.0
6527,CUL7,GO:0000281,mitotic cytokinesis,2.0
6528,CUL7,GO:0001570,vasculogenesis,2.0
6529,CUL7,GO:0001837,epithelial to mesenchymal transition,2.0
6530,CUL7,GO:0001890,placenta development,2.0
6531,CUL7,GO:0005515,protein binding,2.0
6532,CUL7,GO:0005680,anaphase-promoting complex,2.0
6533,CUL7,GO:0005737,cytoplasm,2.0
6534,CUL7,GO:0005794,Golgi apparatus,2.0
6536,CUL7,GO:0005813,centrosome,2.0
6537,CUL7,GO:0005829,cytosol,2.0
6538,CUL7,GO:0006508,proteolysis,2.0
6539,CUL7,GO:0006511,ubiquitin-dependent protein catabolic process,2.0
6540,CUL7,GO:0007030,Golgi organization,2.0
6541,CUL7,GO:0007088,regulation of mitotic nuclear division,2.0
6543,CUL7,GO:0016567,protein ubiquitination,2.0
6547,CUL7,GO:0031461,cullin-RING ubiquitin ligase complex,2.0
6548,CUL7,GO:0031467,Cul7-RING ubiquitin ligase complex,2.0
6549,CUL7,GO:0031625,ubiquitin protein ligase binding,2.0
6550,CUL7,GO:0048471,perinuclear region of cytoplasm,2.0
6551,CUL7,GO:0050775,positive regulation of dendrite morphogenesis,2.0
6553,CUL7,GO:1990393,3M complex,2.0
6554,CUX1,GO:0000122,negative regulation of transcription by RNA polymerase II,2.0
6555,CUX1,GO:0000785,chromatin,2.0
6556,CUX1,GO:0000977,RNA polymerase II transcription regulatory region sequence-specific DNA binding,2.0
6558,CUX1,GO:0000981,"DNA-binding transcription factor activity, RNA polymerase II-specific",2.0
6560,CUX1,GO:0005634,nucleus,2.0
6562,CUX1,GO:0005654,nucleoplasm,2.0
6563,CUX1,GO:0005794,Golgi apparatus,2.0
6564,CUX1,GO:0005829,cytosol,2.0
6565,CUX1,GO:0006357,regulation of transcription by RNA polymerase II,2.0
6566,CUX1,GO:0043565,sequence-specific DNA binding,2.0
6567,CUX1,GO:0050775,positive regulation of dendrite morphogenesis,2.0
6568,CUX1,GO:1990837,sequence-specific double-stranded DNA binding,2.0
6569,CUX2,GO:0000122,negative regulation of transcription by RNA polymerase II,2.0
6570,CUX2,GO:0000785,chromatin,2.0
6571,CUX2,GO:0000977,RNA polymerase II transcription regulatory region sequence-specific DNA binding,2.0
6573,CUX2,GO:0000978,RNA polymerase II cis-regulatory region sequence-specific DNA binding,2.0
6574,CUX2,GO:0000981,"DNA-binding transcription factor activity, RNA polymerase II-specific",2.0
6576,CUX2,GO:0001227,"DNA-binding transcription repressor activity, RNA polymerase II-specific",2.0
6577,CUX2,GO:0005515,protein binding,2.0
6578,CUX2,GO:0005634,nucleus,2.0
6580,CUX2,GO:0006357,regulation of transcription by RNA polymerase II,2.0
6581,CUX2,GO:0007614,short-term memory,2.0
6582,CUX2,GO:0010628,positive regulation of gene expression,2.0
6583,CUX2,GO:0043565,sequence-specific DNA binding,2.0
6584,CUX2,GO:0050775,positive regulation of dendrite morphogenesis,2.0
6585,CUX2,GO:0050890,cognition,2.0
6586,CUX2,GO:0051965,positive regulation of synapse assembly,2.0
6587,CUX2,GO:0061003,positive regulation of dendritic spine morphogenesis,2.0
6588,CUX2,GO:0070062,extracellular exosome,2.0
6589,CUX2,GO:0071310,cellular response to organic substance,2.0
6590,CUX2,GO:1990837,sequence-specific double-stranded DNA binding,2.0
6591,CUX2,GO:2000463,positive regulation of excitatory postsynaptic potential,2.0
6592,CX3CR1,GO:0002052,positive regulation of neuroblast proliferation,2.0
6593,CX3CR1,GO:0002250,adaptive immune response,2.0
6594,CX3CR1,GO:0002282,microglial cell activation involved in immune response,2.0
6595,CX3CR1,GO:0002931,response to ischemia,2.0
6596,CX3CR1,GO:0004930,G protein-coupled receptor activity,2.0
6597,CX3CR1,GO:0004950,chemokine receptor activity,2.0
6598,CX3CR1,GO:0005515,protein binding,2.0
6599,CX3CR1,GO:0005886,plasma membrane,2.0
6602,CX3CR1,GO:0006935,chemotaxis,2.0
6603,CX3CR1,GO:0006955,immune response,2.0
6605,CX3CR1,GO:0006968,cellular defense response,2.0
6606,CX3CR1,GO:0007155,cell adhesion,2.0
6608,CX3CR1,GO:0007186,G protein-coupled receptor signaling pathway,2.0
6609,CX3CR1,GO:0007200,phospholipase C-activating G protein-coupled receptor signaling pathway,2.0
6610,CX3CR1,GO:0007204,positive regulation of cytosolic calcium ion concentration,2.0
6611,CX3CR1,GO:0007267,cell-cell signaling,2.0
6612,CX3CR1,GO:0007420,brain development,2.0
6613,CX3CR1,GO:0007613,memory,2.0
6614,CX3CR1,GO:0008528,G protein-coupled peptide receptor activity,2.0
6615,CX3CR1,GO:0009611,response to wounding,2.0
6616,CX3CR1,GO:0009897,external side of plasma membrane,2.0
6617,CX3CR1,GO:0009986,cell surface,2.0
6620,CX3CR1,GO:0016493,C-C chemokine receptor activity,2.0
6621,CX3CR1,GO:0016495,C-X3-C chemokine receptor activity,2.0
6622,CX3CR1,GO:0019722,calcium-mediated signaling,2.0
6623,CX3CR1,GO:0019957,C-C chemokine binding,2.0
6624,CX3CR1,GO:0019960,C-X3-C chemokine binding,2.0
6626,CX3CR1,GO:0021626,central nervous system maturation,2.0
6627,CX3CR1,GO:0030336,negative regulation of cell migration,2.0
6628,CX3CR1,GO:0030595,leukocyte chemotaxis,2.0
6629,CX3CR1,GO:0031737,CX3C chemokine receptor binding,2.0
6630,CX3CR1,GO:0032680,regulation of tumor necrosis factor production,2.0
6631,CX3CR1,GO:0032691,negative regulation of interleukin-1 beta production,2.0
6632,CX3CR1,GO:0032809,neuronal cell body membrane,2.0
6633,CX3CR1,GO:0035176,social behavior,2.0
6634,CX3CR1,GO:0035425,autocrine signaling,2.0
6635,CX3CR1,GO:0043005,neuron projection,2.0
6636,CX3CR1,GO:0045087,innate immune response,2.0
6637,CX3CR1,GO:0045428,regulation of nitric oxide biosynthetic process,2.0
6638,CX3CR1,GO:0045766,positive regulation of angiogenesis,2.0
6639,CX3CR1,GO:0048167,regulation of synaptic plasticity,2.0
6640,CX3CR1,GO:0048471,perinuclear region of cytoplasm,2.0
6641,CX3CR1,GO:0048874,host-mediated regulation of intestinal microbiota composition,2.0
6642,CX3CR1,GO:0050767,regulation of neurogenesis,2.0
6643,CX3CR1,GO:0050769,positive regulation of neurogenesis,2.0
6644,CX3CR1,GO:0050804,modulation of chemical synaptic transmission,2.0
6645,CX3CR1,GO:0050901,leukocyte tethering or rolling,2.0
6646,CX3CR1,GO:0051092,positive regulation of NF-kappaB transcription factor activity,2.0
6647,CX3CR1,GO:0051897,positive regulation of protein kinase B signaling,2.0
6648,CX3CR1,GO:0060074,synapse maturation,2.0
6649,CX3CR1,GO:0060326,cell chemotaxis,2.0
6650,CX3CR1,GO:0061760,antifungal innate immune response,2.0
6652,CX3CR1,GO:0070098,chemokine-mediated signaling pathway,2.0
6653,CX3CR1,GO:0071222,cellular response to lipopolysaccharide,2.0
6654,CX3CR1,GO:0071560,cellular response to transforming growth factor beta stimulus,2.0
6655,CX3CR1,GO:0090026,positive regulation of monocyte chemotaxis,2.0
6656,CX3CR1,GO:0097447,dendritic tree,2.0
6657,CX3CR1,GO:0098883,synapse pruning,2.0
6659,CX3CR1,GO:0110091,negative regulation of hippocampal neuron apoptotic process,2.0
6660,CX3CR1,GO:0150090,"multiple spine synapse organization, single dendrite",2.0
6661,CX3CR1,GO:1900272,negative regulation of long-term synaptic potentiation,2.0
6662,CX3CR1,GO:1903721,positive regulation of I-kappaB phosphorylation,2.0
6663,CX3CR1,GO:1904139,regulation of microglial cell migration,2.0
6664,CX3CR1,GO:1904141,positive regulation of microglial cell migration,2.0
6665,CX3CR1,GO:1904150,negative regulation of microglial cell mediated cytotoxicity,2.0
6666,CX3CR1,GO:2001234,negative regulation of apoptotic signaling pathway,2.0
6667,CYFIP1,GO:0000340,RNA 7-methylguanosine cap binding,2.0
6668,CYFIP1,GO:0000902,cell morphogenesis,2.0
6669,CYFIP1,GO:0001726,ruffle,2.0
6670,CYFIP1,GO:0005515,protein binding,2.0
6671,CYFIP1,GO:0005576,extracellular region,2.0
6672,CYFIP1,GO:0005829,cytosol,2.0
6673,CYFIP1,GO:0005845,mRNA cap binding complex,2.0
6674,CYFIP1,GO:0005925,focal adhesion,2.0
6675,CYFIP1,GO:0006417,regulation of translation,2.0
6676,CYFIP1,GO:0007411,axon guidance,2.0
6677,CYFIP1,GO:0008360,regulation of cell shape,2.0
6678,CYFIP1,GO:0010592,positive regulation of lamellipodium assembly,2.0
6679,CYFIP1,GO:0016601,Rac protein signal transduction,2.0
6680,CYFIP1,GO:0030027,lamellipodium,2.0
6681,CYFIP1,GO:0030031,cell projection assembly,2.0
6682,CYFIP1,GO:0030032,lamellipodium assembly,2.0
6684,CYFIP1,GO:0030833,regulation of actin filament polymerization,2.0
6685,CYFIP1,GO:0031209,SCAR complex,2.0
6687,CYFIP1,GO:0031267,small GTPase binding,2.0
6689,CYFIP1,GO:0031529,ruffle organization,2.0
6690,CYFIP1,GO:0031641,regulation of myelination,2.0
6691,CYFIP1,GO:0032433,filopodium tip,2.0
6692,CYFIP1,GO:0032869,cellular response to insulin stimulus,2.0
6693,CYFIP1,GO:0034774,secretory granule lumen,2.0
6694,CYFIP1,GO:0035580,specific granule lumen,2.0
6695,CYFIP1,GO:0043005,neuron projection,2.0
6697,CYFIP1,GO:0043025,neuronal cell body,2.0
6698,CYFIP1,GO:0043195,terminal bouton,2.0
6699,CYFIP1,GO:0043197,dendritic spine,2.0
6700,CYFIP1,GO:0044294,dendritic growth cone,2.0
6701,CYFIP1,GO:0044295,axonal growth cone,2.0
6702,CYFIP1,GO:0045182,translation regulator activity,2.0
6703,CYFIP1,GO:0045202,synapse,2.0
6704,CYFIP1,GO:0045773,positive regulation of axon extension,2.0
6705,CYFIP1,GO:0048471,perinuclear region of cytoplasm,2.0
6706,CYFIP1,GO:0048675,axon extension,2.0
6707,CYFIP1,GO:0050890,cognition,2.0
6708,CYFIP1,GO:0051015,actin filament binding,2.0
6709,CYFIP1,GO:0051388,positive regulation of neurotrophin TRK receptor signaling pathway,2.0
6710,CYFIP1,GO:0051602,response to electrical stimulus,2.0
6711,CYFIP1,GO:0060076,excitatory synapse,2.0
6712,CYFIP1,GO:0070062,extracellular exosome,2.0
6713,CYFIP1,GO:0090724,central region of growth cone,2.0
6714,CYFIP1,GO:0090725,peripheral region of growth cone,2.0
6715,CYFIP1,GO:0097484,dendrite extension,2.0
6716,CYFIP1,GO:0099563,modification of synaptic structure,2.0
6717,CYFIP1,GO:0099578,"regulation of translation at postsynapse, modulating synaptic transmission",2.0
6718,CYFIP1,GO:1900006,positive regulation of dendrite development,2.0
6719,CYFIP1,GO:1900029,positive regulation of ruffle assembly,2.0
6720,CYFIP1,GO:1903422,negative regulation of synaptic vesicle recycling,2.0
6721,CYFIP1,GO:1904724,tertiary granule lumen,2.0
6722,CYFIP1,GO:1905274,regulation of modification of postsynaptic actin cytoskeleton,2.0
6723,CYFIP1,GO:2000601,positive regulation of Arp2/3 complex-mediated actin nucleation,2.0
6724,CYLC2,GO:0005200,structural constituent of cytoskeleton,2.0
6725,CYLC2,GO:0005634,nucleus,2.0
6726,CYLC2,GO:0007010,cytoskeleton organization,2.0
6727,CYLC2,GO:0007283,spermatogenesis,2.0
6728,CYLC2,GO:0030154,cell differentiation,2.0
6729,CYLC2,GO:0033150,cytoskeletal calyx,2.0
6752,DAGLA,GO:0004465,lipoprotein lipase activity,2.0
6753,DAGLA,GO:0004806,triglyceride lipase activity,2.0
6754,DAGLA,GO:0005515,protein binding,2.0
6755,DAGLA,GO:0005737,cytoplasm,2.0
6756,DAGLA,GO:0005886,plasma membrane,2.0
6758,DAGLA,GO:0007216,G protein-coupled glutamate receptor signaling pathway,2.0
6759,DAGLA,GO:0007405,neuroblast proliferation,2.0
6760,DAGLA,GO:0016042,lipid catabolic process,2.0
6761,DAGLA,GO:0016298,lipase activity,2.0
6762,DAGLA,GO:0019369,arachidonic acid metabolic process,2.0
6765,DAGLA,GO:0022008,neurogenesis,2.0
6766,DAGLA,GO:0031901,early endosome membrane,2.0
6767,DAGLA,GO:0032590,dendrite membrane,2.0
6769,DAGLA,GO:0032591,dendritic spine membrane,2.0
6770,DAGLA,GO:0042136,neurotransmitter biosynthetic process,2.0
6772,DAGLA,GO:0043196,varicosity,2.0
6773,DAGLA,GO:0045211,postsynaptic membrane,2.0
6774,DAGLA,GO:0046340,diacylglycerol catabolic process,2.0
6776,DAGLA,GO:0046872,metal ion binding,2.0
6777,DAGLA,GO:0047372,acylglycerol lipase activity,2.0
6778,DAGLA,GO:0071926,endocannabinoid signaling pathway,2.0
6779,DAGLA,GO:0098839,postsynaptic density membrane,2.0
6780,DAGLA,GO:0098921,retrograde trans-synaptic signaling by endocannabinoid,2.0
6783,DAGLA,GO:0150077,regulation of neuroinflammatory response,2.0
6784,DAPP1,GO:0005515,protein binding,2.0
6785,DAPP1,GO:0005543,phospholipid binding,2.0
6786,DAPP1,GO:0005547,"phosphatidylinositol-3,4,5-trisphosphate binding",2.0
6787,DAPP1,GO:0005829,cytosol,2.0
6788,DAPP1,GO:0005886,plasma membrane,2.0
6790,DAPP1,GO:0006470,protein dephosphorylation,2.0
6791,DAPP1,GO:0007165,signal transduction,2.0
6792,DAPP1,GO:0043325,"phosphatidylinositol-3,4-bisphosphate binding",2.0
6793,DDC,GO:0004058,aromatic-L-amino-acid decarboxylase activity,2.0
6795,DDC,GO:0005515,protein binding,2.0
6796,DDC,GO:0005737,cytoplasm,2.0
6797,DDC,GO:0005829,cytosol,2.0
6798,DDC,GO:0006520,amino acid metabolic process,2.0
6799,DDC,GO:0006584,catecholamine metabolic process,2.0
6800,DDC,GO:0007623,circadian rhythm,2.0
6801,DDC,GO:0008021,synaptic vesicle,2.0
6802,DDC,GO:0010259,multicellular organism aging,2.0
6803,DDC,GO:0015842,aminergic neurotransmitter loading into synaptic vesicle,2.0
6804,DDC,GO:0016597,amino acid binding,2.0
6805,DDC,GO:0016831,carboxy-lyase activity,2.0
6806,DDC,GO:0019899,enzyme binding,2.0
6807,DDC,GO:0019904,protein domain specific binding,2.0
6808,DDC,GO:0030170,pyridoxal phosphate binding,2.0
6809,DDC,GO:0030424,axon,2.0
6810,DDC,GO:0033076,isoquinoline alkaloid metabolic process,2.0
6811,DDC,GO:0036467,5-hydroxy-L-tryptophan decarboxylase activity,2.0
6812,DDC,GO:0036468,L-dopa decarboxylase activity,2.0
6813,DDC,GO:0042416,dopamine biosynthetic process,2.0
6814,DDC,GO:0042427,serotonin biosynthetic process,2.0
6815,DDC,GO:0043025,neuronal cell body,2.0
6816,DDC,GO:0046684,response to pyrethroid,2.0
6817,DDC,GO:0052314,phytoalexin metabolic process,2.0
6818,DDC,GO:0070062,extracellular exosome,2.0
6819,DDC,GO:0071312,cellular response to alkaloid,2.0
6820,DDC,GO:0071363,cellular response to growth factor stimulus,2.0
6821,DDC,GO:0071466,cellular response to xenobiotic stimulus,2.0
6830,CPEB4,GO:0000900,mRNA regulatory element binding translation repressor activity,2.0
6831,CPEB4,GO:0002931,response to ischemia,2.0
6832,CPEB4,GO:0003723,RNA binding,2.0
6833,CPEB4,GO:0003730,mRNA 3'-UTR binding,2.0
6834,CPEB4,GO:0005515,protein binding,2.0
6835,CPEB4,GO:0005634,nucleus,2.0
6838,CPEB4,GO:0005737,cytoplasm,2.0
6841,CPEB4,GO:0005783,endoplasmic reticulum,2.0
6842,CPEB4,GO:0006412,translation,2.0
6843,CPEB4,GO:0008135,"translation factor activity, RNA binding",2.0
6844,CPEB4,GO:0014069,postsynaptic density,2.0
6845,CPEB4,GO:0030425,dendrite,2.0
6846,CPEB4,GO:0030426,growth cone,2.0
6847,CPEB4,GO:0035235,ionotropic glutamate receptor signaling pathway,2.0
6848,CPEB4,GO:0036294,cellular response to decreased oxygen levels,2.0
6849,CPEB4,GO:0042149,cellular response to glucose starvation,2.0
6850,CPEB4,GO:0043005,neuron projection,2.0
6851,CPEB4,GO:0043022,ribosome binding,2.0
6852,CPEB4,GO:0043197,dendritic spine,2.0
6853,CPEB4,GO:0043524,negative regulation of neuron apoptotic process,2.0
6854,CPEB4,GO:0045202,synapse,2.0
6855,CPEB4,GO:0046872,metal ion binding,2.0
6856,CPEB4,GO:0048471,perinuclear region of cytoplasm,2.0
6857,CPEB4,GO:0071230,cellular response to amino acid stimulus,2.0
6858,CPEB4,GO:1990124,messenger ribonucleoprotein complex,2.0
6859,CPEB4,GO:2000766,negative regulation of cytoplasmic translation,2.0
6860,CYP11B1,GO:0004507,steroid 11-beta-monooxygenase activity,2.0
6864,CYP11B1,GO:0005506,iron ion binding,2.0
6865,CYP11B1,GO:0005739,mitochondrion,2.0
6866,CYP11B1,GO:0005743,mitochondrial inner membrane,2.0
6869,CYP11B1,GO:0006700,C21-steroid hormone biosynthetic process,2.0
6871,CYP11B1,GO:0006704,glucocorticoid biosynthetic process,2.0
6873,CYP11B1,GO:0006955,immune response,2.0
6874,CYP11B1,GO:0008203,cholesterol metabolic process,2.0
6875,CYP11B1,GO:0008217,regulation of blood pressure,2.0
6876,CYP11B1,GO:0016125,sterol metabolic process,2.0
6877,CYP11B1,GO:0020037,heme binding,2.0
6878,CYP11B1,GO:0032342,aldosterone biosynthetic process,2.0
6881,CYP11B1,GO:0032870,cellular response to hormone stimulus,2.0
6882,CYP11B1,GO:0034650,cortisol metabolic process,2.0
6883,CYP11B1,GO:0034651,cortisol biosynthetic process,2.0
6885,CYP11B1,GO:0035865,cellular response to potassium ion,2.0
6886,CYP11B1,GO:0042593,glucose homeostasis,2.0
6887,CYP11B1,GO:0047783,corticosterone 18-monooxygenase activity,2.0
6888,CYP11B1,GO:0071375,cellular response to peptide hormone stimulus,2.0
6889,DCC,GO:0001764,neuron migration,2.0
6890,DCC,GO:0004888,transmembrane signaling receptor activity,2.0
6891,DCC,GO:0005042,netrin receptor activity,2.0
6892,DCC,GO:0005515,protein binding,2.0
6893,DCC,GO:0005829,cytosol,2.0
6894,DCC,GO:0005886,plasma membrane,2.0
6896,DCC,GO:0006915,apoptotic process,2.0
6897,DCC,GO:0007409,axonogenesis,2.0
6898,DCC,GO:0007411,axon guidance,2.0
6899,DCC,GO:0009986,cell surface,2.0
6900,DCC,GO:0010977,negative regulation of neuron projection development,2.0
6901,DCC,GO:0021965,spinal cord ventral commissure morphogenesis,2.0
6902,DCC,GO:0033563,dorsal/ventral axon guidance,2.0
6903,DCC,GO:0033564,anterior/posterior axon guidance,2.0
6904,DCC,GO:0038007,netrin-activated signaling pathway,2.0
6905,DCC,GO:0044295,axonal growth cone,2.0
6906,DCC,GO:0048671,negative regulation of collateral sprouting,2.0
6907,DCC,GO:0098609,cell-cell adhesion,2.0
6908,DCC,GO:0098685,Schaffer collateral - CA1 synapse,2.0
6909,DCC,GO:0098839,postsynaptic density membrane,2.0
6910,DCC,GO:0099170,postsynaptic modulation of chemical synaptic transmission,2.0
6911,DCC,GO:1901214,regulation of neuron death,2.0
6912,DCC,GO:2000171,negative regulation of dendrite development,2.0
6913,DDHD2,GO:0000266,mitochondrial fission,2.0
6914,DDHD2,GO:0004620,phospholipase activity,2.0
6915,DDHD2,GO:0004806,triglyceride lipase activity,2.0
6916,DDHD2,GO:0005737,cytoplasm,2.0
6917,DDHD2,GO:0005793,endoplasmic reticulum-Golgi intermediate compartment,2.0
6918,DDHD2,GO:0005794,Golgi apparatus,2.0
6919,DDHD2,GO:0005829,cytosol,2.0
6921,DDHD2,GO:0007626,locomotory behavior,2.0
6922,DDHD2,GO:0008542,visual learning,2.0
6923,DDHD2,GO:0016020,membrane,2.0
6924,DDHD2,GO:0019433,triglyceride catabolic process,2.0
6925,DDHD2,GO:0030134,COPII-coated ER to Golgi transport vesicle,2.0
6926,DDHD2,GO:0034389,lipid droplet organization,2.0
6927,DDHD2,GO:0034451,centriolar satellite,2.0
6928,DDHD2,GO:0046872,metal ion binding,2.0
6929,DDHD2,GO:0090141,positive regulation of mitochondrial fission,2.0
7052,DDX53,GO:0003723,RNA binding,2.0
7053,DDX53,GO:0003724,RNA helicase activity,2.0
7054,DDX53,GO:0005524,ATP binding,2.0
7055,DDX53,GO:0005654,nucleoplasm,2.0
7056,DDX53,GO:0005730,nucleolus,2.0
7057,DDX53,GO:0005829,cytosol,2.0
7058,DDX53,GO:0016887,ATP hydrolysis activity,2.0
7059,DDX53,GO:0043231,intracellular membrane-bounded organelle,2.0
7082,DENR,GO:0001731,formation of translation preinitiation complex,2.0
7084,DENR,GO:0002188,translation reinitiation,2.0
7085,DENR,GO:0003674,molecular_function,2.0
7086,DENR,GO:0003729,mRNA binding,2.0
7087,DENR,GO:0003743,translation initiation factor activity,2.0
7088,DENR,GO:0005515,protein binding,2.0
7089,DENR,GO:0005575,cellular_component,2.0
7090,DENR,GO:0032790,ribosome disassembly,2.0
7091,DENR,GO:0075522,IRES-dependent viral translational initiation,2.0
7163,DIP2C,GO:0003674,molecular_function,2.0
7164,DIP2C,GO:0005575,cellular_component,2.0
7165,DIP2C,GO:0008150,biological_process,2.0
7166,DIPK2A,GO:0000139,Golgi membrane,2.0
7167,DIPK2A,GO:0005615,extracellular space,2.0
7169,DIPK2A,GO:0014066,regulation of phosphatidylinositol 3-kinase signaling,2.0
7171,DIPK2A,GO:0030126,COPI vesicle coat,2.0
7173,DIPK2A,GO:0034392,negative regulation of smooth muscle cell apoptotic process,2.0
7174,DIPK2A,GO:0060038,cardiac muscle cell proliferation,2.0
7176,DIPK2A,GO:1900020,positive regulation of protein kinase C activity,2.0
7177,DISC1,GO:0000226,microtubule cytoskeleton organization,2.0
7178,DISC1,GO:0001764,neuron migration,2.0
7180,DISC1,GO:0001954,positive regulation of cell-matrix adhesion,2.0
7181,DISC1,GO:0002052,positive regulation of neuroblast proliferation,2.0
7182,DISC1,GO:0005515,protein binding,2.0
7183,DISC1,GO:0005634,nucleus,2.0
7184,DISC1,GO:0005739,mitochondrion,2.0
7186,DISC1,GO:0005783,endoplasmic reticulum,2.0
7187,DISC1,GO:0005813,centrosome,2.0
7189,DISC1,GO:0005829,cytosol,2.0
7190,DISC1,GO:0005871,kinesin complex,2.0
7191,DISC1,GO:0005874,microtubule,2.0
7192,DISC1,GO:0006511,ubiquitin-dependent protein catabolic process,2.0
7193,DISC1,GO:0008021,synaptic vesicle,2.0
7194,DISC1,GO:0010976,positive regulation of neuron projection development,2.0
7195,DISC1,GO:0014069,postsynaptic density,2.0
7196,DISC1,GO:0019894,kinesin binding,2.0
7197,DISC1,GO:0021846,cell proliferation in forebrain,2.0
7198,DISC1,GO:0021852,pyramidal neuron migration to cerebral cortex,2.0
7199,DISC1,GO:0030177,positive regulation of Wnt signaling pathway,2.0
7200,DISC1,GO:0030286,dynein complex,2.0
7201,DISC1,GO:0031929,TOR signaling,2.0
7202,DISC1,GO:0032091,negative regulation of protein binding,2.0
7203,DISC1,GO:0036064,ciliary basal body,2.0
7204,DISC1,GO:0042802,identical protein binding,2.0
7205,DISC1,GO:0044297,cell body,2.0
7206,DISC1,GO:0044877,protein-containing complex binding,2.0
7207,DISC1,GO:0045111,intermediate filament cytoskeleton,2.0
7209,DISC1,GO:0045773,positive regulation of axon extension,2.0
7210,DISC1,GO:0048471,perinuclear region of cytoplasm,2.0
7211,DISC1,GO:0051560,mitochondrial calcium ion homeostasis,2.0
7212,DISC1,GO:0051602,response to electrical stimulus,2.0
7213,DISC1,GO:0051966,"regulation of synaptic transmission, glutamatergic",2.0
7214,DISC1,GO:0060070,canonical Wnt signaling pathway,2.0
7215,DISC1,GO:0060090,molecular adaptor activity,2.0
7216,DISC1,GO:0060271,cilium assembly,2.0
7217,DISC1,GO:0060998,regulation of dendritic spine development,2.0
7218,DISC1,GO:0070050,neuron cellular homeostasis,2.0
7219,DISC1,GO:0071539,protein localization to centrosome,2.0
7220,DISC1,GO:0090128,regulation of synapse maturation,2.0
7221,DISC1,GO:0090724,central region of growth cone,2.0
7222,DISC1,GO:0097546,ciliary base,2.0
7223,DISC1,GO:0098793,presynapse,2.0
7224,DISC1,GO:0098978,glutamatergic synapse,2.0
7225,DISC1,GO:0098982,GABA-ergic synapse,2.0
7226,DISC1,GO:0099175,regulation of postsynapse organization,2.0
7227,DISC1,GO:1905515,non-motile cilium assembly,2.0
7228,DISC1,GO:2000060,positive regulation of ubiquitin-dependent protein catabolic process,2.0
7229,DIXDC1,GO:0003779,actin binding,2.0
7230,DIXDC1,GO:0005515,protein binding,2.0
7231,DIXDC1,GO:0005829,cytosol,2.0
7233,DIXDC1,GO:0005856,cytoskeleton,2.0
7234,DIXDC1,GO:0005925,focal adhesion,2.0
7235,DIXDC1,GO:0019904,protein domain specific binding,2.0
7236,DIXDC1,GO:0021695,cerebellar cortex development,2.0
7237,DIXDC1,GO:0021799,cerebral cortex radially oriented cell migration,2.0
7238,DIXDC1,GO:0021869,forebrain ventricular zone progenitor cell division,2.0
7239,DIXDC1,GO:0030177,positive regulation of Wnt signaling pathway,2.0
7240,DIXDC1,GO:0031435,mitogen-activated protein kinase kinase kinase binding,2.0
7241,DIXDC1,GO:0032956,regulation of actin cytoskeleton organization,2.0
7242,DIXDC1,GO:0032991,protein-containing complex,2.0
7243,DIXDC1,GO:0043015,gamma-tubulin binding,2.0
7244,DIXDC1,GO:0043025,neuronal cell body,2.0
7245,DIXDC1,GO:0043679,axon terminus,2.0
7246,DIXDC1,GO:0045665,negative regulation of neuron differentiation,2.0
7247,DIXDC1,GO:0046330,positive regulation of JNK cascade,2.0
7248,DIXDC1,GO:0050772,positive regulation of axonogenesis,2.0
7249,DIXDC1,GO:0060070,canonical Wnt signaling pathway,2.0
7251,DIXDC1,GO:0070507,regulation of microtubule cytoskeleton organization,2.0
7252,DLG1,GO:0000122,negative regulation of transcription by RNA polymerase II,2.0
7253,DLG1,GO:0001658,branching involved in ureteric bud morphogenesis,2.0
7254,DLG1,GO:0001771,immunological synapse formation,2.0
7255,DLG1,GO:0001772,immunological synapse,2.0
7257,DLG1,GO:0001935,endothelial cell proliferation,2.0
7258,DLG1,GO:0002088,lens development in camera-type eye,2.0
7259,DLG1,GO:0004385,guanylate kinase activity,2.0
7260,DLG1,GO:0004721,phosphoprotein phosphatase activity,2.0
7261,DLG1,GO:0005515,protein binding,2.0
7262,DLG1,GO:0005604,basement membrane,2.0
7263,DLG1,GO:0005634,nucleus,2.0
7264,DLG1,GO:0005737,cytoplasm,2.0
7265,DLG1,GO:0005783,endoplasmic reticulum,2.0
7266,DLG1,GO:0005789,endoplasmic reticulum membrane,2.0
7267,DLG1,GO:0005794,Golgi apparatus,2.0
7268,DLG1,GO:0005829,cytosol,2.0
7269,DLG1,GO:0005874,microtubule,2.0
7270,DLG1,GO:0005886,plasma membrane,2.0
7271,DLG1,GO:0005911,cell-cell junction,2.0
7272,DLG1,GO:0005912,adherens junction,2.0
7273,DLG1,GO:0005923,bicellular tight junction,2.0
7274,DLG1,GO:0007015,actin filament organization,2.0
7275,DLG1,GO:0007163,establishment or maintenance of cell polarity,2.0
7276,DLG1,GO:0007268,chemical synaptic transmission,2.0
7277,DLG1,GO:0008022,protein C-terminus binding,2.0
7278,DLG1,GO:0008092,cytoskeletal protein binding,2.0
7279,DLG1,GO:0008284,positive regulation of cell population proliferation,2.0
7280,DLG1,GO:0008360,regulation of cell shape,2.0
7281,DLG1,GO:0009790,embryo development,2.0
7282,DLG1,GO:0009898,cytoplasmic side of plasma membrane,2.0
7283,DLG1,GO:0014704,intercalated disc,2.0
7284,DLG1,GO:0015459,potassium channel regulator activity,2.0
7287,DLG1,GO:0016323,basolateral plasma membrane,2.0
7289,DLG1,GO:0016324,apical plasma membrane,2.0
7290,DLG1,GO:0016328,lateral plasma membrane,2.0
7291,DLG1,GO:0019901,protein kinase binding,2.0
7292,DLG1,GO:0019902,phosphatase binding,2.0
7293,DLG1,GO:0030041,actin filament polymerization,2.0
7294,DLG1,GO:0030054,cell junction,2.0
7296,DLG1,GO:0030432,peristalsis,2.0
7297,DLG1,GO:0030838,positive regulation of actin filament polymerization,2.0
7298,DLG1,GO:0030866,cortical actin cytoskeleton organization,2.0
7299,DLG1,GO:0030953,astral microtubule organization,2.0
7300,DLG1,GO:0031253,cell projection membrane,2.0
7301,DLG1,GO:0031434,mitogen-activated protein kinase kinase binding,2.0
7302,DLG1,GO:0031503,protein-containing complex localization,2.0
7303,DLG1,GO:0031579,membrane raft organization,2.0
7304,DLG1,GO:0031594,neuromuscular junction,2.0
7305,DLG1,GO:0031641,regulation of myelination,2.0
7306,DLG1,GO:0032147,activation of protein kinase activity,2.0
7307,DLG1,GO:0033268,node of Ranvier,2.0
7308,DLG1,GO:0035748,myelin sheath abaxonal region,2.0
7309,DLG1,GO:0042098,T cell proliferation,2.0
7310,DLG1,GO:0042130,negative regulation of T cell proliferation,2.0
7311,DLG1,GO:0042383,sarcolemma,2.0
7312,DLG1,GO:0042391,regulation of membrane potential,2.0
7313,DLG1,GO:0042982,amyloid precursor protein metabolic process,2.0
7314,DLG1,GO:0043005,neuron projection,2.0
7315,DLG1,GO:0043113,receptor clustering,2.0
7316,DLG1,GO:0043219,lateral loop,2.0
7317,DLG1,GO:0043268,positive regulation of potassium ion transport,2.0
7318,DLG1,GO:0043491,protein kinase B signaling,2.0
7319,DLG1,GO:0043622,cortical microtubule organization,2.0
7320,DLG1,GO:0044325,transmembrane transporter binding,2.0
7321,DLG1,GO:0045121,membrane raft,2.0
7322,DLG1,GO:0045197,establishment or maintenance of epithelial cell apical/basal polarity,2.0
7324,DLG1,GO:0045296,cadherin binding,2.0
7325,DLG1,GO:0046037,GMP metabolic process,2.0
7326,DLG1,GO:0046710,GDP metabolic process,2.0
7327,DLG1,GO:0048471,perinuclear region of cytoplasm,2.0
7328,DLG1,GO:0048608,reproductive structure development,2.0
7329,DLG1,GO:0048704,embryonic skeletal system morphogenesis,2.0
7330,DLG1,GO:0048745,smooth muscle tissue development,2.0
7331,DLG1,GO:0050680,negative regulation of epithelial cell proliferation,2.0
7332,DLG1,GO:0051660,establishment of centrosome localization,2.0
7333,DLG1,GO:0051898,negative regulation of protein kinase B signaling,2.0
7334,DLG1,GO:0060022,hard palate development,2.0
7335,DLG1,GO:0060090,molecular adaptor activity,2.0
7336,DLG1,GO:0070062,extracellular exosome,2.0
7337,DLG1,GO:0070373,negative regulation of ERK1 and ERK2 cascade,2.0
7338,DLG1,GO:0070830,bicellular tight junction assembly,2.0
7339,DLG1,GO:0072659,protein localization to plasma membrane,2.0
7341,DLG1,GO:0097016,L27 domain binding,2.0
7342,DLG1,GO:0097025,MPP7-DLG1-LIN7 complex,2.0
7343,DLG1,GO:0097060,synaptic membrane,2.0
7344,DLG1,GO:0097120,receptor localization to synapse,2.0
7345,DLG1,GO:0098609,cell-cell adhesion,2.0
7347,DLG1,GO:0098839,postsynaptic density membrane,2.0
7348,DLG1,GO:0098911,regulation of ventricular cardiac muscle cell action potential,2.0
7349,DLG1,GO:0098919,structural constituent of postsynaptic density,2.0
7350,DLG1,GO:0098978,glutamatergic synapse,2.0
7351,DLG1,GO:0099562,maintenance of postsynaptic density structure,2.0
7352,DLG1,GO:0099645,neurotransmitter receptor localization to postsynaptic specialization membrane,2.0
7353,DLG1,GO:1901222,regulation of NIK/NF-kappaB signaling,2.0
7354,DLG1,GO:1902305,regulation of sodium ion transmembrane transport,2.0
7355,DLG1,GO:1902473,regulation of protein localization to synapse,2.0
7356,DLG1,GO:1903078,positive regulation of protein localization to plasma membrane,2.0
7357,DLG1,GO:1903286,regulation of potassium ion import,2.0
7358,DLG1,GO:1903753,negative regulation of p38MAPK cascade,2.0
7359,DLG1,GO:1903760,regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization,2.0
7360,DLG1,GO:1903764,regulation of potassium ion export across plasma membrane,2.0
7361,DLG1,GO:2000134,negative regulation of G1/S transition of mitotic cell cycle,2.0
7362,DLG2,GO:0004385,guanylate kinase activity,2.0
7363,DLG2,GO:0005515,protein binding,2.0
7364,DLG2,GO:0005829,cytosol,2.0
7365,DLG2,GO:0005886,plasma membrane,2.0
7366,DLG2,GO:0005912,adherens junction,2.0
7367,DLG2,GO:0007268,chemical synaptic transmission,2.0
7368,DLG2,GO:0009790,embryo development,2.0
7369,DLG2,GO:0014069,postsynaptic density,2.0
7370,DLG2,GO:0016020,membrane,2.0
7371,DLG2,GO:0016323,basolateral plasma membrane,2.0
7372,DLG2,GO:0019900,kinase binding,2.0
7373,DLG2,GO:0030054,cell junction,2.0
7374,DLG2,GO:0031594,neuromuscular junction,2.0
7375,DLG2,GO:0035865,cellular response to potassium ion,2.0
7376,DLG2,GO:0043005,neuron projection,2.0
7377,DLG2,GO:0043113,receptor clustering,2.0
7378,DLG2,GO:0043204,perikaryon,2.0
7379,DLG2,GO:0044224,juxtaparanode region of axon,2.0
7380,DLG2,GO:0045197,establishment or maintenance of epithelial cell apical/basal polarity,2.0
7382,DLG2,GO:0046037,GMP metabolic process,2.0
7383,DLG2,GO:0046710,GDP metabolic process,2.0
7384,DLG2,GO:0097120,receptor localization to synapse,2.0
7385,DLG2,GO:0098609,cell-cell adhesion,2.0
7386,DLG2,GO:0098839,postsynaptic density membrane,2.0
7387,DLG2,GO:0099641,anterograde axonal protein transport,2.0
7388,DLG2,GO:0099642,retrograde axonal protein transport,2.0
7389,DLG2,GO:1904115,axon cytoplasm,2.0
7475,DLGAP1,GO:0005515,protein binding,2.0
7476,DLGAP1,GO:0005575,cellular_component,2.0
7477,DLGAP1,GO:0005886,plasma membrane,2.0
7478,DLGAP1,GO:0007268,chemical synaptic transmission,2.0
7479,DLGAP1,GO:0014069,postsynaptic density,2.0
7480,DLGAP1,GO:0044877,protein-containing complex binding,2.0
7481,DLGAP1,GO:0060090,molecular adaptor activity,2.0
7482,DLGAP1,GO:0098962,regulation of postsynaptic neurotransmitter receptor activity,2.0
7483,DLGAP1,GO:0098978,glutamatergic synapse,2.0
7484,DLGAP1,GO:0099572,postsynaptic specialization,2.0
7485,DLGAP2,GO:0005515,protein binding,2.0
7486,DLGAP2,GO:0005883,neurofilament,2.0
7487,DLGAP2,GO:0005886,plasma membrane,2.0
7488,DLGAP2,GO:0007270,neuron-neuron synaptic transmission,2.0
7489,DLGAP2,GO:0014069,postsynaptic density,2.0
7490,DLGAP2,GO:0060090,molecular adaptor activity,2.0
7491,DLGAP2,GO:0098962,regulation of postsynaptic neurotransmitter receptor activity,2.0
7492,DLGAP2,GO:0098978,glutamatergic synapse,2.0
7493,DLGAP2,GO:0099572,postsynaptic specialization,2.0
7494,DLGAP3,GO:0001540,amyloid-beta binding,2.0
7495,DLGAP3,GO:0005515,protein binding,2.0
7496,DLGAP3,GO:0005886,plasma membrane,2.0
7497,DLGAP3,GO:0014069,postsynaptic density,2.0
7498,DLGAP3,GO:0023052,signaling,2.0
7499,DLGAP3,GO:0031594,neuromuscular junction,2.0
7500,DLGAP3,GO:0060090,molecular adaptor activity,2.0
7501,DLGAP3,GO:0098962,regulation of postsynaptic neurotransmitter receptor activity,2.0
7502,DLGAP3,GO:0098978,glutamatergic synapse,2.0
7503,DLGAP3,GO:0098981,cholinergic synapse,2.0
7504,DLGAP3,GO:0099563,modification of synaptic structure,2.0
7505,DLGAP3,GO:0099572,postsynaptic specialization,2.0
7506,DLL1,GO:0001709,cell fate determination,2.0
7507,DLL1,GO:0001756,somitogenesis,2.0
7508,DLL1,GO:0001757,somite specification,2.0
7509,DLL1,GO:0001947,heart looping,2.0
7510,DLL1,GO:0002085,inhibition of neuroepithelial cell differentiation,2.0
7511,DLL1,GO:0002315,marginal zone B cell differentiation,2.0
7512,DLL1,GO:0003323,type B pancreatic cell development,2.0
7513,DLL1,GO:0005112,Notch binding,2.0
7515,DLL1,GO:0005509,calcium ion binding,2.0
7516,DLL1,GO:0005515,protein binding,2.0
7517,DLL1,GO:0005576,extracellular region,2.0
7518,DLL1,GO:0005886,plasma membrane,2.0
7521,DLL1,GO:0005912,adherens junction,2.0
7522,DLL1,GO:0007219,Notch signaling pathway,2.0
7527,DLL1,GO:0007368,determination of left/right symmetry,2.0
7528,DLL1,GO:0007386,compartment pattern specification,2.0
7529,DLL1,GO:0008217,regulation of blood pressure,2.0
7530,DLL1,GO:0008284,positive regulation of cell population proliferation,2.0
7531,DLL1,GO:0008285,negative regulation of cell population proliferation,2.0
7532,DLL1,GO:0009954,proximal/distal pattern formation,2.0
7533,DLL1,GO:0010628,positive regulation of gene expression,2.0
7534,DLL1,GO:0014002,astrocyte development,2.0
7535,DLL1,GO:0014807,regulation of somitogenesis,2.0
7536,DLL1,GO:0016324,apical plasma membrane,2.0
7537,DLL1,GO:0021510,spinal cord development,2.0
7538,DLL1,GO:0021688,cerebellar molecular layer formation,2.0
7539,DLL1,GO:0021693,cerebellar Purkinje cell layer structural organization,2.0
7540,DLL1,GO:0030097,hemopoiesis,2.0
7541,DLL1,GO:0030099,myeloid cell differentiation,2.0
7542,DLL1,GO:0030154,cell differentiation,2.0
7543,DLL1,GO:0030155,regulation of cell adhesion,2.0
7544,DLL1,GO:0030857,negative regulation of epithelial cell differentiation,2.0
7545,DLL1,GO:0030957,Tat protein binding,2.0
7546,DLL1,GO:0031410,cytoplasmic vesicle,2.0
7547,DLL1,GO:0032693,negative regulation of interleukin-10 production,2.0
7548,DLL1,GO:0034351,negative regulation of glial cell apoptotic process,2.0
7549,DLL1,GO:0035265,organ growth,2.0
7550,DLL1,GO:0040008,regulation of growth,2.0
7551,DLL1,GO:0042491,inner ear auditory receptor cell differentiation,2.0
7552,DLL1,GO:0045121,membrane raft,2.0
7553,DLL1,GO:0045596,negative regulation of cell differentiation,2.0
7554,DLL1,GO:0045605,negative regulation of epidermal cell differentiation,2.0
7555,DLL1,GO:0045608,negative regulation of inner ear auditory receptor cell differentiation,2.0
7556,DLL1,GO:0045611,negative regulation of hemocyte differentiation,2.0
7557,DLL1,GO:0045638,negative regulation of myeloid cell differentiation,2.0
7558,DLL1,GO:0045662,negative regulation of myoblast differentiation,2.0
7559,DLL1,GO:0045665,negative regulation of neuron differentiation,2.0
7560,DLL1,GO:0045746,negative regulation of Notch signaling pathway,2.0
7561,DLL1,GO:0045747,positive regulation of Notch signaling pathway,2.0
7562,DLL1,GO:0045807,positive regulation of endocytosis,2.0
7563,DLL1,GO:0045944,positive regulation of transcription by RNA polymerase II,2.0
7564,DLL1,GO:0046331,lateral inhibition,2.0
7565,DLL1,GO:0048018,receptor ligand activity,2.0
7566,DLL1,GO:0048630,skeletal muscle tissue growth,2.0
7567,DLL1,GO:0048631,regulation of skeletal muscle tissue growth,2.0
7568,DLL1,GO:0048633,positive regulation of skeletal muscle tissue growth,2.0
7569,DLL1,GO:0048665,neuron fate specification,2.0
7570,DLL1,GO:0050767,regulation of neurogenesis,2.0
7571,DLL1,GO:0051302,regulation of cell division,2.0
7572,DLL1,GO:0060041,retina development in camera-type eye,2.0
7573,DLL1,GO:0060042,retina morphogenesis in camera-type eye,2.0
7574,DLL1,GO:0060563,neuroepithelial cell differentiation,2.0
7575,DLL1,GO:0060853,Notch signaling pathway involved in arterial endothelial cell fate commitment,2.0
7576,DLL1,GO:0070986,left/right axis specification,2.0
7577,DLL1,GO:0072006,nephron development,2.0
7578,DLL1,GO:0072014,proximal tubule development,2.0
7579,DLL1,GO:0072070,loop of Henle development,2.0
7580,DLL1,GO:0072583,clathrin-dependent endocytosis,2.0
7581,DLL1,GO:0097009,energy homeostasis,2.0
7582,DLL1,GO:0097102,endothelial tip cell fate specification,2.0
7583,DLL1,GO:0097110,scaffold protein binding,2.0
7584,DLL1,GO:0097150,neuronal stem cell population maintenance,2.0
7586,DLL1,GO:0098773,skin epidermis development,2.0
7587,DLL1,GO:1900746,regulation of vascular endothelial growth factor signaling pathway,2.0
7588,DLL1,GO:1903672,positive regulation of sprouting angiogenesis,2.0
7589,DLL1,GO:2000726,negative regulation of cardiac muscle cell differentiation,2.0
7590,DLX3,GO:0000785,chromatin,2.0
7591,DLX3,GO:0000978,RNA polymerase II cis-regulatory region sequence-specific DNA binding,2.0
7592,DLX3,GO:0000981,"DNA-binding transcription factor activity, RNA polymerase II-specific",2.0
7594,DLX3,GO:0001228,"DNA-binding transcription activator activity, RNA polymerase II-specific",2.0
7595,DLX3,GO:0001568,blood vessel development,2.0
7596,DLX3,GO:0001890,placenta development,2.0
7597,DLX3,GO:0003677,DNA binding,2.0
7598,DLX3,GO:0003682,chromatin binding,2.0
7599,DLX3,GO:0003700,DNA-binding transcription factor activity,2.0
7600,DLX3,GO:0005515,protein binding,2.0
7601,DLX3,GO:0005634,nucleus,2.0
7602,DLX3,GO:0006357,regulation of transcription by RNA polymerase II,2.0
7603,DLX3,GO:0009790,embryo development,2.0
7604,DLX3,GO:0010467,gene expression,2.0
7605,DLX3,GO:0016055,Wnt signaling pathway,2.0
7606,DLX3,GO:0030154,cell differentiation,2.0
7607,DLX3,GO:0030509,BMP signaling pathway,2.0
7608,DLX3,GO:0030855,epithelial cell differentiation,2.0
7609,DLX3,GO:0031069,hair follicle morphogenesis,2.0
7610,DLX3,GO:0035315,hair cell differentiation,2.0
7611,DLX3,GO:0042475,odontogenesis of dentin-containing tooth,2.0
7612,DLX3,GO:0045944,positive regulation of transcription by RNA polymerase II,2.0
7613,DLX3,GO:0071335,hair follicle cell proliferation,2.0
7614,DLX3,GO:0071895,odontoblast differentiation,2.0
7615,DLX3,GO:1990837,sequence-specific double-stranded DNA binding,2.0
7616,DLX6,GO:0000785,chromatin,2.0
7617,DLX6,GO:0000978,RNA polymerase II cis-regulatory region sequence-specific DNA binding,2.0
7618,DLX6,GO:0000981,"DNA-binding transcription factor activity, RNA polymerase II-specific",2.0
7620,DLX6,GO:0001501,skeletal system development,2.0
7621,DLX6,GO:0003700,DNA-binding transcription factor activity,2.0
7622,DLX6,GO:0005634,nucleus,2.0
7623,DLX6,GO:0006357,regulation of transcription by RNA polymerase II,2.0
7624,DLX6,GO:0007399,nervous system development,2.0
7625,DLX6,GO:0009790,embryo development,2.0
7626,DLX6,GO:0030154,cell differentiation,2.0
7627,DLX6,GO:0030326,embryonic limb morphogenesis,2.0
7628,DLX6,GO:0030855,epithelial cell differentiation,2.0
7629,DLX6,GO:0042472,inner ear morphogenesis,2.0
7630,DLX6,GO:0048646,anatomical structure formation involved in morphogenesis,2.0
7631,DLX6,GO:0050679,positive regulation of epithelial cell proliferation,2.0
7632,DLX6,GO:0060021,roof of mouth development,2.0
7633,DLX6,GO:0060322,head development,2.0
7634,DLX6,GO:1990837,sequence-specific double-stranded DNA binding,2.0
7727,DMWD,GO:0003674,molecular_function,2.0
7728,DMWD,GO:0005575,cellular_component,2.0
7729,DMWD,GO:0005634,nucleus,2.0
7730,DMWD,GO:0030425,dendrite,2.0
7731,DMWD,GO:0043204,perikaryon,2.0
7732,DMXL2,GO:0005615,extracellular space,2.0
7733,DMXL2,GO:0007035,vacuolar acidification,2.0
7734,DMXL2,GO:0008021,synaptic vesicle,2.0
7735,DMXL2,GO:0030672,synaptic vesicle membrane,2.0
7736,DMXL2,GO:0031267,small GTPase binding,2.0
7737,DMXL2,GO:0043291,RAVE complex,2.0
7738,DMXL2,GO:0098992,neuronal dense core vesicle,2.0
7739,DNAH10,GO:0005524,ATP binding,2.0
7740,DNAH10,GO:0005874,microtubule,2.0
7741,DNAH10,GO:0005930,axoneme,2.0
7742,DNAH10,GO:0007018,microtubule-based movement,2.0
7743,DNAH10,GO:0008569,minus-end-directed microtubule motor activity,2.0
7744,DNAH10,GO:0030286,dynein complex,2.0
7745,DNAH10,GO:0045505,dynein intermediate chain binding,2.0
7746,DNAH10,GO:0051959,dynein light intermediate chain binding,2.0
7747,DNAH10,GO:0097729,9+2 motile cilium,2.0
7748,DNAH17,GO:0003341,cilium movement,2.0
7749,DNAH17,GO:0003777,microtubule motor activity,2.0
7750,DNAH17,GO:0005524,ATP binding,2.0
7751,DNAH17,GO:0005858,axonemal dynein complex,2.0
7752,DNAH17,GO:0005874,microtubule,2.0
7753,DNAH17,GO:0005930,axoneme,2.0
7755,DNAH17,GO:0007018,microtubule-based movement,2.0
7756,DNAH17,GO:0008569,minus-end-directed microtubule motor activity,2.0
7757,DNAH17,GO:0030286,dynein complex,2.0
7758,DNAH17,GO:0031514,motile cilium,2.0
7759,DNAH17,GO:0036126,sperm flagellum,2.0
7760,DNAH17,GO:0036157,outer dynein arm,2.0
7761,DNAH17,GO:0036158,outer dynein arm assembly,2.0
7762,DNAH17,GO:0045505,dynein intermediate chain binding,2.0
7763,DNAH17,GO:0051959,dynein light intermediate chain binding,2.0
7764,DNAH17,GO:0060285,cilium-dependent cell motility,2.0
7765,DNAH3,GO:0003777,microtubule motor activity,2.0
7766,DNAH3,GO:0005524,ATP binding,2.0
7767,DNAH3,GO:0005858,axonemal dynein complex,2.0
7768,DNAH3,GO:0005874,microtubule,2.0
7769,DNAH3,GO:0007018,microtubule-based movement,2.0
7770,DNAH3,GO:0008569,minus-end-directed microtubule motor activity,2.0
7771,DNAH3,GO:0030286,dynein complex,2.0
7772,DNAH3,GO:0045505,dynein intermediate chain binding,2.0
7773,DNAH3,GO:0051959,dynein light intermediate chain binding,2.0
7774,DNAH3,GO:0060285,cilium-dependent cell motility,2.0
7775,DNAH3,GO:0097729,9+2 motile cilium,2.0
7776,DNER,GO:0001764,neuron migration,2.0
7777,DNER,GO:0004888,transmembrane signaling receptor activity,2.0
7778,DNER,GO:0005112,Notch binding,2.0
7779,DNER,GO:0005509,calcium ion binding,2.0
7780,DNER,GO:0005515,protein binding,2.0
7781,DNER,GO:0005769,early endosome,2.0
7782,DNER,GO:0005886,plasma membrane,2.0
7783,DNER,GO:0006897,endocytosis,2.0
7784,DNER,GO:0007219,Notch signaling pathway,2.0
7785,DNER,GO:0007220,Notch receptor processing,2.0
7786,DNER,GO:0007416,synapse assembly,2.0
7787,DNER,GO:0007417,central nervous system development,2.0
7788,DNER,GO:0010001,glial cell differentiation,2.0
7789,DNER,GO:0030276,clathrin binding,2.0
7790,DNER,GO:0030425,dendrite,2.0
7791,DNER,GO:0043025,neuronal cell body,2.0
7792,DNER,GO:0048741,skeletal muscle fiber development,2.0
7846,DOCK1,GO:0005085,guanyl-nucleotide exchange factor activity,2.0
7848,DOCK1,GO:0005096,GTPase activator activity,2.0
7849,DOCK1,GO:0005515,protein binding,2.0
7850,DOCK1,GO:0005654,nucleoplasm,2.0
7851,DOCK1,GO:0005737,cytoplasm,2.0
7853,DOCK1,GO:0005829,cytosol,2.0
7855,DOCK1,GO:0005886,plasma membrane,2.0
7856,DOCK1,GO:0006911,"phagocytosis, engulfment",2.0
7857,DOCK1,GO:0006915,apoptotic process,2.0
7858,DOCK1,GO:0007165,signal transduction,2.0
7859,DOCK1,GO:0007229,integrin-mediated signaling pathway,2.0
7860,DOCK1,GO:0007264,small GTPase mediated signal transduction,2.0
7861,DOCK1,GO:0007520,myoblast fusion,2.0
7862,DOCK1,GO:0010634,positive regulation of epithelial cell migration,2.0
7863,DOCK1,GO:0016477,cell migration,2.0
7864,DOCK1,GO:0016607,nuclear speck,2.0
7865,DOCK1,GO:0017124,SH3 domain binding,2.0
7866,DOCK1,GO:0031267,small GTPase binding,2.0
7867,DOCK1,GO:0032045,guanyl-nucleotide exchange factor complex,2.0
7868,DOCK1,GO:0050790,regulation of catalytic activity,2.0
7869,DOCK1,GO:1900026,positive regulation of substrate adhesion-dependent cell spreading,2.0
7870,DOCK4,GO:0005085,guanyl-nucleotide exchange factor activity,2.0
7872,DOCK4,GO:0005096,GTPase activator activity,2.0
7873,DOCK4,GO:0005515,protein binding,2.0
7874,DOCK4,GO:0005730,nucleolus,2.0
7875,DOCK4,GO:0005737,cytoplasm,2.0
7876,DOCK4,GO:0005794,Golgi apparatus,2.0
7877,DOCK4,GO:0005829,cytosol,2.0
7879,DOCK4,GO:0005886,plasma membrane,2.0
7881,DOCK4,GO:0007264,small GTPase mediated signal transduction,2.0
7882,DOCK4,GO:0016020,membrane,2.0
7883,DOCK4,GO:0017124,SH3 domain binding,2.0
7884,DOCK4,GO:0030165,PDZ domain binding,2.0
7885,DOCK4,GO:0030971,receptor tyrosine kinase binding,2.0
7886,DOCK4,GO:0031267,small GTPase binding,2.0
7888,DOCK4,GO:0032420,stereocilium,2.0
7889,DOCK4,GO:0032421,stereocilium bundle,2.0
7890,DOCK4,GO:0050790,regulation of catalytic activity,2.0
7891,DOCK4,GO:0060326,cell chemotaxis,2.0
7893,DOCK4,GO:1904694,negative regulation of vascular associated smooth muscle contraction,2.0
7894,DOCK4,GO:1904754,positive regulation of vascular associated smooth muscle cell migration,2.0
7895,DOCK8,GO:0001771,immunological synapse formation,2.0
7896,DOCK8,GO:0005085,guanyl-nucleotide exchange factor activity,2.0
7899,DOCK8,GO:0005515,protein binding,2.0
7900,DOCK8,GO:0005737,cytoplasm,2.0
7901,DOCK8,GO:0005829,cytosol,2.0
7902,DOCK8,GO:0007264,small GTPase mediated signal transduction,2.0
7903,DOCK8,GO:0016020,membrane,2.0
7904,DOCK8,GO:0031252,cell leading edge,2.0
7905,DOCK8,GO:0031256,leading edge membrane,2.0
7906,DOCK8,GO:0031258,lamellipodium membrane,2.0
7907,DOCK8,GO:0036336,dendritic cell migration,2.0
7908,DOCK8,GO:0043547,positive regulation of GTPase activity,2.0
7910,DOCK8,GO:0051056,regulation of small GTPase mediated signal transduction,2.0
7911,DOCK8,GO:0061485,memory T cell proliferation,2.0
7912,DOCK8,GO:0070233,negative regulation of T cell apoptotic process,2.0
7913,DOCK8,GO:1903905,positive regulation of establishment of T cell polarity,2.0
7915,DOCK8,GO:1990869,cellular response to chemokine,2.0
7916,DOCK8,GO:2000406,positive regulation of T cell migration,2.0
7929,DPP10,GO:0005886,plasma membrane,2.0
7930,DPP10,GO:0006508,proteolysis,2.0
7931,DPP10,GO:0008076,voltage-gated potassium channel complex,2.0
7933,DPP10,GO:0008236,serine-type peptidase activity,2.0
7934,DPP10,GO:0008239,dipeptidyl-peptidase activity,2.0
7936,DPP10,GO:0015459,potassium channel regulator activity,2.0
7937,DPP10,GO:0016020,membrane,2.0
7938,DPP10,GO:0044325,transmembrane transporter binding,2.0
7939,DPP10,GO:0072659,protein localization to plasma membrane,2.0
7940,DPP10,GO:1901379,regulation of potassium ion transmembrane transport,2.0
7942,DPP10,GO:1903078,positive regulation of protein localization to plasma membrane,2.0
7943,DPP3,GO:0004177,aminopeptidase activity,2.0
7944,DPP3,GO:0005515,protein binding,2.0
7945,DPP3,GO:0005737,cytoplasm,2.0
7946,DPP3,GO:0005829,cytosol,2.0
7947,DPP3,GO:0006508,proteolysis,2.0
7948,DPP3,GO:0008235,metalloexopeptidase activity,2.0
7949,DPP3,GO:0008239,dipeptidyl-peptidase activity,2.0
7951,DPP3,GO:0008270,zinc ion binding,2.0
7952,DPP3,GO:0070062,extracellular exosome,2.0
7953,DPP4,GO:0001618,virus receptor activity,2.0
7954,DPP4,GO:0001662,behavioral fear response,2.0
7955,DPP4,GO:0001666,response to hypoxia,2.0
7956,DPP4,GO:0002020,protease binding,2.0
7957,DPP4,GO:0004177,aminopeptidase activity,2.0
7958,DPP4,GO:0004252,serine-type endopeptidase activity,2.0
7959,DPP4,GO:0005102,signaling receptor binding,2.0
7960,DPP4,GO:0005515,protein binding,2.0
7961,DPP4,GO:0005576,extracellular region,2.0
7962,DPP4,GO:0005765,lysosomal membrane,2.0
7963,DPP4,GO:0005886,plasma membrane,2.0
7966,DPP4,GO:0005925,focal adhesion,2.0
7967,DPP4,GO:0006508,proteolysis,2.0
7969,DPP4,GO:0007155,cell adhesion,2.0
7970,DPP4,GO:0008236,serine-type peptidase activity,2.0
7971,DPP4,GO:0008239,dipeptidyl-peptidase activity,2.0
7973,DPP4,GO:0008284,positive regulation of cell population proliferation,2.0
7974,DPP4,GO:0009986,cell surface,2.0
7975,DPP4,GO:0010716,negative regulation of extracellular matrix disassembly,2.0
7976,DPP4,GO:0016020,membrane,2.0
7977,DPP4,GO:0016324,apical plasma membrane,2.0
7978,DPP4,GO:0016486,peptide hormone processing,2.0
7979,DPP4,GO:0019065,receptor-mediated endocytosis of virus by host cell,2.0
7980,DPP4,GO:0030027,lamellipodium,2.0
7981,DPP4,GO:0030139,endocytic vesicle,2.0
7982,DPP4,GO:0031258,lamellipodium membrane,2.0
7983,DPP4,GO:0031295,T cell costimulation,2.0
7984,DPP4,GO:0033632,regulation of cell-cell adhesion mediated by integrin,2.0
7985,DPP4,GO:0035641,locomotory exploration behavior,2.0
7986,DPP4,GO:0036343,psychomotor behavior,2.0
7987,DPP4,GO:0042110,T cell activation,2.0
7988,DPP4,GO:0042802,identical protein binding,2.0
7989,DPP4,GO:0042803,protein homodimerization activity,2.0
7990,DPP4,GO:0043542,endothelial cell migration,2.0
7991,DPP4,GO:0045121,membrane raft,2.0
7992,DPP4,GO:0045499,chemorepellent activity,2.0
7994,DPP4,GO:0046581,intercellular canaliculus,2.0
7995,DPP4,GO:0046718,viral entry into host cell,2.0
7996,DPP4,GO:0046813,receptor-mediated virion attachment to host cell,2.0
7997,DPP4,GO:0050919,negative chemotaxis,2.0
7998,DPP4,GO:0061025,membrane fusion,2.0
7999,DPP4,GO:0070062,extracellular exosome,2.0
8000,DPP4,GO:0090024,negative regulation of neutrophil chemotaxis,2.0
8001,DPP4,GO:0120116,glucagon processing,2.0
8002,DPP6,GO:0005886,plasma membrane,2.0
8003,DPP6,GO:0006508,proteolysis,2.0
8004,DPP6,GO:0008076,voltage-gated potassium channel complex,2.0
8006,DPP6,GO:0008236,serine-type peptidase activity,2.0
8007,DPP6,GO:0008239,dipeptidyl-peptidase activity,2.0
8009,DPP6,GO:0015459,potassium channel regulator activity,2.0
8011,DPP6,GO:0016020,membrane,2.0
8012,DPP6,GO:0072659,protein localization to plasma membrane,2.0
8013,DPP6,GO:1901379,regulation of potassium ion transmembrane transport,2.0
8016,DPYD,GO:0002058,uracil binding,2.0
8017,DPYD,GO:0005515,protein binding,2.0
8018,DPYD,GO:0005737,cytoplasm,2.0
8019,DPYD,GO:0005829,cytosol,2.0
8022,DPYD,GO:0006145,purine nucleobase catabolic process,2.0
8023,DPYD,GO:0006208,pyrimidine nucleobase catabolic process,2.0
8025,DPYD,GO:0006210,thymine catabolic process,2.0
8027,DPYD,GO:0006212,uracil catabolic process,2.0
8029,DPYD,GO:0006214,thymidine catabolic process,2.0
8030,DPYD,GO:0006248,CMP catabolic process,2.0
8031,DPYD,GO:0006249,dCMP catabolic process,2.0
8032,DPYD,GO:0017113,dihydropyrimidine dehydrogenase (NADP+) activity,2.0
8036,DPYD,GO:0019483,beta-alanine biosynthetic process,2.0
8037,DPYD,GO:0042803,protein homodimerization activity,2.0
8039,DPYD,GO:0046050,UMP catabolic process,2.0
8040,DPYD,GO:0046079,dUMP catabolic process,2.0
8041,DPYD,GO:0046872,metal ion binding,2.0
8042,DPYD,GO:0050660,flavin adenine dinucleotide binding,2.0
8043,DPYD,GO:0050661,NADP binding,2.0
8045,DPYD,GO:0051536,iron-sulfur cluster binding,2.0
8046,DPYD,GO:0051539,"4 iron, 4 sulfur cluster binding",2.0
8067,DPYSL3,GO:0004157,dihydropyrimidinase activity,2.0
8068,DPYSL3,GO:0005515,protein binding,2.0
8069,DPYSL3,GO:0005615,extracellular space,2.0
8070,DPYSL3,GO:0005829,cytosol,2.0
8072,DPYSL3,GO:0006208,pyrimidine nucleobase catabolic process,2.0
8073,DPYSL3,GO:0010976,positive regulation of neuron projection development,2.0
8074,DPYSL3,GO:0010977,negative regulation of neuron projection development,2.0
8075,DPYSL3,GO:0017124,SH3 domain binding,2.0
8076,DPYSL3,GO:0030027,lamellipodium,2.0
8077,DPYSL3,GO:0030336,negative regulation of cell migration,2.0
8078,DPYSL3,GO:0030426,growth cone,2.0
8079,DPYSL3,GO:0031005,filamin binding,2.0
8080,DPYSL3,GO:0031941,filamentous actin,2.0
8081,DPYSL3,GO:0035374,chondroitin sulfate binding,2.0
8082,DPYSL3,GO:0042802,identical protein binding,2.0
8083,DPYSL3,GO:0044297,cell body,2.0
8084,DPYSL3,GO:0045202,synapse,2.0
8085,DPYSL3,GO:0048666,neuron development,2.0
8086,DPYSL3,GO:0048678,response to axon injury,2.0
8087,DPYSL3,GO:0051017,actin filament bundle assembly,2.0
8088,DPYSL3,GO:0051491,positive regulation of filopodium assembly,2.0
8089,DPYSL3,GO:0051764,actin crosslink formation,2.0
8091,DPYSL3,GO:0070382,exocytic vesicle,2.0
8092,DPYSL3,GO:0071345,cellular response to cytokine stimulus,2.0
8093,DRD2,GO:0000139,Golgi membrane,2.0
8094,DRD2,GO:0001591,"dopamine neurotransmitter receptor activity, coupled via Gi/Go",2.0
8096,DRD2,GO:0001659,temperature homeostasis,2.0
8097,DRD2,GO:0001666,response to hypoxia,2.0
8098,DRD2,GO:0001669,acrosomal vesicle,2.0
8099,DRD2,GO:0001933,negative regulation of protein phosphorylation,2.0
8100,DRD2,GO:0001975,response to amphetamine,2.0
8101,DRD2,GO:0001976,nervous system process involved in regulation of systemic arterial blood pressure,2.0
8102,DRD2,GO:0002027,regulation of heart rate,2.0
8103,DRD2,GO:0002028,regulation of sodium ion transport,2.0
8104,DRD2,GO:0002031,G protein-coupled receptor internalization,2.0
8105,DRD2,GO:0002052,positive regulation of neuroblast proliferation,2.0
8106,DRD2,GO:0002092,positive regulation of receptor internalization,2.0
8107,DRD2,GO:0004930,G protein-coupled receptor activity,2.0
8108,DRD2,GO:0005515,protein binding,2.0
8109,DRD2,GO:0005886,plasma membrane,2.0
8112,DRD2,GO:0005929,cilium,2.0
8113,DRD2,GO:0006914,autophagy,2.0
8114,DRD2,GO:0007194,negative regulation of adenylate cyclase activity,2.0
8115,DRD2,GO:0007195,adenylate cyclase-inhibiting dopamine receptor signaling pathway,2.0
8117,DRD2,GO:0007270,neuron-neuron synaptic transmission,2.0
8118,DRD2,GO:0007405,neuroblast proliferation,2.0
8119,DRD2,GO:0007409,axonogenesis,2.0
8120,DRD2,GO:0007416,synapse assembly,2.0
8121,DRD2,GO:0007608,sensory perception of smell,2.0
8122,DRD2,GO:0007616,long-term memory,2.0
8123,DRD2,GO:0007625,grooming behavior,2.0
8124,DRD2,GO:0007626,locomotory behavior,2.0
8125,DRD2,GO:0007628,adult walking behavior,2.0
8126,DRD2,GO:0008104,protein localization,2.0
8127,DRD2,GO:0008285,negative regulation of cell population proliferation,2.0
8128,DRD2,GO:0008306,associative learning,2.0
8129,DRD2,GO:0008542,visual learning,2.0
8130,DRD2,GO:0009410,response to xenobiotic stimulus,2.0
8131,DRD2,GO:0009416,response to light stimulus,2.0
8132,DRD2,GO:0009636,response to toxic substance,2.0
8133,DRD2,GO:0010039,response to iron ion,2.0
8134,DRD2,GO:0014059,regulation of dopamine secretion,2.0
8135,DRD2,GO:0014069,postsynaptic density,2.0
8136,DRD2,GO:0014854,response to inactivity,2.0
8137,DRD2,GO:0016055,Wnt signaling pathway,2.0
8138,DRD2,GO:0016328,lateral plasma membrane,2.0
8139,DRD2,GO:0021756,striatum development,2.0
8140,DRD2,GO:0021769,orbitofrontal cortex development,2.0
8141,DRD2,GO:0021853,cerebral cortex GABAergic interneuron migration,2.0
8142,DRD2,GO:0021984,adenohypophysis development,2.0
8143,DRD2,GO:0030139,endocytic vesicle,2.0
8144,DRD2,GO:0030336,negative regulation of cell migration,2.0
8145,DRD2,GO:0030424,axon,2.0
8146,DRD2,GO:0030425,dendrite,2.0
8147,DRD2,GO:0030432,peristalsis,2.0
8148,DRD2,GO:0030672,synaptic vesicle membrane,2.0
8149,DRD2,GO:0031223,auditory behavior,2.0
8150,DRD2,GO:0032147,activation of protein kinase activity,2.0
8151,DRD2,GO:0032228,"regulation of synaptic transmission, GABAergic",2.0
8152,DRD2,GO:0032467,positive regulation of cytokinesis,2.0
8153,DRD2,GO:0032922,circadian regulation of gene expression,2.0
8154,DRD2,GO:0033602,negative regulation of dopamine secretion,2.0
8155,DRD2,GO:0034776,response to histamine,2.0
8156,DRD2,GO:0035094,response to nicotine,2.0
8157,DRD2,GO:0035240,dopamine binding,2.0
8158,DRD2,GO:0035255,ionotropic glutamate receptor binding,2.0
8159,DRD2,GO:0035810,positive regulation of urine volume,2.0
8160,DRD2,GO:0035815,positive regulation of renal sodium excretion,2.0
8161,DRD2,GO:0036126,sperm flagellum,2.0
8162,DRD2,GO:0040018,positive regulation of multicellular organism growth,2.0
8163,DRD2,GO:0042220,response to cocaine,2.0
8164,DRD2,GO:0042321,"negative regulation of circadian sleep/wake cycle, sleep",2.0
8165,DRD2,GO:0042417,dopamine metabolic process,2.0
8166,DRD2,GO:0042734,presynaptic membrane,2.0
8167,DRD2,GO:0042756,drinking behavior,2.0
8168,DRD2,GO:0042802,identical protein binding,2.0
8169,DRD2,GO:0043197,dendritic spine,2.0
8170,DRD2,GO:0043204,perikaryon,2.0
8171,DRD2,GO:0043266,regulation of potassium ion transport,2.0
8173,DRD2,GO:0043278,response to morphine,2.0
8174,DRD2,GO:0043473,pigmentation,2.0
8175,DRD2,GO:0043491,protein kinase B signaling,2.0
8176,DRD2,GO:0043666,regulation of phosphoprotein phosphatase activity,2.0
8177,DRD2,GO:0043679,axon terminus,2.0
8178,DRD2,GO:0044877,protein-containing complex binding,2.0
8179,DRD2,GO:0045211,postsynaptic membrane,2.0
8180,DRD2,GO:0045745,positive regulation of G protein-coupled receptor signaling pathway,2.0
8181,DRD2,GO:0045776,negative regulation of blood pressure,2.0
8182,DRD2,GO:0045824,negative regulation of innate immune response,2.0
8183,DRD2,GO:0045944,positive regulation of transcription by RNA polymerase II,2.0
8184,DRD2,GO:0046676,negative regulation of insulin secretion,2.0
8185,DRD2,GO:0046717,acid secretion,2.0
8186,DRD2,GO:0048148,behavioral response to cocaine,2.0
8187,DRD2,GO:0048149,behavioral response to ethanol,2.0
8188,DRD2,GO:0048169,regulation of long-term neuronal synaptic plasticity,2.0
8189,DRD2,GO:0048678,response to axon injury,2.0
8190,DRD2,GO:0048755,branching morphogenesis of a nerve,2.0
8191,DRD2,GO:0050482,arachidonic acid secretion,2.0
8192,DRD2,GO:0050673,epithelial cell proliferation,2.0
8193,DRD2,GO:0050680,negative regulation of epithelial cell proliferation,2.0
8194,DRD2,GO:0050709,negative regulation of protein secretion,2.0
8195,DRD2,GO:0051209,release of sequestered calcium ion into cytosol,2.0
8196,DRD2,GO:0051481,negative regulation of cytosolic calcium ion concentration,2.0
8197,DRD2,GO:0051482,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway,2.0
8198,DRD2,GO:0051583,dopamine uptake involved in synaptic transmission,2.0
8199,DRD2,GO:0051584,regulation of dopamine uptake involved in synaptic transmission,2.0
8200,DRD2,GO:0051586,positive regulation of dopamine uptake involved in synaptic transmission,2.0
8201,DRD2,GO:0051823,regulation of synapse structural plasticity,2.0
8202,DRD2,GO:0051898,negative regulation of protein kinase B signaling,2.0
8204,DRD2,GO:0051967,"negative regulation of synaptic transmission, glutamatergic",2.0
8206,DRD2,GO:0060079,excitatory postsynaptic potential,2.0
8207,DRD2,GO:0060124,positive regulation of growth hormone secretion,2.0
8208,DRD2,GO:0060134,prepulse inhibition,2.0
8209,DRD2,GO:0060158,phospholipase C-activating dopamine receptor signaling pathway,2.0
8211,DRD2,GO:0060160,negative regulation of dopamine receptor signaling pathway,2.0
8212,DRD2,GO:0060170,ciliary membrane,2.0
8213,DRD2,GO:0060548,negative regulation of cell death,2.0
8214,DRD2,GO:0070374,positive regulation of ERK1 and ERK2 cascade,2.0
8215,DRD2,GO:0071880,adenylate cyclase-activating adrenergic receptor signaling pathway,2.0
8216,DRD2,GO:0090325,regulation of locomotion involved in locomotory behavior,2.0
8217,DRD2,GO:0097730,non-motile cilium,2.0
8218,DRD2,GO:0098691,dopaminergic synapse,2.0
8219,DRD2,GO:0098978,glutamatergic synapse,2.0
8220,DRD2,GO:0098982,GABA-ergic synapse,2.0
8221,DRD2,GO:0099170,postsynaptic modulation of chemical synaptic transmission,2.0
8222,DRD2,GO:0099171,presynaptic modulation of chemical synaptic transmission,2.0
8223,DRD2,GO:1900168,positive regulation of glial cell-derived neurotrophic factor production,2.0
8224,DRD2,GO:1900273,positive regulation of long-term synaptic potentiation,2.0
8225,DRD2,GO:1901363,heterocyclic compound binding,2.0
8226,DRD2,GO:1901386,negative regulation of voltage-gated calcium channel activity,2.0
8227,DRD2,GO:1990384,hyaloid vascular plexus regression,2.0
8228,DRD2,GO:2001223,negative regulation of neuron migration,2.0
8229,DRD3,GO:0000122,negative regulation of transcription by RNA polymerase II,2.0
8230,DRD3,GO:0001591,"dopamine neurotransmitter receptor activity, coupled via Gi/Go",2.0
8233,DRD3,GO:0001963,"synaptic transmission, dopaminergic",2.0
8234,DRD3,GO:0002031,G protein-coupled receptor internalization,2.0
8235,DRD3,GO:0004930,G protein-coupled receptor activity,2.0
8236,DRD3,GO:0005515,protein binding,2.0
8237,DRD3,GO:0005886,plasma membrane,2.0
8241,DRD3,GO:0006874,cellular calcium ion homeostasis,2.0
8242,DRD3,GO:0006914,autophagy,2.0
8243,DRD3,GO:0007186,G protein-coupled receptor signaling pathway,2.0
8244,DRD3,GO:0007191,adenylate cyclase-activating dopamine receptor signaling pathway,2.0
8245,DRD3,GO:0007194,negative regulation of adenylate cyclase activity,2.0
8246,DRD3,GO:0007195,adenylate cyclase-inhibiting dopamine receptor signaling pathway,2.0
8248,DRD3,GO:0007611,learning or memory,2.0
8249,DRD3,GO:0007612,learning,2.0
8250,DRD3,GO:0007626,locomotory behavior,2.0
8251,DRD3,GO:0008284,positive regulation of cell population proliferation,2.0
8252,DRD3,GO:0008542,visual learning,2.0
8253,DRD3,GO:0009410,response to xenobiotic stimulus,2.0
8254,DRD3,GO:0014059,regulation of dopamine secretion,2.0
8256,DRD3,GO:0019904,protein domain specific binding,2.0
8257,DRD3,GO:0030139,endocytic vesicle,2.0
8258,DRD3,GO:0031748,D1 dopamine receptor binding,2.0
8259,DRD3,GO:0032416,negative regulation of sodium:proton antiporter activity,2.0
8260,DRD3,GO:0032467,positive regulation of cytokinesis,2.0
8261,DRD3,GO:0032922,circadian regulation of gene expression,2.0
8262,DRD3,GO:0034776,response to histamine,2.0
8263,DRD3,GO:0035176,social behavior,2.0
8264,DRD3,GO:0035483,gastric emptying,2.0
8265,DRD3,GO:0035815,positive regulation of renal sodium excretion,2.0
8266,DRD3,GO:0042220,response to cocaine,2.0
8267,DRD3,GO:0042417,dopamine metabolic process,2.0
8268,DRD3,GO:0042995,cell projection,2.0
8269,DRD3,GO:0043066,negative regulation of apoptotic process,2.0
8270,DRD3,GO:0043266,regulation of potassium ion transport,2.0
8271,DRD3,GO:0043278,response to morphine,2.0
8272,DRD3,GO:0045177,apical part of cell,2.0
8273,DRD3,GO:0045187,"regulation of circadian sleep/wake cycle, sleep",2.0
8274,DRD3,GO:0045471,response to ethanol,2.0
8275,DRD3,GO:0045776,negative regulation of blood pressure,2.0
8276,DRD3,GO:0045840,positive regulation of mitotic nuclear division,2.0
8277,DRD3,GO:0045944,positive regulation of transcription by RNA polymerase II,2.0
8278,DRD3,GO:0046717,acid secretion,2.0
8279,DRD3,GO:0048148,behavioral response to cocaine,2.0
8281,DRD3,GO:0048715,negative regulation of oligodendrocyte differentiation,2.0
8282,DRD3,GO:0050482,arachidonic acid secretion,2.0
8283,DRD3,GO:0050709,negative regulation of protein secretion,2.0
8284,DRD3,GO:0050883,"musculoskeletal movement, spinal reflex action",2.0
8285,DRD3,GO:0051481,negative regulation of cytosolic calcium ion concentration,2.0
8286,DRD3,GO:0051482,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway,2.0
8287,DRD3,GO:0051584,regulation of dopamine uptake involved in synaptic transmission,2.0
8288,DRD3,GO:0051898,negative regulation of protein kinase B signaling,2.0
8289,DRD3,GO:0051967,"negative regulation of synaptic transmission, glutamatergic",2.0
8290,DRD3,GO:0060134,prepulse inhibition,2.0
8291,DRD3,GO:0060158,phospholipase C-activating dopamine receptor signaling pathway,2.0
8292,DRD3,GO:0060161,positive regulation of dopamine receptor signaling pathway,2.0
8293,DRD3,GO:0071880,adenylate cyclase-activating adrenergic receptor signaling pathway,2.0
8294,DRD3,GO:0090325,regulation of locomotion involved in locomotory behavior,2.0
8295,DRD3,GO:0098839,postsynaptic density membrane,2.0
8296,DRD3,GO:0098978,glutamatergic synapse,2.0
8297,DRD3,GO:0098982,GABA-ergic synapse,2.0
8298,DRD3,GO:0099149,regulation of postsynaptic neurotransmitter receptor internalization,2.0
8299,DRD3,GO:1901386,negative regulation of voltage-gated calcium channel activity,2.0
8333,DST,GO:0003779,actin binding,2.0
8334,DST,GO:0005178,integrin binding,2.0
8335,DST,GO:0005198,structural molecule activity,2.0
8336,DST,GO:0005509,calcium ion binding,2.0
8337,DST,GO:0005515,protein binding,2.0
8338,DST,GO:0005604,basement membrane,2.0
8339,DST,GO:0005634,nucleus,2.0
8340,DST,GO:0005635,nuclear envelope,2.0
8341,DST,GO:0005654,nucleoplasm,2.0
8342,DST,GO:0005737,cytoplasm,2.0
8344,DST,GO:0005789,endoplasmic reticulum membrane,2.0
8345,DST,GO:0005829,cytosol,2.0
8347,DST,GO:0005882,intermediate filament,2.0
8348,DST,GO:0005925,focal adhesion,2.0
8350,DST,GO:0005938,cell cortex,2.0
8351,DST,GO:0007010,cytoskeleton organization,2.0
8352,DST,GO:0007155,cell adhesion,2.0
8353,DST,GO:0007229,integrin-mediated signaling pathway,2.0
8354,DST,GO:0008017,microtubule binding,2.0
8355,DST,GO:0008022,protein C-terminus binding,2.0
8356,DST,GO:0008090,retrograde axonal transport,2.0
8357,DST,GO:0009611,response to wounding,2.0
8358,DST,GO:0009925,basal plasma membrane,2.0
8359,DST,GO:0015630,microtubule cytoskeleton,2.0
8360,DST,GO:0016020,membrane,2.0
8361,DST,GO:0030011,maintenance of cell polarity,2.0
8362,DST,GO:0030018,Z disc,2.0
8363,DST,GO:0030056,hemidesmosome,2.0
8365,DST,GO:0031252,cell leading edge,2.0
8366,DST,GO:0031410,cytoplasmic vesicle,2.0
8367,DST,GO:0031581,hemidesmosome assembly,2.0
8368,DST,GO:0031673,H zone,2.0
8369,DST,GO:0035371,microtubule plus-end,2.0
8370,DST,GO:0042060,wound healing,2.0
8371,DST,GO:0045104,intermediate filament cytoskeleton organization,2.0
8374,DST,GO:0048870,cell motility,2.0
8375,DST,GO:0051010,microtubule plus-end binding,2.0
8376,DST,GO:1904115,axon cytoplasm,2.0
8377,DUSP15,GO:0004725,protein tyrosine phosphatase activity,2.0
8379,DUSP15,GO:0005515,protein binding,2.0
8380,DUSP15,GO:0005829,cytosol,2.0
8382,DUSP15,GO:0005886,plasma membrane,2.0
8384,DUSP15,GO:0006470,protein dephosphorylation,2.0
8385,DUSP15,GO:0007165,signal transduction,2.0
8386,DUSP15,GO:0008138,protein tyrosine/serine/threonine phosphatase activity,2.0
8387,DUSP15,GO:0016311,dephosphorylation,2.0
8389,DUSP15,GO:0016791,phosphatase activity,2.0
8390,DUSP15,GO:0017018,myosin phosphatase activity,2.0
8391,DUSP15,GO:0048713,regulation of oligodendrocyte differentiation,2.0
8392,DVL3,GO:0000785,chromatin,2.0
8393,DVL3,GO:0001934,positive regulation of protein phosphorylation,2.0
8394,DVL3,GO:0002020,protease binding,2.0
8395,DVL3,GO:0005102,signaling receptor binding,2.0
8396,DVL3,GO:0005109,frizzled binding,2.0
8399,DVL3,GO:0005515,protein binding,2.0
8400,DVL3,GO:0005829,cytosol,2.0
8403,DVL3,GO:0008013,beta-catenin binding,2.0
8404,DVL3,GO:0031267,small GTPase binding,2.0
8405,DVL3,GO:0032880,regulation of protein localization,2.0
8406,DVL3,GO:0035556,intracellular signal transduction,2.0
8407,DVL3,GO:0035567,non-canonical Wnt signaling pathway,2.0
8409,DVL3,GO:0038031,non-canonical Wnt signaling pathway via JNK cascade,2.0
8410,DVL3,GO:0043507,positive regulation of JUN kinase activity,2.0
8411,DVL3,GO:0043547,positive regulation of GTPase activity,2.0
8412,DVL3,GO:0045893,positive regulation of DNA-templated transcription,2.0
8413,DVL3,GO:0045944,positive regulation of transcription by RNA polymerase II,2.0
8414,DVL3,GO:0050821,protein stabilization,2.0
8415,DVL3,GO:0060070,canonical Wnt signaling pathway,2.0
8420,DVL3,GO:0060071,"Wnt signaling pathway, planar cell polarity pathway",2.0
8422,DVL3,GO:0090179,planar cell polarity pathway involved in neural tube closure,2.0
8423,DVL3,GO:0150012,positive regulation of neuron projection arborization,2.0
8424,DYDC1,GO:0005515,protein binding,2.0
8425,DYDC1,GO:0044666,MLL3/4 complex,2.0
8426,DYDC1,GO:0048188,Set1C/COMPASS complex,2.0
8427,DYDC1,GO:0051568,histone H3-K4 methylation,2.0
8428,DYDC2,GO:0005515,protein binding,2.0
8429,DYDC2,GO:0044666,MLL3/4 complex,2.0
8430,DYDC2,GO:0048188,Set1C/COMPASS complex,2.0
8431,DYDC2,GO:0051568,histone H3-K4 methylation,2.0
8472,DLX2,GO:0000122,negative regulation of transcription by RNA polymerase II,2.0
8473,DLX2,GO:0000785,chromatin,2.0
8474,DLX2,GO:0000978,RNA polymerase II cis-regulatory region sequence-specific DNA binding,2.0
8475,DLX2,GO:0000981,"DNA-binding transcription factor activity, RNA polymerase II-specific",2.0
8477,DLX2,GO:0001228,"DNA-binding transcription activator activity, RNA polymerase II-specific",2.0
8478,DLX2,GO:0003682,chromatin binding,2.0
8479,DLX2,GO:0003700,DNA-binding transcription factor activity,2.0
8480,DLX2,GO:0003727,single-stranded RNA binding,2.0
8481,DLX2,GO:0005515,protein binding,2.0
8482,DLX2,GO:0005634,nucleus,2.0
8483,DLX2,GO:0006357,regulation of transcription by RNA polymerase II,2.0
8484,DLX2,GO:0007219,Notch signaling pathway,2.0
8485,DLX2,GO:0007420,brain development,2.0
8486,DLX2,GO:0009790,embryo development,2.0
8487,DLX2,GO:0009954,proximal/distal pattern formation,2.0
8488,DLX2,GO:0014016,neuroblast differentiation,2.0
8489,DLX2,GO:0021544,subpallium development,2.0
8490,DLX2,GO:0021766,hippocampus development,2.0
8491,DLX2,GO:0021772,olfactory bulb development,2.0
8492,DLX2,GO:0021879,forebrain neuron differentiation,2.0
8493,DLX2,GO:0021893,cerebral cortex GABAergic interneuron fate commitment,2.0
8494,DLX2,GO:0030154,cell differentiation,2.0
8495,DLX2,GO:0042475,odontogenesis of dentin-containing tooth,2.0
8496,DLX2,GO:0045597,positive regulation of cell differentiation,2.0
8497,DLX2,GO:0045746,negative regulation of Notch signaling pathway,2.0
8498,DLX2,GO:0045944,positive regulation of transcription by RNA polymerase II,2.0
8499,DLX2,GO:0046533,negative regulation of photoreceptor cell differentiation,2.0
8500,DLX2,GO:0048701,embryonic cranial skeleton morphogenesis,2.0
8501,DLX2,GO:0048709,oligodendrocyte differentiation,2.0
8502,DLX2,GO:0048715,negative regulation of oligodendrocyte differentiation,2.0
8503,DLX2,GO:0048755,branching morphogenesis of a nerve,2.0
8504,DLX2,GO:0051216,cartilage development,2.0
8505,DLX2,GO:1902871,positive regulation of amacrine cell differentiation,2.0
8506,DLX2,GO:1990837,sequence-specific double-stranded DNA binding,2.0
8507,DRD1,GO:0001588,"dopamine neurotransmitter receptor activity, coupled via Gs",2.0
8510,DRD1,GO:0001659,temperature homeostasis,2.0
8511,DRD1,GO:0001661,conditioned taste aversion,2.0
8512,DRD1,GO:0001662,behavioral fear response,2.0
8513,DRD1,GO:0001932,regulation of protein phosphorylation,2.0
8514,DRD1,GO:0001963,"synaptic transmission, dopaminergic",2.0
8515,DRD1,GO:0001975,response to amphetamine,2.0
8516,DRD1,GO:0004930,G protein-coupled receptor activity,2.0
8517,DRD1,GO:0004952,dopamine neurotransmitter receptor activity,2.0
8518,DRD1,GO:0005515,protein binding,2.0
8519,DRD1,GO:0005634,nucleus,2.0
8520,DRD1,GO:0005789,endoplasmic reticulum membrane,2.0
8521,DRD1,GO:0005886,plasma membrane,2.0
8525,DRD1,GO:0005929,cilium,2.0
8526,DRD1,GO:0006468,protein phosphorylation,2.0
8527,DRD1,GO:0006606,protein import into nucleus,2.0
8528,DRD1,GO:0007187,"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger",2.0
8529,DRD1,GO:0007189,adenylate cyclase-activating G protein-coupled receptor signaling pathway,2.0
8530,DRD1,GO:0007190,activation of adenylate cyclase activity,2.0
8531,DRD1,GO:0007191,adenylate cyclase-activating dopamine receptor signaling pathway,2.0
8532,DRD1,GO:0007212,dopamine receptor signaling pathway,2.0
8533,DRD1,GO:0007416,synapse assembly,2.0
8534,DRD1,GO:0007613,memory,2.0
8535,DRD1,GO:0007617,mating behavior,2.0
8536,DRD1,GO:0007625,grooming behavior,2.0
8537,DRD1,GO:0007628,adult walking behavior,2.0
8538,DRD1,GO:0008542,visual learning,2.0
8539,DRD1,GO:0009410,response to xenobiotic stimulus,2.0
8540,DRD1,GO:0010628,positive regulation of gene expression,2.0
8541,DRD1,GO:0014002,astrocyte development,2.0
8542,DRD1,GO:0015872,dopamine transport,2.0
8543,DRD1,GO:0019226,transmission of nerve impulse,2.0
8544,DRD1,GO:0019228,neuronal action potential,2.0
8545,DRD1,GO:0021542,dentate gyrus development,2.0
8546,DRD1,GO:0021756,striatum development,2.0
8547,DRD1,GO:0021853,cerebral cortex GABAergic interneuron migration,2.0
8548,DRD1,GO:0030335,positive regulation of cell migration,2.0
8549,DRD1,GO:0030432,peristalsis,2.0
8550,DRD1,GO:0035106,operant conditioning,2.0
8551,DRD1,GO:0035240,dopamine binding,2.0
8552,DRD1,GO:0035249,"synaptic transmission, glutamatergic",2.0
8553,DRD1,GO:0042053,regulation of dopamine metabolic process,2.0
8554,DRD1,GO:0042311,vasodilation,2.0
8555,DRD1,GO:0042417,dopamine metabolic process,2.0
8556,DRD1,GO:0042711,maternal behavior,2.0
8557,DRD1,GO:0042734,presynaptic membrane,2.0
8558,DRD1,GO:0043197,dendritic spine,2.0
8559,DRD1,GO:0043268,positive regulation of potassium ion transport,2.0
8560,DRD1,GO:0045211,postsynaptic membrane,2.0
8561,DRD1,GO:0046323,glucose import,2.0
8562,DRD1,GO:0046959,habituation,2.0
8563,DRD1,GO:0046960,sensitization,2.0
8564,DRD1,GO:0048148,behavioral response to cocaine,2.0
8565,DRD1,GO:0051281,positive regulation of release of sequestered calcium ion into cytosol,2.0
8566,DRD1,GO:0051482,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway,2.0
8567,DRD1,GO:0051584,regulation of dopamine uptake involved in synaptic transmission,2.0
8568,DRD1,GO:0051968,"positive regulation of synaptic transmission, glutamatergic",2.0
8569,DRD1,GO:0060134,prepulse inhibition,2.0
8570,DRD1,GO:0060158,phospholipase C-activating dopamine receptor signaling pathway,2.0
8571,DRD1,GO:0060170,ciliary membrane,2.0
8572,DRD1,GO:0060291,long-term synaptic potentiation,2.0
8573,DRD1,GO:0060292,long-term synaptic depression,2.0
8574,DRD1,GO:0071870,cellular response to catecholamine stimulus,2.0
8575,DRD1,GO:0071880,adenylate cyclase-activating adrenergic receptor signaling pathway,2.0
8576,DRD1,GO:0097730,non-motile cilium,2.0
8577,DRD1,GO:0098978,glutamatergic synapse,2.0
8578,DRD1,GO:0098982,GABA-ergic synapse,2.0
8579,DRD1,GO:0099010,modification of postsynaptic structure,2.0
8580,DRD1,GO:0099171,presynaptic modulation of chemical synaptic transmission,2.0
8581,DRD1,GO:1903351,cellular response to dopamine,2.0
8582,DRD1,GO:2001224,positive regulation of neuron migration,2.0
8649,ECPAS,GO:0000502,proteasome complex,2.0
8650,ECPAS,GO:0005515,protein binding,2.0
8651,ECPAS,GO:0005634,nucleus,2.0
8653,ECPAS,GO:0005654,nucleoplasm,2.0
8654,ECPAS,GO:0005737,cytoplasm,2.0
8655,ECPAS,GO:0005769,early endosome,2.0
8656,ECPAS,GO:0005770,late endosome,2.0
8657,ECPAS,GO:0005771,multivesicular body,2.0
8658,ECPAS,GO:0005783,endoplasmic reticulum,2.0
8659,ECPAS,GO:0005793,endoplasmic reticulum-Golgi intermediate compartment,2.0
8660,ECPAS,GO:0005802,trans-Golgi network,2.0
8661,ECPAS,GO:0005813,centrosome,2.0
8662,ECPAS,GO:0016020,membrane,2.0
8663,ECPAS,GO:0030134,COPII-coated ER to Golgi transport vesicle,2.0
8664,ECPAS,GO:0030139,endocytic vesicle,2.0
8665,ECPAS,GO:0030433,ubiquitin-dependent ERAD pathway,2.0
8667,ECPAS,GO:0031410,cytoplasmic vesicle,2.0
8668,ECPAS,GO:0043248,proteasome assembly,2.0
8669,ECPAS,GO:0060090,molecular adaptor activity,2.0
8670,ECPAS,GO:0070628,proteasome binding,2.0
8687,EFR3A,GO:0005829,cytosol,2.0
8688,EFR3A,GO:0005886,plasma membrane,2.0
8690,EFR3A,GO:0046854,phosphatidylinositol phosphate biosynthetic process,2.0
8691,EFR3A,GO:0072659,protein localization to plasma membrane,2.0
8693,EGR3,GO:0000785,chromatin,2.0
8694,EGR3,GO:0000978,RNA polymerase II cis-regulatory region sequence-specific DNA binding,2.0
8695,EGR3,GO:0000981,"DNA-binding transcription factor activity, RNA polymerase II-specific",2.0
8697,EGR3,GO:0001228,"DNA-binding transcription activator activity, RNA polymerase II-specific",2.0
8698,EGR3,GO:0001938,positive regulation of endothelial cell proliferation,2.0
8699,EGR3,GO:0002042,cell migration involved in sprouting angiogenesis,2.0
8700,EGR3,GO:0003700,DNA-binding transcription factor activity,2.0
8701,EGR3,GO:0005654,nucleoplasm,2.0
8702,EGR3,GO:0006357,regulation of transcription by RNA polymerase II,2.0
8703,EGR3,GO:0007274,neuromuscular synaptic transmission,2.0
8704,EGR3,GO:0007422,peripheral nervous system development,2.0
8705,EGR3,GO:0007517,muscle organ development,2.0
8706,EGR3,GO:0007623,circadian rhythm,2.0
8707,EGR3,GO:0033089,positive regulation of T cell differentiation in thymus,2.0
8708,EGR3,GO:0035767,endothelial cell chemotaxis,2.0
8709,EGR3,GO:0035924,cellular response to vascular endothelial growth factor stimulus,2.0
8710,EGR3,GO:0043066,negative regulation of apoptotic process,2.0
8711,EGR3,GO:0044344,cellular response to fibroblast growth factor stimulus,2.0
8712,EGR3,GO:0045202,synapse,2.0
8713,EGR3,GO:0045586,regulation of gamma-delta T cell differentiation,2.0
8714,EGR3,GO:0045944,positive regulation of transcription by RNA polymerase II,2.0
8715,EGR3,GO:0046872,metal ion binding,2.0
8716,EGR3,GO:1990837,sequence-specific double-stranded DNA binding,2.0
8767,EIF4E,GO:0000082,G1/S transition of mitotic cell cycle,2.0
8768,EIF4E,GO:0000339,RNA cap binding,2.0
8769,EIF4E,GO:0000340,RNA 7-methylguanosine cap binding,2.0
8771,EIF4E,GO:0000932,P-body,2.0
8772,EIF4E,GO:0001662,behavioral fear response,2.0
8773,EIF4E,GO:0003723,RNA binding,2.0
8774,EIF4E,GO:0003743,translation initiation factor activity,2.0
8777,EIF4E,GO:0005515,protein binding,2.0
8778,EIF4E,GO:0005634,nucleus,2.0
8779,EIF4E,GO:0005737,cytoplasm,2.0
8780,EIF4E,GO:0005829,cytosol,2.0
8782,EIF4E,GO:0005845,mRNA cap binding complex,2.0
8783,EIF4E,GO:0006413,translational initiation,2.0
8784,EIF4E,GO:0006417,regulation of translation,2.0
8785,EIF4E,GO:0010494,cytoplasmic stress granule,2.0
8786,EIF4E,GO:0010507,negative regulation of autophagy,2.0
8787,EIF4E,GO:0016281,eukaryotic translation initiation factor 4F complex,2.0
8790,EIF4E,GO:0016442,RISC complex,2.0
8791,EIF4E,GO:0017148,negative regulation of translation,2.0
8792,EIF4E,GO:0019827,stem cell population maintenance,2.0
8793,EIF4E,GO:0019899,enzyme binding,2.0
8794,EIF4E,GO:0030182,neuron differentiation,2.0
8795,EIF4E,GO:0030324,lung development,2.0
8796,EIF4E,GO:0031370,eukaryotic initiation factor 4G binding,2.0
8797,EIF4E,GO:0033391,chromatoid body,2.0
8798,EIF4E,GO:0036464,cytoplasmic ribonucleoprotein granule,2.0
8799,EIF4E,GO:0045665,negative regulation of neuron differentiation,2.0
8800,EIF4E,GO:0045931,positive regulation of mitotic cell cycle,2.0
8801,EIF4E,GO:0048471,perinuclear region of cytoplasm,2.0
8802,EIF4E,GO:0070062,extracellular exosome,2.0
8803,EIF4E,GO:0071549,cellular response to dexamethasone stimulus,2.0
8804,EIF4E,GO:0098978,glutamatergic synapse,2.0
8805,EIF4E,GO:0099524,postsynaptic cytosol,2.0
8806,EIF4E,GO:0099578,"regulation of translation at postsynapse, modulating synaptic transmission",2.0
8807,EIF4E,GO:0140297,DNA-binding transcription factor binding,2.0
8867,ELAVL2,GO:0003723,RNA binding,2.0
8868,ELAVL2,GO:0003730,mRNA 3'-UTR binding,2.0
8869,ELAVL2,GO:0005515,protein binding,2.0
8870,ELAVL2,GO:0005654,nucleoplasm,2.0
8871,ELAVL2,GO:0006355,regulation of DNA-templated transcription,2.0
8872,ELAVL2,GO:1990904,ribonucleoprotein complex,2.0
8877,ELOVL2,GO:0005515,protein binding,2.0
8878,ELOVL2,GO:0005783,endoplasmic reticulum,2.0
8879,ELOVL2,GO:0005789,endoplasmic reticulum membrane,2.0
8881,ELOVL2,GO:0006636,unsaturated fatty acid biosynthetic process,2.0
8882,ELOVL2,GO:0009922,fatty acid elongase activity,2.0
8886,ELOVL2,GO:0019367,"fatty acid elongation, saturated fatty acid",2.0
8887,ELOVL2,GO:0030148,sphingolipid biosynthetic process,2.0
8888,ELOVL2,GO:0034625,"fatty acid elongation, monounsaturated fatty acid",2.0
8889,ELOVL2,GO:0034626,"fatty acid elongation, polyunsaturated fatty acid",2.0
8891,ELOVL2,GO:0035338,long-chain fatty-acyl-CoA biosynthetic process,2.0
8892,ELOVL2,GO:0036109,alpha-linolenic acid metabolic process,2.0
8893,ELOVL2,GO:0042761,very long-chain fatty acid biosynthetic process,2.0
8895,ELOVL2,GO:0043651,linoleic acid metabolic process,2.0
8896,ELOVL2,GO:0102756,very-long-chain 3-ketoacyl-CoA synthase activity,2.0
8897,ELP2,GO:0000993,RNA polymerase II complex binding,2.0
8898,ELP2,GO:0002098,tRNA wobble uridine modification,2.0
8899,ELP2,GO:0005654,nucleoplasm,2.0
8900,ELP2,GO:0005737,cytoplasm,2.0
8901,ELP2,GO:0005829,cytosol,2.0
8902,ELP2,GO:0006357,regulation of transcription by RNA polymerase II,2.0
8903,ELP2,GO:0006368,transcription elongation by RNA polymerase II promoter,2.0
8904,ELP2,GO:0006417,regulation of translation,2.0
8905,ELP2,GO:0008023,transcription elongation factor complex,2.0
8906,ELP2,GO:0019901,protein kinase binding,2.0
8907,ELP2,GO:0033588,elongator holoenzyme complex,2.0
8910,ELP2,GO:0046425,regulation of receptor signaling pathway via JAK-STAT,2.0
8911,ELP4,GO:0000993,RNA polymerase II complex binding,2.0
8912,ELP4,GO:0002098,tRNA wobble uridine modification,2.0
8914,ELP4,GO:0005515,protein binding,2.0
8915,ELP4,GO:0005654,nucleoplasm,2.0
8916,ELP4,GO:0005737,cytoplasm,2.0
8918,ELP4,GO:0006357,regulation of transcription by RNA polymerase II,2.0
8920,ELP4,GO:0006368,transcription elongation by RNA polymerase II promoter,2.0
8921,ELP4,GO:0006417,regulation of translation,2.0
8922,ELP4,GO:0008023,transcription elongation factor complex,2.0
8924,ELP4,GO:0008607,phosphorylase kinase regulator activity,2.0
8925,ELP4,GO:0033588,elongator holoenzyme complex,2.0
8928,ELP4,GO:0050790,regulation of catalytic activity,2.0
8929,EMSY,GO:0005515,protein binding,2.0
8930,EMSY,GO:0005654,nucleoplasm,2.0
8932,EMSY,GO:0006281,DNA repair,2.0
8933,EMSY,GO:0006325,chromatin organization,2.0
8934,EMSY,GO:0006355,regulation of DNA-templated transcription,2.0
8935,EN2,GO:0000785,chromatin,2.0
8936,EN2,GO:0000978,RNA polymerase II cis-regulatory region sequence-specific DNA binding,2.0
8937,EN2,GO:0000981,"DNA-binding transcription factor activity, RNA polymerase II-specific",2.0
8939,EN2,GO:0001650,fibrillar center,2.0
8940,EN2,GO:0005634,nucleus,2.0
8941,EN2,GO:0005654,nucleoplasm,2.0
8942,EN2,GO:0005730,nucleolus,2.0
8943,EN2,GO:0006357,regulation of transcription by RNA polymerase II,2.0
8944,EN2,GO:0016020,membrane,2.0
8945,EN2,GO:0030182,neuron differentiation,2.0
8946,EN2,GO:0030901,midbrain development,2.0
8947,EN2,GO:0030902,hindbrain development,2.0
8948,EN2,GO:0043524,negative regulation of neuron apoptotic process,2.0
8949,EN2,GO:0045944,positive regulation of transcription by RNA polymerase II,2.0
8950,EN2,GO:0048666,neuron development,2.0
8951,EN2,GO:0071542,dopaminergic neuron differentiation,2.0
8952,EN2,GO:1990403,embryonic brain development,2.0
8953,EN2,GO:1990837,sequence-specific double-stranded DNA binding,2.0
9138,EP400,GO:0000786,nucleosome,2.0
9139,EP400,GO:0000812,Swr1 complex,2.0
9141,EP400,GO:0003677,DNA binding,2.0
9142,EP400,GO:0003682,chromatin binding,2.0
9143,EP400,GO:0004386,helicase activity,2.0
9144,EP400,GO:0005515,protein binding,2.0
9145,EP400,GO:0005524,ATP binding,2.0
9146,EP400,GO:0005654,nucleoplasm,2.0
9147,EP400,GO:0006281,DNA repair,2.0
9148,EP400,GO:0006338,chromatin remodeling,2.0
9149,EP400,GO:0016573,histone acetylation,2.0
9150,EP400,GO:0016607,nuclear speck,2.0
9151,EP400,GO:0016787,hydrolase activity,2.0
9152,EP400,GO:0035267,NuA4 histone acetyltransferase complex,2.0
9154,EP400,GO:0042981,regulation of apoptotic process,2.0
9155,EP400,GO:0043967,histone H4 acetylation,2.0
9157,EP400,GO:0043968,histone H2A acetylation,2.0
9158,EP400,GO:0045893,positive regulation of DNA-templated transcription,2.0
9159,EP400,GO:0051726,regulation of cell cycle,2.0
9160,EP400,GO:0140658,ATP-dependent chromatin remodeler activity,2.0
9161,EP400,GO:1905168,positive regulation of double-strand break repair via homologous recombination,2.0
9162,EP400,GO:1990405,protein antigen binding,2.0
9163,EP400,GO:2000779,regulation of double-strand break repair,2.0
9164,EPC2,GO:0000786,nucleosome,2.0
9165,EPC2,GO:0005634,nucleus,2.0
9166,EPC2,GO:0006281,DNA repair,2.0
9167,EPC2,GO:0006325,chromatin organization,2.0
9168,EPC2,GO:0006357,regulation of transcription by RNA polymerase II,2.0
9169,EPC2,GO:0016573,histone acetylation,2.0
9170,EPC2,GO:0032777,Piccolo NuA4 histone acetyltransferase complex,2.0
9171,EPC2,GO:0035267,NuA4 histone acetyltransferase complex,2.0
9172,EPC2,GO:0042981,regulation of apoptotic process,2.0
9173,EPC2,GO:0043967,histone H4 acetylation,2.0
9174,EPC2,GO:0043968,histone H2A acetylation,2.0
9175,EPC2,GO:0045893,positive regulation of DNA-templated transcription,2.0
9176,EPC2,GO:0051726,regulation of cell cycle,2.0
9177,EPC2,GO:1905168,positive regulation of double-strand break repair via homologous recombination,2.0
9178,EPC2,GO:2000779,regulation of double-strand break repair,2.0
9179,EPHA1,GO:0001525,angiogenesis,2.0
9180,EPHA1,GO:0001954,positive regulation of cell-matrix adhesion,2.0
9181,EPHA1,GO:0001968,fibronectin binding,2.0
9182,EPHA1,GO:0004672,protein kinase activity,2.0
9183,EPHA1,GO:0004714,transmembrane receptor protein tyrosine kinase activity,2.0
9184,EPHA1,GO:0005005,transmembrane-ephrin receptor activity,2.0
9186,EPHA1,GO:0005524,ATP binding,2.0
9187,EPHA1,GO:0005886,plasma membrane,2.0
9190,EPHA1,GO:0006469,negative regulation of protein kinase activity,2.0
9191,EPHA1,GO:0007166,cell surface receptor signaling pathway,2.0
9192,EPHA1,GO:0007169,transmembrane receptor protein tyrosine kinase signaling pathway,2.0
9193,EPHA1,GO:0007275,multicellular organism development,2.0
9194,EPHA1,GO:0007411,axon guidance,2.0
9195,EPHA1,GO:0008284,positive regulation of cell population proliferation,2.0
9196,EPHA1,GO:0018108,peptidyl-tyrosine phosphorylation,2.0
9197,EPHA1,GO:0019901,protein kinase binding,2.0
9198,EPHA1,GO:0030335,positive regulation of cell migration,2.0
9199,EPHA1,GO:0030336,negative regulation of cell migration,2.0
9200,EPHA1,GO:0033674,positive regulation of kinase activity,2.0
9201,EPHA1,GO:0034446,substrate adhesion-dependent cell spreading,2.0
9202,EPHA1,GO:0043005,neuron projection,2.0
9203,EPHA1,GO:0043087,regulation of GTPase activity,2.0
9204,EPHA1,GO:0043235,receptor complex,2.0
9205,EPHA1,GO:0045766,positive regulation of angiogenesis,2.0
9207,EPHA1,GO:0046777,protein autophosphorylation,2.0
9208,EPHA1,GO:0048013,ephrin receptor signaling pathway,2.0
9209,EPHA1,GO:0051496,positive regulation of stress fiber assembly,2.0
9210,EPHA1,GO:0090630,activation of GTPase activity,2.0
9265,EPHB2,GO:0001525,angiogenesis,2.0
9267,EPHB2,GO:0001540,amyloid-beta binding,2.0
9269,EPHB2,GO:0001655,urogenital system development,2.0
9270,EPHB2,GO:0001933,negative regulation of protein phosphorylation,2.0
9271,EPHB2,GO:0002639,positive regulation of immunoglobulin production,2.0
9272,EPHB2,GO:0004713,protein tyrosine kinase activity,2.0
9273,EPHB2,GO:0004714,transmembrane receptor protein tyrosine kinase activity,2.0
9274,EPHB2,GO:0005005,transmembrane-ephrin receptor activity,2.0
9277,EPHB2,GO:0005102,signaling receptor binding,2.0
9278,EPHB2,GO:0005515,protein binding,2.0
9279,EPHB2,GO:0005524,ATP binding,2.0
9280,EPHB2,GO:0005576,extracellular region,2.0
9281,EPHB2,GO:0005654,nucleoplasm,2.0
9282,EPHB2,GO:0005794,Golgi apparatus,2.0
9283,EPHB2,GO:0005829,cytosol,2.0
9284,EPHB2,GO:0005886,plasma membrane,2.0
9288,EPHB2,GO:0006469,negative regulation of protein kinase activity,2.0
9289,EPHB2,GO:0007162,negative regulation of cell adhesion,2.0
9290,EPHB2,GO:0007169,transmembrane receptor protein tyrosine kinase signaling pathway,2.0
9291,EPHB2,GO:0007275,multicellular organism development,2.0
9292,EPHB2,GO:0007399,nervous system development,2.0
9293,EPHB2,GO:0007411,axon guidance,2.0
9295,EPHB2,GO:0007413,axonal fasciculation,2.0
9296,EPHB2,GO:0007611,learning or memory,2.0
9297,EPHB2,GO:0007612,learning,2.0
9298,EPHB2,GO:0008046,axon guidance receptor activity,2.0
9299,EPHB2,GO:0009986,cell surface,2.0
9300,EPHB2,GO:0010628,positive regulation of gene expression,2.0
9301,EPHB2,GO:0016310,phosphorylation,2.0
9302,EPHB2,GO:0018108,peptidyl-tyrosine phosphorylation,2.0
9303,EPHB2,GO:0021631,optic nerve morphogenesis,2.0
9304,EPHB2,GO:0021934,hindbrain tangential cell migration,2.0
9305,EPHB2,GO:0021952,central nervous system projection neuron axonogenesis,2.0
9306,EPHB2,GO:0022038,corpus callosum development,2.0
9307,EPHB2,GO:0030193,regulation of blood coagulation,2.0
9308,EPHB2,GO:0030335,positive regulation of cell migration,2.0
9309,EPHB2,GO:0030424,axon,2.0
9310,EPHB2,GO:0030425,dendrite,2.0
9311,EPHB2,GO:0030890,positive regulation of B cell proliferation,2.0
9312,EPHB2,GO:0031290,retinal ganglion cell axon guidance,2.0
9313,EPHB2,GO:0031915,positive regulation of synaptic plasticity,2.0
9314,EPHB2,GO:0032760,positive regulation of tumor necrosis factor production,2.0
9315,EPHB2,GO:0033674,positive regulation of kinase activity,2.0
9316,EPHB2,GO:0042113,B cell activation,2.0
9317,EPHB2,GO:0042472,inner ear morphogenesis,2.0
9318,EPHB2,GO:0042734,presynaptic membrane,2.0
9319,EPHB2,GO:0042802,identical protein binding,2.0
9320,EPHB2,GO:0043005,neuron projection,2.0
9321,EPHB2,GO:0043025,neuronal cell body,2.0
9322,EPHB2,GO:0043197,dendritic spine,2.0
9323,EPHB2,GO:0043235,receptor complex,2.0
9324,EPHB2,GO:0044877,protein-containing complex binding,2.0
9325,EPHB2,GO:0045211,postsynaptic membrane,2.0
9326,EPHB2,GO:0046425,regulation of receptor signaling pathway via JAK-STAT,2.0
9327,EPHB2,GO:0046580,negative regulation of Ras protein signal transduction,2.0
9328,EPHB2,GO:0048013,ephrin receptor signaling pathway,2.0
9329,EPHB2,GO:0048168,regulation of neuronal synaptic plasticity,2.0
9330,EPHB2,GO:0048170,positive regulation of long-term neuronal synaptic plasticity,2.0
9331,EPHB2,GO:0048593,camera-type eye morphogenesis,2.0
9332,EPHB2,GO:0050771,negative regulation of axonogenesis,2.0
9333,EPHB2,GO:0050878,regulation of body fluid levels,2.0
9334,EPHB2,GO:0051489,regulation of filopodium assembly,2.0
9335,EPHB2,GO:0051965,positive regulation of synapse assembly,2.0
9336,EPHB2,GO:0060021,roof of mouth development,2.0
9337,EPHB2,GO:0060996,dendritic spine development,2.0
9338,EPHB2,GO:0060997,dendritic spine morphogenesis,2.0
9339,EPHB2,GO:0061003,positive regulation of dendritic spine morphogenesis,2.0
9340,EPHB2,GO:0070373,negative regulation of ERK1 and ERK2 cascade,2.0
9341,EPHB2,GO:0071222,cellular response to lipopolysaccharide,2.0
9342,EPHB2,GO:0071679,commissural neuron axon guidance,2.0
9343,EPHB2,GO:0097104,postsynaptic membrane assembly,2.0
9344,EPHB2,GO:0098686,hippocampal mossy fiber to CA3 synapse,2.0
9345,EPHB2,GO:0098794,postsynapse,2.0
9346,EPHB2,GO:0098978,glutamatergic synapse,2.0
9347,EPHB2,GO:0099557,"trans-synaptic signaling by trans-synaptic complex, modulating synaptic transmission",2.0
9348,EPHB2,GO:0106028,neuron projection retraction,2.0
9349,EPHB2,GO:0110077,vesicle-mediated intercellular transport,2.0
9350,EPHB2,GO:0120192,tight junction assembly,2.0
9351,EPHB2,GO:1900016,negative regulation of cytokine production involved in inflammatory response,2.0
9352,EPHB2,GO:1900273,positive regulation of long-term synaptic potentiation,2.0
9353,EPHB2,GO:1903078,positive regulation of protein localization to plasma membrane,2.0
9354,EPHB2,GO:1904646,cellular response to amyloid-beta,2.0
9355,EPHB2,GO:1904782,negative regulation of NMDA glutamate receptor activity,2.0
9356,EPHB2,GO:1904783,positive regulation of NMDA glutamate receptor activity,2.0
9357,EPHB2,GO:2000316,regulation of T-helper 17 type immune response,2.0
9358,EPHB2,GO:2000822,regulation of behavioral fear response,2.0
9359,EPPK1,GO:0003723,RNA binding,2.0
9360,EPPK1,GO:0005198,structural molecule activity,2.0
9361,EPPK1,GO:0005515,protein binding,2.0
9362,EPPK1,GO:0005737,cytoplasm,2.0
9363,EPPK1,GO:0005856,cytoskeleton,2.0
9364,EPPK1,GO:0005882,intermediate filament,2.0
9365,EPPK1,GO:0005923,bicellular tight junction,2.0
9366,EPPK1,GO:0010839,negative regulation of keratinocyte proliferation,2.0
9367,EPPK1,GO:0016020,membrane,2.0
9368,EPPK1,GO:0016323,basolateral plasma membrane,2.0
9369,EPPK1,GO:0016327,apicolateral plasma membrane,2.0
9370,EPPK1,GO:0019215,intermediate filament binding,2.0
9371,EPPK1,GO:0030054,cell junction,2.0
9372,EPPK1,GO:0030056,hemidesmosome,2.0
9373,EPPK1,GO:0030336,negative regulation of cell migration,2.0
9374,EPPK1,GO:0042060,wound healing,2.0
9376,EPPK1,GO:0042995,cell projection,2.0
9377,EPPK1,GO:0045095,keratin filament,2.0
9379,EPPK1,GO:0045104,intermediate filament cytoskeleton organization,2.0
9380,EPPK1,GO:0045109,intermediate filament organization,2.0
9383,EPPK1,GO:0045110,intermediate filament bundle assembly,2.0
9384,EPPK1,GO:0045111,intermediate filament cytoskeleton,2.0
9385,EPPK1,GO:0050680,negative regulation of epithelial cell proliferation,2.0
9386,EPPK1,GO:0051548,negative regulation of keratinocyte migration,2.0
9387,EPPK1,GO:0061045,negative regulation of wound healing,2.0
9388,EPPK1,GO:0071944,cell periphery,2.0
9389,EPPK1,GO:0097356,perinucleolar compartment,2.0
9390,EPPK1,GO:1905041,regulation of epithelium regeneration,2.0
9391,EPPK1,GO:1990254,keratin filament binding,2.0
9392,ERBIN,GO:0005102,signaling receptor binding,2.0
9394,ERBIN,GO:0005176,ErbB-2 class receptor binding,2.0
9395,ERBIN,GO:0005200,structural constituent of cytoskeleton,2.0
9396,ERBIN,GO:0005515,protein binding,2.0
9397,ERBIN,GO:0005604,basement membrane,2.0
9398,ERBIN,GO:0005634,nucleus,2.0
9399,ERBIN,GO:0005737,cytoplasm,2.0
9400,ERBIN,GO:0005886,plasma membrane,2.0
9402,ERBIN,GO:0006605,protein targeting,2.0
9403,ERBIN,GO:0007155,cell adhesion,2.0
9404,ERBIN,GO:0007165,signal transduction,2.0
9405,ERBIN,GO:0007173,epidermal growth factor receptor signaling pathway,2.0
9406,ERBIN,GO:0007229,integrin-mediated signaling pathway,2.0
9407,ERBIN,GO:0009925,basal plasma membrane,2.0
9408,ERBIN,GO:0016323,basolateral plasma membrane,2.0
9410,ERBIN,GO:0016607,nuclear speck,2.0
9411,ERBIN,GO:0030054,cell junction,2.0
9412,ERBIN,GO:0030056,hemidesmosome,2.0
9413,ERBIN,GO:0031965,nuclear membrane,2.0
9414,ERBIN,GO:0032088,negative regulation of NF-kappaB transcription factor activity,2.0
9416,ERBIN,GO:0032495,response to muramyl dipeptide,2.0
9417,ERBIN,GO:0032496,response to lipopolysaccharide,2.0
9418,ERBIN,GO:0045104,intermediate filament cytoskeleton organization,2.0
9419,ERBIN,GO:0045175,basal protein localization,2.0
9420,ERBIN,GO:0045197,establishment or maintenance of epithelial cell apical/basal polarity,2.0
9421,ERBIN,GO:0046579,positive regulation of Ras protein signal transduction,2.0
9422,ERBIN,GO:0070433,negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway,2.0
9423,ERBIN,GO:0071356,cellular response to tumor necrosis factor,2.0
9425,ERBIN,GO:0071638,negative regulation of monocyte chemotactic protein-1 production,2.0
9426,ERBIN,GO:0098794,postsynapse,2.0
9427,ERBIN,GO:0098978,glutamatergic synapse,2.0
9428,ERBIN,GO:0099072,regulation of postsynaptic membrane neurotransmitter receptor levels,2.0
9429,ERG,GO:0000785,chromatin,2.0
9430,ERG,GO:0000978,RNA polymerase II cis-regulatory region sequence-specific DNA binding,2.0
9431,ERG,GO:0000981,"DNA-binding transcription factor activity, RNA polymerase II-specific",2.0
9433,ERG,GO:0001228,"DNA-binding transcription activator activity, RNA polymerase II-specific",2.0
9434,ERG,GO:0003677,DNA binding,2.0
9435,ERG,GO:0003682,chromatin binding,2.0
9436,ERG,GO:0005515,protein binding,2.0
9437,ERG,GO:0005634,nucleus,2.0
9438,ERG,GO:0005737,cytoplasm,2.0
9439,ERG,GO:0006357,regulation of transcription by RNA polymerase II,2.0
9440,ERG,GO:0006468,protein phosphorylation,2.0
9441,ERG,GO:0007165,signal transduction,2.0
9442,ERG,GO:0030154,cell differentiation,2.0
9443,ERG,GO:0045944,positive regulation of transcription by RNA polymerase II,2.0
9445,ERG,GO:1990837,sequence-specific double-stranded DNA binding,2.0
9446,ERG,GO:1990904,ribonucleoprotein complex,2.0
9447,ERMN,GO:0001763,morphogenesis of a branching structure,2.0
9448,ERMN,GO:0005515,protein binding,2.0
9449,ERMN,GO:0005737,cytoplasm,2.0
9450,ERMN,GO:0005856,cytoskeleton,2.0
9451,ERMN,GO:0005938,cell cortex,2.0
9453,ERMN,GO:0007015,actin filament organization,2.0
9455,ERMN,GO:0008360,regulation of cell shape,2.0
9457,ERMN,GO:0030175,filopodium,2.0
9458,ERMN,GO:0031344,regulation of cell projection organization,2.0
9460,ERMN,GO:0033269,internode region of axon,2.0
9462,ERMN,GO:0033270,paranode region of axon,2.0
9464,ERMN,GO:0043025,neuronal cell body,2.0
9465,ERMN,GO:0043209,myelin sheath,2.0
9466,ERMN,GO:0051015,actin filament binding,2.0
9467,ERMN,GO:0070062,extracellular exosome,2.0
9468,ERMN,GO:0097386,glial cell projection,2.0
9469,ESR2,GO:0000122,negative regulation of transcription by RNA polymerase II,2.0
9470,ESR2,GO:0000785,chromatin,2.0
9471,ESR2,GO:0000978,RNA polymerase II cis-regulatory region sequence-specific DNA binding,2.0
9473,ESR2,GO:0000981,"DNA-binding transcription factor activity, RNA polymerase II-specific",2.0
9474,ESR2,GO:0003677,DNA binding,2.0
9475,ESR2,GO:0003707,nuclear steroid receptor activity,2.0
9476,ESR2,GO:0004879,nuclear receptor activity,2.0
9479,ESR2,GO:0005496,steroid binding,2.0
9481,ESR2,GO:0005515,protein binding,2.0
9482,ESR2,GO:0005634,nucleus,2.0
9484,ESR2,GO:0005654,nucleoplasm,2.0
9486,ESR2,GO:0005739,mitochondrion,2.0
9487,ESR2,GO:0006355,regulation of DNA-templated transcription,2.0
9488,ESR2,GO:0006357,regulation of transcription by RNA polymerase II,2.0
9489,ESR2,GO:0007165,signal transduction,2.0
9490,ESR2,GO:0007267,cell-cell signaling,2.0
9491,ESR2,GO:0008270,zinc ion binding,2.0
9492,ESR2,GO:0019899,enzyme binding,2.0
9493,ESR2,GO:0030284,nuclear estrogen receptor activity,2.0
9496,ESR2,GO:0030308,negative regulation of cell growth,2.0
9497,ESR2,GO:0030518,intracellular steroid hormone receptor signaling pathway,2.0
9498,ESR2,GO:0030520,intracellular estrogen receptor signaling pathway,2.0
9499,ESR2,GO:0034056,estrogen response element binding,2.0
9500,ESR2,GO:0043231,intracellular membrane-bounded organelle,2.0
9501,ESR2,GO:0045893,positive regulation of DNA-templated transcription,2.0
9502,ESR2,GO:0048019,receptor antagonist activity,2.0
9503,ESR2,GO:0051091,positive regulation of DNA-binding transcription factor activity,2.0
9504,ESR2,GO:0071392,cellular response to estradiol stimulus,2.0
9505,ESR2,GO:2000272,negative regulation of signaling receptor activity,2.0
9506,ESRRB,GO:0000785,chromatin,2.0
9507,ESRRB,GO:0000793,condensed chromosome,2.0
9508,ESRRB,GO:0000978,RNA polymerase II cis-regulatory region sequence-specific DNA binding,2.0
9510,ESRRB,GO:0000981,"DNA-binding transcription factor activity, RNA polymerase II-specific",2.0
9512,ESRRB,GO:0000987,cis-regulatory region sequence-specific DNA binding,2.0
9513,ESRRB,GO:0000993,RNA polymerase II complex binding,2.0
9514,ESRRB,GO:0001228,"DNA-binding transcription activator activity, RNA polymerase II-specific",2.0
9515,ESRRB,GO:0001892,embryonic placenta development,2.0
9516,ESRRB,GO:0003676,nucleic acid binding,2.0
9517,ESRRB,GO:0003700,DNA-binding transcription factor activity,2.0
9518,ESRRB,GO:0003707,nuclear steroid receptor activity,2.0
9519,ESRRB,GO:0004879,nuclear receptor activity,2.0
9520,ESRRB,GO:0005496,steroid binding,2.0
9521,ESRRB,GO:0005634,nucleus,2.0
9522,ESRRB,GO:0005654,nucleoplasm,2.0
9524,ESRRB,GO:0005737,cytoplasm,2.0
9525,ESRRB,GO:0005829,cytosol,2.0
9526,ESRRB,GO:0006355,regulation of DNA-templated transcription,2.0
9527,ESRRB,GO:0006357,regulation of transcription by RNA polymerase II,2.0
9528,ESRRB,GO:0008270,zinc ion binding,2.0
9529,ESRRB,GO:0017145,stem cell division,2.0
9530,ESRRB,GO:0019827,stem cell population maintenance,2.0
9531,ESRRB,GO:0030522,intracellular receptor signaling pathway,2.0
9532,ESRRB,GO:0043401,steroid hormone mediated signaling pathway,2.0
9533,ESRRB,GO:0043565,sequence-specific DNA binding,2.0
9534,ESRRB,GO:0043697,cell dedifferentiation,2.0
9535,ESRRB,GO:0045494,photoreceptor cell maintenance,2.0
9536,ESRRB,GO:0045893,positive regulation of DNA-templated transcription,2.0
9537,ESRRB,GO:0045944,positive regulation of transcription by RNA polymerase II,2.0
9538,ESRRB,GO:0048839,inner ear development,2.0
9539,ESRRB,GO:0061629,RNA polymerase II-specific DNA-binding transcription factor binding,2.0
9540,ESRRB,GO:0071931,positive regulation of transcription involved in G1/S transition of mitotic cell cycle,2.0
9541,ESRRB,GO:0090282,positive regulation of transcription involved in G2/M transition of mitotic cell cycle,2.0
9542,ESRRB,GO:1902459,positive regulation of stem cell population maintenance,2.0
9543,ESRRB,GO:1990837,sequence-specific double-stranded DNA binding,2.0
9544,ESRRB,GO:2000035,regulation of stem cell division,2.0
9545,ESRRB,GO:2000737,negative regulation of stem cell differentiation,2.0
9546,ETFB,GO:0005515,protein binding,2.0
9547,ETFB,GO:0005739,mitochondrion,2.0
9548,ETFB,GO:0005759,mitochondrial matrix,2.0
9551,ETFB,GO:0009055,electron transfer activity,2.0
9553,ETFB,GO:0009063,amino acid catabolic process,2.0
9554,ETFB,GO:0022904,respiratory electron transport chain,2.0
9555,ETFB,GO:0033539,fatty acid beta-oxidation using acyl-CoA dehydrogenase,2.0
9556,ETFB,GO:0045251,electron transfer flavoprotein complex,2.0
9557,EXOC3,GO:0000145,exocyst,2.0
9559,EXOC3,GO:0000149,SNARE binding,2.0
9560,EXOC3,GO:0000281,mitotic cytokinesis,2.0
9561,EXOC3,GO:0005515,protein binding,2.0
9562,EXOC3,GO:0005794,Golgi apparatus,2.0
9563,EXOC3,GO:0005829,cytosol,2.0
9564,EXOC3,GO:0006887,exocytosis,2.0
9565,EXOC3,GO:0006904,vesicle docking involved in exocytosis,2.0
9566,EXOC3,GO:0015031,protein transport,2.0
9567,EXOC3,GO:0030426,growth cone,2.0
9568,EXOC3,GO:0030496,midbody,2.0
9569,EXOC3,GO:0030667,secretory granule membrane,2.0
9570,EXOC3,GO:0042734,presynaptic membrane,2.0
9571,EXOC3,GO:0045296,cadherin binding,2.0
9572,EXOC3,GO:0048471,perinuclear region of cytoplasm,2.0
9573,EXOC3,GO:0051601,exocyst localization,2.0
9574,EXOC3,GO:0090148,membrane fission,2.0
9575,EXOC3,GO:0090522,vesicle tethering involved in exocytosis,2.0
9576,EXOC5,GO:0000145,exocyst,2.0
9578,EXOC5,GO:0000281,mitotic cytokinesis,2.0
9579,EXOC5,GO:0001736,establishment of planar polarity,2.0
9580,EXOC5,GO:0005515,protein binding,2.0
9581,EXOC5,GO:0005737,cytoplasm,2.0
9582,EXOC5,GO:0005829,cytosol,2.0
9583,EXOC5,GO:0006887,exocytosis,2.0
9584,EXOC5,GO:0006892,post-Golgi vesicle-mediated transport,2.0
9585,EXOC5,GO:0006893,Golgi to plasma membrane transport,2.0
9586,EXOC5,GO:0006904,vesicle docking involved in exocytosis,2.0
9587,EXOC5,GO:0015031,protein transport,2.0
9588,EXOC5,GO:0030496,midbody,2.0
9589,EXOC5,GO:0031267,small GTPase binding,2.0
9590,EXOC5,GO:0047485,protein N-terminus binding,2.0
9591,EXOC5,GO:0072659,protein localization to plasma membrane,2.0
9592,EXOC5,GO:0090148,membrane fission,2.0
9593,EXOC5,GO:0090522,vesicle tethering involved in exocytosis,2.0
9594,EXOC5,GO:1904019,epithelial cell apoptotic process,2.0
9595,EXOC5,GO:1905515,non-motile cilium assembly,2.0
9596,EXOC6,GO:0000145,exocyst,2.0
9598,EXOC6,GO:0000281,mitotic cytokinesis,2.0
9599,EXOC6,GO:0005515,protein binding,2.0
9600,EXOC6,GO:0005829,cytosol,2.0
9601,EXOC6,GO:0005886,plasma membrane,2.0
9602,EXOC6,GO:0006886,intracellular protein transport,2.0
9603,EXOC6,GO:0006887,exocytosis,2.0
9604,EXOC6,GO:0006893,Golgi to plasma membrane transport,2.0
9605,EXOC6,GO:0006904,vesicle docking involved in exocytosis,2.0
9606,EXOC6,GO:0030426,growth cone,2.0
9607,EXOC6,GO:0048471,perinuclear region of cytoplasm,2.0
9608,EXOC6,GO:0090148,membrane fission,2.0
9609,EXOC6,GO:0090522,vesicle tethering involved in exocytosis,2.0
9610,EXOC6,GO:0090543,Flemming body,2.0
9611,EXOC6B,GO:0000145,exocyst,2.0
9613,EXOC6B,GO:0000281,mitotic cytokinesis,2.0
9614,EXOC6B,GO:0005515,protein binding,2.0
9615,EXOC6B,GO:0006886,intracellular protein transport,2.0
9616,EXOC6B,GO:0006887,exocytosis,2.0
9617,EXOC6B,GO:0006893,Golgi to plasma membrane transport,2.0
9618,EXOC6B,GO:0006904,vesicle docking involved in exocytosis,2.0
9619,EXOC6B,GO:0090148,membrane fission,2.0
9620,EXOC6B,GO:0090522,vesicle tethering involved in exocytosis,2.0
9621,EXT1,GO:0000139,Golgi membrane,2.0
9622,EXT1,GO:0001501,skeletal system development,2.0
9623,EXT1,GO:0001503,ossification,2.0
9624,EXT1,GO:0001958,endochondral ossification,2.0
9625,EXT1,GO:0001974,blood vessel remodeling,2.0
9626,EXT1,GO:0002067,glandular epithelial cell differentiation,2.0
9627,EXT1,GO:0002524,hypersensitivity,2.0
9628,EXT1,GO:0003128,heart field specification,2.0
9629,EXT1,GO:0003415,chondrocyte hypertrophy,2.0
9630,EXT1,GO:0003416,endochondral bone growth,2.0
9631,EXT1,GO:0005515,protein binding,2.0
9632,EXT1,GO:0005783,endoplasmic reticulum,2.0
9633,EXT1,GO:0005789,endoplasmic reticulum membrane,2.0
9635,EXT1,GO:0005794,Golgi apparatus,2.0
9637,EXT1,GO:0006024,glycosaminoglycan biosynthetic process,2.0
9638,EXT1,GO:0006486,protein glycosylation,2.0
9639,EXT1,GO:0007033,vacuole organization,2.0
9640,EXT1,GO:0007165,signal transduction,2.0
9641,EXT1,GO:0007369,gastrulation,2.0
9642,EXT1,GO:0007411,axon guidance,2.0
9643,EXT1,GO:0007492,endoderm development,2.0
9644,EXT1,GO:0007498,mesoderm development,2.0
9645,EXT1,GO:0008217,regulation of blood pressure,2.0
9646,EXT1,GO:0008375,acetylglucosaminyltransferase activity,2.0
9648,EXT1,GO:0008543,fibroblast growth factor receptor signaling pathway,2.0
9649,EXT1,GO:0009642,response to light intensity,2.0
9650,EXT1,GO:0010467,gene expression,2.0
9651,EXT1,GO:0014033,neural crest cell differentiation,2.0
9652,EXT1,GO:0015012,heparan sulfate proteoglycan biosynthetic process,2.0
9654,EXT1,GO:0015014,"heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process",2.0
9655,EXT1,GO:0015020,glucuronosyltransferase activity,2.0
9657,EXT1,GO:0016020,membrane,2.0
9658,EXT1,GO:0016757,glycosyltransferase activity,2.0
9660,EXT1,GO:0017145,stem cell division,2.0
9661,EXT1,GO:0019882,antigen processing and presentation,2.0
9662,EXT1,GO:0021554,optic nerve development,2.0
9663,EXT1,GO:0021772,olfactory bulb development,2.0
9664,EXT1,GO:0030163,protein catabolic process,2.0
9665,EXT1,GO:0030199,collagen fibril organization,2.0
9666,EXT1,GO:0030204,chondroitin sulfate metabolic process,2.0
9667,EXT1,GO:0030210,heparin biosynthetic process,2.0
9668,EXT1,GO:0030509,BMP signaling pathway,2.0
9669,EXT1,GO:0031069,hair follicle morphogenesis,2.0
9670,EXT1,GO:0032836,glomerular basement membrane development,2.0
9671,EXT1,GO:0033627,cell adhesion mediated by integrin,2.0
9672,EXT1,GO:0033692,cellular polysaccharide biosynthetic process,2.0
9673,EXT1,GO:0035176,social behavior,2.0
9674,EXT1,GO:0035249,"synaptic transmission, glutamatergic",2.0
9675,EXT1,GO:0035264,multicellular organism growth,2.0
9676,EXT1,GO:0035988,chondrocyte proliferation,2.0
9677,EXT1,GO:0036022,limb joint morphogenesis,2.0
9678,EXT1,GO:0036336,dendritic cell migration,2.0
9679,EXT1,GO:0036339,lymphocyte adhesion to endothelial cell of high endothelial venule,2.0
9680,EXT1,GO:0042044,fluid transport,2.0
9681,EXT1,GO:0042060,wound healing,2.0
9682,EXT1,GO:0042311,vasodilation,2.0
9683,EXT1,GO:0042328,heparan sulfate N-acetylglucosaminyltransferase activity,2.0
9684,EXT1,GO:0042596,fear response,2.0
9685,EXT1,GO:0042803,protein homodimerization activity,2.0
9686,EXT1,GO:0043931,ossification involved in bone maturation,2.0
9687,EXT1,GO:0045165,cell fate commitment,2.0
9688,EXT1,GO:0045202,synapse,2.0
9689,EXT1,GO:0045453,bone resorption,2.0
9690,EXT1,GO:0046872,metal ion binding,2.0
9691,EXT1,GO:0046982,protein heterodimerization activity,2.0
9692,EXT1,GO:0048733,sebaceous gland development,2.0
9693,EXT1,GO:0050508,glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity,2.0
9695,EXT1,GO:0050509,N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity,2.0
9697,EXT1,GO:0050891,multicellular organismal water homeostasis,2.0
9698,EXT1,GO:0050901,leukocyte tethering or rolling,2.0
9699,EXT1,GO:0051923,sulfation,2.0
9700,EXT1,GO:0055078,sodium ion homeostasis,2.0
9701,EXT1,GO:0060047,heart contraction,2.0
9702,EXT1,GO:0060070,canonical Wnt signaling pathway,2.0
9703,EXT1,GO:0060218,hematopoietic stem cell differentiation,2.0
9704,EXT1,GO:0060351,cartilage development involved in endochondral bone morphogenesis,2.0
9705,EXT1,GO:0060441,epithelial tube branching involved in lung morphogenesis,2.0
9706,EXT1,GO:0060506,smoothened signaling pathway involved in lung development,2.0
9707,EXT1,GO:0060560,developmental growth involved in morphogenesis,2.0
9708,EXT1,GO:0060792,sweat gland development,2.0
9709,EXT1,GO:0061484,hematopoietic stem cell homeostasis,2.0
9710,EXT1,GO:0061744,motor behavior,2.0
9711,EXT1,GO:0061974,perichondral bone morphogenesis,2.0
9712,EXT1,GO:0062094,stomach development,2.0
9713,EXT1,GO:0065003,protein-containing complex assembly,2.0
9714,EXT1,GO:0070593,dendrite self-avoidance,2.0
9715,EXT1,GO:0071503,response to heparin,2.0
9716,EXT1,GO:0071625,vocalization behavior,2.0
9717,EXT1,GO:0071711,basement membrane organization,2.0
9718,EXT1,GO:0071847,TNFSF11-mediated signaling pathway,2.0
9719,EXT1,GO:0072112,podocyte differentiation,2.0
9720,EXT1,GO:0072498,embryonic skeletal joint development,2.0
9721,EXT1,GO:0097021,lymphocyte migration into lymphoid organs,2.0
9722,EXT1,GO:0097241,hematopoietic stem cell migration to bone marrow,2.0
9723,EXT1,GO:0098586,cellular response to virus,2.0
9724,EXT1,GO:0120193,tight junction organization,2.0
9725,EXT1,GO:1901706,mesenchymal cell differentiation involved in bone development,2.0
9726,EXT1,GO:1904888,cranial skeletal system development,2.0
9727,EXT1,GO:1990823,response to leukemia inhibitory factor,2.0
9752,FABP5,GO:0001972,retinoic acid binding,2.0
9753,FABP5,GO:0005324,long-chain fatty acid transporter activity,2.0
9754,FABP5,GO:0005504,fatty acid binding,2.0
9756,FABP5,GO:0005515,protein binding,2.0
9757,FABP5,GO:0005576,extracellular region,2.0
9758,FABP5,GO:0005634,nucleus,2.0
9760,FABP5,GO:0005654,nucleoplasm,2.0
9761,FABP5,GO:0005737,cytoplasm,2.0
9763,FABP5,GO:0005829,cytosol,2.0
9765,FABP5,GO:0005886,plasma membrane,2.0
9766,FABP5,GO:0006006,glucose metabolic process,2.0
9767,FABP5,GO:0006629,lipid metabolic process,2.0
9768,FABP5,GO:0006656,phosphatidylcholine biosynthetic process,2.0
9769,FABP5,GO:0008289,lipid binding,2.0
9770,FABP5,GO:0008544,epidermis development,2.0
9771,FABP5,GO:0010829,negative regulation of glucose transmembrane transport,2.0
9772,FABP5,GO:0014069,postsynaptic density,2.0
9773,FABP5,GO:0015908,fatty acid transport,2.0
9774,FABP5,GO:0015909,long-chain fatty acid transport,2.0
9775,FABP5,GO:0030667,secretory granule membrane,2.0
9776,FABP5,GO:0031392,regulation of prostaglandin biosynthetic process,2.0
9777,FABP5,GO:0035360,positive regulation of peroxisome proliferator activated receptor signaling pathway,2.0
9778,FABP5,GO:0035578,azurophil granule lumen,2.0
9779,FABP5,GO:0042593,glucose homeostasis,2.0
9780,FABP5,GO:0042802,identical protein binding,2.0
9781,FABP5,GO:0045202,synapse,2.0
9782,FABP5,GO:0051930,regulation of sensory perception of pain,2.0
9783,FABP5,GO:0070062,extracellular exosome,2.0
9784,FABP5,GO:0099178,regulation of retrograde trans-synaptic signaling by endocanabinoid,2.0
9785,FABP5,GO:0120162,positive regulation of cold-induced thermogenesis,2.0
9786,FABP5,GO:1990379,lipid transport across blood-brain barrier,2.0
9787,FAM47A,GO:0005515,protein binding,2.0
9788,FAM98C,GO:0005515,protein binding,2.0
9789,FAM98C,GO:0072669,tRNA-splicing ligase complex,2.0
9790,FAN1,GO:0000287,magnesium ion binding,2.0
9791,FAN1,GO:0000724,double-strand break repair via homologous recombination,2.0
9792,FAN1,GO:0004528,phosphodiesterase I activity,2.0
9793,FAN1,GO:0005515,protein binding,2.0
9794,FAN1,GO:0005634,nucleus,2.0
9796,FAN1,GO:0005654,nucleoplasm,2.0
9798,FAN1,GO:0005829,cytosol,2.0
9799,FAN1,GO:0006281,DNA repair,2.0
9800,FAN1,GO:0006289,nucleotide-excision repair,2.0
9802,FAN1,GO:0008409,5'-3' exonuclease activity,2.0
9804,FAN1,GO:0017108,5'-flap endonuclease activity,2.0
9806,FAN1,GO:0036297,interstrand cross-link repair,2.0
9808,FAN1,GO:0045171,intercellular bridge,2.0
9809,FAN1,GO:0070336,flap-structured DNA binding,2.0
9811,FAN1,GO:0090305,nucleic acid phosphodiester bond hydrolysis,2.0
9812,FAN1,GO:0140036,ubiquitin-dependent protein binding,2.0
9813,FAT1,GO:0002088,lens development in camera-type eye,2.0
9814,FAT1,GO:0003382,epithelial cell morphogenesis,2.0
9815,FAT1,GO:0003412,establishment of epithelial cell apical/basal polarity involved in camera-type eye morphogenesis,2.0
9816,FAT1,GO:0005509,calcium ion binding,2.0
9817,FAT1,GO:0005515,protein binding,2.0
9818,FAT1,GO:0005634,nucleus,2.0
9819,FAT1,GO:0005886,plasma membrane,2.0
9820,FAT1,GO:0005911,cell-cell junction,2.0
9821,FAT1,GO:0005925,focal adhesion,2.0
9822,FAT1,GO:0007015,actin filament organization,2.0
9823,FAT1,GO:0007155,cell adhesion,2.0
9824,FAT1,GO:0007156,homophilic cell adhesion via plasma membrane adhesion molecules,2.0
9825,FAT1,GO:0007163,establishment or maintenance of cell polarity,2.0
9826,FAT1,GO:0007267,cell-cell signaling,2.0
9827,FAT1,GO:0009653,anatomical structure morphogenesis,2.0
9828,FAT1,GO:0016324,apical plasma membrane,2.0
9829,FAT1,GO:0016477,cell migration,2.0
9830,FAT1,GO:0030027,lamellipodium,2.0
9831,FAT1,GO:0030175,filopodium,2.0
9832,FAT1,GO:0048471,perinuclear region of cytoplasm,2.0
9833,FAT1,GO:0070062,extracellular exosome,2.0
9834,FAT1,GO:0098609,cell-cell adhesion,2.0
9836,FBN1,GO:0001501,skeletal system development,2.0
9837,FBN1,GO:0001527,microfibril,2.0
9838,FBN1,GO:0001656,metanephros development,2.0
9839,FBN1,GO:0005178,integrin binding,2.0
9840,FBN1,GO:0005179,hormone activity,2.0
9841,FBN1,GO:0005201,extracellular matrix structural constituent,2.0
9844,FBN1,GO:0005509,calcium ion binding,2.0
9845,FBN1,GO:0005515,protein binding,2.0
9846,FBN1,GO:0005576,extracellular region,2.0
9849,FBN1,GO:0005604,basement membrane,2.0
9850,FBN1,GO:0005615,extracellular space,2.0
9852,FBN1,GO:0005788,endoplasmic reticulum lumen,2.0
9853,FBN1,GO:0007165,signal transduction,2.0
9854,FBN1,GO:0007507,heart development,2.0
9855,FBN1,GO:0008201,heparin binding,2.0
9856,FBN1,GO:0009653,anatomical structure morphogenesis,2.0
9857,FBN1,GO:0030023,extracellular matrix constituent conferring elasticity,2.0
9858,FBN1,GO:0031012,extracellular matrix,2.0
9860,FBN1,GO:0033627,cell adhesion mediated by integrin,2.0
9861,FBN1,GO:0035582,sequestering of BMP in extracellular matrix,2.0
9862,FBN1,GO:0035583,sequestering of TGFbeta in extracellular matrix,2.0
9863,FBN1,GO:0042802,identical protein binding,2.0
9864,FBN1,GO:0043010,camera-type eye development,2.0
9865,FBN1,GO:0044877,protein-containing complex binding,2.0
9866,FBN1,GO:0045671,negative regulation of osteoclast differentiation,2.0
9867,FBN1,GO:0048048,embryonic eye morphogenesis,2.0
9868,FBN1,GO:0048050,post-embryonic eye morphogenesis,2.0
9869,FBN1,GO:0062023,collagen-containing extracellular matrix,2.0
9871,FBN1,GO:0071560,cellular response to transforming growth factor beta stimulus,2.0
9872,FBN1,GO:1990314,cellular response to insulin-like growth factor stimulus,2.0
9873,FBN1,GO:2001205,negative regulation of osteoclast development,2.0
9875,FBXO11,GO:0000151,ubiquitin ligase complex,2.0
9876,FBXO11,GO:0004842,ubiquitin-protein transferase activity,2.0
9877,FBXO11,GO:0005515,protein binding,2.0
9878,FBXO11,GO:0005634,nucleus,2.0
9879,FBXO11,GO:0005654,nucleoplasm,2.0
9880,FBXO11,GO:0005694,chromosome,2.0
9881,FBXO11,GO:0005730,nucleolus,2.0
9882,FBXO11,GO:0005737,cytoplasm,2.0
9883,FBXO11,GO:0005829,cytosol,2.0
9884,FBXO11,GO:0006479,protein methylation,2.0
9885,FBXO11,GO:0006511,ubiquitin-dependent protein catabolic process,2.0
9887,FBXO11,GO:0007605,sensory perception of sound,2.0
9888,FBXO11,GO:0008270,zinc ion binding,2.0
9889,FBXO11,GO:0016274,protein-arginine N-methyltransferase activity,2.0
9890,FBXO11,GO:0016567,protein ubiquitination,2.0
9893,FBXO11,GO:0036211,protein modification process,2.0
9894,FBXO11,GO:0042981,regulation of apoptotic process,2.0
9895,FBXO11,GO:0045732,positive regulation of protein catabolic process,2.0
9896,FBXO11,GO:1904878,negative regulation of calcium ion transmembrane transport via high voltage-gated calcium channel,2.0
9897,FBXO33,GO:0005515,protein binding,2.0
9898,FBXO33,GO:0016567,protein ubiquitination,2.0
9899,FBXO33,GO:0019005,SCF ubiquitin ligase complex,2.0
9900,FBXO33,GO:0031146,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process,2.0
9901,FBXO33,GO:0031398,positive regulation of protein ubiquitination,2.0
9902,FBXO40,GO:0005737,cytoplasm,2.0
9904,FBXO40,GO:0005829,cytosol,2.0
9905,FBXO40,GO:0008270,zinc ion binding,2.0
9906,FBXO40,GO:0016567,protein ubiquitination,2.0
9907,FBXO40,GO:0042692,muscle cell differentiation,2.0
9908,FBXO40,GO:0061630,ubiquitin protein ligase activity,2.0
9909,FCRL6,GO:0004888,transmembrane signaling receptor activity,2.0
9910,FCRL6,GO:0005515,protein binding,2.0
9911,FCRL6,GO:0005886,plasma membrane,2.0
9913,FCRL6,GO:0007166,cell surface receptor signaling pathway,2.0
9914,FCRL6,GO:0009897,external side of plasma membrane,2.0
9915,FCRL6,GO:0019902,phosphatase binding,2.0
9916,FCRL6,GO:0019903,protein phosphatase binding,2.0
9917,FCRL6,GO:0042289,MHC class II protein binding,2.0
9918,FEZF2,GO:0000122,negative regulation of transcription by RNA polymerase II,2.0
9919,FEZF2,GO:0000978,RNA polymerase II cis-regulatory region sequence-specific DNA binding,2.0
9920,FEZF2,GO:0001227,"DNA-binding transcription repressor activity, RNA polymerase II-specific",2.0
9921,FEZF2,GO:0001228,"DNA-binding transcription activator activity, RNA polymerase II-specific",2.0
9922,FEZF2,GO:0003682,chromatin binding,2.0
9923,FEZF2,GO:0005634,nucleus,2.0
9924,FEZF2,GO:0007413,axonal fasciculation,2.0
9925,FEZF2,GO:0007626,locomotory behavior,2.0
9926,FEZF2,GO:0008285,negative regulation of cell population proliferation,2.0
9927,FEZF2,GO:0010468,regulation of gene expression,2.0
9928,FEZF2,GO:0016358,dendrite development,2.0
9929,FEZF2,GO:0021542,dentate gyrus development,2.0
9930,FEZF2,GO:0021797,forebrain anterior/posterior pattern specification,2.0
9931,FEZF2,GO:0021853,cerebral cortex GABAergic interneuron migration,2.0
9932,FEZF2,GO:0021902,commitment of neuronal cell to specific neuron type in forebrain,2.0
9933,FEZF2,GO:0043697,cell dedifferentiation,2.0
9934,FEZF2,GO:0045665,negative regulation of neuron differentiation,2.0
9935,FEZF2,GO:0045666,positive regulation of neuron differentiation,2.0
9936,FEZF2,GO:0045944,positive regulation of transcription by RNA polymerase II,2.0
9937,FEZF2,GO:0046872,metal ion binding,2.0
9938,FEZF2,GO:0048664,neuron fate determination,2.0
9939,FEZF2,GO:0050767,regulation of neurogenesis,2.0
9940,FEZF2,GO:1902667,regulation of axon guidance,2.0
9941,FGA,GO:0002250,adaptive immune response,2.0
9942,FGA,GO:0005102,signaling receptor binding,2.0
9943,FGA,GO:0005198,structural molecule activity,2.0
9945,FGA,GO:0005201,extracellular matrix structural constituent,2.0
9947,FGA,GO:0005515,protein binding,2.0
9948,FGA,GO:0005576,extracellular region,2.0
9950,FGA,GO:0005577,fibrinogen complex,2.0
9952,FGA,GO:0005615,extracellular space,2.0
9953,FGA,GO:0005783,endoplasmic reticulum,2.0
9954,FGA,GO:0005788,endoplasmic reticulum lumen,2.0
9955,FGA,GO:0005886,plasma membrane,2.0
9956,FGA,GO:0007160,cell-matrix adhesion,2.0
9957,FGA,GO:0009897,external side of plasma membrane,2.0
9958,FGA,GO:0009986,cell surface,2.0
9959,FGA,GO:0031091,platelet alpha granule,2.0
9960,FGA,GO:0031093,platelet alpha granule lumen,2.0
9961,FGA,GO:0031639,plasminogen activation,2.0
9962,FGA,GO:0034116,positive regulation of heterotypic cell-cell adhesion,2.0
9964,FGA,GO:0042730,fibrinolysis,2.0
9966,FGA,GO:0043152,induction of bacterial agglutination,2.0
9967,FGA,GO:0045087,innate immune response,2.0
9968,FGA,GO:0045907,positive regulation of vasoconstriction,2.0
9969,FGA,GO:0045921,positive regulation of exocytosis,2.0
9970,FGA,GO:0046872,metal ion binding,2.0
9971,FGA,GO:0050714,positive regulation of protein secretion,2.0
9972,FGA,GO:0050839,cell adhesion molecule binding,2.0
9973,FGA,GO:0051258,protein polymerization,2.0
9975,FGA,GO:0051592,response to calcium ion,2.0
9976,FGA,GO:0062023,collagen-containing extracellular matrix,2.0
9977,FGA,GO:0065003,protein-containing complex assembly,2.0
9979,FGA,GO:0070062,extracellular exosome,2.0
9980,FGA,GO:0070374,positive regulation of ERK1 and ERK2 cascade,2.0
9982,FGA,GO:0070527,platelet aggregation,2.0
9985,FGA,GO:0072377,"blood coagulation, common pathway",2.0
9987,FGA,GO:0072378,"blood coagulation, fibrin clot formation",2.0
9988,FGA,GO:0072562,blood microparticle,2.0
9989,FGA,GO:0090277,positive regulation of peptide hormone secretion,2.0
9991,FGA,GO:1900026,positive regulation of substrate adhesion-dependent cell spreading,2.0
9992,FGA,GO:1902042,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors,2.0
9994,FGA,GO:1903561,extracellular vesicle,2.0
9995,FGA,GO:2000352,negative regulation of endothelial cell apoptotic process,2.0
10051,FGFR1,GO:0000165,MAPK cascade,2.0
10052,FGFR1,GO:0001501,skeletal system development,2.0
10053,FGFR1,GO:0001764,neuron migration,2.0
10054,FGFR1,GO:0001837,epithelial to mesenchymal transition,2.0
10055,FGFR1,GO:0004713,protein tyrosine kinase activity,2.0
10056,FGFR1,GO:0004714,transmembrane receptor protein tyrosine kinase activity,2.0
10057,FGFR1,GO:0005007,fibroblast growth factor receptor activity,2.0
10060,FGFR1,GO:0005515,protein binding,2.0
10061,FGFR1,GO:0005524,ATP binding,2.0
10062,FGFR1,GO:0005576,extracellular region,2.0
10063,FGFR1,GO:0005634,nucleus,2.0
10064,FGFR1,GO:0005829,cytosol,2.0
10065,FGFR1,GO:0005886,plasma membrane,2.0
10068,FGFR1,GO:0006468,protein phosphorylation,2.0
10069,FGFR1,GO:0007169,transmembrane receptor protein tyrosine kinase signaling pathway,2.0
10070,FGFR1,GO:0007275,multicellular organism development,2.0
10071,FGFR1,GO:0008201,heparin binding,2.0
10072,FGFR1,GO:0008284,positive regulation of cell population proliferation,2.0
10075,FGFR1,GO:0008543,fibroblast growth factor receptor signaling pathway,2.0
10079,FGFR1,GO:0010518,positive regulation of phospholipase activity,2.0
10080,FGFR1,GO:0010863,positive regulation of phospholipase C activity,2.0
10081,FGFR1,GO:0014068,positive regulation of phosphatidylinositol 3-kinase signaling,2.0
10082,FGFR1,GO:0016020,membrane,2.0
10083,FGFR1,GO:0016477,cell migration,2.0
10084,FGFR1,GO:0017134,fibroblast growth factor binding,2.0
10086,FGFR1,GO:0018108,peptidyl-tyrosine phosphorylation,2.0
10087,FGFR1,GO:0031410,cytoplasmic vesicle,2.0
10088,FGFR1,GO:0033674,positive regulation of kinase activity,2.0
10089,FGFR1,GO:0042802,identical protein binding,2.0
10090,FGFR1,GO:0042803,protein homodimerization activity,2.0
10091,FGFR1,GO:0043009,chordate embryonic development,2.0
10092,FGFR1,GO:0043235,receptor complex,2.0
10094,FGFR1,GO:0043406,positive regulation of MAP kinase activity,2.0
10095,FGFR1,GO:0043410,positive regulation of MAPK cascade,2.0
10097,FGFR1,GO:0043536,positive regulation of blood vessel endothelial cell migration,2.0
10098,FGFR1,GO:0045595,regulation of cell differentiation,2.0
10099,FGFR1,GO:0045597,positive regulation of cell differentiation,2.0
10100,FGFR1,GO:0045666,positive regulation of neuron differentiation,2.0
10101,FGFR1,GO:0046777,protein autophosphorylation,2.0
10102,FGFR1,GO:0048015,phosphatidylinositol-mediated signaling,2.0
10103,FGFR1,GO:0048705,skeletal system morphogenesis,2.0
10104,FGFR1,GO:0051897,positive regulation of protein kinase B signaling,2.0
10105,FGFR1,GO:0090722,receptor-receptor interaction,2.0
10106,FGFR1,GO:1905564,positive regulation of vascular endothelial cell proliferation,2.0
10107,FGFR1,GO:2000546,positive regulation of endothelial cell chemotaxis to fibroblast growth factor,2.0
10108,FGFR1,GO:2001239,regulation of extrinsic apoptotic signaling pathway in absence of ligand,2.0
10109,FHIT,GO:0000166,nucleotide binding,2.0
10110,FHIT,GO:0001650,fibrillar center,2.0
10111,FHIT,GO:0005515,protein binding,2.0
10112,FHIT,GO:0005634,nucleus,2.0
10113,FHIT,GO:0005737,cytoplasm,2.0
10115,FHIT,GO:0005739,mitochondrion,2.0
10116,FHIT,GO:0005829,cytosol,2.0
10117,FHIT,GO:0005886,plasma membrane,2.0
10119,FHIT,GO:0006163,purine nucleotide metabolic process,2.0
10121,FHIT,GO:0015964,diadenosine triphosphate catabolic process,2.0
10123,FHIT,GO:0031625,ubiquitin protein ligase binding,2.0
10125,FHIT,GO:0032435,negative regulation of proteasomal ubiquitin-dependent protein catabolic process,2.0
10127,FHIT,GO:0042802,identical protein binding,2.0
10128,FHIT,GO:0043530,adenosine 5'-monophosphoramidase activity,2.0
10129,FHIT,GO:0047352,adenylylsulfate-ammonia adenylyltransferase activity,2.0
10130,FHIT,GO:0047627,adenylylsulfatase activity,2.0
10131,FHIT,GO:0047710,bis(5'-adenosyl)-triphosphatase activity,2.0
10133,FHIT,GO:0072332,intrinsic apoptotic signaling pathway by p53 class mediator,2.0
10353,FRG1,GO:0000398,"mRNA splicing, via spliceosome",2.0
10354,FRG1,GO:0003723,RNA binding,2.0
10355,FRG1,GO:0005515,protein binding,2.0
10356,FRG1,GO:0005730,nucleolus,2.0
10357,FRG1,GO:0006364,rRNA processing,2.0
10358,FRG1,GO:0007517,muscle organ development,2.0
10359,FRG1,GO:0015030,Cajal body,2.0
10360,FRG1,GO:0030018,Z disc,2.0
10361,FRG1,GO:0051015,actin filament binding,2.0
10362,FRG1,GO:0055120,striated muscle dense body,2.0
10363,FRG1,GO:0071013,catalytic step 2 spliceosome,2.0
10365,FRK,GO:0000122,negative regulation of transcription by RNA polymerase II,2.0
10366,FRK,GO:0004713,protein tyrosine kinase activity,2.0
10368,FRK,GO:0004715,non-membrane spanning protein tyrosine kinase activity,2.0
10369,FRK,GO:0005102,signaling receptor binding,2.0
10370,FRK,GO:0005515,protein binding,2.0
10371,FRK,GO:0005524,ATP binding,2.0
10372,FRK,GO:0005576,extracellular region,2.0
10373,FRK,GO:0005634,nucleus,2.0
10374,FRK,GO:0005654,nucleoplasm,2.0
10375,FRK,GO:0005829,cytosol,2.0
10377,FRK,GO:0007169,transmembrane receptor protein tyrosine kinase signaling pathway,2.0
10378,FRK,GO:0018108,peptidyl-tyrosine phosphorylation,2.0
10379,FRK,GO:0030154,cell differentiation,2.0
10380,FRK,GO:0031234,extrinsic component of cytoplasmic side of plasma membrane,2.0
10381,FRK,GO:0035578,azurophil granule lumen,2.0
10382,FRK,GO:0035580,specific granule lumen,2.0
10383,FRK,GO:0045087,innate immune response,2.0
10384,FRK,GO:0070062,extracellular exosome,2.0
10447,GABBR2,GO:0004888,transmembrane signaling receptor activity,2.0
10448,GABBR2,GO:0004965,G protein-coupled GABA receptor activity,2.0
10449,GABBR2,GO:0005515,protein binding,2.0
10450,GABBR2,GO:0005737,cytoplasm,2.0
10451,GABBR2,GO:0005886,plasma membrane,2.0
10453,GABBR2,GO:0007186,G protein-coupled receptor signaling pathway,2.0
10454,GABBR2,GO:0007193,adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway,2.0
10455,GABBR2,GO:0007194,negative regulation of adenylate cyclase activity,2.0
10456,GABBR2,GO:0007214,gamma-aminobutyric acid signaling pathway,2.0
10458,GABBR2,GO:0007268,chemical synaptic transmission,2.0
10459,GABBR2,GO:0038039,G protein-coupled receptor heterodimeric complex,2.0
10461,GABBR2,GO:0043005,neuron projection,2.0
10462,GABBR2,GO:0045211,postsynaptic membrane,2.0
10463,GABBR2,GO:0046982,protein heterodimerization activity,2.0
10464,GABBR2,GO:0051932,"synaptic transmission, GABAergic",2.0
10465,GABBR2,GO:0150099,neuron-glial cell signaling,2.0
10466,GABBR2,GO:1902710,GABA receptor complex,2.0
10467,GABBR2,GO:1902712,G protein-coupled GABA receptor complex,2.0
10500,GABRA4,GO:0004890,GABA-A receptor activity,2.0
10501,GABRA4,GO:0005231,excitatory extracellular ligand-gated ion channel activity,2.0
10502,GABRA4,GO:0005237,inhibitory extracellular ligand-gated ion channel activity,2.0
10503,GABRA4,GO:0005254,chloride channel activity,2.0
10504,GABRA4,GO:0005886,plasma membrane,2.0
10506,GABRA4,GO:0007165,signal transduction,2.0
10507,GABRA4,GO:0007214,gamma-aminobutyric acid signaling pathway,2.0
10508,GABRA4,GO:0007268,chemical synaptic transmission,2.0
10509,GABRA4,GO:0008503,benzodiazepine receptor activity,2.0
10510,GABRA4,GO:0022851,GABA-gated chloride ion channel activity,2.0
10511,GABRA4,GO:0030594,neurotransmitter receptor activity,2.0
10512,GABRA4,GO:0032590,dendrite membrane,2.0
10513,GABRA4,GO:0034220,ion transmembrane transport,2.0
10514,GABRA4,GO:0034707,chloride channel complex,2.0
10515,GABRA4,GO:0042391,regulation of membrane potential,2.0
10516,GABRA4,GO:0043005,neuron projection,2.0
10517,GABRA4,GO:0045202,synapse,2.0
10518,GABRA4,GO:0050877,nervous system process,2.0
10519,GABRA4,GO:0051932,"synaptic transmission, GABAergic",2.0
10520,GABRA4,GO:0060078,regulation of postsynaptic membrane potential,2.0
10521,GABRA4,GO:0060079,excitatory postsynaptic potential,2.0
10522,GABRA4,GO:0098794,postsynapse,2.0
10523,GABRA4,GO:0098982,GABA-ergic synapse,2.0
10524,GABRA4,GO:0099634,postsynaptic specialization membrane,2.0
10525,GABRA4,GO:1902476,chloride transmembrane transport,2.0
10526,GABRA4,GO:1902711,GABA-A receptor complex,2.0
10527,GABRA4,GO:1904315,transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential,2.0
10616,GABRG3,GO:0004890,GABA-A receptor activity,2.0
10617,GABRG3,GO:0005231,excitatory extracellular ligand-gated ion channel activity,2.0
10618,GABRG3,GO:0005237,inhibitory extracellular ligand-gated ion channel activity,2.0
10619,GABRG3,GO:0005254,chloride channel activity,2.0
10620,GABRG3,GO:0005886,plasma membrane,2.0
10622,GABRG3,GO:0007165,signal transduction,2.0
10623,GABRG3,GO:0007214,gamma-aminobutyric acid signaling pathway,2.0
10624,GABRG3,GO:0007268,chemical synaptic transmission,2.0
10625,GABRG3,GO:0008503,benzodiazepine receptor activity,2.0
10626,GABRG3,GO:0009410,response to xenobiotic stimulus,2.0
10627,GABRG3,GO:0022851,GABA-gated chloride ion channel activity,2.0
10628,GABRG3,GO:0030594,neurotransmitter receptor activity,2.0
10629,GABRG3,GO:0032590,dendrite membrane,2.0
10630,GABRG3,GO:0034220,ion transmembrane transport,2.0
10631,GABRG3,GO:0034707,chloride channel complex,2.0
10632,GABRG3,GO:0042391,regulation of membrane potential,2.0
10633,GABRG3,GO:0043005,neuron projection,2.0
10634,GABRG3,GO:0045202,synapse,2.0
10635,GABRG3,GO:0045211,postsynaptic membrane,2.0
10636,GABRG3,GO:0050877,nervous system process,2.0
10637,GABRG3,GO:0051932,"synaptic transmission, GABAergic",2.0
10638,GABRG3,GO:0060078,regulation of postsynaptic membrane potential,2.0
10639,GABRG3,GO:0060079,excitatory postsynaptic potential,2.0
10640,GABRG3,GO:0098794,postsynapse,2.0
10641,GABRG3,GO:0098982,GABA-ergic synapse,2.0
10642,GABRG3,GO:1902476,chloride transmembrane transport,2.0
10643,GABRG3,GO:1902711,GABA-A receptor complex,2.0
10644,GABRG3,GO:1904315,transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential,2.0
10645,GALNT10,GO:0000139,Golgi membrane,2.0
10646,GALNT10,GO:0004653,polypeptide N-acetylgalactosaminyltransferase activity,2.0
10649,GALNT10,GO:0005794,Golgi apparatus,2.0
10650,GALNT10,GO:0006493,protein O-linked glycosylation,2.0
10652,GALNT10,GO:0016266,O-glycan processing,2.0
10654,GALNT10,GO:0030246,carbohydrate binding,2.0
10655,GALNT10,GO:0046872,metal ion binding,2.0
10656,GALNT13,GO:0000139,Golgi membrane,2.0
10657,GALNT13,GO:0004653,polypeptide N-acetylgalactosaminyltransferase activity,2.0
10660,GALNT13,GO:0005794,Golgi apparatus,2.0
10661,GALNT13,GO:0006493,protein O-linked glycosylation,2.0
10662,GALNT13,GO:0016266,O-glycan processing,2.0
10663,GALNT13,GO:0018242,protein O-linked glycosylation via serine,2.0
10664,GALNT13,GO:0018243,protein O-linked glycosylation via threonine,2.0
10665,GALNT13,GO:0030246,carbohydrate binding,2.0
10666,GALNT13,GO:0046872,metal ion binding,2.0
10667,GALNT14,GO:0000139,Golgi membrane,2.0
10668,GALNT14,GO:0004653,polypeptide N-acetylgalactosaminyltransferase activity,2.0
10670,GALNT14,GO:0005794,Golgi apparatus,2.0
10671,GALNT14,GO:0006493,protein O-linked glycosylation,2.0
10672,GALNT14,GO:0016266,O-glycan processing,2.0
10673,GALNT14,GO:0030246,carbohydrate binding,2.0
10674,GALNT14,GO:0046872,metal ion binding,2.0
10699,GALNT8,GO:0000139,Golgi membrane,2.0
10700,GALNT8,GO:0004653,polypeptide N-acetylgalactosaminyltransferase activity,2.0
10702,GALNT8,GO:0005794,Golgi apparatus,2.0
10703,GALNT8,GO:0006493,protein O-linked glycosylation,2.0
10704,GALNT8,GO:0016266,O-glycan processing,2.0
10705,GALNT8,GO:0030246,carbohydrate binding,2.0
10706,GALNT8,GO:0046872,metal ion binding,2.0
10723,GBE1,GO:0003844,"1,4-alpha-glucan branching enzyme activity",2.0
10727,GBE1,GO:0004553,"hydrolase activity, hydrolyzing O-glycosyl compounds",2.0
10728,GBE1,GO:0005515,protein binding,2.0
10729,GBE1,GO:0005737,cytoplasm,2.0
10730,GBE1,GO:0005829,cytosol,2.0
10731,GBE1,GO:0005975,carbohydrate metabolic process,2.0
10732,GBE1,GO:0005977,glycogen metabolic process,2.0
10733,GBE1,GO:0005978,glycogen biosynthetic process,2.0
10737,GBE1,GO:0006091,generation of precursor metabolites and energy,2.0
10738,GBE1,GO:0030246,carbohydrate binding,2.0
10739,GBE1,GO:0043169,cation binding,2.0
10740,GBE1,GO:0043524,negative regulation of neuron apoptotic process,2.0
10741,GBE1,GO:0070062,extracellular exosome,2.0
10742,GBE1,GO:0102752,"1,4-alpha-glucan branching enzyme activity (using a glucosylated glycogenin as primer for glycogen synthesis)",2.0
10743,GDA,GO:0000255,allantoin metabolic process,2.0
10744,GDA,GO:0005829,cytosol,2.0
10746,GDA,GO:0006139,nucleobase-containing compound metabolic process,2.0
10747,GDA,GO:0006147,guanine catabolic process,2.0
10748,GDA,GO:0006161,deoxyguanosine catabolic process,2.0
10749,GDA,GO:0007399,nervous system development,2.0
10750,GDA,GO:0008270,zinc ion binding,2.0
10751,GDA,GO:0008892,guanine deaminase activity,2.0
10752,GDA,GO:0019239,deaminase activity,2.0
10753,GDA,GO:0046038,GMP catabolic process,2.0
10754,GDA,GO:0046055,dGMP catabolic process,2.0
10755,GDA,GO:0046098,guanine metabolic process,2.0
10790,GGNBP2,GO:0005634,nucleus,2.0
10791,GGNBP2,GO:0005737,cytoplasm,2.0
10792,GGNBP2,GO:0007283,spermatogenesis,2.0
10793,GGNBP2,GO:0008285,negative regulation of cell population proliferation,2.0
10794,GGNBP2,GO:0010629,negative regulation of gene expression,2.0
10795,GGNBP2,GO:0030154,cell differentiation,2.0
10796,GGNBP2,GO:0031410,cytoplasmic vesicle,2.0
10797,GGNBP2,GO:0033140,negative regulation of peptidyl-serine phosphorylation of STAT protein,2.0
10798,GGNBP2,GO:0042532,negative regulation of tyrosine phosphorylation of STAT protein,2.0
10799,GGNBP2,GO:0060716,labyrinthine layer blood vessel development,2.0
10800,GGNBP2,GO:0061099,negative regulation of protein tyrosine kinase activity,2.0
10839,GLIS1,GO:0000122,negative regulation of transcription by RNA polymerase II,2.0
10840,GLIS1,GO:0000978,RNA polymerase II cis-regulatory region sequence-specific DNA binding,2.0
10841,GLIS1,GO:0000981,"DNA-binding transcription factor activity, RNA polymerase II-specific",2.0
10842,GLIS1,GO:0001228,"DNA-binding transcription activator activity, RNA polymerase II-specific",2.0
10843,GLIS1,GO:0005515,protein binding,2.0
10844,GLIS1,GO:0005634,nucleus,2.0
10846,GLIS1,GO:0006357,regulation of transcription by RNA polymerase II,2.0
10847,GLIS1,GO:0030154,cell differentiation,2.0
10848,GLIS1,GO:0045944,positive regulation of transcription by RNA polymerase II,2.0
10849,GLIS1,GO:0046872,metal ion binding,2.0
10850,GLIS1,GO:1990837,sequence-specific double-stranded DNA binding,2.0
10851,GLO1,GO:0004462,lactoylglutathione lyase activity,2.0
10852,GLO1,GO:0005515,protein binding,2.0
10853,GLO1,GO:0005654,nucleoplasm,2.0
10854,GLO1,GO:0005737,cytoplasm,2.0
10855,GLO1,GO:0005829,cytosol,2.0
10857,GLO1,GO:0005886,plasma membrane,2.0
10858,GLO1,GO:0005975,carbohydrate metabolic process,2.0
10859,GLO1,GO:0006357,regulation of transcription by RNA polymerase II,2.0
10860,GLO1,GO:0006749,glutathione metabolic process,2.0
10861,GLO1,GO:0008270,zinc ion binding,2.0
10862,GLO1,GO:0009438,methylglyoxal metabolic process,2.0
10863,GLO1,GO:0030316,osteoclast differentiation,2.0
10864,GLO1,GO:0043066,negative regulation of apoptotic process,2.0
10867,GLO1,GO:0070062,extracellular exosome,2.0
10868,GLRA2,GO:0004888,transmembrane signaling receptor activity,2.0
10869,GLRA2,GO:0005231,excitatory extracellular ligand-gated ion channel activity,2.0
10870,GLRA2,GO:0005254,chloride channel activity,2.0
10871,GLRA2,GO:0005886,plasma membrane,2.0
10874,GLRA2,GO:0007165,signal transduction,2.0
10875,GLRA2,GO:0007218,neuropeptide signaling pathway,2.0
10877,GLRA2,GO:0007268,chemical synaptic transmission,2.0
10878,GLRA2,GO:0016594,glycine binding,2.0
10879,GLRA2,GO:0016934,extracellularly glycine-gated chloride channel activity,2.0
10880,GLRA2,GO:0022852,glycine-gated chloride ion channel activity,2.0
10881,GLRA2,GO:0030594,neurotransmitter receptor activity,2.0
10882,GLRA2,GO:0034220,ion transmembrane transport,2.0
10884,GLRA2,GO:0034707,chloride channel complex,2.0
10885,GLRA2,GO:0042391,regulation of membrane potential,2.0
10886,GLRA2,GO:0043005,neuron projection,2.0
10887,GLRA2,GO:0043200,response to amino acid,2.0
10888,GLRA2,GO:0045202,synapse,2.0
10889,GLRA2,GO:0045211,postsynaptic membrane,2.0
10890,GLRA2,GO:0046872,metal ion binding,2.0
10891,GLRA2,GO:0050877,nervous system process,2.0
10892,GLRA2,GO:0060012,"synaptic transmission, glycinergic",2.0
10893,GLRA2,GO:0060079,excitatory postsynaptic potential,2.0
10894,GLRA2,GO:0071230,cellular response to amino acid stimulus,2.0
10895,GLRA2,GO:0071294,cellular response to zinc ion,2.0
10896,GLRA2,GO:0071361,cellular response to ethanol,2.0
10897,GLRA2,GO:0098690,glycinergic synapse,2.0
10898,GLRA2,GO:1902476,chloride transmembrane transport,2.0
10900,GLRA2,GO:1904315,transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential,2.0
10934,GNAS,GO:0001664,G protein-coupled receptor binding,2.0
10935,GNAS,GO:0003924,GTPase activity,2.0
10936,GNAS,GO:0005159,insulin-like growth factor receptor binding,2.0
10937,GNAS,GO:0005515,protein binding,2.0
10938,GNAS,GO:0005525,GTP binding,2.0
10939,GNAS,GO:0005829,cytosol,2.0
10941,GNAS,GO:0005834,heterotrimeric G-protein complex,2.0
10942,GNAS,GO:0007188,adenylate cyclase-modulating G protein-coupled receptor signaling pathway,2.0
10943,GNAS,GO:0007189,adenylate cyclase-activating G protein-coupled receptor signaling pathway,2.0
10944,GNAS,GO:0007191,adenylate cyclase-activating dopamine receptor signaling pathway,2.0
10945,GNAS,GO:0007606,sensory perception of chemical stimulus,2.0
10946,GNAS,GO:0010856,adenylate cyclase activator activity,2.0
10947,GNAS,GO:0016020,membrane,2.0
10950,GNAS,GO:0016324,apical plasma membrane,2.0
10951,GNAS,GO:0031279,regulation of cyclase activity,2.0
10952,GNAS,GO:0031683,G-protein beta/gamma-subunit complex binding,2.0
10953,GNAS,GO:0031698,beta-2 adrenergic receptor binding,2.0
10954,GNAS,GO:0031748,D1 dopamine receptor binding,2.0
10955,GNAS,GO:0031852,mu-type opioid receptor binding,2.0
10956,GNAS,GO:0035255,ionotropic glutamate receptor binding,2.0
10957,GNAS,GO:0046872,metal ion binding,2.0
10958,GNAS,GO:0048589,developmental growth,2.0
10959,GNAS,GO:0051430,corticotropin-releasing hormone receptor 1 binding,2.0
10960,GNAS,GO:0060348,bone development,2.0
10961,GNAS,GO:0070062,extracellular exosome,2.0
10962,GNAS,GO:0070527,platelet aggregation,2.0
10963,GNAS,GO:0120162,positive regulation of cold-induced thermogenesis,2.0
10964,GNB1L,GO:0003674,molecular_function,2.0
10983,GPC4,GO:0005515,protein binding,2.0
10984,GPC4,GO:0005634,nucleus,2.0
10985,GPC4,GO:0005796,Golgi lumen,2.0
10986,GPC4,GO:0005886,plasma membrane,2.0
10987,GPC4,GO:0009897,external side of plasma membrane,2.0
10988,GPC4,GO:0009966,regulation of signal transduction,2.0
10989,GPC4,GO:0009986,cell surface,2.0
10990,GPC4,GO:0016055,Wnt signaling pathway,2.0
10991,GPC4,GO:0016477,cell migration,2.0
10992,GPC4,GO:0043202,lysosomal lumen,2.0
10993,GPC4,GO:0045202,synapse,2.0
10994,GPC4,GO:0060071,"Wnt signaling pathway, planar cell polarity pathway",2.0
10995,GPC4,GO:0062023,collagen-containing extracellular matrix,2.0
10996,GPC4,GO:0070062,extracellular exosome,2.0
10997,GPC4,GO:0098696,regulation of neurotransmitter receptor localization to postsynaptic specialization membrane,2.0
10998,GPC4,GO:0098978,glutamatergic synapse,2.0
10999,GPC4,GO:0099560,synaptic membrane adhesion,2.0
11000,GPC4,GO:1904929,"coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway",2.0
11001,GPC4,GO:1905475,regulation of protein localization to membrane,2.0
11002,GPC4,GO:1905606,regulation of presynapse assembly,2.0
11015,GPC6,GO:0005515,protein binding,2.0
11016,GPC6,GO:0005615,extracellular space,2.0
11017,GPC6,GO:0005634,nucleus,2.0
11018,GPC6,GO:0005796,Golgi lumen,2.0
11019,GPC6,GO:0005886,plasma membrane,2.0
11020,GPC6,GO:0009966,regulation of signal transduction,2.0
11021,GPC6,GO:0009986,cell surface,2.0
11022,GPC6,GO:0016477,cell migration,2.0
11024,GPC6,GO:0043202,lysosomal lumen,2.0
11025,GPC6,GO:0045202,synapse,2.0
11026,GPC6,GO:0060071,"Wnt signaling pathway, planar cell polarity pathway",2.0
11027,GPC6,GO:0062023,collagen-containing extracellular matrix,2.0
11028,GPC6,GO:0098696,regulation of neurotransmitter receptor localization to postsynaptic specialization membrane,2.0
11029,GPC6,GO:0099560,synaptic membrane adhesion,2.0
11030,GPC6,GO:1904929,"coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway",2.0
11031,GPC6,GO:1905475,regulation of protein localization to membrane,2.0
11032,GPC6,GO:1905606,regulation of presynapse assembly,2.0
11033,GPD2,GO:0004368,glycerol-3-phosphate dehydrogenase (quinone) activity,2.0
11035,GPD2,GO:0005509,calcium ion binding,2.0
11036,GPD2,GO:0005739,mitochondrion,2.0
11038,GPD2,GO:0005743,mitochondrial inner membrane,2.0
11039,GPD2,GO:0006072,glycerol-3-phosphate metabolic process,2.0
11040,GPD2,GO:0006127,glycerophosphate shuttle,2.0
11041,GPD2,GO:0009331,glycerol-3-phosphate dehydrogenase complex,2.0
11042,GPD2,GO:0019563,glycerol catabolic process,2.0
11043,GPD2,GO:0052591,sn-glycerol-3-phosphate:ubiquinone-8 oxidoreductase activity,2.0
11044,GPHN,GO:0005515,protein binding,2.0
11045,GPHN,GO:0005524,ATP binding,2.0
11046,GPHN,GO:0005737,cytoplasm,2.0
11047,GPHN,GO:0005829,cytosol,2.0
11049,GPHN,GO:0005856,cytoskeleton,2.0
11050,GPHN,GO:0005886,plasma membrane,2.0
11051,GPHN,GO:0006777,Mo-molybdopterin cofactor biosynthetic process,2.0
11052,GPHN,GO:0007529,establishment of synaptic specificity at neuromuscular junction,2.0
11053,GPHN,GO:0008940,nitrate reductase activity,2.0
11054,GPHN,GO:0010038,response to metal ion,2.0
11055,GPHN,GO:0014069,postsynaptic density,2.0
11056,GPHN,GO:0018315,molybdenum incorporation into molybdenum-molybdopterin complex,2.0
11057,GPHN,GO:0030425,dendrite,2.0
11059,GPHN,GO:0032324,molybdopterin cofactor biosynthetic process,2.0
11062,GPHN,GO:0042802,identical protein binding,2.0
11063,GPHN,GO:0043546,molybdopterin cofactor binding,2.0
11064,GPHN,GO:0045211,postsynaptic membrane,2.0
11066,GPHN,GO:0046872,metal ion binding,2.0
11067,GPHN,GO:0061598,molybdopterin adenylyltransferase activity,2.0
11068,GPHN,GO:0061599,molybdopterin molybdotransferase activity,2.0
11069,GPHN,GO:0072579,glycine receptor clustering,2.0
11070,GPHN,GO:0097060,synaptic membrane,2.0
11072,GPHN,GO:0097112,gamma-aminobutyric acid receptor clustering,2.0
11075,GPHN,GO:0098970,postsynaptic neurotransmitter receptor diffusion trapping,2.0
11076,GPHN,GO:0099572,postsynaptic specialization,2.0
11077,GPHN,GO:0099634,postsynaptic specialization membrane,2.0
11078,GPR37,GO:0000151,ubiquitin ligase complex,2.0
11079,GPR37,GO:0004930,G protein-coupled receptor activity,2.0
11080,GPR37,GO:0005515,protein binding,2.0
11081,GPR37,GO:0005737,cytoplasm,2.0
11082,GPR37,GO:0005783,endoplasmic reticulum,2.0
11083,GPR37,GO:0005789,endoplasmic reticulum membrane,2.0
11084,GPR37,GO:0005886,plasma membrane,2.0
11087,GPR37,GO:0007186,G protein-coupled receptor signaling pathway,2.0
11088,GPR37,GO:0007193,adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway,2.0
11090,GPR37,GO:0007218,neuropeptide signaling pathway,2.0
11091,GPR37,GO:0008188,neuropeptide receptor activity,2.0
11092,GPR37,GO:0008528,G protein-coupled peptide receptor activity,2.0
11094,GPR37,GO:0009986,cell surface,2.0
11095,GPR37,GO:0016358,dendrite development,2.0
11096,GPR37,GO:0030165,PDZ domain binding,2.0
11097,GPR37,GO:0030544,Hsp70 protein binding,2.0
11098,GPR37,GO:0031072,heat shock protein binding,2.0
11099,GPR37,GO:0031625,ubiquitin protein ligase binding,2.0
11100,GPR37,GO:0031987,locomotion involved in locomotory behavior,2.0
11101,GPR37,GO:0036505,prosaposin receptor activity,2.0
11103,GPR37,GO:0042277,peptide binding,2.0
11104,GPR37,GO:0042416,dopamine biosynthetic process,2.0
11105,GPR37,GO:0042923,neuropeptide binding,2.0
11106,GPR37,GO:0043235,receptor complex,2.0
11108,GPR37,GO:0043410,positive regulation of MAPK cascade,2.0
11110,GPR37,GO:0045202,synapse,2.0
11111,GPR37,GO:0045964,positive regulation of dopamine metabolic process,2.0
11112,GPR37,GO:1903206,negative regulation of hydrogen peroxide-induced cell death,2.0
11113,GPR85,GO:0004930,G protein-coupled receptor activity,2.0
11115,GPR85,GO:0005515,protein binding,2.0
11116,GPR85,GO:0005783,endoplasmic reticulum,2.0
11117,GPR85,GO:0005886,plasma membrane,2.0
11119,GPR85,GO:0007165,signal transduction,2.0
11120,GPR85,GO:0007186,G protein-coupled receptor signaling pathway,2.0
11142,GRIA1,GO:0001540,amyloid-beta binding,2.0
11143,GRIA1,GO:0004971,AMPA glutamate receptor activity,2.0
11145,GRIA1,GO:0005515,protein binding,2.0
11146,GRIA1,GO:0005789,endoplasmic reticulum membrane,2.0
11148,GRIA1,GO:0005886,plasma membrane,2.0
11151,GRIA1,GO:0007165,signal transduction,2.0
11152,GRIA1,GO:0007268,chemical synaptic transmission,2.0
11153,GRIA1,GO:0007616,long-term memory,2.0
11154,GRIA1,GO:0008066,glutamate receptor activity,2.0
11155,GRIA1,GO:0009986,cell surface,2.0
11156,GRIA1,GO:0012507,ER to Golgi transport vesicle membrane,2.0
11157,GRIA1,GO:0014069,postsynaptic density,2.0
11158,GRIA1,GO:0015276,ligand-gated ion channel activity,2.0
11159,GRIA1,GO:0030165,PDZ domain binding,2.0
11160,GRIA1,GO:0030425,dendrite,2.0
11161,GRIA1,GO:0030666,endocytic vesicle membrane,2.0
11162,GRIA1,GO:0030672,synaptic vesicle membrane,2.0
11163,GRIA1,GO:0031623,receptor internalization,2.0
11164,GRIA1,GO:0031901,early endosome membrane,2.0
11165,GRIA1,GO:0032281,AMPA glutamate receptor complex,2.0
11167,GRIA1,GO:0032591,dendritic spine membrane,2.0
11168,GRIA1,GO:0033116,endoplasmic reticulum-Golgi intermediate compartment membrane,2.0
11169,GRIA1,GO:0034220,ion transmembrane transport,2.0
11170,GRIA1,GO:0035235,ionotropic glutamate receptor signaling pathway,2.0
11171,GRIA1,GO:0038023,signaling receptor activity,2.0
11172,GRIA1,GO:0043025,neuronal cell body,2.0
11173,GRIA1,GO:0043197,dendritic spine,2.0
11175,GRIA1,GO:0044308,axonal spine,2.0
11176,GRIA1,GO:0044309,neuron spine,2.0
11177,GRIA1,GO:0055037,recycling endosome,2.0
11178,GRIA1,GO:0055038,recycling endosome membrane,2.0
11179,GRIA1,GO:0060076,excitatory synapse,2.0
11180,GRIA1,GO:0060078,regulation of postsynaptic membrane potential,2.0
11181,GRIA1,GO:0060292,long-term synaptic depression,2.0
11182,GRIA1,GO:0071242,cellular response to ammonium ion,2.0
11183,GRIA1,GO:0097060,synaptic membrane,2.0
11184,GRIA1,GO:0098793,presynapse,2.0
11185,GRIA1,GO:0098839,postsynaptic density membrane,2.0
11186,GRIA1,GO:0098978,glutamatergic synapse,2.0
11187,GRIA1,GO:0099505,regulation of presynaptic membrane potential,2.0
11188,GRIA1,GO:0099507,ligand-gated ion channel activity involved in regulation of presynaptic membrane potential,2.0
11191,GRIA1,GO:0099544,perisynaptic space,2.0
11192,GRIA1,GO:0099566,regulation of postsynaptic cytosolic calcium ion concentration,2.0
11193,GRIA1,GO:0099583,neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration,2.0
11194,GRIA1,GO:1904315,transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential,2.0
11227,GAS2,GO:0001544,initiation of primordial ovarian follicle growth,2.0
11228,GAS2,GO:0001547,antral ovarian follicle growth,2.0
11229,GAS2,GO:0005829,cytosol,2.0
11230,GAS2,GO:0005884,actin filament,2.0
11231,GAS2,GO:0006915,apoptotic process,2.0
11232,GAS2,GO:0007049,cell cycle,2.0
11233,GAS2,GO:0008017,microtubule binding,2.0
11234,GAS2,GO:0008093,cytoskeletal anchor activity,2.0
11235,GAS2,GO:0008360,regulation of cell shape,2.0
11236,GAS2,GO:0008593,regulation of Notch signaling pathway,2.0
11237,GAS2,GO:0016020,membrane,2.0
11238,GAS2,GO:0030728,ovulation,2.0
11239,GAS2,GO:0051015,actin filament binding,2.0
11240,GAS2,GO:0051726,regulation of cell cycle,2.0
11241,GAS2,GO:0051764,actin crosslink formation,2.0
11242,GAS2,GO:0071711,basement membrane organization,2.0
11265,GRID1,GO:0004970,ionotropic glutamate receptor activity,2.0
11266,GRID1,GO:0005886,plasma membrane,2.0
11267,GRID1,GO:0008066,glutamate receptor activity,2.0
11268,GRID1,GO:0015276,ligand-gated ion channel activity,2.0
11269,GRID1,GO:0034220,ion transmembrane transport,2.0
11270,GRID1,GO:0035176,social behavior,2.0
11271,GRID1,GO:0035235,ionotropic glutamate receptor signaling pathway,2.0
11272,GRID1,GO:0035249,"synaptic transmission, glutamatergic",2.0
11273,GRID1,GO:0038023,signaling receptor activity,2.0
11274,GRID1,GO:0042802,identical protein binding,2.0
11275,GRID1,GO:0045211,postsynaptic membrane,2.0
11276,GRID1,GO:0050804,modulation of chemical synaptic transmission,2.0
11277,GRID1,GO:0060078,regulation of postsynaptic membrane potential,2.0
11278,GRID1,GO:0070062,extracellular exosome,2.0
11279,GRID1,GO:0098839,postsynaptic density membrane,2.0
11280,GRID1,GO:0098978,glutamatergic synapse,2.0
11281,GRID1,GO:0098982,GABA-ergic synapse,2.0
11282,GRID1,GO:0099175,regulation of postsynapse organization,2.0
11283,GRID1,GO:1904315,transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential,2.0
11284,GRID2,GO:0004970,ionotropic glutamate receptor activity,2.0
11285,GRID2,GO:0005515,protein binding,2.0
11286,GRID2,GO:0005886,plasma membrane,2.0
11288,GRID2,GO:0007157,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules,2.0
11289,GRID2,GO:0007215,glutamate receptor signaling pathway,2.0
11290,GRID2,GO:0008066,glutamate receptor activity,2.0
11291,GRID2,GO:0008104,protein localization,2.0
11292,GRID2,GO:0008328,ionotropic glutamate receptor complex,2.0
11293,GRID2,GO:0010975,regulation of neuron projection development,2.0
11294,GRID2,GO:0015276,ligand-gated ion channel activity,2.0
11295,GRID2,GO:0021707,cerebellar granule cell differentiation,2.0
11296,GRID2,GO:0030165,PDZ domain binding,2.0
11297,GRID2,GO:0034220,ion transmembrane transport,2.0
11298,GRID2,GO:0035235,ionotropic glutamate receptor signaling pathway,2.0
11299,GRID2,GO:0035249,"synaptic transmission, glutamatergic",2.0
11301,GRID2,GO:0038023,signaling receptor activity,2.0
11302,GRID2,GO:0042802,identical protein binding,2.0
11303,GRID2,GO:0043197,dendritic spine,2.0
11304,GRID2,GO:0043523,regulation of neuron apoptotic process,2.0
11305,GRID2,GO:0045202,synapse,2.0
11306,GRID2,GO:0045211,postsynaptic membrane,2.0
11307,GRID2,GO:0050804,modulation of chemical synaptic transmission,2.0
11308,GRID2,GO:0051965,positive regulation of synapse assembly,2.0
11309,GRID2,GO:0060079,excitatory postsynaptic potential,2.0
11310,GRID2,GO:0060134,prepulse inhibition,2.0
11311,GRID2,GO:0097110,scaffold protein binding,2.0
11312,GRID2,GO:0098688,parallel fiber to Purkinje cell synapse,2.0
11313,GRID2,GO:0098839,postsynaptic density membrane,2.0
11314,GRID2,GO:0098978,glutamatergic synapse,2.0
11315,GRID2,GO:0099151,regulation of postsynaptic density assembly,2.0
11316,GRID2,GO:1900454,positive regulation of long-term synaptic depression,2.0
11317,GRID2,GO:1904315,transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential,2.0
11318,GRID2,GO:1904861,excitatory synapse assembly,2.0
11319,GRID2,GO:1905606,regulation of presynapse assembly,2.0
11320,GRID2IP,GO:0045211,postsynaptic membrane,2.0
11321,GRID2IP,GO:0060292,long-term synaptic depression,2.0
11322,GRID2IP,GO:0098688,parallel fiber to Purkinje cell synapse,2.0
11323,GRID2IP,GO:0099072,regulation of postsynaptic membrane neurotransmitter receptor levels,2.0
11324,GRID2IP,GO:0099092,"postsynaptic density, intracellular component",2.0
11325,GRID2IP,GO:0099566,regulation of postsynaptic cytosolic calcium ion concentration,2.0
11326,GRID2IP,GO:0150048,cerebellar granule cell to Purkinje cell synapse,2.0
11327,GRIK2,GO:0000149,SNARE binding,2.0
11328,GRIK2,GO:0001662,behavioral fear response,2.0
11329,GRIK2,GO:0005234,extracellularly glutamate-gated ion channel activity,2.0
11330,GRIK2,GO:0005886,plasma membrane,2.0
11332,GRIK2,GO:0006874,cellular calcium ion homeostasis,2.0
11333,GRIK2,GO:0007215,glutamate receptor signaling pathway,2.0
11334,GRIK2,GO:0007268,chemical synaptic transmission,2.0
11335,GRIK2,GO:0008066,glutamate receptor activity,2.0
11336,GRIK2,GO:0014069,postsynaptic density,2.0
11337,GRIK2,GO:0015276,ligand-gated ion channel activity,2.0
11338,GRIK2,GO:0015277,kainate selective glutamate receptor activity,2.0
11340,GRIK2,GO:0019228,neuronal action potential,2.0
11341,GRIK2,GO:0030165,PDZ domain binding,2.0
11342,GRIK2,GO:0031624,ubiquitin conjugating enzyme binding,2.0
11343,GRIK2,GO:0031625,ubiquitin protein ligase binding,2.0
11344,GRIK2,GO:0032839,dendrite cytoplasm,2.0
11345,GRIK2,GO:0032983,kainate selective glutamate receptor complex,2.0
11346,GRIK2,GO:0034220,ion transmembrane transport,2.0
11347,GRIK2,GO:0035235,ionotropic glutamate receptor signaling pathway,2.0
11348,GRIK2,GO:0035249,"synaptic transmission, glutamatergic",2.0
11349,GRIK2,GO:0038023,signaling receptor activity,2.0
11350,GRIK2,GO:0042734,presynaptic membrane,2.0
11351,GRIK2,GO:0042802,identical protein binding,2.0
11352,GRIK2,GO:0043113,receptor clustering,2.0
11353,GRIK2,GO:0043195,terminal bouton,2.0
11354,GRIK2,GO:0043204,perikaryon,2.0
11355,GRIK2,GO:0043524,negative regulation of neuron apoptotic process,2.0
11356,GRIK2,GO:0043525,positive regulation of neuron apoptotic process,2.0
11357,GRIK2,GO:0045211,postsynaptic membrane,2.0
11358,GRIK2,GO:0046328,regulation of JNK cascade,2.0
11359,GRIK2,GO:0048169,regulation of long-term neuronal synaptic plasticity,2.0
11360,GRIK2,GO:0048172,regulation of short-term neuronal synaptic plasticity,2.0
11361,GRIK2,GO:0050804,modulation of chemical synaptic transmission,2.0
11363,GRIK2,GO:0050806,positive regulation of synaptic transmission,2.0
11364,GRIK2,GO:0051402,neuron apoptotic process,2.0
11365,GRIK2,GO:0051967,"negative regulation of synaptic transmission, glutamatergic",2.0
11366,GRIK2,GO:0060079,excitatory postsynaptic potential,2.0
11367,GRIK2,GO:0060080,inhibitory postsynaptic potential,2.0
11368,GRIK2,GO:0097110,scaffold protein binding,2.0
11369,GRIK2,GO:0097471,mossy fiber rosette,2.0
11370,GRIK2,GO:0098686,hippocampal mossy fiber to CA3 synapse,2.0
11371,GRIK2,GO:0098815,modulation of excitatory postsynaptic potential,2.0
11372,GRIK2,GO:0098978,glutamatergic synapse,2.0
11373,GRIK2,GO:0099171,presynaptic modulation of chemical synaptic transmission,2.0
11374,GRIK2,GO:0099505,regulation of presynaptic membrane potential,2.0
11375,GRIK2,GO:0099507,ligand-gated ion channel activity involved in regulation of presynaptic membrane potential,2.0
11376,GRIK2,GO:0120169,detection of cold stimulus involved in thermoception,2.0
11377,GRIK2,GO:1904315,transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential,2.0
11378,GRIK3,GO:0001640,adenylate cyclase inhibiting G protein-coupled glutamate receptor activity,2.0
11379,GRIK3,GO:0004970,ionotropic glutamate receptor activity,2.0
11381,GRIK3,GO:0005886,plasma membrane,2.0
11384,GRIK3,GO:0007196,adenylate cyclase-inhibiting G protein-coupled glutamate receptor signaling pathway,2.0
11385,GRIK3,GO:0007215,glutamate receptor signaling pathway,2.0
11386,GRIK3,GO:0007216,G protein-coupled glutamate receptor signaling pathway,2.0
11387,GRIK3,GO:0008066,glutamate receptor activity,2.0
11389,GRIK3,GO:0015276,ligand-gated ion channel activity,2.0
11390,GRIK3,GO:0015277,kainate selective glutamate receptor activity,2.0
11392,GRIK3,GO:0030424,axon,2.0
11393,GRIK3,GO:0030425,dendrite,2.0
11394,GRIK3,GO:0032839,dendrite cytoplasm,2.0
11395,GRIK3,GO:0032983,kainate selective glutamate receptor complex,2.0
11396,GRIK3,GO:0034220,ion transmembrane transport,2.0
11397,GRIK3,GO:0035235,ionotropic glutamate receptor signaling pathway,2.0
11398,GRIK3,GO:0035249,"synaptic transmission, glutamatergic",2.0
11399,GRIK3,GO:0038023,signaling receptor activity,2.0
11400,GRIK3,GO:0042391,regulation of membrane potential,2.0
11402,GRIK3,GO:0042734,presynaptic membrane,2.0
11403,GRIK3,GO:0043195,terminal bouton,2.0
11404,GRIK3,GO:0043204,perikaryon,2.0
11405,GRIK3,GO:0045211,postsynaptic membrane,2.0
11406,GRIK3,GO:0050804,modulation of chemical synaptic transmission,2.0
11407,GRIK3,GO:0051967,"negative regulation of synaptic transmission, glutamatergic",2.0
11408,GRIK3,GO:0060078,regulation of postsynaptic membrane potential,2.0
11409,GRIK3,GO:0098978,glutamatergic synapse,2.0
11410,GRIK3,GO:0099505,regulation of presynaptic membrane potential,2.0
11411,GRIK3,GO:0099507,ligand-gated ion channel activity involved in regulation of presynaptic membrane potential,2.0
11412,GRIK3,GO:1904315,transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential,2.0
11413,GRIK4,GO:0005886,plasma membrane,2.0
11415,GRIK4,GO:0007215,glutamate receptor signaling pathway,2.0
11416,GRIK4,GO:0007268,chemical synaptic transmission,2.0
11417,GRIK4,GO:0008066,glutamate receptor activity,2.0
11418,GRIK4,GO:0015276,ligand-gated ion channel activity,2.0
11419,GRIK4,GO:0015277,kainate selective glutamate receptor activity,2.0
11420,GRIK4,GO:0032983,kainate selective glutamate receptor complex,2.0
11421,GRIK4,GO:0034220,ion transmembrane transport,2.0
11422,GRIK4,GO:0035235,ionotropic glutamate receptor signaling pathway,2.0
11423,GRIK4,GO:0035249,"synaptic transmission, glutamatergic",2.0
11424,GRIK4,GO:0038023,signaling receptor activity,2.0
11425,GRIK4,GO:0042734,presynaptic membrane,2.0
11426,GRIK4,GO:0045211,postsynaptic membrane,2.0
11427,GRIK4,GO:0050804,modulation of chemical synaptic transmission,2.0
11428,GRIK4,GO:0060078,regulation of postsynaptic membrane potential,2.0
11429,GRIK4,GO:0098686,hippocampal mossy fiber to CA3 synapse,2.0
11430,GRIK4,GO:0099505,regulation of presynaptic membrane potential,2.0
11431,GRIK4,GO:0099507,ligand-gated ion channel activity involved in regulation of presynaptic membrane potential,2.0
11434,GRIK4,GO:1904315,transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential,2.0
11435,GRIK5,GO:0005654,nucleoplasm,2.0
11436,GRIK5,GO:0005783,endoplasmic reticulum,2.0
11437,GRIK5,GO:0005886,plasma membrane,2.0
11440,GRIK5,GO:0006621,protein retention in ER lumen,2.0
11441,GRIK5,GO:0008066,glutamate receptor activity,2.0
11442,GRIK5,GO:0015276,ligand-gated ion channel activity,2.0
11443,GRIK5,GO:0015277,kainate selective glutamate receptor activity,2.0
11444,GRIK5,GO:0017124,SH3 domain binding,2.0
11445,GRIK5,GO:0030165,PDZ domain binding,2.0
11446,GRIK5,GO:0030425,dendrite,2.0
11447,GRIK5,GO:0031630,regulation of synaptic vesicle fusion to presynaptic active zone membrane,2.0
11448,GRIK5,GO:0032983,kainate selective glutamate receptor complex,2.0
11449,GRIK5,GO:0034220,ion transmembrane transport,2.0
11450,GRIK5,GO:0035235,ionotropic glutamate receptor signaling pathway,2.0
11451,GRIK5,GO:0035249,"synaptic transmission, glutamatergic",2.0
11452,GRIK5,GO:0038023,signaling receptor activity,2.0
11453,GRIK5,GO:0042734,presynaptic membrane,2.0
11454,GRIK5,GO:0042802,identical protein binding,2.0
11455,GRIK5,GO:0043113,receptor clustering,2.0
11456,GRIK5,GO:0043195,terminal bouton,2.0
11457,GRIK5,GO:0043204,perikaryon,2.0
11458,GRIK5,GO:0043525,positive regulation of neuron apoptotic process,2.0
11459,GRIK5,GO:0045211,postsynaptic membrane,2.0
11460,GRIK5,GO:0050804,modulation of chemical synaptic transmission,2.0
11461,GRIK5,GO:0051649,establishment of localization in cell,2.0
11462,GRIK5,GO:0060079,excitatory postsynaptic potential,2.0
11463,GRIK5,GO:0071333,cellular response to glucose stimulus,2.0
11464,GRIK5,GO:0098686,hippocampal mossy fiber to CA3 synapse,2.0
11465,GRIK5,GO:0098839,postsynaptic density membrane,2.0
11466,GRIK5,GO:0098978,glutamatergic synapse,2.0
11467,GRIK5,GO:0099505,regulation of presynaptic membrane potential,2.0
11468,GRIK5,GO:0099507,ligand-gated ion channel activity involved in regulation of presynaptic membrane potential,2.0
11471,GRIK5,GO:1904315,transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential,2.0
11546,GPX1,GO:0001659,temperature homeostasis,2.0
11547,GPX1,GO:0001885,endothelial cell development,2.0
11548,GPX1,GO:0002862,negative regulation of inflammatory response to antigenic stimulus,2.0
11549,GPX1,GO:0004601,peroxidase activity,2.0
11550,GPX1,GO:0004602,glutathione peroxidase activity,2.0
11552,GPX1,GO:0005634,nucleus,2.0
11553,GPX1,GO:0005737,cytoplasm,2.0
11554,GPX1,GO:0005739,mitochondrion,2.0
11556,GPX1,GO:0005759,mitochondrial matrix,2.0
11557,GPX1,GO:0005829,cytosol,2.0
11560,GPX1,GO:0006641,triglyceride metabolic process,2.0
11561,GPX1,GO:0006749,glutathione metabolic process,2.0
11563,GPX1,GO:0007568,aging,2.0
11564,GPX1,GO:0007605,sensory perception of sound,2.0
11565,GPX1,GO:0008631,intrinsic apoptotic signaling pathway in response to oxidative stress,2.0
11566,GPX1,GO:0009410,response to xenobiotic stimulus,2.0
11567,GPX1,GO:0009609,response to symbiotic bacterium,2.0
11568,GPX1,GO:0009650,UV protection,2.0
11569,GPX1,GO:0009725,response to hormone,2.0
11570,GPX1,GO:0010269,response to selenium ion,2.0
11572,GPX1,GO:0010332,response to gamma radiation,2.0
11573,GPX1,GO:0017124,SH3 domain binding,2.0
11574,GPX1,GO:0018158,protein oxidation,2.0
11575,GPX1,GO:0019369,arachidonic acid metabolic process,2.0
11576,GPX1,GO:0019372,lipoxygenase pathway,2.0
11577,GPX1,GO:0032355,response to estradiol,2.0
11578,GPX1,GO:0033194,response to hydroperoxide,2.0
11579,GPX1,GO:0033599,regulation of mammary gland epithelial cell proliferation,2.0
11580,GPX1,GO:0034599,cellular response to oxidative stress,2.0
11581,GPX1,GO:0035094,response to nicotine,2.0
11582,GPX1,GO:0040029,epigenetic regulation of gene expression,2.0
11583,GPX1,GO:0042311,vasodilation,2.0
11584,GPX1,GO:0042542,response to hydrogen peroxide,2.0
11586,GPX1,GO:0042744,hydrogen peroxide catabolic process,2.0
11588,GPX1,GO:0043154,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process,2.0
11589,GPX1,GO:0043403,skeletal muscle tissue regeneration,2.0
11590,GPX1,GO:0043534,blood vessel endothelial cell migration,2.0
11591,GPX1,GO:0045444,fat cell differentiation,2.0
11592,GPX1,GO:0045445,myoblast differentiation,2.0
11593,GPX1,GO:0045454,cell redox homeostasis,2.0
11594,GPX1,GO:0047066,phospholipid-hydroperoxide glutathione peroxidase activity,2.0
11595,GPX1,GO:0048144,fibroblast proliferation,2.0
11596,GPX1,GO:0048741,skeletal muscle fiber development,2.0
11597,GPX1,GO:0051402,neuron apoptotic process,2.0
11598,GPX1,GO:0051450,myoblast proliferation,2.0
11599,GPX1,GO:0051593,response to folic acid,2.0
11600,GPX1,GO:0051702,biological process involved in interaction with symbiont,2.0
11601,GPX1,GO:0051897,positive regulation of protein kinase B signaling,2.0
11602,GPX1,GO:0060047,heart contraction,2.0
11603,GPX1,GO:0060055,angiogenesis involved in wound healing,2.0
11604,GPX1,GO:0061136,regulation of proteasomal protein catabolic process,2.0
11605,GPX1,GO:0071333,cellular response to glucose stimulus,2.0
11606,GPX1,GO:0090201,negative regulation of release of cytochrome c from mitochondria,2.0
11607,GPX1,GO:0097413,Lewy body,2.0
11608,GPX1,GO:0098869,cellular oxidant detoxification,2.0
11609,GPX1,GO:1902042,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors,2.0
11610,GPX1,GO:1902176,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,2.0
11611,GPX1,GO:1902905,positive regulation of supramolecular fiber organization,2.0
11735,GRIP1,GO:0005515,protein binding,2.0
11736,GRIP1,GO:0005789,endoplasmic reticulum membrane,2.0
11737,GRIP1,GO:0005829,cytosol,2.0
11738,GRIP1,GO:0005886,plasma membrane,2.0
11740,GRIP1,GO:0008013,beta-catenin binding,2.0
11741,GRIP1,GO:0008022,protein C-terminus binding,2.0
11742,GRIP1,GO:0014069,postsynaptic density,2.0
11743,GRIP1,GO:0016358,dendrite development,2.0
11744,GRIP1,GO:0030159,signaling receptor complex adaptor activity,2.0
11745,GRIP1,GO:0030425,dendrite,2.0
11746,GRIP1,GO:0031410,cytoplasmic vesicle,2.0
11747,GRIP1,GO:0035259,nuclear glucocorticoid receptor binding,2.0
11749,GRIP1,GO:0035556,intracellular signal transduction,2.0
11750,GRIP1,GO:0043005,neuron projection,2.0
11751,GRIP1,GO:0043204,perikaryon,2.0
11752,GRIP1,GO:0045211,postsynaptic membrane,2.0
11753,GRIP1,GO:0098887,"neurotransmitter receptor transport, endosome to postsynaptic membrane",2.0
11754,GRIP1,GO:0150012,positive regulation of neuron projection arborization,2.0
11755,GRK4,GO:0004672,protein kinase activity,2.0
11756,GRK4,GO:0005524,ATP binding,2.0
11757,GRK4,GO:0005737,cytoplasm,2.0
11758,GRK4,GO:0005829,cytosol,2.0
11759,GRK4,GO:0005886,plasma membrane,2.0
11760,GRK4,GO:0005938,cell cortex,2.0
11761,GRK4,GO:0006468,protein phosphorylation,2.0
11762,GRK4,GO:0007165,signal transduction,2.0
11763,GRK4,GO:0008277,regulation of G protein-coupled receptor signaling pathway,2.0
11764,GRK4,GO:0009966,regulation of signal transduction,2.0
11765,GRK4,GO:0022400,regulation of rhodopsin mediated signaling pathway,2.0
11766,GRK4,GO:0031623,receptor internalization,2.0
11767,GRK4,GO:0050254,rhodopsin kinase activity,2.0
11768,GRK4,GO:0097381,photoreceptor disc membrane,2.0
11769,GRM5,GO:0001640,adenylate cyclase inhibiting G protein-coupled glutamate receptor activity,2.0
11770,GRM5,GO:0001932,regulation of protein phosphorylation,2.0
11771,GRM5,GO:0002029,desensitization of G protein-coupled receptor signaling pathway,2.0
11772,GRM5,GO:0004930,G protein-coupled receptor activity,2.0
11773,GRM5,GO:0005515,protein binding,2.0
11774,GRM5,GO:0005737,cytoplasm,2.0
11775,GRM5,GO:0005886,plasma membrane,2.0
11778,GRM5,GO:0006355,regulation of DNA-templated transcription,2.0
11779,GRM5,GO:0006417,regulation of translation,2.0
11780,GRM5,GO:0006448,regulation of translational elongation,2.0
11781,GRM5,GO:0006468,protein phosphorylation,2.0
11782,GRM5,GO:0007196,adenylate cyclase-inhibiting G protein-coupled glutamate receptor signaling pathway,2.0
11783,GRM5,GO:0007205,protein kinase C-activating G protein-coupled receptor signaling pathway,2.0
11784,GRM5,GO:0007206,phospholipase C-activating G protein-coupled glutamate receptor signaling pathway,2.0
11785,GRM5,GO:0007216,G protein-coupled glutamate receptor signaling pathway,2.0
11787,GRM5,GO:0007268,chemical synaptic transmission,2.0
11788,GRM5,GO:0007611,learning or memory,2.0
11789,GRM5,GO:0007612,learning,2.0
11790,GRM5,GO:0007626,locomotory behavior,2.0
11791,GRM5,GO:0008066,glutamate receptor activity,2.0
11792,GRM5,GO:0030296,protein tyrosine kinase activator activity,2.0
11793,GRM5,GO:0031687,A2A adenosine receptor binding,2.0
11794,GRM5,GO:0035584,calcium-mediated signaling using intracellular calcium source,2.0
11795,GRM5,GO:0040013,negative regulation of locomotion,2.0
11796,GRM5,GO:0042802,identical protein binding,2.0
11797,GRM5,GO:0043197,dendritic spine,2.0
11798,GRM5,GO:0043198,dendritic shaft,2.0
11799,GRM5,GO:0043410,positive regulation of MAPK cascade,2.0
11800,GRM5,GO:0048170,positive regulation of long-term neuronal synaptic plasticity,2.0
11801,GRM5,GO:0050808,synapse organization,2.0
11802,GRM5,GO:0050890,cognition,2.0
11803,GRM5,GO:0051966,"regulation of synaptic transmission, glutamatergic",2.0
11804,GRM5,GO:0060078,regulation of postsynaptic membrane potential,2.0
11805,GRM5,GO:0061098,positive regulation of protein tyrosine kinase activity,2.0
11806,GRM5,GO:0097449,astrocyte projection,2.0
11807,GRM5,GO:0098685,Schaffer collateral - CA1 synapse,2.0
11808,GRM5,GO:0098839,postsynaptic density membrane,2.0
11809,GRM5,GO:0098978,glutamatergic synapse,2.0
11810,GRM5,GO:0099530,G protein-coupled receptor activity involved in regulation of postsynaptic membrane potential,2.0
11811,GRM5,GO:0099553,"trans-synaptic signaling by endocannabinoid, modulating synaptic transmission",2.0
11812,GRM5,GO:0099566,regulation of postsynaptic cytosolic calcium ion concentration,2.0
11813,GRM5,GO:0099583,neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration,2.0
11814,GRM5,GO:1902938,regulation of intracellular calcium activated chloride channel activity,2.0
11815,GRM5,GO:1904646,cellular response to amyloid-beta,2.0
11817,GRM5,GO:1990782,protein tyrosine kinase binding,2.0
11818,GRM7,GO:0001640,adenylate cyclase inhibiting G protein-coupled glutamate receptor activity,2.0
11819,GRM7,GO:0001642,group III metabotropic glutamate receptor activity,2.0
11821,GRM7,GO:0001662,behavioral fear response,2.0
11822,GRM7,GO:0005886,plasma membrane,2.0
11826,GRM7,GO:0005938,cell cortex,2.0
11827,GRM7,GO:0007196,adenylate cyclase-inhibiting G protein-coupled glutamate receptor signaling pathway,2.0
11828,GRM7,GO:0007216,G protein-coupled glutamate receptor signaling pathway,2.0
11829,GRM7,GO:0007268,chemical synaptic transmission,2.0
11830,GRM7,GO:0007605,sensory perception of sound,2.0
11831,GRM7,GO:0008066,glutamate receptor activity,2.0
11832,GRM7,GO:0010855,adenylate cyclase inhibitor activity,2.0
11833,GRM7,GO:0014050,negative regulation of glutamate secretion,2.0
11834,GRM7,GO:0016020,membrane,2.0
11835,GRM7,GO:0030424,axon,2.0
11836,GRM7,GO:0030425,dendrite,2.0
11837,GRM7,GO:0031279,regulation of cyclase activity,2.0
11838,GRM7,GO:0032279,asymmetric synapse,2.0
11839,GRM7,GO:0043086,negative regulation of catalytic activity,2.0
11840,GRM7,GO:0043198,dendritic shaft,2.0
11841,GRM7,GO:0043235,receptor complex,2.0
11842,GRM7,GO:0045211,postsynaptic membrane,2.0
11843,GRM7,GO:0046983,protein dimerization activity,2.0
11844,GRM7,GO:0048786,presynaptic active zone,2.0
11845,GRM7,GO:0051966,"regulation of synaptic transmission, glutamatergic",2.0
11846,GRM7,GO:0061564,axon development,2.0
11847,GRM7,GO:0070085,glycosylation,2.0
11848,GRM7,GO:0070905,serine binding,2.0
11849,GSTM1,GO:0004364,glutathione transferase activity,2.0
11851,GSTM1,GO:0005737,cytoplasm,2.0
11852,GSTM1,GO:0005829,cytosol,2.0
11854,GSTM1,GO:0006693,prostaglandin metabolic process,2.0
11855,GSTM1,GO:0006749,glutathione metabolic process,2.0
11857,GSTM1,GO:0018916,nitrobenzene metabolic process,2.0
11858,GSTM1,GO:0019899,enzyme binding,2.0
11859,GSTM1,GO:0042178,xenobiotic catabolic process,2.0
11860,GSTM1,GO:0042803,protein homodimerization activity,2.0
11861,GSTM1,GO:0043295,glutathione binding,2.0
11862,GSTM1,GO:0045171,intercellular bridge,2.0
11863,GSTM1,GO:0051122,hepoxilin biosynthetic process,2.0
11864,GSTM1,GO:0070458,cellular detoxification of nitrogen compound,2.0
11865,GSTM1,GO:1901687,glutathione derivative biosynthetic process,2.0
11866,GTF2I,GO:0000981,"DNA-binding transcription factor activity, RNA polymerase II-specific",2.0
11867,GTF2I,GO:0001228,"DNA-binding transcription activator activity, RNA polymerase II-specific",2.0
11868,GTF2I,GO:0003677,DNA binding,2.0
11869,GTF2I,GO:0003700,DNA-binding transcription factor activity,2.0
11870,GTF2I,GO:0005515,protein binding,2.0
11871,GTF2I,GO:0005634,nucleus,2.0
11873,GTF2I,GO:0005654,nucleoplasm,2.0
11874,GTF2I,GO:0005737,cytoplasm,2.0
11875,GTF2I,GO:0006366,transcription by RNA polymerase II,2.0
11876,GTF2I,GO:0016020,membrane,2.0
11877,GTF2I,GO:0016525,negative regulation of angiogenesis,2.0
11878,GTF2I,GO:0045944,positive regulation of transcription by RNA polymerase II,2.0
11879,GTF2I,GO:0061629,RNA polymerase II-specific DNA-binding transcription factor binding,2.0
11880,GUCY1A2,GO:0004383,guanylate cyclase activity,2.0
11881,GUCY1A2,GO:0005515,protein binding,2.0
11882,GUCY1A2,GO:0005525,GTP binding,2.0
11883,GUCY1A2,GO:0005829,cytosol,2.0
11884,GUCY1A2,GO:0006182,cGMP biosynthetic process,2.0
11885,GUCY1A2,GO:0007165,signal transduction,2.0
11886,GUCY1A2,GO:0007263,nitric oxide mediated signal transduction,2.0
11887,GUCY1A2,GO:0008074,"guanylate cyclase complex, soluble",2.0
11888,GUCY1A2,GO:0010750,positive regulation of nitric oxide mediated signal transduction,2.0
11889,GUCY1A2,GO:0019934,cGMP-mediated signaling,2.0
11890,GUCY1A2,GO:0020037,heme binding,2.0
11891,GUCY1A2,GO:0070482,response to oxygen levels,2.0
11908,H2BC11,GO:0000786,nucleosome,2.0
11910,H2BC11,GO:0001530,lipopolysaccharide binding,2.0
11911,H2BC11,GO:0002227,innate immune response in mucosa,2.0
11912,H2BC11,GO:0003677,DNA binding,2.0
11914,H2BC11,GO:0005515,protein binding,2.0
11915,H2BC11,GO:0005615,extracellular space,2.0
11916,H2BC11,GO:0005634,nucleus,2.0
11918,H2BC11,GO:0005654,nucleoplasm,2.0
11920,H2BC11,GO:0005829,cytosol,2.0
11921,H2BC11,GO:0005886,plasma membrane,2.0
11922,H2BC11,GO:0006334,nucleosome assembly,2.0
11924,H2BC11,GO:0010804,negative regulation of tumor necrosis factor-mediated signaling pathway,2.0
11925,H2BC11,GO:0019731,antibacterial humoral response,2.0
11926,H2BC11,GO:0030527,structural constituent of chromatin,2.0
11927,H2BC11,GO:0031640,killing of cells of another organism,2.0
11928,H2BC11,GO:0043505,CENP-A containing nucleosome,2.0
11929,H2BC11,GO:0046982,protein heterodimerization activity,2.0
11930,H2BC11,GO:0050829,defense response to Gram-negative bacterium,2.0
11931,H2BC11,GO:0050830,defense response to Gram-positive bacterium,2.0
11932,H2BC11,GO:0061644,protein localization to CENP-A containing chromatin,2.0
11933,H2BC11,GO:0061844,antimicrobial humoral immune response mediated by antimicrobial peptide,2.0
12117,HDAC4,GO:0000118,histone deacetylase complex,2.0
12119,HDAC4,GO:0000122,negative regulation of transcription by RNA polymerase II,2.0
12124,HDAC4,GO:0000976,transcription cis-regulatory region binding,2.0
12125,HDAC4,GO:0000978,RNA polymerase II cis-regulatory region sequence-specific DNA binding,2.0
12126,HDAC4,GO:0004407,histone deacetylase activity,2.0
12128,HDAC4,GO:0005515,protein binding,2.0
12129,HDAC4,GO:0005634,nucleus,2.0
12130,HDAC4,GO:0005654,nucleoplasm,2.0
12132,HDAC4,GO:0005737,cytoplasm,2.0
12134,HDAC4,GO:0005829,cytosol,2.0
12135,HDAC4,GO:0006338,chromatin remodeling,2.0
12136,HDAC4,GO:0006476,protein deacetylation,2.0
12137,HDAC4,GO:0006954,inflammatory response,2.0
12138,HDAC4,GO:0007399,nervous system development,2.0
12139,HDAC4,GO:0008134,transcription factor binding,2.0
12140,HDAC4,GO:0008270,zinc ion binding,2.0
12141,HDAC4,GO:0008284,positive regulation of cell population proliferation,2.0
12142,HDAC4,GO:0010832,negative regulation of myotube differentiation,2.0
12143,HDAC4,GO:0014894,response to denervation involved in regulation of muscle adaptation,2.0
12144,HDAC4,GO:0014898,cardiac muscle hypertrophy in response to stress,2.0
12145,HDAC4,GO:0016575,histone deacetylation,2.0
12148,HDAC4,GO:0016607,nuclear speck,2.0
12149,HDAC4,GO:0016925,protein sumoylation,2.0
12150,HDAC4,GO:0017053,transcription repressor complex,2.0
12151,HDAC4,GO:0019789,SUMO transferase activity,2.0
12152,HDAC4,GO:0030183,B cell differentiation,2.0
12153,HDAC4,GO:0030955,potassium ion binding,2.0
12154,HDAC4,GO:0033235,positive regulation of protein sumoylation,2.0
12155,HDAC4,GO:0033558,protein lysine deacetylase activity,2.0
12157,HDAC4,GO:0034983,peptidyl-lysine deacetylation,2.0
12158,HDAC4,GO:0040029,epigenetic regulation of gene expression,2.0
12159,HDAC4,GO:0042113,B cell activation,2.0
12160,HDAC4,GO:0042802,identical protein binding,2.0
12161,HDAC4,GO:0042826,histone deacetylase binding,2.0
12162,HDAC4,GO:0043393,regulation of protein binding,2.0
12163,HDAC4,GO:0043433,negative regulation of DNA-binding transcription factor activity,2.0
12164,HDAC4,GO:0043565,sequence-specific DNA binding,2.0
12165,HDAC4,GO:0045820,negative regulation of glycolytic process,2.0
12166,HDAC4,GO:0045892,negative regulation of DNA-templated transcription,2.0
12168,HDAC4,GO:0045893,positive regulation of DNA-templated transcription,2.0
12169,HDAC4,GO:0045944,positive regulation of transcription by RNA polymerase II,2.0
12171,HDAC4,GO:0051091,positive regulation of DNA-binding transcription factor activity,2.0
12172,HDAC4,GO:0061629,RNA polymerase II-specific DNA-binding transcription factor binding,2.0
12173,HDAC4,GO:0070555,response to interleukin-1,2.0
12174,HDAC4,GO:0070932,histone H3 deacetylation,2.0
12175,HDAC4,GO:0070933,histone H4 deacetylation,2.0
12177,HDAC4,GO:0140297,DNA-binding transcription factor binding,2.0
12222,HECW2,GO:0000209,protein polyubiquitination,2.0
12223,HECW2,GO:0005515,protein binding,2.0
12224,HECW2,GO:0005737,cytoplasm,2.0
12225,HECW2,GO:0016567,protein ubiquitination,2.0
12226,HECW2,GO:0030071,regulation of mitotic metaphase/anaphase transition,2.0
12227,HECW2,GO:0043161,proteasome-mediated ubiquitin-dependent protein catabolic process,2.0
12228,HECW2,GO:0048814,regulation of dendrite morphogenesis,2.0
12229,HECW2,GO:0061630,ubiquitin protein ligase activity,2.0
12230,HECW2,GO:0072686,mitotic spindle,2.0
12231,HECW2,GO:2000650,negative regulation of sodium ion transmembrane transporter activity,2.0
12241,HERC1,GO:0004842,ubiquitin-protein transferase activity,2.0
12242,HERC1,GO:0005085,guanyl-nucleotide exchange factor activity,2.0
12243,HERC1,GO:0005737,cytoplasm,2.0
12244,HERC1,GO:0005794,Golgi apparatus,2.0
12245,HERC1,GO:0005829,cytosol,2.0
12246,HERC1,GO:0006914,autophagy,2.0
12247,HERC1,GO:0010507,negative regulation of autophagy,2.0
12248,HERC1,GO:0016020,membrane,2.0
12249,HERC1,GO:0016567,protein ubiquitination,2.0
12250,HERC1,GO:0021702,cerebellar Purkinje cell differentiation,2.0
12251,HERC1,GO:0022038,corpus callosum development,2.0
12252,HERC1,GO:0031175,neuron projection development,2.0
12253,HERC1,GO:0050790,regulation of catalytic activity,2.0
12254,HERC1,GO:0050885,neuromuscular process controlling balance,2.0
12287,HIVEP3,GO:0000978,RNA polymerase II cis-regulatory region sequence-specific DNA binding,2.0
12288,HIVEP3,GO:0000981,"DNA-binding transcription factor activity, RNA polymerase II-specific",2.0
12289,HIVEP3,GO:0005515,protein binding,2.0
12290,HIVEP3,GO:0005634,nucleus,2.0
12291,HIVEP3,GO:0005737,cytoplasm,2.0
12292,HIVEP3,GO:0006357,regulation of transcription by RNA polymerase II,2.0
12293,HIVEP3,GO:0035914,skeletal muscle cell differentiation,2.0
12294,HIVEP3,GO:0045893,positive regulation of DNA-templated transcription,2.0
12295,HIVEP3,GO:0046872,metal ion binding,2.0
12296,HLA-A,GO:0000139,Golgi membrane,2.0
12297,HLA-A,GO:0001913,T cell mediated cytotoxicity,2.0
12298,HLA-A,GO:0001916,positive regulation of T cell mediated cytotoxicity,2.0
12299,HLA-A,GO:0002419,T cell mediated cytotoxicity directed against tumor cell target,2.0
12300,HLA-A,GO:0002485,"antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent",2.0
12301,HLA-A,GO:0002486,"antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent",2.0
12302,HLA-A,GO:0002726,positive regulation of T cell cytokine production,2.0
12303,HLA-A,GO:0003723,RNA binding,2.0
12304,HLA-A,GO:0005102,signaling receptor binding,2.0
12305,HLA-A,GO:0005515,protein binding,2.0
12306,HLA-A,GO:0005783,endoplasmic reticulum,2.0
12307,HLA-A,GO:0005789,endoplasmic reticulum membrane,2.0
12308,HLA-A,GO:0005794,Golgi apparatus,2.0
12309,HLA-A,GO:0005797,Golgi medial cisterna,2.0
12310,HLA-A,GO:0005886,plasma membrane,2.0
12313,HLA-A,GO:0006955,immune response,2.0
12315,HLA-A,GO:0009986,cell surface,2.0
12316,HLA-A,GO:0012507,ER to Golgi transport vesicle membrane,2.0
12317,HLA-A,GO:0016020,membrane,2.0
12318,HLA-A,GO:0016045,detection of bacterium,2.0
12319,HLA-A,GO:0019731,antibacterial humoral response,2.0
12320,HLA-A,GO:0019885,antigen processing and presentation of endogenous peptide antigen via MHC class I,2.0
12321,HLA-A,GO:0030670,phagocytic vesicle membrane,2.0
12322,HLA-A,GO:0030881,beta-2-microglobulin binding,2.0
12325,HLA-A,GO:0031901,early endosome membrane,2.0
12326,HLA-A,GO:0032729,positive regulation of type II interferon production,2.0
12327,HLA-A,GO:0036037,"CD8-positive, alpha-beta T cell activation",2.0
12328,HLA-A,GO:0042270,protection from natural killer cell mediated cytotoxicity,2.0
12330,HLA-A,GO:0042590,antigen processing and presentation of exogenous peptide antigen via MHC class I,2.0
12331,HLA-A,GO:0042605,peptide antigen binding,2.0
12333,HLA-A,GO:0042608,T cell receptor binding,2.0
12334,HLA-A,GO:0042610,CD8 receptor binding,2.0
12335,HLA-A,GO:0042612,MHC class I protein complex,2.0
12336,HLA-A,GO:0042824,MHC class I peptide loading complex,2.0
12337,HLA-A,GO:0045087,innate immune response,2.0
12338,HLA-A,GO:0046977,TAP binding,2.0
12339,HLA-A,GO:0050830,defense response to Gram-positive bacterium,2.0
12340,HLA-A,GO:0050852,T cell receptor signaling pathway,2.0
12341,HLA-A,GO:0055038,recycling endosome membrane,2.0
12342,HLA-A,GO:0062061,TAP complex binding,2.0
12343,HLA-A,GO:0070062,extracellular exosome,2.0
12344,HLA-A,GO:0070971,endoplasmic reticulum exit site,2.0
12345,HLA-A,GO:2000566,"positive regulation of CD8-positive, alpha-beta T cell proliferation",2.0
12346,HLA-A,GO:2000568,positive regulation of memory T cell activation,2.0
12347,HLA-A,GO:2001187,"positive regulation of CD8-positive, alpha-beta T cell activation",2.0
12348,HLA-B,GO:0000139,Golgi membrane,2.0
12349,HLA-B,GO:0001916,positive regulation of T cell mediated cytotoxicity,2.0
12350,HLA-B,GO:0002250,adaptive immune response,2.0
12351,HLA-B,GO:0002486,"antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent",2.0
12352,HLA-B,GO:0002667,regulation of T cell anergy,2.0
12353,HLA-B,GO:0005102,signaling receptor binding,2.0
12354,HLA-B,GO:0005515,protein binding,2.0
12355,HLA-B,GO:0005783,endoplasmic reticulum,2.0
12356,HLA-B,GO:0005789,endoplasmic reticulum membrane,2.0
12357,HLA-B,GO:0005794,Golgi apparatus,2.0
12358,HLA-B,GO:0005886,plasma membrane,2.0
12360,HLA-B,GO:0006952,defense response,2.0
12361,HLA-B,GO:0006955,immune response,2.0
12363,HLA-B,GO:0009986,cell surface,2.0
12365,HLA-B,GO:0012507,ER to Golgi transport vesicle membrane,2.0
12366,HLA-B,GO:0016020,membrane,2.0
12368,HLA-B,GO:0016045,detection of bacterium,2.0
12369,HLA-B,GO:0030667,secretory granule membrane,2.0
12370,HLA-B,GO:0030670,phagocytic vesicle membrane,2.0
12371,HLA-B,GO:0031901,early endosome membrane,2.0
12372,HLA-B,GO:0032655,regulation of interleukin-12 production,2.0
12373,HLA-B,GO:0032675,regulation of interleukin-6 production,2.0
12374,HLA-B,GO:0042270,protection from natural killer cell mediated cytotoxicity,2.0
12375,HLA-B,GO:0042605,peptide antigen binding,2.0
12376,HLA-B,GO:0042612,MHC class I protein complex,2.0
12377,HLA-B,GO:0045087,innate immune response,2.0
12378,HLA-B,GO:0046977,TAP binding,2.0
12380,HLA-B,GO:0051087,chaperone binding,2.0
12381,HLA-B,GO:0055038,recycling endosome membrane,2.0
12382,HLA-B,GO:0070062,extracellular exosome,2.0
12383,HLA-B,GO:2001198,regulation of dendritic cell differentiation,2.0
12384,HLA-DPB1,GO:0000139,Golgi membrane,2.0
12385,HLA-DPB1,GO:0002250,adaptive immune response,2.0
12386,HLA-DPB1,GO:0002381,immunoglobulin production involved in immunoglobulin-mediated immune response,2.0
12387,HLA-DPB1,GO:0002503,peptide antigen assembly with MHC class II protein complex,2.0
12388,HLA-DPB1,GO:0005515,protein binding,2.0
12389,HLA-DPB1,GO:0005765,lysosomal membrane,2.0
12390,HLA-DPB1,GO:0005789,endoplasmic reticulum membrane,2.0
12391,HLA-DPB1,GO:0005886,plasma membrane,2.0
12392,HLA-DPB1,GO:0009986,cell surface,2.0
12393,HLA-DPB1,GO:0010008,endosome membrane,2.0
12394,HLA-DPB1,GO:0012507,ER to Golgi transport vesicle membrane,2.0
12395,HLA-DPB1,GO:0016020,membrane,2.0
12396,HLA-DPB1,GO:0019886,antigen processing and presentation of exogenous peptide antigen via MHC class II,2.0
12399,HLA-DPB1,GO:0023026,MHC class II protein complex binding,2.0
12400,HLA-DPB1,GO:0030658,transport vesicle membrane,2.0
12401,HLA-DPB1,GO:0030666,endocytic vesicle membrane,2.0
12402,HLA-DPB1,GO:0030669,clathrin-coated endocytic vesicle membrane,2.0
12403,HLA-DPB1,GO:0032588,trans-Golgi network membrane,2.0
12404,HLA-DPB1,GO:0032729,positive regulation of type II interferon production,2.0
12405,HLA-DPB1,GO:0042102,positive regulation of T cell proliferation,2.0
12406,HLA-DPB1,GO:0042605,peptide antigen binding,2.0
12407,HLA-DPB1,GO:0042613,MHC class II protein complex,2.0
12409,HLA-DPB1,GO:0050852,T cell receptor signaling pathway,2.0
12410,HLA-DPB1,GO:0050870,positive regulation of T cell activation,2.0
12412,HLA-DRB1,GO:0000139,Golgi membrane,2.0
12413,HLA-DRB1,GO:0001772,immunological synapse,2.0
12414,HLA-DRB1,GO:0001916,positive regulation of T cell mediated cytotoxicity,2.0
12415,HLA-DRB1,GO:0001934,positive regulation of protein phosphorylation,2.0
12416,HLA-DRB1,GO:0002381,immunoglobulin production involved in immunoglobulin-mediated immune response,2.0
12417,HLA-DRB1,GO:0002437,inflammatory response to antigenic stimulus,2.0
12418,HLA-DRB1,GO:0002469,myeloid dendritic cell antigen processing and presentation,2.0
12419,HLA-DRB1,GO:0002491,antigen processing and presentation of endogenous peptide antigen via MHC class II,2.0
12420,HLA-DRB1,GO:0002503,peptide antigen assembly with MHC class II protein complex,2.0
12422,HLA-DRB1,GO:0002842,positive regulation of T cell mediated immune response to tumor cell,2.0
12423,HLA-DRB1,GO:0002862,negative regulation of inflammatory response to antigenic stimulus,2.0
12424,HLA-DRB1,GO:0005200,structural constituent of cytoskeleton,2.0
12425,HLA-DRB1,GO:0005515,protein binding,2.0
12426,HLA-DRB1,GO:0005615,extracellular space,2.0
12427,HLA-DRB1,GO:0005765,lysosomal membrane,2.0
12430,HLA-DRB1,GO:0005789,endoplasmic reticulum membrane,2.0
12431,HLA-DRB1,GO:0005882,intermediate filament,2.0
12432,HLA-DRB1,GO:0005886,plasma membrane,2.0
12433,HLA-DRB1,GO:0006955,immune response,2.0
12437,HLA-DRB1,GO:0006959,humoral immune response,2.0
12438,HLA-DRB1,GO:0007010,cytoskeleton organization,2.0
12439,HLA-DRB1,GO:0007165,signal transduction,2.0
12441,HLA-DRB1,GO:0008544,epidermis development,2.0
12442,HLA-DRB1,GO:0009897,external side of plasma membrane,2.0
12443,HLA-DRB1,GO:0009986,cell surface,2.0
12444,HLA-DRB1,GO:0012507,ER to Golgi transport vesicle membrane,2.0
12445,HLA-DRB1,GO:0016020,membrane,2.0
12448,HLA-DRB1,GO:0016045,detection of bacterium,2.0
12449,HLA-DRB1,GO:0019886,antigen processing and presentation of exogenous peptide antigen via MHC class II,2.0
12451,HLA-DRB1,GO:0023026,MHC class II protein complex binding,2.0
12453,HLA-DRB1,GO:0030225,macrophage differentiation,2.0
12454,HLA-DRB1,GO:0030247,polysaccharide binding,2.0
12455,HLA-DRB1,GO:0030658,transport vesicle membrane,2.0
12456,HLA-DRB1,GO:0030666,endocytic vesicle membrane,2.0
12457,HLA-DRB1,GO:0030669,clathrin-coated endocytic vesicle membrane,2.0
12458,HLA-DRB1,GO:0031902,late endosome membrane,2.0
12460,HLA-DRB1,GO:0032395,MHC class II receptor activity,2.0
12463,HLA-DRB1,GO:0032588,trans-Golgi network membrane,2.0
12464,HLA-DRB1,GO:0032653,regulation of interleukin-10 production,2.0
12465,HLA-DRB1,GO:0032673,regulation of interleukin-4 production,2.0
12466,HLA-DRB1,GO:0032689,negative regulation of type II interferon production,2.0
12467,HLA-DRB1,GO:0032831,"positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation",2.0
12468,HLA-DRB1,GO:0033674,positive regulation of kinase activity,2.0
12469,HLA-DRB1,GO:0035774,positive regulation of insulin secretion involved in cellular response to glucose stimulus,2.0
12470,HLA-DRB1,GO:0042088,T-helper 1 type immune response,2.0
12471,HLA-DRB1,GO:0042130,negative regulation of T cell proliferation,2.0
12472,HLA-DRB1,GO:0042605,peptide antigen binding,2.0
12473,HLA-DRB1,GO:0042608,T cell receptor binding,2.0
12474,HLA-DRB1,GO:0042609,CD4 receptor binding,2.0
12475,HLA-DRB1,GO:0042613,MHC class II protein complex,2.0
12478,HLA-DRB1,GO:0043123,positive regulation of I-kappaB kinase/NF-kappaB signaling,2.0
12479,HLA-DRB1,GO:0043382,positive regulation of memory T cell differentiation,2.0
12480,HLA-DRB1,GO:0043410,positive regulation of MAPK cascade,2.0
12481,HLA-DRB1,GO:0045622,regulation of T-helper cell differentiation,2.0
12482,HLA-DRB1,GO:0045657,positive regulation of monocyte differentiation,2.0
12483,HLA-DRB1,GO:0045893,positive regulation of DNA-templated transcription,2.0
12484,HLA-DRB1,GO:0046598,positive regulation of viral entry into host cell,2.0
12485,HLA-DRB1,GO:0050852,T cell receptor signaling pathway,2.0
12486,HLA-DRB1,GO:0050870,positive regulation of T cell activation,2.0
12487,HLA-DRB1,GO:0051262,protein tetramerization,2.0
12488,HLA-DRB1,GO:0070062,extracellular exosome,2.0
12489,HLA-DRB1,GO:0070374,positive regulation of ERK1 and ERK2 cascade,2.0
12490,HLA-DRB1,GO:2000516,"positive regulation of CD4-positive, alpha-beta T cell activation",2.0
12491,HNRNPD,GO:0001889,liver development,2.0
12492,HNRNPD,GO:0003680,minor groove of adenine-thymine-rich DNA binding,2.0
12493,HNRNPD,GO:0003682,chromatin binding,2.0
12494,HNRNPD,GO:0003723,RNA binding,2.0
12498,HNRNPD,GO:0005515,protein binding,2.0
12499,HNRNPD,GO:0005634,nucleus,2.0
12500,HNRNPD,GO:0005654,nucleoplasm,2.0
12503,HNRNPD,GO:0005829,cytosol,2.0
12505,HNRNPD,GO:0006355,regulation of DNA-templated transcription,2.0
12506,HNRNPD,GO:0006396,RNA processing,2.0
12507,HNRNPD,GO:0006401,RNA catabolic process,2.0
12508,HNRNPD,GO:0010468,regulation of gene expression,2.0
12509,HNRNPD,GO:0014069,postsynaptic density,2.0
12510,HNRNPD,GO:0021549,cerebellum development,2.0
12511,HNRNPD,GO:0032204,regulation of telomere maintenance,2.0
12512,HNRNPD,GO:0035925,mRNA 3'-UTR AU-rich region binding,2.0
12513,HNRNPD,GO:0042162,telomeric DNA binding,2.0
12514,HNRNPD,GO:0042752,regulation of circadian rhythm,2.0
12515,HNRNPD,GO:0042826,histone deacetylase binding,2.0
12516,HNRNPD,GO:0045727,positive regulation of translation,2.0
12517,HNRNPD,GO:0045893,positive regulation of DNA-templated transcription,2.0
12518,HNRNPD,GO:0051592,response to calcium ion,2.0
12519,HNRNPD,GO:0051602,response to electrical stimulus,2.0
12520,HNRNPD,GO:0061158,3'-UTR-mediated mRNA destabilization,2.0
12521,HNRNPD,GO:0070934,CRD-mediated mRNA stabilization,2.0
12522,HNRNPD,GO:0071230,cellular response to amino acid stimulus,2.0
12523,HNRNPD,GO:0071392,cellular response to estradiol stimulus,2.0
12524,HNRNPD,GO:0071732,cellular response to nitric oxide,2.0
12525,HNRNPD,GO:0097167,circadian regulation of translation,2.0
12526,HNRNPD,GO:0098978,glutamatergic synapse,2.0
12527,HNRNPD,GO:0106002,mCRD-mediated mRNA stability complex,2.0
12528,HNRNPD,GO:1900152,"negative regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay",2.0
12529,HNRNPD,GO:1901355,response to rapamycin,2.0
12530,HNRNPD,GO:1904355,positive regulation of telomere capping,2.0
12531,HNRNPD,GO:1904383,response to sodium phosphate,2.0
12532,HNRNPD,GO:1904586,cellular response to putrescine,2.0
12533,HNRNPD,GO:1905663,positive regulation of telomerase RNA reverse transcriptase activity,2.0
12534,HNRNPD,GO:1990828,hepatocyte dedifferentiation,2.0
12535,HNRNPD,GO:1990904,ribonucleoprotein complex,2.0
12536,HNRNPD,GO:2000767,positive regulation of cytoplasmic translation,2.0
12537,HNRNPF,GO:0000398,"mRNA splicing, via spliceosome",2.0
12538,HNRNPF,GO:0003723,RNA binding,2.0
12540,HNRNPF,GO:0003727,single-stranded RNA binding,2.0
12541,HNRNPF,GO:0005515,protein binding,2.0
12542,HNRNPF,GO:0005634,nucleus,2.0
12543,HNRNPF,GO:0005654,nucleoplasm,2.0
12546,HNRNPF,GO:0005829,cytosol,2.0
12547,HNRNPF,GO:0005886,plasma membrane,2.0
12548,HNRNPF,GO:0006396,RNA processing,2.0
12549,HNRNPF,GO:0016020,membrane,2.0
12550,HNRNPF,GO:0017025,TBP-class protein binding,2.0
12551,HNRNPF,GO:0043484,regulation of RNA splicing,2.0
12554,HNRNPF,GO:0045202,synapse,2.0
12555,HNRNPF,GO:0071013,catalytic step 2 spliceosome,2.0
12556,HNRNPF,GO:1990904,ribonucleoprotein complex,2.0
12570,HNRNPK,GO:0000398,"mRNA splicing, via spliceosome",2.0
12571,HNRNPK,GO:0000785,chromatin,2.0
12572,HNRNPK,GO:0002102,podosome,2.0
12573,HNRNPK,GO:0003677,DNA binding,2.0
12574,HNRNPK,GO:0003723,RNA binding,2.0
12575,HNRNPK,GO:0003729,mRNA binding,2.0
12576,HNRNPK,GO:0005515,protein binding,2.0
12577,HNRNPK,GO:0005634,nucleus,2.0
12579,HNRNPK,GO:0005654,nucleoplasm,2.0
12581,HNRNPK,GO:0005737,cytoplasm,2.0
12583,HNRNPK,GO:0005925,focal adhesion,2.0
12584,HNRNPK,GO:0006357,regulation of transcription by RNA polymerase II,2.0
12585,HNRNPK,GO:0006396,RNA processing,2.0
12586,HNRNPK,GO:0007165,signal transduction,2.0
12587,HNRNPK,GO:0010468,regulation of gene expression,2.0
12588,HNRNPK,GO:0010494,cytoplasmic stress granule,2.0
12589,HNRNPK,GO:0010988,regulation of low-density lipoprotein particle clearance,2.0
12590,HNRNPK,GO:0016020,membrane,2.0
12591,HNRNPK,GO:0019904,protein domain specific binding,2.0
12592,HNRNPK,GO:0042802,identical protein binding,2.0
12593,HNRNPK,GO:0042995,cell projection,2.0
12594,HNRNPK,GO:0043066,negative regulation of apoptotic process,2.0
12595,HNRNPK,GO:0045296,cadherin binding,2.0
12596,HNRNPK,GO:0045892,negative regulation of DNA-templated transcription,2.0
12597,HNRNPK,GO:0045944,positive regulation of transcription by RNA polymerase II,2.0
12598,HNRNPK,GO:0048024,"regulation of mRNA splicing, via spliceosome",2.0
12599,HNRNPK,GO:0048025,"negative regulation of mRNA splicing, via spliceosome",2.0
12600,HNRNPK,GO:0048260,positive regulation of receptor-mediated endocytosis,2.0
12601,HNRNPK,GO:0070062,extracellular exosome,2.0
12602,HNRNPK,GO:0071013,catalytic step 2 spliceosome,2.0
12603,HNRNPK,GO:1902165,regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,2.0
12604,HNRNPK,GO:1905599,positive regulation of low-density lipoprotein receptor activity,2.0
12605,HNRNPK,GO:1990904,ribonucleoprotein complex,2.0
12606,HNRNPR,GO:0000398,"mRNA splicing, via spliceosome",2.0
12607,HNRNPR,GO:0003723,RNA binding,2.0
12610,HNRNPR,GO:0003729,mRNA binding,2.0
12611,HNRNPR,GO:0005515,protein binding,2.0
12612,HNRNPR,GO:0005634,nucleus,2.0
12613,HNRNPR,GO:0005654,nucleoplasm,2.0
12615,HNRNPR,GO:0005681,spliceosomal complex,2.0
12616,HNRNPR,GO:0005730,nucleolus,2.0
12617,HNRNPR,GO:0005783,endoplasmic reticulum,2.0
12618,HNRNPR,GO:0006397,mRNA processing,2.0
12619,HNRNPR,GO:0071013,catalytic step 2 spliceosome,2.0
12620,HNRNPR,GO:1990904,ribonucleoprotein complex,2.0
12748,HNRNPUL2,GO:0003723,RNA binding,2.0
12750,HNRNPUL2,GO:0005634,nucleus,2.0
12751,HNRNPUL2,GO:0005654,nucleoplasm,2.0
12753,HNRNPUL2,GO:0008150,biological_process,2.0
12754,HNRNPUL2,GO:0016020,membrane,2.0
12755,HNRNPUL2,GO:0045202,synapse,2.0
12756,HOMER1,GO:0003009,skeletal muscle contraction,2.0
12757,HOMER1,GO:0005515,protein binding,2.0
12758,HOMER1,GO:0005737,cytoplasm,2.0
12759,HOMER1,GO:0005829,cytosol,2.0
12760,HOMER1,GO:0005886,plasma membrane,2.0
12761,HOMER1,GO:0007206,phospholipase C-activating G protein-coupled glutamate receptor signaling pathway,2.0
12762,HOMER1,GO:0007216,G protein-coupled glutamate receptor signaling pathway,2.0
12763,HOMER1,GO:0007268,chemical synaptic transmission,2.0
12764,HOMER1,GO:0007623,circadian rhythm,2.0
12765,HOMER1,GO:0009967,positive regulation of signal transduction,2.0
12766,HOMER1,GO:0014069,postsynaptic density,2.0
12767,HOMER1,GO:0030018,Z disc,2.0
12768,HOMER1,GO:0030424,axon,2.0
12769,HOMER1,GO:0030425,dendrite,2.0
12770,HOMER1,GO:0031802,type 5 metabotropic glutamate receptor binding,2.0
12771,HOMER1,GO:0035094,response to nicotine,2.0
12772,HOMER1,GO:0035256,G protein-coupled glutamate receptor binding,2.0
12773,HOMER1,GO:0035418,protein localization to synapse,2.0
12774,HOMER1,GO:0035591,signaling adaptor activity,2.0
12775,HOMER1,GO:0043025,neuronal cell body,2.0
12776,HOMER1,GO:0043034,costamere,2.0
12777,HOMER1,GO:0043197,dendritic spine,2.0
12778,HOMER1,GO:0043198,dendritic shaft,2.0
12779,HOMER1,GO:0044309,neuron spine,2.0
12780,HOMER1,GO:0044325,transmembrane transporter binding,2.0
12781,HOMER1,GO:0044877,protein-containing complex binding,2.0
12782,HOMER1,GO:0045177,apical part of cell,2.0
12783,HOMER1,GO:0048148,behavioral response to cocaine,2.0
12784,HOMER1,GO:0048741,skeletal muscle fiber development,2.0
12785,HOMER1,GO:0051262,protein tetramerization,2.0
12786,HOMER1,GO:0051592,response to calcium ion,2.0
12787,HOMER1,GO:0051928,positive regulation of calcium ion transport,2.0
12788,HOMER1,GO:0051966,"regulation of synaptic transmission, glutamatergic",2.0
12789,HOMER1,GO:0060076,excitatory synapse,2.0
12790,HOMER1,GO:0090279,regulation of calcium ion import,2.0
12791,HOMER1,GO:0097110,scaffold protein binding,2.0
12792,HOMER1,GO:0098962,regulation of postsynaptic neurotransmitter receptor activity,2.0
12793,HOMER1,GO:0098978,glutamatergic synapse,2.0
12794,HOMER1,GO:0099173,postsynapse organization,2.0
12795,HOMER1,GO:0099186,structural constituent of postsynapse,2.0
12796,HOMER1,GO:0099524,postsynaptic cytosol,2.0
12797,HOMER1,GO:1902950,regulation of dendritic spine maintenance,2.0
12798,HOMER1,GO:2001256,regulation of store-operated calcium entry,2.0
12800,HOMER1,GO:2001257,regulation of cation channel activity,2.0
12904,HSD11B1,GO:0005496,steroid binding,2.0
12905,HSD11B1,GO:0005789,endoplasmic reticulum membrane,2.0
12908,HSD11B1,GO:0006706,steroid catabolic process,2.0
12909,HSD11B1,GO:0016020,membrane,2.0
12910,HSD11B1,GO:0016491,oxidoreductase activity,2.0
12911,HSD11B1,GO:0030324,lung development,2.0
12912,HSD11B1,GO:0042803,protein homodimerization activity,2.0
12913,HSD11B1,GO:0043231,intracellular membrane-bounded organelle,2.0
12914,HSD11B1,GO:0047022,7-beta-hydroxysteroid dehydrogenase (NADP+) activity,2.0
12915,HSD11B1,GO:0050661,NADP binding,2.0
12916,HSD11B1,GO:0070524,11-beta-hydroxysteroid dehydrogenase (NADP+) activity,2.0
12918,HSD11B1,GO:0102196,cortisol dehydrogenase activity,2.0
12919,HTR1B,GO:0002031,G protein-coupled receptor internalization,2.0
12920,HTR1B,GO:0004993,G protein-coupled serotonin receptor activity,2.0
12922,HTR1B,GO:0005515,protein binding,2.0
12923,HTR1B,GO:0005783,endoplasmic reticulum,2.0
12924,HTR1B,GO:0005886,plasma membrane,2.0
12928,HTR1B,GO:0007187,"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger",2.0
12929,HTR1B,GO:0007193,adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway,2.0
12930,HTR1B,GO:0007198,adenylate cyclase-inhibiting serotonin receptor signaling pathway,2.0
12932,HTR1B,GO:0007205,protein kinase C-activating G protein-coupled receptor signaling pathway,2.0
12933,HTR1B,GO:0007268,chemical synaptic transmission,2.0
12934,HTR1B,GO:0014053,negative regulation of gamma-aminobutyric acid secretion,2.0
12935,HTR1B,GO:0014059,regulation of dopamine secretion,2.0
12936,HTR1B,GO:0014063,negative regulation of serotonin secretion,2.0
12937,HTR1B,GO:0030425,dendrite,2.0
12938,HTR1B,GO:0030594,neurotransmitter receptor activity,2.0
12939,HTR1B,GO:0032229,"negative regulation of synaptic transmission, GABAergic",2.0
12940,HTR1B,GO:0042220,response to cocaine,2.0
12941,HTR1B,GO:0042310,vasoconstriction,2.0
12942,HTR1B,GO:0042734,presynaptic membrane,2.0
12943,HTR1B,GO:0042756,drinking behavior,2.0
12944,HTR1B,GO:0044305,calyx of Held,2.0
12945,HTR1B,GO:0045471,response to ethanol,2.0
12946,HTR1B,GO:0046849,bone remodeling,2.0
12947,HTR1B,GO:0050795,regulation of behavior,2.0
12948,HTR1B,GO:0051378,serotonin binding,2.0
12949,HTR1B,GO:0051385,response to mineralocorticoid,2.0
12950,HTR1B,GO:0051967,"negative regulation of synaptic transmission, glutamatergic",2.0
12951,HTR1B,GO:0071312,cellular response to alkaloid,2.0
12952,HTR1B,GO:0071466,cellular response to xenobiotic stimulus,2.0
12953,HTR1B,GO:0071502,cellular response to temperature stimulus,2.0
12954,HTR1B,GO:0098666,G protein-coupled serotonin receptor complex,2.0
12955,HTR1B,GO:0099154,serotonergic synapse,2.0
12956,HTR1B,GO:0099171,presynaptic modulation of chemical synaptic transmission,2.0
12957,HTR1B,GO:0099509,regulation of presynaptic cytosolic calcium ion concentration,2.0
12958,HTR1B,GO:0099626,voltage-gated calcium channel activity involved in regulation of presynaptic cytosolic calcium levels,2.0
12959,HTR1B,GO:1904707,positive regulation of vascular associated smooth muscle cell proliferation,2.0
12960,HTR1B,GO:2000300,regulation of synaptic vesicle exocytosis,2.0
12961,HTR3A,GO:0005231,excitatory extracellular ligand-gated ion channel activity,2.0
12962,HTR3A,GO:0005515,protein binding,2.0
12963,HTR3A,GO:0005886,plasma membrane,2.0
12965,HTR3A,GO:0007165,signal transduction,2.0
12966,HTR3A,GO:0007210,serotonin receptor signaling pathway,2.0
12967,HTR3A,GO:0007268,chemical synaptic transmission,2.0
12968,HTR3A,GO:0022850,serotonin-gated cation-selective channel activity,2.0
12970,HTR3A,GO:0030594,neurotransmitter receptor activity,2.0
12971,HTR3A,GO:0032154,cleavage furrow,2.0
12972,HTR3A,GO:0034220,ion transmembrane transport,2.0
12973,HTR3A,GO:0042391,regulation of membrane potential,2.0
12974,HTR3A,GO:0043005,neuron projection,2.0
12975,HTR3A,GO:0045202,synapse,2.0
12976,HTR3A,GO:0045211,postsynaptic membrane,2.0
12977,HTR3A,GO:0050877,nervous system process,2.0
12978,HTR3A,GO:0051378,serotonin binding,2.0
12979,HTR3A,GO:0060079,excitatory postsynaptic potential,2.0
12980,HTR3A,GO:0098662,inorganic cation transmembrane transport,2.0
12981,HTR3A,GO:1904315,transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential,2.0
12982,HTR3A,GO:1904602,serotonin-activated cation-selective channel complex,2.0
12984,HTR3C,GO:0005231,excitatory extracellular ligand-gated ion channel activity,2.0
12985,HTR3C,GO:0005515,protein binding,2.0
12986,HTR3C,GO:0005886,plasma membrane,2.0
12988,HTR3C,GO:0007165,signal transduction,2.0
12989,HTR3C,GO:0007210,serotonin receptor signaling pathway,2.0
12990,HTR3C,GO:0007268,chemical synaptic transmission,2.0
12991,HTR3C,GO:0022850,serotonin-gated cation-selective channel activity,2.0
12993,HTR3C,GO:0030594,neurotransmitter receptor activity,2.0
12994,HTR3C,GO:0034220,ion transmembrane transport,2.0
12995,HTR3C,GO:0042391,regulation of membrane potential,2.0
12996,HTR3C,GO:0043005,neuron projection,2.0
12997,HTR3C,GO:0045202,synapse,2.0
12998,HTR3C,GO:0050877,nervous system process,2.0
12999,HTR3C,GO:0060079,excitatory postsynaptic potential,2.0
13000,HTR3C,GO:0098662,inorganic cation transmembrane transport,2.0
13001,HTR3C,GO:0098794,postsynapse,2.0
13002,HTR3C,GO:1904315,transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential,2.0
13003,HTR3C,GO:1904602,serotonin-activated cation-selective channel complex,2.0
13041,HYDIN,GO:0002064,epithelial cell development,2.0
13042,HYDIN,GO:0003341,cilium movement,2.0
13043,HYDIN,GO:0005930,axoneme,2.0
13044,HYDIN,GO:0021591,ventricular system development,2.0
13045,HYDIN,GO:0060438,trachea development,2.0
13046,HYDIN,GO:1904158,axonemal central apparatus assembly,2.0
13047,HYDIN,GO:1990716,axonemal central apparatus,2.0
13048,HYDIN,GO:1990718,axonemal central pair projection,2.0
13049,ICA1,GO:0000139,Golgi membrane,2.0
13050,ICA1,GO:0005515,protein binding,2.0
13051,ICA1,GO:0005737,cytoplasm,2.0
13052,ICA1,GO:0005794,Golgi apparatus,2.0
13053,ICA1,GO:0005829,cytosol,2.0
13055,ICA1,GO:0006836,neurotransmitter transport,2.0
13056,ICA1,GO:0019904,protein domain specific binding,2.0
13057,ICA1,GO:0030667,secretory granule membrane,2.0
13058,ICA1,GO:0030672,synaptic vesicle membrane,2.0
13059,ICA1,GO:0043231,intracellular membrane-bounded organelle,2.0
13060,ICA1,GO:0050796,regulation of insulin secretion,2.0
13061,ICA1,GO:0051049,regulation of transport,2.0
13062,ICA1,GO:0140090,membrane curvature sensor activity,2.0
13182,IL1R2,GO:0004908,interleukin-1 receptor activity,2.0
13183,IL1R2,GO:0004910,"interleukin-1, type II, blocking receptor activity",2.0
13184,IL1R2,GO:0005515,protein binding,2.0
13185,IL1R2,GO:0005576,extracellular region,2.0
13186,IL1R2,GO:0005737,cytoplasm,2.0
13187,IL1R2,GO:0005886,plasma membrane,2.0
13188,IL1R2,GO:0006955,immune response,2.0
13189,IL1R2,GO:0010955,negative regulation of protein processing,2.0
13190,IL1R2,GO:0016485,protein processing,2.0
13191,IL1R2,GO:0019221,cytokine-mediated signaling pathway,2.0
13192,IL1R2,GO:0019966,interleukin-1 binding,2.0
13193,IL1R2,GO:0032690,negative regulation of interleukin-1 alpha production,2.0
13194,IL1R2,GO:1900016,negative regulation of cytokine production involved in inflammatory response,2.0
13195,IL1R2,GO:2000660,negative regulation of interleukin-1-mediated signaling pathway,2.0
13196,IL1RAPL1,GO:0005102,signaling receptor binding,2.0
13197,IL1RAPL1,GO:0005515,protein binding,2.0
13198,IL1RAPL1,GO:0005737,cytoplasm,2.0
13199,IL1RAPL1,GO:0005886,plasma membrane,2.0
13201,IL1RAPL1,GO:0007157,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules,2.0
13202,IL1RAPL1,GO:0007165,signal transduction,2.0
13203,IL1RAPL1,GO:0009986,cell surface,2.0
13204,IL1RAPL1,GO:0010975,regulation of neuron projection development,2.0
13205,IL1RAPL1,GO:0019966,interleukin-1 binding,2.0
13206,IL1RAPL1,GO:0030182,neuron differentiation,2.0
13207,IL1RAPL1,GO:0030424,axon,2.0
13208,IL1RAPL1,GO:0030425,dendrite,2.0
13209,IL1RAPL1,GO:0045211,postsynaptic membrane,2.0
13210,IL1RAPL1,GO:0045920,negative regulation of exocytosis,2.0
13212,IL1RAPL1,GO:0050135,NAD(P)+ nucleosidase activity,2.0
13213,IL1RAPL1,GO:0050775,positive regulation of dendrite morphogenesis,2.0
13214,IL1RAPL1,GO:0051965,positive regulation of synapse assembly,2.0
13215,IL1RAPL1,GO:0061809,"NAD+ nucleotidase, cyclic ADP-ribose generating",2.0
13216,IL1RAPL1,GO:0097105,presynaptic membrane assembly,2.0
13217,IL1RAPL1,GO:0098978,glutamatergic synapse,2.0
13219,IL1RAPL1,GO:0099175,regulation of postsynapse organization,2.0
13221,IL1RAPL1,GO:0099545,trans-synaptic signaling by trans-synaptic complex,2.0
13223,IL1RAPL1,GO:1905606,regulation of presynapse assembly,2.0
13225,IL1RAPL2,GO:0004908,interleukin-1 receptor activity,2.0
13226,IL1RAPL2,GO:0004910,"interleukin-1, type II, blocking receptor activity",2.0
13227,IL1RAPL2,GO:0005886,plasma membrane,2.0
13228,IL1RAPL2,GO:0007417,central nervous system development,2.0
13229,IL1RAPL2,GO:0019221,cytokine-mediated signaling pathway,2.0
13230,IL1RAPL2,GO:0050135,NAD(P)+ nucleosidase activity,2.0
13231,IL1RAPL2,GO:0061809,"NAD+ nucleotidase, cyclic ADP-ribose generating",2.0
13232,IL1RAPL2,GO:0098978,glutamatergic synapse,2.0
13234,IL1RAPL2,GO:1905606,regulation of presynapse assembly,2.0
13236,ILF2,GO:0003677,DNA binding,2.0
13238,ILF2,GO:0003723,RNA binding,2.0
13239,ILF2,GO:0003725,double-stranded RNA binding,2.0
13241,ILF2,GO:0005515,protein binding,2.0
13242,ILF2,GO:0005576,extracellular region,2.0
13244,ILF2,GO:0005634,nucleus,2.0
13245,ILF2,GO:0005654,nucleoplasm,2.0
13246,ILF2,GO:0005730,nucleolus,2.0
13247,ILF2,GO:0016020,membrane,2.0
13248,ILF2,GO:0035580,specific granule lumen,2.0
13249,ILF2,GO:0045893,positive regulation of DNA-templated transcription,2.0
13251,ILF2,GO:1904724,tertiary granule lumen,2.0
13252,ILF2,GO:1904813,ficolin-1-rich granule lumen,2.0
13253,ILF2,GO:1990904,ribonucleoprotein complex,2.0
13254,IMMP2L,GO:0001541,ovarian follicle development,2.0
13255,IMMP2L,GO:0004175,endopeptidase activity,2.0
13256,IMMP2L,GO:0004252,serine-type endopeptidase activity,2.0
13257,IMMP2L,GO:0005743,mitochondrial inner membrane,2.0
13258,IMMP2L,GO:0006465,signal peptide processing,2.0
13259,IMMP2L,GO:0006627,protein processing involved in protein targeting to mitochondrion,2.0
13261,IMMP2L,GO:0006801,superoxide metabolic process,2.0
13262,IMMP2L,GO:0006974,cellular response to DNA damage stimulus,2.0
13263,IMMP2L,GO:0007283,spermatogenesis,2.0
13264,IMMP2L,GO:0007420,brain development,2.0
13265,IMMP2L,GO:0008015,blood circulation,2.0
13266,IMMP2L,GO:0008233,peptidase activity,2.0
13267,IMMP2L,GO:0022904,respiratory electron transport chain,2.0
13268,IMMP2L,GO:0030728,ovulation,2.0
13269,IMMP2L,GO:0033108,mitochondrial respiratory chain complex assembly,2.0
13270,IMMP2L,GO:0042720,mitochondrial inner membrane peptidase complex,2.0
13273,IMMP2L,GO:0061300,cerebellum vasculature development,2.0
13274,INPP1,GO:0004441,"inositol-1,4-bisphosphate 1-phosphatase activity",2.0
13276,INPP1,GO:0005515,protein binding,2.0
13277,INPP1,GO:0005829,cytosol,2.0
13278,INPP1,GO:0006796,phosphate-containing compound metabolic process,2.0
13279,INPP1,GO:0007165,signal transduction,2.0
13280,INPP1,GO:0046854,phosphatidylinositol phosphate biosynthetic process,2.0
13281,INPP1,GO:0046855,inositol phosphate dephosphorylation,2.0
13282,INPP1,GO:0046872,metal ion binding,2.0
13283,INPP1,GO:0052829,"inositol-1,3,4-trisphosphate 1-phosphatase activity",2.0
13297,INTS6,GO:0004888,transmembrane signaling receptor activity,2.0
13298,INTS6,GO:0005515,protein binding,2.0
13299,INTS6,GO:0005634,nucleus,2.0
13301,INTS6,GO:0005654,nucleoplasm,2.0
13303,INTS6,GO:0015629,actin cytoskeleton,2.0
13304,INTS6,GO:0016180,snRNA processing,2.0
13306,INTS6,GO:0032039,integrator complex,2.0
13309,INTS6,GO:0034243,regulation of transcription elongation by RNA polymerase II,2.0
13310,INTS6,GO:0034472,snRNA 3'-end processing,2.0
13311,IQGAP3,GO:0000082,G1/S transition of mitotic cell cycle,2.0
13312,IQGAP3,GO:0001934,positive regulation of protein phosphorylation,2.0
13313,IQGAP3,GO:0005096,GTPase activator activity,2.0
13314,IQGAP3,GO:0005515,protein binding,2.0
13315,IQGAP3,GO:0005516,calmodulin binding,2.0
13317,IQGAP3,GO:0005737,cytoplasm,2.0
13318,IQGAP3,GO:0005829,cytosol,2.0
13319,IQGAP3,GO:0005911,cell-cell junction,2.0
13320,IQGAP3,GO:0006468,protein phosphorylation,2.0
13321,IQGAP3,GO:0007265,Ras protein signal transduction,2.0
13322,IQGAP3,GO:0008361,regulation of cell size,2.0
13323,IQGAP3,GO:0010467,gene expression,2.0
13324,IQGAP3,GO:0010628,positive regulation of gene expression,2.0
13325,IQGAP3,GO:0010629,negative regulation of gene expression,2.0
13326,IQGAP3,GO:0016328,lateral plasma membrane,2.0
13327,IQGAP3,GO:0031267,small GTPase binding,2.0
13328,IQGAP3,GO:0032956,regulation of actin cytoskeleton organization,2.0
13329,IQGAP3,GO:0033598,mammary gland epithelial cell proliferation,2.0
13330,IQGAP3,GO:0033601,positive regulation of mammary gland epithelial cell proliferation,2.0
13331,IQGAP3,GO:0043087,regulation of GTPase activity,2.0
13332,IQGAP3,GO:0043410,positive regulation of MAPK cascade,2.0
13333,IQGAP3,GO:0051015,actin filament binding,2.0
13334,IQGAP3,GO:0070371,ERK1 and ERK2 cascade,2.0
13335,IQGAP3,GO:0070856,myosin VI light chain binding,2.0
13336,IQGAP3,GO:0071310,cellular response to organic substance,2.0
13401,ITGB3,GO:0001618,virus receptor activity,2.0
13402,ITGB3,GO:0001934,positive regulation of protein phosphorylation,2.0
13403,ITGB3,GO:0001938,positive regulation of endothelial cell proliferation,2.0
13404,ITGB3,GO:0001954,positive regulation of cell-matrix adhesion,2.0
13405,ITGB3,GO:0001968,fibronectin binding,2.0
13407,ITGB3,GO:0002020,protease binding,2.0
13408,ITGB3,GO:0003756,protein disulfide isomerase activity,2.0
13409,ITGB3,GO:0005080,protein kinase C binding,2.0
13410,ITGB3,GO:0005161,platelet-derived growth factor receptor binding,2.0
13411,ITGB3,GO:0005178,integrin binding,2.0
13413,ITGB3,GO:0005515,protein binding,2.0
13414,ITGB3,GO:0005634,nucleus,2.0
13415,ITGB3,GO:0005654,nucleoplasm,2.0
13416,ITGB3,GO:0005886,plasma membrane,2.0
13418,ITGB3,GO:0005911,cell-cell junction,2.0
13419,ITGB3,GO:0005925,focal adhesion,2.0
13422,ITGB3,GO:0007044,cell-substrate junction assembly,2.0
13423,ITGB3,GO:0007155,cell adhesion,2.0
13424,ITGB3,GO:0007160,cell-matrix adhesion,2.0
13426,ITGB3,GO:0007229,integrin-mediated signaling pathway,2.0
13429,ITGB3,GO:0007566,embryo implantation,2.0
13430,ITGB3,GO:0007596,blood coagulation,2.0
13431,ITGB3,GO:0008305,integrin complex,2.0
13433,ITGB3,GO:0009314,response to radiation,2.0
13434,ITGB3,GO:0009897,external side of plasma membrane,2.0
13435,ITGB3,GO:0009986,cell surface,2.0
13438,ITGB3,GO:0010595,positive regulation of endothelial cell migration,2.0
13439,ITGB3,GO:0010628,positive regulation of gene expression,2.0
13440,ITGB3,GO:0010745,negative regulation of macrophage derived foam cell differentiation,2.0
13441,ITGB3,GO:0010763,positive regulation of fibroblast migration,2.0
13442,ITGB3,GO:0010888,negative regulation of lipid storage,2.0
13443,ITGB3,GO:0014823,response to activity,2.0
13444,ITGB3,GO:0014909,smooth muscle cell migration,2.0
13445,ITGB3,GO:0014911,positive regulation of smooth muscle cell migration,2.0
13446,ITGB3,GO:0015026,coreceptor activity,2.0
13447,ITGB3,GO:0016324,apical plasma membrane,2.0
13448,ITGB3,GO:0016477,cell migration,2.0
13449,ITGB3,GO:0017134,fibroblast growth factor binding,2.0
13450,ITGB3,GO:0019899,enzyme binding,2.0
13451,ITGB3,GO:0019960,C-X3-C chemokine binding,2.0
13452,ITGB3,GO:0030168,platelet activation,2.0
13453,ITGB3,GO:0030949,positive regulation of vascular endothelial growth factor receptor signaling pathway,2.0
13454,ITGB3,GO:0031092,platelet alpha granule membrane,2.0
13455,ITGB3,GO:0031258,lamellipodium membrane,2.0
13456,ITGB3,GO:0031527,filopodium membrane,2.0
13457,ITGB3,GO:0031528,microvillus membrane,2.0
13458,ITGB3,GO:0031589,cell-substrate adhesion,2.0
13459,ITGB3,GO:0031994,insulin-like growth factor I binding,2.0
13460,ITGB3,GO:0032147,activation of protein kinase activity,2.0
13461,ITGB3,GO:0032369,negative regulation of lipid transport,2.0
13462,ITGB3,GO:0032587,ruffle membrane,2.0
13463,ITGB3,GO:0032880,regulation of protein localization,2.0
13464,ITGB3,GO:0032956,regulation of actin cytoskeleton organization,2.0
13465,ITGB3,GO:0032991,protein-containing complex,2.0
13466,ITGB3,GO:0033627,cell adhesion mediated by integrin,2.0
13468,ITGB3,GO:0033630,positive regulation of cell adhesion mediated by integrin,2.0
13469,ITGB3,GO:0033690,positive regulation of osteoblast proliferation,2.0
13470,ITGB3,GO:0034113,heterotypic cell-cell adhesion,2.0
13471,ITGB3,GO:0034446,substrate adhesion-dependent cell spreading,2.0
13472,ITGB3,GO:0034683,integrin alphav-beta3 complex,2.0
13473,ITGB3,GO:0035295,tube development,2.0
13474,ITGB3,GO:0035866,alphav-beta3 integrin-PKCalpha complex,2.0
13475,ITGB3,GO:0035867,alphav-beta3 integrin-IGF-1-IGF1R complex,2.0
13476,ITGB3,GO:0035868,alphav-beta3 integrin-HMGB1 complex,2.0
13477,ITGB3,GO:0036120,cellular response to platelet-derived growth factor stimulus,2.0
13478,ITGB3,GO:0038027,apolipoprotein A-I-mediated signaling pathway,2.0
13479,ITGB3,GO:0038132,neuregulin binding,2.0
13480,ITGB3,GO:0042060,wound healing,2.0
13481,ITGB3,GO:0042470,melanosome,2.0
13482,ITGB3,GO:0042802,identical protein binding,2.0
13483,ITGB3,GO:0043184,vascular endothelial growth factor receptor 2 binding,2.0
13485,ITGB3,GO:0043235,receptor complex,2.0
13486,ITGB3,GO:0043277,apoptotic cell clearance,2.0
13487,ITGB3,GO:0045124,regulation of bone resorption,2.0
13488,ITGB3,GO:0045202,synapse,2.0
13489,ITGB3,GO:0045211,postsynaptic membrane,2.0
13490,ITGB3,GO:0045766,positive regulation of angiogenesis,2.0
13491,ITGB3,GO:0045780,positive regulation of bone resorption,2.0
13492,ITGB3,GO:0046718,viral entry into host cell,2.0
13493,ITGB3,GO:0048008,platelet-derived growth factor receptor signaling pathway,2.0
13494,ITGB3,GO:0048146,positive regulation of fibroblast proliferation,2.0
13495,ITGB3,GO:0048333,mesodermal cell differentiation,2.0
13496,ITGB3,GO:0048661,positive regulation of smooth muscle cell proliferation,2.0
13497,ITGB3,GO:0050731,positive regulation of peptidyl-tyrosine phosphorylation,2.0
13498,ITGB3,GO:0050748,negative regulation of lipoprotein metabolic process,2.0
13499,ITGB3,GO:0050839,cell adhesion molecule binding,2.0
13500,ITGB3,GO:0050840,extracellular matrix binding,2.0
13501,ITGB3,GO:0050919,negative chemotaxis,2.0
13502,ITGB3,GO:0051279,regulation of release of sequestered calcium ion into cytosol,2.0
13503,ITGB3,GO:0051611,regulation of serotonin uptake,2.0
13504,ITGB3,GO:0060055,angiogenesis involved in wound healing,2.0
13505,ITGB3,GO:0060548,negative regulation of cell death,2.0
13506,ITGB3,GO:0061097,regulation of protein tyrosine kinase activity,2.0
13507,ITGB3,GO:0070051,fibrinogen binding,2.0
13509,ITGB3,GO:0070062,extracellular exosome,2.0
13510,ITGB3,GO:0070374,positive regulation of ERK1 and ERK2 cascade,2.0
13511,ITGB3,GO:0070527,platelet aggregation,2.0
13512,ITGB3,GO:0071062,alphav-beta3 integrin-vitronectin complex,2.0
13513,ITGB3,GO:0071133,alpha9-beta1 integrin-ADAM8 complex,2.0
13514,ITGB3,GO:0071260,cellular response to mechanical stimulus,2.0
13515,ITGB3,GO:0071466,cellular response to xenobiotic stimulus,2.0
13516,ITGB3,GO:0072126,positive regulation of glomerular mesangial cell proliferation,2.0
13517,ITGB3,GO:0098690,glycinergic synapse,2.0
13518,ITGB3,GO:0098880,maintenance of postsynaptic specialization structure,2.0
13519,ITGB3,GO:0098978,glutamatergic synapse,2.0
13522,ITGB3,GO:0099149,regulation of postsynaptic neurotransmitter receptor internalization,2.0
13525,ITGB3,GO:0150054,regulation of postsynaptic neurotransmitter receptor diffusion trapping,2.0
13526,ITGB3,GO:1900026,positive regulation of substrate adhesion-dependent cell spreading,2.0
13527,ITGB3,GO:1900731,positive regulation of adenylate cyclase-inhibiting opioid receptor signaling pathway,2.0
13528,ITGB3,GO:1901163,regulation of trophoblast cell migration,2.0
13529,ITGB3,GO:1903053,regulation of extracellular matrix organization,2.0
13530,ITGB3,GO:1905598,negative regulation of low-density lipoprotein receptor activity,2.0
13531,ITGB3,GO:1990314,cellular response to insulin-like growth factor stimulus,2.0
13532,ITGB3,GO:2000406,positive regulation of T cell migration,2.0
13533,ITPR1,GO:0000902,cell morphogenesis,2.0
13534,ITPR1,GO:0001666,response to hypoxia,2.0
13535,ITPR1,GO:0005220,"inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity",2.0
13538,ITPR1,GO:0005509,calcium ion binding,2.0
13539,ITPR1,GO:0005515,protein binding,2.0
13540,ITPR1,GO:0005637,nuclear inner membrane,2.0
13541,ITPR1,GO:0005730,nucleolus,2.0
13542,ITPR1,GO:0005783,endoplasmic reticulum,2.0
13544,ITPR1,GO:0005789,endoplasmic reticulum membrane,2.0
13546,ITPR1,GO:0005886,plasma membrane,2.0
13547,ITPR1,GO:0005955,calcineurin complex,2.0
13548,ITPR1,GO:0006816,calcium ion transport,2.0
13549,ITPR1,GO:0007165,signal transduction,2.0
13550,ITPR1,GO:0009791,post-embryonic development,2.0
13551,ITPR1,GO:0010506,regulation of autophagy,2.0
13552,ITPR1,GO:0014069,postsynaptic density,2.0
13553,ITPR1,GO:0015085,calcium ion transmembrane transporter activity,2.0
13554,ITPR1,GO:0015278,calcium-release channel activity,2.0
13555,ITPR1,GO:0016020,membrane,2.0
13556,ITPR1,GO:0016529,sarcoplasmic reticulum,2.0
13557,ITPR1,GO:0019855,calcium channel inhibitor activity,2.0
13558,ITPR1,GO:0019904,protein domain specific binding,2.0
13559,ITPR1,GO:0030658,transport vesicle membrane,2.0
13560,ITPR1,GO:0030659,cytoplasmic vesicle membrane,2.0
13561,ITPR1,GO:0030667,secretory granule membrane,2.0
13562,ITPR1,GO:0031088,platelet dense granule membrane,2.0
13563,ITPR1,GO:0031094,platelet dense tubular network,2.0
13564,ITPR1,GO:0031095,platelet dense tubular network membrane,2.0
13565,ITPR1,GO:0032024,positive regulation of insulin secretion,2.0
13566,ITPR1,GO:0032469,endoplasmic reticulum calcium ion homeostasis,2.0
13567,ITPR1,GO:0035091,phosphatidylinositol binding,2.0
13569,ITPR1,GO:0042045,epithelial fluid transport,2.0
13570,ITPR1,GO:0048016,inositol phosphate-mediated signaling,2.0
13571,ITPR1,GO:0048471,perinuclear region of cytoplasm,2.0
13572,ITPR1,GO:0050849,negative regulation of calcium-mediated signaling,2.0
13573,ITPR1,GO:0050882,voluntary musculoskeletal movement,2.0
13574,ITPR1,GO:0051209,release of sequestered calcium ion into cytosol,2.0
13576,ITPR1,GO:0070059,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress,2.0
13577,ITPR1,GO:0070679,"inositol 1,4,5 trisphosphate binding",2.0
13578,ITPR1,GO:0098685,Schaffer collateral - CA1 synapse,2.0
13579,ITPR1,GO:0098695,"inositol 1,4,5-trisphosphate receptor activity involved in regulation of postsynaptic cytosolic calcium levels",2.0
13580,ITPR1,GO:0099566,regulation of postsynaptic cytosolic calcium ion concentration,2.0
13581,ITSN1,GO:0005085,guanyl-nucleotide exchange factor activity,2.0
13583,ITSN1,GO:0005509,calcium ion binding,2.0
13584,ITSN1,GO:0005515,protein binding,2.0
13585,ITSN1,GO:0005635,nuclear envelope,2.0
13586,ITSN1,GO:0005737,cytoplasm,2.0
13587,ITSN1,GO:0005829,cytosol,2.0
13588,ITSN1,GO:0005886,plasma membrane,2.0
13590,ITSN1,GO:0005905,clathrin-coated pit,2.0
13593,ITSN1,GO:0006887,exocytosis,2.0
13594,ITSN1,GO:0006897,endocytosis,2.0
13595,ITSN1,GO:0008104,protein localization,2.0
13596,ITSN1,GO:0015031,protein transport,2.0
13597,ITSN1,GO:0016197,endosomal transport,2.0
13598,ITSN1,GO:0030027,lamellipodium,2.0
13599,ITSN1,GO:0035556,intracellular signal transduction,2.0
13600,ITSN1,GO:0042734,presynaptic membrane,2.0
13601,ITSN1,GO:0043005,neuron projection,2.0
13602,ITSN1,GO:0050790,regulation of catalytic activity,2.0
13603,ITSN1,GO:0051056,regulation of small GTPase mediated signal transduction,2.0
13604,ITSN1,GO:0055037,recycling endosome,2.0
13605,ITSN1,GO:0060090,molecular adaptor activity,2.0
13607,ITSN1,GO:0070064,proline-rich region binding,2.0
13608,ITSN1,GO:0097708,intracellular vesicle,2.0
13609,ITSN1,GO:0098793,presynapse,2.0
13610,ITSN1,GO:0150007,clathrin-dependent synaptic vesicle endocytosis,2.0
13611,JARID2,GO:0000122,negative regulation of transcription by RNA polymerase II,2.0
13612,JARID2,GO:0001889,liver development,2.0
13613,JARID2,GO:0003677,DNA binding,2.0
13614,JARID2,GO:0003682,chromatin binding,2.0
13615,JARID2,GO:0005634,nucleus,2.0
13617,JARID2,GO:0005654,nucleoplasm,2.0
13619,JARID2,GO:0005739,mitochondrion,2.0
13620,JARID2,GO:0006338,chromatin remodeling,2.0
13621,JARID2,GO:0007417,central nervous system development,2.0
13622,JARID2,GO:0009048,dosage compensation by inactivation of X chromosome,2.0
13623,JARID2,GO:0010614,negative regulation of cardiac muscle hypertrophy,2.0
13624,JARID2,GO:0016570,histone modification,2.0
13625,JARID2,GO:0032452,histone demethylase activity,2.0
13627,JARID2,GO:0034647,histone H3K4me/H3K4me2/H3K4me3 demethylase activity,2.0
13628,JARID2,GO:0035097,histone methyltransferase complex,2.0
13629,JARID2,GO:0035098,ESC/E(Z) complex,2.0
13630,JARID2,GO:0043130,ubiquitin binding,2.0
13631,JARID2,GO:0046976,histone H3K27 methyltransferase activity,2.0
13632,JARID2,GO:0048536,spleen development,2.0
13633,JARID2,GO:0048538,thymus development,2.0
13634,JARID2,GO:0048863,stem cell differentiation,2.0
13635,JARID2,GO:0060038,cardiac muscle cell proliferation,2.0
13636,JARID2,GO:0060044,negative regulation of cardiac muscle cell proliferation,2.0
13637,JARID2,GO:0061649,ubiquitin modification-dependent histone binding,2.0
13638,JARID2,GO:0140718,facultative heterochromatin formation,2.0
13639,JARID2,GO:1902682,protein localization to pericentric heterochromatin,2.0
13640,JARID2,GO:1990830,cellular response to leukemia inhibitory factor,2.0
13641,HLA-G,GO:0000139,Golgi membrane,2.0
13642,HLA-G,GO:0001915,negative regulation of T cell mediated cytotoxicity,2.0
13643,HLA-G,GO:0001916,positive regulation of T cell mediated cytotoxicity,2.0
13644,HLA-G,GO:0002451,peripheral B cell tolerance induction,2.0
13645,HLA-G,GO:0002474,antigen processing and presentation of peptide antigen via MHC class I,2.0
13646,HLA-G,GO:0002476,antigen processing and presentation of endogenous peptide antigen via MHC class Ib,2.0
13648,HLA-G,GO:0002486,"antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent",2.0
13649,HLA-G,GO:0002645,positive regulation of tolerance induction,2.0
13650,HLA-G,GO:0002666,positive regulation of T cell tolerance induction,2.0
13651,HLA-G,GO:0002729,positive regulation of natural killer cell cytokine production,2.0
13652,HLA-G,GO:0002767,immune response-inhibiting cell surface receptor signaling pathway,2.0
13653,HLA-G,GO:0005102,signaling receptor binding,2.0
13655,HLA-G,GO:0005515,protein binding,2.0
13656,HLA-G,GO:0005615,extracellular space,2.0
13657,HLA-G,GO:0005769,early endosome,2.0
13658,HLA-G,GO:0005789,endoplasmic reticulum membrane,2.0
13659,HLA-G,GO:0005886,plasma membrane,2.0
13661,HLA-G,GO:0006955,immune response,2.0
13662,HLA-G,GO:0006968,cellular defense response,2.0
13663,HLA-G,GO:0009897,external side of plasma membrane,2.0
13664,HLA-G,GO:0012507,ER to Golgi transport vesicle membrane,2.0
13665,HLA-G,GO:0016020,membrane,2.0
13666,HLA-G,GO:0016525,negative regulation of angiogenesis,2.0
13667,HLA-G,GO:0030670,phagocytic vesicle membrane,2.0
13668,HLA-G,GO:0031527,filopodium membrane,2.0
13669,HLA-G,GO:0031901,early endosome membrane,2.0
13670,HLA-G,GO:0032735,positive regulation of interleukin-12 production,2.0
13671,HLA-G,GO:0033106,cis-Golgi network membrane,2.0
13672,HLA-G,GO:0042130,negative regulation of T cell proliferation,2.0
13673,HLA-G,GO:0042270,protection from natural killer cell mediated cytotoxicity,2.0
13674,HLA-G,GO:0042605,peptide antigen binding,2.0
13676,HLA-G,GO:0042610,CD8 receptor binding,2.0
13677,HLA-G,GO:0042612,MHC class I protein complex,2.0
13678,HLA-G,GO:0042802,identical protein binding,2.0
13679,HLA-G,GO:0042803,protein homodimerization activity,2.0
13680,HLA-G,GO:0045591,positive regulation of regulatory T cell differentiation,2.0
13681,HLA-G,GO:0045953,negative regulation of natural killer cell mediated cytotoxicity,2.0
13683,HLA-G,GO:0050777,negative regulation of immune response,2.0
13684,HLA-G,GO:0051898,negative regulation of protein kinase B signaling,2.0
13685,HLA-G,GO:0055038,recycling endosome membrane,2.0
13686,HLA-G,GO:0060907,positive regulation of macrophage cytokine production,2.0
13687,HLA-G,GO:0070207,protein homotrimerization,2.0
13688,HLA-G,GO:0070317,negative regulation of G0 to G1 transition,2.0
13689,HLA-G,GO:2000353,positive regulation of endothelial cell apoptotic process,2.0
13690,HLA-G,GO:2000774,positive regulation of cellular senescence,2.0
13691,HLA-G,GO:2001199,negative regulation of dendritic cell differentiation,2.0
13692,HMGN1,GO:0000785,chromatin,2.0
13693,HMGN1,GO:0003677,DNA binding,2.0
13694,HMGN1,GO:0003682,chromatin binding,2.0
13695,HMGN1,GO:0005515,protein binding,2.0
13696,HMGN1,GO:0005634,nucleus,2.0
13698,HMGN1,GO:0005654,nucleoplasm,2.0
13700,HMGN1,GO:0005737,cytoplasm,2.0
13701,HMGN1,GO:0006325,chromatin organization,2.0
13702,HMGN1,GO:0031492,nucleosomal DNA binding,2.0
13703,HMGN1,GO:0032786,"positive regulation of DNA-templated transcription, elongation",2.0
13704,HS3ST5,GO:0000139,Golgi membrane,2.0
13705,HS3ST5,GO:0005515,protein binding,2.0
13706,HS3ST5,GO:0006477,protein sulfation,2.0
13707,HS3ST5,GO:0008467,[heparan sulfate]-glucosamine 3-sulfotransferase 1 activity,2.0
13710,HS3ST5,GO:0015012,heparan sulfate proteoglycan biosynthetic process,2.0
13711,HS3ST5,GO:0015015,"heparan sulfate proteoglycan biosynthetic process, enzymatic modification",2.0
13712,HS3ST5,GO:0016020,membrane,2.0
13713,HS3ST5,GO:0046596,regulation of viral entry into host cell,2.0
13714,HS3ST5,GO:0050656,3'-phosphoadenosine 5'-phosphosulfate binding,2.0
13715,HS3ST5,GO:0050819,negative regulation of coagulation,2.0
13716,JMJD1C,GO:0000118,histone deacetylase complex,2.0
13717,JMJD1C,GO:0000785,chromatin,2.0
13718,JMJD1C,GO:0003712,transcription coregulator activity,2.0
13719,JMJD1C,GO:0005515,protein binding,2.0
13720,JMJD1C,GO:0005654,nucleoplasm,2.0
13721,JMJD1C,GO:0006325,chromatin organization,2.0
13722,JMJD1C,GO:0006351,DNA-templated transcription,2.0
13723,JMJD1C,GO:0006355,regulation of DNA-templated transcription,2.0
13724,JMJD1C,GO:0006357,regulation of transcription by RNA polymerase II,2.0
13725,JMJD1C,GO:0007596,blood coagulation,2.0
13726,JMJD1C,GO:0031490,chromatin DNA binding,2.0
13727,JMJD1C,GO:0032454,histone H3K9 demethylase activity,2.0
13729,JMJD1C,GO:0033169,histone H3-K9 demethylation,2.0
13730,JMJD1C,GO:0046872,metal ion binding,2.0
13731,JMJD1C,GO:0046966,nuclear thyroid hormone receptor binding,2.0
13732,JMJD1C,GO:0051213,dioxygenase activity,2.0
13733,KANK1,GO:0005515,protein binding,2.0
13734,KANK1,GO:0005634,nucleus,2.0
13735,KANK1,GO:0005737,cytoplasm,2.0
13737,KANK1,GO:0005856,cytoskeleton,2.0
13738,KANK1,GO:0005886,plasma membrane,2.0
13740,KANK1,GO:0008013,beta-catenin binding,2.0
13741,KANK1,GO:0008283,cell population proliferation,2.0
13742,KANK1,GO:0010977,negative regulation of neuron projection development,2.0
13743,KANK1,GO:0030036,actin cytoskeleton organization,2.0
13744,KANK1,GO:0030177,positive regulation of Wnt signaling pathway,2.0
13745,KANK1,GO:0030336,negative regulation of cell migration,2.0
13746,KANK1,GO:0030837,negative regulation of actin filament polymerization,2.0
13749,KANK1,GO:0032587,ruffle membrane,2.0
13750,KANK1,GO:0035023,regulation of Rho protein signal transduction,2.0
13751,KANK1,GO:0035024,negative regulation of Rho protein signal transduction,2.0
13752,KANK1,GO:0046627,negative regulation of insulin receptor signaling pathway,2.0
13753,KANK1,GO:0090263,positive regulation of canonical Wnt signaling pathway,2.0
13754,KANK1,GO:0090303,positive regulation of wound healing,2.0
13755,KANK1,GO:0090521,podocyte cell migration,2.0
13756,KANK1,GO:1900025,negative regulation of substrate adhesion-dependent cell spreading,2.0
13757,KANK1,GO:1900028,negative regulation of ruffle assembly,2.0
13758,KANK1,GO:2000114,regulation of establishment of cell polarity,2.0
13759,KANK1,GO:2000393,negative regulation of lamellipodium morphogenesis,2.0
13777,KAT2B,GO:0000123,histone acetyltransferase complex,2.0
13778,KAT2B,GO:0000124,SAGA complex,2.0
13780,KAT2B,GO:0000776,kinetochore,2.0
13781,KAT2B,GO:0000977,RNA polymerase II transcription regulatory region sequence-specific DNA binding,2.0
13782,KAT2B,GO:0003682,chromatin binding,2.0
13783,KAT2B,GO:0003712,transcription coregulator activity,2.0
13784,KAT2B,GO:0003713,transcription coactivator activity,2.0
13785,KAT2B,GO:0004145,diamine N-acetyltransferase activity,2.0
13786,KAT2B,GO:0004402,histone acetyltransferase activity,2.0
13789,KAT2B,GO:0004468,"lysine N-acetyltransferase activity, acting on acetyl phosphate as donor",2.0
13791,KAT2B,GO:0004861,cyclin-dependent protein serine/threonine kinase inhibitor activity,2.0
13792,KAT2B,GO:0005515,protein binding,2.0
13793,KAT2B,GO:0005634,nucleus,2.0
13795,KAT2B,GO:0005654,nucleoplasm,2.0
13797,KAT2B,GO:0005813,centrosome,2.0
13798,KAT2B,GO:0005829,cytosol,2.0
13799,KAT2B,GO:0006094,gluconeogenesis,2.0
13800,KAT2B,GO:0006282,regulation of DNA repair,2.0
13801,KAT2B,GO:0006338,chromatin remodeling,2.0
13804,KAT2B,GO:0006351,DNA-templated transcription,2.0
13805,KAT2B,GO:0006355,regulation of DNA-templated transcription,2.0
13806,KAT2B,GO:0006357,regulation of transcription by RNA polymerase II,2.0
13807,KAT2B,GO:0006473,protein acetylation,2.0
13808,KAT2B,GO:0007049,cell cycle,2.0
13809,KAT2B,GO:0007507,heart development,2.0
13810,KAT2B,GO:0008285,negative regulation of cell population proliferation,2.0
13811,KAT2B,GO:0010484,histone H3 acetyltransferase activity,2.0
13812,KAT2B,GO:0010835,regulation of protein ADP-ribosylation,2.0
13813,KAT2B,GO:0016407,acetyltransferase activity,2.0
13814,KAT2B,GO:0016573,histone acetylation,2.0
13815,KAT2B,GO:0018076,N-terminal peptidyl-lysine acetylation,2.0
13816,KAT2B,GO:0018393,internal peptidyl-lysine acetylation,2.0
13817,KAT2B,GO:0018394,peptidyl-lysine acetylation,2.0
13818,KAT2B,GO:0019901,protein kinase binding,2.0
13819,KAT2B,GO:0031063,regulation of histone deacetylation,2.0
13820,KAT2B,GO:0031672,A band,2.0
13821,KAT2B,GO:0031674,I band,2.0
13822,KAT2B,GO:0032869,cellular response to insulin stimulus,2.0
13823,KAT2B,GO:0032991,protein-containing complex,2.0
13825,KAT2B,GO:0035521,monoubiquitinated histone deubiquitination,2.0
13826,KAT2B,GO:0035522,monoubiquitinated histone H2A deubiquitination,2.0
13827,KAT2B,GO:0042641,actomyosin,2.0
13828,KAT2B,GO:0042826,histone deacetylase binding,2.0
13829,KAT2B,GO:0043484,regulation of RNA splicing,2.0
13830,KAT2B,GO:0043966,histone H3 acetylation,2.0
13833,KAT2B,GO:0043970,histone H3-K9 acetylation,2.0
13834,KAT2B,GO:0044154,histone H3-K14 acetylation,2.0
13835,KAT2B,GO:0045722,positive regulation of gluconeogenesis,2.0
13836,KAT2B,GO:0045736,negative regulation of cyclin-dependent protein serine/threonine kinase activity,2.0
13837,KAT2B,GO:0045815,transcription initiation-coupled chromatin remodeling,2.0
13838,KAT2B,GO:0045893,positive regulation of DNA-templated transcription,2.0
13839,KAT2B,GO:0045944,positive regulation of transcription by RNA polymerase II,2.0
13841,KAT2B,GO:0045995,regulation of embryonic development,2.0
13842,KAT2B,GO:0046600,negative regulation of centriole replication,2.0
13843,KAT2B,GO:0048511,rhythmic process,2.0
13844,KAT2B,GO:0051302,regulation of cell division,2.0
13845,KAT2B,GO:0051726,regulation of cell cycle,2.0
13846,KAT2B,GO:0060173,limb development,2.0
13847,KAT2B,GO:0061733,peptide-lysine-N-acetyltransferase activity,2.0
13849,KAT2B,GO:0072686,mitotic spindle,2.0
13850,KAT2B,GO:0090043,regulation of tubulin deacetylation,2.0
13851,KAT2B,GO:0140297,DNA-binding transcription factor binding,2.0
13852,KAT2B,GO:0140672,ATAC complex,2.0
13855,KAT2B,GO:1902425,positive regulation of attachment of mitotic spindle microtubules to kinetochore,2.0
13856,KAT2B,GO:2000233,negative regulation of rRNA processing,2.0
13857,KAT6A,GO:0000786,nucleosome,2.0
13858,KAT6A,GO:0003677,DNA binding,2.0
13859,KAT6A,GO:0003712,transcription coregulator activity,2.0
13860,KAT6A,GO:0003713,transcription coactivator activity,2.0
13862,KAT6A,GO:0004402,histone acetyltransferase activity,2.0
13864,KAT6A,GO:0005515,protein binding,2.0
13865,KAT6A,GO:0005634,nucleus,2.0
13867,KAT6A,GO:0005654,nucleoplasm,2.0
13868,KAT6A,GO:0005730,nucleolus,2.0
13869,KAT6A,GO:0005829,cytosol,2.0
13870,KAT6A,GO:0006334,nucleosome assembly,2.0
13871,KAT6A,GO:0006351,DNA-templated transcription,2.0
13872,KAT6A,GO:0006355,regulation of DNA-templated transcription,2.0
13874,KAT6A,GO:0006473,protein acetylation,2.0
13875,KAT6A,GO:0008270,zinc ion binding,2.0
13876,KAT6A,GO:0010628,positive regulation of gene expression,2.0
13877,KAT6A,GO:0016407,acetyltransferase activity,2.0
13878,KAT6A,GO:0016605,PML body,2.0
13879,KAT6A,GO:0016607,nuclear speck,2.0
13880,KAT6A,GO:0030099,myeloid cell differentiation,2.0
13881,KAT6A,GO:0036408,histone H3K14 acetyltransferase activity,2.0
13882,KAT6A,GO:0042393,histone binding,2.0
13883,KAT6A,GO:0043966,histone H3 acetylation,2.0
13884,KAT6A,GO:0043995,histone H4K5 acetyltransferase activity,2.0
13885,KAT6A,GO:0043996,histone H4K8 acetyltransferase activity,2.0
13886,KAT6A,GO:0043997,histone H4K12 acetyltransferase activity,2.0
13887,KAT6A,GO:0045892,negative regulation of DNA-templated transcription,2.0
13889,KAT6A,GO:0045893,positive regulation of DNA-templated transcription,2.0
13890,KAT6A,GO:0045944,positive regulation of transcription by RNA polymerase II,2.0
13891,KAT6A,GO:0046972,histone H4K16 acetyltransferase activity,2.0
13892,KAT6A,GO:0048513,animal organ development,2.0
13893,KAT6A,GO:0050793,regulation of developmental process,2.0
13894,KAT6A,GO:0051276,chromosome organization,2.0
13895,KAT6A,GO:0070776,MOZ/MORF histone acetyltransferase complex,2.0
13898,KAT6A,GO:0090398,cellular senescence,2.0
13899,KAT6A,GO:0140297,DNA-binding transcription factor binding,2.0
13900,KAT6A,GO:1901796,regulation of signal transduction by p53 class mediator,2.0
13901,KAT6A,GO:1903706,regulation of hemopoiesis,2.0
13932,KATNAL1,GO:0000922,spindle pole,2.0
13933,KATNAL1,GO:0005515,protein binding,2.0
13934,KATNAL1,GO:0005524,ATP binding,2.0
13935,KATNAL1,GO:0005737,cytoplasm,2.0
13936,KATNAL1,GO:0005813,centrosome,2.0
13937,KATNAL1,GO:0005819,spindle,2.0
13938,KATNAL1,GO:0005874,microtubule,2.0
13939,KATNAL1,GO:0007283,spermatogenesis,2.0
13940,KATNAL1,GO:0008017,microtubule binding,2.0
13941,KATNAL1,GO:0008352,katanin complex,2.0
13942,KATNAL1,GO:0008568,microtubule severing ATPase activity,2.0
13943,KATNAL1,GO:0015630,microtubule cytoskeleton,2.0
13945,KATNAL1,GO:0016853,isomerase activity,2.0
13946,KATNAL1,GO:0016887,ATP hydrolysis activity,2.0
13947,KATNAL1,GO:0031122,cytoplasmic microtubule organization,2.0
13948,KATNAL1,GO:0042802,identical protein binding,2.0
13949,KATNAL1,GO:0051013,microtubule severing,2.0
14075,KCNC1,GO:0005249,voltage-gated potassium channel activity,2.0
14076,KCNC1,GO:0005251,delayed rectifier potassium channel activity,2.0
14078,KCNC1,GO:0005515,protein binding,2.0
14079,KCNC1,GO:0005886,plasma membrane,2.0
14080,KCNC1,GO:0006813,potassium ion transport,2.0
14081,KCNC1,GO:0008076,voltage-gated potassium channel complex,2.0
14084,KCNC1,GO:0009636,response to toxic substance,2.0
14085,KCNC1,GO:0009642,response to light intensity,2.0
14086,KCNC1,GO:0009986,cell surface,2.0
14087,KCNC1,GO:0010996,response to auditory stimulus,2.0
14088,KCNC1,GO:0014075,response to amine,2.0
14089,KCNC1,GO:0016020,membrane,2.0
14090,KCNC1,GO:0019894,kinesin binding,2.0
14091,KCNC1,GO:0021549,cerebellum development,2.0
14092,KCNC1,GO:0021554,optic nerve development,2.0
14093,KCNC1,GO:0021759,globus pallidus development,2.0
14094,KCNC1,GO:0022038,corpus callosum development,2.0
14095,KCNC1,GO:0030424,axon,2.0
14096,KCNC1,GO:0030673,axolemma,2.0
14097,KCNC1,GO:0032590,dendrite membrane,2.0
14098,KCNC1,GO:0032809,neuronal cell body membrane,2.0
14100,KCNC1,GO:0035864,response to potassium ion,2.0
14101,KCNC1,GO:0042734,presynaptic membrane,2.0
14102,KCNC1,GO:0044305,calyx of Held,2.0
14103,KCNC1,GO:0044325,transmembrane transporter binding,2.0
14104,KCNC1,GO:0045211,postsynaptic membrane,2.0
14105,KCNC1,GO:0051260,protein homooligomerization,2.0
14106,KCNC1,GO:0051262,protein tetramerization,2.0
14107,KCNC1,GO:0071466,cellular response to xenobiotic stimulus,2.0
14108,KCNC1,GO:0071774,response to fibroblast growth factor,2.0
14109,KCNC1,GO:0071805,potassium ion transmembrane transport,2.0
14111,KCNC1,GO:0099505,regulation of presynaptic membrane potential,2.0
14112,KCNC1,GO:0099508,voltage-gated ion channel activity involved in regulation of presynaptic membrane potential,2.0
14113,KCNC1,GO:1903818,positive regulation of voltage-gated potassium channel activity,2.0
14114,KCNC1,GO:1990089,response to nerve growth factor,2.0
14162,KCND2,GO:0001508,action potential,2.0
14163,KCND2,GO:0005249,voltage-gated potassium channel activity,2.0
14167,KCND2,GO:0005250,A-type (transient outward) potassium channel activity,2.0
14170,KCND2,GO:0005515,protein binding,2.0
14171,KCND2,GO:0005886,plasma membrane,2.0
14174,KCND2,GO:0007268,chemical synaptic transmission,2.0
14175,KCND2,GO:0008076,voltage-gated potassium channel complex,2.0
14177,KCND2,GO:0014069,postsynaptic density,2.0
14178,KCND2,GO:0016020,membrane,2.0
14179,KCND2,GO:0019228,neuronal action potential,2.0
14180,KCND2,GO:0019233,sensory perception of pain,2.0
14181,KCND2,GO:0032809,neuronal cell body membrane,2.0
14182,KCND2,GO:0034765,regulation of ion transmembrane transport,2.0
14183,KCND2,GO:0043197,dendritic spine,2.0
14186,KCND2,GO:0043204,perikaryon,2.0
14187,KCND2,GO:0044853,plasma membrane raft,2.0
14188,KCND2,GO:0045211,postsynaptic membrane,2.0
14190,KCND2,GO:0045475,locomotor rhythm,2.0
14191,KCND2,GO:0046872,metal ion binding,2.0
14192,KCND2,GO:0051260,protein homooligomerization,2.0
14193,KCND2,GO:0060078,regulation of postsynaptic membrane potential,2.0
14194,KCND2,GO:0070161,anchoring junction,2.0
14195,KCND2,GO:0071456,cellular response to hypoxia,2.0
14196,KCND2,GO:0071805,potassium ion transmembrane transport,2.0
14198,KCND2,GO:0098978,glutamatergic synapse,2.0
14199,KCND2,GO:0098982,GABA-ergic synapse,2.0
14200,KCND2,GO:0099634,postsynaptic specialization membrane,2.0
14201,KCND2,GO:1905030,voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential,2.0
14202,KCND3,GO:0005249,voltage-gated potassium channel activity,2.0
14203,KCND3,GO:0005250,A-type (transient outward) potassium channel activity,2.0
14204,KCND3,GO:0005515,protein binding,2.0
14205,KCND3,GO:0005886,plasma membrane,2.0
14206,KCND3,GO:0006813,potassium ion transport,2.0
14207,KCND3,GO:0008076,voltage-gated potassium channel complex,2.0
14209,KCND3,GO:0014069,postsynaptic density,2.0
14210,KCND3,GO:0016020,membrane,2.0
14211,KCND3,GO:0034765,regulation of ion transmembrane transport,2.0
14212,KCND3,GO:0042383,sarcolemma,2.0
14213,KCND3,GO:0043025,neuronal cell body,2.0
14214,KCND3,GO:0043197,dendritic spine,2.0
14215,KCND3,GO:0044325,transmembrane transporter binding,2.0
14216,KCND3,GO:0045211,postsynaptic membrane,2.0
14217,KCND3,GO:0046872,metal ion binding,2.0
14218,KCND3,GO:0051260,protein homooligomerization,2.0
14219,KCND3,GO:0071805,potassium ion transmembrane transport,2.0
14220,KCND3,GO:0086008,voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization,2.0
14221,KCND3,GO:0086009,membrane repolarization,2.0
14222,KCND3,GO:0086013,membrane repolarization during cardiac muscle cell action potential,2.0
14223,KCND3,GO:0086091,regulation of heart rate by cardiac conduction,2.0
14224,KCND3,GO:0097623,potassium ion export across plasma membrane,2.0
14227,KCND3,GO:0098915,membrane repolarization during ventricular cardiac muscle cell action potential,2.0
14228,KCND3,GO:0098982,GABA-ergic synapse,2.0
14229,KCND3,GO:0099625,ventricular cardiac muscle cell membrane repolarization,2.0
14230,KCND3,GO:0099634,postsynaptic specialization membrane,2.0
14231,KCND3,GO:1902282,voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization,2.0
14232,KCNJ10,GO:0005242,inward rectifier potassium channel activity,2.0
14233,KCNJ10,GO:0005515,protein binding,2.0
14234,KCNJ10,GO:0005524,ATP binding,2.0
14235,KCNJ10,GO:0005886,plasma membrane,2.0
14237,KCNJ10,GO:0006813,potassium ion transport,2.0
14238,KCNJ10,GO:0007601,visual perception,2.0
14239,KCNJ10,GO:0007628,adult walking behavior,2.0
14240,KCNJ10,GO:0015272,ATP-activated inward rectifier potassium channel activity,2.0
14241,KCNJ10,GO:0016323,basolateral plasma membrane,2.0
14242,KCNJ10,GO:0022010,central nervous system myelination,2.0
14243,KCNJ10,GO:0034765,regulation of ion transmembrane transport,2.0
14244,KCNJ10,GO:0035865,cellular response to potassium ion,2.0
14245,KCNJ10,GO:0044297,cell body,2.0
14246,KCNJ10,GO:0048169,regulation of long-term neuronal synaptic plasticity,2.0
14247,KCNJ10,GO:0051935,glutamate reuptake,2.0
14248,KCNJ10,GO:0055075,potassium ion homeostasis,2.0
14249,KCNJ10,GO:0060075,regulation of resting membrane potential,2.0
14250,KCNJ10,GO:0097449,astrocyte projection,2.0
14251,KCNJ10,GO:0097546,ciliary base,2.0
14252,KCNJ10,GO:0098793,presynapse,2.0
14253,KCNJ10,GO:1905515,non-motile cilium assembly,2.0
14254,KCNJ10,GO:1990573,potassium ion import across plasma membrane,2.0
14255,KCNJ15,GO:0005242,inward rectifier potassium channel activity,2.0
14256,KCNJ15,GO:0005515,protein binding,2.0
14257,KCNJ15,GO:0005886,plasma membrane,2.0
14259,KCNJ15,GO:0006813,potassium ion transport,2.0
14260,KCNJ15,GO:0034765,regulation of ion transmembrane transport,2.0
14261,KCNJ15,GO:1990573,potassium ion import across plasma membrane,2.0
14262,KCNK7,GO:0005267,potassium channel activity,2.0
14263,KCNK7,GO:0005886,plasma membrane,2.0
14265,KCNK7,GO:0006813,potassium ion transport,2.0
14266,KCNK7,GO:0015271,outward rectifier potassium channel activity,2.0
14267,KCNK7,GO:0022841,potassium ion leak channel activity,2.0
14268,KCNK7,GO:0030322,stabilization of membrane potential,2.0
14269,KCNK7,GO:0034765,regulation of ion transmembrane transport,2.0
14270,KCNK7,GO:0071805,potassium ion transmembrane transport,2.0
14271,KCNMA1,GO:0001666,response to hypoxia,2.0
14272,KCNMA1,GO:0003779,actin binding,2.0
14273,KCNMA1,GO:0005249,voltage-gated potassium channel activity,2.0
14275,KCNMA1,GO:0005515,protein binding,2.0
14276,KCNMA1,GO:0005886,plasma membrane,2.0
14277,KCNMA1,GO:0005901,caveola,2.0
14278,KCNMA1,GO:0006813,potassium ion transport,2.0
14279,KCNMA1,GO:0006970,response to osmotic stress,2.0
14280,KCNMA1,GO:0008076,voltage-gated potassium channel complex,2.0
14281,KCNMA1,GO:0015269,calcium-activated potassium channel activity,2.0
14282,KCNMA1,GO:0016020,membrane,2.0
14283,KCNMA1,GO:0016324,apical plasma membrane,2.0
14284,KCNMA1,GO:0030007,cellular potassium ion homeostasis,2.0
14285,KCNMA1,GO:0034465,response to carbon monoxide,2.0
14287,KCNMA1,GO:0034765,regulation of ion transmembrane transport,2.0
14288,KCNMA1,GO:0042391,regulation of membrane potential,2.0
14289,KCNMA1,GO:0043065,positive regulation of apoptotic process,2.0
14290,KCNMA1,GO:0045211,postsynaptic membrane,2.0
14291,KCNMA1,GO:0045794,negative regulation of cell volume,2.0
14292,KCNMA1,GO:0046872,metal ion binding,2.0
14293,KCNMA1,GO:0051592,response to calcium ion,2.0
14294,KCNMA1,GO:0060072,large conductance calcium-activated potassium channel activity,2.0
14297,KCNMA1,GO:0060073,micturition,2.0
14298,KCNMA1,GO:0060083,smooth muscle contraction involved in micturition,2.0
14299,KCNMA1,GO:0060087,relaxation of vascular associated smooth muscle,2.0
14300,KCNMA1,GO:0071805,potassium ion transmembrane transport,2.0
14301,KCNQ2,GO:0005249,voltage-gated potassium channel activity,2.0
14303,KCNQ2,GO:0005251,delayed rectifier potassium channel activity,2.0
14304,KCNQ2,GO:0005515,protein binding,2.0
14305,KCNQ2,GO:0005516,calmodulin binding,2.0
14307,KCNQ2,GO:0005886,plasma membrane,2.0
14310,KCNQ2,GO:0007268,chemical synaptic transmission,2.0
14311,KCNQ2,GO:0007399,nervous system development,2.0
14312,KCNQ2,GO:0008076,voltage-gated potassium channel complex,2.0
14314,KCNQ2,GO:0016020,membrane,2.0
14315,KCNQ2,GO:0030506,ankyrin binding,2.0
14316,KCNQ2,GO:0033268,node of Ranvier,2.0
14317,KCNQ2,GO:0034765,regulation of ion transmembrane transport,2.0
14318,KCNQ2,GO:0043194,axon initial segment,2.0
14320,KCNQ2,GO:0045202,synapse,2.0
14321,KCNQ2,GO:0071805,potassium ion transmembrane transport,2.0
14346,KCNS3,GO:0005249,voltage-gated potassium channel activity,2.0
14347,KCNS3,GO:0005251,delayed rectifier potassium channel activity,2.0
14348,KCNS3,GO:0005794,Golgi apparatus,2.0
14349,KCNS3,GO:0005829,cytosol,2.0
14350,KCNS3,GO:0005886,plasma membrane,2.0
14352,KCNS3,GO:0006813,potassium ion transport,2.0
14353,KCNS3,GO:0008076,voltage-gated potassium channel complex,2.0
14354,KCNS3,GO:0015459,potassium channel regulator activity,2.0
14355,KCNS3,GO:0016020,membrane,2.0
14356,KCNS3,GO:0034765,regulation of ion transmembrane transport,2.0
14357,KCNS3,GO:0051260,protein homooligomerization,2.0
14358,KCNS3,GO:0071805,potassium ion transmembrane transport,2.0
14359,KCTD13,GO:0004842,ubiquitin-protein transferase activity,2.0
14361,KCTD13,GO:0005515,protein binding,2.0
14362,KCTD13,GO:0005654,nucleoplasm,2.0
14363,KCTD13,GO:0005829,cytosol,2.0
14364,KCTD13,GO:0016477,cell migration,2.0
14365,KCTD13,GO:0016567,protein ubiquitination,2.0
14368,KCTD13,GO:0016604,nuclear body,2.0
14369,KCTD13,GO:0019904,protein domain specific binding,2.0
14370,KCTD13,GO:0031267,small GTPase binding,2.0
14371,KCTD13,GO:0031463,Cul3-RING ubiquitin ligase complex,2.0
14373,KCTD13,GO:0035024,negative regulation of Rho protein signal transduction,2.0
14376,KCTD13,GO:0042802,identical protein binding,2.0
14377,KCTD13,GO:0043149,stress fiber assembly,2.0
14378,KCTD13,GO:0043161,proteasome-mediated ubiquitin-dependent protein catabolic process,2.0
14380,KCTD13,GO:0045740,positive regulation of DNA replication,2.0
14381,KCTD13,GO:0050806,positive regulation of synaptic transmission,2.0
14382,KCTD13,GO:0051260,protein homooligomerization,2.0
14383,KCTD13,GO:0061351,neural precursor cell proliferation,2.0
14384,KDM1B,GO:0000122,negative regulation of transcription by RNA polymerase II,2.0
14385,KDM1B,GO:0000786,nucleosome,2.0
14386,KDM1B,GO:0003682,chromatin binding,2.0
14387,KDM1B,GO:0005515,protein binding,2.0
14388,KDM1B,GO:0005634,nucleus,2.0
14389,KDM1B,GO:0005654,nucleoplasm,2.0
14391,KDM1B,GO:0006349,regulation of gene expression by genomic imprinting,2.0
14392,KDM1B,GO:0008134,transcription factor binding,2.0
14393,KDM1B,GO:0008270,zinc ion binding,2.0
14394,KDM1B,GO:0016491,oxidoreductase activity,2.0
14395,KDM1B,GO:0032452,histone demethylase activity,2.0
14396,KDM1B,GO:0034720,histone H3-K4 demethylation,2.0
14397,KDM1B,GO:0042393,histone binding,2.0
14398,KDM1B,GO:0043046,DNA methylation involved in gamete generation,2.0
14399,KDM1B,GO:0044030,regulation of DNA methylation,2.0
14400,KDM1B,GO:0045944,positive regulation of transcription by RNA polymerase II,2.0
14401,KDM1B,GO:0050660,flavin adenine dinucleotide binding,2.0
14402,KDM1B,GO:0071949,FAD binding,2.0
14403,KDM1B,GO:0140682,FAD-dependent H3K4me/H3K4me3 demethylase activity,2.0
14437,KDM4B,GO:0005634,nucleus,2.0
14438,KDM4B,GO:0005654,nucleoplasm,2.0
14439,KDM4B,GO:0006338,chromatin remodeling,2.0
14440,KDM4B,GO:0007420,brain development,2.0
14441,KDM4B,GO:0032452,histone demethylase activity,2.0
14443,KDM4B,GO:0032454,histone H3K9 demethylase activity,2.0
14446,KDM4B,GO:0046872,metal ion binding,2.0
14447,KDM4B,GO:0051864,histone H3K36 demethylase activity,2.0
14448,KDM4B,GO:0070076,histone lysine demethylation,2.0
14449,KDM4B,GO:0140684,histone H3K9me2/H3K9me3 demethylase activity,2.0
14450,KDM4C,GO:0000785,chromatin,2.0
14451,KDM4C,GO:0001825,blastocyst formation,2.0
14452,KDM4C,GO:0005634,nucleus,2.0
14453,KDM4C,GO:0005654,nucleoplasm,2.0
14454,KDM4C,GO:0005721,pericentric heterochromatin,2.0
14455,KDM4C,GO:0006338,chromatin remodeling,2.0
14456,KDM4C,GO:0006357,regulation of transcription by RNA polymerase II,2.0
14457,KDM4C,GO:0008270,zinc ion binding,2.0
14458,KDM4C,GO:0008284,positive regulation of cell population proliferation,2.0
14459,KDM4C,GO:0019827,stem cell population maintenance,2.0
14460,KDM4C,GO:0019899,enzyme binding,2.0
14461,KDM4C,GO:0032452,histone demethylase activity,2.0
14464,KDM4C,GO:0032454,histone H3K9 demethylase activity,2.0
14467,KDM4C,GO:0033169,histone H3-K9 demethylation,2.0
14468,KDM4C,GO:0050681,nuclear androgen receptor binding,2.0
14469,KDM4C,GO:0051864,histone H3K36 demethylase activity,2.0
14471,KDM4C,GO:0060765,regulation of androgen receptor signaling pathway,2.0
14472,KDM4C,GO:0140684,histone H3K9me2/H3K9me3 demethylase activity,2.0
14473,KDM4C,GO:1900113,negative regulation of histone H3-K9 trimethylation,2.0
14474,KDM4C,GO:2000736,regulation of stem cell differentiation,2.0
14475,KDM5A,GO:0000122,negative regulation of transcription by RNA polymerase II,2.0
14476,KDM5A,GO:0000976,transcription cis-regulatory region binding,2.0
14477,KDM5A,GO:0003677,DNA binding,2.0
14478,KDM5A,GO:0003713,transcription coactivator activity,2.0
14479,KDM5A,GO:0004857,enzyme inhibitor activity,2.0
14480,KDM5A,GO:0005515,protein binding,2.0
14481,KDM5A,GO:0005634,nucleus,2.0
14483,KDM5A,GO:0005654,nucleoplasm,2.0
14484,KDM5A,GO:0005730,nucleolus,2.0
14485,KDM5A,GO:0006338,chromatin remodeling,2.0
14486,KDM5A,GO:0008270,zinc ion binding,2.0
14487,KDM5A,GO:0031490,chromatin DNA binding,2.0
14488,KDM5A,GO:0032452,histone demethylase activity,2.0
14490,KDM5A,GO:0032922,circadian regulation of gene expression,2.0
14491,KDM5A,GO:0032993,protein-DNA complex,2.0
14492,KDM5A,GO:0034647,histone H3K4me/H3K4me2/H3K4me3 demethylase activity,2.0
14494,KDM5A,GO:0034720,histone H3-K4 demethylation,2.0
14495,KDM5A,GO:0035064,methylated histone binding,2.0
14496,KDM5A,GO:0042393,histone binding,2.0
14497,KDM5A,GO:0043086,negative regulation of catalytic activity,2.0
14498,KDM5A,GO:0045893,positive regulation of DNA-templated transcription,2.0
14499,KDM5A,GO:0051090,regulation of DNA-binding transcription factor activity,2.0
14500,KDM5A,GO:0140718,facultative heterochromatin formation,2.0
14554,KDM6A,GO:0000978,RNA polymerase II cis-regulatory region sequence-specific DNA binding,2.0
14555,KDM6A,GO:0005515,protein binding,2.0
14556,KDM6A,GO:0005634,nucleus,2.0
14557,KDM6A,GO:0005654,nucleoplasm,2.0
14558,KDM6A,GO:0006338,chromatin remodeling,2.0
14559,KDM6A,GO:0007507,heart development,2.0
14560,KDM6A,GO:0010468,regulation of gene expression,2.0
14561,KDM6A,GO:0031490,chromatin DNA binding,2.0
14562,KDM6A,GO:0032452,histone demethylase activity,2.0
14563,KDM6A,GO:0035097,histone methyltransferase complex,2.0
14564,KDM6A,GO:0044666,MLL3/4 complex,2.0
14567,KDM6A,GO:0046872,metal ion binding,2.0
14568,KDM6A,GO:0051568,histone H3-K4 methylation,2.0
14570,KDM6A,GO:0071557,histone H3-K27 demethylation,2.0
14571,KDM6A,GO:0071558,histone H3K27me2/H3K27me3 demethylase activity,2.0
14595,KHDRBS2,GO:0000381,"regulation of alternative mRNA splicing, via spliceosome",2.0
14596,KHDRBS2,GO:0003729,mRNA binding,2.0
14597,KHDRBS2,GO:0005515,protein binding,2.0
14598,KHDRBS2,GO:0005634,nucleus,2.0
14599,KHDRBS2,GO:0005654,nucleoplasm,2.0
14600,KHDRBS2,GO:0006397,mRNA processing,2.0
14601,KHDRBS2,GO:0008143,poly(A) binding,2.0
14602,KHDRBS2,GO:0008266,poly(U) RNA binding,2.0
14603,KHDRBS2,GO:0017124,SH3 domain binding,2.0
14604,KHDRBS2,GO:0042169,SH2 domain binding,2.0
14605,KHDRBS2,GO:0048024,"regulation of mRNA splicing, via spliceosome",2.0
14607,KIAA1586,GO:0016925,protein sumoylation,2.0
14610,KIAA1586,GO:0061665,SUMO ligase activity,2.0
14612,KIF13B,GO:0003777,microtubule motor activity,2.0
14614,KIF13B,GO:0005515,protein binding,2.0
14615,KIF13B,GO:0005524,ATP binding,2.0
14616,KIF13B,GO:0005737,cytoplasm,2.0
14617,KIF13B,GO:0005871,kinesin complex,2.0
14618,KIF13B,GO:0005874,microtubule,2.0
14619,KIF13B,GO:0006605,protein targeting,2.0
14620,KIF13B,GO:0007018,microtubule-based movement,2.0
14622,KIF13B,GO:0007165,signal transduction,2.0
14623,KIF13B,GO:0008017,microtubule binding,2.0
14624,KIF13B,GO:0016887,ATP hydrolysis activity,2.0
14625,KIF13B,GO:0019901,protein kinase binding,2.0
14626,KIF13B,GO:0030424,axon,2.0
14627,KIF13B,GO:0042110,T cell activation,2.0
14628,KIF13B,GO:0050770,regulation of axonogenesis,2.0
14629,KIF13B,GO:0071889,14-3-3 protein binding,2.0
14630,KIF14,GO:0001558,regulation of cell growth,2.0
14631,KIF14,GO:0003777,microtubule motor activity,2.0
14632,KIF14,GO:0005515,protein binding,2.0
14633,KIF14,GO:0005524,ATP binding,2.0
14634,KIF14,GO:0005634,nucleus,2.0
14635,KIF14,GO:0005829,cytosol,2.0
14637,KIF14,GO:0005871,kinesin complex,2.0
14638,KIF14,GO:0005874,microtubule,2.0
14640,KIF14,GO:0005886,plasma membrane,2.0
14641,KIF14,GO:0007018,microtubule-based movement,2.0
14642,KIF14,GO:0007019,microtubule depolymerization,2.0
14643,KIF14,GO:0007080,mitotic metaphase plate congression,2.0
14644,KIF14,GO:0008017,microtubule binding,2.0
14646,KIF14,GO:0008284,positive regulation of cell population proliferation,2.0
14648,KIF14,GO:0008574,plus-end-directed microtubule motor activity,2.0
14649,KIF14,GO:0010389,regulation of G2/M transition of mitotic cell cycle,2.0
14650,KIF14,GO:0015631,tubulin binding,2.0
14651,KIF14,GO:0016020,membrane,2.0
14652,KIF14,GO:0016887,ATP hydrolysis activity,2.0
14654,KIF14,GO:0019901,protein kinase binding,2.0
14655,KIF14,GO:0021685,cerebellar granular layer structural organization,2.0
14656,KIF14,GO:0021693,cerebellar Purkinje cell layer structural organization,2.0
14657,KIF14,GO:0021695,cerebellar cortex development,2.0
14658,KIF14,GO:0021766,hippocampus development,2.0
14659,KIF14,GO:0021772,olfactory bulb development,2.0
14660,KIF14,GO:0021846,cell proliferation in forebrain,2.0
14661,KIF14,GO:0021987,cerebral cortex development,2.0
14662,KIF14,GO:0030155,regulation of cell adhesion,2.0
14663,KIF14,GO:0030165,PDZ domain binding,2.0
14664,KIF14,GO:0030334,regulation of cell migration,2.0
14665,KIF14,GO:0030496,midbody,2.0
14666,KIF14,GO:0031146,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process,2.0
14667,KIF14,GO:0031641,regulation of myelination,2.0
14668,KIF14,GO:0032147,activation of protein kinase activity,2.0
14669,KIF14,GO:0032467,positive regulation of cytokinesis,2.0
14670,KIF14,GO:0032487,regulation of Rap protein signal transduction,2.0
14671,KIF14,GO:0033624,negative regulation of integrin activation,2.0
14672,KIF14,GO:0034446,substrate adhesion-dependent cell spreading,2.0
14673,KIF14,GO:0043066,negative regulation of apoptotic process,2.0
14674,KIF14,GO:0043161,proteasome-mediated ubiquitin-dependent protein catabolic process,2.0
14675,KIF14,GO:0043523,regulation of neuron apoptotic process,2.0
14676,KIF14,GO:0043524,negative regulation of neuron apoptotic process,2.0
14677,KIF14,GO:0045184,establishment of protein localization,2.0
14678,KIF14,GO:0051233,spindle midzone,2.0
14679,KIF14,GO:0051301,cell division,2.0
14680,KIF14,GO:0090543,Flemming body,2.0
14681,KIF14,GO:1903429,regulation of cell maturation,2.0
14682,KIF14,GO:2000045,regulation of G1/S transition of mitotic cell cycle,2.0
14683,KIF1A,GO:0003774,cytoskeletal motor activity,2.0
14684,KIF1A,GO:0003777,microtubule motor activity,2.0
14685,KIF1A,GO:0005515,protein binding,2.0
14686,KIF1A,GO:0005524,ATP binding,2.0
14687,KIF1A,GO:0005871,kinesin complex,2.0
14688,KIF1A,GO:0005874,microtubule,2.0
14689,KIF1A,GO:0007018,microtubule-based movement,2.0
14690,KIF1A,GO:0008017,microtubule binding,2.0
14691,KIF1A,GO:0008089,anterograde axonal transport,2.0
14692,KIF1A,GO:0008574,plus-end-directed microtubule motor activity,2.0
14693,KIF1A,GO:0016192,vesicle-mediated transport,2.0
14694,KIF1A,GO:0016887,ATP hydrolysis activity,2.0
14695,KIF1A,GO:0030424,axon,2.0
14696,KIF1A,GO:0030425,dendrite,2.0
14697,KIF1A,GO:0030705,cytoskeleton-dependent intracellular transport,2.0
14698,KIF1A,GO:0042802,identical protein binding,2.0
14699,KIF1A,GO:0045202,synapse,2.0
14700,KIF1A,GO:0048471,perinuclear region of cytoplasm,2.0
14701,KIF1A,GO:0060998,regulation of dendritic spine development,2.0
14702,KIF1A,GO:0061001,regulation of dendritic spine morphogenesis,2.0
14703,KIF1A,GO:0098674,extrinsic component of neuronal dense core vesicle membrane,2.0
14704,KIF1A,GO:0098992,neuronal dense core vesicle,2.0
14705,KIF1A,GO:0099519,dense core granule cytoskeletal transport,2.0
14706,KIF1A,GO:1904115,axon cytoplasm,2.0
14707,KIF1A,GO:1990048,anterograde neuronal dense core vesicle transport,2.0
14708,KIF1A,GO:1990049,retrograde neuronal dense core vesicle transport,2.0
14709,KIF5C,GO:0003777,microtubule motor activity,2.0
14710,KIF5C,GO:0005515,protein binding,2.0
14711,KIF5C,GO:0005524,ATP binding,2.0
14712,KIF5C,GO:0005871,kinesin complex,2.0
14713,KIF5C,GO:0005874,microtubule,2.0
14714,KIF5C,GO:0006996,organelle organization,2.0
14715,KIF5C,GO:0007018,microtubule-based movement,2.0
14716,KIF5C,GO:0007411,axon guidance,2.0
14717,KIF5C,GO:0008017,microtubule binding,2.0
14718,KIF5C,GO:0008045,motor neuron axon guidance,2.0
14719,KIF5C,GO:0008574,plus-end-directed microtubule motor activity,2.0
14720,KIF5C,GO:0016887,ATP hydrolysis activity,2.0
14721,KIF5C,GO:0030705,cytoskeleton-dependent intracellular transport,2.0
14722,KIF5C,GO:0032839,dendrite cytoplasm,2.0
14723,KIF5C,GO:0035253,ciliary rootlet,2.0
14724,KIF5C,GO:0043025,neuronal cell body,2.0
14725,KIF5C,GO:0044295,axonal growth cone,2.0
14726,KIF5C,GO:0048489,synaptic vesicle transport,2.0
14727,KIF5C,GO:0051028,mRNA transport,2.0
14728,KIF5C,GO:0098971,anterograde dendritic transport of neurotransmitter receptor complex,2.0
14729,KIF5C,GO:0099641,anterograde axonal protein transport,2.0
14730,KIF5C,GO:0150034,distal axon,2.0
14731,KIF5C,GO:1904115,axon cytoplasm,2.0
14732,KIRREL3,GO:0001764,neuron migration,2.0
14733,KIRREL3,GO:0002121,inter-male aggressive behavior,2.0
14734,KIRREL3,GO:0005515,protein binding,2.0
14735,KIRREL3,GO:0005576,extracellular region,2.0
14736,KIRREL3,GO:0005886,plasma membrane,2.0
14738,KIRREL3,GO:0005911,cell-cell junction,2.0
14739,KIRREL3,GO:0007156,homophilic cell adhesion via plasma membrane adhesion molecules,2.0
14740,KIRREL3,GO:0007416,synapse assembly,2.0
14742,KIRREL3,GO:0008021,synaptic vesicle,2.0
14743,KIRREL3,GO:0016020,membrane,2.0
14744,KIRREL3,GO:0021740,principal sensory nucleus of trigeminal nerve development,2.0
14745,KIRREL3,GO:0021766,hippocampus development,2.0
14746,KIRREL3,GO:0030097,hemopoiesis,2.0
14747,KIRREL3,GO:0030424,axon,2.0
14748,KIRREL3,GO:0030425,dendrite,2.0
14749,KIRREL3,GO:0043198,dendritic shaft,2.0
14750,KIRREL3,GO:0048812,neuron projection morphogenesis,2.0
14751,KIRREL3,GO:0050839,cell adhesion molecule binding,2.0
14752,KIRREL3,GO:0072102,glomerulus morphogenesis,2.0
14753,KIRREL3,GO:0098609,cell-cell adhesion,2.0
14754,KLF16,GO:0000122,negative regulation of transcription by RNA polymerase II,2.0
14755,KLF16,GO:0000785,chromatin,2.0
14756,KLF16,GO:0000978,RNA polymerase II cis-regulatory region sequence-specific DNA binding,2.0
14757,KLF16,GO:0000981,"DNA-binding transcription factor activity, RNA polymerase II-specific",2.0
14759,KLF16,GO:0001227,"DNA-binding transcription repressor activity, RNA polymerase II-specific",2.0
14760,KLF16,GO:0005515,protein binding,2.0
14761,KLF16,GO:0005634,nucleus,2.0
14762,KLF16,GO:0006357,regulation of transcription by RNA polymerase II,2.0
14763,KLF16,GO:0007212,dopamine receptor signaling pathway,2.0
14764,KLF16,GO:0046872,metal ion binding,2.0
14765,KLF16,GO:1990837,sequence-specific double-stranded DNA binding,2.0
14961,KRR1,GO:0003723,RNA binding,2.0
14962,KRR1,GO:0005515,protein binding,2.0
14963,KRR1,GO:0005654,nucleoplasm,2.0
14965,KRR1,GO:0005694,chromosome,2.0
14966,KRR1,GO:0005730,nucleolus,2.0
14968,KRR1,GO:0005737,cytoplasm,2.0
14969,KRR1,GO:0006364,rRNA processing,2.0
14970,KRR1,GO:0016020,membrane,2.0
14971,KRR1,GO:0032040,small-subunit processome,2.0
14972,KRR1,GO:0045171,intercellular bridge,2.0
14973,KRT26,GO:0005198,structural molecule activity,2.0
14974,KRT26,GO:0005515,protein binding,2.0
14975,KRT26,GO:0005829,cytosol,2.0
14976,KRT26,GO:0005856,cytoskeleton,2.0
14977,KRT26,GO:0005882,intermediate filament,2.0
14978,KRT26,GO:0070062,extracellular exosome,2.0
14979,LAMA1,GO:0002011,morphogenesis of an epithelial sheet,2.0
14980,LAMA1,GO:0005102,signaling receptor binding,2.0
14981,LAMA1,GO:0005201,extracellular matrix structural constituent,2.0
14983,LAMA1,GO:0005515,protein binding,2.0
14984,LAMA1,GO:0005576,extracellular region,2.0
14985,LAMA1,GO:0005604,basement membrane,2.0
14988,LAMA1,GO:0005606,laminin-1 complex,2.0
14990,LAMA1,GO:0005608,laminin-3 complex,2.0
14991,LAMA1,GO:0005615,extracellular space,2.0
14992,LAMA1,GO:0005911,cell-cell junction,2.0
14993,LAMA1,GO:0006468,protein phosphorylation,2.0
14994,LAMA1,GO:0007155,cell adhesion,2.0
14995,LAMA1,GO:0007166,cell surface receptor signaling pathway,2.0
14996,LAMA1,GO:0007411,axon guidance,2.0
14997,LAMA1,GO:0008022,protein C-terminus binding,2.0
14998,LAMA1,GO:0009887,animal organ morphogenesis,2.0
14999,LAMA1,GO:0009888,tissue development,2.0
15000,LAMA1,GO:0016020,membrane,2.0
15001,LAMA1,GO:0030334,regulation of cell migration,2.0
15002,LAMA1,GO:0031012,extracellular matrix,2.0
15003,LAMA1,GO:0043010,camera-type eye development,2.0
15004,LAMA1,GO:0043208,glycosphingolipid binding,2.0
15005,LAMA1,GO:0045198,establishment of epithelial cell apical/basal polarity,2.0
15006,LAMA1,GO:0045785,positive regulation of cell adhesion,2.0
15007,LAMA1,GO:0045995,regulation of embryonic development,2.0
15008,LAMA1,GO:0048514,blood vessel morphogenesis,2.0
15009,LAMA1,GO:0051149,positive regulation of muscle cell differentiation,2.0
15010,LAMA1,GO:0060441,epithelial tube branching involved in lung morphogenesis,2.0
15011,LAMA1,GO:0060445,branching involved in salivary gland morphogenesis,2.0
15012,LAMA1,GO:0061304,retinal blood vessel morphogenesis,2.0
15013,LAMA1,GO:0062023,collagen-containing extracellular matrix,2.0
15015,LAMA1,GO:0098637,protein complex involved in cell-matrix adhesion,2.0
15016,LAMA1,GO:0110011,regulation of basement membrane organization,2.0
15017,LAMA1,GO:2001046,positive regulation of integrin-mediated signaling pathway,2.0
15018,LAMB1,GO:0005178,integrin binding,2.0
15019,LAMB1,GO:0005198,structural molecule activity,2.0
15020,LAMB1,GO:0005201,extracellular matrix structural constituent,2.0
15024,LAMB1,GO:0005515,protein binding,2.0
15025,LAMB1,GO:0005576,extracellular region,2.0
15026,LAMB1,GO:0005604,basement membrane,2.0
15029,LAMB1,GO:0005606,laminin-1 complex,2.0
15032,LAMB1,GO:0005607,laminin-2 complex,2.0
15034,LAMB1,GO:0005615,extracellular space,2.0
15035,LAMB1,GO:0005788,endoplasmic reticulum lumen,2.0
15036,LAMB1,GO:0007155,cell adhesion,2.0
15037,LAMB1,GO:0009887,animal organ morphogenesis,2.0
15038,LAMB1,GO:0009888,tissue development,2.0
15039,LAMB1,GO:0016477,cell migration,2.0
15040,LAMB1,GO:0021812,neuronal-glial interaction involved in cerebral cortex radial glia guided migration,2.0
15041,LAMB1,GO:0030335,positive regulation of cell migration,2.0
15042,LAMB1,GO:0031175,neuron projection development,2.0
15043,LAMB1,GO:0034446,substrate adhesion-dependent cell spreading,2.0
15045,LAMB1,GO:0035987,endodermal cell differentiation,2.0
15046,LAMB1,GO:0042476,odontogenesis,2.0
15047,LAMB1,GO:0043256,laminin complex,2.0
15048,LAMB1,GO:0043257,laminin-8 complex,2.0
15050,LAMB1,GO:0043259,laminin-10 complex,2.0
15051,LAMB1,GO:0045785,positive regulation of cell adhesion,2.0
15052,LAMB1,GO:0048471,perinuclear region of cytoplasm,2.0
15053,LAMB1,GO:0050679,positive regulation of epithelial cell proliferation,2.0
15054,LAMB1,GO:0051149,positive regulation of muscle cell differentiation,2.0
15055,LAMB1,GO:0062023,collagen-containing extracellular matrix,2.0
15057,LAMB1,GO:0070062,extracellular exosome,2.0
15058,LAMB1,GO:0070831,basement membrane assembly,2.0
15059,LAMB1,GO:0098637,protein complex involved in cell-matrix adhesion,2.0
15060,LAMB1,GO:0110011,regulation of basement membrane organization,2.0
15061,LAMB1,GO:2001046,positive regulation of integrin-mediated signaling pathway,2.0
15208,LEMD3,GO:0005515,protein binding,2.0
15209,LEMD3,GO:0005637,nuclear inner membrane,2.0
15211,LEMD3,GO:0006998,nuclear envelope organization,2.0
15212,LEMD3,GO:0016020,membrane,2.0
15213,LEMD3,GO:0030512,negative regulation of transforming growth factor beta receptor signaling pathway,2.0
15214,LEMD3,GO:0030514,negative regulation of BMP signaling pathway,2.0
15216,LEMD3,GO:0031490,chromatin DNA binding,2.0
15217,LEMD3,GO:0031965,nuclear membrane,2.0
15218,LEMD3,GO:0032926,negative regulation of activin receptor signaling pathway,2.0
15219,LEMD3,GO:1902531,regulation of intracellular signal transduction,2.0
15220,LEO1,GO:0001650,fibrillar center,2.0
15221,LEO1,GO:0001711,endodermal cell fate commitment,2.0
15222,LEO1,GO:0005515,protein binding,2.0
15223,LEO1,GO:0005634,nucleus,2.0
15224,LEO1,GO:0005654,nucleoplasm,2.0
15226,LEO1,GO:0005813,centrosome,2.0
15227,LEO1,GO:0006368,transcription elongation by RNA polymerase II promoter,2.0
15228,LEO1,GO:0006378,mRNA polyadenylation,2.0
15229,LEO1,GO:0010390,histone monoubiquitination,2.0
15230,LEO1,GO:0016055,Wnt signaling pathway,2.0
15231,LEO1,GO:0016593,Cdc73/Paf1 complex,2.0
15232,LEO1,GO:0019827,stem cell population maintenance,2.0
15233,LEO1,GO:0031442,positive regulation of mRNA 3'-end processing,2.0
15234,LEO1,GO:0032968,positive regulation of transcription elongation by RNA polymerase II,2.0
15235,LEO1,GO:0033523,histone H2B ubiquitination,2.0
15236,LEO1,GO:0045638,negative regulation of myeloid cell differentiation,2.0
15237,LEO1,GO:1990269,RNA polymerase II C-terminal domain phosphoserine binding,2.0
15246,LEP,GO:0000122,negative regulation of transcription by RNA polymerase II,2.0
15247,LEP,GO:0001525,angiogenesis,2.0
15248,LEP,GO:0001542,ovulation from ovarian follicle,2.0
15249,LEP,GO:0001666,response to hypoxia,2.0
15250,LEP,GO:0001890,placenta development,2.0
15251,LEP,GO:0001934,positive regulation of protein phosphorylation,2.0
15252,LEP,GO:0001936,regulation of endothelial cell proliferation,2.0
15253,LEP,GO:0002021,response to dietary excess,2.0
15254,LEP,GO:0003300,cardiac muscle hypertrophy,2.0
15255,LEP,GO:0003677,DNA binding,2.0
15256,LEP,GO:0005179,hormone activity,2.0
15257,LEP,GO:0005515,protein binding,2.0
15258,LEP,GO:0005576,extracellular region,2.0
15259,LEP,GO:0005615,extracellular space,2.0
15261,LEP,GO:0005829,cytosol,2.0
15262,LEP,GO:0006006,glucose metabolic process,2.0
15263,LEP,GO:0006111,regulation of gluconeogenesis,2.0
15264,LEP,GO:0006112,energy reserve metabolic process,2.0
15265,LEP,GO:0006114,glycerol biosynthetic process,2.0
15266,LEP,GO:0006629,lipid metabolic process,2.0
15267,LEP,GO:0006635,fatty acid beta-oxidation,2.0
15268,LEP,GO:0006909,phagocytosis,2.0
15269,LEP,GO:0007260,tyrosine phosphorylation of STAT protein,2.0
15270,LEP,GO:0007565,female pregnancy,2.0
15271,LEP,GO:0007623,circadian rhythm,2.0
15272,LEP,GO:0008203,cholesterol metabolic process,2.0
15273,LEP,GO:0008206,bile acid metabolic process,2.0
15274,LEP,GO:0008217,regulation of blood pressure,2.0
15275,LEP,GO:0008340,determination of adult lifespan,2.0
15276,LEP,GO:0008343,adult feeding behavior,2.0
15277,LEP,GO:0010507,negative regulation of autophagy,2.0
15278,LEP,GO:0010888,negative regulation of lipid storage,2.0
15279,LEP,GO:0014068,positive regulation of phosphatidylinositol 3-kinase signaling,2.0
15282,LEP,GO:0014823,response to activity,2.0
15283,LEP,GO:0019953,sexual reproduction,2.0
15284,LEP,GO:0021954,central nervous system neuron development,2.0
15285,LEP,GO:0030073,insulin secretion,2.0
15286,LEP,GO:0030217,T cell differentiation,2.0
15287,LEP,GO:0030300,regulation of intestinal cholesterol absorption,2.0
15288,LEP,GO:0032008,positive regulation of TOR signaling,2.0
15290,LEP,GO:0032099,negative regulation of appetite,2.0
15291,LEP,GO:0032310,prostaglandin secretion,2.0
15292,LEP,GO:0032355,response to estradiol,2.0
15293,LEP,GO:0032735,positive regulation of interleukin-12 production,2.0
15294,LEP,GO:0032755,positive regulation of interleukin-6 production,2.0
15295,LEP,GO:0032757,positive regulation of interleukin-8 production,2.0
15296,LEP,GO:0032760,positive regulation of tumor necrosis factor production,2.0
15297,LEP,GO:0032814,regulation of natural killer cell activation,2.0
15298,LEP,GO:0032817,regulation of natural killer cell proliferation,2.0
15299,LEP,GO:0032868,response to insulin,2.0
15300,LEP,GO:0032869,cellular response to insulin stimulus,2.0
15301,LEP,GO:0033197,response to vitamin E,2.0
15302,LEP,GO:0033210,leptin-mediated signaling pathway,2.0
15303,LEP,GO:0033686,positive regulation of luteinizing hormone secretion,2.0
15304,LEP,GO:0035360,positive regulation of peroxisome proliferator activated receptor signaling pathway,2.0
15305,LEP,GO:0035556,intracellular signal transduction,2.0
15306,LEP,GO:0035630,bone mineralization involved in bone maturation,2.0
15307,LEP,GO:0035904,aorta development,2.0
15308,LEP,GO:0038108,negative regulation of appetite by leptin-mediated signaling pathway,2.0
15310,LEP,GO:0042102,positive regulation of T cell proliferation,2.0
15311,LEP,GO:0042269,regulation of natural killer cell mediated cytotoxicity,2.0
15312,LEP,GO:0042307,positive regulation of protein import into nucleus,2.0
15313,LEP,GO:0042445,hormone metabolic process,2.0
15314,LEP,GO:0042531,positive regulation of tyrosine phosphorylation of STAT protein,2.0
15315,LEP,GO:0042593,glucose homeostasis,2.0
15316,LEP,GO:0042755,eating behavior,2.0
15317,LEP,GO:0043066,negative regulation of apoptotic process,2.0
15318,LEP,GO:0043270,positive regulation of ion transport,2.0
15319,LEP,GO:0043410,positive regulation of MAPK cascade,2.0
15321,LEP,GO:0044320,cellular response to leptin stimulus,2.0
15322,LEP,GO:0045471,response to ethanol,2.0
15323,LEP,GO:0045765,regulation of angiogenesis,2.0
15324,LEP,GO:0045906,negative regulation of vasoconstriction,2.0
15325,LEP,GO:0046325,negative regulation of glucose import,2.0
15326,LEP,GO:0046427,positive regulation of receptor signaling pathway via JAK-STAT,2.0
15328,LEP,GO:0046628,positive regulation of insulin receptor signaling pathway,2.0
15329,LEP,GO:0046850,regulation of bone remodeling,2.0
15330,LEP,GO:0046881,positive regulation of follicle-stimulating hormone secretion,2.0
15331,LEP,GO:0048639,positive regulation of developmental growth,2.0
15332,LEP,GO:0050796,regulation of insulin secretion,2.0
15333,LEP,GO:0050810,regulation of steroid biosynthetic process,2.0
15334,LEP,GO:0050892,intestinal absorption,2.0
15335,LEP,GO:0050901,leukocyte tethering or rolling,2.0
15336,LEP,GO:0050999,regulation of nitric-oxide synthase activity,2.0
15337,LEP,GO:0051428,peptide hormone receptor binding,2.0
15338,LEP,GO:0051541,elastin metabolic process,2.0
15339,LEP,GO:0051726,regulation of cell cycle,2.0
15340,LEP,GO:0051897,positive regulation of protein kinase B signaling,2.0
15341,LEP,GO:0060587,regulation of lipoprotein lipid oxidation,2.0
15342,LEP,GO:0060612,adipose tissue development,2.0
15343,LEP,GO:0061037,negative regulation of cartilage development,2.0
15344,LEP,GO:0070093,negative regulation of glucagon secretion,2.0
15345,LEP,GO:0071298,cellular response to L-ascorbic acid,2.0
15346,LEP,GO:0071300,cellular response to retinoic acid,2.0
15347,LEP,GO:0090335,regulation of brown fat cell differentiation,2.0
15348,LEP,GO:0098868,bone growth,2.0
15349,LEP,GO:0120162,positive regulation of cold-induced thermogenesis,2.0
15350,LEP,GO:1900015,regulation of cytokine production involved in inflammatory response,2.0
15351,LEP,GO:1900745,positive regulation of p38MAPK cascade,2.0
15353,LEP,GO:1904651,positive regulation of fat cell apoptotic process,2.0
15354,LEP,GO:1990051,activation of protein kinase C activity,2.0
15356,LEP,GO:1990460,leptin receptor binding,2.0
15357,LEP,GO:2000379,positive regulation of reactive oxygen species metabolic process,2.0
15358,LEP,GO:2000486,negative regulation of glutamine transport,2.0
15359,LEP,GO:2000491,positive regulation of hepatic stellate cell activation,2.0
15360,LILRB2,GO:0001540,amyloid-beta binding,2.0
15362,LILRB2,GO:0002250,adaptive immune response,2.0
15363,LILRB2,GO:0002578,negative regulation of antigen processing and presentation,2.0
15364,LILRB2,GO:0002645,positive regulation of tolerance induction,2.0
15365,LILRB2,GO:0002666,positive regulation of T cell tolerance induction,2.0
15366,LILRB2,GO:0002767,immune response-inhibiting cell surface receptor signaling pathway,2.0
15368,LILRB2,GO:0002774,Fc receptor mediated inhibitory signaling pathway,2.0
15369,LILRB2,GO:0005515,protein binding,2.0
15370,LILRB2,GO:0005615,extracellular space,2.0
15371,LILRB2,GO:0005737,cytoplasm,2.0
15372,LILRB2,GO:0005886,plasma membrane,2.0
15375,LILRB2,GO:0006955,immune response,2.0
15376,LILRB2,GO:0006968,cellular defense response,2.0
15377,LILRB2,GO:0007165,signal transduction,2.0
15379,LILRB2,GO:0007166,cell surface receptor signaling pathway,2.0
15380,LILRB2,GO:0007267,cell-cell signaling,2.0
15381,LILRB2,GO:0007611,learning or memory,2.0
15382,LILRB2,GO:0008157,protein phosphatase 1 binding,2.0
15383,LILRB2,GO:0009986,cell surface,2.0
15384,LILRB2,GO:0016020,membrane,2.0
15385,LILRB2,GO:0019221,cytokine-mediated signaling pathway,2.0
15386,LILRB2,GO:0023025,MHC class Ib protein complex binding,2.0
15387,LILRB2,GO:0023029,MHC class Ib protein binding,2.0
15389,LILRB2,GO:0032396,inhibitory MHC class I receptor activity,2.0
15392,LILRB2,GO:0032755,positive regulation of interleukin-6 production,2.0
15393,LILRB2,GO:0034113,heterotypic cell-cell adhesion,2.0
15394,LILRB2,GO:0035307,positive regulation of protein dephosphorylation,2.0
15395,LILRB2,GO:0042102,positive regulation of T cell proliferation,2.0
15396,LILRB2,GO:0042130,negative regulation of T cell proliferation,2.0
15398,LILRB2,GO:0042288,MHC class I protein binding,2.0
15400,LILRB2,GO:0042803,protein homodimerization activity,2.0
15401,LILRB2,GO:0044877,protein-containing complex binding,2.0
15402,LILRB2,GO:0045591,positive regulation of regulatory T cell differentiation,2.0
15403,LILRB2,GO:0050839,cell adhesion molecule binding,2.0
15404,LILRB2,GO:0051248,negative regulation of protein metabolic process,2.0
15405,LILRB2,GO:0051926,negative regulation of calcium ion transport,2.0
15406,LILRB2,GO:0070821,tertiary granule membrane,2.0
15407,LILRB2,GO:0071222,cellular response to lipopolysaccharide,2.0
15408,LILRB2,GO:0101003,ficolin-1-rich granule membrane,2.0
15409,LILRB2,GO:0140105,interleukin-10-mediated signaling pathway,2.0
15410,LILRB2,GO:1900271,regulation of long-term synaptic potentiation,2.0
15411,LILRB2,GO:1900454,positive regulation of long-term synaptic depression,2.0
15412,LILRB2,GO:1905875,negative regulation of postsynaptic density organization,2.0
15413,LILRB2,GO:2000524,negative regulation of T cell costimulation,2.0
15414,LILRB2,GO:2001198,regulation of dendritic cell differentiation,2.0
15415,LIN7B,GO:0005515,protein binding,2.0
15416,LIN7B,GO:0005886,plasma membrane,2.0
15417,LIN7B,GO:0005911,cell-cell junction,2.0
15418,LIN7B,GO:0005923,bicellular tight junction,2.0
15419,LIN7B,GO:0006887,exocytosis,2.0
15420,LIN7B,GO:0007269,neurotransmitter secretion,2.0
15421,LIN7B,GO:0015031,protein transport,2.0
15422,LIN7B,GO:0016323,basolateral plasma membrane,2.0
15423,LIN7B,GO:0019904,protein domain specific binding,2.0
15424,LIN7B,GO:0030165,PDZ domain binding,2.0
15425,LIN7B,GO:0045199,maintenance of epithelial cell apical/basal polarity,2.0
15426,LIN7B,GO:0045202,synapse,2.0
15427,LIN7B,GO:0097016,L27 domain binding,2.0
15428,LIN7B,GO:0097025,MPP7-DLG1-LIN7 complex,2.0
15429,LIN7B,GO:0098793,presynapse,2.0
15430,LIN7B,GO:0098839,postsynaptic density membrane,2.0
15431,LIN7B,GO:1903361,protein localization to basolateral plasma membrane,2.0
15444,LMX1B,GO:0000785,chromatin,2.0
15445,LMX1B,GO:0000977,RNA polymerase II transcription regulatory region sequence-specific DNA binding,2.0
15447,LMX1B,GO:0000981,"DNA-binding transcription factor activity, RNA polymerase II-specific",2.0
15450,LMX1B,GO:0003700,DNA-binding transcription factor activity,2.0
15451,LMX1B,GO:0005515,protein binding,2.0
15452,LMX1B,GO:0005634,nucleus,2.0
15454,LMX1B,GO:0006355,regulation of DNA-templated transcription,2.0
15455,LMX1B,GO:0006357,regulation of transcription by RNA polymerase II,2.0
15456,LMX1B,GO:0009953,dorsal/ventral pattern formation,2.0
15457,LMX1B,GO:0030182,neuron differentiation,2.0
15459,LMX1B,GO:0045944,positive regulation of transcription by RNA polymerase II,2.0
15461,LMX1B,GO:0046872,metal ion binding,2.0
15462,LMX1B,GO:0071542,dopaminergic neuron differentiation,2.0
15463,LMX1B,GO:1990837,sequence-specific double-stranded DNA binding,2.0
15481,LRBA,GO:0000423,mitophagy,2.0
15482,LRBA,GO:0003674,molecular_function,2.0
15483,LRBA,GO:0005515,protein binding,2.0
15484,LRBA,GO:0005765,lysosomal membrane,2.0
15485,LRBA,GO:0005789,endoplasmic reticulum membrane,2.0
15486,LRBA,GO:0005794,Golgi apparatus,2.0
15487,LRBA,GO:0005829,cytosol,2.0
15488,LRBA,GO:0005886,plasma membrane,2.0
15489,LRBA,GO:0008104,protein localization,2.0
15490,LRBA,GO:0016020,membrane,2.0
15492,LRBA,GO:0019901,protein kinase binding,2.0
15493,LRBA,GO:0034497,protein localization to phagophore assembly site,2.0
15494,LRFN2,GO:0005886,plasma membrane,2.0
15495,LRFN2,GO:0009986,cell surface,2.0
15496,LRFN2,GO:0050804,modulation of chemical synaptic transmission,2.0
15497,LRFN2,GO:0098685,Schaffer collateral - CA1 synapse,2.0
15498,LRFN2,GO:0098793,presynapse,2.0
15499,LRFN2,GO:0098839,postsynaptic density membrane,2.0
15500,LRFN2,GO:0099175,regulation of postsynapse organization,2.0
15501,LRFN5,GO:0005515,protein binding,2.0
15502,LRFN5,GO:0009986,cell surface,2.0
15503,LRFN5,GO:0043031,negative regulation of macrophage activation,2.0
15504,LRFN5,GO:0050728,negative regulation of inflammatory response,2.0
15505,LRFN5,GO:0098839,postsynaptic density membrane,2.0
15506,LRFN5,GO:0098978,glutamatergic synapse,2.0
15507,LRFN5,GO:0098982,GABA-ergic synapse,2.0
15508,LRFN5,GO:0099560,synaptic membrane adhesion,2.0
15509,LRFN5,GO:1905606,regulation of presynapse assembly,2.0
15510,LRP1,GO:0001523,retinoid metabolic process,2.0
15511,LRP1,GO:0001540,amyloid-beta binding,2.0
15512,LRP1,GO:0002265,astrocyte activation involved in immune response,2.0
15513,LRP1,GO:0003723,RNA binding,2.0
15514,LRP1,GO:0005041,low-density lipoprotein particle receptor activity,2.0
15515,LRP1,GO:0005044,scavenger receptor activity,2.0
15516,LRP1,GO:0005509,calcium ion binding,2.0
15517,LRP1,GO:0005515,protein binding,2.0
15518,LRP1,GO:0005634,nucleus,2.0
15519,LRP1,GO:0005765,lysosomal membrane,2.0
15520,LRP1,GO:0005769,early endosome,2.0
15521,LRP1,GO:0005794,Golgi apparatus,2.0
15522,LRP1,GO:0005856,cytoskeleton,2.0
15523,LRP1,GO:0005886,plasma membrane,2.0
15526,LRP1,GO:0005905,clathrin-coated pit,2.0
15527,LRP1,GO:0005925,focal adhesion,2.0
15528,LRP1,GO:0006629,lipid metabolic process,2.0
15529,LRP1,GO:0006898,receptor-mediated endocytosis,2.0
15532,LRP1,GO:0006909,phagocytosis,2.0
15535,LRP1,GO:0007041,lysosomal transport,2.0
15536,LRP1,GO:0007167,enzyme-linked receptor protein signaling pathway,2.0
15537,LRP1,GO:0010629,negative regulation of gene expression,2.0
15538,LRP1,GO:0010715,regulation of extracellular matrix disassembly,2.0
15539,LRP1,GO:0010875,positive regulation of cholesterol efflux,2.0
15540,LRP1,GO:0010942,positive regulation of cell death,2.0
15541,LRP1,GO:0014912,negative regulation of smooth muscle cell migration,2.0
15542,LRP1,GO:0016020,membrane,2.0
15543,LRP1,GO:0016323,basolateral plasma membrane,2.0
15544,LRP1,GO:0016964,alpha-2 macroglobulin receptor activity,2.0
15546,LRP1,GO:0030178,negative regulation of Wnt signaling pathway,2.0
15547,LRP1,GO:0030226,apolipoprotein receptor activity,2.0
15548,LRP1,GO:0030666,endocytic vesicle membrane,2.0
15549,LRP1,GO:0031623,receptor internalization,2.0
15550,LRP1,GO:0032050,clathrin heavy chain binding,2.0
15551,LRP1,GO:0032092,positive regulation of protein binding,2.0
15552,LRP1,GO:0032370,positive regulation of lipid transport,2.0
15553,LRP1,GO:0032374,regulation of cholesterol transport,2.0
15554,LRP1,GO:0032429,regulation of phospholipase A2 activity,2.0
15555,LRP1,GO:0032956,regulation of actin cytoskeleton organization,2.0
15556,LRP1,GO:0034185,apolipoprotein binding,2.0
15559,LRP1,GO:0035909,aorta morphogenesis,2.0
15560,LRP1,GO:0038023,signaling receptor activity,2.0
15561,LRP1,GO:0038024,cargo receptor activity,2.0
15565,LRP1,GO:0042953,lipoprotein transport,2.0
15566,LRP1,GO:0043235,receptor complex,2.0
15567,LRP1,GO:0043277,apoptotic cell clearance,2.0
15568,LRP1,GO:0043395,heparan sulfate proteoglycan binding,2.0
15569,LRP1,GO:0044877,protein-containing complex binding,2.0
15570,LRP1,GO:0045056,transcytosis,2.0
15571,LRP1,GO:0045807,positive regulation of endocytosis,2.0
15572,LRP1,GO:0060392,negative regulation of SMAD protein signal transduction,2.0
15573,LRP1,GO:0060394,negative regulation of pathway-restricted SMAD protein phosphorylation,2.0
15574,LRP1,GO:0070325,lipoprotein particle receptor binding,2.0
15575,LRP1,GO:0097242,amyloid-beta clearance,2.0
15577,LRP1,GO:0098797,plasma membrane protein complex,2.0
15578,LRP1,GO:0150093,amyloid-beta clearance by transcytosis,2.0
15581,LRP1,GO:0150094,amyloid-beta clearance by cellular catabolic process,2.0
15584,LRP1,GO:0150104,transport across blood-brain barrier,2.0
15586,LRP1,GO:1900223,positive regulation of amyloid-beta clearance,2.0
15588,LRP1,GO:1903078,positive regulation of protein localization to plasma membrane,2.0
15589,LRP1,GO:1904300,positive regulation of transcytosis,2.0
15590,LRP1,GO:1904646,cellular response to amyloid-beta,2.0
15591,LRP1,GO:1905049,negative regulation of metallopeptidase activity,2.0
15592,LRP1,GO:1905167,positive regulation of lysosomal protein catabolic process,2.0
15593,LRP1,GO:2000587,negative regulation of platelet-derived growth factor receptor-beta signaling pathway,2.0
15594,LRP2,GO:0001523,retinoid metabolic process,2.0
15595,LRP2,GO:0001822,kidney development,2.0
15596,LRP2,GO:0001843,neural tube closure,2.0
15597,LRP2,GO:0003139,secondary heart field specification,2.0
15598,LRP2,GO:0003148,outflow tract septum morphogenesis,2.0
15599,LRP2,GO:0003223,ventricular compact myocardium morphogenesis,2.0
15600,LRP2,GO:0003281,ventricular septum development,2.0
15601,LRP2,GO:0005041,low-density lipoprotein particle receptor activity,2.0
15602,LRP2,GO:0005509,calcium ion binding,2.0
15603,LRP2,GO:0005515,protein binding,2.0
15604,LRP2,GO:0005764,lysosome,2.0
15605,LRP2,GO:0005765,lysosomal membrane,2.0
15606,LRP2,GO:0005783,endoplasmic reticulum,2.0
15607,LRP2,GO:0005794,Golgi apparatus,2.0
15608,LRP2,GO:0005886,plasma membrane,2.0
15610,LRP2,GO:0005905,clathrin-coated pit,2.0
15611,LRP2,GO:0006629,lipid metabolic process,2.0
15612,LRP2,GO:0006897,endocytosis,2.0
15613,LRP2,GO:0006898,receptor-mediated endocytosis,2.0
15616,LRP2,GO:0007605,sensory perception of sound,2.0
15617,LRP2,GO:0008283,cell population proliferation,2.0
15618,LRP2,GO:0008584,male gonad development,2.0
15619,LRP2,GO:0009897,external side of plasma membrane,2.0
15620,LRP2,GO:0015031,protein transport,2.0
15621,LRP2,GO:0015889,cobalamin transport,2.0
15622,LRP2,GO:0016324,apical plasma membrane,2.0
15625,LRP2,GO:0017124,SH3 domain binding,2.0
15626,LRP2,GO:0030001,metal ion transport,2.0
15627,LRP2,GO:0030424,axon,2.0
15628,LRP2,GO:0030425,dendrite,2.0
15629,LRP2,GO:0030514,negative regulation of BMP signaling pathway,2.0
15630,LRP2,GO:0030669,clathrin-coated endocytic vesicle membrane,2.0
15631,LRP2,GO:0030900,forebrain development,2.0
15632,LRP2,GO:0031526,brush border membrane,2.0
15633,LRP2,GO:0031904,endosome lumen,2.0
15634,LRP2,GO:0031994,insulin-like growth factor I binding,2.0
15635,LRP2,GO:0034311,diol metabolic process,2.0
15636,LRP2,GO:0035904,aorta development,2.0
15637,LRP2,GO:0038024,cargo receptor activity,2.0
15639,LRP2,GO:0042359,vitamin D metabolic process,2.0
15640,LRP2,GO:0042562,hormone binding,2.0
15641,LRP2,GO:0043066,negative regulation of apoptotic process,2.0
15642,LRP2,GO:0043235,receptor complex,2.0
15645,LRP2,GO:0044321,response to leptin,2.0
15646,LRP2,GO:0045056,transcytosis,2.0
15647,LRP2,GO:0050769,positive regulation of neurogenesis,2.0
15648,LRP2,GO:0051087,chaperone binding,2.0
15650,LRP2,GO:0051897,positive regulation of protein kinase B signaling,2.0
15651,LRP2,GO:0060068,vagina development,2.0
15652,LRP2,GO:0060982,coronary artery morphogenesis,2.0
15653,LRP2,GO:0061156,pulmonary artery morphogenesis,2.0
15654,LRP2,GO:0070062,extracellular exosome,2.0
15655,LRP2,GO:0070447,positive regulation of oligodendrocyte progenitor proliferation,2.0
15656,LRP2,GO:0071363,cellular response to growth factor stimulus,2.0
15657,LRP2,GO:0097242,amyloid-beta clearance,2.0
15658,LRP2,GO:0140058,neuron projection arborization,2.0
15659,LRP2,GO:0140318,protein transporter activity,2.0
15660,LRP2,GO:0150104,transport across blood-brain barrier,2.0
15661,LRP2,GO:1904447,folate import across plasma membrane,2.0
15662,LRP2,GO:1905167,positive regulation of lysosomal protein catabolic process,2.0
15663,LRRC1,GO:0005829,cytosol,2.0
15664,LRRC1,GO:0016020,membrane,2.0
15665,LRRC4,GO:0005515,protein binding,2.0
15666,LRRC4,GO:0005886,plasma membrane,2.0
15667,LRRC4,GO:0043197,dendritic spine,2.0
15668,LRRC4,GO:0050804,modulation of chemical synaptic transmission,2.0
15669,LRRC4,GO:0060076,excitatory synapse,2.0
15670,LRRC4,GO:0097119,postsynaptic density protein 95 clustering,2.0
15671,LRRC4,GO:0098685,Schaffer collateral - CA1 synapse,2.0
15672,LRRC4,GO:0098839,postsynaptic density membrane,2.0
15673,LRRC4,GO:0098978,glutamatergic synapse,2.0
15674,LRRC4,GO:0099560,synaptic membrane adhesion,2.0
15675,LRRC4,GO:1904861,excitatory synapse assembly,2.0
15702,LZTS2,GO:0000281,mitotic cytokinesis,2.0
15703,LZTS2,GO:0005515,protein binding,2.0
15704,LZTS2,GO:0005813,centrosome,2.0
15705,LZTS2,GO:0005829,cytosol,2.0
15706,LZTS2,GO:0005874,microtubule,2.0
15707,LZTS2,GO:0005886,plasma membrane,2.0
15708,LZTS2,GO:0016055,Wnt signaling pathway,2.0
15709,LZTS2,GO:0030496,midbody,2.0
15710,LZTS2,GO:0031982,vesicle,2.0
15711,LZTS2,GO:0051013,microtubule severing,2.0
15712,LZTS2,GO:0051168,nuclear export,2.0
15713,LZTS2,GO:0051255,spindle midzone assembly,2.0
15714,LZTS2,GO:0090090,negative regulation of canonical Wnt signaling pathway,2.0
15715,MACROD2,GO:0005634,nucleus,2.0
15716,MACROD2,GO:0005654,nucleoplasm,2.0
15718,MACROD2,GO:0005730,nucleolus,2.0
15719,MACROD2,GO:0006974,cellular response to DNA damage stimulus,2.0
15721,MACROD2,GO:0007420,brain development,2.0
15722,MACROD2,GO:0009617,response to bacterium,2.0
15723,MACROD2,GO:0016798,"hydrolase activity, acting on glycosyl bonds",2.0
15724,MACROD2,GO:0019213,deacetylase activity,2.0
15725,MACROD2,GO:0042278,purine nucleoside metabolic process,2.0
15727,MACROD2,GO:0051725,protein de-ADP-ribosylation,2.0
15728,MACROD2,GO:0140291,peptidyl-glutamate ADP-deribosylation,2.0
15730,MACROD2,GO:0140293,ADP-ribosylglutamate hydrolase activity,2.0
15747,MAOA,GO:0005515,protein binding,2.0
15748,MAOA,GO:0005739,mitochondrion,2.0
15751,MAOA,GO:0005741,mitochondrial outer membrane,2.0
15752,MAOA,GO:0005829,cytosol,2.0
15753,MAOA,GO:0006576,biogenic amine metabolic process,2.0
15754,MAOA,GO:0008131,primary amine oxidase activity,2.0
15756,MAOA,GO:0009967,positive regulation of signal transduction,2.0
15757,MAOA,GO:0042135,neurotransmitter catabolic process,2.0
15758,MAOA,GO:0042420,dopamine catabolic process,2.0
15759,MAOA,GO:0050660,flavin adenine dinucleotide binding,2.0
15760,MAOA,GO:0052595,aliphatic amine oxidase activity,2.0
15761,MAOA,GO:0052596,phenethylamine:oxygen oxidoreductase (deaminating) activity,2.0
15762,MAOA,GO:0097621,monoamine oxidase activity,2.0
15763,MAOB,GO:0005515,protein binding,2.0
15764,MAOB,GO:0005739,mitochondrion,2.0
15767,MAOB,GO:0005740,mitochondrial envelope,2.0
15768,MAOB,GO:0005741,mitochondrial outer membrane,2.0
15769,MAOB,GO:0008131,primary amine oxidase activity,2.0
15772,MAOB,GO:0009055,electron transfer activity,2.0
15773,MAOB,GO:0009410,response to xenobiotic stimulus,2.0
15774,MAOB,GO:0009636,response to toxic substance,2.0
15775,MAOB,GO:0010044,response to aluminum ion,2.0
15776,MAOB,GO:0010269,response to selenium ion,2.0
15777,MAOB,GO:0014063,negative regulation of serotonin secretion,2.0
15778,MAOB,GO:0021762,substantia nigra development,2.0
15779,MAOB,GO:0022900,electron transport chain,2.0
15780,MAOB,GO:0032496,response to lipopolysaccharide,2.0
15781,MAOB,GO:0042135,neurotransmitter catabolic process,2.0
15782,MAOB,GO:0042420,dopamine catabolic process,2.0
15783,MAOB,GO:0042802,identical protein binding,2.0
15784,MAOB,GO:0045471,response to ethanol,2.0
15785,MAOB,GO:0045964,positive regulation of dopamine metabolic process,2.0
15786,MAOB,GO:0050660,flavin adenine dinucleotide binding,2.0
15787,MAOB,GO:0050665,hydrogen peroxide biosynthetic process,2.0
15788,MAOB,GO:0051412,response to corticosterone,2.0
15789,MAOB,GO:0052595,aliphatic amine oxidase activity,2.0
15790,MAOB,GO:0052596,phenethylamine:oxygen oxidoreductase (deaminating) activity,2.0
15791,MAOB,GO:0097621,monoamine oxidase activity,2.0
15854,MAPK3,GO:0000165,MAPK cascade,2.0
15855,MAPK3,GO:0001784,phosphotyrosine residue binding,2.0
15856,MAPK3,GO:0001934,positive regulation of protein phosphorylation,2.0
15857,MAPK3,GO:0004674,protein serine/threonine kinase activity,2.0
15860,MAPK3,GO:0004707,MAP kinase activity,2.0
15863,MAPK3,GO:0004708,MAP kinase kinase activity,2.0
15864,MAPK3,GO:0005515,protein binding,2.0
15865,MAPK3,GO:0005524,ATP binding,2.0
15866,MAPK3,GO:0005634,nucleus,2.0
15868,MAPK3,GO:0005635,nuclear envelope,2.0
15869,MAPK3,GO:0005654,nucleoplasm,2.0
15870,MAPK3,GO:0005737,cytoplasm,2.0
15872,MAPK3,GO:0005739,mitochondrion,2.0
15873,MAPK3,GO:0005769,early endosome,2.0
15874,MAPK3,GO:0005770,late endosome,2.0
15875,MAPK3,GO:0005788,endoplasmic reticulum lumen,2.0
15876,MAPK3,GO:0005794,Golgi apparatus,2.0
15877,MAPK3,GO:0005829,cytosol,2.0
15878,MAPK3,GO:0005856,cytoskeleton,2.0
15879,MAPK3,GO:0005886,plasma membrane,2.0
15880,MAPK3,GO:0005901,caveola,2.0
15882,MAPK3,GO:0005925,focal adhesion,2.0
15883,MAPK3,GO:0006351,DNA-templated transcription,2.0
15884,MAPK3,GO:0006468,protein phosphorylation,2.0
15885,MAPK3,GO:0006915,apoptotic process,2.0
15886,MAPK3,GO:0007049,cell cycle,2.0
15887,MAPK3,GO:0007166,cell surface receptor signaling pathway,2.0
15888,MAPK3,GO:0008286,insulin receptor signaling pathway,2.0
15889,MAPK3,GO:0010628,positive regulation of gene expression,2.0
15890,MAPK3,GO:0010759,positive regulation of macrophage chemotaxis,2.0
15891,MAPK3,GO:0016310,phosphorylation,2.0
15892,MAPK3,GO:0019233,sensory perception of pain,2.0
15893,MAPK3,GO:0019902,phosphatase binding,2.0
15894,MAPK3,GO:0030278,regulation of ossification,2.0
15895,MAPK3,GO:0030509,BMP signaling pathway,2.0
15896,MAPK3,GO:0030641,regulation of cellular pH,2.0
15897,MAPK3,GO:0030878,thyroid gland development,2.0
15898,MAPK3,GO:0031143,pseudopodium,2.0
15899,MAPK3,GO:0031281,positive regulation of cyclase activity,2.0
15900,MAPK3,GO:0031663,lipopolysaccharide-mediated signaling pathway,2.0
15901,MAPK3,GO:0032212,positive regulation of telomere maintenance via telomerase,2.0
15902,MAPK3,GO:0032872,regulation of stress-activated MAPK cascade,2.0
15903,MAPK3,GO:0034198,cellular response to amino acid starvation,2.0
15904,MAPK3,GO:0034614,cellular response to reactive oxygen species,2.0
15905,MAPK3,GO:0035556,intracellular signal transduction,2.0
15906,MAPK3,GO:0038083,peptidyl-tyrosine autophosphorylation,2.0
15907,MAPK3,GO:0042473,outer ear morphogenesis,2.0
15908,MAPK3,GO:0042770,signal transduction in response to DNA damage,2.0
15909,MAPK3,GO:0042802,identical protein binding,2.0
15910,MAPK3,GO:0043330,response to exogenous dsRNA,2.0
15911,MAPK3,GO:0045944,positive regulation of transcription by RNA polymerase II,2.0
15912,MAPK3,GO:0048009,insulin-like growth factor receptor signaling pathway,2.0
15913,MAPK3,GO:0048538,thymus development,2.0
15914,MAPK3,GO:0050804,modulation of chemical synaptic transmission,2.0
15915,MAPK3,GO:0051090,regulation of DNA-binding transcription factor activity,2.0
15916,MAPK3,GO:0051216,cartilage development,2.0
15917,MAPK3,GO:0051403,stress-activated MAPK cascade,2.0
15918,MAPK3,GO:0051493,regulation of cytoskeleton organization,2.0
15919,MAPK3,GO:0051973,positive regulation of telomerase activity,2.0
15920,MAPK3,GO:0060020,Bergmann glial cell differentiation,2.0
15921,MAPK3,GO:0060324,face development,2.0
15922,MAPK3,GO:0060425,lung morphogenesis,2.0
15923,MAPK3,GO:0060440,trachea formation,2.0
15924,MAPK3,GO:0061308,cardiac neural crest cell development involved in heart development,2.0
15925,MAPK3,GO:0070371,ERK1 and ERK2 cascade,2.0
15926,MAPK3,GO:0070374,positive regulation of ERK1 and ERK2 cascade,2.0
15927,MAPK3,GO:0070498,interleukin-1-mediated signaling pathway,2.0
15928,MAPK3,GO:0070849,response to epidermal growth factor,2.0
15929,MAPK3,GO:0071260,cellular response to mechanical stimulus,2.0
15930,MAPK3,GO:0071276,cellular response to cadmium ion,2.0
15931,MAPK3,GO:0071356,cellular response to tumor necrosis factor,2.0
15932,MAPK3,GO:0072584,caveolin-mediated endocytosis,2.0
15933,MAPK3,GO:0090170,regulation of Golgi inheritance,2.0
15934,MAPK3,GO:0098792,xenophagy,2.0
15935,MAPK3,GO:0098978,glutamatergic synapse,2.0
15936,MAPK3,GO:0106310,protein serine kinase activity,2.0
15937,MAPK3,GO:0120041,positive regulation of macrophage proliferation,2.0
15938,MAPK3,GO:0140297,DNA-binding transcription factor binding,2.0
15939,MAPK3,GO:1903351,cellular response to dopamine,2.0
15940,MAPK3,GO:1904355,positive regulation of telomere capping,2.0
15941,MAPK3,GO:1904417,positive regulation of xenophagy,2.0
15942,MAPK3,GO:2000641,regulation of early endosome to late endosome transport,2.0
15943,MAPK3,GO:2000657,negative regulation of apolipoprotein binding,2.0
16103,MAPT-AS1,GO:0031047,RNA-mediated gene silencing,2.0
16104,MAPT-AS1,GO:1905642,negative regulation of DNA methylation,2.0
16105,MARK1,GO:0000226,microtubule cytoskeleton organization,2.0
16107,MARK1,GO:0000287,magnesium ion binding,2.0
16108,MARK1,GO:0001764,neuron migration,2.0
16109,MARK1,GO:0001786,phosphatidylserine binding,2.0
16110,MARK1,GO:0004674,protein serine/threonine kinase activity,2.0
16113,MARK1,GO:0005515,protein binding,2.0
16114,MARK1,GO:0005524,ATP binding,2.0
16115,MARK1,GO:0005546,"phosphatidylinositol-4,5-bisphosphate binding",2.0
16116,MARK1,GO:0005737,cytoplasm,2.0
16119,MARK1,GO:0005856,cytoskeleton,2.0
16120,MARK1,GO:0005886,plasma membrane,2.0
16121,MARK1,GO:0006468,protein phosphorylation,2.0
16123,MARK1,GO:0007010,cytoskeleton organization,2.0
16124,MARK1,GO:0010628,positive regulation of gene expression,2.0
16125,MARK1,GO:0010629,negative regulation of gene expression,2.0
16126,MARK1,GO:0010719,negative regulation of epithelial to mesenchymal transition,2.0
16127,MARK1,GO:0010975,regulation of neuron projection development,2.0
16128,MARK1,GO:0015630,microtubule cytoskeleton,2.0
16129,MARK1,GO:0016055,Wnt signaling pathway,2.0
16130,MARK1,GO:0018105,peptidyl-serine phosphorylation,2.0
16131,MARK1,GO:0030425,dendrite,2.0
16132,MARK1,GO:0035556,intracellular signal transduction,2.0
16134,MARK1,GO:0048156,tau protein binding,2.0
16135,MARK1,GO:0050321,tau-protein kinase activity,2.0
16139,MARK1,GO:0050773,regulation of dendrite development,2.0
16140,MARK1,GO:0051654,establishment of mitochondrion localization,2.0
16141,MARK1,GO:0070300,phosphatidic acid binding,2.0
16142,MARK1,GO:0106310,protein serine kinase activity,2.0
16143,MARK2,GO:0000226,microtubule cytoskeleton organization,2.0
16144,MARK2,GO:0000287,magnesium ion binding,2.0
16145,MARK2,GO:0000422,autophagy of mitochondrion,2.0
16146,MARK2,GO:0001764,neuron migration,2.0
16147,MARK2,GO:0003723,RNA binding,2.0
16148,MARK2,GO:0004674,protein serine/threonine kinase activity,2.0
16153,MARK2,GO:0005515,protein binding,2.0
16154,MARK2,GO:0005524,ATP binding,2.0
16155,MARK2,GO:0005654,nucleoplasm,2.0
16156,MARK2,GO:0005737,cytoplasm,2.0
16158,MARK2,GO:0005739,mitochondrion,2.0
16159,MARK2,GO:0005884,actin filament,2.0
16160,MARK2,GO:0005886,plasma membrane,2.0
16161,MARK2,GO:0006468,protein phosphorylation,2.0
16164,MARK2,GO:0008289,lipid binding,2.0
16165,MARK2,GO:0010976,positive regulation of neuron projection development,2.0
16166,MARK2,GO:0016020,membrane,2.0
16167,MARK2,GO:0016055,Wnt signaling pathway,2.0
16168,MARK2,GO:0016328,lateral plasma membrane,2.0
16169,MARK2,GO:0018105,peptidyl-serine phosphorylation,2.0
16171,MARK2,GO:0018107,peptidyl-threonine phosphorylation,2.0
16172,MARK2,GO:0030010,establishment of cell polarity,2.0
16174,MARK2,GO:0030295,protein kinase activator activity,2.0
16175,MARK2,GO:0030425,dendrite,2.0
16176,MARK2,GO:0032147,activation of protein kinase activity,2.0
16177,MARK2,GO:0035556,intracellular signal transduction,2.0
16179,MARK2,GO:0045197,establishment or maintenance of epithelial cell apical/basal polarity,2.0
16180,MARK2,GO:0045296,cadherin binding,2.0
16181,MARK2,GO:0046777,protein autophosphorylation,2.0
16182,MARK2,GO:0048156,tau protein binding,2.0
16184,MARK2,GO:0050321,tau-protein kinase activity,2.0
16188,MARK2,GO:0050770,regulation of axonogenesis,2.0
16189,MARK2,GO:0051493,regulation of cytoskeleton organization,2.0
16190,MARK2,GO:0051646,mitochondrion localization,2.0
16191,MARK2,GO:0061564,axon development,2.0
16192,MARK2,GO:0070507,regulation of microtubule cytoskeleton organization,2.0
16193,MARK2,GO:0071963,establishment or maintenance of cell polarity regulating cell shape,2.0
16194,MARK2,GO:0097427,microtubule bundle,2.0
16195,MARK2,GO:0106310,protein serine kinase activity,2.0
16196,MARK2,GO:1904526,regulation of microtubule binding,2.0
16207,MBD1,GO:0003677,DNA binding,2.0
16208,MBD1,GO:0005515,protein binding,2.0
16209,MBD1,GO:0005634,nucleus,2.0
16210,MBD1,GO:0005654,nucleoplasm,2.0
16211,MBD1,GO:0005694,chromosome,2.0
16212,MBD1,GO:0006366,transcription by RNA polymerase II,2.0
16213,MBD1,GO:0008270,zinc ion binding,2.0
16214,MBD1,GO:0008327,methyl-CpG binding,2.0
16216,MBD1,GO:0010385,double-stranded methylated DNA binding,2.0
16217,MBD1,GO:0016363,nuclear matrix,2.0
16218,MBD1,GO:0016607,nuclear speck,2.0
16219,MBD1,GO:0045322,unmethylated CpG binding,2.0
16220,MBD1,GO:0045892,negative regulation of DNA-templated transcription,2.0
16221,MBD3,GO:0000122,negative regulation of transcription by RNA polymerase II,2.0
16222,MBD3,GO:0000785,chromatin,2.0
16223,MBD3,GO:0000792,heterochromatin,2.0
16224,MBD3,GO:0001701,in utero embryonic development,2.0
16225,MBD3,GO:0003677,DNA binding,2.0
16226,MBD3,GO:0005515,protein binding,2.0
16227,MBD3,GO:0005654,nucleoplasm,2.0
16228,MBD3,GO:0005737,cytoplasm,2.0
16229,MBD3,GO:0006338,chromatin remodeling,2.0
16231,MBD3,GO:0006346,DNA methylation-dependent heterochromatin formation,2.0
16232,MBD3,GO:0007420,brain development,2.0
16233,MBD3,GO:0007507,heart development,2.0
16234,MBD3,GO:0007568,aging,2.0
16235,MBD3,GO:0008327,methyl-CpG binding,2.0
16236,MBD3,GO:0009888,tissue development,2.0
16237,MBD3,GO:0016573,histone acetylation,2.0
16238,MBD3,GO:0016575,histone deacetylation,2.0
16239,MBD3,GO:0016581,NuRD complex,2.0
16241,MBD3,GO:0031492,nucleosomal DNA binding,2.0
16242,MBD3,GO:0031667,response to nutrient levels,2.0
16243,MBD3,GO:0032355,response to estradiol,2.0
16244,MBD3,GO:0032991,protein-containing complex,2.0
16245,MBD3,GO:0042659,regulation of cell fate specification,2.0
16246,MBD3,GO:0044030,regulation of DNA methylation,2.0
16247,MBD3,GO:0045892,negative regulation of DNA-templated transcription,2.0
16248,MBD3,GO:0045893,positive regulation of DNA-templated transcription,2.0
16249,MBD3,GO:0048568,embryonic organ development,2.0
16250,MBD3,GO:2000736,regulation of stem cell differentiation,2.0
16251,MBD4,GO:0003677,DNA binding,2.0
16252,MBD4,GO:0003696,satellite DNA binding,2.0
16253,MBD4,GO:0004520,endodeoxyribonuclease activity,2.0
16254,MBD4,GO:0005515,protein binding,2.0
16255,MBD4,GO:0005634,nucleus,2.0
16256,MBD4,GO:0005654,nucleoplasm,2.0
16257,MBD4,GO:0006281,DNA repair,2.0
16258,MBD4,GO:0008263,pyrimidine-specific mismatch base pair DNA N-glycosylase activity,2.0
16259,MBD4,GO:0016607,nuclear speck,2.0
16260,MBD4,GO:0019104,DNA N-glycosylase activity,2.0
16261,MBD4,GO:0045008,depyrimidination,2.0
16279,MBD6,GO:0001650,fibrillar center,2.0
16280,MBD6,GO:0003677,DNA binding,2.0
16281,MBD6,GO:0003682,chromatin binding,2.0
16283,MBD6,GO:0005515,protein binding,2.0
16284,MBD6,GO:0005634,nucleus,2.0
16286,MBD6,GO:0005654,nucleoplasm,2.0
16288,MBD6,GO:0005694,chromosome,2.0
16289,MBD6,GO:0010369,chromocenter,2.0
16317,MCM4,GO:0000727,double-strand break repair via break-induced replication,2.0
16318,MCM4,GO:0000781,"chromosome, telomeric region",2.0
16319,MCM4,GO:0003678,DNA helicase activity,2.0
16320,MCM4,GO:0003697,single-stranded DNA binding,2.0
16322,MCM4,GO:0005515,protein binding,2.0
16323,MCM4,GO:0005524,ATP binding,2.0
16324,MCM4,GO:0005634,nucleus,2.0
16327,MCM4,GO:0005654,nucleoplasm,2.0
16329,MCM4,GO:0006260,DNA replication,2.0
16330,MCM4,GO:0006268,DNA unwinding involved in DNA replication,2.0
16332,MCM4,GO:0006271,DNA strand elongation involved in DNA replication,2.0
16333,MCM4,GO:0016020,membrane,2.0
16334,MCM4,GO:0016887,ATP hydrolysis activity,2.0
16335,MCM4,GO:0017116,single-stranded DNA helicase activity,2.0
16336,MCM4,GO:0030174,regulation of DNA-templated DNA replication initiation,2.0
16337,MCM4,GO:0042555,MCM complex,2.0
16340,MCM4,GO:0071162,CMG complex,2.0
16342,MCM4,GO:1902975,mitotic DNA replication initiation,2.0
16343,MCM6,GO:0000727,double-strand break repair via break-induced replication,2.0
16344,MCM6,GO:0000781,"chromosome, telomeric region",2.0
16345,MCM6,GO:0003678,DNA helicase activity,2.0
16346,MCM6,GO:0003697,single-stranded DNA binding,2.0
16348,MCM6,GO:0005515,protein binding,2.0
16349,MCM6,GO:0005524,ATP binding,2.0
16350,MCM6,GO:0005634,nucleus,2.0
16353,MCM6,GO:0005654,nucleoplasm,2.0
16355,MCM6,GO:0006260,DNA replication,2.0
16356,MCM6,GO:0006268,DNA unwinding involved in DNA replication,2.0
16358,MCM6,GO:0006270,DNA replication initiation,2.0
16359,MCM6,GO:0016887,ATP hydrolysis activity,2.0
16360,MCM6,GO:0017116,single-stranded DNA helicase activity,2.0
16361,MCM6,GO:0030174,regulation of DNA-templated DNA replication initiation,2.0
16362,MCM6,GO:0042555,MCM complex,2.0
16365,MCM6,GO:0042802,identical protein binding,2.0
16366,MCM6,GO:0071162,CMG complex,2.0
16368,MCM6,GO:1902969,mitotic DNA replication,2.0
16369,MCM6,GO:1990518,single-stranded 3'-5' DNA helicase activity,2.0
16370,MCPH1,GO:0000122,negative regulation of transcription by RNA polymerase II,2.0
16371,MCPH1,GO:0000132,establishment of mitotic spindle orientation,2.0
16372,MCPH1,GO:0000278,mitotic cell cycle,2.0
16373,MCPH1,GO:0005515,protein binding,2.0
16374,MCPH1,GO:0005654,nucleoplasm,2.0
16375,MCPH1,GO:0005737,cytoplasm,2.0
16376,MCPH1,GO:0005815,microtubule organizing center,2.0
16377,MCPH1,GO:0021987,cerebral cortex development,2.0
16378,MCPH1,GO:0042802,identical protein binding,2.0
16379,MCPH1,GO:0043549,regulation of kinase activity,2.0
16380,MCPH1,GO:0046605,regulation of centrosome cycle,2.0
16381,MCPH1,GO:0050727,regulation of inflammatory response,2.0
16382,MCPH1,GO:0060348,bone development,2.0
16383,MCPH1,GO:0060623,regulation of chromosome condensation,2.0
16384,MCPH1,GO:0071539,protein localization to centrosome,2.0
16385,MCPH1,GO:0097150,neuronal stem cell population maintenance,2.0
16386,MDGA2,GO:0005576,extracellular region,2.0
16387,MDGA2,GO:0005886,plasma membrane,2.0
16388,MDGA2,GO:0007399,nervous system development,2.0
16389,MDGA2,GO:0021522,spinal cord motor neuron differentiation,2.0
16470,MED12L,GO:0003713,transcription coactivator activity,2.0
16471,MED12L,GO:0005515,protein binding,2.0
16472,MED12L,GO:0006351,DNA-templated transcription,2.0
16473,MED12L,GO:0008013,beta-catenin binding,2.0
16474,MED12L,GO:0008134,transcription factor binding,2.0
16475,MED12L,GO:0016592,mediator complex,2.0
16476,MED12L,GO:0045944,positive regulation of transcription by RNA polymerase II,2.0
16501,MED23,GO:0003713,transcription coactivator activity,2.0
16502,MED23,GO:0005515,protein binding,2.0
16503,MED23,GO:0005634,nucleus,2.0
16504,MED23,GO:0005654,nucleoplasm,2.0
16505,MED23,GO:0005667,transcription regulator complex,2.0
16507,MED23,GO:0006355,regulation of DNA-templated transcription,2.0
16508,MED23,GO:0006357,regulation of transcription by RNA polymerase II,2.0
16509,MED23,GO:0006367,transcription initiation at RNA polymerase II promoter,2.0
16510,MED23,GO:0010628,positive regulation of gene expression,2.0
16511,MED23,GO:0016592,mediator complex,2.0
16512,MED23,GO:0032968,positive regulation of transcription elongation by RNA polymerase II,2.0
16513,MED23,GO:0051123,RNA polymerase II preinitiation complex assembly,2.0
16514,MED23,GO:0060261,positive regulation of transcription initiation by RNA polymerase II,2.0
16515,MED23,GO:0070847,core mediator complex,2.0
16637,MEGF10,GO:0001849,complement component C1q complex binding,2.0
16638,MEGF10,GO:0001891,phagocytic cup,2.0
16639,MEGF10,GO:0005044,scavenger receptor activity,2.0
16640,MEGF10,GO:0005112,Notch binding,2.0
16642,MEGF10,GO:0005886,plasma membrane,2.0
16643,MEGF10,GO:0014719,skeletal muscle satellite cell activation,2.0
16644,MEGF10,GO:0014816,skeletal muscle satellite cell differentiation,2.0
16645,MEGF10,GO:0014841,skeletal muscle satellite cell proliferation,2.0
16646,MEGF10,GO:0022409,positive regulation of cell-cell adhesion,2.0
16647,MEGF10,GO:0033002,muscle cell proliferation,2.0
16648,MEGF10,GO:0034109,homotypic cell-cell adhesion,2.0
16649,MEGF10,GO:0042995,cell projection,2.0
16650,MEGF10,GO:0043277,apoptotic cell clearance,2.0
16651,MEGF10,GO:0043652,engulfment of apoptotic cell,2.0
16652,MEGF10,GO:0043654,recognition of apoptotic cell,2.0
16653,MEGF10,GO:0048627,myoblast development,2.0
16654,MEGF10,GO:0048641,regulation of skeletal muscle tissue development,2.0
16655,MEGF10,GO:0051147,regulation of muscle cell differentiation,2.0
16656,MEGF10,GO:0051451,myoblast migration,2.0
16657,MEGF10,GO:0055001,muscle cell development,2.0
16658,MEGF10,GO:1902742,apoptotic process involved in development,2.0
16659,MEGF10,GO:2000288,positive regulation of myoblast proliferation,2.0
16660,MEGF11,GO:0005515,protein binding,2.0
16661,MEGF11,GO:0010842,retina layer formation,2.0
16662,MEGF11,GO:0016323,basolateral plasma membrane,2.0
16663,MEGF11,GO:0034109,homotypic cell-cell adhesion,2.0
16694,MEMO1,GO:0005515,protein binding,2.0
16695,MEMO1,GO:0005634,nucleus,2.0
16696,MEMO1,GO:0005829,cytosol,2.0
16698,MEMO1,GO:0032886,regulation of microtubule-based process,2.0
16699,MET,GO:0001886,endothelial cell morphogenesis,2.0
16700,MET,GO:0001889,liver development,2.0
16701,MET,GO:0004713,protein tyrosine kinase activity,2.0
16703,MET,GO:0004714,transmembrane receptor protein tyrosine kinase activity,2.0
16704,MET,GO:0005008,hepatocyte growth factor receptor activity,2.0
16705,MET,GO:0005515,protein binding,2.0
16706,MET,GO:0005524,ATP binding,2.0
16707,MET,GO:0005576,extracellular region,2.0
16708,MET,GO:0005886,plasma membrane,2.0
16710,MET,GO:0006909,phagocytosis,2.0
16711,MET,GO:0007165,signal transduction,2.0
16712,MET,GO:0007166,cell surface receptor signaling pathway,2.0
16713,MET,GO:0007169,transmembrane receptor protein tyrosine kinase signaling pathway,2.0
16714,MET,GO:0007275,multicellular organism development,2.0
16715,MET,GO:0007399,nervous system development,2.0
16716,MET,GO:0009925,basal plasma membrane,2.0
16718,MET,GO:0009986,cell surface,2.0
16719,MET,GO:0010507,negative regulation of autophagy,2.0
16720,MET,GO:0016020,membrane,2.0
16721,MET,GO:0016477,cell migration,2.0
16722,MET,GO:0017154,semaphorin receptor activity,2.0
16723,MET,GO:0018108,peptidyl-tyrosine phosphorylation,2.0
16724,MET,GO:0019903,protein phosphatase binding,2.0
16725,MET,GO:0030182,neuron differentiation,2.0
16726,MET,GO:0031016,pancreas development,2.0
16727,MET,GO:0031116,positive regulation of microtubule polymerization,2.0
16728,MET,GO:0033674,positive regulation of kinase activity,2.0
16729,MET,GO:0035024,negative regulation of Rho protein signal transduction,2.0
16730,MET,GO:0042802,identical protein binding,2.0
16731,MET,GO:0043235,receptor complex,2.0
16732,MET,GO:0045944,positive regulation of transcription by RNA polymerase II,2.0
16733,MET,GO:0048012,hepatocyte growth factor receptor signaling pathway,2.0
16734,MET,GO:0048754,branching morphogenesis of an epithelial tube,2.0
16735,MET,GO:0050918,positive chemotaxis,2.0
16736,MET,GO:0051497,negative regulation of stress fiber assembly,2.0
16737,MET,GO:0051897,positive regulation of protein kinase B signaling,2.0
16738,MET,GO:0061436,establishment of skin barrier,2.0
16739,MET,GO:0070495,negative regulation of thrombin-activated receptor signaling pathway,2.0
16740,MET,GO:0071526,semaphorin-plexin signaling pathway,2.0
16741,MET,GO:0140677,molecular function activator activity,2.0
16742,MET,GO:1901299,negative regulation of hydrogen peroxide-mediated programmed cell death,2.0
16743,MET,GO:1905098,negative regulation of guanyl-nucleotide exchange factor activity,2.0
16744,MET,GO:2001028,positive regulation of endothelial cell chemotaxis,2.0
16745,MFRP,GO:0003674,molecular_function,2.0
16746,MFRP,GO:0005515,protein binding,2.0
16747,MFRP,GO:0007601,visual perception,2.0
16748,MFRP,GO:0009792,embryo development ending in birth or egg hatching,2.0
16749,MFRP,GO:0016020,membrane,2.0
16750,MFRP,GO:0016324,apical plasma membrane,2.0
16751,MFRP,GO:0042462,eye photoreceptor cell development,2.0
16752,MFRP,GO:0060041,retina development in camera-type eye,2.0
16753,MIB1,GO:0001568,blood vessel development,2.0
16754,MIB1,GO:0001701,in utero embryonic development,2.0
16755,MIB1,GO:0001756,somitogenesis,2.0
16756,MIB1,GO:0001841,neural tube formation,2.0
16757,MIB1,GO:0001947,heart looping,2.0
16758,MIB1,GO:0004842,ubiquitin-protein transferase activity,2.0
16760,MIB1,GO:0005515,protein binding,2.0
16761,MIB1,GO:0005737,cytoplasm,2.0
16762,MIB1,GO:0005813,centrosome,2.0
16763,MIB1,GO:0005829,cytosol,2.0
16764,MIB1,GO:0005886,plasma membrane,2.0
16765,MIB1,GO:0006511,ubiquitin-dependent protein catabolic process,2.0
16766,MIB1,GO:0006897,endocytosis,2.0
16767,MIB1,GO:0007219,Notch signaling pathway,2.0
16768,MIB1,GO:0008270,zinc ion binding,2.0
16769,MIB1,GO:0014069,postsynaptic density,2.0
16770,MIB1,GO:0016567,protein ubiquitination,2.0
16772,MIB1,GO:0030182,neuron differentiation,2.0
16773,MIB1,GO:0031410,cytoplasmic vesicle,2.0
16774,MIB1,GO:0045665,negative regulation of neuron differentiation,2.0
16775,MIB1,GO:0045807,positive regulation of endocytosis,2.0
16812,MIR137,GO:0001933,negative regulation of protein phosphorylation,2.0
16813,MIR137,GO:0003730,mRNA 3'-UTR binding,2.0
16814,MIR137,GO:0007406,negative regulation of neuroblast proliferation,2.0
16815,MIR137,GO:0008285,negative regulation of cell population proliferation,2.0
16816,MIR137,GO:0016442,RISC complex,2.0
16817,MIR137,GO:0016525,negative regulation of angiogenesis,2.0
16818,MIR137,GO:0030336,negative regulation of cell migration,2.0
16820,MIR137,GO:0035195,miRNA-mediated gene silencing,2.0
16822,MIR137,GO:0035279,miRNA-mediated gene silencing by mRNA destabilization,2.0
16823,MIR137,GO:0043065,positive regulation of apoptotic process,2.0
16824,MIR137,GO:0043537,negative regulation of blood vessel endothelial cell migration,2.0
16825,MIR137,GO:0045666,positive regulation of neuron differentiation,2.0
16826,MIR137,GO:0051898,negative regulation of protein kinase B signaling,2.0
16827,MIR137,GO:1903231,mRNA base-pairing translational repressor activity,2.0
16828,MIR137,GO:1904706,negative regulation of vascular associated smooth muscle cell proliferation,2.0
16829,MIR137,GO:1904753,negative regulation of vascular associated smooth muscle cell migration,2.0
16830,MIR137,GO:2000134,negative regulation of G1/S transition of mitotic cell cycle,2.0
16840,MLANA,GO:0005515,protein binding,2.0
16841,MLANA,GO:0005789,endoplasmic reticulum membrane,2.0
16843,MLANA,GO:0005794,Golgi apparatus,2.0
16844,MLANA,GO:0005802,trans-Golgi network,2.0
16846,MLANA,GO:0005886,plasma membrane,2.0
16847,MLANA,GO:0042470,melanosome,2.0
16849,MRTFB,GO:0003713,transcription coactivator activity,2.0
16852,MRTFB,GO:0005515,protein binding,2.0
16853,MRTFB,GO:0005634,nucleus,2.0
16855,MRTFB,GO:0007517,muscle organ development,2.0
16856,MRTFB,GO:0045296,cadherin binding,2.0
16857,MRTFB,GO:0045844,positive regulation of striated muscle tissue development,2.0
16858,MRTFB,GO:0045944,positive regulation of transcription by RNA polymerase II,2.0
16860,MRTFB,GO:0051145,smooth muscle cell differentiation,2.0
16861,MRTFB,GO:1902895,positive regulation of miRNA transcription,2.0
16883,MSR1,GO:0001540,amyloid-beta binding,2.0
16885,MSR1,GO:0005044,scavenger receptor activity,2.0
16886,MSR1,GO:0005515,protein binding,2.0
16887,MSR1,GO:0005581,collagen trimer,2.0
16888,MSR1,GO:0005829,cytosol,2.0
16889,MSR1,GO:0005886,plasma membrane,2.0
16891,MSR1,GO:0006898,receptor-mediated endocytosis,2.0
16893,MSR1,GO:0006911,"phagocytosis, engulfment",2.0
16894,MSR1,GO:0009897,external side of plasma membrane,2.0
16895,MSR1,GO:0010629,negative regulation of gene expression,2.0
16896,MSR1,GO:0010744,positive regulation of macrophage derived foam cell differentiation,2.0
16897,MSR1,GO:0010886,positive regulation of cholesterol storage,2.0
16899,MSR1,GO:0016020,membrane,2.0
16900,MSR1,GO:0030169,low-density lipoprotein particle binding,2.0
16902,MSR1,GO:0030301,cholesterol transport,2.0
16903,MSR1,GO:0030666,endocytic vesicle membrane,2.0
16904,MSR1,GO:0034362,low-density lipoprotein particle,2.0
16905,MSR1,GO:0034381,plasma lipoprotein particle clearance,2.0
16907,MSR1,GO:0038024,cargo receptor activity,2.0
16908,MSR1,GO:0042953,lipoprotein transport,2.0
16909,MSR1,GO:0051649,establishment of localization in cell,2.0
16910,MSR1,GO:0071407,cellular response to organic cyclic compound,2.0
16911,MSR1,GO:0097242,amyloid-beta clearance,2.0
16965,MTF1,GO:0000978,RNA polymerase II cis-regulatory region sequence-specific DNA binding,2.0
16967,MTF1,GO:0000981,"DNA-binding transcription factor activity, RNA polymerase II-specific",2.0
16968,MTF1,GO:0000987,cis-regulatory region sequence-specific DNA binding,2.0
16969,MTF1,GO:0001228,"DNA-binding transcription activator activity, RNA polymerase II-specific",2.0
16971,MTF1,GO:0003677,DNA binding,2.0
16972,MTF1,GO:0003700,DNA-binding transcription factor activity,2.0
16973,MTF1,GO:0005515,protein binding,2.0
16974,MTF1,GO:0005634,nucleus,2.0
16975,MTF1,GO:0005654,nucleoplasm,2.0
16977,MTF1,GO:0005737,cytoplasm,2.0
16978,MTF1,GO:0006351,DNA-templated transcription,2.0
16979,MTF1,GO:0006357,regulation of transcription by RNA polymerase II,2.0
16980,MTF1,GO:0006979,response to oxidative stress,2.0
16981,MTF1,GO:0007417,central nervous system development,2.0
16982,MTF1,GO:0010038,response to metal ion,2.0
16983,MTF1,GO:0035035,histone acetyltransferase binding,2.0
16984,MTF1,GO:0045944,positive regulation of transcription by RNA polymerase II,2.0
16986,MTF1,GO:0046686,response to cadmium ion,2.0
16987,MTF1,GO:0046872,metal ion binding,2.0
16988,MTF1,GO:0071294,cellular response to zinc ion,2.0
16989,MTF1,GO:1990079,cartilage homeostasis,2.0
16990,MTF1,GO:1990837,sequence-specific double-stranded DNA binding,2.0
16991,MTHFR,GO:0001666,response to hypoxia,2.0
16992,MTHFR,GO:0001843,neural tube closure,2.0
16994,MTHFR,GO:0004489,methylenetetrahydrofolate reductase (NAD(P)H) activity,2.0
16998,MTHFR,GO:0005829,cytosol,2.0
17000,MTHFR,GO:0006555,methionine metabolic process,2.0
17001,MTHFR,GO:0009086,methionine biosynthetic process,2.0
17002,MTHFR,GO:0009410,response to xenobiotic stimulus,2.0
17003,MTHFR,GO:0031060,regulation of histone methylation,2.0
17004,MTHFR,GO:0033274,response to vitamin B2,2.0
17005,MTHFR,GO:0035999,tetrahydrofolate interconversion,2.0
17010,MTHFR,GO:0043200,response to amino acid,2.0
17011,MTHFR,GO:0044877,protein-containing complex binding,2.0
17012,MTHFR,GO:0045202,synapse,2.0
17013,MTHFR,GO:0046500,S-adenosylmethionine metabolic process,2.0
17014,MTHFR,GO:0050660,flavin adenine dinucleotide binding,2.0
17015,MTHFR,GO:0050661,NADP binding,2.0
17016,MTHFR,GO:0050667,homocysteine metabolic process,2.0
17017,MTHFR,GO:0051593,response to folic acid,2.0
17018,MTHFR,GO:0070555,response to interleukin-1,2.0
17019,MTHFR,GO:0070828,heterochromatin organization,2.0
17020,MTHFR,GO:0071949,FAD binding,2.0
17021,MTHFR,GO:0072341,modified amino acid binding,2.0
17022,MTHFR,GO:0106312,methylenetetrahydrofolate reductase NADH activity,2.0
17023,MTHFR,GO:0106313,methylenetetrahydrofolate reductase NADPH activity,2.0
17165,MUC12,GO:0001558,regulation of cell growth,2.0
17166,MUC12,GO:0003674,molecular_function,2.0
17167,MUC12,GO:0005796,Golgi lumen,2.0
17168,MUC12,GO:0005886,plasma membrane,2.0
17170,MUC4,GO:0005176,ErbB-2 class receptor binding,2.0
17171,MUC4,GO:0005615,extracellular space,2.0
17173,MUC4,GO:0005796,Golgi lumen,2.0
17174,MUC4,GO:0005886,plasma membrane,2.0
17175,MUC4,GO:0007160,cell-matrix adhesion,2.0
17176,MUC4,GO:0010469,regulation of signaling receptor activity,2.0
17177,MUC4,GO:0016020,membrane,2.0
17178,MUC4,GO:0030197,"extracellular matrix constituent, lubricant activity",2.0
17179,MUC4,GO:0030277,maintenance of gastrointestinal epithelium,2.0
17180,MUC4,GO:0031012,extracellular matrix,2.0
17181,MUC4,GO:0031982,vesicle,2.0
17182,MUC4,GO:0070062,extracellular exosome,2.0
17183,MYH10,GO:0000146,microfilament motor activity,2.0
17186,MYH10,GO:0000281,mitotic cytokinesis,2.0
17188,MYH10,GO:0001725,stress fiber,2.0
17189,MYH10,GO:0003779,actin binding,2.0
17190,MYH10,GO:0005515,protein binding,2.0
17191,MYH10,GO:0005516,calmodulin binding,2.0
17192,MYH10,GO:0005524,ATP binding,2.0
17194,MYH10,GO:0005634,nucleus,2.0
17195,MYH10,GO:0005737,cytoplasm,2.0
17197,MYH10,GO:0005829,cytosol,2.0
17199,MYH10,GO:0005844,polysome,2.0
17200,MYH10,GO:0005938,cell cortex,2.0
17201,MYH10,GO:0007155,cell adhesion,2.0
17202,MYH10,GO:0008360,regulation of cell shape,2.0
17203,MYH10,GO:0016459,myosin complex,2.0
17204,MYH10,GO:0016460,myosin II complex,2.0
17206,MYH10,GO:0030027,lamellipodium,2.0
17207,MYH10,GO:0030048,actin filament-based movement,2.0
17208,MYH10,GO:0030496,midbody,2.0
17209,MYH10,GO:0031032,actomyosin structure organization,2.0
17211,MYH10,GO:0032154,cleavage furrow,2.0
17212,MYH10,GO:0032982,myosin filament,2.0
17213,MYH10,GO:0035613,RNA stem-loop binding,2.0
17214,MYH10,GO:0042641,actomyosin,2.0
17215,MYH10,GO:0043531,ADP binding,2.0
17216,MYH10,GO:0048027,mRNA 5'-UTR binding,2.0
17217,MYH10,GO:0050714,positive regulation of protein secretion,2.0
17218,MYH10,GO:0051015,actin filament binding,2.0
17221,MYH10,GO:0070062,extracellular exosome,2.0
17222,MYH10,GO:0097513,myosin II filament,2.0
17223,MYH4,GO:0000146,microfilament motor activity,2.0
17225,MYH4,GO:0003725,double-stranded RNA binding,2.0
17226,MYH4,GO:0005516,calmodulin binding,2.0
17227,MYH4,GO:0005524,ATP binding,2.0
17228,MYH4,GO:0005737,cytoplasm,2.0
17229,MYH4,GO:0005859,muscle myosin complex,2.0
17230,MYH4,GO:0006936,muscle contraction,2.0
17232,MYH4,GO:0016460,myosin II complex,2.0
17233,MYH4,GO:0016887,ATP hydrolysis activity,2.0
17234,MYH4,GO:0030016,myofibril,2.0
17235,MYH4,GO:0030017,sarcomere,2.0
17236,MYH4,GO:0030048,actin filament-based movement,2.0
17237,MYH4,GO:0030049,muscle filament sliding,2.0
17238,MYH4,GO:0032982,myosin filament,2.0
17239,MYH4,GO:0046034,ATP metabolic process,2.0
17240,MYH4,GO:0051015,actin filament binding,2.0
17241,MYH9,GO:0000146,microfilament motor activity,2.0
17244,MYH9,GO:0000212,meiotic spindle organization,2.0
17245,MYH9,GO:0001525,angiogenesis,2.0
17246,MYH9,GO:0001701,in utero embryonic development,2.0
17247,MYH9,GO:0001725,stress fiber,2.0
17248,MYH9,GO:0001726,ruffle,2.0
17249,MYH9,GO:0001768,establishment of T cell polarity,2.0
17250,MYH9,GO:0001772,immunological synapse,2.0
17251,MYH9,GO:0001778,plasma membrane repair,2.0
17252,MYH9,GO:0001931,uropod,2.0
17253,MYH9,GO:0003723,RNA binding,2.0
17254,MYH9,GO:0003774,cytoskeletal motor activity,2.0
17255,MYH9,GO:0003779,actin binding,2.0
17256,MYH9,GO:0005178,integrin binding,2.0
17257,MYH9,GO:0005515,protein binding,2.0
17258,MYH9,GO:0005516,calmodulin binding,2.0
17259,MYH9,GO:0005524,ATP binding,2.0
17260,MYH9,GO:0005634,nucleus,2.0
17261,MYH9,GO:0005737,cytoplasm,2.0
17263,MYH9,GO:0005819,spindle,2.0
17264,MYH9,GO:0005826,actomyosin contractile ring,2.0
17265,MYH9,GO:0005829,cytosol,2.0
17267,MYH9,GO:0005886,plasma membrane,2.0
17268,MYH9,GO:0005903,brush border,2.0
17269,MYH9,GO:0005912,adherens junction,2.0
17270,MYH9,GO:0005925,focal adhesion,2.0
17271,MYH9,GO:0006509,membrane protein ectodomain proteolysis,2.0
17272,MYH9,GO:0006911,"phagocytosis, engulfment",2.0
17273,MYH9,GO:0007229,integrin-mediated signaling pathway,2.0
17274,MYH9,GO:0007520,myoblast fusion,2.0
17275,MYH9,GO:0008360,regulation of cell shape,2.0
17276,MYH9,GO:0009898,cytoplasmic side of plasma membrane,2.0
17277,MYH9,GO:0015031,protein transport,2.0
17278,MYH9,GO:0015629,actin cytoskeleton,2.0
17279,MYH9,GO:0016020,membrane,2.0
17280,MYH9,GO:0016460,myosin II complex,2.0
17282,MYH9,GO:0016604,nuclear body,2.0
17283,MYH9,GO:0019904,protein domain specific binding,2.0
17284,MYH9,GO:0030048,actin filament-based movement,2.0
17286,MYH9,GO:0030220,platelet formation,2.0
17287,MYH9,GO:0030224,monocyte differentiation,2.0
17288,MYH9,GO:0031032,actomyosin structure organization,2.0
17289,MYH9,GO:0031252,cell leading edge,2.0
17290,MYH9,GO:0031532,actin cytoskeleton reorganization,2.0
17291,MYH9,GO:0031594,neuromuscular junction,2.0
17292,MYH9,GO:0032154,cleavage furrow,2.0
17293,MYH9,GO:0032418,lysosome localization,2.0
17294,MYH9,GO:0032506,cytokinetic process,2.0
17295,MYH9,GO:0032796,uropod organization,2.0
17296,MYH9,GO:0032982,myosin filament,2.0
17297,MYH9,GO:0032991,protein-containing complex,2.0
17298,MYH9,GO:0042641,actomyosin,2.0
17299,MYH9,GO:0042802,identical protein binding,2.0
17300,MYH9,GO:0042803,protein homodimerization activity,2.0
17301,MYH9,GO:0043495,protein-membrane adaptor activity,2.0
17302,MYH9,GO:0043531,ADP binding,2.0
17303,MYH9,GO:0043534,blood vessel endothelial cell migration,2.0
17304,MYH9,GO:0045055,regulated exocytosis,2.0
17305,MYH9,GO:0045296,cadherin binding,2.0
17306,MYH9,GO:0050900,leukocyte migration,2.0
17307,MYH9,GO:0051015,actin filament binding,2.0
17311,MYH9,GO:0051295,establishment of meiotic spindle localization,2.0
17312,MYH9,GO:0060471,cortical granule exocytosis,2.0
17313,MYH9,GO:0060473,cortical granule,2.0
17314,MYH9,GO:0070062,extracellular exosome,2.0
17315,MYH9,GO:0070527,platelet aggregation,2.0
17316,MYH9,GO:0097513,myosin II filament,2.0
17317,MYH9,GO:1903919,negative regulation of actin filament severing,2.0
17319,MYH9,GO:1903923,positive regulation of protein processing in phagocytic vesicle,2.0
17320,MYH9,GO:1905684,regulation of plasma membrane repair,2.0
17350,MYO16,GO:0003774,cytoskeletal motor activity,2.0
17351,MYO16,GO:0005515,protein binding,2.0
17352,MYO16,GO:0005524,ATP binding,2.0
17353,MYO16,GO:0005654,nucleoplasm,2.0
17355,MYO16,GO:0005737,cytoplasm,2.0
17356,MYO16,GO:0005886,plasma membrane,2.0
17357,MYO16,GO:0008285,negative regulation of cell population proliferation,2.0
17358,MYO16,GO:0014065,phosphatidylinositol 3-kinase signaling,2.0
17359,MYO16,GO:0016459,myosin complex,2.0
17360,MYO16,GO:0019903,protein phosphatase binding,2.0
17361,MYO16,GO:0021549,cerebellum development,2.0
17362,MYO16,GO:0048471,perinuclear region of cytoplasm,2.0
17364,MYO16,GO:0048812,neuron projection morphogenesis,2.0
17365,MYO16,GO:0051015,actin filament binding,2.0
17367,MYO16,GO:2000134,negative regulation of G1/S transition of mitotic cell cycle,2.0
17369,MYO1E,GO:0000146,microfilament motor activity,2.0
17370,MYO1E,GO:0001570,vasculogenesis,2.0
17371,MYO1E,GO:0001701,in utero embryonic development,2.0
17372,MYO1E,GO:0003094,glomerular filtration,2.0
17373,MYO1E,GO:0005515,protein binding,2.0
17374,MYO1E,GO:0005516,calmodulin binding,2.0
17375,MYO1E,GO:0005524,ATP binding,2.0
17376,MYO1E,GO:0005737,cytoplasm,2.0
17378,MYO1E,GO:0005856,cytoskeleton,2.0
17379,MYO1E,GO:0005886,plasma membrane,2.0
17380,MYO1E,GO:0005902,microvillus,2.0
17381,MYO1E,GO:0005903,brush border,2.0
17382,MYO1E,GO:0005912,adherens junction,2.0
17383,MYO1E,GO:0006807,nitrogen compound metabolic process,2.0
17384,MYO1E,GO:0006897,endocytosis,2.0
17385,MYO1E,GO:0007015,actin filament organization,2.0
17386,MYO1E,GO:0015629,actin cytoskeleton,2.0
17387,MYO1E,GO:0016459,myosin complex,2.0
17388,MYO1E,GO:0016887,ATP hydrolysis activity,2.0
17389,MYO1E,GO:0030050,vesicle transport along actin filament,2.0
17390,MYO1E,GO:0031982,vesicle,2.0
17391,MYO1E,GO:0032437,cuticular plate,2.0
17392,MYO1E,GO:0032836,glomerular basement membrane development,2.0
17393,MYO1E,GO:0035091,phosphatidylinositol binding,2.0
17394,MYO1E,GO:0035166,post-embryonic hemopoiesis,2.0
17395,MYO1E,GO:0045334,clathrin-coated endocytic vesicle,2.0
17396,MYO1E,GO:0048008,platelet-derived growth factor receptor signaling pathway,2.0
17397,MYO1E,GO:0051015,actin filament binding,2.0
17399,MYO1E,GO:0070062,extracellular exosome,2.0
17400,MYO1E,GO:0072015,podocyte development,2.0
17401,MYO5A,GO:0000146,microfilament motor activity,2.0
17403,MYO5A,GO:0001726,ruffle,2.0
17404,MYO5A,GO:0003723,RNA binding,2.0
17405,MYO5A,GO:0005515,protein binding,2.0
17406,MYO5A,GO:0005516,calmodulin binding,2.0
17407,MYO5A,GO:0005524,ATP binding,2.0
17408,MYO5A,GO:0005737,cytoplasm,2.0
17410,MYO5A,GO:0005764,lysosome,2.0
17411,MYO5A,GO:0005769,early endosome,2.0
17412,MYO5A,GO:0005770,late endosome,2.0
17413,MYO5A,GO:0005777,peroxisome,2.0
17414,MYO5A,GO:0005783,endoplasmic reticulum,2.0
17415,MYO5A,GO:0005829,cytosol,2.0
17416,MYO5A,GO:0005884,actin filament,2.0
17417,MYO5A,GO:0006892,post-Golgi vesicle-mediated transport,2.0
17418,MYO5A,GO:0007015,actin filament organization,2.0
17419,MYO5A,GO:0015031,protein transport,2.0
17420,MYO5A,GO:0015629,actin cytoskeleton,2.0
17421,MYO5A,GO:0016020,membrane,2.0
17423,MYO5A,GO:0016192,vesicle-mediated transport,2.0
17424,MYO5A,GO:0016459,myosin complex,2.0
17425,MYO5A,GO:0030048,actin filament-based movement,2.0
17426,MYO5A,GO:0030050,vesicle transport along actin filament,2.0
17428,MYO5A,GO:0030426,growth cone,2.0
17429,MYO5A,GO:0031267,small GTPase binding,2.0
17430,MYO5A,GO:0031982,vesicle,2.0
17431,MYO5A,GO:0032402,melanosome transport,2.0
17432,MYO5A,GO:0032433,filopodium tip,2.0
17433,MYO5A,GO:0032593,insulin-responsive compartment,2.0
17434,MYO5A,GO:0032869,cellular response to insulin stimulus,2.0
17435,MYO5A,GO:0042470,melanosome,2.0
17436,MYO5A,GO:0043005,neuron projection,2.0
17437,MYO5A,GO:0051015,actin filament binding,2.0
17438,MYO5A,GO:0055037,recycling endosome,2.0
17439,MYO5A,GO:0070062,extracellular exosome,2.0
17440,MYO5A,GO:0072659,protein localization to plasma membrane,2.0
17441,MYO5A,GO:1903358,regulation of Golgi organization,2.0
17442,MYO5C,GO:0000146,microfilament motor activity,2.0
17443,MYO5C,GO:0005516,calmodulin binding,2.0
17444,MYO5C,GO:0005524,ATP binding,2.0
17445,MYO5C,GO:0005737,cytoplasm,2.0
17446,MYO5C,GO:0007015,actin filament organization,2.0
17447,MYO5C,GO:0015629,actin cytoskeleton,2.0
17448,MYO5C,GO:0016459,myosin complex,2.0
17449,MYO5C,GO:0030050,vesicle transport along actin filament,2.0
17450,MYO5C,GO:0031982,vesicle,2.0
17451,MYO5C,GO:0051015,actin filament binding,2.0
17452,MYO5C,GO:0070062,extracellular exosome,2.0
17453,MYO9B,GO:0000146,microfilament motor activity,2.0
17455,MYO9B,GO:0001726,ruffle,2.0
17456,MYO9B,GO:0003779,actin binding,2.0
17457,MYO9B,GO:0005096,GTPase activator activity,2.0
17459,MYO9B,GO:0005515,protein binding,2.0
17460,MYO9B,GO:0005516,calmodulin binding,2.0
17461,MYO9B,GO:0005524,ATP binding,2.0
17463,MYO9B,GO:0005737,cytoplasm,2.0
17464,MYO9B,GO:0005829,cytosol,2.0
17466,MYO9B,GO:0005884,actin filament,2.0
17468,MYO9B,GO:0005938,cell cortex,2.0
17469,MYO9B,GO:0007266,Rho protein signal transduction,2.0
17470,MYO9B,GO:0008270,zinc ion binding,2.0
17471,MYO9B,GO:0015629,actin cytoskeleton,2.0
17472,MYO9B,GO:0016020,membrane,2.0
17473,MYO9B,GO:0016459,myosin complex,2.0
17474,MYO9B,GO:0016887,ATP hydrolysis activity,2.0
17475,MYO9B,GO:0030027,lamellipodium,2.0
17476,MYO9B,GO:0030048,actin filament-based movement,2.0
17479,MYO9B,GO:0031267,small GTPase binding,2.0
17480,MYO9B,GO:0032011,ARF protein signal transduction,2.0
17481,MYO9B,GO:0035023,regulation of Rho protein signal transduction,2.0
17482,MYO9B,GO:0035385,Roundabout signaling pathway,2.0
17483,MYO9B,GO:0042803,protein homodimerization activity,2.0
17484,MYO9B,GO:0043008,ATP-dependent protein binding,2.0
17485,MYO9B,GO:0043531,ADP binding,2.0
17486,MYO9B,GO:0048471,perinuclear region of cytoplasm,2.0
17487,MYO9B,GO:0048495,Roundabout binding,2.0
17488,MYO9B,GO:0050790,regulation of catalytic activity,2.0
17489,MYO9B,GO:0051015,actin filament binding,2.0
17490,MYO9B,GO:0051056,regulation of small GTPase mediated signal transduction,2.0
17491,MYO9B,GO:0072673,lamellipodium morphogenesis,2.0
17592,NAALADL2,GO:0005515,protein binding,2.0
17593,NAALADL2,GO:0005654,nucleoplasm,2.0
17594,NAALADL2,GO:0009617,response to bacterium,2.0
17595,NAALADL2,GO:0016020,membrane,2.0
17611,NAV2,GO:0003025,regulation of systemic arterial blood pressure by baroreceptor feedback,2.0
17612,NAV2,GO:0005515,protein binding,2.0
17613,NAV2,GO:0005524,ATP binding,2.0
17614,NAV2,GO:0005614,interstitial matrix,2.0
17615,NAV2,GO:0005654,nucleoplasm,2.0
17616,NAV2,GO:0007399,nervous system development,2.0
17617,NAV2,GO:0007605,sensory perception of sound,2.0
17618,NAV2,GO:0007608,sensory perception of smell,2.0
17619,NAV2,GO:0007626,locomotory behavior,2.0
17620,NAV2,GO:0008201,heparin binding,2.0
17621,NAV2,GO:0016887,ATP hydrolysis activity,2.0
17622,NAV2,GO:0021554,optic nerve development,2.0
17623,NAV2,GO:0021563,glossopharyngeal nerve development,2.0
17624,NAV2,GO:0021564,vagus nerve development,2.0
17625,NAV2,GO:0022008,neurogenesis,2.0
17626,NAV2,GO:0032508,DNA duplex unwinding,2.0
17627,NAV2,GO:0043138,3'-5' DNA helicase activity,2.0
17628,NAV3,GO:0005524,ATP binding,2.0
17629,NAV3,GO:0005640,nuclear outer membrane,2.0
17630,NAV3,GO:0007026,negative regulation of microtubule depolymerization,2.0
17631,NAV3,GO:0007399,nervous system development,2.0
17632,NAV3,GO:0008017,microtubule binding,2.0
17633,NAV3,GO:0016887,ATP hydrolysis activity,2.0
17634,NAV3,GO:0022008,neurogenesis,2.0
17635,NAV3,GO:0030336,negative regulation of cell migration,2.0
17636,NAV3,GO:0031116,positive regulation of microtubule polymerization,2.0
17637,NAV3,GO:0032703,negative regulation of interleukin-2 production,2.0
17638,NAV3,GO:1990752,microtubule end,2.0
17690,NCKAP5,GO:0001578,microtubule bundle formation,2.0
17691,NCKAP5,GO:0005575,cellular_component,2.0
17692,NCKAP5,GO:0007019,microtubule depolymerization,2.0
17693,NCKAP5,GO:0008150,biological_process,2.0
17694,NCKAP5,GO:0035371,microtubule plus-end,2.0
17739,NCOR1,GO:0000118,histone deacetylase complex,2.0
17740,NCOR1,GO:0000122,negative regulation of transcription by RNA polymerase II,2.0
17742,NCOR1,GO:0000785,chromatin,2.0
17743,NCOR1,GO:0000976,transcription cis-regulatory region binding,2.0
17744,NCOR1,GO:0003714,transcription corepressor activity,2.0
17747,NCOR1,GO:0005515,protein binding,2.0
17748,NCOR1,GO:0005634,nucleus,2.0
17750,NCOR1,GO:0005654,nucleoplasm,2.0
17752,NCOR1,GO:0005829,cytosol,2.0
17753,NCOR1,GO:0006325,chromatin organization,2.0
17754,NCOR1,GO:0006357,regulation of transcription by RNA polymerase II,2.0
17755,NCOR1,GO:0016020,membrane,2.0
17756,NCOR1,GO:0016922,nuclear receptor binding,2.0
17757,NCOR1,GO:0017053,transcription repressor complex,2.0
17758,NCOR1,GO:0042826,histone deacetylase binding,2.0
17759,NCOR1,GO:0045475,locomotor rhythm,2.0
17760,NCOR1,GO:0045820,negative regulation of glycolytic process,2.0
17761,NCOR1,GO:0045892,negative regulation of DNA-templated transcription,2.0
17763,NCOR1,GO:0045922,negative regulation of fatty acid metabolic process,2.0
17764,NCOR1,GO:0046329,negative regulation of JNK cascade,2.0
17765,NCOR1,GO:0046966,nuclear thyroid hormone receptor binding,2.0
17766,NCOR1,GO:0051225,spindle assembly,2.0
17767,NCOR1,GO:0060766,negative regulation of androgen receptor signaling pathway,2.0
17768,NCOR1,GO:0061629,RNA polymerase II-specific DNA-binding transcription factor binding,2.0
17769,NCOR1,GO:0072686,mitotic spindle,2.0
17770,NCOR1,GO:1902894,negative regulation of miRNA transcription,2.0
17771,NEGR1,GO:0005515,protein binding,2.0
17772,NEGR1,GO:0005576,extracellular region,2.0
17773,NEGR1,GO:0005886,plasma membrane,2.0
17774,NEGR1,GO:0007420,brain development,2.0
17775,NEGR1,GO:0007626,locomotory behavior,2.0
17776,NEGR1,GO:0007631,feeding behavior,2.0
17777,NEGR1,GO:0010976,positive regulation of neuron projection development,2.0
17778,NEGR1,GO:0030425,dendrite,2.0
17779,NEGR1,GO:0031175,neuron projection development,2.0
17780,NEGR1,GO:0043025,neuronal cell body,2.0
17781,NEGR1,GO:0051963,regulation of synapse assembly,2.0
17782,NEGR1,GO:0098609,cell-cell adhesion,2.0
17783,MNT,GO:0000122,negative regulation of transcription by RNA polymerase II,2.0
17785,MNT,GO:0000785,chromatin,2.0
17786,MNT,GO:0000977,RNA polymerase II transcription regulatory region sequence-specific DNA binding,2.0
17787,MNT,GO:0000978,RNA polymerase II cis-regulatory region sequence-specific DNA binding,2.0
17788,MNT,GO:0000981,"DNA-binding transcription factor activity, RNA polymerase II-specific",2.0
17790,MNT,GO:0001227,"DNA-binding transcription repressor activity, RNA polymerase II-specific",2.0
17792,MNT,GO:0003682,chromatin binding,2.0
17793,MNT,GO:0003700,DNA-binding transcription factor activity,2.0
17794,MNT,GO:0005515,protein binding,2.0
17795,MNT,GO:0005654,nucleoplasm,2.0
17796,MNT,GO:0006357,regulation of transcription by RNA polymerase II,2.0
17797,MNT,GO:0006366,transcription by RNA polymerase II,2.0
17798,MNT,GO:0046983,protein dimerization activity,2.0
17799,MNT,GO:0051726,regulation of cell cycle,2.0
17800,MNT,GO:0090398,cellular senescence,2.0
17801,MNT,GO:2001234,negative regulation of apoptotic signaling pathway,2.0
17819,NDUFA5,GO:0005515,protein binding,2.0
17820,NDUFA5,GO:0005743,mitochondrial inner membrane,2.0
17821,NDUFA5,GO:0005747,mitochondrial respiratory chain complex I,2.0
17825,NDUFA5,GO:0006120,"mitochondrial electron transport, NADH to ubiquinone",2.0
17826,NDUFA5,GO:0008137,NADH dehydrogenase (ubiquinone) activity,2.0
17827,NDUFA5,GO:0009060,aerobic respiration,2.0
17828,NDUFA5,GO:0022904,respiratory electron transport chain,2.0
17829,NDUFA5,GO:0032981,mitochondrial respiratory chain complex I assembly,2.0
17830,NDUFA5,GO:0042776,proton motive force-driven mitochondrial ATP synthesis,2.0
17831,NEO1,GO:0001764,neuron migration,2.0
17832,NEO1,GO:0005515,protein binding,2.0
17833,NEO1,GO:0005654,nucleoplasm,2.0
17834,NEO1,GO:0005794,Golgi apparatus,2.0
17835,NEO1,GO:0005886,plasma membrane,2.0
17838,NEO1,GO:0007155,cell adhesion,2.0
17839,NEO1,GO:0007411,axon guidance,2.0
17840,NEO1,GO:0009986,cell surface,2.0
17841,NEO1,GO:0030513,positive regulation of BMP signaling pathway,2.0
17842,NEO1,GO:0038023,signaling receptor activity,2.0
17843,NEO1,GO:0039706,co-receptor binding,2.0
17844,NEO1,GO:0044295,axonal growth cone,2.0
17845,NEO1,GO:0055072,iron ion homeostasis,2.0
17846,NEO1,GO:0098609,cell-cell adhesion,2.0
17847,NEO1,GO:0098797,plasma membrane protein complex,2.0
17971,NFE2L3,GO:0000122,negative regulation of transcription by RNA polymerase II,2.0
17972,NFE2L3,GO:0000785,chromatin,2.0
17973,NFE2L3,GO:0000978,RNA polymerase II cis-regulatory region sequence-specific DNA binding,2.0
17974,NFE2L3,GO:0000981,"DNA-binding transcription factor activity, RNA polymerase II-specific",2.0
17976,NFE2L3,GO:0001227,"DNA-binding transcription repressor activity, RNA polymerase II-specific",2.0
17977,NFE2L3,GO:0003700,DNA-binding transcription factor activity,2.0
17978,NFE2L3,GO:0005515,protein binding,2.0
17979,NFE2L3,GO:0005634,nucleus,2.0
17981,NFE2L3,GO:0006357,regulation of transcription by RNA polymerase II,2.0
17983,NFE2L3,GO:0006366,transcription by RNA polymerase II,2.0
17984,NFE2L3,GO:0090575,RNA polymerase II transcription regulator complex,2.0
17985,NFE2L3,GO:0140467,integrated stress response signaling,2.0
17986,NFIA,GO:0000785,chromatin,2.0
17987,NFIA,GO:0000978,RNA polymerase II cis-regulatory region sequence-specific DNA binding,2.0
17989,NFIA,GO:0000981,"DNA-binding transcription factor activity, RNA polymerase II-specific",2.0
17991,NFIA,GO:0001228,"DNA-binding transcription activator activity, RNA polymerase II-specific",2.0
17992,NFIA,GO:0003682,chromatin binding,2.0
17993,NFIA,GO:0003700,DNA-binding transcription factor activity,2.0
17994,NFIA,GO:0005634,nucleus,2.0
17997,NFIA,GO:0005654,nucleoplasm,2.0
17998,NFIA,GO:0006260,DNA replication,2.0
17999,NFIA,GO:0006355,regulation of DNA-templated transcription,2.0
18000,NFIA,GO:0006357,regulation of transcription by RNA polymerase II,2.0
18001,NFIA,GO:0019079,viral genome replication,2.0
18002,NFIA,GO:0030054,cell junction,2.0
18003,NFIA,GO:0045944,positive regulation of transcription by RNA polymerase II,2.0
18004,NFIA,GO:0060074,synapse maturation,2.0
18005,NFIA,GO:0072189,ureter development,2.0
18006,NFIA,GO:0140297,DNA-binding transcription factor binding,2.0
18007,NFIB,GO:0000785,chromatin,2.0
18008,NFIB,GO:0000978,RNA polymerase II cis-regulatory region sequence-specific DNA binding,2.0
18010,NFIB,GO:0000981,"DNA-binding transcription factor activity, RNA polymerase II-specific",2.0
18013,NFIB,GO:0001228,"DNA-binding transcription activator activity, RNA polymerase II-specific",2.0
18014,NFIB,GO:0001650,fibrillar center,2.0
18015,NFIB,GO:0002062,chondrocyte differentiation,2.0
18016,NFIB,GO:0002067,glandular epithelial cell differentiation,2.0
18017,NFIB,GO:0003677,DNA binding,2.0
18018,NFIB,GO:0005515,protein binding,2.0
18019,NFIB,GO:0005634,nucleus,2.0
18021,NFIB,GO:0005654,nucleoplasm,2.0
18022,NFIB,GO:0006260,DNA replication,2.0
18023,NFIB,GO:0006357,regulation of transcription by RNA polymerase II,2.0
18024,NFIB,GO:0007420,brain development,2.0
18025,NFIB,GO:0009617,response to bacterium,2.0
18026,NFIB,GO:0010001,glial cell differentiation,2.0
18027,NFIB,GO:0021740,principal sensory nucleus of trigeminal nerve development,2.0
18028,NFIB,GO:0021960,anterior commissure morphogenesis,2.0
18029,NFIB,GO:0030902,hindbrain development,2.0
18030,NFIB,GO:0044300,cerebellar mossy fiber,2.0
18031,NFIB,GO:0045893,positive regulation of DNA-templated transcription,2.0
18032,NFIB,GO:0045944,positive regulation of transcription by RNA polymerase II,2.0
18033,NFIB,GO:0060486,club cell differentiation,2.0
18034,NFIB,GO:0060509,type I pneumocyte differentiation,2.0
18035,NFIB,GO:0060510,type II pneumocyte differentiation,2.0
18036,NFIB,GO:0060662,salivary gland cavitation,2.0
18037,NFIB,GO:0060689,cell differentiation involved in salivary gland development,2.0
18038,NFIB,GO:0061141,lung ciliated cell differentiation,2.0
18039,NFIB,GO:0071679,commissural neuron axon guidance,2.0
18040,NFIB,GO:0072089,stem cell proliferation,2.0
18041,NFIB,GO:1902894,negative regulation of miRNA transcription,2.0
18042,NFIB,GO:1990837,sequence-specific double-stranded DNA binding,2.0
18043,NFIB,GO:2000647,negative regulation of stem cell proliferation,2.0
18044,NFIB,GO:2000791,negative regulation of mesenchymal cell proliferation involved in lung development,2.0
18045,NFIB,GO:2000795,negative regulation of epithelial cell proliferation involved in lung morphogenesis,2.0
18059,NINL,GO:0005509,calcium ion binding,2.0
18060,NINL,GO:0005515,protein binding,2.0
18061,NINL,GO:0005813,centrosome,2.0
18062,NINL,GO:0005829,cytosol,2.0
18064,NINL,GO:0005874,microtubule,2.0
18065,NINL,GO:0015630,microtubule cytoskeleton,2.0
18066,NINL,GO:0034454,microtubule anchoring at centrosome,2.0
18067,NINL,GO:0045171,intercellular bridge,2.0
18068,NIPA1,GO:0005515,protein binding,2.0
18069,NIPA1,GO:0005769,early endosome,2.0
18070,NIPA1,GO:0005886,plasma membrane,2.0
18071,NIPA1,GO:0015095,magnesium ion transmembrane transporter activity,2.0
18072,NIPA1,GO:0015693,magnesium ion transport,2.0
18073,NIPA1,GO:0016020,membrane,2.0
18074,NIPA1,GO:0055085,transmembrane transport,2.0
18075,NIPA1,GO:1903830,magnesium ion transmembrane transport,2.0
18076,NIPA2,GO:0005769,early endosome,2.0
18077,NIPA2,GO:0005886,plasma membrane,2.0
18078,NIPA2,GO:0015095,magnesium ion transmembrane transporter activity,2.0
18079,NIPA2,GO:0015693,magnesium ion transport,2.0
18080,NIPA2,GO:0016020,membrane,2.0
18081,NIPA2,GO:1903830,magnesium ion transmembrane transport,2.0
18177,NLGN1,GO:0001540,amyloid-beta binding,2.0
18178,NLGN1,GO:0005794,Golgi apparatus,2.0
18179,NLGN1,GO:0005886,plasma membrane,2.0
18184,NLGN1,GO:0006605,protein targeting,2.0
18185,NLGN1,GO:0007157,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules,2.0
18186,NLGN1,GO:0007158,neuron cell-cell adhesion,2.0
18191,NLGN1,GO:0007268,chemical synaptic transmission,2.0
18192,NLGN1,GO:0007399,nervous system development,2.0
18194,NLGN1,GO:0007416,synapse assembly,2.0
18196,NLGN1,GO:0009986,cell surface,2.0
18198,NLGN1,GO:0010841,"positive regulation of circadian sleep/wake cycle, wakefulness",2.0
18199,NLGN1,GO:0010976,positive regulation of neuron projection development,2.0
18200,NLGN1,GO:0014069,postsynaptic density,2.0
18201,NLGN1,GO:0016020,membrane,2.0
18202,NLGN1,GO:0016080,synaptic vesicle targeting,2.0
18203,NLGN1,GO:0016339,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules,2.0
18205,NLGN1,GO:0023041,neuronal signal transduction,2.0
18206,NLGN1,GO:0030165,PDZ domain binding,2.0
18207,NLGN1,GO:0030425,dendrite,2.0
18208,NLGN1,GO:0031175,neuron projection development,2.0
18210,NLGN1,GO:0031594,neuromuscular junction,2.0
18211,NLGN1,GO:0032230,"positive regulation of synaptic transmission, GABAergic",2.0
18213,NLGN1,GO:0032433,filopodium tip,2.0
18214,NLGN1,GO:0035418,protein localization to synapse,2.0
18215,NLGN1,GO:0038023,signaling receptor activity,2.0
18217,NLGN1,GO:0042043,neurexin family protein binding,2.0
18220,NLGN1,GO:0042802,identical protein binding,2.0
18221,NLGN1,GO:0043083,synaptic cleft,2.0
18222,NLGN1,GO:0043197,dendritic spine,2.0
18223,NLGN1,GO:0043235,receptor complex,2.0
18224,NLGN1,GO:0045184,establishment of protein localization,2.0
18225,NLGN1,GO:0045202,synapse,2.0
18227,NLGN1,GO:0045211,postsynaptic membrane,2.0
18228,NLGN1,GO:0045664,regulation of neuron differentiation,2.0
18229,NLGN1,GO:0048488,synaptic vesicle endocytosis,2.0
18230,NLGN1,GO:0048511,rhythmic process,2.0
18231,NLGN1,GO:0048789,cytoskeletal matrix organization at active zone,2.0
18232,NLGN1,GO:0048812,neuron projection morphogenesis,2.0
18233,NLGN1,GO:0050804,modulation of chemical synaptic transmission,2.0
18235,NLGN1,GO:0050839,cell adhesion molecule binding,2.0
18236,NLGN1,GO:0051491,positive regulation of filopodium assembly,2.0
18237,NLGN1,GO:0051965,positive regulation of synapse assembly,2.0
18239,NLGN1,GO:0051968,"positive regulation of synaptic transmission, glutamatergic",2.0
18241,NLGN1,GO:0060074,synapse maturation,2.0
18242,NLGN1,GO:0060076,excitatory synapse,2.0
18244,NLGN1,GO:0060077,inhibitory synapse,2.0
18245,NLGN1,GO:0060999,positive regulation of dendritic spine development,2.0
18247,NLGN1,GO:0061002,negative regulation of dendritic spine morphogenesis,2.0
18248,NLGN1,GO:0071277,cellular response to calcium ion,2.0
18249,NLGN1,GO:0072553,terminal button organization,2.0
18250,NLGN1,GO:0090125,cell-cell adhesion involved in synapse maturation,2.0
18251,NLGN1,GO:0097091,synaptic vesicle clustering,2.0
18252,NLGN1,GO:0097104,postsynaptic membrane assembly,2.0
18254,NLGN1,GO:0097105,presynaptic membrane assembly,2.0
18256,NLGN1,GO:0097110,scaffold protein binding,2.0
18257,NLGN1,GO:0097113,AMPA glutamate receptor clustering,2.0
18258,NLGN1,GO:0097114,NMDA glutamate receptor clustering,2.0
18259,NLGN1,GO:0097115,neurexin clustering involved in presynaptic membrane assembly,2.0
18260,NLGN1,GO:0097119,postsynaptic density protein 95 clustering,2.0
18261,NLGN1,GO:0097120,receptor localization to synapse,2.0
18262,NLGN1,GO:0098635,protein complex involved in cell-cell adhesion,2.0
18263,NLGN1,GO:0098793,presynapse,2.0
18264,NLGN1,GO:0098794,postsynapse,2.0
18265,NLGN1,GO:0098978,glutamatergic synapse,2.0
18266,NLGN1,GO:0098982,GABA-ergic synapse,2.0
18267,NLGN1,GO:0098984,neuron to neuron synapse,2.0
18268,NLGN1,GO:0098985,"asymmetric, glutamatergic, excitatory synapse",2.0
18269,NLGN1,GO:0099054,presynapse assembly,2.0
18270,NLGN1,GO:0099558,maintenance of synapse structure,2.0
18271,NLGN1,GO:0099634,postsynaptic specialization membrane,2.0
18273,NLGN1,GO:0140058,neuron projection arborization,2.0
18274,NLGN1,GO:1900029,positive regulation of ruffle assembly,2.0
18275,NLGN1,GO:1900075,positive regulation of neuromuscular synaptic transmission,2.0
18276,NLGN1,GO:1900244,positive regulation of synaptic vesicle endocytosis,2.0
18277,NLGN1,GO:1902533,positive regulation of intracellular signal transduction,2.0
18278,NLGN1,GO:1904861,excitatory synapse assembly,2.0
18279,NLGN1,GO:2000302,positive regulation of synaptic vesicle exocytosis,2.0
18280,NLGN1,GO:2000310,regulation of NMDA receptor activity,2.0
18282,NLGN1,GO:2000311,regulation of AMPA receptor activity,2.0
18283,NLGN1,GO:2000463,positive regulation of excitatory postsynaptic potential,2.0
18453,NLGN4Y,GO:0005515,protein binding,2.0
18454,NLGN4Y,GO:0005886,plasma membrane,2.0
18456,NLGN4Y,GO:0007158,neuron cell-cell adhesion,2.0
18458,NLGN4Y,GO:0007268,chemical synaptic transmission,2.0
18459,NLGN4Y,GO:0007612,learning,2.0
18460,NLGN4Y,GO:0009986,cell surface,2.0
18461,NLGN4Y,GO:0016020,membrane,2.0
18462,NLGN4Y,GO:0035176,social behavior,2.0
18463,NLGN4Y,GO:0038023,signaling receptor activity,2.0
18464,NLGN4Y,GO:0042043,neurexin family protein binding,2.0
18465,NLGN4Y,GO:0045202,synapse,2.0
18466,NLGN4Y,GO:0048488,synaptic vesicle endocytosis,2.0
18467,NLGN4Y,GO:0050804,modulation of chemical synaptic transmission,2.0
18468,NLGN4Y,GO:0050839,cell adhesion molecule binding,2.0
18469,NLGN4Y,GO:0071625,vocalization behavior,2.0
18470,NLGN4Y,GO:0097104,postsynaptic membrane assembly,2.0
18471,NLGN4Y,GO:0097105,presynaptic membrane assembly,2.0
18472,NLGN4Y,GO:0097110,scaffold protein binding,2.0
18473,NLGN4Y,GO:0098793,presynapse,2.0
18474,NLGN4Y,GO:0098839,postsynaptic density membrane,2.0
18475,NLGN4Y,GO:0098983,"symmetric, GABA-ergic, inhibitory synapse",2.0
18476,NLGN4Y,GO:0098985,"asymmetric, glutamatergic, excitatory synapse",2.0
18477,NLGN4Y,GO:0099054,presynapse assembly,2.0
18478,NLGN4Y,GO:0099634,postsynaptic specialization membrane,2.0
18498,NPAS2,GO:0000785,chromatin,2.0
18499,NPAS2,GO:0000978,RNA polymerase II cis-regulatory region sequence-specific DNA binding,2.0
18501,NPAS2,GO:0000981,"DNA-binding transcription factor activity, RNA polymerase II-specific",2.0
18503,NPAS2,GO:0003677,DNA binding,2.0
18504,NPAS2,GO:0003700,DNA-binding transcription factor activity,2.0
18505,NPAS2,GO:0005515,protein binding,2.0
18506,NPAS2,GO:0005634,nucleus,2.0
18507,NPAS2,GO:0005654,nucleoplasm,2.0
18509,NPAS2,GO:0005829,cytosol,2.0
18510,NPAS2,GO:0006357,regulation of transcription by RNA polymerase II,2.0
18511,NPAS2,GO:0006974,cellular response to DNA damage stimulus,2.0
18512,NPAS2,GO:0007417,central nervous system development,2.0
18513,NPAS2,GO:0009410,response to xenobiotic stimulus,2.0
18514,NPAS2,GO:0032922,circadian regulation of gene expression,2.0
18516,NPAS2,GO:0045739,positive regulation of DNA repair,2.0
18517,NPAS2,GO:0045893,positive regulation of DNA-templated transcription,2.0
18519,NPAS2,GO:0045944,positive regulation of transcription by RNA polymerase II,2.0
18520,NPAS2,GO:0046872,metal ion binding,2.0
18521,NPAS2,GO:0046983,protein dimerization activity,2.0
18522,NPAS2,GO:0051775,response to redox state,2.0
18523,NPAS2,GO:0051879,Hsp90 protein binding,2.0
18524,NPAS2,GO:0060548,negative regulation of cell death,2.0
18525,NPAS2,GO:1990513,CLOCK-BMAL transcription complex,2.0
18526,NPAS2,GO:1990837,sequence-specific double-stranded DNA binding,2.0
18527,NPAS2,GO:2000987,positive regulation of behavioral fear response,2.0
18528,NPAS2,GO:2001020,regulation of response to DNA damage stimulus,2.0
18543,NR1D1,GO:0000122,negative regulation of transcription by RNA polymerase II,2.0
18547,NR1D1,GO:0000785,chromatin,2.0
18549,NR1D1,GO:0000976,transcription cis-regulatory region binding,2.0
18550,NR1D1,GO:0000977,RNA polymerase II transcription regulatory region sequence-specific DNA binding,2.0
18551,NR1D1,GO:0000978,RNA polymerase II cis-regulatory region sequence-specific DNA binding,2.0
18554,NR1D1,GO:0000981,"DNA-binding transcription factor activity, RNA polymerase II-specific",2.0
18555,NR1D1,GO:0001222,transcription corepressor binding,2.0
18557,NR1D1,GO:0001227,"DNA-binding transcription repressor activity, RNA polymerase II-specific",2.0
18558,NR1D1,GO:0001678,cellular glucose homeostasis,2.0
18559,NR1D1,GO:0003707,nuclear steroid receptor activity,2.0
18560,NR1D1,GO:0004879,nuclear receptor activity,2.0
18561,NR1D1,GO:0005515,protein binding,2.0
18562,NR1D1,GO:0005634,nucleus,2.0
18563,NR1D1,GO:0005654,nucleoplasm,2.0
18564,NR1D1,GO:0005737,cytoplasm,2.0
18565,NR1D1,GO:0005978,glycogen biosynthetic process,2.0
18566,NR1D1,GO:0008270,zinc ion binding,2.0
18567,NR1D1,GO:0009755,hormone-mediated signaling pathway,2.0
18568,NR1D1,GO:0010498,proteasomal protein catabolic process,2.0
18569,NR1D1,GO:0016604,nuclear body,2.0
18570,NR1D1,GO:0019216,regulation of lipid metabolic process,2.0
18571,NR1D1,GO:0020037,heme binding,2.0
18572,NR1D1,GO:0030154,cell differentiation,2.0
18573,NR1D1,GO:0030425,dendrite,2.0
18574,NR1D1,GO:0030522,intracellular receptor signaling pathway,2.0
18575,NR1D1,GO:0031648,protein destabilization,2.0
18576,NR1D1,GO:0032922,circadian regulation of gene expression,2.0
18577,NR1D1,GO:0034144,negative regulation of toll-like receptor 4 signaling pathway,2.0
18578,NR1D1,GO:0042632,cholesterol homeostasis,2.0
18580,NR1D1,GO:0042749,regulation of circadian sleep/wake cycle,2.0
18581,NR1D1,GO:0042752,regulation of circadian rhythm,2.0
18582,NR1D1,GO:0043124,negative regulation of I-kappaB kinase/NF-kappaB signaling,2.0
18583,NR1D1,GO:0043197,dendritic spine,2.0
18584,NR1D1,GO:0043401,steroid hormone mediated signaling pathway,2.0
18585,NR1D1,GO:0044321,response to leptin,2.0
18587,NR1D1,GO:0045598,regulation of fat cell differentiation,2.0
18588,NR1D1,GO:0045892,negative regulation of DNA-templated transcription,2.0
18590,NR1D1,GO:0045893,positive regulation of DNA-templated transcription,2.0
18591,NR1D1,GO:0045944,positive regulation of transcription by RNA polymerase II,2.0
18592,NR1D1,GO:0050728,negative regulation of inflammatory response,2.0
18593,NR1D1,GO:0060086,circadian temperature homeostasis,2.0
18594,NR1D1,GO:0061178,regulation of insulin secretion involved in cellular response to glucose stimulus,2.0
18595,NR1D1,GO:0061469,regulation of type B pancreatic cell proliferation,2.0
18596,NR1D1,GO:0061889,negative regulation of astrocyte activation,2.0
18597,NR1D1,GO:0070859,positive regulation of bile acid biosynthetic process,2.0
18598,NR1D1,GO:0070888,E-box binding,2.0
18599,NR1D1,GO:0071222,cellular response to lipopolysaccharide,2.0
18600,NR1D1,GO:0071347,cellular response to interleukin-1,2.0
18601,NR1D1,GO:0071356,cellular response to tumor necrosis factor,2.0
18602,NR1D1,GO:0120163,negative regulation of cold-induced thermogenesis,2.0
18603,NR1D1,GO:0150079,negative regulation of neuroinflammatory response,2.0
18604,NR1D1,GO:1903979,negative regulation of microglial cell activation,2.0
18605,NR1D1,GO:1990837,sequence-specific double-stranded DNA binding,2.0
18606,NR2F1,GO:0000122,negative regulation of transcription by RNA polymerase II,2.0
18608,NR2F1,GO:0000978,RNA polymerase II cis-regulatory region sequence-specific DNA binding,2.0
18610,NR2F1,GO:0001227,"DNA-binding transcription repressor activity, RNA polymerase II-specific",2.0
18611,NR2F1,GO:0003700,DNA-binding transcription factor activity,2.0
18612,NR2F1,GO:0004879,nuclear receptor activity,2.0
18613,NR2F1,GO:0005515,protein binding,2.0
18614,NR2F1,GO:0005634,nucleus,2.0
18615,NR2F1,GO:0005654,nucleoplasm,2.0
18617,NR2F1,GO:0005829,cytosol,2.0
18618,NR2F1,GO:0006357,regulation of transcription by RNA polymerase II,2.0
18619,NR2F1,GO:0007165,signal transduction,2.0
18620,NR2F1,GO:0007399,nervous system development,2.0
18621,NR2F1,GO:0008270,zinc ion binding,2.0
18622,NR2F1,GO:0010977,negative regulation of neuron projection development,2.0
18623,NR2F1,GO:0030154,cell differentiation,2.0
18624,NR2F1,GO:0030522,intracellular receptor signaling pathway,2.0
18625,NR2F1,GO:0043565,sequence-specific DNA binding,2.0
18626,NR2F1,GO:0044323,retinoic acid-responsive element binding,2.0
18627,NR2F1,GO:0045944,positive regulation of transcription by RNA polymerase II,2.0
18628,NR2F1,GO:0048856,anatomical structure development,2.0
18629,NR2F1,GO:1990837,sequence-specific double-stranded DNA binding,2.0
18706,NRCAM,GO:0001525,angiogenesis,2.0
18707,NRCAM,GO:0001764,neuron migration,2.0
18708,NRCAM,GO:0005515,protein binding,2.0
18709,NRCAM,GO:0005576,extracellular region,2.0
18710,NRCAM,GO:0005886,plasma membrane,2.0
18713,NRCAM,GO:0007409,axonogenesis,2.0
18714,NRCAM,GO:0007411,axon guidance,2.0
18715,NRCAM,GO:0007413,axonal fasciculation,2.0
18716,NRCAM,GO:0007416,synapse assembly,2.0
18717,NRCAM,GO:0007417,central nervous system development,2.0
18718,NRCAM,GO:0007420,brain development,2.0
18719,NRCAM,GO:0008104,protein localization,2.0
18720,NRCAM,GO:0009897,external side of plasma membrane,2.0
18721,NRCAM,GO:0010975,regulation of neuron projection development,2.0
18722,NRCAM,GO:0019227,neuronal action potential propagation,2.0
18723,NRCAM,GO:0030424,axon,2.0
18724,NRCAM,GO:0030506,ankyrin binding,2.0
18725,NRCAM,GO:0030516,regulation of axon extension,2.0
18726,NRCAM,GO:0031290,retinal ganglion cell axon guidance,2.0
18727,NRCAM,GO:0034113,heterotypic cell-cell adhesion,2.0
18728,NRCAM,GO:0043005,neuron projection,2.0
18729,NRCAM,GO:0043194,axon initial segment,2.0
18730,NRCAM,GO:0045162,clustering of voltage-gated sodium channels,2.0
18731,NRCAM,GO:0045666,positive regulation of neuron differentiation,2.0
18732,NRCAM,GO:0086080,protein binding involved in heterotypic cell-cell adhesion,2.0
18733,NRCAM,GO:0098609,cell-cell adhesion,2.0
18735,NRCAM,GO:0098632,cell-cell adhesion mediator activity,2.0
18736,NRCAM,GO:0098839,postsynaptic density membrane,2.0
18737,NRCAM,GO:0098978,glutamatergic synapse,2.0
18738,NRCAM,GO:0099175,regulation of postsynapse organization,2.0
18739,NRP2,GO:0001525,angiogenesis,2.0
18740,NRP2,GO:0001938,positive regulation of endothelial cell proliferation,2.0
18741,NRP2,GO:0002116,semaphorin receptor complex,2.0
18742,NRP2,GO:0003148,outflow tract septum morphogenesis,2.0
18743,NRP2,GO:0005021,vascular endothelial growth factor receptor activity,2.0
18744,NRP2,GO:0005515,protein binding,2.0
18745,NRP2,GO:0005576,extracellular region,2.0
18746,NRP2,GO:0005886,plasma membrane,2.0
18748,NRP2,GO:0007155,cell adhesion,2.0
18749,NRP2,GO:0007411,axon guidance,2.0
18751,NRP2,GO:0008201,heparin binding,2.0
18752,NRP2,GO:0010595,positive regulation of endothelial cell migration,2.0
18753,NRP2,GO:0016020,membrane,2.0
18754,NRP2,GO:0017154,semaphorin receptor activity,2.0
18756,NRP2,GO:0019838,growth factor binding,2.0
18757,NRP2,GO:0019955,cytokine binding,2.0
18758,NRP2,GO:0021612,facial nerve structural organization,2.0
18759,NRP2,GO:0021649,vestibulocochlear nerve structural organization,2.0
18760,NRP2,GO:0021675,nerve development,2.0
18761,NRP2,GO:0021828,gonadotrophin-releasing hormone neuronal migration to the hypothalamus,2.0
18762,NRP2,GO:0030424,axon,2.0
18763,NRP2,GO:0036486,ventral trunk neural crest cell migration,2.0
18764,NRP2,GO:0038023,signaling receptor activity,2.0
18765,NRP2,GO:0038084,vascular endothelial growth factor signaling pathway,2.0
18766,NRP2,GO:0045211,postsynaptic membrane,2.0
18767,NRP2,GO:0046872,metal ion binding,2.0
18768,NRP2,GO:0048846,axon extension involved in axon guidance,2.0
18769,NRP2,GO:0050919,negative chemotaxis,2.0
18770,NRP2,GO:0061549,sympathetic ganglion development,2.0
18771,NRP2,GO:0061551,trigeminal ganglion development,2.0
18772,NRP2,GO:0097374,sensory neuron axon guidance,2.0
18773,NRP2,GO:0097490,sympathetic neuron projection extension,2.0
18774,NRP2,GO:0097491,sympathetic neuron projection guidance,2.0
18775,NRP2,GO:0098978,glutamatergic synapse,2.0
18776,NRP2,GO:0099175,regulation of postsynapse organization,2.0
18777,NRP2,GO:1901166,neural crest cell migration involved in autonomic nervous system development,2.0
18778,NRP2,GO:1902285,semaphorin-plexin signaling pathway involved in neuron projection guidance,2.0
18779,NRP2,GO:1903375,facioacoustic ganglion development,2.0
18780,NRP2,GO:1904835,dorsal root ganglion morphogenesis,2.0
18781,NRP2,GO:1990830,cellular response to leukemia inhibitory factor,2.0
18884,NSD2,GO:0000122,negative regulation of transcription by RNA polymerase II,2.0
18885,NSD2,GO:0000785,chromatin,2.0
18886,NSD2,GO:0003149,membranous septum morphogenesis,2.0
18887,NSD2,GO:0003289,atrial septum primum morphogenesis,2.0
18888,NSD2,GO:0003290,atrial septum secundum morphogenesis,2.0
18889,NSD2,GO:0003682,chromatin binding,2.0
18890,NSD2,GO:0005515,protein binding,2.0
18891,NSD2,GO:0005634,nucleus,2.0
18892,NSD2,GO:0005654,nucleoplasm,2.0
18894,NSD2,GO:0005730,nucleolus,2.0
18895,NSD2,GO:0005737,cytoplasm,2.0
18896,NSD2,GO:0006302,double-strand break repair,2.0
18897,NSD2,GO:0006325,chromatin organization,2.0
18898,NSD2,GO:0006355,regulation of DNA-templated transcription,2.0
18899,NSD2,GO:0010452,histone H3-K36 methylation,2.0
18900,NSD2,GO:0018024,histone lysine N-methyltransferase activity,2.0
18901,NSD2,GO:0034770,histone H4-K20 methylation,2.0
18902,NSD2,GO:0042799,histone H4K20 methyltransferase activity,2.0
18903,NSD2,GO:0043565,sequence-specific DNA binding,2.0
18904,NSD2,GO:0046872,metal ion binding,2.0
18905,NSD2,GO:0046975,histone H3K36 methyltransferase activity,2.0
18907,NSD2,GO:0048298,positive regulation of isotype switching to IgA isotypes,2.0
18908,NSD2,GO:0060348,bone development,2.0
18909,NSD2,GO:0070201,regulation of establishment of protein localization,2.0
18910,NSD2,GO:2001032,regulation of double-strand break repair via nonhomologous end joining,2.0
18911,NSMCE3,GO:0000122,negative regulation of transcription by RNA polymerase II,2.0
18912,NSMCE3,GO:0000724,double-strand break repair via homologous recombination,2.0
18913,NSMCE3,GO:0000781,"chromosome, telomeric region",2.0
18914,NSMCE3,GO:0005515,protein binding,2.0
18915,NSMCE3,GO:0005634,nucleus,2.0
18916,NSMCE3,GO:0005654,nucleoplasm,2.0
18917,NSMCE3,GO:0005737,cytoplasm,2.0
18918,NSMCE3,GO:0006281,DNA repair,2.0
18919,NSMCE3,GO:0016925,protein sumoylation,2.0
18920,NSMCE3,GO:0030915,Smc5-Smc6 complex,2.0
18922,NSMCE3,GO:0031398,positive regulation of protein ubiquitination,2.0
18923,NSMCE3,GO:0032204,regulation of telomere maintenance,2.0
18924,NSMCE3,GO:0034644,cellular response to UV,2.0
18925,NSMCE3,GO:0046983,protein dimerization activity,2.0
18926,NSMCE3,GO:0071478,cellular response to radiation,2.0
18927,NSMCE3,GO:0072711,cellular response to hydroxyurea,2.0
18928,NTNG1,GO:0005515,protein binding,2.0
18929,NTNG1,GO:0005576,extracellular region,2.0
18930,NTNG1,GO:0005886,plasma membrane,2.0
18933,NTNG1,GO:0007409,axonogenesis,2.0
18934,NTNG1,GO:0009887,animal organ morphogenesis,2.0
18935,NTNG1,GO:0009888,tissue development,2.0
18936,NTNG1,GO:0010975,regulation of neuron projection development,2.0
18937,NTNG1,GO:0016477,cell migration,2.0
18938,NTNG1,GO:0034446,substrate adhesion-dependent cell spreading,2.0
18939,NTNG1,GO:0043256,laminin complex,2.0
18940,NTNG1,GO:0048787,presynaptic active zone membrane,2.0
18941,NTNG1,GO:0050804,modulation of chemical synaptic transmission,2.0
18942,NTNG1,GO:0050839,cell adhesion molecule binding,2.0
18943,NTNG1,GO:0070831,basement membrane assembly,2.0
18944,NTNG1,GO:0098632,cell-cell adhesion mediator activity,2.0
18946,NTNG1,GO:0098685,Schaffer collateral - CA1 synapse,2.0
18947,NTNG1,GO:0098978,glutamatergic synapse,2.0
18948,NTNG1,GO:0099560,synaptic membrane adhesion,2.0
18949,NTNG1,GO:0150011,regulation of neuron projection arborization,2.0
18950,NTNG1,GO:2001222,regulation of neuron migration,2.0
18974,NTRK1,GO:0001934,positive regulation of protein phosphorylation,2.0
18975,NTRK1,GO:0004713,protein tyrosine kinase activity,2.0
18976,NTRK1,GO:0004714,transmembrane receptor protein tyrosine kinase activity,2.0
18979,NTRK1,GO:0005004,GPI-linked ephrin receptor activity,2.0
18980,NTRK1,GO:0005030,neurotrophin receptor activity,2.0
18981,NTRK1,GO:0005166,neurotrophin p75 receptor binding,2.0
18982,NTRK1,GO:0005515,protein binding,2.0
18983,NTRK1,GO:0005524,ATP binding,2.0
18984,NTRK1,GO:0005769,early endosome,2.0
18985,NTRK1,GO:0005770,late endosome,2.0
18986,NTRK1,GO:0005886,plasma membrane,2.0
18990,NTRK1,GO:0006468,protein phosphorylation,2.0
18991,NTRK1,GO:0007169,transmembrane receptor protein tyrosine kinase signaling pathway,2.0
18992,NTRK1,GO:0007275,multicellular organism development,2.0
18993,NTRK1,GO:0007411,axon guidance,2.0
18994,NTRK1,GO:0007568,aging,2.0
18995,NTRK1,GO:0007611,learning or memory,2.0
18996,NTRK1,GO:0007623,circadian rhythm,2.0
18997,NTRK1,GO:0008285,negative regulation of cell population proliferation,2.0
18998,NTRK1,GO:0009314,response to radiation,2.0
18999,NTRK1,GO:0009410,response to xenobiotic stimulus,2.0
19000,NTRK1,GO:0009986,cell surface,2.0
19001,NTRK1,GO:0010008,endosome membrane,2.0
19002,NTRK1,GO:0010465,nerve growth factor receptor activity,2.0
19004,NTRK1,GO:0010623,programmed cell death involved in cell development,2.0
19005,NTRK1,GO:0010976,positive regulation of neuron projection development,2.0
19006,NTRK1,GO:0014068,positive regulation of phosphatidylinositol 3-kinase signaling,2.0
19007,NTRK1,GO:0018108,peptidyl-tyrosine phosphorylation,2.0
19008,NTRK1,GO:0019900,kinase binding,2.0
19009,NTRK1,GO:0021553,olfactory nerve development,2.0
19010,NTRK1,GO:0030183,B cell differentiation,2.0
19011,NTRK1,GO:0030424,axon,2.0
19012,NTRK1,GO:0030425,dendrite,2.0
19013,NTRK1,GO:0031667,response to nutrient levels,2.0
19014,NTRK1,GO:0031901,early endosome membrane,2.0
19015,NTRK1,GO:0031902,late endosome membrane,2.0
19016,NTRK1,GO:0032991,protein-containing complex,2.0
19017,NTRK1,GO:0033674,positive regulation of kinase activity,2.0
19018,NTRK1,GO:0038083,peptidyl-tyrosine autophosphorylation,2.0
19019,NTRK1,GO:0038180,nerve growth factor signaling pathway,2.0
19021,NTRK1,GO:0042490,mechanoreceptor differentiation,2.0
19022,NTRK1,GO:0042802,identical protein binding,2.0
19023,NTRK1,GO:0042803,protein homodimerization activity,2.0
19024,NTRK1,GO:0043025,neuronal cell body,2.0
19025,NTRK1,GO:0043066,negative regulation of apoptotic process,2.0
19026,NTRK1,GO:0043068,positive regulation of programmed cell death,2.0
19027,NTRK1,GO:0043121,neurotrophin binding,2.0
19028,NTRK1,GO:0043235,receptor complex,2.0
19030,NTRK1,GO:0043524,negative regulation of neuron apoptotic process,2.0
19031,NTRK1,GO:0043547,positive regulation of GTPase activity,2.0
19032,NTRK1,GO:0046579,positive regulation of Ras protein signal transduction,2.0
19033,NTRK1,GO:0046777,protein autophosphorylation,2.0
19034,NTRK1,GO:0048011,neurotrophin TRK receptor signaling pathway,2.0
19035,NTRK1,GO:0048013,ephrin receptor signaling pathway,2.0
19036,NTRK1,GO:0048406,nerve growth factor binding,2.0
19037,NTRK1,GO:0048485,sympathetic nervous system development,2.0
19038,NTRK1,GO:0048678,response to axon injury,2.0
19039,NTRK1,GO:0050965,detection of temperature stimulus involved in sensory perception of pain,2.0
19040,NTRK1,GO:0050966,detection of mechanical stimulus involved in sensory perception of pain,2.0
19041,NTRK1,GO:0051092,positive regulation of NF-kappaB transcription factor activity,2.0
19042,NTRK1,GO:0051402,neuron apoptotic process,2.0
19043,NTRK1,GO:0051599,response to hydrostatic pressure,2.0
19044,NTRK1,GO:0051602,response to electrical stimulus,2.0
19045,NTRK1,GO:0051896,regulation of protein kinase B signaling,2.0
19046,NTRK1,GO:0051965,positive regulation of synapse assembly,2.0
19047,NTRK1,GO:0051968,"positive regulation of synaptic transmission, glutamatergic",2.0
19048,NTRK1,GO:0055038,recycling endosome membrane,2.0
19049,NTRK1,GO:0060009,Sertoli cell development,2.0
19050,NTRK1,GO:0060385,axonogenesis involved in innervation,2.0
19051,NTRK1,GO:0061368,behavioral response to formalin induced pain,2.0
19052,NTRK1,GO:0070374,positive regulation of ERK1 and ERK2 cascade,2.0
19054,NTRK1,GO:0071316,cellular response to nicotine,2.0
19055,NTRK1,GO:1904646,cellular response to amyloid-beta,2.0
19056,NTRK1,GO:1990090,cellular response to nerve growth factor stimulus,2.0
19136,NTRK3,GO:0001764,neuron migration,2.0
19137,NTRK3,GO:0001933,negative regulation of protein phosphorylation,2.0
19138,NTRK3,GO:0001934,positive regulation of protein phosphorylation,2.0
19139,NTRK3,GO:0002039,p53 binding,2.0
19140,NTRK3,GO:0004714,transmembrane receptor protein tyrosine kinase activity,2.0
19141,NTRK3,GO:0005004,GPI-linked ephrin receptor activity,2.0
19142,NTRK3,GO:0005030,neurotrophin receptor activity,2.0
19144,NTRK3,GO:0005515,protein binding,2.0
19145,NTRK3,GO:0005524,ATP binding,2.0
19146,NTRK3,GO:0005737,cytoplasm,2.0
19147,NTRK3,GO:0005886,plasma membrane,2.0
19149,NTRK3,GO:0007169,transmembrane receptor protein tyrosine kinase signaling pathway,2.0
19151,NTRK3,GO:0007275,multicellular organism development,2.0
19152,NTRK3,GO:0007507,heart development,2.0
19153,NTRK3,GO:0008284,positive regulation of cell population proliferation,2.0
19154,NTRK3,GO:0010628,positive regulation of gene expression,2.0
19155,NTRK3,GO:0010976,positive regulation of neuron projection development,2.0
19156,NTRK3,GO:0014068,positive regulation of phosphatidylinositol 3-kinase signaling,2.0
19157,NTRK3,GO:0018108,peptidyl-tyrosine phosphorylation,2.0
19158,NTRK3,GO:0030335,positive regulation of cell migration,2.0
19159,NTRK3,GO:0030424,axon,2.0
19160,NTRK3,GO:0032148,activation of protein kinase B activity,2.0
19161,NTRK3,GO:0033138,positive regulation of peptidyl-serine phosphorylation,2.0
19162,NTRK3,GO:0033674,positive regulation of kinase activity,2.0
19163,NTRK3,GO:0038179,neurotrophin signaling pathway,2.0
19164,NTRK3,GO:0043121,neurotrophin binding,2.0
19165,NTRK3,GO:0043235,receptor complex,2.0
19167,NTRK3,GO:0043406,positive regulation of MAP kinase activity,2.0
19168,NTRK3,GO:0045211,postsynaptic membrane,2.0
19169,NTRK3,GO:0045471,response to ethanol,2.0
19170,NTRK3,GO:0048013,ephrin receptor signaling pathway,2.0
19171,NTRK3,GO:0048665,neuron fate specification,2.0
19172,NTRK3,GO:0048678,response to axon injury,2.0
19173,NTRK3,GO:0048712,negative regulation of astrocyte differentiation,2.0
19174,NTRK3,GO:0050927,positive regulation of positive chemotaxis,2.0
19175,NTRK3,GO:0051412,response to corticosterone,2.0
19176,NTRK3,GO:0051896,regulation of protein kinase B signaling,2.0
19177,NTRK3,GO:0060548,negative regulation of cell death,2.0
19178,NTRK3,GO:0070374,positive regulation of ERK1 and ERK2 cascade,2.0
19179,NTRK3,GO:0071300,cellular response to retinoic acid,2.0
19180,NTRK3,GO:0090102,cochlea development,2.0
19181,NTRK3,GO:0090630,activation of GTPase activity,2.0
19182,NTRK3,GO:0097107,postsynaptic density assembly,2.0
19183,NTRK3,GO:0098978,glutamatergic synapse,2.0
19184,NTRK3,GO:1905606,regulation of presynapse assembly,2.0
19185,NTRK3,GO:1990090,cellular response to nerve growth factor stimulus,2.0
19186,NTRK3,GO:2000251,positive regulation of actin cytoskeleton reorganization,2.0
19187,NUAK1,GO:0001650,fibrillar center,2.0
19188,NUAK1,GO:0002039,p53 binding,2.0
19189,NUAK1,GO:0004674,protein serine/threonine kinase activity,2.0
19192,NUAK1,GO:0005515,protein binding,2.0
19193,NUAK1,GO:0005524,ATP binding,2.0
19194,NUAK1,GO:0005634,nucleus,2.0
19195,NUAK1,GO:0005654,nucleoplasm,2.0
19197,NUAK1,GO:0005737,cytoplasm,2.0
19199,NUAK1,GO:0006468,protein phosphorylation,2.0
19201,NUAK1,GO:0006974,cellular response to DNA damage stimulus,2.0
19202,NUAK1,GO:0007155,cell adhesion,2.0
19203,NUAK1,GO:0015630,microtubule cytoskeleton,2.0
19204,NUAK1,GO:0030155,regulation of cell adhesion,2.0
19205,NUAK1,GO:0035507,regulation of myosin-light-chain-phosphatase activity,2.0
19206,NUAK1,GO:0035556,intracellular signal transduction,2.0
19207,NUAK1,GO:0042127,regulation of cell population proliferation,2.0
19208,NUAK1,GO:0042149,cellular response to glucose starvation,2.0
19209,NUAK1,GO:0046872,metal ion binding,2.0
19210,NUAK1,GO:0106310,protein serine kinase activity,2.0
19211,NUAK1,GO:1901796,regulation of signal transduction by p53 class mediator,2.0
19212,NUAK1,GO:2000772,regulation of cellular senescence,2.0
19213,NUDCD2,GO:0000776,kinetochore,2.0
19214,NUDCD2,GO:0000922,spindle pole,2.0
19215,NUDCD2,GO:0005515,protein binding,2.0
19216,NUDCD2,GO:0005737,cytoplasm,2.0
19217,NUDCD2,GO:0005815,microtubule organizing center,2.0
19218,NUDCD2,GO:0005829,cytosol,2.0
19219,NUDCD2,GO:0006457,protein folding,2.0
19220,NUDCD2,GO:0015630,microtubule cytoskeleton,2.0
19221,NUDCD2,GO:0045171,intercellular bridge,2.0
19222,NUDCD2,GO:0051082,unfolded protein binding,2.0
19223,NUDCD2,GO:0072686,mitotic spindle,2.0
19224,NUP133,GO:0000776,kinetochore,2.0
19225,NUP133,GO:0000972,transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery,2.0
19226,NUP133,GO:0005515,protein binding,2.0
19227,NUP133,GO:0005635,nuclear envelope,2.0
19229,NUP133,GO:0005643,nuclear pore,2.0
19231,NUP133,GO:0005829,cytosol,2.0
19232,NUP133,GO:0006406,mRNA export from nucleus,2.0
19233,NUP133,GO:0006606,protein import into nucleus,2.0
19234,NUP133,GO:0006913,nucleocytoplasmic transport,2.0
19235,NUP133,GO:0006999,nuclear pore organization,2.0
19236,NUP133,GO:0016020,membrane,2.0
19237,NUP133,GO:0016973,poly(A)+ mRNA export from nucleus,2.0
19238,NUP133,GO:0017056,structural constituent of nuclear pore,2.0
19240,NUP133,GO:0021915,neural tube development,2.0
19241,NUP133,GO:0022008,neurogenesis,2.0
19242,NUP133,GO:0031080,nuclear pore outer ring,2.0
19245,NUP133,GO:0031965,nuclear membrane,2.0
19246,NUP133,GO:0048339,paraxial mesoderm development,2.0
19247,NUP133,GO:0061053,somite development,2.0
19248,NUP133,GO:0072006,nephron development,2.0
19287,NXPH1,GO:0005102,signaling receptor binding,2.0
19288,NXPH1,GO:0005576,extracellular region,2.0
19328,ODF3L2,GO:0005515,protein binding,2.0
19329,ODF3L2,GO:0005856,cytoskeleton,2.0
19330,ODF3L2,GO:0005881,cytoplasmic microtubule,2.0
19332,OFD1,GO:0000278,mitotic cell cycle,2.0
19333,OFD1,GO:0005515,protein binding,2.0
19334,OFD1,GO:0005576,extracellular region,2.0
19335,OFD1,GO:0005634,nucleus,2.0
19336,OFD1,GO:0005813,centrosome,2.0
19338,OFD1,GO:0005814,centriole,2.0
19339,OFD1,GO:0005829,cytosol,2.0
19340,OFD1,GO:0005929,cilium,2.0
19341,OFD1,GO:0007099,centriole replication,2.0
19342,OFD1,GO:0015630,microtubule cytoskeleton,2.0
19343,OFD1,GO:0016020,membrane,2.0
19344,OFD1,GO:0031514,motile cilium,2.0
19345,OFD1,GO:0034451,centriolar satellite,2.0
19346,OFD1,GO:0036064,ciliary basal body,2.0
19348,OFD1,GO:0042802,identical protein binding,2.0
19349,OFD1,GO:0043014,alpha-tubulin binding,2.0
19350,OFD1,GO:0043015,gamma-tubulin binding,2.0
19351,OFD1,GO:0060271,cilium assembly,2.0
19353,OFD1,GO:0060287,epithelial cilium movement involved in determination of left/right asymmetry,2.0
19354,OFD1,GO:0090307,mitotic spindle assembly,2.0
19355,OPHN1,GO:0003779,actin binding,2.0
19356,OPHN1,GO:0005096,GTPase activator activity,2.0
19357,OPHN1,GO:0005543,phospholipid binding,2.0
19358,OPHN1,GO:0005737,cytoplasm,2.0
19359,OPHN1,GO:0006930,"substrate-dependent cell migration, cell extension",2.0
19360,OPHN1,GO:0007165,signal transduction,2.0
19361,OPHN1,GO:0007399,nervous system development,2.0
19362,OPHN1,GO:0007411,axon guidance,2.0
19363,OPHN1,GO:0015629,actin cytoskeleton,2.0
19364,OPHN1,GO:0021707,cerebellar granule cell differentiation,2.0
19365,OPHN1,GO:0021895,cerebral cortex neuron differentiation,2.0
19366,OPHN1,GO:0030036,actin cytoskeleton organization,2.0
19367,OPHN1,GO:0030100,regulation of endocytosis,2.0
19368,OPHN1,GO:0030182,neuron differentiation,2.0
19369,OPHN1,GO:0031175,neuron projection development,2.0
19370,OPHN1,GO:0034329,cell junction assembly,2.0
19371,OPHN1,GO:0035023,regulation of Rho protein signal transduction,2.0
19372,OPHN1,GO:0035255,ionotropic glutamate receptor binding,2.0
19373,OPHN1,GO:0043195,terminal bouton,2.0
19374,OPHN1,GO:0043197,dendritic spine,2.0
19375,OPHN1,GO:0045198,establishment of epithelial cell apical/basal polarity,2.0
19376,OPHN1,GO:0048488,synaptic vesicle endocytosis,2.0
19377,OPHN1,GO:0048667,cell morphogenesis involved in neuron differentiation,2.0
19378,OPHN1,GO:0050790,regulation of catalytic activity,2.0
19379,OPHN1,GO:0051966,"regulation of synaptic transmission, glutamatergic",2.0
19380,OPHN1,GO:0098880,maintenance of postsynaptic specialization structure,2.0
19381,OPHN1,GO:0098978,glutamatergic synapse,2.0
19384,OPHN1,GO:0099149,regulation of postsynaptic neurotransmitter receptor internalization,2.0
19387,OPHN1,GO:1900242,regulation of synaptic vesicle endocytosis,2.0
19388,OPHN1,GO:1901799,negative regulation of proteasomal protein catabolic process,2.0
19389,OR1C1,GO:0004930,G protein-coupled receptor activity,2.0
19390,OR1C1,GO:0004984,olfactory receptor activity,2.0
19392,OR1C1,GO:0005886,plasma membrane,2.0
19394,OR1C1,GO:0007165,signal transduction,2.0
19395,OR1C1,GO:0007186,G protein-coupled receptor signaling pathway,2.0
19396,OR1C1,GO:0007608,sensory perception of smell,2.0
19397,OR1C1,GO:0016020,membrane,2.0
19398,OR1C1,GO:0050911,detection of chemical stimulus involved in sensory perception of smell,2.0
19399,OR2T10,GO:0004930,G protein-coupled receptor activity,2.0
19400,OR2T10,GO:0004984,olfactory receptor activity,2.0
19401,OR2T10,GO:0005886,plasma membrane,2.0
19402,OR2T10,GO:0007186,G protein-coupled receptor signaling pathway,2.0
19403,OR2T10,GO:0050911,detection of chemical stimulus involved in sensory perception of smell,2.0
19404,OR52M1,GO:0004930,G protein-coupled receptor activity,2.0
19405,OR52M1,GO:0004984,olfactory receptor activity,2.0
19406,OR52M1,GO:0005886,plasma membrane,2.0
19407,OR52M1,GO:0007186,G protein-coupled receptor signaling pathway,2.0
19408,OR52M1,GO:0050911,detection of chemical stimulus involved in sensory perception of smell,2.0
19409,OTUD7A,GO:0003677,DNA binding,2.0
19410,OTUD7A,GO:0004843,cysteine-type deubiquitinase activity,2.0
19413,OTUD7A,GO:0005634,nucleus,2.0
19414,OTUD7A,GO:0005737,cytoplasm,2.0
19415,OTUD7A,GO:0005829,cytosol,2.0
19416,OTUD7A,GO:0008270,zinc ion binding,2.0
19417,OTUD7A,GO:0016579,protein deubiquitination,2.0
19418,OTUD7A,GO:0035871,protein K11-linked deubiquitination,2.0
19420,OTUD7A,GO:0043124,negative regulation of I-kappaB kinase/NF-kappaB signaling,2.0
19421,OTUD7A,GO:0070530,K63-linked polyubiquitin modification-dependent protein binding,2.0
19422,OTUD7A,GO:0070536,protein K63-linked deubiquitination,2.0
19423,OTUD7A,GO:0071108,protein K48-linked deubiquitination,2.0
19424,OTUD7A,GO:0071947,protein deubiquitination involved in ubiquitin-dependent protein catabolic process,2.0
19425,OXT,GO:0001975,response to amphetamine,2.0
19426,OXT,GO:0002027,regulation of heart rate,2.0
19427,OXT,GO:0002125,maternal aggressive behavior,2.0
19428,OXT,GO:0005184,neuropeptide hormone activity,2.0
19429,OXT,GO:0005185,neurohypophyseal hormone activity,2.0
19430,OXT,GO:0005515,protein binding,2.0
19431,OXT,GO:0005576,extracellular region,2.0
19432,OXT,GO:0005615,extracellular space,2.0
19433,OXT,GO:0007165,signal transduction,2.0
19434,OXT,GO:0007204,positive regulation of cytosolic calcium ion concentration,2.0
19435,OXT,GO:0007507,heart development,2.0
19436,OXT,GO:0007565,female pregnancy,2.0
19437,OXT,GO:0007613,memory,2.0
19438,OXT,GO:0007625,grooming behavior,2.0
19439,OXT,GO:0009744,response to sucrose,2.0
19440,OXT,GO:0010701,positive regulation of norepinephrine secretion,2.0
19441,OXT,GO:0014823,response to activity,2.0
19442,OXT,GO:0030141,secretory granule,2.0
19443,OXT,GO:0030431,sleep,2.0
19444,OXT,GO:0031855,oxytocin receptor binding,2.0
19445,OXT,GO:0032094,response to food,2.0
19446,OXT,GO:0032308,positive regulation of prostaglandin secretion,2.0
19447,OXT,GO:0032355,response to estradiol,2.0
19448,OXT,GO:0032526,response to retinoic acid,2.0
19449,OXT,GO:0032570,response to progesterone,2.0
19450,OXT,GO:0034695,response to prostaglandin E,2.0
19451,OXT,GO:0035176,social behavior,2.0
19452,OXT,GO:0035811,negative regulation of urine volume,2.0
19453,OXT,GO:0035815,positive regulation of renal sodium excretion,2.0
19454,OXT,GO:0042220,response to cocaine,2.0
19455,OXT,GO:0042538,hyperosmotic salinity response,2.0
19456,OXT,GO:0042711,maternal behavior,2.0
19457,OXT,GO:0042713,sperm ejaculation,2.0
19458,OXT,GO:0042755,eating behavior,2.0
19459,OXT,GO:0042756,drinking behavior,2.0
19460,OXT,GO:0043195,terminal bouton,2.0
19461,OXT,GO:0043434,response to peptide hormone,2.0
19462,OXT,GO:0045472,response to ether,2.0
19463,OXT,GO:0045776,negative regulation of blood pressure,2.0
19464,OXT,GO:0045777,positive regulation of blood pressure,2.0
19465,OXT,GO:0045778,positive regulation of ossification,2.0
19466,OXT,GO:0045925,positive regulation of female receptivity,2.0
19467,OXT,GO:0050806,positive regulation of synaptic transmission,2.0
19468,OXT,GO:0051384,response to glucocorticoid,2.0
19469,OXT,GO:0051591,response to cAMP,2.0
19470,OXT,GO:0051602,response to electrical stimulus,2.0
19471,OXT,GO:0051930,regulation of sensory perception of pain,2.0
19472,OXT,GO:0051965,positive regulation of synapse assembly,2.0
19473,OXT,GO:0060179,male mating behavior,2.0
19474,OXT,GO:0060406,positive regulation of penile erection,2.0
19475,OXT,GO:0060450,positive regulation of hindgut contraction,2.0
19476,OXT,GO:0060455,negative regulation of gastric acid secretion,2.0
19477,OXT,GO:0070474,positive regulation of uterine smooth muscle contraction,2.0
19478,OXT,GO:0120162,positive regulation of cold-induced thermogenesis,2.0
19479,OXTR,GO:0001967,suckling behavior,2.0
19480,OXTR,GO:0001975,response to amphetamine,2.0
19481,OXTR,GO:0001992,regulation of systemic arterial blood pressure by vasopressin,2.0
19482,OXTR,GO:0004930,G protein-coupled receptor activity,2.0
19483,OXTR,GO:0004990,oxytocin receptor activity,2.0
19484,OXTR,GO:0005000,vasopressin receptor activity,2.0
19485,OXTR,GO:0005886,plasma membrane,2.0
19487,OXTR,GO:0005902,microvillus,2.0
19488,OXTR,GO:0005912,adherens junction,2.0
19489,OXTR,GO:0006936,muscle contraction,2.0
19490,OXTR,GO:0007166,cell surface receptor signaling pathway,2.0
19491,OXTR,GO:0007186,G protein-coupled receptor signaling pathway,2.0
19492,OXTR,GO:0007204,positive regulation of cytosolic calcium ion concentration,2.0
19493,OXTR,GO:0007507,heart development,2.0
19494,OXTR,GO:0007565,female pregnancy,2.0
19495,OXTR,GO:0007595,lactation,2.0
19496,OXTR,GO:0007613,memory,2.0
19497,OXTR,GO:0009410,response to xenobiotic stimulus,2.0
19498,OXTR,GO:0010701,positive regulation of norepinephrine secretion,2.0
19499,OXTR,GO:0016324,apical plasma membrane,2.0
19500,OXTR,GO:0017046,peptide hormone binding,2.0
19501,OXTR,GO:0021537,telencephalon development,2.0
19502,OXTR,GO:0030431,sleep,2.0
19503,OXTR,GO:0032230,"positive regulation of synaptic transmission, GABAergic",2.0
19504,OXTR,GO:0032355,response to estradiol,2.0
19505,OXTR,GO:0032570,response to progesterone,2.0
19506,OXTR,GO:0034059,response to anoxia,2.0
19507,OXTR,GO:0034097,response to cytokine,2.0
19508,OXTR,GO:0035176,social behavior,2.0
19509,OXTR,GO:0042220,response to cocaine,2.0
19510,OXTR,GO:0042277,peptide binding,2.0
19511,OXTR,GO:0042711,maternal behavior,2.0
19512,OXTR,GO:0042713,sperm ejaculation,2.0
19513,OXTR,GO:0042755,eating behavior,2.0
19514,OXTR,GO:0043434,response to peptide hormone,2.0
19515,OXTR,GO:0044849,estrous cycle,2.0
19516,OXTR,GO:0045777,positive regulation of blood pressure,2.0
19517,OXTR,GO:0045907,positive regulation of vasoconstriction,2.0
19518,OXTR,GO:0048565,digestive tract development,2.0
19519,OXTR,GO:0051965,positive regulation of synapse assembly,2.0
19520,OXTR,GO:0051968,"positive regulation of synaptic transmission, glutamatergic",2.0
19521,OXTR,GO:0060137,maternal process involved in parturition,2.0
19522,OXTR,GO:0060406,positive regulation of penile erection,2.0
19523,OXTR,GO:0060455,negative regulation of gastric acid secretion,2.0
19524,OXTR,GO:0070371,ERK1 and ERK2 cascade,2.0
19525,OXTR,GO:0070474,positive regulation of uterine smooth muscle contraction,2.0
19526,OXTR,GO:0120162,positive regulation of cold-induced thermogenesis,2.0
19527,P2RX5,GO:0001614,purinergic nucleotide receptor activity,2.0
19528,P2RX5,GO:0004888,transmembrane signaling receptor activity,2.0
19529,P2RX5,GO:0004931,extracellularly ATP-gated cation channel activity,2.0
19531,P2RX5,GO:0005216,ion channel activity,2.0
19532,P2RX5,GO:0005524,ATP binding,2.0
19533,P2RX5,GO:0005637,nuclear inner membrane,2.0
19534,P2RX5,GO:0005829,cytosol,2.0
19535,P2RX5,GO:0005886,plasma membrane,2.0
19536,P2RX5,GO:0007165,signal transduction,2.0
19537,P2RX5,GO:0007399,nervous system development,2.0
19538,P2RX5,GO:0010524,positive regulation of calcium ion transport into cytosol,2.0
19539,P2RX5,GO:0033198,response to ATP,2.0
19540,P2RX5,GO:0035590,purinergic nucleotide receptor signaling pathway,2.0
19541,P2RX5,GO:0050850,positive regulation of calcium-mediated signaling,2.0
19542,P2RX5,GO:0060079,excitatory postsynaptic potential,2.0
19543,P2RX5,GO:0098655,cation transmembrane transport,2.0
19544,P2RX5,GO:0098794,postsynapse,2.0
19545,P4HA2,GO:0004656,procollagen-proline 4-dioxygenase activity,2.0
19547,P4HA2,GO:0005506,iron ion binding,2.0
19548,P4HA2,GO:0005654,nucleoplasm,2.0
19549,P4HA2,GO:0005783,endoplasmic reticulum,2.0
19551,P4HA2,GO:0005788,endoplasmic reticulum lumen,2.0
19552,P4HA2,GO:0005829,cytosol,2.0
19553,P4HA2,GO:0009055,electron transfer activity,2.0
19554,P4HA2,GO:0018401,peptidyl-proline hydroxylation to 4-hydroxy-L-proline,2.0
19555,P4HA2,GO:0022900,electron transport chain,2.0
19556,P4HA2,GO:0031418,L-ascorbic acid binding,2.0
19557,P4HA2,GO:0043231,intracellular membrane-bounded organelle,2.0
19624,PAFAH1B2,GO:0001650,fibrillar center,2.0
19625,PAFAH1B2,GO:0003847,1-alkyl-2-acetylglycerophosphocholine esterase activity,2.0
19626,PAFAH1B2,GO:0005515,protein binding,2.0
19627,PAFAH1B2,GO:0005576,extracellular region,2.0
19628,PAFAH1B2,GO:0005730,nucleolus,2.0
19629,PAFAH1B2,GO:0005737,cytoplasm,2.0
19631,PAFAH1B2,GO:0005829,cytosol,2.0
19633,PAFAH1B2,GO:0005886,plasma membrane,2.0
19634,PAFAH1B2,GO:0006629,lipid metabolic process,2.0
19635,PAFAH1B2,GO:0007283,spermatogenesis,2.0
19636,PAFAH1B2,GO:0007420,brain development,2.0
19637,PAFAH1B2,GO:0008247,1-alkyl-2-acetylglycerophosphocholine esterase complex,2.0
19638,PAFAH1B2,GO:0016042,lipid catabolic process,2.0
19639,PAFAH1B2,GO:0016239,positive regulation of macroautophagy,2.0
19640,PAFAH1B2,GO:0034774,secretory granule lumen,2.0
19641,PAFAH1B2,GO:0042803,protein homodimerization activity,2.0
19642,PAFAH1B2,GO:0044877,protein-containing complex binding,2.0
19643,PAFAH1B2,GO:0046982,protein heterodimerization activity,2.0
19644,PAFAH1B2,GO:0047179,platelet-activating factor acetyltransferase activity,2.0
19645,PAFAH1B2,GO:0070062,extracellular exosome,2.0
19646,PAFAH1B2,GO:1904813,ficolin-1-rich granule lumen,2.0
19727,PAK2,GO:0002223,stimulatory C-type lectin receptor signaling pathway,2.0
19728,PAK2,GO:0003300,cardiac muscle hypertrophy,2.0
19729,PAK2,GO:0004672,protein kinase activity,2.0
19730,PAK2,GO:0004674,protein serine/threonine kinase activity,2.0
19734,PAK2,GO:0005515,protein binding,2.0
19735,PAK2,GO:0005524,ATP binding,2.0
19736,PAK2,GO:0005634,nucleus,2.0
19737,PAK2,GO:0005737,cytoplasm,2.0
19740,PAK2,GO:0005829,cytosol,2.0
19742,PAK2,GO:0005886,plasma membrane,2.0
19743,PAK2,GO:0005911,cell-cell junction,2.0
19744,PAK2,GO:0006468,protein phosphorylation,2.0
19746,PAK2,GO:0006469,negative regulation of protein kinase activity,2.0
19747,PAK2,GO:0006915,apoptotic process,2.0
19748,PAK2,GO:0007165,signal transduction,2.0
19749,PAK2,GO:0014069,postsynaptic density,2.0
19750,PAK2,GO:0016310,phosphorylation,2.0
19751,PAK2,GO:0018105,peptidyl-serine phosphorylation,2.0
19752,PAK2,GO:0019901,protein kinase binding,2.0
19753,PAK2,GO:0030141,secretory granule,2.0
19754,PAK2,GO:0030296,protein tyrosine kinase activator activity,2.0
19755,PAK2,GO:0031267,small GTPase binding,2.0
19756,PAK2,GO:0034333,adherens junction assembly,2.0
19757,PAK2,GO:0035556,intracellular signal transduction,2.0
19758,PAK2,GO:0042802,identical protein binding,2.0
19759,PAK2,GO:0043066,negative regulation of apoptotic process,2.0
19760,PAK2,GO:0043408,regulation of MAPK cascade,2.0
19761,PAK2,GO:0045296,cadherin binding,2.0
19762,PAK2,GO:0046777,protein autophosphorylation,2.0
19763,PAK2,GO:0048010,vascular endothelial growth factor receptor signaling pathway,2.0
19764,PAK2,GO:0048471,perinuclear region of cytoplasm,2.0
19765,PAK2,GO:0050731,positive regulation of peptidyl-tyrosine phosphorylation,2.0
19766,PAK2,GO:0050770,regulation of axonogenesis,2.0
19767,PAK2,GO:0051179,localization,2.0
19768,PAK2,GO:0051493,regulation of cytoskeleton organization,2.0
19769,PAK2,GO:0051497,negative regulation of stress fiber assembly,2.0
19770,PAK2,GO:0060996,dendritic spine development,2.0
19771,PAK2,GO:0061098,positive regulation of protein tyrosine kinase activity,2.0
19772,PAK2,GO:0070830,bicellular tight junction assembly,2.0
19773,PAK2,GO:0071407,cellular response to organic cyclic compound,2.0
19774,PAK2,GO:0071560,cellular response to transforming growth factor beta stimulus,2.0
19775,PAK2,GO:0098978,glutamatergic synapse,2.0
19776,PAK2,GO:0106310,protein serine kinase activity,2.0
19777,PAK2,GO:0150105,protein localization to cell-cell junction,2.0
19778,PAK2,GO:2001238,positive regulation of extrinsic apoptotic signaling pathway,2.0
19779,PAK2,GO:2001271,negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis,2.0
19780,PAPOLG,GO:0003723,RNA binding,2.0
19781,PAPOLG,GO:0004652,polynucleotide adenylyltransferase activity,2.0
19783,PAPOLG,GO:0005524,ATP binding,2.0
19784,PAPOLG,GO:0005634,nucleus,2.0
19786,PAPOLG,GO:0005654,nucleoplasm,2.0
19787,PAPOLG,GO:0005829,cytosol,2.0
19788,PAPOLG,GO:0006378,mRNA polyadenylation,2.0
19789,PAPOLG,GO:0016020,membrane,2.0
19790,PAPOLG,GO:0016604,nuclear body,2.0
19791,PAPOLG,GO:0043631,RNA polyadenylation,2.0
19792,PAPOLG,GO:0046872,metal ion binding,2.0
19793,PARD3B,GO:0000226,microtubule cytoskeleton organization,2.0
19794,PARD3B,GO:0005515,protein binding,2.0
19795,PARD3B,GO:0005912,adherens junction,2.0
19796,PARD3B,GO:0005923,bicellular tight junction,2.0
19797,PARD3B,GO:0005938,cell cortex,2.0
19798,PARD3B,GO:0007049,cell cycle,2.0
19799,PARD3B,GO:0007155,cell adhesion,2.0
19800,PARD3B,GO:0008104,protein localization,2.0
19801,PARD3B,GO:0012505,endomembrane system,2.0
19802,PARD3B,GO:0016324,apical plasma membrane,2.0
19803,PARD3B,GO:0030010,establishment of cell polarity,2.0
19804,PARD3B,GO:0030054,cell junction,2.0
19805,PARD3B,GO:0032991,protein-containing complex,2.0
19806,PARD3B,GO:0035091,phosphatidylinositol binding,2.0
19807,PARD3B,GO:0043296,apical junction complex,2.0
19808,PARD3B,GO:0045197,establishment or maintenance of epithelial cell apical/basal polarity,2.0
19809,PARD3B,GO:0051301,cell division,2.0
19810,PARD3B,GO:0051660,establishment of centrosome localization,2.0
19811,PATJ,GO:0005515,protein binding,2.0
19812,PATJ,GO:0005737,cytoplasm,2.0
19813,PATJ,GO:0005829,cytosol,2.0
19814,PATJ,GO:0005886,plasma membrane,2.0
19816,PATJ,GO:0005923,bicellular tight junction,2.0
19818,PATJ,GO:0016324,apical plasma membrane,2.0
19820,PATJ,GO:0030054,cell junction,2.0
19821,PATJ,GO:0031023,microtubule organizing center organization,2.0
19822,PATJ,GO:0034451,centriolar satellite,2.0
19823,PATJ,GO:0035089,establishment of apical/basal cell polarity,2.0
19824,PATJ,GO:0035556,intracellular signal transduction,2.0
19825,PATJ,GO:0043296,apical junction complex,2.0
19826,PATJ,GO:0045177,apical part of cell,2.0
19827,PATJ,GO:0045197,establishment or maintenance of epithelial cell apical/basal polarity,2.0
19828,PATJ,GO:0048471,perinuclear region of cytoplasm,2.0
19829,PATJ,GO:0070062,extracellular exosome,2.0
19830,PATJ,GO:0070507,regulation of microtubule cytoskeleton organization,2.0
19831,PATJ,GO:0120192,tight junction assembly,2.0
19951,PBX1,GO:0000086,G2/M transition of mitotic cell cycle,2.0
19952,PBX1,GO:0000785,chromatin,2.0
19953,PBX1,GO:0000976,transcription cis-regulatory region binding,2.0
19954,PBX1,GO:0000977,RNA polymerase II transcription regulatory region sequence-specific DNA binding,2.0
19955,PBX1,GO:0000978,RNA polymerase II cis-regulatory region sequence-specific DNA binding,2.0
19956,PBX1,GO:0000981,"DNA-binding transcription factor activity, RNA polymerase II-specific",2.0
19959,PBX1,GO:0001221,transcription coregulator binding,2.0
19960,PBX1,GO:0001222,transcription corepressor binding,2.0
19961,PBX1,GO:0001228,"DNA-binding transcription activator activity, RNA polymerase II-specific",2.0
19962,PBX1,GO:0001654,eye development,2.0
19963,PBX1,GO:0001655,urogenital system development,2.0
19964,PBX1,GO:0001658,branching involved in ureteric bud morphogenesis,2.0
19965,PBX1,GO:0001779,natural killer cell differentiation,2.0
19966,PBX1,GO:0003677,DNA binding,2.0
19967,PBX1,GO:0003700,DNA-binding transcription factor activity,2.0
19968,PBX1,GO:0005515,protein binding,2.0
19969,PBX1,GO:0005634,nucleus,2.0
19970,PBX1,GO:0005654,nucleoplasm,2.0
19972,PBX1,GO:0005737,cytoplasm,2.0
19973,PBX1,GO:0006357,regulation of transcription by RNA polymerase II,2.0
19974,PBX1,GO:0006694,steroid biosynthetic process,2.0
19975,PBX1,GO:0007420,brain development,2.0
19976,PBX1,GO:0007548,sex differentiation,2.0
19977,PBX1,GO:0009887,animal organ morphogenesis,2.0
19978,PBX1,GO:0009952,anterior/posterior pattern specification,2.0
19979,PBX1,GO:0009954,proximal/distal pattern formation,2.0
19980,PBX1,GO:0010971,positive regulation of G2/M transition of mitotic cell cycle,2.0
19981,PBX1,GO:0030278,regulation of ossification,2.0
19982,PBX1,GO:0030325,adrenal gland development,2.0
19983,PBX1,GO:0030326,embryonic limb morphogenesis,2.0
19984,PBX1,GO:0035162,embryonic hemopoiesis,2.0
19985,PBX1,GO:0045665,negative regulation of neuron differentiation,2.0
19986,PBX1,GO:0045944,positive regulation of transcription by RNA polymerase II,2.0
19987,PBX1,GO:0048536,spleen development,2.0
19988,PBX1,GO:0048538,thymus development,2.0
19989,PBX1,GO:0048568,embryonic organ development,2.0
19990,PBX1,GO:0048666,neuron development,2.0
19991,PBX1,GO:0048706,embryonic skeletal system development,2.0
19992,PBX1,GO:0072089,stem cell proliferation,2.0
19993,PBX1,GO:0090575,RNA polymerase II transcription regulator complex,2.0
19994,PBX1,GO:0140297,DNA-binding transcription factor binding,2.0
19995,PBX1,GO:1990837,sequence-specific double-stranded DNA binding,2.0
19996,PBX1,GO:2000648,positive regulation of stem cell proliferation,2.0
20050,PCDH10,GO:0005509,calcium ion binding,2.0
20051,PCDH10,GO:0005886,plasma membrane,2.0
20052,PCDH10,GO:0007155,cell adhesion,2.0
20053,PCDH10,GO:0007156,homophilic cell adhesion via plasma membrane adhesion molecules,2.0
20054,PCDH10,GO:0007399,nervous system development,2.0
20055,PCDH11X,GO:0005509,calcium ion binding,2.0
20056,PCDH11X,GO:0005886,plasma membrane,2.0
20057,PCDH11X,GO:0007155,cell adhesion,2.0
20058,PCDH11X,GO:0007156,homophilic cell adhesion via plasma membrane adhesion molecules,2.0
20059,PCDH15,GO:0001750,photoreceptor outer segment,2.0
20060,PCDH15,GO:0005509,calcium ion binding,2.0
20061,PCDH15,GO:0005576,extracellular region,2.0
20062,PCDH15,GO:0005886,plasma membrane,2.0
20063,PCDH15,GO:0007155,cell adhesion,2.0
20064,PCDH15,GO:0007156,homophilic cell adhesion via plasma membrane adhesion molecules,2.0
20065,PCDH15,GO:0007605,sensory perception of sound,2.0
20067,PCDH15,GO:0032420,stereocilium,2.0
20068,PCDH15,GO:0045202,synapse,2.0
20069,PCDH15,GO:0045494,photoreceptor cell maintenance,2.0
20070,PCDH15,GO:0048839,inner ear development,2.0
20071,PCDH15,GO:0050953,sensory perception of light stimulus,2.0
20072,PCDH15,GO:0050957,equilibrioception,2.0
20078,PCDH9,GO:0005509,calcium ion binding,2.0
20079,PCDH9,GO:0005886,plasma membrane,2.0
20080,PCDH9,GO:0007155,cell adhesion,2.0
20081,PCDH9,GO:0007156,homophilic cell adhesion via plasma membrane adhesion molecules,2.0
20082,PCDH9,GO:0030426,growth cone,2.0
20083,PCDH9,GO:0044291,cell-cell contact zone,2.0
20084,PCDHA1,GO:0005509,calcium ion binding,2.0
20085,PCDHA1,GO:0005576,extracellular region,2.0
20086,PCDHA1,GO:0005783,endoplasmic reticulum,2.0
20087,PCDHA1,GO:0005886,plasma membrane,2.0
20088,PCDHA1,GO:0007155,cell adhesion,2.0
20089,PCDHA1,GO:0007156,homophilic cell adhesion via plasma membrane adhesion molecules,2.0
20090,PCDHA1,GO:0007399,nervous system development,2.0
20091,PCDHA10,GO:0005509,calcium ion binding,2.0
20092,PCDHA10,GO:0005576,extracellular region,2.0
20093,PCDHA10,GO:0005886,plasma membrane,2.0
20094,PCDHA10,GO:0007155,cell adhesion,2.0
20095,PCDHA10,GO:0007156,homophilic cell adhesion via plasma membrane adhesion molecules,2.0
20096,PCDHA10,GO:0007399,nervous system development,2.0
20097,PCDHA11,GO:0005509,calcium ion binding,2.0
20098,PCDHA11,GO:0005886,plasma membrane,2.0
20099,PCDHA11,GO:0007155,cell adhesion,2.0
20100,PCDHA11,GO:0007156,homophilic cell adhesion via plasma membrane adhesion molecules,2.0
20101,PCDHA11,GO:0007399,nervous system development,2.0
20102,PCDHA12,GO:0005509,calcium ion binding,2.0
20103,PCDHA12,GO:0005886,plasma membrane,2.0
20104,PCDHA12,GO:0007155,cell adhesion,2.0
20105,PCDHA12,GO:0007156,homophilic cell adhesion via plasma membrane adhesion molecules,2.0
20106,PCDHA12,GO:0007399,nervous system development,2.0
20107,PCDHA13,GO:0005509,calcium ion binding,2.0
20108,PCDHA13,GO:0005886,plasma membrane,2.0
20109,PCDHA13,GO:0007155,cell adhesion,2.0
20110,PCDHA13,GO:0007156,homophilic cell adhesion via plasma membrane adhesion molecules,2.0
20111,PCDHA13,GO:0007399,nervous system development,2.0
20112,PCDHA2,GO:0005509,calcium ion binding,2.0
20113,PCDHA2,GO:0005634,nucleus,2.0
20114,PCDHA2,GO:0005783,endoplasmic reticulum,2.0
20115,PCDHA2,GO:0005886,plasma membrane,2.0
20116,PCDHA2,GO:0007155,cell adhesion,2.0
20117,PCDHA2,GO:0007156,homophilic cell adhesion via plasma membrane adhesion molecules,2.0
20118,PCDHA2,GO:0007399,nervous system development,2.0
20119,PCDHA3,GO:0005509,calcium ion binding,2.0
20120,PCDHA3,GO:0005886,plasma membrane,2.0
20121,PCDHA3,GO:0007155,cell adhesion,2.0
20122,PCDHA3,GO:0007156,homophilic cell adhesion via plasma membrane adhesion molecules,2.0
20123,PCDHA3,GO:0007399,nervous system development,2.0
20124,PCDHA4,GO:0005509,calcium ion binding,2.0
20125,PCDHA4,GO:0005515,protein binding,2.0
20126,PCDHA4,GO:0005886,plasma membrane,2.0
20127,PCDHA4,GO:0007155,cell adhesion,2.0
20128,PCDHA4,GO:0007156,homophilic cell adhesion via plasma membrane adhesion molecules,2.0
20129,PCDHA4,GO:0007399,nervous system development,2.0
20130,PCDHA4,GO:0042802,identical protein binding,2.0
20131,PCDHA5,GO:0005509,calcium ion binding,2.0
20132,PCDHA5,GO:0005886,plasma membrane,2.0
20133,PCDHA5,GO:0007155,cell adhesion,2.0
20134,PCDHA5,GO:0007156,homophilic cell adhesion via plasma membrane adhesion molecules,2.0
20135,PCDHA5,GO:0007399,nervous system development,2.0
20136,PCDHA6,GO:0005509,calcium ion binding,2.0
20137,PCDHA6,GO:0005576,extracellular region,2.0
20138,PCDHA6,GO:0005886,plasma membrane,2.0
20139,PCDHA6,GO:0007155,cell adhesion,2.0
20140,PCDHA6,GO:0007156,homophilic cell adhesion via plasma membrane adhesion molecules,2.0
20141,PCDHA6,GO:0007399,nervous system development,2.0
20142,PCDHA7,GO:0005509,calcium ion binding,2.0
20143,PCDHA7,GO:0005886,plasma membrane,2.0
20145,PCDHA7,GO:0007155,cell adhesion,2.0
20146,PCDHA7,GO:0007156,homophilic cell adhesion via plasma membrane adhesion molecules,2.0
20147,PCDHA7,GO:0007399,nervous system development,2.0
20148,PCDHA7,GO:0009988,cell-cell recognition,2.0
20149,PCDHA7,GO:0042802,identical protein binding,2.0
20150,PCDHA8,GO:0005509,calcium ion binding,2.0
20151,PCDHA8,GO:0005886,plasma membrane,2.0
20152,PCDHA8,GO:0007155,cell adhesion,2.0
20153,PCDHA8,GO:0007156,homophilic cell adhesion via plasma membrane adhesion molecules,2.0
20154,PCDHA8,GO:0007399,nervous system development,2.0
20155,PCDHA9,GO:0005509,calcium ion binding,2.0
20156,PCDHA9,GO:0005886,plasma membrane,2.0
20157,PCDHA9,GO:0007155,cell adhesion,2.0
20158,PCDHA9,GO:0007156,homophilic cell adhesion via plasma membrane adhesion molecules,2.0
20159,PCDHA9,GO:0007399,nervous system development,2.0
20160,PCDHAC1,GO:0005509,calcium ion binding,2.0
20161,PCDHAC1,GO:0005886,plasma membrane,2.0
20162,PCDHAC1,GO:0007155,cell adhesion,2.0
20163,PCDHAC1,GO:0007156,homophilic cell adhesion via plasma membrane adhesion molecules,2.0
20164,PCDHAC1,GO:0007399,nervous system development,2.0
20165,PCDHAC2,GO:0005509,calcium ion binding,2.0
20166,PCDHAC2,GO:0005886,plasma membrane,2.0
20167,PCDHAC2,GO:0007155,cell adhesion,2.0
20168,PCDHAC2,GO:0007156,homophilic cell adhesion via plasma membrane adhesion molecules,2.0
20169,PCDHAC2,GO:0007399,nervous system development,2.0
20170,PCM1,GO:0000242,pericentriolar material,2.0
20171,PCM1,GO:0001764,neuron migration,2.0
20172,PCM1,GO:0005515,protein binding,2.0
20173,PCM1,GO:0005654,nucleoplasm,2.0
20174,PCM1,GO:0005737,cytoplasm,2.0
20175,PCM1,GO:0005813,centrosome,2.0
20178,PCM1,GO:0005814,centriole,2.0
20179,PCM1,GO:0005829,cytosol,2.0
20181,PCM1,GO:0007098,centrosome cycle,2.0
20183,PCM1,GO:0016020,membrane,2.0
20184,PCM1,GO:0022027,interkinetic nuclear migration,2.0
20185,PCM1,GO:0031122,cytoplasmic microtubule organization,2.0
20186,PCM1,GO:0031965,nuclear membrane,2.0
20187,PCM1,GO:0032991,protein-containing complex,2.0
20188,PCM1,GO:0034451,centriolar satellite,2.0
20190,PCM1,GO:0034453,microtubule anchoring,2.0
20191,PCM1,GO:0034454,microtubule anchoring at centrosome,2.0
20192,PCM1,GO:0035176,social behavior,2.0
20193,PCM1,GO:0035735,intraciliary transport involved in cilium assembly,2.0
20195,PCM1,GO:0035869,ciliary transition zone,2.0
20196,PCM1,GO:0036064,ciliary basal body,2.0
20197,PCM1,GO:0042802,identical protein binding,2.0
20198,PCM1,GO:0045177,apical part of cell,2.0
20199,PCM1,GO:0050768,negative regulation of neurogenesis,2.0
20200,PCM1,GO:0060271,cilium assembly,2.0
20201,PCM1,GO:0071539,protein localization to centrosome,2.0
20204,PCM1,GO:0090316,positive regulation of intracellular protein transport,2.0
20205,PCM1,GO:0097150,neuronal stem cell population maintenance,2.0
20206,PCM1,GO:0097730,non-motile cilium,2.0
20207,PCM1,GO:1905515,non-motile cilium assembly,2.0
20208,PDCD1,GO:0001783,B cell apoptotic process,2.0
20209,PDCD1,GO:0002250,adaptive immune response,2.0
20210,PDCD1,GO:0002644,negative regulation of tolerance induction,2.0
20211,PDCD1,GO:0002903,negative regulation of B cell apoptotic process,2.0
20212,PDCD1,GO:0005515,protein binding,2.0
20213,PDCD1,GO:0005886,plasma membrane,2.0
20214,PDCD1,GO:0006915,apoptotic process,2.0
20215,PDCD1,GO:0006959,humoral immune response,2.0
20216,PDCD1,GO:0009897,external side of plasma membrane,2.0
20217,PDCD1,GO:0050776,regulation of immune response,2.0
20218,PDCD1,GO:0050777,negative regulation of immune response,2.0
20219,PDCD1,GO:0070234,positive regulation of T cell apoptotic process,2.0
20221,PDCD1,GO:1902482,regulatory T cell apoptotic process,2.0
20222,PDE1C,GO:0004114,"3',5'-cyclic-nucleotide phosphodiesterase activity",2.0
20223,PDE1C,GO:0004115,"3',5'-cyclic-AMP phosphodiesterase activity",2.0
20224,PDE1C,GO:0004117,"calmodulin-activated dual specificity 3',5'-cyclic-GMP, 3',5'-cyclic-AMP phosphodiesterase activity",2.0
20225,PDE1C,GO:0005516,calmodulin binding,2.0
20226,PDE1C,GO:0005764,lysosome,2.0
20227,PDE1C,GO:0005829,cytosol,2.0
20228,PDE1C,GO:0007165,signal transduction,2.0
20229,PDE1C,GO:0043025,neuronal cell body,2.0
20230,PDE1C,GO:0046872,metal ion binding,2.0
20231,PDE1C,GO:0047555,"3',5'-cyclic-GMP phosphodiesterase activity",2.0
20232,PDE1C,GO:0048101,"calmodulin-activated 3',5'-cyclic-GMP phosphodiesterase activity",2.0
20262,PDK2,GO:0004672,protein kinase activity,2.0
20263,PDK2,GO:0004740,pyruvate dehydrogenase (acetyl-transferring) kinase activity,2.0
20266,PDK2,GO:0005515,protein binding,2.0
20267,PDK2,GO:0005524,ATP binding,2.0
20268,PDK2,GO:0005654,nucleoplasm,2.0
20269,PDK2,GO:0005739,mitochondrion,2.0
20271,PDK2,GO:0005759,mitochondrial matrix,2.0
20272,PDK2,GO:0005829,cytosol,2.0
20273,PDK2,GO:0005967,mitochondrial pyruvate dehydrogenase complex,2.0
20274,PDK2,GO:0006006,glucose metabolic process,2.0
20275,PDK2,GO:0006111,regulation of gluconeogenesis,2.0
20276,PDK2,GO:0006468,protein phosphorylation,2.0
20277,PDK2,GO:0006885,regulation of pH,2.0
20278,PDK2,GO:0008286,insulin receptor signaling pathway,2.0
20279,PDK2,GO:0010510,regulation of acetyl-CoA biosynthetic process from pyruvate,2.0
20281,PDK2,GO:0010565,regulation of cellular ketone metabolic process,2.0
20282,PDK2,GO:0010906,regulation of glucose metabolic process,2.0
20284,PDK2,GO:0031670,cellular response to nutrient,2.0
20285,PDK2,GO:0034614,cellular response to reactive oxygen species,2.0
20286,PDK2,GO:0042593,glucose homeostasis,2.0
20287,PDK2,GO:0042803,protein homodimerization activity,2.0
20288,PDK2,GO:0050848,regulation of calcium-mediated signaling,2.0
20289,PDK2,GO:0072332,intrinsic apoptotic signaling pathway by p53 class mediator,2.0
20307,PER1,GO:0000122,negative regulation of transcription by RNA polymerase II,2.0
20309,PER1,GO:0000976,transcription cis-regulatory region binding,2.0
20310,PER1,GO:0000978,RNA polymerase II cis-regulatory region sequence-specific DNA binding,2.0
20311,PER1,GO:0001222,transcription corepressor binding,2.0
20312,PER1,GO:0002028,regulation of sodium ion transport,2.0
20313,PER1,GO:0005515,protein binding,2.0
20314,PER1,GO:0005634,nucleus,2.0
20315,PER1,GO:0005654,nucleoplasm,2.0
20316,PER1,GO:0005737,cytoplasm,2.0
20318,PER1,GO:0005829,cytosol,2.0
20319,PER1,GO:0007623,circadian rhythm,2.0
20320,PER1,GO:0009649,entrainment of circadian clock,2.0
20321,PER1,GO:0010608,post-transcriptional regulation of gene expression,2.0
20322,PER1,GO:0019900,kinase binding,2.0
20323,PER1,GO:0031490,chromatin DNA binding,2.0
20324,PER1,GO:0031625,ubiquitin protein ligase binding,2.0
20325,PER1,GO:0032922,circadian regulation of gene expression,2.0
20327,PER1,GO:0042634,regulation of hair cycle,2.0
20328,PER1,GO:0042752,regulation of circadian rhythm,2.0
20329,PER1,GO:0043124,negative regulation of I-kappaB kinase/NF-kappaB signaling,2.0
20330,PER1,GO:0043153,entrainment of circadian clock by photoperiod,2.0
20332,PER1,GO:0043966,histone H3 acetylation,2.0
20333,PER1,GO:0043967,histone H4 acetylation,2.0
20334,PER1,GO:0045892,negative regulation of DNA-templated transcription,2.0
20335,PER1,GO:0045944,positive regulation of transcription by RNA polymerase II,2.0
20336,PER1,GO:0046329,negative regulation of JNK cascade,2.0
20337,PER1,GO:0051591,response to cAMP,2.0
20338,PER1,GO:0070888,E-box binding,2.0
20339,PER1,GO:0070932,histone H3 deacetylation,2.0
20340,PER1,GO:0097167,circadian regulation of translation,2.0
20341,PER1,GO:0140297,DNA-binding transcription factor binding,2.0
20342,PER1,GO:1900015,regulation of cytokine production involved in inflammatory response,2.0
20343,PER1,GO:1900744,regulation of p38MAPK cascade,2.0
20344,PER1,GO:2000323,negative regulation of glucocorticoid receptor signaling pathway,2.0
20345,PER2,GO:0000122,negative regulation of transcription by RNA polymerase II,2.0
20347,PER2,GO:0000976,transcription cis-regulatory region binding,2.0
20349,PER2,GO:0001222,transcription corepressor binding,2.0
20350,PER2,GO:0002931,response to ischemia,2.0
20351,PER2,GO:0003713,transcription coactivator activity,2.0
20352,PER2,GO:0005515,protein binding,2.0
20353,PER2,GO:0005634,nucleus,2.0
20356,PER2,GO:0005654,nucleoplasm,2.0
20357,PER2,GO:0005730,nucleolus,2.0
20358,PER2,GO:0005737,cytoplasm,2.0
20359,PER2,GO:0005829,cytosol,2.0
20360,PER2,GO:0005978,glycogen biosynthetic process,2.0
20361,PER2,GO:0006094,gluconeogenesis,2.0
20362,PER2,GO:0006631,fatty acid metabolic process,2.0
20363,PER2,GO:0007623,circadian rhythm,2.0
20364,PER2,GO:0019229,regulation of vasoconstriction,2.0
20365,PER2,GO:0019249,lactate biosynthetic process,2.0
20366,PER2,GO:0031397,negative regulation of protein ubiquitination,2.0
20367,PER2,GO:0032922,circadian regulation of gene expression,2.0
20369,PER2,GO:0042752,regulation of circadian rhythm,2.0
20370,PER2,GO:0042754,negative regulation of circadian rhythm,2.0
20371,PER2,GO:0043153,entrainment of circadian clock by photoperiod,2.0
20372,PER2,GO:0045892,negative regulation of DNA-templated transcription,2.0
20373,PER2,GO:0045893,positive regulation of DNA-templated transcription,2.0
20374,PER2,GO:0048471,perinuclear region of cytoplasm,2.0
20375,PER2,GO:0050767,regulation of neurogenesis,2.0
20376,PER2,GO:0050796,regulation of insulin secretion,2.0
20377,PER2,GO:0050872,white fat cell differentiation,2.0
20378,PER2,GO:0051726,regulation of cell cycle,2.0
20379,PER2,GO:0051946,regulation of glutamate uptake involved in transmission of nerve impulse,2.0
20380,PER2,GO:0070345,negative regulation of fat cell proliferation,2.0
20381,PER2,GO:0070932,histone H3 deacetylation,2.0
20382,PER2,GO:0097167,circadian regulation of translation,2.0
20383,PER2,GO:0120162,positive regulation of cold-induced thermogenesis,2.0
20384,PER2,GO:2000678,negative regulation of transcription regulatory region DNA binding,2.0
20385,PEX7,GO:0001764,neuron migration,2.0
20386,PEX7,GO:0001958,endochondral ossification,2.0
20387,PEX7,GO:0005053,peroxisome matrix targeting signal-2 binding,2.0
20389,PEX7,GO:0005515,protein binding,2.0
20390,PEX7,GO:0005777,peroxisome,2.0
20391,PEX7,GO:0005778,peroxisomal membrane,2.0
20392,PEX7,GO:0005782,peroxisomal matrix,2.0
20395,PEX7,GO:0005829,cytosol,2.0
20399,PEX7,GO:0006635,fatty acid beta-oxidation,2.0
20400,PEX7,GO:0007031,peroxisome organization,2.0
20401,PEX7,GO:0008611,ether lipid biosynthetic process,2.0
20402,PEX7,GO:0016558,protein import into peroxisome matrix,2.0
20406,PEX7,GO:0019899,enzyme binding,2.0
20407,PEX7,GO:0042803,protein homodimerization activity,2.0
20481,PHF7,GO:0005515,protein binding,2.0
20482,PHF7,GO:0005634,nucleus,2.0
20484,PHF7,GO:0005654,nucleoplasm,2.0
20485,PHF7,GO:0005794,Golgi apparatus,2.0
20486,PHF7,GO:0005829,cytosol,2.0
20487,PHF7,GO:0005886,plasma membrane,2.0
20488,PHF7,GO:0016607,nuclear speck,2.0
20489,PHF7,GO:0046872,metal ion binding,2.0
20543,OR2M4,GO:0004930,G protein-coupled receptor activity,2.0
20544,OR2M4,GO:0004984,olfactory receptor activity,2.0
20545,OR2M4,GO:0005886,plasma membrane,2.0
20546,OR2M4,GO:0007186,G protein-coupled receptor signaling pathway,2.0
20547,OR2M4,GO:0007608,sensory perception of smell,2.0
20548,OR2M4,GO:0016020,membrane,2.0
20549,OR2M4,GO:0050911,detection of chemical stimulus involved in sensory perception of smell,2.0
20550,OTX1,GO:0000785,chromatin,2.0
20551,OTX1,GO:0000978,RNA polymerase II cis-regulatory region sequence-specific DNA binding,2.0
20553,OTX1,GO:0000981,"DNA-binding transcription factor activity, RNA polymerase II-specific",2.0
20555,OTX1,GO:0001228,"DNA-binding transcription activator activity, RNA polymerase II-specific",2.0
20556,OTX1,GO:0005515,protein binding,2.0
20557,OTX1,GO:0005634,nucleus,2.0
20558,OTX1,GO:0006357,regulation of transcription by RNA polymerase II,2.0
20559,OTX1,GO:0009952,anterior/posterior pattern specification,2.0
20560,OTX1,GO:0022037,metencephalon development,2.0
20561,OTX1,GO:0030901,midbrain development,2.0
20562,OTX1,GO:0042472,inner ear morphogenesis,2.0
20563,OTX1,GO:0045944,positive regulation of transcription by RNA polymerase II,2.0
20564,OTX1,GO:0048852,diencephalon morphogenesis,2.0
20565,OTX1,GO:1990837,sequence-specific double-stranded DNA binding,2.0
20566,PHB1,GO:0000122,negative regulation of transcription by RNA polymerase II,2.0
20567,PHB1,GO:0001649,osteoblast differentiation,2.0
20568,PHB1,GO:0001850,complement component C3a binding,2.0
20569,PHB1,GO:0001851,complement component C3b binding,2.0
20570,PHB1,GO:0002639,positive regulation of immunoglobulin production,2.0
20571,PHB1,GO:0003714,transcription corepressor activity,2.0
20572,PHB1,GO:0005515,protein binding,2.0
20573,PHB1,GO:0005634,nucleus,2.0
20575,PHB1,GO:0005654,nucleoplasm,2.0
20576,PHB1,GO:0005737,cytoplasm,2.0
20577,PHB1,GO:0005739,mitochondrion,2.0
20580,PHB1,GO:0005743,mitochondrial inner membrane,2.0
20582,PHB1,GO:0005769,early endosome,2.0
20583,PHB1,GO:0005886,plasma membrane,2.0
20584,PHB1,GO:0006355,regulation of DNA-templated transcription,2.0
20585,PHB1,GO:0007005,mitochondrion organization,2.0
20588,PHB1,GO:0007165,signal transduction,2.0
20589,PHB1,GO:0007202,activation of phospholipase C activity,2.0
20590,PHB1,GO:0008022,protein C-terminus binding,2.0
20591,PHB1,GO:0008285,negative regulation of cell population proliferation,2.0
20592,PHB1,GO:0009986,cell surface,2.0
20593,PHB1,GO:0010628,positive regulation of gene expression,2.0
20594,PHB1,GO:0010942,positive regulation of cell death,2.0
20595,PHB1,GO:0010944,negative regulation of transcription by competitive promoter binding,2.0
20596,PHB1,GO:0016020,membrane,2.0
20597,PHB1,GO:0016575,histone deacetylation,2.0
20598,PHB1,GO:0019899,enzyme binding,2.0
20599,PHB1,GO:0023035,CD40 signaling pathway,2.0
20600,PHB1,GO:0030308,negative regulation of cell growth,2.0
20601,PHB1,GO:0031871,proteinase activated receptor binding,2.0
20602,PHB1,GO:0032740,positive regulation of interleukin-17 production,2.0
20603,PHB1,GO:0035632,mitochondrial prohibitin complex,2.0
20605,PHB1,GO:0039529,RIG-I signaling pathway,2.0
20606,PHB1,GO:0042113,B cell activation,2.0
20607,PHB1,GO:0042177,negative regulation of protein catabolic process,2.0
20608,PHB1,GO:0042826,histone deacetylase binding,2.0
20609,PHB1,GO:0042981,regulation of apoptotic process,2.0
20610,PHB1,GO:0044830,modulation by host of viral RNA genome replication,2.0
20611,PHB1,GO:0045745,positive regulation of G protein-coupled receptor signaling pathway,2.0
20612,PHB1,GO:0045892,negative regulation of DNA-templated transcription,2.0
20614,PHB1,GO:0045893,positive regulation of DNA-templated transcription,2.0
20615,PHB1,GO:0045917,positive regulation of complement activation,2.0
20616,PHB1,GO:0046718,viral entry into host cell,2.0
20617,PHB1,GO:0046982,protein heterodimerization activity,2.0
20618,PHB1,GO:0048661,positive regulation of smooth muscle cell proliferation,2.0
20619,PHB1,GO:0050821,protein stabilization,2.0
20621,PHB1,GO:0050847,progesterone receptor signaling pathway,2.0
20622,PHB1,GO:0051897,positive regulation of protein kinase B signaling,2.0
20623,PHB1,GO:0060766,negative regulation of androgen receptor signaling pathway,2.0
20625,PHB1,GO:0070062,extracellular exosome,2.0
20626,PHB1,GO:0070373,negative regulation of ERK1 and ERK2 cascade,2.0
20627,PHB1,GO:0070374,positive regulation of ERK1 and ERK2 cascade,2.0
20628,PHB1,GO:0071354,cellular response to interleukin-6,2.0
20629,PHB1,GO:0071897,DNA biosynthetic process,2.0
20630,PHB1,GO:0072538,T-helper 17 type immune response,2.0
20631,PHB1,GO:0140374,antiviral innate immune response,2.0
20632,PHB1,GO:1901224,positive regulation of NIK/NF-kappaB signaling,2.0
20633,PHB1,GO:1990051,activation of protein kinase C activity,2.0
20634,PHB1,GO:2000323,negative regulation of glucocorticoid receptor signaling pathway,2.0
20635,PHRF1,GO:0006366,transcription by RNA polymerase II,2.0
20636,PHRF1,GO:0006397,mRNA processing,2.0
20637,PHRF1,GO:0016020,membrane,2.0
20638,PHRF1,GO:0019904,protein domain specific binding,2.0
20639,PHRF1,GO:0046872,metal ion binding,2.0
20640,PHRF1,GO:0070063,RNA polymerase binding,2.0
20727,PIK3CG,GO:0001525,angiogenesis,2.0
20728,PIK3CG,GO:0001819,positive regulation of cytokine production,2.0
20729,PIK3CG,GO:0002250,adaptive immune response,2.0
20730,PIK3CG,GO:0002407,dendritic cell chemotaxis,2.0
20731,PIK3CG,GO:0002675,positive regulation of acute inflammatory response,2.0
20732,PIK3CG,GO:0002679,respiratory burst involved in defense response,2.0
20733,PIK3CG,GO:0003376,sphingosine-1-phosphate receptor signaling pathway,2.0
20734,PIK3CG,GO:0004672,protein kinase activity,2.0
20735,PIK3CG,GO:0004674,protein serine/threonine kinase activity,2.0
20736,PIK3CG,GO:0005515,protein binding,2.0
20737,PIK3CG,GO:0005524,ATP binding,2.0
20738,PIK3CG,GO:0005737,cytoplasm,2.0
20740,PIK3CG,GO:0005829,cytosol,2.0
20742,PIK3CG,GO:0005886,plasma membrane,2.0
20744,PIK3CG,GO:0005942,phosphatidylinositol 3-kinase complex,2.0
20745,PIK3CG,GO:0005943,"phosphatidylinositol 3-kinase complex, class IA",2.0
20747,PIK3CG,GO:0005944,"phosphatidylinositol 3-kinase complex, class IB",2.0
20749,PIK3CG,GO:0006468,protein phosphorylation,2.0
20750,PIK3CG,GO:0006897,endocytosis,2.0
20751,PIK3CG,GO:0006954,inflammatory response,2.0
20752,PIK3CG,GO:0006955,immune response,2.0
20753,PIK3CG,GO:0007186,G protein-coupled receptor signaling pathway,2.0
20755,PIK3CG,GO:0007204,positive regulation of cytosolic calcium ion concentration,2.0
20756,PIK3CG,GO:0010595,positive regulation of endothelial cell migration,2.0
20757,PIK3CG,GO:0010818,T cell chemotaxis,2.0
20758,PIK3CG,GO:0010897,negative regulation of triglyceride catabolic process,2.0
20759,PIK3CG,GO:0014065,phosphatidylinositol 3-kinase signaling,2.0
20763,PIK3CG,GO:0016020,membrane,2.0
20766,PIK3CG,GO:0016301,kinase activity,2.0
20767,PIK3CG,GO:0016303,1-phosphatidylinositol-3-kinase activity,2.0
20769,PIK3CG,GO:0016310,phosphorylation,2.0
20770,PIK3CG,GO:0016477,cell migration,2.0
20771,PIK3CG,GO:0030593,neutrophil chemotaxis,2.0
20772,PIK3CG,GO:0032252,secretory granule localization,2.0
20773,PIK3CG,GO:0033628,regulation of cell adhesion mediated by integrin,2.0
20774,PIK3CG,GO:0035004,phosphatidylinositol 3-kinase activity,2.0
20775,PIK3CG,GO:0035005,1-phosphatidylinositol-4-phosphate 3-kinase activity,2.0
20777,PIK3CG,GO:0035022,positive regulation of Rac protein signal transduction,2.0
20778,PIK3CG,GO:0035747,natural killer cell chemotaxis,2.0
20779,PIK3CG,GO:0036092,phosphatidylinositol-3-phosphate biosynthetic process,2.0
20780,PIK3CG,GO:0042098,T cell proliferation,2.0
20781,PIK3CG,GO:0042110,T cell activation,2.0
20782,PIK3CG,GO:0042802,identical protein binding,2.0
20783,PIK3CG,GO:0043303,mast cell degranulation,2.0
20784,PIK3CG,GO:0043406,positive regulation of MAP kinase activity,2.0
20785,PIK3CG,GO:0045087,innate immune response,2.0
20786,PIK3CG,GO:0046854,phosphatidylinositol phosphate biosynthetic process,2.0
20788,PIK3CG,GO:0046875,ephrin receptor binding,2.0
20789,PIK3CG,GO:0046934,"phosphatidylinositol-4,5-bisphosphate 3-kinase activity",2.0
20790,PIK3CG,GO:0048015,phosphatidylinositol-mediated signaling,2.0
20791,PIK3CG,GO:0051897,positive regulation of protein kinase B signaling,2.0
20792,PIK3CG,GO:0052742,phosphatidylinositol kinase activity,2.0
20793,PIK3CG,GO:0052812,"phosphatidylinositol-3,4-bisphosphate 5-kinase activity",2.0
20794,PIK3CG,GO:0055118,negative regulation of cardiac muscle contraction,2.0
20795,PIK3CG,GO:0070527,platelet aggregation,2.0
20796,PIK3CG,GO:0071320,cellular response to cAMP,2.0
20797,PIK3CG,GO:0072672,neutrophil extravasation,2.0
20798,PIK3CG,GO:0097284,hepatocyte apoptotic process,2.0
20799,PIK3CG,GO:0106310,protein serine kinase activity,2.0
20800,PIK3CG,GO:1903169,regulation of calcium ion transmembrane transport,2.0
20801,PIK3CG,GO:2000270,negative regulation of fibroblast apoptotic process,2.0
20834,PITX1,GO:0000785,chromatin,2.0
20835,PITX1,GO:0000978,RNA polymerase II cis-regulatory region sequence-specific DNA binding,2.0
20836,PITX1,GO:0000981,"DNA-binding transcription factor activity, RNA polymerase II-specific",2.0
20838,PITX1,GO:0001228,"DNA-binding transcription activator activity, RNA polymerase II-specific",2.0
20839,PITX1,GO:0001501,skeletal system development,2.0
20840,PITX1,GO:0003700,DNA-binding transcription factor activity,2.0
20841,PITX1,GO:0005515,protein binding,2.0
20842,PITX1,GO:0005634,nucleus,2.0
20844,PITX1,GO:0005667,transcription regulator complex,2.0
20845,PITX1,GO:0005737,cytoplasm,2.0
20846,PITX1,GO:0006357,regulation of transcription by RNA polymerase II,2.0
20847,PITX1,GO:0009653,anatomical structure morphogenesis,2.0
20848,PITX1,GO:0014707,branchiomeric skeletal muscle development,2.0
20849,PITX1,GO:0021983,pituitary gland development,2.0
20850,PITX1,GO:0035116,embryonic hindlimb morphogenesis,2.0
20851,PITX1,GO:0045892,negative regulation of DNA-templated transcription,2.0
20852,PITX1,GO:0045944,positive regulation of transcription by RNA polymerase II,2.0
20853,PITX1,GO:0048625,myoblast fate commitment,2.0
20854,PITX1,GO:0051216,cartilage development,2.0
20855,PITX1,GO:0061629,RNA polymerase II-specific DNA-binding transcription factor binding,2.0
20856,PITX1,GO:1990837,sequence-specific double-stranded DNA binding,2.0
20863,PLAUR,GO:0001934,positive regulation of protein phosphorylation,2.0
20864,PLAUR,GO:0005102,signaling receptor binding,2.0
20865,PLAUR,GO:0005515,protein binding,2.0
20866,PLAUR,GO:0005576,extracellular region,2.0
20867,PLAUR,GO:0005788,endoplasmic reticulum lumen,2.0
20868,PLAUR,GO:0005789,endoplasmic reticulum membrane,2.0
20869,PLAUR,GO:0005886,plasma membrane,2.0
20872,PLAUR,GO:0005925,focal adhesion,2.0
20873,PLAUR,GO:0006935,chemotaxis,2.0
20874,PLAUR,GO:0007165,signal transduction,2.0
20875,PLAUR,GO:0007596,blood coagulation,2.0
20876,PLAUR,GO:0009986,cell surface,2.0
20877,PLAUR,GO:0010755,regulation of plasminogen activation,2.0
20878,PLAUR,GO:0016020,membrane,2.0
20879,PLAUR,GO:0019898,extrinsic component of membrane,2.0
20880,PLAUR,GO:0019899,enzyme binding,2.0
20881,PLAUR,GO:0019904,protein domain specific binding,2.0
20882,PLAUR,GO:0030155,regulation of cell adhesion,2.0
20883,PLAUR,GO:0030162,regulation of proteolysis,2.0
20884,PLAUR,GO:0030377,urokinase plasminogen activator receptor activity,2.0
20885,PLAUR,GO:0034112,positive regulation of homotypic cell-cell adhesion,2.0
20886,PLAUR,GO:0035579,specific granule membrane,2.0
20887,PLAUR,GO:0038023,signaling receptor activity,2.0
20888,PLAUR,GO:0038195,urokinase plasminogen activator signaling pathway,2.0
20889,PLAUR,GO:0042995,cell projection,2.0
20890,PLAUR,GO:0043066,negative regulation of apoptotic process,2.0
20891,PLAUR,GO:0043388,positive regulation of DNA binding,2.0
20892,PLAUR,GO:0045742,positive regulation of epidermal growth factor receptor signaling pathway,2.0
20893,PLAUR,GO:0051917,regulation of fibrinolysis,2.0
20894,PLAUR,GO:0090200,positive regulation of release of cytochrome c from mitochondria,2.0
20895,PLAUR,GO:0098637,protein complex involved in cell-matrix adhesion,2.0
20896,PLAUR,GO:1905370,serine-type endopeptidase complex,2.0
20897,PLAUR,GO:2001243,negative regulation of intrinsic apoptotic signaling pathway,2.0
20898,PLAUR,GO:2001268,negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,2.0
20899,PLCB1,GO:0000086,G2/M transition of mitotic cell cycle,2.0
20900,PLCB1,GO:0000785,chromatin,2.0
20901,PLCB1,GO:0004435,phosphatidylinositol phospholipase C activity,2.0
20905,PLCB1,GO:0004629,phospholipase C activity,2.0
20906,PLCB1,GO:0005096,GTPase activator activity,2.0
20907,PLCB1,GO:0005509,calcium ion binding,2.0
20908,PLCB1,GO:0005515,protein binding,2.0
20909,PLCB1,GO:0005516,calmodulin binding,2.0
20911,PLCB1,GO:0005521,lamin binding,2.0
20912,PLCB1,GO:0005546,"phosphatidylinositol-4,5-bisphosphate binding",2.0
20913,PLCB1,GO:0005634,nucleus,2.0
20914,PLCB1,GO:0005737,cytoplasm,2.0
20916,PLCB1,GO:0005829,cytosol,2.0
20917,PLCB1,GO:0007165,signal transduction,2.0
20918,PLCB1,GO:0007186,G protein-coupled receptor signaling pathway,2.0
20919,PLCB1,GO:0007213,G protein-coupled acetylcholine receptor signaling pathway,2.0
20920,PLCB1,GO:0007215,glutamate receptor signaling pathway,2.0
20921,PLCB1,GO:0007612,learning,2.0
20922,PLCB1,GO:0007613,memory,2.0
20924,PLCB1,GO:0008277,regulation of G protein-coupled receptor signaling pathway,2.0
20925,PLCB1,GO:0016607,nuclear speck,2.0
20927,PLCB1,GO:0019899,enzyme binding,2.0
20928,PLCB1,GO:0021987,cerebral cortex development,2.0
20929,PLCB1,GO:0031161,phosphatidylinositol catabolic process,2.0
20930,PLCB1,GO:0031965,nuclear membrane,2.0
20931,PLCB1,GO:0032024,positive regulation of insulin secretion,2.0
20932,PLCB1,GO:0032735,positive regulation of interleukin-12 production,2.0
20933,PLCB1,GO:0032957,inositol trisphosphate metabolic process,2.0
20934,PLCB1,GO:0032991,protein-containing complex,2.0
20935,PLCB1,GO:0035722,interleukin-12-mediated signaling pathway,2.0
20936,PLCB1,GO:0035723,interleukin-15-mediated signaling pathway,2.0
20937,PLCB1,GO:0040019,positive regulation of embryonic development,2.0
20938,PLCB1,GO:0042802,identical protein binding,2.0
20939,PLCB1,GO:0045444,fat cell differentiation,2.0
20940,PLCB1,GO:0045663,positive regulation of myoblast differentiation,2.0
20941,PLCB1,GO:0045892,negative regulation of DNA-templated transcription,2.0
20942,PLCB1,GO:0045893,positive regulation of DNA-templated transcription,2.0
20943,PLCB1,GO:0046330,positive regulation of JNK cascade,2.0
20944,PLCB1,GO:0046488,phosphatidylinositol metabolic process,2.0
20946,PLCB1,GO:0048009,insulin-like growth factor receptor signaling pathway,2.0
20947,PLCB1,GO:0048015,phosphatidylinositol-mediated signaling,2.0
20948,PLCB1,GO:0048639,positive regulation of developmental growth,2.0
20949,PLCB1,GO:0050790,regulation of catalytic activity,2.0
20950,PLCB1,GO:0060466,activation of meiosis involved in egg activation,2.0
20951,PLCB1,GO:0070062,extracellular exosome,2.0
20952,PLCB1,GO:0070498,interleukin-1-mediated signaling pathway,2.0
20953,PLCB1,GO:0080154,regulation of fertilization,2.0
20954,PLCB1,GO:0098978,glutamatergic synapse,2.0
20955,PLCB1,GO:0098982,GABA-ergic synapse,2.0
20956,PLCB1,GO:0099170,postsynaptic modulation of chemical synaptic transmission,2.0
20957,PLCB1,GO:0099178,regulation of retrograde trans-synaptic signaling by endocanabinoid,2.0
20958,PLCB1,GO:0099524,postsynaptic cytosol,2.0
20959,PLCB1,GO:1900087,positive regulation of G1/S transition of mitotic cell cycle,2.0
20960,PLCB1,GO:1902618,cellular response to fluoride,2.0
20961,PLCB1,GO:1903140,regulation of establishment of endothelial barrier,2.0
20962,PLCB1,GO:1904117,cellular response to vasopressin,2.0
20963,PLCB1,GO:1904637,cellular response to ionomycin,2.0
20964,PLCB1,GO:1905631,cellular response to glyceraldehyde,2.0
20965,PLCB1,GO:2000344,positive regulation of acrosome reaction,2.0
20966,PLCB1,GO:2000438,negative regulation of monocyte extravasation,2.0
20967,PLCB1,GO:2000560,positive regulation of CD24 production,2.0
20968,PLCD4,GO:0004435,phosphatidylinositol phospholipase C activity,2.0
20969,PLCD4,GO:0005085,guanyl-nucleotide exchange factor activity,2.0
20970,PLCD4,GO:0005509,calcium ion binding,2.0
20971,PLCD4,GO:0005515,protein binding,2.0
20972,PLCD4,GO:0005634,nucleus,2.0
20973,PLCD4,GO:0005783,endoplasmic reticulum,2.0
20974,PLCD4,GO:0005789,endoplasmic reticulum membrane,2.0
20975,PLCD4,GO:0005829,cytosol,2.0
20976,PLCD4,GO:0005886,plasma membrane,2.0
20977,PLCD4,GO:0007340,acrosome reaction,2.0
20978,PLCD4,GO:0016042,lipid catabolic process,2.0
20979,PLCD4,GO:0046488,phosphatidylinositol metabolic process,2.0
20980,PLCD4,GO:0048015,phosphatidylinositol-mediated signaling,2.0
20981,PLCD4,GO:0050790,regulation of catalytic activity,2.0
20982,PLN,GO:0001675,acrosome assembly,2.0
20983,PLN,GO:0002026,regulation of the force of heart contraction,2.0
20984,PLN,GO:0004857,enzyme inhibitor activity,2.0
20985,PLN,GO:0005515,protein binding,2.0
20986,PLN,GO:0005739,mitochondrion,2.0
20987,PLN,GO:0005783,endoplasmic reticulum,2.0
20988,PLN,GO:0005789,endoplasmic reticulum membrane,2.0
20989,PLN,GO:0006874,cellular calcium ion homeostasis,2.0
20990,PLN,GO:0007219,Notch signaling pathway,2.0
20991,PLN,GO:0008015,blood circulation,2.0
20992,PLN,GO:0008016,regulation of heart contraction,2.0
20993,PLN,GO:0010459,negative regulation of heart rate,2.0
20995,PLN,GO:0010881,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion,2.0
20996,PLN,GO:0016020,membrane,2.0
20998,PLN,GO:0016529,sarcoplasmic reticulum,2.0
20999,PLN,GO:0031966,mitochondrial membrane,2.0
21000,PLN,GO:0032780,negative regulation of ATP-dependent activity,2.0
21002,PLN,GO:0033017,sarcoplasmic reticulum membrane,2.0
21004,PLN,GO:0042030,ATPase inhibitor activity,2.0
21007,PLN,GO:0042802,identical protein binding,2.0
21008,PLN,GO:0042803,protein homodimerization activity,2.0
21009,PLN,GO:0043086,negative regulation of catalytic activity,2.0
21010,PLN,GO:0046716,muscle cell cellular homeostasis,2.0
21011,PLN,GO:0048471,perinuclear region of cytoplasm,2.0
21012,PLN,GO:0048738,cardiac muscle tissue development,2.0
21013,PLN,GO:0051117,ATPase binding,2.0
21014,PLN,GO:0051480,regulation of cytosolic calcium ion concentration,2.0
21015,PLN,GO:0051924,regulation of calcium ion transport,2.0
21017,PLN,GO:0051926,negative regulation of calcium ion transport,2.0
21018,PLN,GO:0055119,relaxation of cardiac muscle,2.0
21019,PLN,GO:0060314,regulation of ryanodine-sensitive calcium-release channel activity,2.0
21020,PLN,GO:0086004,regulation of cardiac muscle cell contraction,2.0
21021,PLN,GO:0086023,adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process,2.0
21022,PLN,GO:0086036,regulation of cardiac muscle cell membrane potential,2.0
21023,PLN,GO:0086092,regulation of the force of heart contraction by cardiac conduction,2.0
21024,PLN,GO:0090281,negative regulation of calcium ion import,2.0
21025,PLN,GO:0090534,calcium ion-transporting ATPase complex,2.0
21026,PLN,GO:1901020,negative regulation of calcium ion transmembrane transporter activity,2.0
21028,PLN,GO:1901877,negative regulation of calcium ion binding,2.0
21030,PLN,GO:1901894,regulation of ATPase-coupled calcium transmembrane transporter activity,2.0
21031,PLN,GO:1901895,negative regulation of ATPase-coupled calcium transmembrane transporter activity,2.0
21033,PLN,GO:1901897,regulation of relaxation of cardiac muscle,2.0
21034,PLN,GO:1902081,negative regulation of calcium ion import into sarcoplasmic reticulum,2.0
21036,PLXNA3,GO:0002116,semaphorin receptor complex,2.0
21038,PLXNA3,GO:0005515,protein binding,2.0
21039,PLXNA3,GO:0005886,plasma membrane,2.0
21041,PLXNA3,GO:0007162,negative regulation of cell adhesion,2.0
21042,PLXNA3,GO:0007411,axon guidance,2.0
21043,PLXNA3,GO:0008360,regulation of cell shape,2.0
21044,PLXNA3,GO:0017154,semaphorin receptor activity,2.0
21046,PLXNA3,GO:0021612,facial nerve structural organization,2.0
21047,PLXNA3,GO:0021628,olfactory nerve formation,2.0
21048,PLXNA3,GO:0021637,trigeminal nerve structural organization,2.0
21049,PLXNA3,GO:0021766,hippocampus development,2.0
21050,PLXNA3,GO:0021785,branchiomotor neuron axon guidance,2.0
21051,PLXNA3,GO:0021828,gonadotrophin-releasing hormone neuronal migration to the hypothalamus,2.0
21052,PLXNA3,GO:0021860,pyramidal neuron development,2.0
21053,PLXNA3,GO:0030334,regulation of cell migration,2.0
21054,PLXNA3,GO:0043087,regulation of GTPase activity,2.0
21055,PLXNA3,GO:0048843,negative regulation of axon extension involved in axon guidance,2.0
21056,PLXNA3,GO:0048846,axon extension involved in axon guidance,2.0
21057,PLXNA3,GO:0050772,positive regulation of axonogenesis,2.0
21058,PLXNA3,GO:0050919,negative chemotaxis,2.0
21059,PLXNA3,GO:0051495,positive regulation of cytoskeleton organization,2.0
21060,PLXNA3,GO:0071526,semaphorin-plexin signaling pathway,2.0
21061,PLXNA3,GO:0097485,neuron projection guidance,2.0
21062,PLXNA3,GO:1902287,semaphorin-plexin signaling pathway involved in axon guidance,2.0
21064,PLXNA4,GO:0002116,semaphorin receptor complex,2.0
21066,PLXNA4,GO:0005886,plasma membrane,2.0
21068,PLXNA4,GO:0007162,negative regulation of cell adhesion,2.0
21069,PLXNA4,GO:0008360,regulation of cell shape,2.0
21070,PLXNA4,GO:0017154,semaphorin receptor activity,2.0
21071,PLXNA4,GO:0021612,facial nerve structural organization,2.0
21072,PLXNA4,GO:0021615,glossopharyngeal nerve morphogenesis,2.0
21073,PLXNA4,GO:0021637,trigeminal nerve structural organization,2.0
21074,PLXNA4,GO:0021644,vagus nerve morphogenesis,2.0
21075,PLXNA4,GO:0021784,postganglionic parasympathetic fiber development,2.0
21076,PLXNA4,GO:0021793,chemorepulsion of branchiomotor axon,2.0
21077,PLXNA4,GO:0021960,anterior commissure morphogenesis,2.0
21078,PLXNA4,GO:0030334,regulation of cell migration,2.0
21079,PLXNA4,GO:0035050,embryonic heart tube development,2.0
21080,PLXNA4,GO:0043087,regulation of GTPase activity,2.0
21081,PLXNA4,GO:0048485,sympathetic nervous system development,2.0
21082,PLXNA4,GO:0048841,regulation of axon extension involved in axon guidance,2.0
21083,PLXNA4,GO:0050772,positive regulation of axonogenesis,2.0
21084,PLXNA4,GO:0050923,regulation of negative chemotaxis,2.0
21085,PLXNA4,GO:0071526,semaphorin-plexin signaling pathway,2.0
21086,PLXNA4,GO:0097492,sympathetic neuron axon guidance,2.0
21087,PLXNA4,GO:0099558,maintenance of synapse structure,2.0
21088,PLXNA4,GO:0150053,cerebellar climbing fiber to Purkinje cell synapse,2.0
21089,PLXNA4,GO:1902287,semaphorin-plexin signaling pathway involved in axon guidance,2.0
21090,PLXNB1,GO:0002116,semaphorin receptor complex,2.0
21093,PLXNB1,GO:0004888,transmembrane signaling receptor activity,2.0
21094,PLXNB1,GO:0005096,GTPase activator activity,2.0
21095,PLXNB1,GO:0005515,protein binding,2.0
21096,PLXNB1,GO:0005576,extracellular region,2.0
21097,PLXNB1,GO:0005886,plasma membrane,2.0
21101,PLXNB1,GO:0007162,negative regulation of cell adhesion,2.0
21103,PLXNB1,GO:0008360,regulation of cell shape,2.0
21105,PLXNB1,GO:0014068,positive regulation of phosphatidylinositol 3-kinase signaling,2.0
21106,PLXNB1,GO:0016477,cell migration,2.0
21107,PLXNB1,GO:0017154,semaphorin receptor activity,2.0
21110,PLXNB1,GO:0030215,semaphorin receptor binding,2.0
21111,PLXNB1,GO:0030334,regulation of cell migration,2.0
21112,PLXNB1,GO:0032794,GTPase activating protein binding,2.0
21113,PLXNB1,GO:0033689,negative regulation of osteoblast proliferation,2.0
21114,PLXNB1,GO:0035556,intracellular signal transduction,2.0
21115,PLXNB1,GO:0043087,regulation of GTPase activity,2.0
21116,PLXNB1,GO:0043547,positive regulation of GTPase activity,2.0
21117,PLXNB1,GO:0043931,ossification involved in bone maturation,2.0
21118,PLXNB1,GO:0048812,neuron projection morphogenesis,2.0
21119,PLXNB1,GO:0050772,positive regulation of axonogenesis,2.0
21120,PLXNB1,GO:0051493,regulation of cytoskeleton organization,2.0
21121,PLXNB1,GO:0071526,semaphorin-plexin signaling pathway,2.0
21122,PLXNB1,GO:1900220,semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis,2.0
21123,PLXNB1,GO:1902287,semaphorin-plexin signaling pathway involved in axon guidance,2.0
21124,PLXNB1,GO:1904862,inhibitory synapse assembly,2.0
21125,PNPLA7,GO:0004622,lysophospholipase activity,2.0
21126,PNPLA7,GO:0005783,endoplasmic reticulum,2.0
21127,PNPLA7,GO:0005789,endoplasmic reticulum membrane,2.0
21128,PNPLA7,GO:0005811,lipid droplet,2.0
21129,PNPLA7,GO:0034638,phosphatidylcholine catabolic process,2.0
21130,PNPLA7,GO:0102545,phosphatidyl phospholipase B activity,2.0
21148,POLA2,GO:0003674,molecular_function,2.0
21149,POLA2,GO:0003677,DNA binding,2.0
21150,POLA2,GO:0005515,protein binding,2.0
21151,POLA2,GO:0005654,nucleoplasm,2.0
21153,POLA2,GO:0005658,alpha DNA polymerase:primase complex,2.0
21156,POLA2,GO:0005829,cytosol,2.0
21157,POLA2,GO:0006260,DNA replication,2.0
21158,POLA2,GO:0006269,"DNA replication, synthesis of RNA primer",2.0
21159,POLA2,GO:0006270,DNA replication initiation,2.0
21161,POLA2,GO:0006606,protein import into nucleus,2.0
21222,POMT1,GO:0000030,mannosyltransferase activity,2.0
21223,POMT1,GO:0001669,acrosomal vesicle,2.0
21224,POMT1,GO:0004169,dolichyl-phosphate-mannose-protein mannosyltransferase activity,2.0
21225,POMT1,GO:0005783,endoplasmic reticulum,2.0
21226,POMT1,GO:0005789,endoplasmic reticulum membrane,2.0
21228,POMT1,GO:0006493,protein O-linked glycosylation,2.0
21229,POMT1,GO:0016020,membrane,2.0
21230,POMT1,GO:0016529,sarcoplasmic reticulum,2.0
21231,POMT1,GO:0030198,extracellular matrix organization,2.0
21232,POMT1,GO:0035269,protein O-linked mannosylation,2.0
21233,POMT1,GO:0046872,metal ion binding,2.0
21234,POMT1,GO:1904100,positive regulation of protein O-linked glycosylation,2.0
21235,POT1,GO:0000781,"chromosome, telomeric region",2.0
21237,POT1,GO:0000783,nuclear telomere cap complex,2.0
21239,POT1,GO:0005515,protein binding,2.0
21240,POT1,GO:0005654,nucleoplasm,2.0
21242,POT1,GO:0007004,telomere maintenance via telomerase,2.0
21243,POT1,GO:0010521,telomerase inhibitor activity,2.0
21245,POT1,GO:0016233,telomere capping,2.0
21250,POT1,GO:0017151,DEAD/H-box RNA helicase binding,2.0
21251,POT1,GO:0032202,telomere assembly,2.0
21252,POT1,GO:0032206,positive regulation of telomere maintenance,2.0
21253,POT1,GO:0032210,regulation of telomere maintenance via telomerase,2.0
21255,POT1,GO:0032211,negative regulation of telomere maintenance via telomerase,2.0
21257,POT1,GO:0032212,positive regulation of telomere maintenance via telomerase,2.0
21259,POT1,GO:0032508,DNA duplex unwinding,2.0
21260,POT1,GO:0042162,telomeric DNA binding,2.0
21261,POT1,GO:0043047,single-stranded telomeric DNA binding,2.0
21263,POT1,GO:0051096,positive regulation of helicase activity,2.0
21264,POT1,GO:0051973,positive regulation of telomerase activity,2.0
21266,POT1,GO:0051974,negative regulation of telomerase activity,2.0
21268,POT1,GO:0060383,positive regulation of DNA strand elongation,2.0
21269,POT1,GO:0061820,telomeric D-loop disassembly,2.0
21270,POT1,GO:0061821,telomeric D-loop binding,2.0
21271,POT1,GO:0061849,telomeric G-quadruplex DNA binding,2.0
21272,POT1,GO:0070187,shelterin complex,2.0
21276,POT1,GO:0070200,establishment of protein localization to telomere,2.0
21277,POT1,GO:0098505,G-rich strand telomeric DNA binding,2.0
21279,POT1,GO:1905773,8-hydroxy-2'-deoxyguanosine DNA binding,2.0
21280,POT1,GO:1905774,regulation of DNA helicase activity,2.0
21281,POT1,GO:1905776,positive regulation of DNA helicase activity,2.0
21282,POT1,GO:1990955,G-rich single-stranded DNA binding,2.0
21283,POT1,GO:2001032,regulation of double-strand break repair via nonhomologous end joining,2.0
21313,PPFIA1,GO:0005515,protein binding,2.0
21314,PPFIA1,GO:0005737,cytoplasm,2.0
21315,PPFIA1,GO:0005829,cytosol,2.0
21317,PPFIA1,GO:0005925,focal adhesion,2.0
21318,PPFIA1,GO:0007160,cell-matrix adhesion,2.0
21319,PPFIA1,GO:0007165,signal transduction,2.0
21320,PPFIA1,GO:0030424,axon,2.0
21321,PPFIA1,GO:0032991,protein-containing complex,2.0
21322,PPFIA1,GO:0048786,presynaptic active zone,2.0
21324,PPFIA1,GO:0050808,synapse organization,2.0
21325,PPFIA1,GO:0051497,negative regulation of stress fiber assembly,2.0
21326,PPFIA1,GO:0097444,spine apparatus,2.0
21327,PPFIA1,GO:0098685,Schaffer collateral - CA1 synapse,2.0
21328,PPFIA1,GO:0099072,regulation of postsynaptic membrane neurotransmitter receptor levels,2.0
21329,PPFIA1,GO:1903077,negative regulation of protein localization to plasma membrane,2.0
21330,PPM1D,GO:0000086,G2/M transition of mitotic cell cycle,2.0
21331,PPM1D,GO:0004674,protein serine/threonine kinase activity,2.0
21332,PPM1D,GO:0004722,protein serine/threonine phosphatase activity,2.0
21334,PPM1D,GO:0005515,protein binding,2.0
21335,PPM1D,GO:0005634,nucleus,2.0
21337,PPM1D,GO:0005654,nucleoplasm,2.0
21339,PPM1D,GO:0005730,nucleolus,2.0
21340,PPM1D,GO:0005829,cytosol,2.0
21342,PPM1D,GO:0006306,DNA methylation,2.0
21343,PPM1D,GO:0006470,protein dephosphorylation,2.0
21344,PPM1D,GO:0008285,negative regulation of cell population proliferation,2.0
21345,PPM1D,GO:0009267,cellular response to starvation,2.0
21346,PPM1D,GO:0009314,response to radiation,2.0
21347,PPM1D,GO:0009617,response to bacterium,2.0
21348,PPM1D,GO:0017018,myosin phosphatase activity,2.0
21349,PPM1D,GO:0030330,"DNA damage response, signal transduction by p53 class mediator",2.0
21350,PPM1D,GO:0031507,heterochromatin formation,2.0
21351,PPM1D,GO:0035970,peptidyl-threonine dephosphorylation,2.0
21353,PPM1D,GO:0045814,"negative regulation of gene expression, epigenetic",2.0
21355,PPM1D,GO:0046872,metal ion binding,2.0
21356,PPM1D,GO:0051019,mitogen-activated protein kinase binding,2.0
21358,PPM1D,GO:0060260,regulation of transcription initiation by RNA polymerase II,2.0
21485,PPP2R1B,GO:0000159,protein phosphatase type 2A complex,2.0
21486,PPP2R1B,GO:0005515,protein binding,2.0
21487,PPP2R1B,GO:0005737,cytoplasm,2.0
21488,PPP2R1B,GO:0006470,protein dephosphorylation,2.0
21489,PPP2R1B,GO:0019888,protein phosphatase regulator activity,2.0
21490,PPP2R1B,GO:0045121,membrane raft,2.0
21491,PPP2R1B,GO:0050790,regulation of catalytic activity,2.0
21492,PPP2R1B,GO:0060561,apoptotic process involved in morphogenesis,2.0
21493,PPP2R1B,GO:0070062,extracellular exosome,2.0
21494,PPP2R1B,GO:2001241,positive regulation of extrinsic apoptotic signaling pathway in absence of ligand,2.0
21646,PREX1,GO:0005085,guanyl-nucleotide exchange factor activity,2.0
21647,PREX1,GO:0005096,GTPase activator activity,2.0
21648,PREX1,GO:0005515,protein binding,2.0
21649,PREX1,GO:0005543,phospholipid binding,2.0
21650,PREX1,GO:0005829,cytosol,2.0
21652,PREX1,GO:0005886,plasma membrane,2.0
21654,PREX1,GO:0006801,superoxide metabolic process,2.0
21655,PREX1,GO:0007186,G protein-coupled receptor signaling pathway,2.0
21656,PREX1,GO:0019899,enzyme binding,2.0
21657,PREX1,GO:0030041,actin filament polymerization,2.0
21658,PREX1,GO:0030217,T cell differentiation,2.0
21659,PREX1,GO:0030593,neutrophil chemotaxis,2.0
21660,PREX1,GO:0035556,intracellular signal transduction,2.0
21661,PREX1,GO:0042119,neutrophil activation,2.0
21662,PREX1,GO:0043547,positive regulation of GTPase activity,2.0
21663,PREX1,GO:0051056,regulation of small GTPase mediated signal transduction,2.0
21664,PREX1,GO:1900026,positive regulation of substrate adhesion-dependent cell spreading,2.0
21665,PRICKLE1,GO:0001843,neural tube closure,2.0
21666,PRICKLE1,GO:0005515,protein binding,2.0
21667,PRICKLE1,GO:0005634,nucleus,2.0
21668,PRICKLE1,GO:0005829,cytosol,2.0
21670,PRICKLE1,GO:0006606,protein import into nucleus,2.0
21672,PRICKLE1,GO:0008270,zinc ion binding,2.0
21673,PRICKLE1,GO:0009410,response to xenobiotic stimulus,2.0
21674,PRICKLE1,GO:0016358,dendrite development,2.0
21675,PRICKLE1,GO:0031398,positive regulation of protein ubiquitination,2.0
21676,PRICKLE1,GO:0031965,nuclear membrane,2.0
21677,PRICKLE1,GO:0032436,positive regulation of proteasomal ubiquitin-dependent protein catabolic process,2.0
21678,PRICKLE1,GO:0035904,aorta development,2.0
21679,PRICKLE1,GO:0045892,negative regulation of DNA-templated transcription,2.0
21680,PRICKLE1,GO:0048812,neuron projection morphogenesis,2.0
21681,PRICKLE1,GO:0051602,response to electrical stimulus,2.0
21682,PRICKLE1,GO:0060071,"Wnt signaling pathway, planar cell polarity pathway",2.0
21683,PRICKLE1,GO:0060976,coronary vasculature development,2.0
21684,PRICKLE1,GO:0061159,establishment of bipolar cell polarity involved in cell morphogenesis,2.0
21685,PRICKLE1,GO:0085029,extracellular matrix assembly,2.0
21686,PRICKLE1,GO:0090009,primitive streak formation,2.0
21687,PRICKLE1,GO:0090090,negative regulation of canonical Wnt signaling pathway,2.0
21688,PRICKLE1,GO:0090307,mitotic spindle assembly,2.0
21689,PRICKLE1,GO:1905070,anterior visceral endoderm cell migration,2.0
21690,PRICKLE1,GO:1990403,embryonic brain development,2.0
21691,PRICKLE1,GO:2000691,negative regulation of cardiac muscle cell myoblast differentiation,2.0
21692,PRICKLE2,GO:0005737,cytoplasm,2.0
21693,PRICKLE2,GO:0008270,zinc ion binding,2.0
21694,PRICKLE2,GO:0031965,nuclear membrane,2.0
21695,PRICKLE2,GO:0060071,"Wnt signaling pathway, planar cell polarity pathway",2.0
21696,PRKAR1B,GO:0004862,cAMP-dependent protein kinase inhibitor activity,2.0
21698,PRKAR1B,GO:0005515,protein binding,2.0
21699,PRKAR1B,GO:0005737,cytoplasm,2.0
21700,PRKAR1B,GO:0005771,multivesicular body,2.0
21701,PRKAR1B,GO:0005829,cytosol,2.0
21702,PRKAR1B,GO:0005886,plasma membrane,2.0
21703,PRKAR1B,GO:0005952,cAMP-dependent protein kinase complex,2.0
21705,PRKAR1B,GO:0006468,protein phosphorylation,2.0
21706,PRKAR1B,GO:0007611,learning or memory,2.0
21707,PRKAR1B,GO:0008603,cAMP-dependent protein kinase regulator activity,2.0
21709,PRKAR1B,GO:0030552,cAMP binding,2.0
21710,PRKAR1B,GO:0034236,protein kinase A catalytic subunit binding,2.0
21712,PRKAR1B,GO:0097546,ciliary base,2.0
21713,PRKAR1B,GO:0098685,Schaffer collateral - CA1 synapse,2.0
21714,PRKAR1B,GO:0098686,hippocampal mossy fiber to CA3 synapse,2.0
21715,PRKAR1B,GO:0098693,regulation of synaptic vesicle cycle,2.0
21716,PRKAR1B,GO:0098794,postsynapse,2.0
21717,PRKAR1B,GO:0098978,glutamatergic synapse,2.0
21718,PRKAR1B,GO:0140678,molecular function inhibitor activity,2.0
21719,PRKAR1B,GO:1900273,positive regulation of long-term synaptic potentiation,2.0
21720,PRKAR1B,GO:1903367,positive regulation of fear response,2.0
21721,PRKAR1B,GO:1904058,positive regulation of sensory perception of pain,2.0
21722,PRKAR1B,GO:2000463,positive regulation of excitatory postsynaptic potential,2.0
21723,PRKAR1B,GO:2000480,negative regulation of cAMP-dependent protein kinase activity,2.0
21725,PRKCA,GO:0001525,angiogenesis,2.0
21726,PRKCA,GO:0001938,positive regulation of endothelial cell proliferation,2.0
21727,PRKCA,GO:0002159,desmosome assembly,2.0
21728,PRKCA,GO:0004672,protein kinase activity,2.0
21729,PRKCA,GO:0004674,protein serine/threonine kinase activity,2.0
21730,PRKCA,GO:0004697,protein kinase C activity,2.0
21733,PRKCA,GO:0004698,calcium-dependent protein kinase C activity,2.0
21734,PRKCA,GO:0005178,integrin binding,2.0
21735,PRKCA,GO:0005515,protein binding,2.0
21736,PRKCA,GO:0005524,ATP binding,2.0
21737,PRKCA,GO:0005654,nucleoplasm,2.0
21738,PRKCA,GO:0005737,cytoplasm,2.0
21739,PRKCA,GO:0005739,mitochondrion,2.0
21740,PRKCA,GO:0005783,endoplasmic reticulum,2.0
21741,PRKCA,GO:0005829,cytosol,2.0
21743,PRKCA,GO:0005886,plasma membrane,2.0
21745,PRKCA,GO:0006468,protein phosphorylation,2.0
21746,PRKCA,GO:0007077,mitotic nuclear membrane disassembly,2.0
21747,PRKCA,GO:0007155,cell adhesion,2.0
21748,PRKCA,GO:0008270,zinc ion binding,2.0
21749,PRKCA,GO:0010595,positive regulation of endothelial cell migration,2.0
21750,PRKCA,GO:0010613,positive regulation of cardiac muscle hypertrophy,2.0
21751,PRKCA,GO:0016570,histone modification,2.0
21752,PRKCA,GO:0018105,peptidyl-serine phosphorylation,2.0
21754,PRKCA,GO:0018107,peptidyl-threonine phosphorylation,2.0
21755,PRKCA,GO:0019899,enzyme binding,2.0
21756,PRKCA,GO:0030335,positive regulation of cell migration,2.0
21757,PRKCA,GO:0031666,positive regulation of lipopolysaccharide-mediated signaling pathway,2.0
21758,PRKCA,GO:0031966,mitochondrial membrane,2.0
21759,PRKCA,GO:0034351,negative regulation of glial cell apoptotic process,2.0
21760,PRKCA,GO:0035403,histone H3T6 kinase activity,2.0
21761,PRKCA,GO:0035556,intracellular signal transduction,2.0
21762,PRKCA,GO:0035866,alphav-beta3 integrin-PKCalpha complex,2.0
21763,PRKCA,GO:0043488,regulation of mRNA stability,2.0
21764,PRKCA,GO:0043536,positive regulation of blood vessel endothelial cell migration,2.0
21765,PRKCA,GO:0043687,post-translational protein modification,2.0
21766,PRKCA,GO:0045651,positive regulation of macrophage differentiation,2.0
21767,PRKCA,GO:0045766,positive regulation of angiogenesis,2.0
21768,PRKCA,GO:0045780,positive regulation of bone resorption,2.0
21769,PRKCA,GO:0045785,positive regulation of cell adhesion,2.0
21770,PRKCA,GO:0045931,positive regulation of mitotic cell cycle,2.0
21771,PRKCA,GO:0048471,perinuclear region of cytoplasm,2.0
21772,PRKCA,GO:0070062,extracellular exosome,2.0
21773,PRKCA,GO:0070374,positive regulation of ERK1 and ERK2 cascade,2.0
21774,PRKCA,GO:0070555,response to interleukin-1,2.0
21775,PRKCA,GO:0090330,regulation of platelet aggregation,2.0
21776,PRKCA,GO:0097190,apoptotic signaling pathway,2.0
21777,PRKCA,GO:0106071,positive regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway,2.0
21778,PRKCA,GO:0106310,protein serine kinase activity,2.0
21779,PRKCA,GO:2000707,positive regulation of dense core granule biogenesis,2.0
21780,PRKCB,GO:0002250,adaptive immune response,2.0
21781,PRKCB,GO:0003682,chromatin binding,2.0
21782,PRKCB,GO:0004674,protein serine/threonine kinase activity,2.0
21784,PRKCB,GO:0004697,protein kinase C activity,2.0
21787,PRKCB,GO:0004698,calcium-dependent protein kinase C activity,2.0
21788,PRKCB,GO:0005080,protein kinase C binding,2.0
21789,PRKCB,GO:0005246,calcium channel regulator activity,2.0
21790,PRKCB,GO:0005515,protein binding,2.0
21791,PRKCB,GO:0005524,ATP binding,2.0
21792,PRKCB,GO:0005634,nucleus,2.0
21793,PRKCB,GO:0005654,nucleoplasm,2.0
21795,PRKCB,GO:0005737,cytoplasm,2.0
21796,PRKCB,GO:0005829,cytosol,2.0
21798,PRKCB,GO:0005886,plasma membrane,2.0
21800,PRKCB,GO:0006325,chromatin organization,2.0
21801,PRKCB,GO:0006357,regulation of transcription by RNA polymerase II,2.0
21802,PRKCB,GO:0006468,protein phosphorylation,2.0
21803,PRKCB,GO:0006816,calcium ion transport,2.0
21804,PRKCB,GO:0006874,cellular calcium ion homeostasis,2.0
21805,PRKCB,GO:0006915,apoptotic process,2.0
21806,PRKCB,GO:0007077,mitotic nuclear membrane disassembly,2.0
21807,PRKCB,GO:0007165,signal transduction,2.0
21808,PRKCB,GO:0008091,spectrin,2.0
21809,PRKCB,GO:0008270,zinc ion binding,2.0
21810,PRKCB,GO:0010827,regulation of glucose transmembrane transport,2.0
21811,PRKCB,GO:0010829,negative regulation of glucose transmembrane transport,2.0
21812,PRKCB,GO:0016570,histone modification,2.0
21813,PRKCB,GO:0018105,peptidyl-serine phosphorylation,2.0
21814,PRKCB,GO:0030374,nuclear receptor coactivator activity,2.0
21815,PRKCB,GO:0030949,positive regulation of vascular endothelial growth factor receptor signaling pathway,2.0
21816,PRKCB,GO:0035403,histone H3T6 kinase activity,2.0
21817,PRKCB,GO:0035556,intracellular signal transduction,2.0
21818,PRKCB,GO:0042113,B cell activation,2.0
21819,PRKCB,GO:0042393,histone binding,2.0
21820,PRKCB,GO:0042953,lipoprotein transport,2.0
21821,PRKCB,GO:0043123,positive regulation of I-kappaB kinase/NF-kappaB signaling,2.0
21822,PRKCB,GO:0043687,post-translational protein modification,2.0
21823,PRKCB,GO:0044305,calyx of Held,2.0
21824,PRKCB,GO:0045766,positive regulation of angiogenesis,2.0
21825,PRKCB,GO:0045893,positive regulation of DNA-templated transcription,2.0
21826,PRKCB,GO:0046627,negative regulation of insulin receptor signaling pathway,2.0
21827,PRKCB,GO:0050681,nuclear androgen receptor binding,2.0
21828,PRKCB,GO:0050853,B cell receptor signaling pathway,2.0
21829,PRKCB,GO:0050861,positive regulation of B cell receptor signaling pathway,2.0
21830,PRKCB,GO:0051092,positive regulation of NF-kappaB transcription factor activity,2.0
21831,PRKCB,GO:0070062,extracellular exosome,2.0
21832,PRKCB,GO:0071322,cellular response to carbohydrate stimulus,2.0
21833,PRKCB,GO:0099171,presynaptic modulation of chemical synaptic transmission,2.0
21834,PRKCB,GO:0099523,presynaptic cytosol,2.0
21835,PRKCB,GO:0106310,protein serine kinase activity,2.0
21836,PRKCB,GO:2000300,regulation of synaptic vesicle exocytosis,2.0
21915,PRKD2,GO:0001525,angiogenesis,2.0
21916,PRKD2,GO:0001938,positive regulation of endothelial cell proliferation,2.0
21918,PRKD2,GO:0002250,adaptive immune response,2.0
21919,PRKD2,GO:0004672,protein kinase activity,2.0
21920,PRKD2,GO:0004674,protein serine/threonine kinase activity,2.0
21923,PRKD2,GO:0004697,protein kinase C activity,2.0
21924,PRKD2,GO:0004698,calcium-dependent protein kinase C activity,2.0
21925,PRKD2,GO:0005080,protein kinase C binding,2.0
21926,PRKD2,GO:0005515,protein binding,2.0
21927,PRKD2,GO:0005524,ATP binding,2.0
21928,PRKD2,GO:0005634,nucleus,2.0
21929,PRKD2,GO:0005654,nucleoplasm,2.0
21930,PRKD2,GO:0005737,cytoplasm,2.0
21931,PRKD2,GO:0005794,Golgi apparatus,2.0
21932,PRKD2,GO:0005829,cytosol,2.0
21934,PRKD2,GO:0005886,plasma membrane,2.0
21935,PRKD2,GO:0006468,protein phosphorylation,2.0
21937,PRKD2,GO:0007155,cell adhesion,2.0
21938,PRKD2,GO:0010595,positive regulation of endothelial cell migration,2.0
21939,PRKD2,GO:0018105,peptidyl-serine phosphorylation,2.0
21941,PRKD2,GO:0018107,peptidyl-threonine phosphorylation,2.0
21942,PRKD2,GO:0030148,sphingolipid biosynthetic process,2.0
21943,PRKD2,GO:0030949,positive regulation of vascular endothelial growth factor receptor signaling pathway,2.0
21944,PRKD2,GO:0032743,positive regulation of interleukin-2 production,2.0
21945,PRKD2,GO:0032757,positive regulation of interleukin-8 production,2.0
21946,PRKD2,GO:0032793,positive regulation of CREB transcription factor activity,2.0
21947,PRKD2,GO:0033138,positive regulation of peptidyl-serine phosphorylation,2.0
21948,PRKD2,GO:0035556,intracellular signal transduction,2.0
21949,PRKD2,GO:0035924,cellular response to vascular endothelial growth factor stimulus,2.0
21951,PRKD2,GO:0038033,positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway,2.0
21953,PRKD2,GO:0043536,positive regulation of blood vessel endothelial cell migration,2.0
21955,PRKD2,GO:0045743,positive regulation of fibroblast growth factor receptor signaling pathway,2.0
21956,PRKD2,GO:0045766,positive regulation of angiogenesis,2.0
21958,PRKD2,GO:0045785,positive regulation of cell adhesion,2.0
21959,PRKD2,GO:0045944,positive regulation of transcription by RNA polymerase II,2.0
21961,PRKD2,GO:0046777,protein autophosphorylation,2.0
21963,PRKD2,GO:0046872,metal ion binding,2.0
21964,PRKD2,GO:0048010,vascular endothelial growth factor receptor signaling pathway,2.0
21965,PRKD2,GO:0050852,T cell receptor signaling pathway,2.0
21966,PRKD2,GO:0050862,positive regulation of T cell receptor signaling pathway,2.0
21967,PRKD2,GO:0051091,positive regulation of DNA-binding transcription factor activity,2.0
21968,PRKD2,GO:0051092,positive regulation of NF-kappaB transcription factor activity,2.0
21969,PRKD2,GO:0061154,endothelial tube morphogenesis,2.0
21970,PRKD2,GO:0070232,regulation of T cell apoptotic process,2.0
21971,PRKD2,GO:0070374,positive regulation of ERK1 and ERK2 cascade,2.0
21972,PRKD2,GO:0089700,protein kinase D signaling,2.0
21974,PRKD2,GO:0106310,protein serine kinase activity,2.0
21975,PRKD2,GO:1901727,positive regulation of histone deacetylase activity,2.0
21976,PRKD2,GO:1902533,positive regulation of intracellular signal transduction,2.0
21977,PRKD2,GO:2000573,positive regulation of DNA biosynthetic process,2.0
21978,PRKD2,GO:2001028,positive regulation of endothelial cell chemotaxis,2.0
21979,PRKDC,GO:0000460,maturation of 5.8S rRNA,2.0
21980,PRKDC,GO:0000723,telomere maintenance,2.0
21981,PRKDC,GO:0000781,"chromosome, telomeric region",2.0
21982,PRKDC,GO:0001756,somitogenesis,2.0
21983,PRKDC,GO:0001933,negative regulation of protein phosphorylation,2.0
21984,PRKDC,GO:0002218,activation of innate immune response,2.0
21985,PRKDC,GO:0002326,B cell lineage commitment,2.0
21986,PRKDC,GO:0002327,immature B cell differentiation,2.0
21987,PRKDC,GO:0002328,pro-B cell differentiation,2.0
21988,PRKDC,GO:0002360,T cell lineage commitment,2.0
21989,PRKDC,GO:0003690,double-stranded DNA binding,2.0
21990,PRKDC,GO:0003723,RNA binding,2.0
21991,PRKDC,GO:0004672,protein kinase activity,2.0
21993,PRKDC,GO:0004674,protein serine/threonine kinase activity,2.0
21996,PRKDC,GO:0004677,DNA-dependent protein kinase activity,2.0
21997,PRKDC,GO:0005515,protein binding,2.0
21998,PRKDC,GO:0005524,ATP binding,2.0
21999,PRKDC,GO:0005634,nucleus,2.0
22001,PRKDC,GO:0005654,nucleoplasm,2.0
22003,PRKDC,GO:0005667,transcription regulator complex,2.0
22004,PRKDC,GO:0005730,nucleolus,2.0
22005,PRKDC,GO:0005829,cytosol,2.0
22006,PRKDC,GO:0005958,DNA-dependent protein kinase-DNA ligase 4 complex,2.0
22007,PRKDC,GO:0006302,double-strand break repair,2.0
22009,PRKDC,GO:0006303,double-strand break repair via nonhomologous end joining,2.0
22011,PRKDC,GO:0006468,protein phosphorylation,2.0
22014,PRKDC,GO:0006974,cellular response to DNA damage stimulus,2.0
22015,PRKDC,GO:0007420,brain development,2.0
22016,PRKDC,GO:0007507,heart development,2.0
22017,PRKDC,GO:0008630,intrinsic apoptotic signaling pathway in response to DNA damage,2.0
22018,PRKDC,GO:0010332,response to gamma radiation,2.0
22019,PRKDC,GO:0016020,membrane,2.0
22020,PRKDC,GO:0016233,telomere capping,2.0
22021,PRKDC,GO:0018105,peptidyl-serine phosphorylation,2.0
22023,PRKDC,GO:0018107,peptidyl-threonine phosphorylation,2.0
22024,PRKDC,GO:0019899,enzyme binding,2.0
22025,PRKDC,GO:0019904,protein domain specific binding,2.0
22026,PRKDC,GO:0031571,mitotic G1 DNA damage checkpoint signaling,2.0
22027,PRKDC,GO:0031648,protein destabilization,2.0
22028,PRKDC,GO:0032040,small-subunit processome,2.0
22029,PRKDC,GO:0032869,cellular response to insulin stimulus,2.0
22030,PRKDC,GO:0032991,protein-containing complex,2.0
22031,PRKDC,GO:0032993,protein-DNA complex,2.0
22032,PRKDC,GO:0033077,T cell differentiation in thymus,2.0
22033,PRKDC,GO:0033152,immunoglobulin V(D)J recombination,2.0
22034,PRKDC,GO:0033153,T cell receptor V(D)J recombination,2.0
22035,PRKDC,GO:0034462,small-subunit processome assembly,2.0
22036,PRKDC,GO:0034511,U3 snoRNA binding,2.0
22037,PRKDC,GO:0035234,ectopic germ cell programmed cell death,2.0
22038,PRKDC,GO:0036211,protein modification process,2.0
22039,PRKDC,GO:0042752,regulation of circadian rhythm,2.0
22040,PRKDC,GO:0043065,positive regulation of apoptotic process,2.0
22041,PRKDC,GO:0043066,negative regulation of apoptotic process,2.0
22042,PRKDC,GO:0045087,innate immune response,2.0
22043,PRKDC,GO:0045621,positive regulation of lymphocyte differentiation,2.0
22044,PRKDC,GO:0045648,positive regulation of erythrocyte differentiation,2.0
22045,PRKDC,GO:0045727,positive regulation of translation,2.0
22046,PRKDC,GO:0045944,positive regulation of transcription by RNA polymerase II,2.0
22047,PRKDC,GO:0048511,rhythmic process,2.0
22048,PRKDC,GO:0048660,regulation of smooth muscle cell proliferation,2.0
22049,PRKDC,GO:0050678,regulation of epithelial cell proliferation,2.0
22050,PRKDC,GO:0061629,RNA polymerase II-specific DNA-binding transcription factor binding,2.0
22051,PRKDC,GO:0070418,DNA-dependent protein kinase complex,2.0
22052,PRKDC,GO:0070419,nonhomologous end joining complex,2.0
22053,PRKDC,GO:0097681,double-strand break repair via alternative nonhomologous end joining,2.0
22054,PRKDC,GO:0106310,protein serine kinase activity,2.0
22055,PRKDC,GO:1902036,regulation of hematopoietic stem cell differentiation,2.0
22056,PRKDC,GO:1905221,positive regulation of platelet formation,2.0
22057,PRKDC,GO:2001034,positive regulation of double-strand break repair via nonhomologous end joining,2.0
22058,PRKN,GO:0000122,negative regulation of transcription by RNA polymerase II,2.0
22059,PRKN,GO:0000151,ubiquitin ligase complex,2.0
22061,PRKN,GO:0000209,protein polyubiquitination,2.0
22064,PRKN,GO:0000266,mitochondrial fission,2.0
22065,PRKN,GO:0000422,autophagy of mitochondrion,2.0
22068,PRKN,GO:0000423,mitophagy,2.0
22069,PRKN,GO:0001664,G protein-coupled receptor binding,2.0
22070,PRKN,GO:0001933,negative regulation of protein phosphorylation,2.0
22072,PRKN,GO:0001964,startle response,2.0
22073,PRKN,GO:0003714,transcription corepressor activity,2.0
22074,PRKN,GO:0003779,actin binding,2.0
22075,PRKN,GO:0004842,ubiquitin-protein transferase activity,2.0
22077,PRKN,GO:0005515,protein binding,2.0
22078,PRKN,GO:0005634,nucleus,2.0
22079,PRKN,GO:0005737,cytoplasm,2.0
22081,PRKN,GO:0005739,mitochondrion,2.0
22084,PRKN,GO:0005741,mitochondrial outer membrane,2.0
22085,PRKN,GO:0005783,endoplasmic reticulum,2.0
22087,PRKN,GO:0005794,Golgi apparatus,2.0
22089,PRKN,GO:0005829,cytosol,2.0
22093,PRKN,GO:0006511,ubiquitin-dependent protein catabolic process,2.0
22098,PRKN,GO:0006513,protein monoubiquitination,2.0
22100,PRKN,GO:0006979,response to oxidative stress,2.0
22101,PRKN,GO:0007005,mitochondrion organization,2.0
22102,PRKN,GO:0007417,central nervous system development,2.0
22103,PRKN,GO:0007612,learning,2.0
22104,PRKN,GO:0008013,beta-catenin binding,2.0
22105,PRKN,GO:0008270,zinc ion binding,2.0
22106,PRKN,GO:0008344,adult locomotory behavior,2.0
22107,PRKN,GO:0010498,proteasomal protein catabolic process,2.0
22108,PRKN,GO:0010506,regulation of autophagy,2.0
22109,PRKN,GO:0010628,positive regulation of gene expression,2.0
22110,PRKN,GO:0010629,negative regulation of gene expression,2.0
22111,PRKN,GO:0010636,positive regulation of mitochondrial fusion,2.0
22112,PRKN,GO:0010637,negative regulation of mitochondrial fusion,2.0
22113,PRKN,GO:0010821,regulation of mitochondrion organization,2.0
22117,PRKN,GO:0010906,regulation of glucose metabolic process,2.0
22118,PRKN,GO:0010994,free ubiquitin chain polymerization,2.0
22119,PRKN,GO:0014059,regulation of dopamine secretion,2.0
22120,PRKN,GO:0014069,postsynaptic density,2.0
22121,PRKN,GO:0015631,tubulin binding,2.0
22122,PRKN,GO:0016235,aggresome,2.0
22123,PRKN,GO:0016236,macroautophagy,2.0
22124,PRKN,GO:0016567,protein ubiquitination,2.0
22126,PRKN,GO:0016579,protein deubiquitination,2.0
22127,PRKN,GO:0016607,nuclear speck,2.0
22128,PRKN,GO:0017124,SH3 domain binding,2.0
22129,PRKN,GO:0019005,SCF ubiquitin ligase complex,2.0
22130,PRKN,GO:0019899,enzyme binding,2.0
22131,PRKN,GO:0019900,kinase binding,2.0
22132,PRKN,GO:0019901,protein kinase binding,2.0
22133,PRKN,GO:0030163,protein catabolic process,2.0
22134,PRKN,GO:0030165,PDZ domain binding,2.0
22135,PRKN,GO:0030544,Hsp70 protein binding,2.0
22136,PRKN,GO:0031072,heat shock protein binding,2.0
22137,PRKN,GO:0031396,regulation of protein ubiquitination,2.0
22139,PRKN,GO:0031624,ubiquitin conjugating enzyme binding,2.0
22142,PRKN,GO:0031625,ubiquitin protein ligase binding,2.0
22144,PRKN,GO:0031647,regulation of protein stability,2.0
22145,PRKN,GO:0031648,protein destabilization,2.0
22146,PRKN,GO:0032092,positive regulation of protein binding,2.0
22147,PRKN,GO:0032232,negative regulation of actin filament bundle assembly,2.0
22148,PRKN,GO:0032368,regulation of lipid transport,2.0
22149,PRKN,GO:0032436,positive regulation of proteasomal ubiquitin-dependent protein catabolic process,2.0
22151,PRKN,GO:0033132,negative regulation of glucokinase activity,2.0
22152,PRKN,GO:0034620,cellular response to unfolded protein,2.0
22153,PRKN,GO:0034976,response to endoplasmic reticulum stress,2.0
22154,PRKN,GO:0035249,"synaptic transmission, glutamatergic",2.0
22155,PRKN,GO:0035519,protein K29-linked ubiquitination,2.0
22156,PRKN,GO:0036503,ERAD pathway,2.0
22157,PRKN,GO:0042053,regulation of dopamine metabolic process,2.0
22158,PRKN,GO:0042415,norepinephrine metabolic process,2.0
22159,PRKN,GO:0042417,dopamine metabolic process,2.0
22160,PRKN,GO:0042802,identical protein binding,2.0
22161,PRKN,GO:0042826,histone deacetylase binding,2.0
22162,PRKN,GO:0042981,regulation of apoptotic process,2.0
22163,PRKN,GO:0043005,neuron projection,2.0
22164,PRKN,GO:0043123,positive regulation of I-kappaB kinase/NF-kappaB signaling,2.0
22166,PRKN,GO:0043130,ubiquitin binding,2.0
22167,PRKN,GO:0043161,proteasome-mediated ubiquitin-dependent protein catabolic process,2.0
22168,PRKN,GO:0043274,phospholipase binding,2.0
22169,PRKN,GO:0043388,positive regulation of DNA binding,2.0
22170,PRKN,GO:0043524,negative regulation of neuron apoptotic process,2.0
22171,PRKN,GO:0044314,protein K27-linked ubiquitination,2.0
22172,PRKN,GO:0044828,negative regulation by host of viral genome replication,2.0
22173,PRKN,GO:0044877,protein-containing complex binding,2.0
22174,PRKN,GO:0045732,positive regulation of protein catabolic process,2.0
22175,PRKN,GO:0045944,positive regulation of transcription by RNA polymerase II,2.0
22176,PRKN,GO:0046329,negative regulation of JNK cascade,2.0
22177,PRKN,GO:0046676,negative regulation of insulin secretion,2.0
22178,PRKN,GO:0048471,perinuclear region of cytoplasm,2.0
22179,PRKN,GO:0050821,protein stabilization,2.0
22180,PRKN,GO:0051087,chaperone binding,2.0
22181,PRKN,GO:0051582,positive regulation of neurotransmitter uptake,2.0
22182,PRKN,GO:0051583,dopamine uptake involved in synaptic transmission,2.0
22183,PRKN,GO:0051865,protein autoubiquitination,2.0
22184,PRKN,GO:0051881,regulation of mitochondrial membrane potential,2.0
22185,PRKN,GO:0055069,zinc ion homeostasis,2.0
22186,PRKN,GO:0060548,negative regulation of cell death,2.0
22187,PRKN,GO:0060828,regulation of canonical Wnt signaling pathway,2.0
22188,PRKN,GO:0061630,ubiquitin protein ligase activity,2.0
22193,PRKN,GO:0061734,parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization,2.0
22194,PRKN,GO:0070050,neuron cellular homeostasis,2.0
22195,PRKN,GO:0070534,protein K63-linked ubiquitination,2.0
22198,PRKN,GO:0070585,protein localization to mitochondrion,2.0
22199,PRKN,GO:0070842,aggresome assembly,2.0
22200,PRKN,GO:0070936,protein K48-linked ubiquitination,2.0
22201,PRKN,GO:0070979,protein K11-linked ubiquitination,2.0
22202,PRKN,GO:0071287,cellular response to manganese ion,2.0
22203,PRKN,GO:0085020,protein K6-linked ubiquitination,2.0
22205,PRKN,GO:0090090,negative regulation of canonical Wnt signaling pathway,2.0
22207,PRKN,GO:0090141,positive regulation of mitochondrial fission,2.0
22208,PRKN,GO:0090201,negative regulation of release of cytochrome c from mitochondria,2.0
22209,PRKN,GO:0097237,cellular response to toxic substance,2.0
22210,PRKN,GO:0097413,Lewy body,2.0
22211,PRKN,GO:0097602,cullin family protein binding,2.0
22212,PRKN,GO:0098691,dopaminergic synapse,2.0
22213,PRKN,GO:0098779,positive regulation of mitophagy in response to mitochondrial depolarization,2.0
22215,PRKN,GO:0098793,presynapse,2.0
22216,PRKN,GO:0099073,mitochondrion-derived vesicle,2.0
22217,PRKN,GO:0099074,mitochondrion to lysosome transport,2.0
22218,PRKN,GO:0140251,regulation protein catabolic process at presynapse,2.0
22219,PRKN,GO:1900242,regulation of synaptic vesicle endocytosis,2.0
22220,PRKN,GO:1900407,regulation of cellular response to oxidative stress,2.0
22224,PRKN,GO:1901215,negative regulation of neuron death,2.0
22225,PRKN,GO:1901800,positive regulation of proteasomal protein catabolic process,2.0
22226,PRKN,GO:1902236,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,2.0
22228,PRKN,GO:1902254,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator,2.0
22229,PRKN,GO:1902283,negative regulation of primary amine oxidase activity,2.0
22230,PRKN,GO:1902530,positive regulation of protein linear polyubiquitination,2.0
22231,PRKN,GO:1902803,regulation of synaptic vesicle transport,2.0
22232,PRKN,GO:1903202,negative regulation of oxidative stress-induced cell death,2.0
22234,PRKN,GO:1903214,regulation of protein targeting to mitochondrion,2.0
22235,PRKN,GO:1903265,positive regulation of tumor necrosis factor-mediated signaling pathway,2.0
22236,PRKN,GO:1903351,cellular response to dopamine,2.0
22237,PRKN,GO:1903377,negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway,2.0
22238,PRKN,GO:1903382,negative regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway,2.0
22239,PRKN,GO:1903542,negative regulation of exosomal secretion,2.0
22240,PRKN,GO:1903599,positive regulation of autophagy of mitochondrion,2.0
22241,PRKN,GO:1903861,positive regulation of dendrite extension,2.0
22242,PRKN,GO:1904049,negative regulation of spontaneous neurotransmitter secretion,2.0
22243,PRKN,GO:1905281,"positive regulation of retrograde transport, endosome to Golgi",2.0
22244,PRKN,GO:1905366,negative regulation of intralumenal vesicle formation,2.0
22245,PRKN,GO:1905477,positive regulation of protein localization to membrane,2.0
22247,PRKN,GO:1990000,amyloid fibril formation,2.0
22248,PRKN,GO:1990381,ubiquitin-specific protease binding,2.0
22249,PRKN,GO:1990444,F-box domain binding,2.0
22250,PRKN,GO:1990452,Parkin-FBXW7-Cul1 ubiquitin ligase complex,2.0
22251,PRKN,GO:2000377,regulation of reactive oxygen species metabolic process,2.0
22252,PRKN,GO:2000378,negative regulation of reactive oxygen species metabolic process,2.0
22253,PRODH,GO:0004657,proline dehydrogenase activity,2.0
22256,PRODH,GO:0005654,nucleoplasm,2.0
22257,PRODH,GO:0005739,mitochondrion,2.0
22259,PRODH,GO:0005743,mitochondrial inner membrane,2.0
22260,PRODH,GO:0005759,mitochondrial matrix,2.0
22261,PRODH,GO:0006560,proline metabolic process,2.0
22262,PRODH,GO:0006562,proline catabolic process,2.0
22263,PRODH,GO:0008631,intrinsic apoptotic signaling pathway in response to oxidative stress,2.0
22264,PRODH,GO:0010133,proline catabolic process to glutamate,2.0
22266,PRODH,GO:0010942,positive regulation of cell death,2.0
22267,PRODH,GO:0019470,4-hydroxyproline catabolic process,2.0
22268,PRODH,GO:0043231,intracellular membrane-bounded organelle,2.0
22269,PRODH,GO:0071949,FAD binding,2.0
22271,PRPF39,GO:0000243,commitment complex,2.0
22272,PRPF39,GO:0000395,mRNA 5'-splice site recognition,2.0
22273,PRPF39,GO:0005515,protein binding,2.0
22274,PRPF39,GO:0005685,U1 snRNP,2.0
22275,PRPF39,GO:0071004,U2-type prespliceosome,2.0
22311,PRUNE2,GO:0005515,protein binding,2.0
22312,PRUNE2,GO:0005654,nucleoplasm,2.0
22313,PRUNE2,GO:0005730,nucleolus,2.0
22314,PRUNE2,GO:0005737,cytoplasm,2.0
22315,PRUNE2,GO:0005794,Golgi apparatus,2.0
22316,PRUNE2,GO:0005829,cytosol,2.0
22317,PRUNE2,GO:0006915,apoptotic process,2.0
22318,PRUNE2,GO:0016462,pyrophosphatase activity,2.0
22319,PRUNE2,GO:0046872,metal ion binding,2.0
22320,PSD3,GO:0005085,guanyl-nucleotide exchange factor activity,2.0
22321,PSD3,GO:0014069,postsynaptic density,2.0
22322,PSD3,GO:0032012,regulation of ARF protein signal transduction,2.0
22323,PSD3,GO:0032587,ruffle membrane,2.0
22325,PSD3,GO:0050790,regulation of catalytic activity,2.0
22341,PTBP2,GO:0003723,RNA binding,2.0
22342,PTBP2,GO:0003729,mRNA binding,2.0
22343,PTBP2,GO:0005634,nucleus,2.0
22344,PTBP2,GO:0005681,spliceosomal complex,2.0
22345,PTBP2,GO:0006376,mRNA splice site selection,2.0
22346,PTBP2,GO:0021510,spinal cord development,2.0
22347,PTBP2,GO:0021549,cerebellum development,2.0
22348,PTBP2,GO:0030426,growth cone,2.0
22349,PTBP2,GO:0033119,negative regulation of RNA splicing,2.0
22350,PTBP2,GO:0043025,neuronal cell body,2.0
22351,PTBP2,GO:0043484,regulation of RNA splicing,2.0
22352,PTBP2,GO:2000177,regulation of neural precursor cell proliferation,2.0
22522,PON1,GO:0004063,aryldialkylphosphatase activity,2.0
22524,PON1,GO:0004064,arylesterase activity,2.0
22527,PON1,GO:0005509,calcium ion binding,2.0
22528,PON1,GO:0005543,phospholipid binding,2.0
22529,PON1,GO:0005576,extracellular region,2.0
22531,PON1,GO:0005615,extracellular space,2.0
22533,PON1,GO:0005789,endoplasmic reticulum membrane,2.0
22534,PON1,GO:0008203,cholesterol metabolic process,2.0
22535,PON1,GO:0009636,response to toxic substance,2.0
22536,PON1,GO:0010875,positive regulation of cholesterol efflux,2.0
22537,PON1,GO:0019439,aromatic compound catabolic process,2.0
22538,PON1,GO:0031667,response to nutrient levels,2.0
22539,PON1,GO:0032411,positive regulation of transporter activity,2.0
22540,PON1,GO:0034364,high-density lipoprotein particle,2.0
22542,PON1,GO:0034366,spherical high-density lipoprotein particle,2.0
22543,PON1,GO:0034445,negative regulation of plasma lipoprotein oxidation,2.0
22544,PON1,GO:0042803,protein homodimerization activity,2.0
22545,PON1,GO:0046395,carboxylic acid catabolic process,2.0
22546,PON1,GO:0046434,organophosphate catabolic process,2.0
22547,PON1,GO:0046470,phosphatidylcholine metabolic process,2.0
22548,PON1,GO:0051099,positive regulation of binding,2.0
22549,PON1,GO:0070062,extracellular exosome,2.0
22550,PON1,GO:0070542,response to fatty acid,2.0
22551,PON1,GO:0072562,blood microparticle,2.0
22552,PON1,GO:0102007,acyl-L-homoserine-lactone lactonohydrolase activity,2.0
22553,PON1,GO:1902617,response to fluoride,2.0
22554,PPP1R1B,GO:0001975,response to amphetamine,2.0
22555,PPP1R1B,GO:0004860,protein kinase inhibitor activity,2.0
22556,PPP1R1B,GO:0004862,cAMP-dependent protein kinase inhibitor activity,2.0
22557,PPP1R1B,GO:0004864,protein phosphatase inhibitor activity,2.0
22559,PPP1R1B,GO:0005515,protein binding,2.0
22560,PPP1R1B,GO:0005634,nucleus,2.0
22561,PPP1R1B,GO:0005737,cytoplasm,2.0
22562,PPP1R1B,GO:0005829,cytosol,2.0
22563,PPP1R1B,GO:0006351,DNA-templated transcription,2.0
22564,PPP1R1B,GO:0007165,signal transduction,2.0
22565,PPP1R1B,GO:0007621,negative regulation of female receptivity,2.0
22566,PPP1R1B,GO:0007626,locomotory behavior,2.0
22567,PPP1R1B,GO:0008542,visual learning,2.0
22568,PPP1R1B,GO:0019888,protein phosphatase regulator activity,2.0
22569,PPP1R1B,GO:0032515,negative regulation of phosphoprotein phosphatase activity,2.0
22570,PPP1R1B,GO:0035556,intracellular signal transduction,2.0
22571,PPP1R1B,GO:0043025,neuronal cell body,2.0
22572,PPP1R1B,GO:0043278,response to morphine,2.0
22573,PPP1R1B,GO:0048148,behavioral response to cocaine,2.0
22574,PPP1R1B,GO:0071314,cellular response to cocaine,2.0
22575,PPP1R1B,GO:2000480,negative regulation of cAMP-dependent protein kinase activity,2.0
22576,PTGS2,GO:0001516,prostaglandin biosynthetic process,2.0
22579,PTGS2,GO:0001525,angiogenesis,2.0
22580,PTGS2,GO:0004601,peroxidase activity,2.0
22581,PTGS2,GO:0004666,prostaglandin-endoperoxide synthase activity,2.0
22583,PTGS2,GO:0005515,protein binding,2.0
22584,PTGS2,GO:0005637,nuclear inner membrane,2.0
22585,PTGS2,GO:0005640,nuclear outer membrane,2.0
22586,PTGS2,GO:0005737,cytoplasm,2.0
22589,PTGS2,GO:0005783,endoplasmic reticulum,2.0
22590,PTGS2,GO:0005788,endoplasmic reticulum lumen,2.0
22591,PTGS2,GO:0005789,endoplasmic reticulum membrane,2.0
22592,PTGS2,GO:0005901,caveola,2.0
22593,PTGS2,GO:0006954,inflammatory response,2.0
22594,PTGS2,GO:0006979,response to oxidative stress,2.0
22595,PTGS2,GO:0007566,embryo implantation,2.0
22596,PTGS2,GO:0007568,aging,2.0
22597,PTGS2,GO:0007612,learning,2.0
22598,PTGS2,GO:0007613,memory,2.0
22599,PTGS2,GO:0008217,regulation of blood pressure,2.0
22600,PTGS2,GO:0008285,negative regulation of cell population proliferation,2.0
22601,PTGS2,GO:0009410,response to xenobiotic stimulus,2.0
22602,PTGS2,GO:0009624,response to nematode,2.0
22603,PTGS2,GO:0009750,response to fructose,2.0
22604,PTGS2,GO:0010042,response to manganese ion,2.0
22605,PTGS2,GO:0010226,response to lithium ion,2.0
22606,PTGS2,GO:0010575,positive regulation of vascular endothelial growth factor production,2.0
22607,PTGS2,GO:0016702,"oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen",2.0
22608,PTGS2,GO:0019233,sensory perception of pain,2.0
22609,PTGS2,GO:0019371,cyclooxygenase pathway,2.0
22611,PTGS2,GO:0019899,enzyme binding,2.0
22612,PTGS2,GO:0020037,heme binding,2.0
22613,PTGS2,GO:0030282,bone mineralization,2.0
22614,PTGS2,GO:0030728,ovulation,2.0
22615,PTGS2,GO:0031394,positive regulation of prostaglandin biosynthetic process,2.0
22616,PTGS2,GO:0031622,positive regulation of fever generation,2.0
22617,PTGS2,GO:0031915,positive regulation of synaptic plasticity,2.0
22618,PTGS2,GO:0032227,"negative regulation of synaptic transmission, dopaminergic",2.0
22619,PTGS2,GO:0032310,prostaglandin secretion,2.0
22620,PTGS2,GO:0032355,response to estradiol,2.0
22621,PTGS2,GO:0032496,response to lipopolysaccharide,2.0
22622,PTGS2,GO:0032991,protein-containing complex,2.0
22623,PTGS2,GO:0033138,positive regulation of peptidyl-serine phosphorylation,2.0
22624,PTGS2,GO:0033280,response to vitamin D,2.0
22625,PTGS2,GO:0034605,cellular response to heat,2.0
22626,PTGS2,GO:0034612,response to tumor necrosis factor,2.0
22627,PTGS2,GO:0034644,cellular response to UV,2.0
22628,PTGS2,GO:0035633,maintenance of blood-brain barrier,2.0
22629,PTGS2,GO:0042307,positive regulation of protein import into nucleus,2.0
22630,PTGS2,GO:0042633,hair cycle,2.0
22631,PTGS2,GO:0042803,protein homodimerization activity,2.0
22632,PTGS2,GO:0043005,neuron projection,2.0
22634,PTGS2,GO:0043065,positive regulation of apoptotic process,2.0
22635,PTGS2,GO:0043154,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process,2.0
22636,PTGS2,GO:0043231,intracellular membrane-bounded organelle,2.0
22637,PTGS2,GO:0045429,positive regulation of nitric oxide biosynthetic process,2.0
22638,PTGS2,GO:0045786,negative regulation of cell cycle,2.0
22639,PTGS2,GO:0045907,positive regulation of vasoconstriction,2.0
22640,PTGS2,GO:0045986,negative regulation of smooth muscle contraction,2.0
22641,PTGS2,GO:0045987,positive regulation of smooth muscle contraction,2.0
22642,PTGS2,GO:0046697,decidualization,2.0
22643,PTGS2,GO:0046872,metal ion binding,2.0
22644,PTGS2,GO:0048661,positive regulation of smooth muscle cell proliferation,2.0
22645,PTGS2,GO:0050727,regulation of inflammatory response,2.0
22646,PTGS2,GO:0050873,brown fat cell differentiation,2.0
22647,PTGS2,GO:0051384,response to glucocorticoid,2.0
22648,PTGS2,GO:0051926,negative regulation of calcium ion transport,2.0
22649,PTGS2,GO:0051968,"positive regulation of synaptic transmission, glutamatergic",2.0
22650,PTGS2,GO:0070542,response to fatty acid,2.0
22651,PTGS2,GO:0071260,cellular response to mechanical stimulus,2.0
22652,PTGS2,GO:0071284,cellular response to lead ion,2.0
22653,PTGS2,GO:0071318,cellular response to ATP,2.0
22654,PTGS2,GO:0071456,cellular response to hypoxia,2.0
22655,PTGS2,GO:0071471,cellular response to non-ionic osmotic stress,2.0
22656,PTGS2,GO:0071498,cellular response to fluid shear stress,2.0
22657,PTGS2,GO:0071636,positive regulation of transforming growth factor beta production,2.0
22658,PTGS2,GO:0090050,positive regulation of cell migration involved in sprouting angiogenesis,2.0
22659,PTGS2,GO:0090271,positive regulation of fibroblast growth factor production,2.0
22660,PTGS2,GO:0090336,positive regulation of brown fat cell differentiation,2.0
22661,PTGS2,GO:0090362,positive regulation of platelet-derived growth factor production,2.0
22662,PTGS2,GO:0098869,cellular oxidant detoxification,2.0
22663,PTGS2,GO:0150077,regulation of neuroinflammatory response,2.0
22664,PTGS2,GO:1902219,negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress,2.0
22665,PTGS2,GO:1990776,response to angiotensin,2.0
22793,PTPRB,GO:0001525,angiogenesis,2.0
22794,PTPRB,GO:0005001,transmembrane receptor protein tyrosine phosphatase activity,2.0
22795,PTPRB,GO:0005515,protein binding,2.0
22796,PTPRB,GO:0005886,plasma membrane,2.0
22797,PTPRB,GO:0006470,protein dephosphorylation,2.0
22798,PTPRB,GO:0006796,phosphate-containing compound metabolic process,2.0
22799,PTPRB,GO:0008022,protein C-terminus binding,2.0
22800,PTPRB,GO:0008347,glial cell migration,2.0
22801,PTPRB,GO:0016311,dephosphorylation,2.0
22802,PTPRB,GO:0035579,specific granule membrane,2.0
22803,PTPRB,GO:0043235,receptor complex,2.0
22805,PTPRB,GO:0045296,cadherin binding,2.0
22807,PTPRB,GO:0070821,tertiary granule membrane,2.0
22808,PTPRB,GO:1990264,peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity,2.0
22809,PTPRC,GO:0000165,MAPK cascade,2.0
22810,PTPRC,GO:0001779,natural killer cell differentiation,2.0
22811,PTPRC,GO:0001915,negative regulation of T cell mediated cytotoxicity,2.0
22812,PTPRC,GO:0001916,positive regulation of T cell mediated cytotoxicity,2.0
22813,PTPRC,GO:0001960,negative regulation of cytokine-mediated signaling pathway,2.0
22814,PTPRC,GO:0002244,hematopoietic progenitor cell differentiation,2.0
22815,PTPRC,GO:0002639,positive regulation of immunoglobulin production,2.0
22816,PTPRC,GO:0002925,positive regulation of humoral immune response mediated by circulating immunoglobulin,2.0
22817,PTPRC,GO:0004725,protein tyrosine phosphatase activity,2.0
22821,PTPRC,GO:0005001,transmembrane receptor protein tyrosine phosphatase activity,2.0
22822,PTPRC,GO:0005102,signaling receptor binding,2.0
22823,PTPRC,GO:0005515,protein binding,2.0
22824,PTPRC,GO:0005886,plasma membrane,2.0
22827,PTPRC,GO:0005925,focal adhesion,2.0
22828,PTPRC,GO:0006469,negative regulation of protein kinase activity,2.0
22831,PTPRC,GO:0006470,protein dephosphorylation,2.0
22833,PTPRC,GO:0006933,negative regulation of cell adhesion involved in substrate-bound cell migration,2.0
22834,PTPRC,GO:0007159,leukocyte cell-cell adhesion,2.0
22835,PTPRC,GO:0007166,cell surface receptor signaling pathway,2.0
22836,PTPRC,GO:0008201,heparin binding,2.0
22837,PTPRC,GO:0009897,external side of plasma membrane,2.0
22838,PTPRC,GO:0009898,cytoplasmic side of plasma membrane,2.0
22839,PTPRC,GO:0009986,cell surface,2.0
22840,PTPRC,GO:0010332,response to gamma radiation,2.0
22841,PTPRC,GO:0010468,regulation of gene expression,2.0
22842,PTPRC,GO:0016020,membrane,2.0
22844,PTPRC,GO:0016311,dephosphorylation,2.0
22845,PTPRC,GO:0018108,peptidyl-tyrosine phosphorylation,2.0
22846,PTPRC,GO:0019901,protein kinase binding,2.0
22847,PTPRC,GO:0030183,B cell differentiation,2.0
22848,PTPRC,GO:0030217,T cell differentiation,2.0
22849,PTPRC,GO:0030506,ankyrin binding,2.0
22850,PTPRC,GO:0030507,spectrin binding,2.0
22851,PTPRC,GO:0030667,secretory granule membrane,2.0
22852,PTPRC,GO:0030890,positive regulation of B cell proliferation,2.0
22853,PTPRC,GO:0031668,cellular response to extracellular stimulus,2.0
22854,PTPRC,GO:0031953,negative regulation of protein autophosphorylation,2.0
22855,PTPRC,GO:0032059,bleb,2.0
22856,PTPRC,GO:0032677,regulation of interleukin-8 production,2.0
22857,PTPRC,GO:0032703,negative regulation of interleukin-2 production,2.0
22858,PTPRC,GO:0032743,positive regulation of interleukin-2 production,2.0
22859,PTPRC,GO:0032760,positive regulation of tumor necrosis factor production,2.0
22860,PTPRC,GO:0034113,heterotypic cell-cell adhesion,2.0
22861,PTPRC,GO:0035584,calcium-mediated signaling using intracellular calcium source,2.0
22862,PTPRC,GO:0042100,B cell proliferation,2.0
22863,PTPRC,GO:0042102,positive regulation of T cell proliferation,2.0
22864,PTPRC,GO:0042110,T cell activation,2.0
22865,PTPRC,GO:0042492,gamma-delta T cell differentiation,2.0
22866,PTPRC,GO:0043395,heparan sulfate proteoglycan binding,2.0
22867,PTPRC,GO:0043406,positive regulation of MAP kinase activity,2.0
22868,PTPRC,GO:0043410,positive regulation of MAPK cascade,2.0
22869,PTPRC,GO:0044770,cell cycle phase transition,2.0
22870,PTPRC,GO:0044855,plasma membrane raft distribution,2.0
22871,PTPRC,GO:0045059,positive thymic T cell selection,2.0
22872,PTPRC,GO:0045060,negative thymic T cell selection,2.0
22873,PTPRC,GO:0045121,membrane raft,2.0
22874,PTPRC,GO:0045588,positive regulation of gamma-delta T cell differentiation,2.0
22875,PTPRC,GO:0045860,positive regulation of protein kinase activity,2.0
22876,PTPRC,GO:0046425,regulation of receptor signaling pathway via JAK-STAT,2.0
22877,PTPRC,GO:0046633,alpha-beta T cell proliferation,2.0
22878,PTPRC,GO:0046641,positive regulation of alpha-beta T cell proliferation,2.0
22879,PTPRC,GO:0046777,protein autophosphorylation,2.0
22880,PTPRC,GO:0048304,positive regulation of isotype switching to IgG isotypes,2.0
22881,PTPRC,GO:0048539,bone marrow development,2.0
22882,PTPRC,GO:0048864,stem cell development,2.0
22883,PTPRC,GO:0050731,positive regulation of peptidyl-tyrosine phosphorylation,2.0
22885,PTPRC,GO:0050764,regulation of phagocytosis,2.0
22886,PTPRC,GO:0050852,T cell receptor signaling pathway,2.0
22888,PTPRC,GO:0050853,B cell receptor signaling pathway,2.0
22889,PTPRC,GO:0050857,positive regulation of antigen receptor-mediated signaling pathway,2.0
22890,PTPRC,GO:0051209,release of sequestered calcium ion into cytosol,2.0
22891,PTPRC,GO:0051607,defense response to virus,2.0
22892,PTPRC,GO:0051726,regulation of cell cycle,2.0
22893,PTPRC,GO:0061097,regulation of protein tyrosine kinase activity,2.0
22894,PTPRC,GO:0061099,negative regulation of protein tyrosine kinase activity,2.0
22895,PTPRC,GO:0070062,extracellular exosome,2.0
22896,PTPRC,GO:0070373,negative regulation of ERK1 and ERK2 cascade,2.0
22897,PTPRC,GO:0070374,positive regulation of ERK1 and ERK2 cascade,2.0
22898,PTPRC,GO:0097191,extrinsic apoptotic signaling pathway,2.0
22899,PTPRC,GO:0098857,membrane microdomain,2.0
22900,PTPRC,GO:1903615,positive regulation of protein tyrosine phosphatase activity,2.0
22901,PTPRC,GO:1903979,negative regulation of microglial cell activation,2.0
22902,PTPRC,GO:1904155,DN2 thymocyte differentiation,2.0
22903,PTPRC,GO:1905451,positive regulation of Fc-gamma receptor signaling pathway involved in phagocytosis,2.0
22904,PTPRC,GO:2000473,positive regulation of hematopoietic stem cell migration,2.0
22905,PTPRC,GO:2000648,positive regulation of stem cell proliferation,2.0
22906,PTPRC,GO:2001238,positive regulation of extrinsic apoptotic signaling pathway,2.0
22907,PTPRT,GO:0004725,protein tyrosine phosphatase activity,2.0
22909,PTPRT,GO:0005001,transmembrane receptor protein tyrosine phosphatase activity,2.0
22910,PTPRT,GO:0005515,protein binding,2.0
22911,PTPRT,GO:0005886,plasma membrane,2.0
22912,PTPRT,GO:0006470,protein dephosphorylation,2.0
22914,PTPRT,GO:0007155,cell adhesion,2.0
22915,PTPRT,GO:0007156,homophilic cell adhesion via plasma membrane adhesion molecules,2.0
22916,PTPRT,GO:0007165,signal transduction,2.0
22917,PTPRT,GO:0007169,transmembrane receptor protein tyrosine kinase signaling pathway,2.0
22918,PTPRT,GO:0008013,beta-catenin binding,2.0
22919,PTPRT,GO:0009986,cell surface,2.0
22920,PTPRT,GO:0016020,membrane,2.0
22921,PTPRT,GO:0016790,thiolester hydrolase activity,2.0
22922,PTPRT,GO:0019903,protein phosphatase binding,2.0
22923,PTPRT,GO:0030336,negative regulation of cell migration,2.0
22924,PTPRT,GO:0035335,peptidyl-tyrosine dephosphorylation,2.0
22925,PTPRT,GO:0042803,protein homodimerization activity,2.0
22926,PTPRT,GO:0045294,alpha-catenin binding,2.0
22927,PTPRT,GO:0045295,gamma-catenin binding,2.0
22928,PTPRT,GO:0045296,cadherin binding,2.0
22929,PTPRT,GO:0051393,alpha-actinin binding,2.0
22930,PTPRT,GO:0070097,delta-catenin binding,2.0
22931,PTPRT,GO:0071354,cellular response to interleukin-6,2.0
22932,PTPRT,GO:0097677,STAT family protein binding,2.0
22933,PTPRT,GO:1904893,negative regulation of receptor signaling pathway via STAT,2.0
22935,PTPRT,GO:1990264,peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity,2.0
22936,PXDN,GO:0001525,angiogenesis,2.0
22937,PXDN,GO:0001654,eye development,2.0
22938,PXDN,GO:0001960,negative regulation of cytokine-mediated signaling pathway,2.0
22939,PXDN,GO:0004601,peroxidase activity,2.0
22941,PXDN,GO:0005152,interleukin-1 receptor antagonist activity,2.0
22942,PXDN,GO:0005201,extracellular matrix structural constituent,2.0
22944,PXDN,GO:0005576,extracellular region,2.0
22945,PXDN,GO:0005604,basement membrane,2.0
22946,PXDN,GO:0005615,extracellular space,2.0
22948,PXDN,GO:0005783,endoplasmic reticulum,2.0
22949,PXDN,GO:0006955,immune response,2.0
22950,PXDN,GO:0006979,response to oxidative stress,2.0
22951,PXDN,GO:0007155,cell adhesion,2.0
22952,PXDN,GO:0009986,cell surface,2.0
22953,PXDN,GO:0016684,"oxidoreductase activity, acting on peroxide as acceptor",2.0
22955,PXDN,GO:0020037,heme binding,2.0
22956,PXDN,GO:0030198,extracellular matrix organization,2.0
22957,PXDN,GO:0030199,collagen fibril organization,2.0
22958,PXDN,GO:0031012,extracellular matrix,2.0
22959,PXDN,GO:0042744,hydrogen peroxide catabolic process,2.0
22960,PXDN,GO:0043237,laminin-1 binding,2.0
22961,PXDN,GO:0046872,metal ion binding,2.0
22962,PXDN,GO:0051260,protein homooligomerization,2.0
22963,PXDN,GO:0062023,collagen-containing extracellular matrix,2.0
22965,PXDN,GO:0070062,extracellular exosome,2.0
22966,PXDN,GO:0070207,protein homotrimerization,2.0
22968,PXDN,GO:0070831,basement membrane assembly,2.0
22971,PXDN,GO:0071711,basement membrane organization,2.0
22972,PXDN,GO:0098869,cellular oxidant detoxification,2.0
22973,PXDN,GO:0140825,lactoperoxidase activity,2.0
22974,PYHIN1,GO:0002218,activation of innate immune response,2.0
22975,PYHIN1,GO:0003690,double-stranded DNA binding,2.0
22976,PYHIN1,GO:0005654,nucleoplasm,2.0
22977,PYHIN1,GO:0005730,nucleolus,2.0
22979,PYHIN1,GO:0007049,cell cycle,2.0
22980,PYHIN1,GO:0016607,nuclear speck,2.0
22981,PYHIN1,GO:0031625,ubiquitin protein ligase binding,2.0
22982,PYHIN1,GO:0031648,protein destabilization,2.0
22983,PYHIN1,GO:0032731,positive regulation of interleukin-1 beta production,2.0
22984,PYHIN1,GO:0032991,protein-containing complex,2.0
22985,PYHIN1,GO:0035457,cellular response to interferon-alpha,2.0
22986,PYHIN1,GO:0035458,cellular response to interferon-beta,2.0
22987,PYHIN1,GO:0043388,positive regulation of DNA binding,2.0
22988,PYHIN1,GO:0045893,positive regulation of DNA-templated transcription,2.0
22989,PYHIN1,GO:0050821,protein stabilization,2.0
22990,PYHIN1,GO:1900182,positive regulation of protein localization to nucleus,2.0
22991,PYHIN1,GO:1902164,"positive regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator",2.0
22992,PYHIN1,GO:2000060,positive regulation of ubiquitin-dependent protein catabolic process,2.0
22994,QRICH1,GO:0003677,DNA binding,2.0
22995,QRICH1,GO:0005515,protein binding,2.0
22996,QRICH1,GO:0005634,nucleus,2.0
22997,QRICH1,GO:0005654,nucleoplasm,2.0
22998,QRICH1,GO:0005737,cytoplasm,2.0
22999,QRICH1,GO:0005886,plasma membrane,2.0
23000,QRICH1,GO:0030968,endoplasmic reticulum unfolded protein response,2.0
23001,QRICH1,GO:0034976,response to endoplasmic reticulum stress,2.0
23002,QRICH1,GO:0036499,PERK-mediated unfolded protein response,2.0
23003,QRICH1,GO:0043065,positive regulation of apoptotic process,2.0
23004,QRICH1,GO:0045893,positive regulation of DNA-templated transcription,2.0
23005,QRICH1,GO:0070059,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress,2.0
23006,QRICH1,GO:0140467,integrated stress response signaling,2.0
23007,RAB11FIP5,GO:0000139,Golgi membrane,2.0
23008,RAB11FIP5,GO:0005515,protein binding,2.0
23009,RAB11FIP5,GO:0005739,mitochondrion,2.0
23010,RAB11FIP5,GO:0005741,mitochondrial outer membrane,2.0
23011,RAB11FIP5,GO:0005769,early endosome,2.0
23013,RAB11FIP5,GO:0005794,Golgi apparatus,2.0
23014,RAB11FIP5,GO:0030141,secretory granule,2.0
23016,RAB11FIP5,GO:0030658,transport vesicle membrane,2.0
23017,RAB11FIP5,GO:0031267,small GTPase binding,2.0
23018,RAB11FIP5,GO:0031901,early endosome membrane,2.0
23019,RAB11FIP5,GO:0034451,centriolar satellite,2.0
23020,RAB11FIP5,GO:0035773,insulin secretion involved in cellular response to glucose stimulus,2.0
23021,RAB11FIP5,GO:0043015,gamma-tubulin binding,2.0
23022,RAB11FIP5,GO:0043231,intracellular membrane-bounded organelle,2.0
23024,RAB11FIP5,GO:0045055,regulated exocytosis,2.0
23026,RAB11FIP5,GO:0045335,phagocytic vesicle,2.0
23027,RAB11FIP5,GO:0055037,recycling endosome,2.0
23029,RAB11FIP5,GO:0055038,recycling endosome membrane,2.0
23030,RAB11FIP5,GO:0070164,negative regulation of adiponectin secretion,2.0
23031,RAB11FIP5,GO:0071468,cellular response to acidic pH,2.0
23032,RAB11FIP5,GO:2000008,regulation of protein localization to cell surface,2.0
23033,RAB2A,GO:0000139,Golgi membrane,2.0
23035,RAB2A,GO:0001669,acrosomal vesicle,2.0
23036,RAB2A,GO:0003924,GTPase activity,2.0
23038,RAB2A,GO:0005515,protein binding,2.0
23039,RAB2A,GO:0005525,GTP binding,2.0
23041,RAB2A,GO:0005634,nucleus,2.0
23042,RAB2A,GO:0005765,lysosomal membrane,2.0
23043,RAB2A,GO:0005789,endoplasmic reticulum membrane,2.0
23044,RAB2A,GO:0005794,Golgi apparatus,2.0
23045,RAB2A,GO:0005829,cytosol,2.0
23046,RAB2A,GO:0006888,endoplasmic reticulum to Golgi vesicle-mediated transport,2.0
23047,RAB2A,GO:0007030,Golgi organization,2.0
23048,RAB2A,GO:0015031,protein transport,2.0
23049,RAB2A,GO:0016192,vesicle-mediated transport,2.0
23050,RAB2A,GO:0019003,GDP binding,2.0
23051,RAB2A,GO:0033116,endoplasmic reticulum-Golgi intermediate compartment membrane,2.0
23052,RAB2A,GO:0042470,melanosome,2.0
23053,RAB2A,GO:0070062,extracellular exosome,2.0
23054,RAB39B,GO:0000139,Golgi membrane,2.0
23055,RAB39B,GO:0003924,GTPase activity,2.0
23056,RAB39B,GO:0005515,protein binding,2.0
23057,RAB39B,GO:0005525,GTP binding,2.0
23058,RAB39B,GO:0005794,Golgi apparatus,2.0
23060,RAB39B,GO:0005886,plasma membrane,2.0
23061,RAB39B,GO:0006914,autophagy,2.0
23062,RAB39B,GO:0010506,regulation of autophagy,2.0
23063,RAB39B,GO:0015031,protein transport,2.0
23064,RAB39B,GO:0016192,vesicle-mediated transport,2.0
23066,RAB39B,GO:0030659,cytoplasmic vesicle membrane,2.0
23067,RAB39B,GO:0031489,myosin V binding,2.0
23069,RAB39B,GO:0031982,vesicle,2.0
23070,RAB39B,GO:0032482,Rab protein signal transduction,2.0
23071,RAB39B,GO:0043005,neuron projection,2.0
23072,RAB39B,GO:0050808,synapse organization,2.0
23073,RAB43,GO:0000045,autophagosome assembly,2.0
23074,RAB43,GO:0003924,GTPase activity,2.0
23076,RAB43,GO:0005515,protein binding,2.0
23077,RAB43,GO:0005525,GTP binding,2.0
23078,RAB43,GO:0005794,Golgi apparatus,2.0
23079,RAB43,GO:0006886,intracellular protein transport,2.0
23080,RAB43,GO:0007030,Golgi organization,2.0
23081,RAB43,GO:0012505,endomembrane system,2.0
23082,RAB43,GO:0019068,virion assembly,2.0
23083,RAB43,GO:0030670,phagocytic vesicle membrane,2.0
23084,RAB43,GO:0032588,trans-Golgi network membrane,2.0
23085,RAB43,GO:0035526,"retrograde transport, plasma membrane to Golgi",2.0
23086,RAB43,GO:0045335,phagocytic vesicle,2.0
23087,RAB43,GO:0070062,extracellular exosome,2.0
23088,RAB43,GO:0071346,cellular response to type II interferon,2.0
23089,RAB43,GO:0090382,phagosome maturation,2.0
23090,RAB43,GO:1901998,toxin transport,2.0
23229,RAD21L1,GO:0003682,chromatin binding,2.0
23230,RAD21L1,GO:0005634,nucleus,2.0
23231,RAD21L1,GO:0005694,chromosome,2.0
23232,RAD21L1,GO:0007062,sister chromatid cohesion,2.0
23233,RAD21L1,GO:0008278,cohesin complex,2.0
23234,RAD21L1,GO:0030893,meiotic cohesin complex,2.0
23235,RAD21L1,GO:0051321,meiotic cell cycle,2.0
23236,RAD21L1,GO:1990414,replication-born double-strand break repair via sister chromatid exchange,2.0
23299,RANBP17,GO:0005049,nuclear export signal receptor activity,2.0
23300,RANBP17,GO:0005525,GTP binding,2.0
23301,RANBP17,GO:0005643,nuclear pore,2.0
23303,RANBP17,GO:0005737,cytoplasm,2.0
23304,RANBP17,GO:0006606,protein import into nucleus,2.0
23305,RANBP17,GO:0006611,protein export from nucleus,2.0
23306,RANBP17,GO:0031267,small GTPase binding,2.0
23307,RANBP17,GO:0051028,mRNA transport,2.0
23308,RAPGEF4,GO:0002250,adaptive immune response,2.0
23309,RAPGEF4,GO:0005085,guanyl-nucleotide exchange factor activity,2.0
23312,RAPGEF4,GO:0005515,protein binding,2.0
23313,RAPGEF4,GO:0005829,cytosol,2.0
23314,RAPGEF4,GO:0005886,plasma membrane,2.0
23316,RAPGEF4,GO:0007186,G protein-coupled receptor signaling pathway,2.0
23317,RAPGEF4,GO:0007189,adenylate cyclase-activating G protein-coupled receptor signaling pathway,2.0
23318,RAPGEF4,GO:0007265,Ras protein signal transduction,2.0
23319,RAPGEF4,GO:0016020,membrane,2.0
23320,RAPGEF4,GO:0017156,calcium-ion regulated exocytosis,2.0
23321,RAPGEF4,GO:0017157,regulation of exocytosis,2.0
23322,RAPGEF4,GO:0030073,insulin secretion,2.0
23323,RAPGEF4,GO:0030552,cAMP binding,2.0
23324,RAPGEF4,GO:0031267,small GTPase binding,2.0
23325,RAPGEF4,GO:0043547,positive regulation of GTPase activity,2.0
23326,RAPGEF4,GO:0098686,hippocampal mossy fiber to CA3 synapse,2.0
23327,RAPGEF4,GO:0098693,regulation of synaptic vesicle cycle,2.0
23328,RASSF5,GO:0005515,protein binding,2.0
23329,RASSF5,GO:0005634,nucleus,2.0
23330,RASSF5,GO:0005737,cytoplasm,2.0
23331,RASSF5,GO:0005874,microtubule,2.0
23332,RASSF5,GO:0006915,apoptotic process,2.0
23333,RASSF5,GO:0007165,signal transduction,2.0
23334,RASSF5,GO:0031267,small GTPase binding,2.0
23335,RASSF5,GO:0031398,positive regulation of protein ubiquitination,2.0
23336,RASSF5,GO:0042981,regulation of apoptotic process,2.0
23337,RASSF5,GO:0046651,lymphocyte proliferation,2.0
23338,RASSF5,GO:0046872,metal ion binding,2.0
23339,RASSF5,GO:0050672,negative regulation of lymphocyte proliferation,2.0
23340,RASSF5,GO:1900180,regulation of protein localization to nucleus,2.0
23341,RBBP5,GO:0000976,transcription cis-regulatory region binding,2.0
23342,RBBP5,GO:0005515,protein binding,2.0
23343,RBBP5,GO:0005634,nucleus,2.0
23344,RBBP5,GO:0005654,nucleoplasm,2.0
23346,RBBP5,GO:0005730,nucleolus,2.0
23347,RBBP5,GO:0006974,cellular response to DNA damage stimulus,2.0
23348,RBBP5,GO:0035097,histone methyltransferase complex,2.0
23349,RBBP5,GO:0042393,histone binding,2.0
23350,RBBP5,GO:0043627,response to estrogen,2.0
23351,RBBP5,GO:0044665,MLL1/2 complex,2.0
23352,RBBP5,GO:0044666,MLL3/4 complex,2.0
23354,RBBP5,GO:0045815,transcription initiation-coupled chromatin remodeling,2.0
23355,RBBP5,GO:0048188,Set1C/COMPASS complex,2.0
23358,RBBP5,GO:0051568,histone H3-K4 methylation,2.0
23360,RBBP5,GO:0071339,MLL1 complex,2.0
23362,RBFOX1,GO:0000381,"regulation of alternative mRNA splicing, via spliceosome",2.0
23363,RBFOX1,GO:0003723,RNA binding,2.0
23364,RBFOX1,GO:0003729,mRNA binding,2.0
23365,RBFOX1,GO:0003730,mRNA 3'-UTR binding,2.0
23366,RBFOX1,GO:0005515,protein binding,2.0
23367,RBFOX1,GO:0005634,nucleus,2.0
23368,RBFOX1,GO:0005737,cytoplasm,2.0
23370,RBFOX1,GO:0005802,trans-Golgi network,2.0
23371,RBFOX1,GO:0006397,mRNA processing,2.0
23372,RBFOX1,GO:0007399,nervous system development,2.0
23373,RBFOX1,GO:0008022,protein C-terminus binding,2.0
23374,RBFOX1,GO:0008380,RNA splicing,2.0
23375,RBFOX1,GO:0010494,cytoplasmic stress granule,2.0
23376,RBFOX1,GO:0050658,RNA transport,2.0
23377,RBFOX1,GO:0050885,neuromuscular process controlling balance,2.0
23378,RBFOX1,GO:0097165,nuclear stress granule,2.0
23379,RBFOX1,GO:2001014,regulation of skeletal muscle cell differentiation,2.0
23380,RBM27,GO:0003723,RNA binding,2.0
23382,RBM27,GO:0005634,nucleus,2.0
23383,RBM27,GO:0005737,cytoplasm,2.0
23384,RBM27,GO:0006397,mRNA processing,2.0
23385,RBM27,GO:0016607,nuclear speck,2.0
23386,RBM27,GO:0046872,metal ion binding,2.0
23387,REEP3,GO:0005515,protein binding,2.0
23388,REEP3,GO:0005789,endoplasmic reticulum membrane,2.0
23389,REEP3,GO:0005881,cytoplasmic microtubule,2.0
23390,REEP3,GO:0006998,nuclear envelope organization,2.0
23391,REEP3,GO:0007084,mitotic nuclear membrane reassembly,2.0
23392,REEP3,GO:0008017,microtubule binding,2.0
23393,REEP3,GO:0016020,membrane,2.0
23394,REEP3,GO:0051301,cell division,2.0
23395,REEP3,GO:0071782,endoplasmic reticulum tubular network,2.0
23396,REEP3,GO:0071786,endoplasmic reticulum tubular network organization,2.0
23531,RGS7,GO:0001965,G-protein alpha-subunit binding,2.0
23532,RGS7,GO:0001975,response to amphetamine,2.0
23533,RGS7,GO:0003924,GTPase activity,2.0
23534,RGS7,GO:0005096,GTPase activator activity,2.0
23536,RGS7,GO:0005635,nuclear envelope,2.0
23537,RGS7,GO:0005737,cytoplasm,2.0
23538,RGS7,GO:0005829,cytosol,2.0
23539,RGS7,GO:0005886,plasma membrane,2.0
23541,RGS7,GO:0007186,G protein-coupled receptor signaling pathway,2.0
23542,RGS7,GO:0007420,brain development,2.0
23543,RGS7,GO:0008277,regulation of G protein-coupled receptor signaling pathway,2.0
23544,RGS7,GO:0009409,response to cold,2.0
23545,RGS7,GO:0009968,negative regulation of signal transduction,2.0
23546,RGS7,GO:0031681,G-protein beta-subunit binding,2.0
23547,RGS7,GO:0032991,protein-containing complex,2.0
23548,RGS7,GO:0035556,intracellular signal transduction,2.0
23549,RGS7,GO:0043005,neuron projection,2.0
23550,RGS7,GO:0043547,positive regulation of GTPase activity,2.0
23552,RGS7,GO:0045121,membrane raft,2.0
23553,RGS7,GO:0045471,response to ethanol,2.0
23554,RGS7,GO:1901381,positive regulation of potassium ion transmembrane transport,2.0
23584,RHOXF1,GO:0000785,chromatin,2.0
23585,RHOXF1,GO:0000977,RNA polymerase II transcription regulatory region sequence-specific DNA binding,2.0
23586,RHOXF1,GO:0000981,"DNA-binding transcription factor activity, RNA polymerase II-specific",2.0
23588,RHOXF1,GO:0003677,DNA binding,2.0
23589,RHOXF1,GO:0003700,DNA-binding transcription factor activity,2.0
23590,RHOXF1,GO:0005515,protein binding,2.0
23591,RHOXF1,GO:0005634,nucleus,2.0
23592,RHOXF1,GO:0005654,nucleoplasm,2.0
23593,RHOXF1,GO:0005829,cytosol,2.0
23594,RHOXF1,GO:0006355,regulation of DNA-templated transcription,2.0
23595,RHOXF1,GO:0006357,regulation of transcription by RNA polymerase II,2.0
23596,RHOXF1,GO:0010628,positive regulation of gene expression,2.0
23597,RHOXF1,GO:0030521,androgen receptor signaling pathway,2.0
23598,RHOXF1,GO:0048484,enteric nervous system development,2.0
23599,RHOXF1,GO:1990837,sequence-specific double-stranded DNA binding,2.0
23662,RIMS3,GO:0005515,protein binding,2.0
23663,RIMS3,GO:0017156,calcium-ion regulated exocytosis,2.0
23664,RIMS3,GO:0031267,small GTPase binding,2.0
23665,RIMS3,GO:0042391,regulation of membrane potential,2.0
23667,RIMS3,GO:0042734,presynaptic membrane,2.0
23668,RIMS3,GO:0044325,transmembrane transporter binding,2.0
23670,RIMS3,GO:0048167,regulation of synaptic plasticity,2.0
23671,RIMS3,GO:0048786,presynaptic active zone,2.0
23672,RIMS3,GO:0048788,cytoskeleton of presynaptic active zone,2.0
23673,RIMS3,GO:0048791,calcium ion-regulated exocytosis of neurotransmitter,2.0
23674,RIMS3,GO:0050806,positive regulation of synaptic transmission,2.0
23675,RIMS3,GO:2000300,regulation of synaptic vesicle exocytosis,2.0
23676,RIT2,GO:0000165,MAPK cascade,2.0
23677,RIT2,GO:0001932,regulation of protein phosphorylation,2.0
23678,RIT2,GO:0003682,chromatin binding,2.0
23679,RIT2,GO:0003924,GTPase activity,2.0
23682,RIT2,GO:0003925,G protein activity,2.0
23683,RIT2,GO:0005515,protein binding,2.0
23684,RIT2,GO:0005516,calmodulin binding,2.0
23687,RIT2,GO:0005525,GTP binding,2.0
23689,RIT2,GO:0005634,nucleus,2.0
23691,RIT2,GO:0005654,nucleoplasm,2.0
23692,RIT2,GO:0005737,cytoplasm,2.0
23693,RIT2,GO:0005794,Golgi apparatus,2.0
23694,RIT2,GO:0005829,cytosol,2.0
23695,RIT2,GO:0005886,plasma membrane,2.0
23699,RIT2,GO:0007189,adenylate cyclase-activating G protein-coupled receptor signaling pathway,2.0
23700,RIT2,GO:0007264,small GTPase mediated signal transduction,2.0
23701,RIT2,GO:0007265,Ras protein signal transduction,2.0
23703,RIT2,GO:0007268,chemical synaptic transmission,2.0
23704,RIT2,GO:0010976,positive regulation of neuron projection development,2.0
23707,RIT2,GO:0010977,negative regulation of neuron projection development,2.0
23708,RIT2,GO:0019003,GDP binding,2.0
23709,RIT2,GO:0030100,regulation of endocytosis,2.0
23710,RIT2,GO:0030215,semaphorin receptor binding,2.0
23711,RIT2,GO:0032489,regulation of Cdc42 protein signal transduction,2.0
23712,RIT2,GO:0032507,maintenance of protein location in cell,2.0
23713,RIT2,GO:0035556,intracellular signal transduction,2.0
23714,RIT2,GO:0042802,identical protein binding,2.0
23715,RIT2,GO:0043005,neuron projection,2.0
23716,RIT2,GO:0043410,positive regulation of MAPK cascade,2.0
23717,RIT2,GO:0044297,cell body,2.0
23718,RIT2,GO:0045121,membrane raft,2.0
23719,RIT2,GO:0045202,synapse,2.0
23720,RIT2,GO:0045944,positive regulation of transcription by RNA polymerase II,2.0
23721,RIT2,GO:0050848,regulation of calcium-mediated signaling,2.0
23722,RIT2,GO:0097447,dendritic tree,2.0
23745,RNF135,GO:0000209,protein polyubiquitination,2.0
23746,RNF135,GO:0004842,ubiquitin-protein transferase activity,2.0
23749,RNF135,GO:0005515,protein binding,2.0
23750,RNF135,GO:0005737,cytoplasm,2.0
23752,RNF135,GO:0005829,cytosol,2.0
23753,RNF135,GO:0010494,cytoplasmic stress granule,2.0
23754,RNF135,GO:0010994,free ubiquitin chain polymerization,2.0
23755,RNF135,GO:0016567,protein ubiquitination,2.0
23756,RNF135,GO:0032728,positive regulation of interferon-beta production,2.0
23757,RNF135,GO:0039529,RIG-I signaling pathway,2.0
23759,RNF135,GO:0039552,RIG-I binding,2.0
23760,RNF135,GO:0042802,identical protein binding,2.0
23761,RNF135,GO:0043021,ribonucleoprotein complex binding,2.0
23764,RNF135,GO:0045087,innate immune response,2.0
23765,RNF135,GO:0045088,regulation of innate immune response,2.0
23767,RNF135,GO:0046872,metal ion binding,2.0
23768,RNF135,GO:0051260,protein homooligomerization,2.0
23769,RNF135,GO:0061630,ubiquitin protein ligase activity,2.0
23770,RNF135,GO:0070534,protein K63-linked ubiquitination,2.0
23771,RNF135,GO:0140374,antiviral innate immune response,2.0
23772,RNF135,GO:1990904,ribonucleoprotein complex,2.0
23773,RNF25,GO:0004842,ubiquitin-protein transferase activity,2.0
23774,RNF25,GO:0005515,protein binding,2.0
23775,RNF25,GO:0005634,nucleus,2.0
23777,RNF25,GO:0005829,cytosol,2.0
23778,RNF25,GO:0016567,protein ubiquitination,2.0
23781,RNF25,GO:0046872,metal ion binding,2.0
23782,RNF25,GO:0051059,NF-kappaB binding,2.0
23783,RNF25,GO:0051092,positive regulation of NF-kappaB transcription factor activity,2.0
23785,RNF25,GO:0061630,ubiquitin protein ligase activity,2.0
23786,RNF38,GO:0005515,protein binding,2.0
23787,RNF38,GO:0005634,nucleus,2.0
23788,RNF38,GO:0005654,nucleoplasm,2.0
23789,RNF38,GO:0008584,male gonad development,2.0
23790,RNF38,GO:0016567,protein ubiquitination,2.0
23793,RNF38,GO:0036126,sperm flagellum,2.0
23794,RNF38,GO:0046872,metal ion binding,2.0
23795,RNF38,GO:0061630,ubiquitin protein ligase activity,2.0
23797,ROBO2,GO:0001656,metanephros development,2.0
23798,ROBO2,GO:0001657,ureteric bud development,2.0
23799,ROBO2,GO:0003148,outflow tract septum morphogenesis,2.0
23800,ROBO2,GO:0003180,aortic valve morphogenesis,2.0
23801,ROBO2,GO:0003184,pulmonary valve morphogenesis,2.0
23802,ROBO2,GO:0003272,endocardial cushion formation,2.0
23803,ROBO2,GO:0005515,protein binding,2.0
23804,ROBO2,GO:0005886,plasma membrane,2.0
23806,ROBO2,GO:0007156,homophilic cell adhesion via plasma membrane adhesion molecules,2.0
23807,ROBO2,GO:0007411,axon guidance,2.0
23809,ROBO2,GO:0007417,central nervous system development,2.0
23810,ROBO2,GO:0007420,brain development,2.0
23812,ROBO2,GO:0008046,axon guidance receptor activity,2.0
23814,ROBO2,GO:0009986,cell surface,2.0
23815,ROBO2,GO:0016199,axon midline choice point recognition,2.0
23816,ROBO2,GO:0021891,olfactory bulb interneuron development,2.0
23817,ROBO2,GO:0030424,axon,2.0
23818,ROBO2,GO:0030673,axolemma,2.0
23819,ROBO2,GO:0031290,retinal ganglion cell axon guidance,2.0
23820,ROBO2,GO:0032870,cellular response to hormone stimulus,2.0
23821,ROBO2,GO:0035481,positive regulation of Notch signaling pathway involved in heart induction,2.0
23822,ROBO2,GO:0035904,aorta development,2.0
23823,ROBO2,GO:0042802,identical protein binding,2.0
23824,ROBO2,GO:0050772,positive regulation of axonogenesis,2.0
23825,ROBO2,GO:0050925,negative regulation of negative chemotaxis,2.0
23826,ROBO2,GO:0051964,negative regulation of synapse assembly,2.0
23827,ROBO2,GO:0060412,ventricular septum morphogenesis,2.0
23828,ROBO2,GO:0061364,apoptotic process involved in luteolysis,2.0
23829,ROBO2,GO:0070062,extracellular exosome,2.0
23830,ROBO2,GO:0098609,cell-cell adhesion,2.0
23831,ROBO2,GO:0098632,cell-cell adhesion mediator activity,2.0
23917,RPL10,GO:0000027,ribosomal large subunit assembly,2.0
23918,RPL10,GO:0000122,negative regulation of transcription by RNA polymerase II,2.0
23919,RPL10,GO:0002181,cytoplasmic translation,2.0
23920,RPL10,GO:0003723,RNA binding,2.0
23921,RPL10,GO:0003735,structural constituent of ribosome,2.0
23925,RPL10,GO:0005515,protein binding,2.0
23926,RPL10,GO:0005634,nucleus,2.0
23927,RPL10,GO:0005783,endoplasmic reticulum,2.0
23928,RPL10,GO:0005790,smooth endoplasmic reticulum,2.0
23929,RPL10,GO:0005829,cytosol,2.0
23931,RPL10,GO:0006412,translation,2.0
23933,RPL10,GO:0006417,regulation of translation,2.0
23934,RPL10,GO:0016020,membrane,2.0
23935,RPL10,GO:0022625,cytosolic large ribosomal subunit,2.0
23938,RPL10,GO:0022626,cytosolic ribosome,2.0
23939,RPL10,GO:0032991,protein-containing complex,2.0
23940,RPL10,GO:0043066,negative regulation of apoptotic process,2.0
23941,RPL10,GO:0045182,translation regulator activity,2.0
23942,RPL10,GO:1990403,embryonic brain development,2.0
23943,RPS6KA2,GO:0000287,magnesium ion binding,2.0
23944,RPS6KA2,GO:0001556,oocyte maturation,2.0
23945,RPS6KA2,GO:0002035,brain renin-angiotensin system,2.0
23946,RPS6KA2,GO:0004674,protein serine/threonine kinase activity,2.0
23948,RPS6KA2,GO:0004711,ribosomal protein S6 kinase activity,2.0
23949,RPS6KA2,GO:0004712,protein serine/threonine/tyrosine kinase activity,2.0
23950,RPS6KA2,GO:0005515,protein binding,2.0
23951,RPS6KA2,GO:0005524,ATP binding,2.0
23952,RPS6KA2,GO:0005634,nucleus,2.0
23953,RPS6KA2,GO:0005654,nucleoplasm,2.0
23956,RPS6KA2,GO:0005737,cytoplasm,2.0
23958,RPS6KA2,GO:0005829,cytosol,2.0
23959,RPS6KA2,GO:0007165,signal transduction,2.0
23960,RPS6KA2,GO:0007268,chemical synaptic transmission,2.0
23961,RPS6KA2,GO:0007507,heart development,2.0
23962,RPS6KA2,GO:0008285,negative regulation of cell population proliferation,2.0
23963,RPS6KA2,GO:0010628,positive regulation of gene expression,2.0
23964,RPS6KA2,GO:0010659,cardiac muscle cell apoptotic process,2.0
23965,RPS6KA2,GO:0018105,peptidyl-serine phosphorylation,2.0
23966,RPS6KA2,GO:0035556,intracellular signal transduction,2.0
23967,RPS6KA2,GO:0043065,positive regulation of apoptotic process,2.0
23968,RPS6KA2,GO:0045202,synapse,2.0
23969,RPS6KA2,GO:0045786,negative regulation of cell cycle,2.0
23970,RPS6KA2,GO:0045835,negative regulation of meiotic nuclear division,2.0
23971,RPS6KA2,GO:0060047,heart contraction,2.0
23972,RPS6KA2,GO:0070613,regulation of protein processing,2.0
23973,RPS6KA2,GO:0071322,cellular response to carbohydrate stimulus,2.0
23974,RPS6KA2,GO:0072687,meiotic spindle,2.0
23975,RPS6KA2,GO:0106310,protein serine kinase activity,2.0
23976,RPS6KA3,GO:0000287,magnesium ion binding,2.0
23977,RPS6KA3,GO:0001501,skeletal system development,2.0
23978,RPS6KA3,GO:0002224,toll-like receptor signaling pathway,2.0
23979,RPS6KA3,GO:0004672,protein kinase activity,2.0
23980,RPS6KA3,GO:0004674,protein serine/threonine kinase activity,2.0
23982,RPS6KA3,GO:0004711,ribosomal protein S6 kinase activity,2.0
23983,RPS6KA3,GO:0005515,protein binding,2.0
23984,RPS6KA3,GO:0005524,ATP binding,2.0
23985,RPS6KA3,GO:0005654,nucleoplasm,2.0
23988,RPS6KA3,GO:0005730,nucleolus,2.0
23989,RPS6KA3,GO:0005737,cytoplasm,2.0
23990,RPS6KA3,GO:0005829,cytosol,2.0
23992,RPS6KA3,GO:0006915,apoptotic process,2.0
23993,RPS6KA3,GO:0007049,cell cycle,2.0
23994,RPS6KA3,GO:0007165,signal transduction,2.0
23995,RPS6KA3,GO:0007268,chemical synaptic transmission,2.0
23996,RPS6KA3,GO:0007417,central nervous system development,2.0
23997,RPS6KA3,GO:0018105,peptidyl-serine phosphorylation,2.0
23999,RPS6KA3,GO:0019901,protein kinase binding,2.0
24000,RPS6KA3,GO:0030307,positive regulation of cell growth,2.0
24001,RPS6KA3,GO:0032496,response to lipopolysaccharide,2.0
24002,RPS6KA3,GO:0035556,intracellular signal transduction,2.0
24003,RPS6KA3,GO:0043027,cysteine-type endopeptidase inhibitor activity involved in apoptotic process,2.0
24004,RPS6KA3,GO:0043066,negative regulation of apoptotic process,2.0
24005,RPS6KA3,GO:0043154,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process,2.0
24006,RPS6KA3,GO:0043555,regulation of translation in response to stress,2.0
24007,RPS6KA3,GO:0043620,regulation of DNA-templated transcription in response to stress,2.0
24008,RPS6KA3,GO:0045202,synapse,2.0
24009,RPS6KA3,GO:0045597,positive regulation of cell differentiation,2.0
24010,RPS6KA3,GO:0045944,positive regulation of transcription by RNA polymerase II,2.0
24011,RPS6KA3,GO:0106310,protein serine kinase activity,2.0
24024,SAE1,GO:0004839,ubiquitin activating enzyme activity,2.0
24025,SAE1,GO:0005515,protein binding,2.0
24026,SAE1,GO:0005634,nucleus,2.0
24027,SAE1,GO:0005654,nucleoplasm,2.0
24029,SAE1,GO:0005737,cytoplasm,2.0
24030,SAE1,GO:0008022,protein C-terminus binding,2.0
24031,SAE1,GO:0008047,enzyme activator activity,2.0
24032,SAE1,GO:0016567,protein ubiquitination,2.0
24033,SAE1,GO:0016925,protein sumoylation,2.0
24037,SAE1,GO:0019948,SUMO activating enzyme activity,2.0
24038,SAE1,GO:0031510,SUMO activating enzyme complex,2.0
24040,SAE1,GO:0032446,protein modification by small protein conjugation,2.0
24041,SAE1,GO:0033235,positive regulation of protein sumoylation,2.0
24042,SAE1,GO:0043008,ATP-dependent protein binding,2.0
24043,SAE1,GO:0044388,small protein activating enzyme binding,2.0
24044,SAE1,GO:0046982,protein heterodimerization activity,2.0
24045,SAE1,GO:0050790,regulation of catalytic activity,2.0
24046,SAE1,GO:1903955,positive regulation of protein targeting to mitochondrion,2.0
24047,SAMD11,GO:0003682,chromatin binding,2.0
24048,SAMD11,GO:0005515,protein binding,2.0
24049,SAMD11,GO:0005634,nucleus,2.0
24050,SAMD11,GO:0042393,histone binding,2.0
24051,SAMD11,GO:0045892,negative regulation of DNA-templated transcription,2.0
24052,SASH1,GO:0000209,protein polyubiquitination,2.0
24053,SASH1,GO:0001965,G-protein alpha-subunit binding,2.0
24054,SASH1,GO:0005515,protein binding,2.0
24055,SASH1,GO:0005737,cytoplasm,2.0
24056,SASH1,GO:0008022,protein C-terminus binding,2.0
24057,SASH1,GO:0010595,positive regulation of endothelial cell migration,2.0
24058,SASH1,GO:0010632,regulation of epithelial cell migration,2.0
24059,SASH1,GO:0019901,protein kinase binding,2.0
24060,SASH1,GO:0031435,mitogen-activated protein kinase kinase kinase binding,2.0
24062,SASH1,GO:0031666,positive regulation of lipopolysaccharide-mediated signaling pathway,2.0
24063,SASH1,GO:0032991,protein-containing complex,2.0
24064,SASH1,GO:0043507,positive regulation of JUN kinase activity,2.0
24066,SASH1,GO:0045766,positive regulation of angiogenesis,2.0
24067,SASH1,GO:0060090,molecular adaptor activity,2.0
24068,SASH1,GO:1900044,regulation of protein K63-linked ubiquitination,2.0
24069,SASH1,GO:1900745,positive regulation of p38MAPK cascade,2.0
24070,SASH1,GO:1901224,positive regulation of NIK/NF-kappaB signaling,2.0
24072,SASH1,GO:1902498,regulation of protein autoubiquitination,2.0
24093,SATB2,GO:0000118,histone deacetylase complex,2.0
24094,SATB2,GO:0000122,negative regulation of transcription by RNA polymerase II,2.0
24095,SATB2,GO:0000785,chromatin,2.0
24096,SATB2,GO:0000977,RNA polymerase II transcription regulatory region sequence-specific DNA binding,2.0
24097,SATB2,GO:0000978,RNA polymerase II cis-regulatory region sequence-specific DNA binding,2.0
24098,SATB2,GO:0000981,"DNA-binding transcription factor activity, RNA polymerase II-specific",2.0
24100,SATB2,GO:0001228,"DNA-binding transcription activator activity, RNA polymerase II-specific",2.0
24101,SATB2,GO:0001764,neuron migration,2.0
24102,SATB2,GO:0002076,osteoblast development,2.0
24103,SATB2,GO:0003682,chromatin binding,2.0
24104,SATB2,GO:0005515,protein binding,2.0
24105,SATB2,GO:0005654,nucleoplasm,2.0
24107,SATB2,GO:0005667,transcription regulator complex,2.0
24108,SATB2,GO:0006338,chromatin remodeling,2.0
24109,SATB2,GO:0006357,regulation of transcription by RNA polymerase II,2.0
24110,SATB2,GO:0009880,embryonic pattern specification,2.0
24111,SATB2,GO:0016363,nuclear matrix,2.0
24112,SATB2,GO:0042826,histone deacetylase binding,2.0
24113,SATB2,GO:0045944,positive regulation of transcription by RNA polymerase II,2.0
24114,SATB2,GO:0048704,embryonic skeletal system morphogenesis,2.0
24115,SATB2,GO:0051216,cartilage development,2.0
24116,SATB2,GO:0060021,roof of mouth development,2.0
24117,SATB2,GO:0071310,cellular response to organic substance,2.0
24118,SBF1,GO:0005085,guanyl-nucleotide exchange factor activity,2.0
24120,SBF1,GO:0005737,cytoplasm,2.0
24122,SBF1,GO:0005789,endoplasmic reticulum membrane,2.0
24123,SBF1,GO:0005829,cytosol,2.0
24124,SBF1,GO:0006470,protein dephosphorylation,2.0
24125,SBF1,GO:0007286,spermatid development,2.0
24126,SBF1,GO:0008138,protein tyrosine/serine/threonine phosphatase activity,2.0
24127,SBF1,GO:0016020,membrane,2.0
24129,SBF1,GO:0016604,nuclear body,2.0
24130,SBF1,GO:0016791,phosphatase activity,2.0
24131,SBF1,GO:0019208,phosphatase regulator activity,2.0
24132,SBF1,GO:0043087,regulation of GTPase activity,2.0
24133,SBF1,GO:0048471,perinuclear region of cytoplasm,2.0
24134,SCAF1,GO:0003723,RNA binding,2.0
24135,SCAF1,GO:0005515,protein binding,2.0
24136,SCAF1,GO:0005634,nucleus,2.0
24137,SCAF1,GO:0006366,transcription by RNA polymerase II,2.0
24138,SCAF1,GO:0006397,mRNA processing,2.0
24139,SCAF1,GO:0008380,RNA splicing,2.0
24140,SCAF1,GO:0019904,protein domain specific binding,2.0
24141,SCAF1,GO:0099122,RNA polymerase II C-terminal domain binding,2.0
24143,SCAF4,GO:0003723,RNA binding,2.0
24146,SCAF4,GO:0005634,nucleus,2.0
24148,SCAF4,GO:0005654,nucleoplasm,2.0
24149,SCAF4,GO:0006397,mRNA processing,2.0
24150,SCAF4,GO:0008022,protein C-terminus binding,2.0
24151,SCAF4,GO:1990269,RNA polymerase II C-terminal domain phosphoserine binding,2.0
24153,SCAF4,GO:2000805,"negative regulation of termination of RNA polymerase II transcription, poly(A)-coupled",2.0
24155,SCFD2,GO:0003674,molecular_function,2.0
24156,SCFD2,GO:0005575,cellular_component,2.0
24157,SCFD2,GO:0005886,plasma membrane,2.0
24158,SCFD2,GO:0006886,intracellular protein transport,2.0
24159,SCFD2,GO:0006904,vesicle docking involved in exocytosis,2.0
24160,SCFD2,GO:0008150,biological_process,2.0
24161,SCFD2,GO:0016192,vesicle-mediated transport,2.0
24162,SCFD2,GO:0019905,syntaxin binding,2.0
24163,SCFD2,GO:0030141,secretory granule,2.0
24222,SCN4A,GO:0001518,voltage-gated sodium channel complex,2.0
24224,SCN4A,GO:0005244,voltage-gated ion channel activity,2.0
24225,SCN4A,GO:0005248,voltage-gated sodium channel activity,2.0
24227,SCN4A,GO:0005515,protein binding,2.0
24228,SCN4A,GO:0005886,plasma membrane,2.0
24229,SCN4A,GO:0006814,sodium ion transport,2.0
24230,SCN4A,GO:0006936,muscle contraction,2.0
24231,SCN4A,GO:0019228,neuronal action potential,2.0
24232,SCN4A,GO:0030424,axon,2.0
24233,SCN4A,GO:0034765,regulation of ion transmembrane transport,2.0
24234,SCN4A,GO:0035725,sodium ion transmembrane transport,2.0
24236,SCN4A,GO:0086010,membrane depolarization during action potential,2.0
24237,SCN4A,GO:0100001,regulation of skeletal muscle contraction by action potential,2.0
24264,SCN9A,GO:0001518,voltage-gated sodium channel complex,2.0
24265,SCN9A,GO:0005244,voltage-gated ion channel activity,2.0
24266,SCN9A,GO:0005248,voltage-gated sodium channel activity,2.0
24268,SCN9A,GO:0005886,plasma membrane,2.0
24269,SCN9A,GO:0006814,sodium ion transport,2.0
24270,SCN9A,GO:0006954,inflammatory response,2.0
24271,SCN9A,GO:0007623,circadian rhythm,2.0
24272,SCN9A,GO:0009408,response to heat,2.0
24273,SCN9A,GO:0009409,response to cold,2.0
24274,SCN9A,GO:0009636,response to toxic substance,2.0
24275,SCN9A,GO:0009791,post-embryonic development,2.0
24276,SCN9A,GO:0019228,neuronal action potential,2.0
24277,SCN9A,GO:0019233,sensory perception of pain,2.0
24278,SCN9A,GO:0030424,axon,2.0
24280,SCN9A,GO:0031402,sodium ion binding,2.0
24281,SCN9A,GO:0034765,regulation of ion transmembrane transport,2.0
24282,SCN9A,GO:0035725,sodium ion transmembrane transport,2.0
24284,SCN9A,GO:0045759,negative regulation of action potential,2.0
24285,SCN9A,GO:0050965,detection of temperature stimulus involved in sensory perception of pain,2.0
24286,SCN9A,GO:0050974,detection of mechanical stimulus involved in sensory perception,2.0
24287,SCN9A,GO:0061368,behavioral response to formalin induced pain,2.0
24288,SCN9A,GO:0086010,membrane depolarization during action potential,2.0
24289,SCP2,GO:0000062,fatty-acyl-CoA binding,2.0
24290,SCP2,GO:0003988,acetyl-CoA C-acyltransferase activity,2.0
24291,SCP2,GO:0005102,signaling receptor binding,2.0
24292,SCP2,GO:0005515,protein binding,2.0
24293,SCP2,GO:0005654,nucleoplasm,2.0
24294,SCP2,GO:0005739,mitochondrion,2.0
24295,SCP2,GO:0005777,peroxisome,2.0
24296,SCP2,GO:0005782,peroxisomal matrix,2.0
24297,SCP2,GO:0005783,endoplasmic reticulum,2.0
24298,SCP2,GO:0005829,cytosol,2.0
24299,SCP2,GO:0006635,fatty acid beta-oxidation,2.0
24300,SCP2,GO:0006694,steroid biosynthetic process,2.0
24301,SCP2,GO:0006699,bile acid biosynthetic process,2.0
24302,SCP2,GO:0008206,bile acid metabolic process,2.0
24303,SCP2,GO:0015485,cholesterol binding,2.0
24304,SCP2,GO:0015914,phospholipid transport,2.0
24305,SCP2,GO:0016020,membrane,2.0
24306,SCP2,GO:0032385,positive regulation of intracellular cholesterol transport,2.0
24308,SCP2,GO:0032934,sterol binding,2.0
24309,SCP2,GO:0032991,protein-containing complex,2.0
24310,SCP2,GO:0033540,fatty acid beta-oxidation using acyl-CoA oxidase,2.0
24311,SCP2,GO:0033814,propanoyl-CoA C-acyltransferase activity,2.0
24312,SCP2,GO:0036042,long-chain fatty acyl-CoA binding,2.0
24313,SCP2,GO:0036109,alpha-linolenic acid metabolic process,2.0
24314,SCP2,GO:0043231,intracellular membrane-bounded organelle,2.0
24315,SCP2,GO:0050632,propionyl-CoA C2-trimethyltridecanoyltransferase activity,2.0
24318,SCP2,GO:0050633,acetyl-CoA C-myristoyltransferase activity,2.0
24319,SCP2,GO:0070538,oleic acid binding,2.0
24320,SCP2,GO:1901373,lipid hydroperoxide transport,2.0
24321,SDC2,GO:0005515,protein binding,2.0
24322,SDC2,GO:0005788,endoplasmic reticulum lumen,2.0
24323,SDC2,GO:0005796,Golgi lumen,2.0
24324,SDC2,GO:0005886,plasma membrane,2.0
24325,SDC2,GO:0008150,biological_process,2.0
24326,SDC2,GO:0009986,cell surface,2.0
24327,SDC2,GO:0016477,cell migration,2.0
24328,SDC2,GO:0030165,PDZ domain binding,2.0
24329,SDC2,GO:0042802,identical protein binding,2.0
24330,SDC2,GO:0043202,lysosomal lumen,2.0
24331,SDC2,GO:0048813,dendrite morphogenesis,2.0
24332,SDC2,GO:0048814,regulation of dendrite morphogenesis,2.0
24333,SDC2,GO:0062023,collagen-containing extracellular matrix,2.0
24334,SEMA5A,GO:0001755,neural crest cell migration,2.0
24335,SEMA5A,GO:0001938,positive regulation of endothelial cell proliferation,2.0
24336,SEMA5A,GO:0002043,blood vessel endothelial cell proliferation involved in sprouting angiogenesis,2.0
24337,SEMA5A,GO:0005886,plasma membrane,2.0
24338,SEMA5A,GO:0007155,cell adhesion,2.0
24339,SEMA5A,GO:0007162,negative regulation of cell adhesion,2.0
24340,SEMA5A,GO:0007267,cell-cell signaling,2.0
24341,SEMA5A,GO:0007399,nervous system development,2.0
24342,SEMA5A,GO:0007411,axon guidance,2.0
24343,SEMA5A,GO:0007413,axonal fasciculation,2.0
24344,SEMA5A,GO:0016020,membrane,2.0
24346,SEMA5A,GO:0021536,diencephalon development,2.0
24347,SEMA5A,GO:0030215,semaphorin receptor binding,2.0
24349,SEMA5A,GO:0030335,positive regulation of cell migration,2.0
24350,SEMA5A,GO:0030836,positive regulation of actin filament depolymerization,2.0
24351,SEMA5A,GO:0035373,chondroitin sulfate proteoglycan binding,2.0
24352,SEMA5A,GO:0043395,heparan sulfate proteoglycan binding,2.0
24353,SEMA5A,GO:0045499,chemorepellent activity,2.0
24354,SEMA5A,GO:0045545,syndecan binding,2.0
24355,SEMA5A,GO:0045766,positive regulation of angiogenesis,2.0
24356,SEMA5A,GO:0048675,axon extension,2.0
24357,SEMA5A,GO:0048842,positive regulation of axon extension involved in axon guidance,2.0
24358,SEMA5A,GO:0048843,negative regulation of axon extension involved in axon guidance,2.0
24360,SEMA5A,GO:0050918,positive chemotaxis,2.0
24361,SEMA5A,GO:0050919,negative chemotaxis,2.0
24362,SEMA5A,GO:0051897,positive regulation of protein kinase B signaling,2.0
24363,SEMA5A,GO:0060326,cell chemotaxis,2.0
24364,SEMA5A,GO:0070062,extracellular exosome,2.0
24365,SEMA5A,GO:0071526,semaphorin-plexin signaling pathway,2.0
24366,SEMA5A,GO:0090263,positive regulation of canonical Wnt signaling pathway,2.0
24367,SEMA5A,GO:1990256,signal clustering,2.0
24368,SEMA5A,GO:2000352,negative regulation of endothelial cell apoptotic process,2.0
24369,SEMA5A,GO:2001028,positive regulation of endothelial cell chemotaxis,2.0
24387,SET,GO:0000785,chromatin,2.0
24388,SET,GO:0003677,DNA binding,2.0
24389,SET,GO:0003682,chromatin binding,2.0
24390,SET,GO:0004864,protein phosphatase inhibitor activity,2.0
24391,SET,GO:0005515,protein binding,2.0
24392,SET,GO:0005634,nucleus,2.0
24396,SET,GO:0005654,nucleoplasm,2.0
24398,SET,GO:0005737,cytoplasm,2.0
24399,SET,GO:0005783,endoplasmic reticulum,2.0
24400,SET,GO:0005811,lipid droplet,2.0
24401,SET,GO:0005829,cytosol,2.0
24402,SET,GO:0006260,DNA replication,2.0
24403,SET,GO:0006334,nucleosome assembly,2.0
24404,SET,GO:0006337,nucleosome disassembly,2.0
24405,SET,GO:0019888,protein phosphatase regulator activity,2.0
24406,SET,GO:0032991,protein-containing complex,2.0
24407,SET,GO:0035067,negative regulation of histone acetylation,2.0
24408,SET,GO:0042393,histone binding,2.0
24410,SET,GO:0043086,negative regulation of catalytic activity,2.0
24411,SET,GO:0043524,negative regulation of neuron apoptotic process,2.0
24412,SET,GO:0045892,negative regulation of DNA-templated transcription,2.0
24413,SET,GO:0048471,perinuclear region of cytoplasm,2.0
24450,SETD1B,GO:0003723,RNA binding,2.0
24451,SETD1B,GO:0005515,protein binding,2.0
24452,SETD1B,GO:0005654,nucleoplasm,2.0
24454,SETD1B,GO:0005694,chromosome,2.0
24455,SETD1B,GO:0006325,chromatin organization,2.0
24456,SETD1B,GO:0016607,nuclear speck,2.0
24457,SETD1B,GO:0018024,histone lysine N-methyltransferase activity,2.0
24458,SETD1B,GO:0035097,histone methyltransferase complex,2.0
24459,SETD1B,GO:0042800,histone H3K4 methyltransferase activity,2.0
24460,SETD1B,GO:0044648,histone H3-K4 dimethylation,2.0
24461,SETD1B,GO:0048188,Set1C/COMPASS complex,2.0
24464,SETD1B,GO:0051568,histone H3-K4 methylation,2.0
24466,SETD1B,GO:0080182,histone H3-K4 trimethylation,2.0
24467,SETD1B,GO:0097692,histone H3-K4 monomethylation,2.0
24530,SETDB1,GO:0003677,DNA binding,2.0
24531,SETDB1,GO:0003682,chromatin binding,2.0
24532,SETDB1,GO:0005515,protein binding,2.0
24533,SETDB1,GO:0005634,nucleus,2.0
24535,SETDB1,GO:0005654,nucleoplasm,2.0
24537,SETDB1,GO:0005694,chromosome,2.0
24538,SETDB1,GO:0005737,cytoplasm,2.0
24539,SETDB1,GO:0007265,Ras protein signal transduction,2.0
24540,SETDB1,GO:0008270,zinc ion binding,2.0
24541,SETDB1,GO:0010629,negative regulation of gene expression,2.0
24542,SETDB1,GO:0018024,histone lysine N-methyltransferase activity,2.0
24543,SETDB1,GO:0043231,intracellular membrane-bounded organelle,2.0
24544,SETDB1,GO:0045869,negative regulation of single stranded viral RNA replication via double stranded DNA intermediate,2.0
24545,SETDB1,GO:0046974,histone H3K9 methyltransferase activity,2.0
24547,SETDB1,GO:0051567,histone H3-K9 methylation,2.0
24548,SETDB1,GO:0070828,heterochromatin organization,2.0
24549,SETDB1,GO:0090309,positive regulation of DNA methylation-dependent heterochromatin formation,2.0
24552,SETDB1,GO:1990841,promoter-specific chromatin binding,2.0
24553,SETDB2,GO:0000278,mitotic cell cycle,2.0
24554,SETDB2,GO:0001947,heart looping,2.0
24555,SETDB2,GO:0003677,DNA binding,2.0
24556,SETDB2,GO:0005515,protein binding,2.0
24557,SETDB2,GO:0005634,nucleus,2.0
24559,SETDB2,GO:0005654,nucleoplasm,2.0
24561,SETDB2,GO:0005694,chromosome,2.0
24562,SETDB2,GO:0005829,cytosol,2.0
24563,SETDB2,GO:0007059,chromosome segregation,2.0
24564,SETDB2,GO:0008270,zinc ion binding,2.0
24565,SETDB2,GO:0010629,negative regulation of gene expression,2.0
24566,SETDB2,GO:0018024,histone lysine N-methyltransferase activity,2.0
24567,SETDB2,GO:0045892,negative regulation of DNA-templated transcription,2.0
24568,SETDB2,GO:0046974,histone H3K9 methyltransferase activity,2.0
24570,SETDB2,GO:0051301,cell division,2.0
24571,SETDB2,GO:0051567,histone H3-K9 methylation,2.0
24572,SETDB2,GO:0070828,heterochromatin organization,2.0
24573,SETDB2,GO:0070986,left/right axis specification,2.0
24574,SETDB2,GO:0090309,positive regulation of DNA methylation-dependent heterochromatin formation,2.0
24575,SEZ6L2,GO:0005783,endoplasmic reticulum,2.0
24576,SEZ6L2,GO:0005789,endoplasmic reticulum membrane,2.0
24577,SEZ6L2,GO:0005886,plasma membrane,2.0
24578,SEZ6L2,GO:0043025,neuronal cell body,2.0
24579,SEZ6L2,GO:0060074,synapse maturation,2.0
24580,SEZ6L2,GO:0090036,regulation of protein kinase C signaling,2.0
24581,SF3B1,GO:0000245,spliceosomal complex assembly,2.0
24582,SF3B1,GO:0000375,"RNA splicing, via transesterification reactions",2.0
24583,SF3B1,GO:0000398,"mRNA splicing, via spliceosome",2.0
24587,SF3B1,GO:0003723,RNA binding,2.0
24589,SF3B1,GO:0003729,mRNA binding,2.0
24590,SF3B1,GO:0005515,protein binding,2.0
24591,SF3B1,GO:0005634,nucleus,2.0
24593,SF3B1,GO:0005654,nucleoplasm,2.0
24594,SF3B1,GO:0005681,spliceosomal complex,2.0
24596,SF3B1,GO:0005684,U2-type spliceosomal complex,2.0
24597,SF3B1,GO:0005686,U2 snRNP,2.0
24600,SF3B1,GO:0005689,U12-type spliceosomal complex,2.0
24602,SF3B1,GO:0005730,nucleolus,2.0
24603,SF3B1,GO:0006338,chromatin remodeling,2.0
24604,SF3B1,GO:0008380,RNA splicing,2.0
24605,SF3B1,GO:0016607,nuclear speck,2.0
24606,SF3B1,GO:0034693,U11/U12 snRNP,2.0
24607,SF3B1,GO:0035066,positive regulation of histone acetylation,2.0
24608,SF3B1,GO:0045943,positive regulation of transcription by RNA polymerase I,2.0
24609,SF3B1,GO:0045944,positive regulation of transcription by RNA polymerase II,2.0
24610,SF3B1,GO:0045945,positive regulation of transcription by RNA polymerase III,2.0
24611,SF3B1,GO:0071004,U2-type prespliceosome,2.0
24612,SF3B1,GO:0071005,U2-type precatalytic spliceosome,2.0
24613,SF3B1,GO:0071013,catalytic step 2 spliceosome,2.0
24615,SF3B1,GO:0110016,B-WICH complex,2.0
24616,SF3B1,GO:1903241,U2-type prespliceosome assembly,2.0
24617,SF3B1,GO:1990935,splicing factor binding,2.0
24632,SGSM3,GO:0005096,GTPase activator activity,2.0
24634,SGSM3,GO:0005515,protein binding,2.0
24635,SGSM3,GO:0005829,cytosol,2.0
24636,SGSM3,GO:0005921,gap junction,2.0
24637,SGSM3,GO:0007049,cell cycle,2.0
24638,SGSM3,GO:0031267,small GTPase binding,2.0
24640,SGSM3,GO:0032483,regulation of Rab protein signal transduction,2.0
24641,SGSM3,GO:0032486,Rap protein signal transduction,2.0
24642,SGSM3,GO:0043547,positive regulation of GTPase activity,2.0
24643,SGSM3,GO:0045732,positive regulation of protein catabolic process,2.0
24644,SGSM3,GO:0048227,plasma membrane to endosome transport,2.0
24645,SGSM3,GO:0051726,regulation of cell cycle,2.0
24646,SGSM3,GO:0090630,activation of GTPase activity,2.0
24647,SGSM3,GO:1902017,regulation of cilium assembly,2.0
24670,SH3RF3,GO:0005515,protein binding,2.0
24671,SH3RF3,GO:0006915,apoptotic process,2.0
24672,SH3RF3,GO:0016567,protein ubiquitination,2.0
24673,SH3RF3,GO:0032436,positive regulation of proteasomal ubiquitin-dependent protein catabolic process,2.0
24674,SH3RF3,GO:0046330,positive regulation of JNK cascade,2.0
24676,SH3RF3,GO:0046872,metal ion binding,2.0
24677,SH3RF3,GO:0051865,protein autoubiquitination,2.0
24678,SH3RF3,GO:0061630,ubiquitin protein ligase activity,2.0
24680,SHANK1,GO:0005515,protein binding,2.0
24681,SHANK1,GO:0005829,cytosol,2.0
24682,SHANK1,GO:0005886,plasma membrane,2.0
24684,SHANK1,GO:0007616,long-term memory,2.0
24685,SHANK1,GO:0008022,protein C-terminus binding,2.0
24686,SHANK1,GO:0008306,associative learning,2.0
24687,SHANK1,GO:0014069,postsynaptic density,2.0
24689,SHANK1,GO:0016020,membrane,2.0
24690,SHANK1,GO:0017124,SH3 domain binding,2.0
24691,SHANK1,GO:0030160,synaptic receptor adaptor activity,2.0
24693,SHANK1,GO:0030425,dendrite,2.0
24694,SHANK1,GO:0030534,adult behavior,2.0
24695,SHANK1,GO:0031877,somatostatin receptor binding,2.0
24696,SHANK1,GO:0032232,negative regulation of actin filament bundle assembly,2.0
24697,SHANK1,GO:0035176,social behavior,2.0
24698,SHANK1,GO:0035255,ionotropic glutamate receptor binding,2.0
24700,SHANK1,GO:0035418,protein localization to synapse,2.0
24701,SHANK1,GO:0042048,olfactory behavior,2.0
24702,SHANK1,GO:0042802,identical protein binding,2.0
24703,SHANK1,GO:0043005,neuron projection,2.0
24704,SHANK1,GO:0043197,dendritic spine,2.0
24706,SHANK1,GO:0044877,protein-containing complex binding,2.0
24707,SHANK1,GO:0045211,postsynaptic membrane,2.0
24710,SHANK1,GO:0046959,habituation,2.0
24711,SHANK1,GO:0050885,neuromuscular process controlling balance,2.0
24712,SHANK1,GO:0050894,determination of affect,2.0
24713,SHANK1,GO:0060013,righting reflex,2.0
24714,SHANK1,GO:0060074,synapse maturation,2.0
24715,SHANK1,GO:0060076,excitatory synapse,2.0
24716,SHANK1,GO:0060997,dendritic spine morphogenesis,2.0
24717,SHANK1,GO:0060999,positive regulation of dendritic spine development,2.0
24718,SHANK1,GO:0065003,protein-containing complex assembly,2.0
24719,SHANK1,GO:0071532,ankyrin repeat binding,2.0
24720,SHANK1,GO:0071625,vocalization behavior,2.0
24721,SHANK1,GO:0097110,scaffold protein binding,2.0
24722,SHANK1,GO:0098685,Schaffer collateral - CA1 synapse,2.0
24723,SHANK1,GO:0098919,structural constituent of postsynaptic density,2.0
24724,SHANK1,GO:0098978,glutamatergic synapse,2.0
24725,SHANK1,GO:0099562,maintenance of postsynaptic density structure,2.0
24726,SHANK1,GO:2000311,regulation of AMPA receptor activity,2.0
24727,SHANK1,GO:2000463,positive regulation of excitatory postsynaptic potential,2.0
24824,SERPINE1,GO:0001525,angiogenesis,2.0
24825,SERPINE1,GO:0002020,protease binding,2.0
24826,SERPINE1,GO:0004867,serine-type endopeptidase inhibitor activity,2.0
24829,SERPINE1,GO:0005102,signaling receptor binding,2.0
24830,SERPINE1,GO:0005515,protein binding,2.0
24831,SERPINE1,GO:0005576,extracellular region,2.0
24833,SERPINE1,GO:0005615,extracellular space,2.0
24835,SERPINE1,GO:0005886,plasma membrane,2.0
24836,SERPINE1,GO:0010469,regulation of signaling receptor activity,2.0
24837,SERPINE1,GO:0010757,negative regulation of plasminogen activation,2.0
24841,SERPINE1,GO:0010951,negative regulation of endopeptidase activity,2.0
24843,SERPINE1,GO:0014912,negative regulation of smooth muscle cell migration,2.0
24844,SERPINE1,GO:0030194,positive regulation of blood coagulation,2.0
24845,SERPINE1,GO:0030195,negative regulation of blood coagulation,2.0
24846,SERPINE1,GO:0030336,negative regulation of cell migration,2.0
24847,SERPINE1,GO:0031093,platelet alpha granule lumen,2.0
24848,SERPINE1,GO:0032757,positive regulation of interleukin-8 production,2.0
24849,SERPINE1,GO:0033629,negative regulation of cell adhesion mediated by integrin,2.0
24850,SERPINE1,GO:0035491,positive regulation of leukotriene production involved in inflammatory response,2.0
24851,SERPINE1,GO:0042730,fibrinolysis,2.0
24852,SERPINE1,GO:0045766,positive regulation of angiogenesis,2.0
24853,SERPINE1,GO:0048260,positive regulation of receptor-mediated endocytosis,2.0
24854,SERPINE1,GO:0050729,positive regulation of inflammatory response,2.0
24855,SERPINE1,GO:0050829,defense response to Gram-negative bacterium,2.0
24856,SERPINE1,GO:0051918,negative regulation of fibrinolysis,2.0
24858,SERPINE1,GO:0061044,negative regulation of vascular wound healing,2.0
24860,SERPINE1,GO:0061045,negative regulation of wound healing,2.0
24861,SERPINE1,GO:0062023,collagen-containing extracellular matrix,2.0
24865,SERPINE1,GO:0070062,extracellular exosome,2.0
24866,SERPINE1,GO:0071222,cellular response to lipopolysaccharide,2.0
24867,SERPINE1,GO:0090026,positive regulation of monocyte chemotaxis,2.0
24868,SERPINE1,GO:0090399,replicative senescence,2.0
24869,SERPINE1,GO:0097180,serine protease inhibitor complex,2.0
24870,SERPINE1,GO:0097187,dentinogenesis,2.0
24871,SERPINE1,GO:1901331,positive regulation of odontoblast differentiation,2.0
24872,SERPINE1,GO:1902042,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors,2.0
24873,SERPINE1,GO:1904090,peptidase inhibitor complex,2.0
24874,SERPINE1,GO:2000098,negative regulation of smooth muscle cell-matrix adhesion,2.0
24875,SERPINE1,GO:2000352,negative regulation of endothelial cell apoptotic process,2.0
24876,SHOX,GO:0000785,chromatin,2.0
24877,SHOX,GO:0000981,"DNA-binding transcription factor activity, RNA polymerase II-specific",2.0
24879,SHOX,GO:0001228,"DNA-binding transcription activator activity, RNA polymerase II-specific",2.0
24881,SHOX,GO:0001501,skeletal system development,2.0
24882,SHOX,GO:0005515,protein binding,2.0
24883,SHOX,GO:0005634,nucleus,2.0
24884,SHOX,GO:0005654,nucleoplasm,2.0
24885,SHOX,GO:0006357,regulation of transcription by RNA polymerase II,2.0
24886,SHOX,GO:0043231,intracellular membrane-bounded organelle,2.0
24887,SHOX,GO:0043565,sequence-specific DNA binding,2.0
24889,SHOX,GO:0045944,positive regulation of transcription by RNA polymerase II,2.0
24890,SHOX,GO:1990837,sequence-specific double-stranded DNA binding,2.0
24989,SIN3B,GO:0000118,histone deacetylase complex,2.0
24990,SIN3B,GO:0000122,negative regulation of transcription by RNA polymerase II,2.0
24992,SIN3B,GO:0000785,chromatin,2.0
24993,SIN3B,GO:0000805,X chromosome,2.0
24994,SIN3B,GO:0000806,Y chromosome,2.0
24995,SIN3B,GO:0001741,XY body,2.0
24996,SIN3B,GO:0003682,chromatin binding,2.0
24997,SIN3B,GO:0003714,transcription corepressor activity,2.0
24998,SIN3B,GO:0005515,protein binding,2.0
24999,SIN3B,GO:0005634,nucleus,2.0
25001,SIN3B,GO:0005654,nucleoplasm,2.0
25002,SIN3B,GO:0005737,cytoplasm,2.0
25003,SIN3B,GO:0016575,histone deacetylation,2.0
25004,SIN3B,GO:0016580,Sin3 complex,2.0
25006,SIN3B,GO:0030336,negative regulation of cell migration,2.0
25007,SIN3B,GO:0030849,autosome,2.0
25073,SLC12A5,GO:0005886,plasma membrane,2.0
25075,SLC12A5,GO:0006811,ion transport,2.0
25077,SLC12A5,GO:0006873,cellular ion homeostasis,2.0
25078,SLC12A5,GO:0006884,cell volume homeostasis,2.0
25079,SLC12A5,GO:0006971,hypotonic response,2.0
25080,SLC12A5,GO:0007268,chemical synaptic transmission,2.0
25081,SLC12A5,GO:0007612,learning,2.0
25082,SLC12A5,GO:0008519,ammonium transmembrane transporter activity,2.0
25083,SLC12A5,GO:0009410,response to xenobiotic stimulus,2.0
25084,SLC12A5,GO:0015108,chloride transmembrane transporter activity,2.0
25085,SLC12A5,GO:0015379,potassium:chloride symporter activity,2.0
25088,SLC12A5,GO:0016020,membrane,2.0
25089,SLC12A5,GO:0030644,cellular chloride ion homeostasis,2.0
25090,SLC12A5,GO:0032590,dendrite membrane,2.0
25091,SLC12A5,GO:0035264,multicellular organism growth,2.0
25092,SLC12A5,GO:0040040,thermosensory behavior,2.0
25093,SLC12A5,GO:0043005,neuron projection,2.0
25094,SLC12A5,GO:0043025,neuronal cell body,2.0
25096,SLC12A5,GO:0043204,perikaryon,2.0
25097,SLC12A5,GO:0045202,synapse,2.0
25098,SLC12A5,GO:0051452,intracellular pH reduction,2.0
25099,SLC12A5,GO:0055064,chloride ion homeostasis,2.0
25100,SLC12A5,GO:0055075,potassium ion homeostasis,2.0
25101,SLC12A5,GO:0060996,dendritic spine development,2.0
25102,SLC12A5,GO:0071944,cell periphery,2.0
25104,SLC12A5,GO:0072488,ammonium transmembrane transport,2.0
25105,SLC12A5,GO:1902476,chloride transmembrane transport,2.0
25106,SLC12A5,GO:1990573,potassium ion import across plasma membrane,2.0
25107,SLC1A1,GO:0001662,behavioral fear response,2.0
25108,SLC1A1,GO:0001975,response to amphetamine,2.0
25109,SLC1A1,GO:0005253,anion channel activity,2.0
25110,SLC1A1,GO:0005313,L-glutamate transmembrane transporter activity,2.0
25112,SLC1A1,GO:0005314,high-affinity L-glutamate transmembrane transporter activity,2.0
25114,SLC1A1,GO:0005515,protein binding,2.0
25115,SLC1A1,GO:0005783,endoplasmic reticulum,2.0
25116,SLC1A1,GO:0005886,plasma membrane,2.0
25121,SLC1A1,GO:0006750,glutathione biosynthetic process,2.0
25122,SLC1A1,GO:0006801,superoxide metabolic process,2.0
25123,SLC1A1,GO:0006811,ion transport,2.0
25124,SLC1A1,GO:0006836,neurotransmitter transport,2.0
25125,SLC1A1,GO:0006882,cellular zinc ion homeostasis,2.0
25126,SLC1A1,GO:0006919,activation of cysteine-type endopeptidase activity involved in apoptotic process,2.0
25127,SLC1A1,GO:0007212,dopamine receptor signaling pathway,2.0
25128,SLC1A1,GO:0007215,glutamate receptor signaling pathway,2.0
25129,SLC1A1,GO:0007268,chemical synaptic transmission,2.0
25130,SLC1A1,GO:0007420,brain development,2.0
25131,SLC1A1,GO:0007613,memory,2.0
25132,SLC1A1,GO:0007625,grooming behavior,2.0
25133,SLC1A1,GO:0007626,locomotory behavior,2.0
25134,SLC1A1,GO:0009410,response to xenobiotic stimulus,2.0
25135,SLC1A1,GO:0009986,cell surface,2.0
25136,SLC1A1,GO:0010460,positive regulation of heart rate,2.0
25137,SLC1A1,GO:0010467,gene expression,2.0
25138,SLC1A1,GO:0010842,retina layer formation,2.0
25139,SLC1A1,GO:0015108,chloride transmembrane transporter activity,2.0
25140,SLC1A1,GO:0015175,neutral L-amino acid transmembrane transporter activity,2.0
25141,SLC1A1,GO:0015183,L-aspartate transmembrane transporter activity,2.0
25142,SLC1A1,GO:0015501,glutamate:sodium symporter activity,2.0
25144,SLC1A1,GO:0015813,L-glutamate transmembrane transport,2.0
25146,SLC1A1,GO:0016020,membrane,2.0
25148,SLC1A1,GO:0016324,apical plasma membrane,2.0
25149,SLC1A1,GO:0016595,glutamate binding,2.0
25150,SLC1A1,GO:0018105,peptidyl-serine phosphorylation,2.0
25151,SLC1A1,GO:0019221,cytokine-mediated signaling pathway,2.0
25152,SLC1A1,GO:0022008,neurogenesis,2.0
25153,SLC1A1,GO:0030424,axon,2.0
25154,SLC1A1,GO:0030425,dendrite,2.0
25155,SLC1A1,GO:0030534,adult behavior,2.0
25156,SLC1A1,GO:0031901,early endosome membrane,2.0
25157,SLC1A1,GO:0031902,late endosome membrane,2.0
25158,SLC1A1,GO:0032148,activation of protein kinase B activity,2.0
25159,SLC1A1,GO:0032279,asymmetric synapse,2.0
25160,SLC1A1,GO:0033229,cysteine transmembrane transporter activity,2.0
25162,SLC1A1,GO:0035633,maintenance of blood-brain barrier,2.0
25163,SLC1A1,GO:0036293,response to decreased oxygen levels,2.0
25164,SLC1A1,GO:0036475,neuron death in response to oxidative stress,2.0
25165,SLC1A1,GO:0042417,dopamine metabolic process,2.0
25166,SLC1A1,GO:0042802,identical protein binding,2.0
25167,SLC1A1,GO:0042883,cysteine transport,2.0
25168,SLC1A1,GO:0043025,neuronal cell body,2.0
25169,SLC1A1,GO:0043083,synaptic cleft,2.0
25170,SLC1A1,GO:0043197,dendritic spine,2.0
25171,SLC1A1,GO:0043198,dendritic shaft,2.0
25172,SLC1A1,GO:0043204,perikaryon,2.0
25173,SLC1A1,GO:0043278,response to morphine,2.0
25174,SLC1A1,GO:0043524,negative regulation of neuron apoptotic process,2.0
25175,SLC1A1,GO:0043679,axon terminus,2.0
25176,SLC1A1,GO:0045121,membrane raft,2.0
25177,SLC1A1,GO:0046872,metal ion binding,2.0
25178,SLC1A1,GO:0048514,blood vessel morphogenesis,2.0
25179,SLC1A1,GO:0048678,response to axon injury,2.0
25180,SLC1A1,GO:0050808,synapse organization,2.0
25181,SLC1A1,GO:0051938,L-glutamate import,2.0
25182,SLC1A1,GO:0055038,recycling endosome membrane,2.0
25183,SLC1A1,GO:0060013,righting reflex,2.0
25184,SLC1A1,GO:0060047,heart contraction,2.0
25185,SLC1A1,GO:0060291,long-term synaptic potentiation,2.0
25186,SLC1A1,GO:0061744,motor behavior,2.0
25187,SLC1A1,GO:0070062,extracellular exosome,2.0
25188,SLC1A1,GO:0070633,transepithelial transport,2.0
25189,SLC1A1,GO:0070777,D-aspartate transport,2.0
25190,SLC1A1,GO:0070778,L-aspartate transmembrane transport,2.0
25193,SLC1A1,GO:0070779,D-aspartate import across plasma membrane,2.0
25195,SLC1A1,GO:0071242,cellular response to ammonium ion,2.0
25196,SLC1A1,GO:0071288,cellular response to mercury ion,2.0
25197,SLC1A1,GO:0071314,cellular response to cocaine,2.0
25198,SLC1A1,GO:0071407,cellular response to organic cyclic compound,2.0
25199,SLC1A1,GO:0071577,zinc ion transmembrane transport,2.0
25200,SLC1A1,GO:0071944,cell periphery,2.0
25201,SLC1A1,GO:0072347,response to anesthetic,2.0
25202,SLC1A1,GO:0090313,regulation of protein targeting to membrane,2.0
25203,SLC1A1,GO:0090461,cellular glutamate homeostasis,2.0
25204,SLC1A1,GO:0097049,motor neuron apoptotic process,2.0
25205,SLC1A1,GO:0097386,glial cell projection,2.0
25206,SLC1A1,GO:0097440,apical dendrite,2.0
25207,SLC1A1,GO:0098685,Schaffer collateral - CA1 synapse,2.0
25208,SLC1A1,GO:0098712,L-glutamate import across plasma membrane,2.0
25211,SLC1A1,GO:0098793,presynapse,2.0
25212,SLC1A1,GO:0098877,neurotransmitter receptor transport to plasma membrane,2.0
25213,SLC1A1,GO:0099170,postsynaptic modulation of chemical synaptic transmission,2.0
25214,SLC1A1,GO:0099544,perisynaptic space,2.0
25215,SLC1A1,GO:0140009,L-aspartate import across plasma membrane,2.0
25217,SLC1A1,GO:0140010,D-aspartate transmembrane transporter activity,2.0
25218,SLC1A1,GO:0150002,distal dendrite,2.0
25219,SLC1A1,GO:0150104,transport across blood-brain barrier,2.0
25221,SLC1A1,GO:1902476,chloride transmembrane transport,2.0
25222,SLC1A1,GO:1903712,cysteine transmembrane transport,2.0
25223,SLC1A1,GO:1903926,cellular response to bisphenol A,2.0
25224,SLC1A1,GO:1990635,proximal dendrite,2.0
25225,SLC1A1,GO:1990708,conditioned place preference,2.0
25282,SLC22A15,GO:0003674,molecular_function,2.0
25283,SLC22A15,GO:0005575,cellular_component,2.0
25284,SLC22A15,GO:0006811,ion transport,2.0
25285,SLC22A15,GO:0008150,biological_process,2.0
25286,SLC22A15,GO:0016020,membrane,2.0
25287,SLC22A15,GO:0022857,transmembrane transporter activity,2.0
25288,SLC22A15,GO:0055085,transmembrane transport,2.0
25289,SLC22A9,GO:0008514,organic anion transmembrane transporter activity,2.0
25290,SLC22A9,GO:0009914,hormone transport,2.0
25291,SLC22A9,GO:0015347,sodium-independent organic anion transmembrane transporter activity,2.0
25292,SLC22A9,GO:0015636,short-chain fatty acid transmembrane transporter activity,2.0
25293,SLC22A9,GO:0015711,organic anion transport,2.0
25294,SLC22A9,GO:0015912,short-chain fatty acid transport,2.0
25295,SLC22A9,GO:0015913,short-chain fatty acid import,2.0
25296,SLC22A9,GO:0016323,basolateral plasma membrane,2.0
25297,SLC22A9,GO:0043252,sodium-independent organic anion transport,2.0
25298,SLC22A9,GO:0055085,transmembrane transport,2.0
25324,SLC24A2,GO:0001917,photoreceptor inner segment,2.0
25325,SLC24A2,GO:0005262,calcium channel activity,2.0
25326,SLC24A2,GO:0005886,plasma membrane,2.0
25330,SLC24A2,GO:0006811,ion transport,2.0
25331,SLC24A2,GO:0006874,cellular calcium ion homeostasis,2.0
25333,SLC24A2,GO:0007601,visual perception,2.0
25334,SLC24A2,GO:0008273,"calcium, potassium:sodium antiporter activity",2.0
25337,SLC24A2,GO:0015293,symporter activity,2.0
25338,SLC24A2,GO:0034220,ion transmembrane transport,2.0
25339,SLC24A2,GO:0035725,sodium ion transmembrane transport,2.0
25340,SLC24A2,GO:0060291,long-term synaptic potentiation,2.0
25341,SLC24A2,GO:0060292,long-term synaptic depression,2.0
25342,SLC24A2,GO:0070509,calcium ion import,2.0
25343,SLC24A2,GO:0070588,calcium ion transmembrane transport,2.0
25345,SLC24A2,GO:0071805,potassium ion transmembrane transport,2.0
25346,SLC24A2,GO:0098703,calcium ion import across plasma membrane,2.0
25347,SLC25A12,GO:0000514,"3-sulfino-L-alanine: proton, glutamate antiporter activity",2.0
25348,SLC25A12,GO:0000515,"aspartate:glutamate, proton antiporter activity",2.0
25349,SLC25A12,GO:0005313,L-glutamate transmembrane transporter activity,2.0
25350,SLC25A12,GO:0005509,calcium ion binding,2.0
25351,SLC25A12,GO:0005515,protein binding,2.0
25352,SLC25A12,GO:0005739,mitochondrion,2.0
25354,SLC25A12,GO:0005743,mitochondrial inner membrane,2.0
25356,SLC25A12,GO:0006094,gluconeogenesis,2.0
25357,SLC25A12,GO:0006537,glutamate biosynthetic process,2.0
25358,SLC25A12,GO:0006810,transport,2.0
25359,SLC25A12,GO:0009066,aspartate family amino acid metabolic process,2.0
25360,SLC25A12,GO:0010907,positive regulation of glucose metabolic process,2.0
25361,SLC25A12,GO:0015172,acidic amino acid transmembrane transporter activity,2.0
25362,SLC25A12,GO:0015183,L-aspartate transmembrane transporter activity,2.0
25363,SLC25A12,GO:0015804,neutral amino acid transport,2.0
25364,SLC25A12,GO:0015810,aspartate transmembrane transport,2.0
25366,SLC25A12,GO:0015813,L-glutamate transmembrane transport,2.0
25368,SLC25A12,GO:0016020,membrane,2.0
25369,SLC25A12,GO:0022857,transmembrane transporter activity,2.0
25370,SLC25A12,GO:0031643,positive regulation of myelination,2.0
25371,SLC25A12,GO:0042802,identical protein binding,2.0
25372,SLC25A12,GO:0043490,malate-aspartate shuttle,2.0
25374,SLC25A12,GO:0051592,response to calcium ion,2.0
25375,SLC25A12,GO:0070778,L-aspartate transmembrane transport,2.0
25376,SLC25A12,GO:0072337,modified amino acid transport,2.0
25377,SLC25A12,GO:1904024,negative regulation of glucose catabolic process to lactate via pyruvate,2.0
25378,SLC25A12,GO:2001171,positive regulation of ATP biosynthetic process,2.0
25379,SLC25A27,GO:0005739,mitochondrion,2.0
25380,SLC25A27,GO:0005743,mitochondrial inner membrane,2.0
25381,SLC25A27,GO:0009409,response to cold,2.0
25382,SLC25A27,GO:0022857,transmembrane transporter activity,2.0
25383,SLC25A27,GO:0031966,mitochondrial membrane,2.0
25384,SLC25A27,GO:0055085,transmembrane transport,2.0
25385,SLC25A39,GO:0005739,mitochondrion,2.0
25386,SLC25A39,GO:0005743,mitochondrial inner membrane,2.0
25387,SLC25A39,GO:0006783,heme biosynthetic process,2.0
25388,SLC25A39,GO:0006810,transport,2.0
25389,SLC25A39,GO:0160007,glutathione import into mitochondrion,2.0
25390,SLC27A4,GO:0000166,nucleotide binding,2.0
25391,SLC27A4,GO:0001579,medium-chain fatty acid transport,2.0
25392,SLC27A4,GO:0001676,long-chain fatty acid metabolic process,2.0
25393,SLC27A4,GO:0004467,long-chain fatty acid-CoA ligase activity,2.0
25395,SLC27A4,GO:0005324,long-chain fatty acid transporter activity,2.0
25397,SLC27A4,GO:0005783,endoplasmic reticulum,2.0
25399,SLC27A4,GO:0005789,endoplasmic reticulum membrane,2.0
25401,SLC27A4,GO:0005886,plasma membrane,2.0
25403,SLC27A4,GO:0005902,microvillus,2.0
25404,SLC27A4,GO:0006631,fatty acid metabolic process,2.0
25405,SLC27A4,GO:0007584,response to nutrient,2.0
25406,SLC27A4,GO:0015245,fatty acid transmembrane transporter activity,2.0
25407,SLC27A4,GO:0015908,fatty acid transport,2.0
25408,SLC27A4,GO:0015909,long-chain fatty acid transport,2.0
25410,SLC27A4,GO:0016020,membrane,2.0
25411,SLC27A4,GO:0031526,brush border membrane,2.0
25412,SLC27A4,GO:0031957,very long-chain fatty acid-CoA ligase activity,2.0
25413,SLC27A4,GO:0042760,very long-chain fatty acid catabolic process,2.0
25414,SLC27A4,GO:0043065,positive regulation of apoptotic process,2.0
25415,SLC27A4,GO:0043588,skin development,2.0
25416,SLC27A4,GO:0044381,glucose import in response to insulin stimulus,2.0
25417,SLC27A4,GO:0044539,long-chain fatty acid import into cell,2.0
25420,SLC27A4,GO:0046627,negative regulation of insulin receptor signaling pathway,2.0
25421,SLC27A4,GO:0047676,arachidonate-CoA ligase activity,2.0
25422,SLC27A4,GO:0051649,establishment of localization in cell,2.0
25423,SLC27A4,GO:0062003,"negative regulation of all-trans-retinyl-ester hydrolase, 11-cis retinol forming activity",2.0
25424,SLC27A4,GO:0090433,palmitoyl-CoA ligase activity,2.0
25425,SLC27A4,GO:0090434,oleoyl-CoA ligase activity,2.0
25427,SLC27A4,GO:0090630,activation of GTPase activity,2.0
25428,SLC27A4,GO:0150104,transport across blood-brain barrier,2.0
25429,SLC27A4,GO:1901480,oleate transmembrane transporter activity,2.0
25430,SLC27A4,GO:1990379,lipid transport across blood-brain barrier,2.0
25431,SLC29A4,GO:0001692,histamine metabolic process,2.0
25432,SLC29A4,GO:0005326,neurotransmitter transmembrane transporter activity,2.0
25435,SLC29A4,GO:0005337,nucleoside transmembrane transporter activity,2.0
25436,SLC29A4,GO:0005342,organic acid transmembrane transporter activity,2.0
25437,SLC29A4,GO:0005886,plasma membrane,2.0
25440,SLC29A4,GO:0006836,neurotransmitter transport,2.0
25442,SLC29A4,GO:0008324,cation transmembrane transporter activity,2.0
25443,SLC29A4,GO:0008504,monoamine transmembrane transporter activity,2.0
25447,SLC29A4,GO:0015101,organic cation transmembrane transporter activity,2.0
25448,SLC29A4,GO:0015562,efflux transmembrane transporter activity,2.0
25449,SLC29A4,GO:0015695,organic cation transport,2.0
25450,SLC29A4,GO:0015844,monoamine transport,2.0
25451,SLC29A4,GO:0016323,basolateral plasma membrane,2.0
25452,SLC29A4,GO:0016324,apical plasma membrane,2.0
25453,SLC29A4,GO:0019534,toxin transmembrane transporter activity,2.0
25454,SLC29A4,GO:0042908,xenobiotic transport,2.0
25457,SLC29A4,GO:0042910,xenobiotic transmembrane transporter activity,2.0
25459,SLC29A4,GO:0051610,serotonin uptake,2.0
25461,SLC29A4,GO:0051615,histamine uptake,2.0
25463,SLC29A4,GO:0051620,norepinephrine uptake,2.0
25465,SLC29A4,GO:0051625,epinephrine uptake,2.0
25466,SLC29A4,GO:0090494,dopamine uptake,2.0
25468,SLC29A4,GO:0098655,cation transmembrane transport,2.0
25469,SLC29A4,GO:0098793,presynapse,2.0
25470,SLC29A4,GO:0140115,export across plasma membrane,2.0
25471,SLC29A4,GO:0150104,transport across blood-brain barrier,2.0
25472,SLC29A4,GO:1901642,nucleoside transmembrane transport,2.0
25473,SLC29A4,GO:1901998,toxin transport,2.0
25474,SLC29A4,GO:1903825,organic acid transmembrane transport,2.0
25475,SLC35B1,GO:0000139,Golgi membrane,2.0
25476,SLC35B1,GO:0005459,UDP-galactose transmembrane transporter activity,2.0
25477,SLC35B1,GO:0005460,UDP-glucose transmembrane transporter activity,2.0
25478,SLC35B1,GO:0005471,ATP:ADP antiporter activity,2.0
25479,SLC35B1,GO:0005515,protein binding,2.0
25480,SLC35B1,GO:0005789,endoplasmic reticulum membrane,2.0
25482,SLC35B1,GO:0015786,UDP-glucose transmembrane transport,2.0
25483,SLC35B1,GO:0015866,ADP transport,2.0
25484,SLC35B1,GO:0015867,ATP transport,2.0
25485,SLC35B1,GO:0022857,transmembrane transporter activity,2.0
25486,SLC35B1,GO:0043231,intracellular membrane-bounded organelle,2.0
25487,SLC35B1,GO:0072334,UDP-galactose transmembrane transport,2.0
25488,SLC38A10,GO:0003333,amino acid transmembrane transport,2.0
25489,SLC38A10,GO:0005794,Golgi apparatus,2.0
25490,SLC38A10,GO:0006814,sodium ion transport,2.0
25491,SLC38A10,GO:0015179,L-amino acid transmembrane transporter activity,2.0
25492,SLC38A10,GO:0015807,L-amino acid transport,2.0
25493,SLC38A10,GO:0016020,membrane,2.0
25494,SLC38A10,GO:0060348,bone development,2.0
25495,SLC38A10,GO:1902475,L-alpha-amino acid transmembrane transport,2.0
25504,SLC4A10,GO:0005452,solute:inorganic anion antiporter activity,2.0
25505,SLC4A10,GO:0005886,plasma membrane,2.0
25507,SLC4A10,GO:0006821,chloride transport,2.0
25508,SLC4A10,GO:0007601,visual perception,2.0
25509,SLC4A10,GO:0008510,sodium:bicarbonate symporter activity,2.0
25512,SLC4A10,GO:0009416,response to light stimulus,2.0
25513,SLC4A10,GO:0009791,post-embryonic development,2.0
25514,SLC4A10,GO:0015701,bicarbonate transport,2.0
25517,SLC4A10,GO:0016020,membrane,2.0
25518,SLC4A10,GO:0016323,basolateral plasma membrane,2.0
25520,SLC4A10,GO:0016324,apical plasma membrane,2.0
25521,SLC4A10,GO:0021860,pyramidal neuron development,2.0
25522,SLC4A10,GO:0022857,transmembrane transporter activity,2.0
25523,SLC4A10,GO:0030425,dendrite,2.0
25524,SLC4A10,GO:0035264,multicellular organism growth,2.0
25525,SLC4A10,GO:0035641,locomotory exploration behavior,2.0
25526,SLC4A10,GO:0035725,sodium ion transmembrane transport,2.0
25527,SLC4A10,GO:0036477,somatodendritic compartment,2.0
25528,SLC4A10,GO:0043025,neuronal cell body,2.0
25529,SLC4A10,GO:0043204,perikaryon,2.0
25530,SLC4A10,GO:0043679,axon terminus,2.0
25531,SLC4A10,GO:0045202,synapse,2.0
25532,SLC4A10,GO:0048172,regulation of short-term neuronal synaptic plasticity,2.0
25533,SLC4A10,GO:0048854,brain morphogenesis,2.0
25534,SLC4A10,GO:0050801,ion homeostasis,2.0
25535,SLC4A10,GO:0051453,regulation of intracellular pH,2.0
25536,SLC4A10,GO:0055085,transmembrane transport,2.0
25537,SLC4A10,GO:0097440,apical dendrite,2.0
25538,SLC4A10,GO:0097441,basal dendrite,2.0
25539,SLC4A10,GO:0097442,CA3 pyramidal cell dendrite,2.0
25540,SLC4A10,GO:0098656,anion transmembrane transport,2.0
25541,SLC4A10,GO:0098794,postsynapse,2.0
25542,SLC4A10,GO:0140892,"sodium,bicarbonate:chloride antiporter activity",2.0
25543,SLC4A10,GO:1902600,proton transmembrane transport,2.0
25587,SLC6A3,GO:0002020,protease binding,2.0
25588,SLC6A3,GO:0005102,signaling receptor binding,2.0
25589,SLC6A3,GO:0005326,neurotransmitter transmembrane transporter activity,2.0
25590,SLC6A3,GO:0005330,dopamine:sodium symporter activity,2.0
25593,SLC6A3,GO:0005334,norepinephrine:sodium symporter activity,2.0
25594,SLC6A3,GO:0005515,protein binding,2.0
25595,SLC6A3,GO:0005737,cytoplasm,2.0
25596,SLC6A3,GO:0005886,plasma membrane,2.0
25599,SLC6A3,GO:0006836,neurotransmitter transport,2.0
25600,SLC6A3,GO:0007568,aging,2.0
25601,SLC6A3,GO:0007595,lactation,2.0
25602,SLC6A3,GO:0007608,sensory perception of smell,2.0
25603,SLC6A3,GO:0007626,locomotory behavior,2.0
25604,SLC6A3,GO:0008504,monoamine transmembrane transporter activity,2.0
25607,SLC6A3,GO:0009410,response to xenobiotic stimulus,2.0
25608,SLC6A3,GO:0009986,cell surface,2.0
25609,SLC6A3,GO:0010039,response to iron ion,2.0
25610,SLC6A3,GO:0015844,monoamine transport,2.0
25611,SLC6A3,GO:0015872,dopamine transport,2.0
25612,SLC6A3,GO:0015874,norepinephrine transport,2.0
25613,SLC6A3,GO:0016020,membrane,2.0
25614,SLC6A3,GO:0016600,flotillin complex,2.0
25615,SLC6A3,GO:0021984,adenohypophysis development,2.0
25616,SLC6A3,GO:0030424,axon,2.0
25617,SLC6A3,GO:0032809,neuronal cell body membrane,2.0
25618,SLC6A3,GO:0035094,response to nicotine,2.0
25619,SLC6A3,GO:0035240,dopamine binding,2.0
25620,SLC6A3,GO:0035725,sodium ion transmembrane transport,2.0
25621,SLC6A3,GO:0040018,positive regulation of multicellular organism growth,2.0
25622,SLC6A3,GO:0042053,regulation of dopamine metabolic process,2.0
25623,SLC6A3,GO:0042220,response to cocaine,2.0
25624,SLC6A3,GO:0042416,dopamine biosynthetic process,2.0
25625,SLC6A3,GO:0042420,dopamine catabolic process,2.0
25626,SLC6A3,GO:0042734,presynaptic membrane,2.0
25627,SLC6A3,GO:0043005,neuron projection,2.0
25629,SLC6A3,GO:0043025,neuronal cell body,2.0
25630,SLC6A3,GO:0043176,amine binding,2.0
25631,SLC6A3,GO:0043679,axon terminus,2.0
25632,SLC6A3,GO:0044877,protein-containing complex binding,2.0
25633,SLC6A3,GO:0045121,membrane raft,2.0
25634,SLC6A3,GO:0045211,postsynaptic membrane,2.0
25635,SLC6A3,GO:0045471,response to ethanol,2.0
25636,SLC6A3,GO:0046872,metal ion binding,2.0
25637,SLC6A3,GO:0047485,protein N-terminus binding,2.0
25638,SLC6A3,GO:0051583,dopamine uptake involved in synaptic transmission,2.0
25640,SLC6A3,GO:0051591,response to cAMP,2.0
25641,SLC6A3,GO:0051620,norepinephrine uptake,2.0
25642,SLC6A3,GO:0051721,protein phosphatase 2A binding,2.0
25643,SLC6A3,GO:0060134,prepulse inhibition,2.0
25644,SLC6A3,GO:0090494,dopamine uptake,2.0
25646,SLC6A3,GO:0098691,dopaminergic synapse,2.0
25647,SLC6A3,GO:1901363,heterocyclic compound binding,2.0
25648,SLC6A3,GO:1990384,hyaloid vascular plexus regression,2.0
25649,SLC6A4,GO:0001666,response to hypoxia,2.0
25650,SLC6A4,GO:0005326,neurotransmitter transmembrane transporter activity,2.0
25651,SLC6A4,GO:0005335,serotonin:sodium:chloride symporter activity,2.0
25654,SLC6A4,GO:0005515,protein binding,2.0
25655,SLC6A4,GO:0005886,plasma membrane,2.0
25658,SLC6A4,GO:0005925,focal adhesion,2.0
25659,SLC6A4,GO:0006836,neurotransmitter transport,2.0
25660,SLC6A4,GO:0007584,response to nutrient,2.0
25661,SLC6A4,GO:0007613,memory,2.0
25662,SLC6A4,GO:0007623,circadian rhythm,2.0
25663,SLC6A4,GO:0008504,monoamine transmembrane transporter activity,2.0
25665,SLC6A4,GO:0009410,response to xenobiotic stimulus,2.0
25666,SLC6A4,GO:0009636,response to toxic substance,2.0
25667,SLC6A4,GO:0010008,endosome membrane,2.0
25668,SLC6A4,GO:0010628,positive regulation of gene expression,2.0
25669,SLC6A4,GO:0012505,endomembrane system,2.0
25670,SLC6A4,GO:0014064,positive regulation of serotonin secretion,2.0
25671,SLC6A4,GO:0015844,monoamine transport,2.0
25672,SLC6A4,GO:0017075,syntaxin-1 binding,2.0
25673,SLC6A4,GO:0019811,cocaine binding,2.0
25674,SLC6A4,GO:0021941,negative regulation of cerebellar granule cell precursor proliferation,2.0
25675,SLC6A4,GO:0032227,"negative regulation of synaptic transmission, dopaminergic",2.0
25676,SLC6A4,GO:0032355,response to estradiol,2.0
25677,SLC6A4,GO:0035176,social behavior,2.0
25678,SLC6A4,GO:0035725,sodium ion transmembrane transport,2.0
25679,SLC6A4,GO:0042310,vasoconstriction,2.0
25680,SLC6A4,GO:0042713,sperm ejaculation,2.0
25681,SLC6A4,GO:0042734,presynaptic membrane,2.0
25682,SLC6A4,GO:0042802,identical protein binding,2.0
25683,SLC6A4,GO:0043005,neuron projection,2.0
25684,SLC6A4,GO:0045121,membrane raft,2.0
25685,SLC6A4,GO:0045202,synapse,2.0
25686,SLC6A4,GO:0045211,postsynaptic membrane,2.0
25687,SLC6A4,GO:0045665,negative regulation of neuron differentiation,2.0
25688,SLC6A4,GO:0045787,positive regulation of cell cycle,2.0
25689,SLC6A4,GO:0046621,negative regulation of organ growth,2.0
25690,SLC6A4,GO:0046872,metal ion binding,2.0
25691,SLC6A4,GO:0048854,brain morphogenesis,2.0
25692,SLC6A4,GO:0050998,nitric-oxide synthase binding,2.0
25693,SLC6A4,GO:0051015,actin filament binding,2.0
25694,SLC6A4,GO:0051378,serotonin binding,2.0
25695,SLC6A4,GO:0051610,serotonin uptake,2.0
25700,SLC6A4,GO:0071300,cellular response to retinoic acid,2.0
25701,SLC6A4,GO:0071321,cellular response to cGMP,2.0
25702,SLC6A4,GO:0090067,regulation of thalamus size,2.0
25703,SLC6A4,GO:0099154,serotonergic synapse,2.0
25704,SLC6A8,GO:0003674,molecular_function,2.0
25705,SLC6A8,GO:0005308,creatine transmembrane transporter activity,2.0
25706,SLC6A8,GO:0005309,creatine:sodium symporter activity,2.0
25709,SLC6A8,GO:0005886,plasma membrane,2.0
25712,SLC6A8,GO:0006600,creatine metabolic process,2.0
25713,SLC6A8,GO:0006836,neurotransmitter transport,2.0
25714,SLC6A8,GO:0006936,muscle contraction,2.0
25715,SLC6A8,GO:0015881,creatine transmembrane transport,2.0
25717,SLC6A8,GO:0016020,membrane,2.0
25718,SLC6A8,GO:0016324,apical plasma membrane,2.0
25719,SLC6A8,GO:0035725,sodium ion transmembrane transport,2.0
25720,SLC6A8,GO:0071705,nitrogen compound transport,2.0
25721,SLC7A3,GO:0000064,L-ornithine transmembrane transporter activity,2.0
25723,SLC7A3,GO:0005515,protein binding,2.0
25724,SLC7A3,GO:0005886,plasma membrane,2.0
25727,SLC7A3,GO:0006865,amino acid transport,2.0
25729,SLC7A3,GO:0015171,amino acid transmembrane transporter activity,2.0
25731,SLC7A3,GO:0015189,L-lysine transmembrane transporter activity,2.0
25733,SLC7A3,GO:0061459,L-arginine transmembrane transporter activity,2.0
25734,SLC7A3,GO:0097638,L-arginine import across plasma membrane,2.0
25736,SLC7A3,GO:0097639,L-lysine import across plasma membrane,2.0
25737,SLC7A3,GO:0097640,L-ornithine import across plasma membrane,2.0
25738,SLC7A3,GO:0150104,transport across blood-brain barrier,2.0
25739,SLC7A3,GO:1903352,L-ornithine transmembrane transport,2.0
25740,SLC7A3,GO:1903826,L-arginine transmembrane transport,2.0
25741,SLC7A5,GO:0002720,positive regulation of cytokine production involved in immune response,2.0
25742,SLC7A5,GO:0003333,amino acid transmembrane transport,2.0
25743,SLC7A5,GO:0005515,protein binding,2.0
25744,SLC7A5,GO:0005765,lysosomal membrane,2.0
25745,SLC7A5,GO:0005829,cytosol,2.0
25746,SLC7A5,GO:0005886,plasma membrane,2.0
25748,SLC7A5,GO:0009925,basal plasma membrane,2.0
25749,SLC7A5,GO:0010507,negative regulation of autophagy,2.0
25750,SLC7A5,GO:0010629,negative regulation of gene expression,2.0
25751,SLC7A5,GO:0014850,response to muscle activity,2.0
25752,SLC7A5,GO:0015171,amino acid transmembrane transporter activity,2.0
25755,SLC7A5,GO:0015173,aromatic amino acid transmembrane transporter activity,2.0
25756,SLC7A5,GO:0015175,neutral L-amino acid transmembrane transporter activity,2.0
25758,SLC7A5,GO:0015179,L-amino acid transmembrane transporter activity,2.0
25759,SLC7A5,GO:0015190,L-leucine transmembrane transporter activity,2.0
25761,SLC7A5,GO:0015196,L-tryptophan transmembrane transporter activity,2.0
25762,SLC7A5,GO:0015297,antiporter activity,2.0
25763,SLC7A5,GO:0015349,thyroid hormone transmembrane transporter activity,2.0
25764,SLC7A5,GO:0015804,neutral amino acid transport,2.0
25766,SLC7A5,GO:0015818,isoleucine transport,2.0
25767,SLC7A5,GO:0015820,leucine transport,2.0
25768,SLC7A5,GO:0015821,methionine transport,2.0
25769,SLC7A5,GO:0015823,phenylalanine transport,2.0
25771,SLC7A5,GO:0015824,proline transport,2.0
25772,SLC7A5,GO:0015827,tryptophan transport,2.0
25773,SLC7A5,GO:0015828,tyrosine transport,2.0
25774,SLC7A5,GO:0015829,valine transport,2.0
25775,SLC7A5,GO:0016020,membrane,2.0
25777,SLC7A5,GO:0016323,basolateral plasma membrane,2.0
25778,SLC7A5,GO:0016324,apical plasma membrane,2.0
25780,SLC7A5,GO:0031528,microvillus membrane,2.0
25781,SLC7A5,GO:0032328,alanine transport,2.0
25782,SLC7A5,GO:0032729,positive regulation of type II interferon production,2.0
25783,SLC7A5,GO:0032740,positive regulation of interleukin-17 production,2.0
25784,SLC7A5,GO:0032753,positive regulation of interleukin-4 production,2.0
25785,SLC7A5,GO:0042149,cellular response to glucose starvation,2.0
25786,SLC7A5,GO:0042476,odontogenesis,2.0
25787,SLC7A5,GO:0042605,peptide antigen binding,2.0
25788,SLC7A5,GO:0042908,xenobiotic transport,2.0
25789,SLC7A5,GO:0043231,intracellular membrane-bounded organelle,2.0
25790,SLC7A5,GO:0055093,response to hyperoxia,2.0
25791,SLC7A5,GO:0060252,positive regulation of glial cell proliferation,2.0
25792,SLC7A5,GO:0070062,extracellular exosome,2.0
25793,SLC7A5,GO:0070327,thyroid hormone transport,2.0
25794,SLC7A5,GO:0071222,cellular response to lipopolysaccharide,2.0
25795,SLC7A5,GO:0089718,amino acid import across plasma membrane,2.0
25798,SLC7A5,GO:0097421,liver regeneration,2.0
25799,SLC7A5,GO:0098591,external side of apical plasma membrane,2.0
25800,SLC7A5,GO:0098713,leucine import across plasma membrane,2.0
25802,SLC7A5,GO:0150104,transport across blood-brain barrier,2.0
25803,SLC7A5,GO:1902024,L-histidine transport,2.0
25804,SLC7A5,GO:1903577,cellular response to L-arginine,2.0
25805,SLC7A5,GO:1903801,L-leucine import across plasma membrane,2.0
25807,SLC7A5,GO:1904556,L-tryptophan transmembrane transport,2.0
25808,SLC7A5,GO:1905460,negative regulation of vascular associated smooth muscle cell apoptotic process,2.0
25809,SLC7A5,GO:1905534,positive regulation of leucine import across plasma membrane,2.0
25810,SLC7A5,GO:1990184,amino acid transport complex,2.0
25811,SLC7A7,GO:0000821,regulation of arginine metabolic process,2.0
25812,SLC7A7,GO:0003333,amino acid transmembrane transport,2.0
25813,SLC7A7,GO:0005886,plasma membrane,2.0
25814,SLC7A7,GO:0015174,basic amino acid transmembrane transporter activity,2.0
25815,SLC7A7,GO:0015179,L-amino acid transmembrane transporter activity,2.0
25816,SLC7A7,GO:0015807,L-amino acid transport,2.0
25817,SLC7A7,GO:0016323,basolateral plasma membrane,2.0
25818,SLC7A7,GO:1902475,L-alpha-amino acid transmembrane transport,2.0
25819,SLC7A7,GO:1990822,basic amino acid transmembrane transport,2.0
25841,SLC9A9,GO:0005515,protein binding,2.0
25842,SLC9A9,GO:0005886,plasma membrane,2.0
25843,SLC9A9,GO:0006811,ion transport,2.0
25844,SLC9A9,GO:0015385,sodium:proton antiporter activity,2.0
25846,SLC9A9,GO:0015386,potassium:proton antiporter activity,2.0
25847,SLC9A9,GO:0031902,late endosome membrane,2.0
25848,SLC9A9,GO:0051453,regulation of intracellular pH,2.0
25849,SLC9A9,GO:0055037,recycling endosome,2.0
25851,SLC9A9,GO:0071805,potassium ion transmembrane transport,2.0
25852,SLC9A9,GO:0098719,sodium ion import across plasma membrane,2.0
25853,SLC9A9,GO:1902600,proton transmembrane transport,2.0
25854,SLCO1B3,GO:0005886,plasma membrane,2.0
25857,SLCO1B3,GO:0006805,xenobiotic metabolic process,2.0
25858,SLCO1B3,GO:0008514,organic anion transmembrane transporter activity,2.0
25859,SLCO1B3,GO:0015125,bile acid transmembrane transporter activity,2.0
25861,SLCO1B3,GO:0015347,sodium-independent organic anion transmembrane transporter activity,2.0
25863,SLCO1B3,GO:0015711,organic anion transport,2.0
25864,SLCO1B3,GO:0015721,bile acid and bile salt transport,2.0
25866,SLCO1B3,GO:0016323,basolateral plasma membrane,2.0
25867,SLCO1B3,GO:0042167,heme catabolic process,2.0
25868,SLCO1B3,GO:0043252,sodium-independent organic anion transport,2.0
25870,SLCO1B3,GO:0055085,transmembrane transport,2.0
25886,SLITRK5,GO:0005515,protein binding,2.0
25887,SLITRK5,GO:0005886,plasma membrane,2.0
25888,SLITRK5,GO:0007268,chemical synaptic transmission,2.0
25889,SLITRK5,GO:0007409,axonogenesis,2.0
25890,SLITRK5,GO:0007625,grooming behavior,2.0
25891,SLITRK5,GO:0009410,response to xenobiotic stimulus,2.0
25892,SLITRK5,GO:0021756,striatum development,2.0
25893,SLITRK5,GO:0030534,adult behavior,2.0
25894,SLITRK5,GO:0043235,receptor complex,2.0
25895,SLITRK5,GO:0043588,skin development,2.0
25896,SLITRK5,GO:0045202,synapse,2.0
25897,SLITRK5,GO:0048813,dendrite morphogenesis,2.0
25898,SLITRK5,GO:0051965,positive regulation of synapse assembly,2.0
25899,SLITRK5,GO:0072359,circulatory system development,2.0
25900,SLITRK5,GO:1905606,regulation of presynapse assembly,2.0
25901,SMAD4,GO:0000122,negative regulation of transcription by RNA polymerase II,2.0
25902,SMAD4,GO:0000785,chromatin,2.0
25904,SMAD4,GO:0000976,transcription cis-regulatory region binding,2.0
25905,SMAD4,GO:0000978,RNA polymerase II cis-regulatory region sequence-specific DNA binding,2.0
25907,SMAD4,GO:0000981,"DNA-binding transcription factor activity, RNA polymerase II-specific",2.0
25909,SMAD4,GO:0001223,transcription coactivator binding,2.0
25910,SMAD4,GO:0001228,"DNA-binding transcription activator activity, RNA polymerase II-specific",2.0
25911,SMAD4,GO:0001541,ovarian follicle development,2.0
25912,SMAD4,GO:0001649,osteoblast differentiation,2.0
25913,SMAD4,GO:0001658,branching involved in ureteric bud morphogenesis,2.0
25914,SMAD4,GO:0001666,response to hypoxia,2.0
25915,SMAD4,GO:0001701,in utero embryonic development,2.0
25916,SMAD4,GO:0001702,gastrulation with mouth forming second,2.0
25917,SMAD4,GO:0001837,epithelial to mesenchymal transition,2.0
25918,SMAD4,GO:0003148,outflow tract septum morphogenesis,2.0
25919,SMAD4,GO:0003161,cardiac conduction system development,2.0
25920,SMAD4,GO:0003190,atrioventricular valve formation,2.0
25921,SMAD4,GO:0003198,epithelial to mesenchymal transition involved in endocardial cushion formation,2.0
25922,SMAD4,GO:0003220,left ventricular cardiac muscle tissue morphogenesis,2.0
25923,SMAD4,GO:0003251,positive regulation of cell proliferation involved in heart valve morphogenesis,2.0
25924,SMAD4,GO:0003360,brainstem development,2.0
25925,SMAD4,GO:0003677,DNA binding,2.0
25926,SMAD4,GO:0003682,chromatin binding,2.0
25927,SMAD4,GO:0003700,DNA-binding transcription factor activity,2.0
25928,SMAD4,GO:0005515,protein binding,2.0
25929,SMAD4,GO:0005518,collagen binding,2.0
25930,SMAD4,GO:0005634,nucleus,2.0
25931,SMAD4,GO:0005654,nucleoplasm,2.0
25933,SMAD4,GO:0005667,transcription regulator complex,2.0
25935,SMAD4,GO:0005737,cytoplasm,2.0
25936,SMAD4,GO:0005813,centrosome,2.0
25937,SMAD4,GO:0005829,cytosol,2.0
25939,SMAD4,GO:0006351,DNA-templated transcription,2.0
25941,SMAD4,GO:0006357,regulation of transcription by RNA polymerase II,2.0
25942,SMAD4,GO:0006366,transcription by RNA polymerase II,2.0
25943,SMAD4,GO:0006879,cellular iron ion homeostasis,2.0
25944,SMAD4,GO:0007179,transforming growth factor beta receptor signaling pathway,2.0
25948,SMAD4,GO:0007183,SMAD protein complex assembly,2.0
25949,SMAD4,GO:0007283,spermatogenesis,2.0
25950,SMAD4,GO:0007338,single fertilization,2.0
25951,SMAD4,GO:0007411,axon guidance,2.0
25952,SMAD4,GO:0007568,aging,2.0
25953,SMAD4,GO:0008283,cell population proliferation,2.0
25954,SMAD4,GO:0008285,negative regulation of cell population proliferation,2.0
25955,SMAD4,GO:0009653,anatomical structure morphogenesis,2.0
25956,SMAD4,GO:0010614,negative regulation of cardiac muscle hypertrophy,2.0
25957,SMAD4,GO:0010631,epithelial cell migration,2.0
25958,SMAD4,GO:0010666,positive regulation of cardiac muscle cell apoptotic process,2.0
25959,SMAD4,GO:0010718,positive regulation of epithelial to mesenchymal transition,2.0
25960,SMAD4,GO:0010862,positive regulation of pathway-restricted SMAD protein phosphorylation,2.0
25961,SMAD4,GO:0014033,neural crest cell differentiation,2.0
25962,SMAD4,GO:0017015,regulation of transforming growth factor beta receptor signaling pathway,2.0
25963,SMAD4,GO:0030154,cell differentiation,2.0
25964,SMAD4,GO:0030308,negative regulation of cell growth,2.0
25965,SMAD4,GO:0030325,adrenal gland development,2.0
25966,SMAD4,GO:0030509,BMP signaling pathway,2.0
25969,SMAD4,GO:0030511,positive regulation of transforming growth factor beta receptor signaling pathway,2.0
25970,SMAD4,GO:0030513,positive regulation of BMP signaling pathway,2.0
25971,SMAD4,GO:0031005,filamin binding,2.0
25972,SMAD4,GO:0032444,activin responsive factor complex,2.0
25973,SMAD4,GO:0032525,somite rostral/caudal axis specification,2.0
25974,SMAD4,GO:0032909,regulation of transforming growth factor beta2 production,2.0
25975,SMAD4,GO:0032924,activin receptor signaling pathway,2.0
25976,SMAD4,GO:0033686,positive regulation of luteinizing hormone secretion,2.0
25977,SMAD4,GO:0035556,intracellular signal transduction,2.0
25978,SMAD4,GO:0036302,atrioventricular canal development,2.0
25979,SMAD4,GO:0042060,wound healing,2.0
25980,SMAD4,GO:0042118,endothelial cell activation,2.0
25981,SMAD4,GO:0042177,negative regulation of protein catabolic process,2.0
25982,SMAD4,GO:0042733,embryonic digit morphogenesis,2.0
25983,SMAD4,GO:0042802,identical protein binding,2.0
25984,SMAD4,GO:0042803,protein homodimerization activity,2.0
25985,SMAD4,GO:0043199,sulfate binding,2.0
25986,SMAD4,GO:0043565,sequence-specific DNA binding,2.0
25987,SMAD4,GO:0045892,negative regulation of DNA-templated transcription,2.0
25988,SMAD4,GO:0045893,positive regulation of DNA-templated transcription,2.0
25989,SMAD4,GO:0045944,positive regulation of transcription by RNA polymerase II,2.0
25991,SMAD4,GO:0046872,metal ion binding,2.0
25992,SMAD4,GO:0046881,positive regulation of follicle-stimulating hormone secretion,2.0
25993,SMAD4,GO:0048382,mesendoderm development,2.0
25994,SMAD4,GO:0048589,developmental growth,2.0
25995,SMAD4,GO:0048663,neuron fate commitment,2.0
25996,SMAD4,GO:0048733,sebaceous gland development,2.0
25997,SMAD4,GO:0048859,formation of anatomical boundary,2.0
25998,SMAD4,GO:0051098,regulation of binding,2.0
25999,SMAD4,GO:0051571,positive regulation of histone H3-K4 methylation,2.0
26000,SMAD4,GO:0051797,regulation of hair follicle development,2.0
26001,SMAD4,GO:0060065,uterus development,2.0
26002,SMAD4,GO:0060391,positive regulation of SMAD protein signal transduction,2.0
26003,SMAD4,GO:0060395,SMAD protein signal transduction,2.0
26005,SMAD4,GO:0060412,ventricular septum morphogenesis,2.0
26006,SMAD4,GO:0060548,negative regulation of cell death,2.0
26007,SMAD4,GO:0060956,endocardial cell differentiation,2.0
26008,SMAD4,GO:0061040,female gonad morphogenesis,2.0
26009,SMAD4,GO:0061629,RNA polymerase II-specific DNA-binding transcription factor binding,2.0
26010,SMAD4,GO:0062009,secondary palate development,2.0
26011,SMAD4,GO:0070102,interleukin-6-mediated signaling pathway,2.0
26012,SMAD4,GO:0070371,ERK1 and ERK2 cascade,2.0
26013,SMAD4,GO:0070373,negative regulation of ERK1 and ERK2 cascade,2.0
26014,SMAD4,GO:0070411,I-SMAD binding,2.0
26016,SMAD4,GO:0070412,R-SMAD binding,2.0
26017,SMAD4,GO:0071141,SMAD protein complex,2.0
26019,SMAD4,GO:0071144,heteromeric SMAD protein complex,2.0
26021,SMAD4,GO:0071333,cellular response to glucose stimulus,2.0
26022,SMAD4,GO:0071559,response to transforming growth factor beta,2.0
26023,SMAD4,GO:0071773,cellular response to BMP stimulus,2.0
26024,SMAD4,GO:0072133,metanephric mesenchyme morphogenesis,2.0
26025,SMAD4,GO:0072134,nephrogenic mesenchyme morphogenesis,2.0
26026,SMAD4,GO:0072520,seminiferous tubule development,2.0
26027,SMAD4,GO:1901522,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus,2.0
26028,SMAD4,GO:1902895,positive regulation of miRNA transcription,2.0
26029,SMAD4,GO:1905305,negative regulation of cardiac myofibril assembly,2.0
26030,SMAD4,GO:2000617,positive regulation of histone H3-K9 acetylation,2.0
26248,SMC3,GO:0000278,mitotic cell cycle,2.0
26249,SMC3,GO:0000775,"chromosome, centromeric region",2.0
26250,SMC3,GO:0000785,chromatin,2.0
26251,SMC3,GO:0000800,lateral element,2.0
26252,SMC3,GO:0003682,chromatin binding,2.0
26253,SMC3,GO:0003690,double-stranded DNA binding,2.0
26254,SMC3,GO:0003777,microtubule motor activity,2.0
26255,SMC3,GO:0005515,protein binding,2.0
26256,SMC3,GO:0005524,ATP binding,2.0
26257,SMC3,GO:0005634,nucleus,2.0
26258,SMC3,GO:0005654,nucleoplasm,2.0
26260,SMC3,GO:0005694,chromosome,2.0
26261,SMC3,GO:0005829,cytosol,2.0
26262,SMC3,GO:0006275,regulation of DNA replication,2.0
26263,SMC3,GO:0006281,DNA repair,2.0
26264,SMC3,GO:0007062,sister chromatid cohesion,2.0
26266,SMC3,GO:0007064,mitotic sister chromatid cohesion,2.0
26267,SMC3,GO:0008278,cohesin complex,2.0
26269,SMC3,GO:0016363,nuclear matrix,2.0
26270,SMC3,GO:0016887,ATP hydrolysis activity,2.0
26271,SMC3,GO:0019827,stem cell population maintenance,2.0
26272,SMC3,GO:0030893,meiotic cohesin complex,2.0
26273,SMC3,GO:0034087,establishment of mitotic sister chromatid cohesion,2.0
26274,SMC3,GO:0034089,establishment of meiotic sister chromatid cohesion,2.0
26275,SMC3,GO:0036033,mediator complex binding,2.0
26276,SMC3,GO:0046982,protein heterodimerization activity,2.0
26277,SMC3,GO:0048487,beta-tubulin binding,2.0
26278,SMC3,GO:0051301,cell division,2.0
26279,SMC3,GO:0051321,meiotic cell cycle,2.0
26280,SMC3,GO:0061775,cohesin loader activity,2.0
26281,SMC3,GO:0070840,dynein complex binding,2.0
26282,SMC3,GO:0090307,mitotic spindle assembly,2.0
26283,SMC3,GO:0097431,mitotic spindle pole,2.0
26284,SMG6,GO:0000184,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay",2.0
26287,SMG6,GO:0000781,"chromosome, telomeric region",2.0
26288,SMG6,GO:0003723,RNA binding,2.0
26289,SMG6,GO:0004521,endoribonuclease activity,2.0
26292,SMG6,GO:0005515,protein binding,2.0
26293,SMG6,GO:0005634,nucleus,2.0
26294,SMG6,GO:0005697,telomerase holoenzyme complex,2.0
26296,SMG6,GO:0005730,nucleolus,2.0
26297,SMG6,GO:0005737,cytoplasm,2.0
26298,SMG6,GO:0005829,cytosol,2.0
26300,SMG6,GO:0006406,mRNA export from nucleus,2.0
26301,SMG6,GO:0032204,regulation of telomere maintenance,2.0
26302,SMG6,GO:0032210,regulation of telomere maintenance via telomerase,2.0
26304,SMG6,GO:0035303,regulation of dephosphorylation,2.0
26305,SMG6,GO:0042162,telomeric DNA binding,2.0
26307,SMG6,GO:0043021,ribonucleoprotein complex binding,2.0
26308,SMG6,GO:0046872,metal ion binding,2.0
26309,SMG6,GO:0051972,regulation of telomerase activity,2.0
26310,SMG6,GO:0070034,telomerase RNA binding,2.0
26312,SMG6,GO:0070182,DNA polymerase binding,2.0
26313,SMG6,GO:0090502,"RNA phosphodiester bond hydrolysis, endonucleolytic",2.0
26314,SMG6,GO:1904354,negative regulation of telomere capping,2.0
26315,SMURF1,GO:0000209,protein polyubiquitination,2.0
26317,SMURF1,GO:0004842,ubiquitin-protein transferase activity,2.0
26318,SMURF1,GO:0005515,protein binding,2.0
26319,SMURF1,GO:0005543,phospholipid binding,2.0
26320,SMURF1,GO:0005654,nucleoplasm,2.0
26321,SMURF1,GO:0005737,cytoplasm,2.0
26323,SMURF1,GO:0005739,mitochondrion,2.0
26324,SMURF1,GO:0005829,cytosol,2.0
26325,SMURF1,GO:0005886,plasma membrane,2.0
26326,SMURF1,GO:0006511,ubiquitin-dependent protein catabolic process,2.0
26327,SMURF1,GO:0006611,protein export from nucleus,2.0
26328,SMURF1,GO:0007398,ectoderm development,2.0
26329,SMURF1,GO:0016567,protein ubiquitination,2.0
26331,SMURF1,GO:0030154,cell differentiation,2.0
26332,SMURF1,GO:0030424,axon,2.0
26333,SMURF1,GO:0030509,BMP signaling pathway,2.0
26334,SMURF1,GO:0030512,negative regulation of transforming growth factor beta receptor signaling pathway,2.0
26335,SMURF1,GO:0030514,negative regulation of BMP signaling pathway,2.0
26338,SMURF1,GO:0030579,ubiquitin-dependent SMAD protein catabolic process,2.0
26340,SMURF1,GO:0032801,receptor catabolic process,2.0
26341,SMURF1,GO:0034394,protein localization to cell surface,2.0
26342,SMURF1,GO:0043025,neuronal cell body,2.0
26343,SMURF1,GO:0043161,proteasome-mediated ubiquitin-dependent protein catabolic process,2.0
26345,SMURF1,GO:0045773,positive regulation of axon extension,2.0
26346,SMURF1,GO:0048185,activin binding,2.0
26347,SMURF1,GO:0060071,"Wnt signaling pathway, planar cell polarity pathway",2.0
26348,SMURF1,GO:0061630,ubiquitin protein ligase activity,2.0
26351,SMURF1,GO:0061736,engulfment of target by autophagosome,2.0
26352,SMURF1,GO:0061753,substrate localization to autophagosome,2.0
26353,SMURF1,GO:0070062,extracellular exosome,2.0
26354,SMURF1,GO:0070411,I-SMAD binding,2.0
26355,SMURF1,GO:0070412,R-SMAD binding,2.0
26356,SMURF1,GO:0071211,protein targeting to vacuole involved in autophagy,2.0
26357,SMURF1,GO:0072659,protein localization to plasma membrane,2.0
26358,SMURF1,GO:1903861,positive regulation of dendrite extension,2.0
26359,SMURF1,GO:2000060,positive regulation of ubiquitin-dependent protein catabolic process,2.0
26360,SNAP25,GO:0001504,neurotransmitter uptake,2.0
26361,SNAP25,GO:0001917,photoreceptor inner segment,2.0
26362,SNAP25,GO:0005249,voltage-gated potassium channel activity,2.0
26363,SNAP25,GO:0005484,SNAP receptor activity,2.0
26364,SNAP25,GO:0005515,protein binding,2.0
26365,SNAP25,GO:0005737,cytoplasm,2.0
26367,SNAP25,GO:0005802,trans-Golgi network,2.0
26368,SNAP25,GO:0005829,cytosol,2.0
26369,SNAP25,GO:0005856,cytoskeleton,2.0
26370,SNAP25,GO:0005886,plasma membrane,2.0
26372,SNAP25,GO:0006887,exocytosis,2.0
26373,SNAP25,GO:0006906,vesicle fusion,2.0
26374,SNAP25,GO:0007268,chemical synaptic transmission,2.0
26375,SNAP25,GO:0007626,locomotory behavior,2.0
26376,SNAP25,GO:0008021,synaptic vesicle,2.0
26377,SNAP25,GO:0008289,lipid binding,2.0
26378,SNAP25,GO:0008306,associative learning,2.0
26379,SNAP25,GO:0010975,regulation of neuron projection development,2.0
26380,SNAP25,GO:0016020,membrane,2.0
26381,SNAP25,GO:0016079,synaptic vesicle exocytosis,2.0
26382,SNAP25,GO:0016081,synaptic vesicle docking,2.0
26383,SNAP25,GO:0016082,synaptic vesicle priming,2.0
26384,SNAP25,GO:0017075,syntaxin-1 binding,2.0
26386,SNAP25,GO:0019905,syntaxin binding,2.0
26387,SNAP25,GO:0030426,growth cone,2.0
26388,SNAP25,GO:0031201,SNARE complex,2.0
26392,SNAP25,GO:0031234,extrinsic component of cytoplasmic side of plasma membrane,2.0
26393,SNAP25,GO:0031629,synaptic vesicle fusion to presynaptic active zone membrane,2.0
26394,SNAP25,GO:0031982,vesicle,2.0
26395,SNAP25,GO:0035579,specific granule membrane,2.0
26396,SNAP25,GO:0036477,somatodendritic compartment,2.0
26397,SNAP25,GO:0042734,presynaptic membrane,2.0
26398,SNAP25,GO:0043005,neuron projection,2.0
26399,SNAP25,GO:0048306,calcium-dependent protein binding,2.0
26400,SNAP25,GO:0048471,perinuclear region of cytoplasm,2.0
26401,SNAP25,GO:0050796,regulation of insulin secretion,2.0
26402,SNAP25,GO:0051179,localization,2.0
26403,SNAP25,GO:0060090,molecular adaptor activity,2.0
26404,SNAP25,GO:0060291,long-term synaptic potentiation,2.0
26405,SNAP25,GO:0070032,synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex,2.0
26406,SNAP25,GO:0070821,tertiary granule membrane,2.0
26407,SNAP25,GO:0071805,potassium ion transmembrane transport,2.0
26408,SNAP25,GO:0097470,ribbon synapse,2.0
26409,SNAP25,GO:0098794,postsynapse,2.0
26410,SNAP25,GO:0098967,exocytic insertion of neurotransmitter receptor to postsynaptic membrane,2.0
26411,SNAP25,GO:0098978,glutamatergic synapse,2.0
26412,SNAP25,GO:0099525,presynaptic dense core vesicle exocytosis,2.0
26413,SNAP25,GO:0099590,neurotransmitter receptor internalization,2.0
26414,SND1,GO:0001649,osteoblast differentiation,2.0
26415,SND1,GO:0003712,transcription coregulator activity,2.0
26416,SND1,GO:0003723,RNA binding,2.0
26419,SND1,GO:0004518,nuclease activity,2.0
26420,SND1,GO:0004519,endonuclease activity,2.0
26421,SND1,GO:0004521,endoribonuclease activity,2.0
26422,SND1,GO:0005515,protein binding,2.0
26423,SND1,GO:0005634,nucleus,2.0
26424,SND1,GO:0005829,cytosol,2.0
26427,SND1,GO:0006351,DNA-templated transcription,2.0
26428,SND1,GO:0006402,mRNA catabolic process,2.0
26429,SND1,GO:0010564,regulation of cell cycle process,2.0
26430,SND1,GO:0010587,miRNA catabolic process,2.0
26431,SND1,GO:0016020,membrane,2.0
26432,SND1,GO:0016442,RISC complex,2.0
26433,SND1,GO:0031047,RNA-mediated gene silencing,2.0
26434,SND1,GO:0042470,melanosome,2.0
26435,SND1,GO:0045296,cadherin binding,2.0
26436,SND1,GO:0070062,extracellular exosome,2.0
26437,SND1,GO:0090502,"RNA phosphodiester bond hydrolysis, endonucleolytic",2.0
26438,SND1,GO:0097433,dense body,2.0
26439,SND1,GO:1905172,RISC complex binding,2.0
26440,SNTG2,GO:0003779,actin binding,2.0
26441,SNTG2,GO:0005198,structural molecule activity,2.0
26442,SNTG2,GO:0005515,protein binding,2.0
26443,SNTG2,GO:0005622,intracellular anatomical structure,2.0
26444,SNTG2,GO:0005654,nucleoplasm,2.0
26445,SNTG2,GO:0005737,cytoplasm,2.0
26446,SNTG2,GO:0005856,cytoskeleton,2.0
26447,SNTG2,GO:0005886,plasma membrane,2.0
26448,SNTG2,GO:0007417,central nervous system development,2.0
26449,SNTG2,GO:0016010,dystrophin-associated glycoprotein complex,2.0
26450,SNTG2,GO:0016013,syntrophin complex,2.0
26451,SNTG2,GO:0030165,PDZ domain binding,2.0
26452,SNTG2,GO:0042383,sarcolemma,2.0
26453,SNTG2,GO:0097109,neuroligin family protein binding,2.0
26470,SNX5,GO:0001726,ruffle,2.0
26471,SNX5,GO:0001891,phagocytic cup,2.0
26472,SNX5,GO:0005515,protein binding,2.0
26473,SNX5,GO:0005768,endosome,2.0
26474,SNX5,GO:0005829,cytosol,2.0
26475,SNX5,GO:0005903,brush border,2.0
26476,SNX5,GO:0006886,intracellular protein transport,2.0
26477,SNX5,GO:0006907,pinocytosis,2.0
26479,SNX5,GO:0007174,epidermal growth factor catabolic process,2.0
26480,SNX5,GO:0009898,cytoplasmic side of plasma membrane,2.0
26481,SNX5,GO:0010314,phosphatidylinositol-5-phosphate binding,2.0
26482,SNX5,GO:0016241,regulation of macroautophagy,2.0
26483,SNX5,GO:0030904,retromer complex,2.0
26484,SNX5,GO:0030905,"retromer, tubulation complex",2.0
26485,SNX5,GO:0031748,D1 dopamine receptor binding,2.0
26486,SNX5,GO:0034452,dynactin binding,2.0
26488,SNX5,GO:0035091,phosphatidylinositol binding,2.0
26491,SNX5,GO:0035815,positive regulation of renal sodium excretion,2.0
26492,SNX5,GO:0042147,"retrograde transport, endosome to Golgi",2.0
26495,SNX5,GO:0043231,intracellular membrane-bounded organelle,2.0
26496,SNX5,GO:0045296,cadherin binding,2.0
26497,SNX5,GO:0045776,negative regulation of blood pressure,2.0
26498,SNX5,GO:0045893,positive regulation of DNA-templated transcription,2.0
26499,SNX5,GO:0046628,positive regulation of insulin receptor signaling pathway,2.0
26500,SNX5,GO:0048471,perinuclear region of cytoplasm,2.0
26501,SNX5,GO:0070273,phosphatidylinositol-4-phosphate binding,2.0
26502,SNX5,GO:0070685,macropinocytic cup,2.0
26503,SNX5,GO:0080025,"phosphatidylinositol-3,5-bisphosphate binding",2.0
26504,SNX5,GO:0097422,tubular endosome,2.0
26505,SNX5,GO:0098559,cytoplasmic side of early endosome membrane,2.0
26506,SOD1,GO:0000303,response to superoxide,2.0
26507,SOD1,GO:0001541,ovarian follicle development,2.0
26508,SOD1,GO:0001819,positive regulation of cytokine production,2.0
26509,SOD1,GO:0001890,placenta development,2.0
26510,SOD1,GO:0001895,retina homeostasis,2.0
26511,SOD1,GO:0001975,response to amphetamine,2.0
26512,SOD1,GO:0002262,myeloid cell homeostasis,2.0
26513,SOD1,GO:0004784,superoxide dismutase activity,2.0
26515,SOD1,GO:0005507,copper ion binding,2.0
26517,SOD1,GO:0005515,protein binding,2.0
26518,SOD1,GO:0005576,extracellular region,2.0
26519,SOD1,GO:0005615,extracellular space,2.0
26520,SOD1,GO:0005634,nucleus,2.0
26523,SOD1,GO:0005654,nucleoplasm,2.0
26524,SOD1,GO:0005737,cytoplasm,2.0
26525,SOD1,GO:0005739,mitochondrion,2.0
26527,SOD1,GO:0005758,mitochondrial intermembrane space,2.0
26528,SOD1,GO:0005759,mitochondrial matrix,2.0
26529,SOD1,GO:0005764,lysosome,2.0
26530,SOD1,GO:0005777,peroxisome,2.0
26533,SOD1,GO:0005829,cytosol,2.0
26536,SOD1,GO:0005886,plasma membrane,2.0
26537,SOD1,GO:0006749,glutathione metabolic process,2.0
26538,SOD1,GO:0006801,superoxide metabolic process,2.0
26540,SOD1,GO:0006879,cellular iron ion homeostasis,2.0
26541,SOD1,GO:0006915,apoptotic process,2.0
26542,SOD1,GO:0007283,spermatogenesis,2.0
26543,SOD1,GO:0007566,embryo implantation,2.0
26545,SOD1,GO:0007568,aging,2.0
26546,SOD1,GO:0007605,sensory perception of sound,2.0
26547,SOD1,GO:0007626,locomotory behavior,2.0
26548,SOD1,GO:0008089,anterograde axonal transport,2.0
26549,SOD1,GO:0008090,retrograde axonal transport,2.0
26550,SOD1,GO:0008217,regulation of blood pressure,2.0
26551,SOD1,GO:0008270,zinc ion binding,2.0
26552,SOD1,GO:0009408,response to heat,2.0
26553,SOD1,GO:0009410,response to xenobiotic stimulus,2.0
26554,SOD1,GO:0010033,response to organic substance,2.0
26555,SOD1,GO:0019226,transmission of nerve impulse,2.0
26556,SOD1,GO:0019430,removal of superoxide radicals,2.0
26559,SOD1,GO:0030346,protein phosphatase 2B binding,2.0
26560,SOD1,GO:0031045,dense core granule,2.0
26561,SOD1,GO:0031267,small GTPase binding,2.0
26562,SOD1,GO:0031410,cytoplasmic vesicle,2.0
26563,SOD1,GO:0031667,response to nutrient levels,2.0
26564,SOD1,GO:0032287,peripheral nervous system myelin maintenance,2.0
26565,SOD1,GO:0032839,dendrite cytoplasm,2.0
26566,SOD1,GO:0032930,positive regulation of superoxide anion generation,2.0
26567,SOD1,GO:0032991,protein-containing complex,2.0
26568,SOD1,GO:0033081,regulation of T cell differentiation in thymus,2.0
26569,SOD1,GO:0034465,response to carbon monoxide,2.0
26570,SOD1,GO:0035234,ectopic germ cell programmed cell death,2.0
26571,SOD1,GO:0035865,cellular response to potassium ion,2.0
26572,SOD1,GO:0040014,regulation of multicellular organism growth,2.0
26573,SOD1,GO:0042542,response to hydrogen peroxide,2.0
26574,SOD1,GO:0042554,superoxide anion generation,2.0
26575,SOD1,GO:0042802,identical protein binding,2.0
26576,SOD1,GO:0043025,neuronal cell body,2.0
26577,SOD1,GO:0043065,positive regulation of apoptotic process,2.0
26578,SOD1,GO:0043085,positive regulation of catalytic activity,2.0
26579,SOD1,GO:0043087,regulation of GTPase activity,2.0
26580,SOD1,GO:0043167,ion binding,2.0
26581,SOD1,GO:0043410,positive regulation of MAPK cascade,2.0
26582,SOD1,GO:0043524,negative regulation of neuron apoptotic process,2.0
26583,SOD1,GO:0045471,response to ethanol,2.0
26584,SOD1,GO:0045541,negative regulation of cholesterol biosynthetic process,2.0
26585,SOD1,GO:0045859,regulation of protein kinase activity,2.0
26586,SOD1,GO:0046620,regulation of organ growth,2.0
26587,SOD1,GO:0046677,response to antibiotic,2.0
26588,SOD1,GO:0046688,response to copper ion,2.0
26589,SOD1,GO:0046716,muscle cell cellular homeostasis,2.0
26590,SOD1,GO:0048538,thymus development,2.0
26591,SOD1,GO:0048678,response to axon injury,2.0
26592,SOD1,GO:0050665,hydrogen peroxide biosynthetic process,2.0
26594,SOD1,GO:0050728,negative regulation of inflammatory response,2.0
26595,SOD1,GO:0050766,positive regulation of phagocytosis,2.0
26596,SOD1,GO:0051087,chaperone binding,2.0
26597,SOD1,GO:0051093,negative regulation of developmental process,2.0
26598,SOD1,GO:0051881,regulation of mitochondrial membrane potential,2.0
26599,SOD1,GO:0060047,heart contraction,2.0
26600,SOD1,GO:0060052,neurofilament cytoskeleton organization,2.0
26601,SOD1,GO:0060087,relaxation of vascular associated smooth muscle,2.0
26602,SOD1,GO:0060088,auditory receptor cell stereocilium organization,2.0
26603,SOD1,GO:0070062,extracellular exosome,2.0
26604,SOD1,GO:0071276,cellular response to cadmium ion,2.0
26605,SOD1,GO:0071318,cellular response to ATP,2.0
26606,SOD1,GO:0072593,reactive oxygen species metabolic process,2.0
26607,SOD1,GO:0097332,response to antipsychotic drug,2.0
26608,SOD1,GO:1902177,positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,2.0
26609,SOD1,GO:1904115,axon cytoplasm,2.0
26610,SOD1,GO:2000242,negative regulation of reproductive process,2.0
26626,SORCS3,GO:0005515,protein binding,2.0
26627,SORCS3,GO:0007218,neuropeptide signaling pathway,2.0
26628,SORCS3,GO:0007612,learning,2.0
26629,SORCS3,GO:0007613,memory,2.0
26630,SORCS3,GO:0008188,neuropeptide receptor activity,2.0
26631,SORCS3,GO:0016020,membrane,2.0
26633,SORCS3,GO:0098839,postsynaptic density membrane,2.0
26634,SORCS3,GO:0098978,glutamatergic synapse,2.0
26635,SORCS3,GO:0099170,postsynaptic modulation of chemical synaptic transmission,2.0
26636,SORCS3,GO:1900452,regulation of long-term synaptic depression,2.0
26692,SPARCL1,GO:0005509,calcium ion binding,2.0
26693,SPARCL1,GO:0005515,protein binding,2.0
26694,SPARCL1,GO:0005518,collagen binding,2.0
26695,SPARCL1,GO:0005576,extracellular region,2.0
26696,SPARCL1,GO:0005615,extracellular space,2.0
26698,SPARCL1,GO:0005788,endoplasmic reticulum lumen,2.0
26699,SPARCL1,GO:0007165,signal transduction,2.0
26700,SPARCL1,GO:0048856,anatomical structure development,2.0
26701,SPARCL1,GO:0050840,extracellular matrix binding,2.0
26702,SPARCL1,GO:0062023,collagen-containing extracellular matrix,2.0
26703,SPARCL1,GO:0098978,glutamatergic synapse,2.0
26704,SPARCL1,GO:0099560,synaptic membrane adhesion,2.0
26759,SPEN,GO:0000122,negative regulation of transcription by RNA polymerase II,2.0
26760,SPEN,GO:0003677,DNA binding,2.0
26761,SPEN,GO:0003714,transcription corepressor activity,2.0
26762,SPEN,GO:0003723,RNA binding,2.0
26763,SPEN,GO:0003729,mRNA binding,2.0
26764,SPEN,GO:0005515,protein binding,2.0
26765,SPEN,GO:0005634,nucleus,2.0
26766,SPEN,GO:0005654,nucleoplasm,2.0
26767,SPEN,GO:0006357,regulation of transcription by RNA polymerase II,2.0
26768,SPEN,GO:0007219,Notch signaling pathway,2.0
26769,SPEN,GO:0017053,transcription repressor complex,2.0
26770,SPEN,GO:0045892,negative regulation of DNA-templated transcription,2.0
26771,SPEN,GO:0050769,positive regulation of neurogenesis,2.0
26772,SPEN,GO:0061629,RNA polymerase II-specific DNA-binding transcription factor binding,2.0
26773,SPEN,GO:0070062,extracellular exosome,2.0
26774,SPP2,GO:0001501,skeletal system development,2.0
26775,SPP2,GO:0004866,endopeptidase inhibitor activity,2.0
26776,SPP2,GO:0005576,extracellular region,2.0
26777,SPP2,GO:0005788,endoplasmic reticulum lumen,2.0
26778,SPP2,GO:0010951,negative regulation of endopeptidase activity,2.0
26779,SPP2,GO:0031089,platelet dense granule lumen,2.0
26780,SPP2,GO:0046849,bone remodeling,2.0
26781,SPP2,GO:0062023,collagen-containing extracellular matrix,2.0
26782,SPRY2,GO:0000132,establishment of mitotic spindle orientation,2.0
26783,SPRY2,GO:0005515,protein binding,2.0
26784,SPRY2,GO:0005634,nucleus,2.0
26785,SPRY2,GO:0005829,cytosol,2.0
26788,SPRY2,GO:0005856,cytoskeleton,2.0
26789,SPRY2,GO:0005886,plasma membrane,2.0
26790,SPRY2,GO:0007605,sensory perception of sound,2.0
26791,SPRY2,GO:0008285,negative regulation of cell population proliferation,2.0
26792,SPRY2,GO:0008543,fibroblast growth factor receptor signaling pathway,2.0
26793,SPRY2,GO:0010628,positive regulation of gene expression,2.0
26794,SPRY2,GO:0010719,negative regulation of epithelial to mesenchymal transition,2.0
26795,SPRY2,GO:0010801,negative regulation of peptidyl-threonine phosphorylation,2.0
26796,SPRY2,GO:0015629,actin cytoskeleton,2.0
26797,SPRY2,GO:0015630,microtubule cytoskeleton,2.0
26798,SPRY2,GO:0016020,membrane,2.0
26799,SPRY2,GO:0016525,negative regulation of angiogenesis,2.0
26800,SPRY2,GO:0019901,protein kinase binding,2.0
26801,SPRY2,GO:0030291,protein serine/threonine kinase inhibitor activity,2.0
26802,SPRY2,GO:0030335,positive regulation of cell migration,2.0
26803,SPRY2,GO:0030512,negative regulation of transforming growth factor beta receptor signaling pathway,2.0
26804,SPRY2,GO:0031345,negative regulation of cell projection organization,2.0
26805,SPRY2,GO:0031397,negative regulation of protein ubiquitination,2.0
26806,SPRY2,GO:0032587,ruffle membrane,2.0
26807,SPRY2,GO:0033138,positive regulation of peptidyl-serine phosphorylation,2.0
26808,SPRY2,GO:0034260,negative regulation of GTPase activity,2.0
26809,SPRY2,GO:0035924,cellular response to vascular endothelial growth factor stimulus,2.0
26810,SPRY2,GO:0040037,negative regulation of fibroblast growth factor receptor signaling pathway,2.0
26811,SPRY2,GO:0042472,inner ear morphogenesis,2.0
26812,SPRY2,GO:0043066,negative regulation of apoptotic process,2.0
26813,SPRY2,GO:0043407,negative regulation of MAP kinase activity,2.0
26814,SPRY2,GO:0043539,protein serine/threonine kinase activator activity,2.0
26815,SPRY2,GO:0045165,cell fate commitment,2.0
26816,SPRY2,GO:0046580,negative regulation of Ras protein signal transduction,2.0
26817,SPRY2,GO:0048513,animal organ development,2.0
26818,SPRY2,GO:0051387,negative regulation of neurotrophin TRK receptor signaling pathway,2.0
26819,SPRY2,GO:0051897,positive regulation of protein kinase B signaling,2.0
26820,SPRY2,GO:0060437,lung growth,2.0
26821,SPRY2,GO:0060449,bud elongation involved in lung branching,2.0
26822,SPRY2,GO:0070371,ERK1 and ERK2 cascade,2.0
26823,SPRY2,GO:0070373,negative regulation of ERK1 and ERK2 cascade,2.0
26826,SPRY2,GO:0070374,positive regulation of ERK1 and ERK2 cascade,2.0
26827,SPRY2,GO:0071902,positive regulation of protein serine/threonine kinase activity,2.0
26828,SPRY2,GO:1900747,negative regulation of vascular endothelial growth factor signaling pathway,2.0
26829,SPRY2,GO:1902747,negative regulation of lens fiber cell differentiation,2.0
26830,SPRY2,GO:1990752,microtubule end,2.0
26831,SPRY2,GO:1990830,cellular response to leukemia inhibitory factor,2.0
26832,SPTBN1,GO:0000281,mitotic cytokinesis,2.0
26833,SPTBN1,GO:0003723,RNA binding,2.0
26834,SPTBN1,GO:0003779,actin binding,2.0
26835,SPTBN1,GO:0005200,structural constituent of cytoskeleton,2.0
26836,SPTBN1,GO:0005515,protein binding,2.0
26837,SPTBN1,GO:0005516,calmodulin binding,2.0
26838,SPTBN1,GO:0005543,phospholipid binding,2.0
26839,SPTBN1,GO:0005730,nucleolus,2.0
26840,SPTBN1,GO:0005737,cytoplasm,2.0
26841,SPTBN1,GO:0005829,cytosol,2.0
26843,SPTBN1,GO:0005886,plasma membrane,2.0
26845,SPTBN1,GO:0007009,plasma membrane organization,2.0
26846,SPTBN1,GO:0007182,common-partner SMAD protein phosphorylation,2.0
26847,SPTBN1,GO:0007417,central nervous system development,2.0
26848,SPTBN1,GO:0008091,spectrin,2.0
26849,SPTBN1,GO:0014069,postsynaptic density,2.0
26850,SPTBN1,GO:0014731,spectrin-associated cytoskeleton,2.0
26851,SPTBN1,GO:0021556,central nervous system formation,2.0
26852,SPTBN1,GO:0030036,actin cytoskeleton organization,2.0
26854,SPTBN1,GO:0030054,cell junction,2.0
26855,SPTBN1,GO:0030506,ankyrin binding,2.0
26857,SPTBN1,GO:0030673,axolemma,2.0
26858,SPTBN1,GO:0030864,cortical actin cytoskeleton,2.0
26859,SPTBN1,GO:0031430,M band,2.0
26860,SPTBN1,GO:0032437,cuticular plate,2.0
26861,SPTBN1,GO:0032743,positive regulation of interleukin-2 production,2.0
26862,SPTBN1,GO:0042995,cell projection,2.0
26863,SPTBN1,GO:0043001,Golgi to plasma membrane protein transport,2.0
26864,SPTBN1,GO:0045296,cadherin binding,2.0
26865,SPTBN1,GO:0051015,actin filament binding,2.0
26866,SPTBN1,GO:0051020,GTPase binding,2.0
26867,SPTBN1,GO:0051693,actin filament capping,2.0
26868,SPTBN1,GO:0060390,regulation of SMAD protein signal transduction,2.0
26869,SPTBN1,GO:0070062,extracellular exosome,2.0
26870,SPTBN1,GO:0071709,membrane assembly,2.0
26871,SPTBN1,GO:0072659,protein localization to plasma membrane,2.0
26873,SPTBN1,GO:0098978,glutamatergic synapse,2.0
26874,SPTBN1,GO:1903076,regulation of protein localization to plasma membrane,2.0
26875,SPTBN1,GO:1903078,positive regulation of protein localization to plasma membrane,2.0
26898,SRGAP3,GO:0005096,GTPase activator activity,2.0
26899,SRGAP3,GO:0005515,protein binding,2.0
26900,SRGAP3,GO:0005737,cytoplasm,2.0
26901,SRGAP3,GO:0005829,cytosol,2.0
26902,SRGAP3,GO:0007165,signal transduction,2.0
26903,SRGAP3,GO:0030336,negative regulation of cell migration,2.0
26904,SRGAP3,GO:0050790,regulation of catalytic activity,2.0
26905,SRGAP3,GO:0051056,regulation of small GTPase mediated signal transduction,2.0
26922,SRRM2,GO:0000398,"mRNA splicing, via spliceosome",2.0
26924,SRRM2,GO:0003723,RNA binding,2.0
26925,SRRM2,GO:0003729,mRNA binding,2.0
26926,SRRM2,GO:0005515,protein binding,2.0
26927,SRRM2,GO:0005634,nucleus,2.0
26928,SRRM2,GO:0005654,nucleoplasm,2.0
26929,SRRM2,GO:0015030,Cajal body,2.0
26930,SRRM2,GO:0016607,nuclear speck,2.0
26931,SRRM2,GO:0047485,protein N-terminus binding,2.0
26932,SRRM2,GO:0070742,C2H2 zinc finger domain binding,2.0
26933,SRRM2,GO:0071005,U2-type precatalytic spliceosome,2.0
26934,SRRM2,GO:0071007,U2-type catalytic step 2 spliceosome,2.0
26935,SRRM2,GO:0071013,catalytic step 2 spliceosome,2.0
26936,SRSF11,GO:0003723,RNA binding,2.0
26938,SRSF11,GO:0005515,protein binding,2.0
26939,SRSF11,GO:0005634,nucleus,2.0
26940,SRSF11,GO:0005654,nucleoplasm,2.0
26942,SRSF11,GO:0006397,mRNA processing,2.0
26943,SRSF11,GO:0008380,RNA splicing,2.0
26944,SRSF11,GO:0016607,nuclear speck,2.0
26945,SSRP1,GO:0003677,DNA binding,2.0
26946,SSRP1,GO:0003723,RNA binding,2.0
26947,SSRP1,GO:0005515,protein binding,2.0
26948,SSRP1,GO:0005634,nucleus,2.0
26949,SSRP1,GO:0005654,nucleoplasm,2.0
26950,SSRP1,GO:0005730,nucleolus,2.0
26951,SSRP1,GO:0006260,DNA replication,2.0
26952,SSRP1,GO:0006281,DNA repair,2.0
26953,SSRP1,GO:0006334,nucleosome assembly,2.0
26954,SSRP1,GO:0006337,nucleosome disassembly,2.0
26955,SSRP1,GO:0031491,nucleosome binding,2.0
26956,SSRP1,GO:0035101,FACT complex,2.0
26958,SSRP1,GO:0042393,histone binding,2.0
26959,SSRP1,GO:1902275,regulation of chromatin organization,2.0
26961,ST7,GO:0005515,protein binding,2.0
26962,ST7,GO:0016020,membrane,2.0
26963,ST7,GO:0030198,extracellular matrix organization,2.0
26964,ST7,GO:0045595,regulation of cell differentiation,2.0
26965,ST8SIA2,GO:0000139,Golgi membrane,2.0
26966,ST8SIA2,GO:0001574,ganglioside biosynthetic process,2.0
26967,ST8SIA2,GO:0003828,"alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity",2.0
26970,ST8SIA2,GO:0005769,early endosome,2.0
26971,ST8SIA2,GO:0005886,plasma membrane,2.0
26972,ST8SIA2,GO:0005975,carbohydrate metabolic process,2.0
26973,ST8SIA2,GO:0006486,protein glycosylation,2.0
26976,ST8SIA2,GO:0006491,N-glycan processing,2.0
26978,ST8SIA2,GO:0007399,nervous system development,2.0
26979,ST8SIA2,GO:0009311,oligosaccharide metabolic process,2.0
26981,ST8SIA2,GO:0033691,sialic acid binding,2.0
26982,ST8SIA2,GO:0036211,protein modification process,2.0
26983,ST8SIA2,GO:0042220,response to cocaine,2.0
26984,ST8SIA2,GO:0048471,perinuclear region of cytoplasm,2.0
26985,ST8SIA2,GO:0051965,positive regulation of synapse assembly,2.0
26986,ST8SIA2,GO:0055037,recycling endosome,2.0
26987,ST8SIA2,GO:0097503,sialylation,2.0
26988,ST8SIA2,GO:1901216,positive regulation of neuron death,2.0
26989,ST8SIA2,GO:1990138,neuron projection extension,2.0
27012,STX1A,GO:0000149,SNARE binding,2.0
27013,STX1A,GO:0001956,positive regulation of neurotransmitter secretion,2.0
27014,STX1A,GO:0005484,SNAP receptor activity,2.0
27015,STX1A,GO:0005515,protein binding,2.0
27016,STX1A,GO:0005576,extracellular region,2.0
27017,STX1A,GO:0005829,cytosol,2.0
27018,STX1A,GO:0005886,plasma membrane,2.0
27021,STX1A,GO:0006886,intracellular protein transport,2.0
27022,STX1A,GO:0006887,exocytosis,2.0
27023,STX1A,GO:0006906,vesicle fusion,2.0
27024,STX1A,GO:0008021,synaptic vesicle,2.0
27025,STX1A,GO:0009629,response to gravity,2.0
27026,STX1A,GO:0010701,positive regulation of norepinephrine secretion,2.0
27027,STX1A,GO:0010807,regulation of synaptic vesicle priming,2.0
27028,STX1A,GO:0012505,endomembrane system,2.0
27029,STX1A,GO:0016020,membrane,2.0
27030,STX1A,GO:0016079,synaptic vesicle exocytosis,2.0
27031,STX1A,GO:0016081,synaptic vesicle docking,2.0
27032,STX1A,GO:0016925,protein sumoylation,2.0
27033,STX1A,GO:0017156,calcium-ion regulated exocytosis,2.0
27034,STX1A,GO:0019855,calcium channel inhibitor activity,2.0
27035,STX1A,GO:0019869,chloride channel inhibitor activity,2.0
27036,STX1A,GO:0019900,kinase binding,2.0
27037,STX1A,GO:0019904,protein domain specific binding,2.0
27038,STX1A,GO:0030073,insulin secretion,2.0
27039,STX1A,GO:0030141,secretory granule,2.0
27040,STX1A,GO:0030424,axon,2.0
27041,STX1A,GO:0030672,synaptic vesicle membrane,2.0
27042,STX1A,GO:0031201,SNARE complex,2.0
27045,STX1A,GO:0031629,synaptic vesicle fusion to presynaptic active zone membrane,2.0
27046,STX1A,GO:0031965,nuclear membrane,2.0
27047,STX1A,GO:0032028,myosin head/neck binding,2.0
27048,STX1A,GO:0032940,secretion by cell,2.0
27049,STX1A,GO:0033605,positive regulation of catecholamine secretion,2.0
27050,STX1A,GO:0035493,SNARE complex assembly,2.0
27051,STX1A,GO:0042641,actomyosin,2.0
27052,STX1A,GO:0042802,identical protein binding,2.0
27053,STX1A,GO:0043005,neuron projection,2.0
27054,STX1A,GO:0043008,ATP-dependent protein binding,2.0
27055,STX1A,GO:0044325,transmembrane transporter binding,2.0
27056,STX1A,GO:0044877,protein-containing complex binding,2.0
27057,STX1A,GO:0045956,positive regulation of calcium ion-dependent exocytosis,2.0
27058,STX1A,GO:0047485,protein N-terminus binding,2.0
27059,STX1A,GO:0048278,vesicle docking,2.0
27060,STX1A,GO:0048306,calcium-dependent protein binding,2.0
27061,STX1A,GO:0048488,synaptic vesicle endocytosis,2.0
27062,STX1A,GO:0048787,presynaptic active zone membrane,2.0
27063,STX1A,GO:0050796,regulation of insulin secretion,2.0
27064,STX1A,GO:0070032,synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex,2.0
27065,STX1A,GO:0070033,synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex,2.0
27066,STX1A,GO:0070044,synaptobrevin 2-SNAP-25-syntaxin-1a complex,2.0
27067,STX1A,GO:0072657,protein localization to membrane,2.0
27068,STX1A,GO:0098685,Schaffer collateral - CA1 synapse,2.0
27069,STX1A,GO:0098839,postsynaptic density membrane,2.0
27070,STX1A,GO:0098978,glutamatergic synapse,2.0
27071,STX1A,GO:2000463,positive regulation of excitatory postsynaptic potential,2.0
27139,STXBP5,GO:0005096,GTPase activator activity,2.0
27140,STXBP5,GO:0005737,cytoplasm,2.0
27141,STXBP5,GO:0005829,cytosol,2.0
27142,STXBP5,GO:0005886,plasma membrane,2.0
27143,STXBP5,GO:0005892,acetylcholine-gated channel complex,2.0
27144,STXBP5,GO:0006887,exocytosis,2.0
27145,STXBP5,GO:0008021,synaptic vesicle,2.0
27146,STXBP5,GO:0010807,regulation of synaptic vesicle priming,2.0
27147,STXBP5,GO:0015031,protein transport,2.0
27148,STXBP5,GO:0017075,syntaxin-1 binding,2.0
27149,STXBP5,GO:0017157,regulation of exocytosis,2.0
27151,STXBP5,GO:0019905,syntaxin binding,2.0
27152,STXBP5,GO:0031201,SNARE complex,2.0
27153,STXBP5,GO:0045159,myosin II binding,2.0
27154,STXBP5,GO:0045921,positive regulation of exocytosis,2.0
27155,STXBP5,GO:0050708,regulation of protein secretion,2.0
27156,STXBP5,GO:0050790,regulation of catalytic activity,2.0
27157,STXBP5,GO:0098674,extrinsic component of neuronal dense core vesicle membrane,2.0
27158,STXBP5,GO:0098686,hippocampal mossy fiber to CA3 synapse,2.0
27159,STXBP5,GO:2000300,regulation of synaptic vesicle exocytosis,2.0
27160,STYK1,GO:0004713,protein tyrosine kinase activity,2.0
27161,STYK1,GO:0004715,non-membrane spanning protein tyrosine kinase activity,2.0
27162,STYK1,GO:0005102,signaling receptor binding,2.0
27163,STYK1,GO:0005515,protein binding,2.0
27164,STYK1,GO:0005524,ATP binding,2.0
27165,STYK1,GO:0005886,plasma membrane,2.0
27166,STYK1,GO:0007169,transmembrane receptor protein tyrosine kinase signaling pathway,2.0
27167,STYK1,GO:0018108,peptidyl-tyrosine phosphorylation,2.0
27168,STYK1,GO:0030154,cell differentiation,2.0
27169,STYK1,GO:0031234,extrinsic component of cytoplasmic side of plasma membrane,2.0
27170,STYK1,GO:0045087,innate immune response,2.0
27171,SUPT16H,GO:0003723,RNA binding,2.0
27172,SUPT16H,GO:0005515,protein binding,2.0
27173,SUPT16H,GO:0005634,nucleus,2.0
27174,SUPT16H,GO:0005654,nucleoplasm,2.0
27176,SUPT16H,GO:0006260,DNA replication,2.0
27177,SUPT16H,GO:0006281,DNA repair,2.0
27178,SUPT16H,GO:0006334,nucleosome assembly,2.0
27179,SUPT16H,GO:0006337,nucleosome disassembly,2.0
27180,SUPT16H,GO:0006366,transcription by RNA polymerase II,2.0
27181,SUPT16H,GO:0006368,transcription elongation by RNA polymerase II promoter,2.0
27182,SUPT16H,GO:0031491,nucleosome binding,2.0
27183,SUPT16H,GO:0032786,"positive regulation of DNA-templated transcription, elongation",2.0
27184,SUPT16H,GO:0035101,FACT complex,2.0
27186,SYAP1,GO:0005515,protein binding,2.0
27187,SYAP1,GO:0005634,nucleus,2.0
27188,SYAP1,GO:0005654,nucleoplasm,2.0
27189,SYAP1,GO:0005737,cytoplasm,2.0
27190,SYAP1,GO:0005794,Golgi apparatus,2.0
27192,SYAP1,GO:0005829,cytosol,2.0
27193,SYAP1,GO:0030154,cell differentiation,2.0
27194,SYAP1,GO:0030424,axon,2.0
27195,SYAP1,GO:0030425,dendrite,2.0
27196,SYAP1,GO:0030426,growth cone,2.0
27197,SYAP1,GO:0031234,extrinsic component of cytoplasmic side of plasma membrane,2.0
27198,SYAP1,GO:0032869,cellular response to insulin stimulus,2.0
27199,SYAP1,GO:0036120,cellular response to platelet-derived growth factor stimulus,2.0
27200,SYAP1,GO:0038203,TORC2 signaling,2.0
27202,SYAP1,GO:0042734,presynaptic membrane,2.0
27203,SYAP1,GO:0043204,perikaryon,2.0
27204,SYAP1,GO:0045202,synapse,2.0
27205,SYAP1,GO:0045211,postsynaptic membrane,2.0
27206,SYAP1,GO:0045600,positive regulation of fat cell differentiation,2.0
27207,SYAP1,GO:0048172,regulation of short-term neuronal synaptic plasticity,2.0
27208,SYAP1,GO:0048471,perinuclear region of cytoplasm,2.0
27209,SYAP1,GO:0070062,extracellular exosome,2.0
27210,SYAP1,GO:0071364,cellular response to epidermal growth factor stimulus,2.0
27211,SYAP1,GO:0071902,positive regulation of protein serine/threonine kinase activity,2.0
27212,SYAP1,GO:1990314,cellular response to insulin-like growth factor stimulus,2.0
27274,SYN2,GO:0005515,protein binding,2.0
27275,SYN2,GO:0005524,ATP binding,2.0
27276,SYN2,GO:0005886,plasma membrane,2.0
27277,SYN2,GO:0007268,chemical synaptic transmission,2.0
27278,SYN2,GO:0007269,neurotransmitter secretion,2.0
27280,SYN2,GO:0014069,postsynaptic density,2.0
27281,SYN2,GO:0017156,calcium-ion regulated exocytosis,2.0
27282,SYN2,GO:0030672,synaptic vesicle membrane,2.0
27284,SYN2,GO:0031201,SNARE complex,2.0
27285,SYN2,GO:0042802,identical protein binding,2.0
27286,SYN2,GO:0045202,synapse,2.0
27287,SYN2,GO:0097091,synaptic vesicle clustering,2.0
27288,SYN2,GO:0098685,Schaffer collateral - CA1 synapse,2.0
27289,SYN2,GO:0098978,glutamatergic synapse,2.0
27290,SYNCRIP,GO:0000398,"mRNA splicing, via spliceosome",2.0
27291,SYNCRIP,GO:0001649,osteoblast differentiation,2.0
27292,SYNCRIP,GO:0003723,RNA binding,2.0
27294,SYNCRIP,GO:0003729,mRNA binding,2.0
27295,SYNCRIP,GO:0005515,protein binding,2.0
27296,SYNCRIP,GO:0005634,nucleus,2.0
27297,SYNCRIP,GO:0005654,nucleoplasm,2.0
27298,SYNCRIP,GO:0005783,endoplasmic reticulum,2.0
27299,SYNCRIP,GO:0005829,cytosol,2.0
27300,SYNCRIP,GO:0006396,RNA processing,2.0
27301,SYNCRIP,GO:0008143,poly(A) binding,2.0
27302,SYNCRIP,GO:0008380,RNA splicing,2.0
27303,SYNCRIP,GO:0016020,membrane,2.0
27304,SYNCRIP,GO:0017148,negative regulation of translation,2.0
27306,SYNCRIP,GO:0048027,mRNA 5'-UTR binding,2.0
27307,SYNCRIP,GO:0070934,CRD-mediated mRNA stabilization,2.0
27310,SYNCRIP,GO:0070937,CRD-mediated mRNA stability complex,2.0
27313,SYNCRIP,GO:0071013,catalytic step 2 spliceosome,2.0
27314,SYNCRIP,GO:0071204,histone pre-mRNA 3'end processing complex,2.0
27315,SYNCRIP,GO:0071346,cellular response to type II interferon,2.0
27316,SYNCRIP,GO:0097452,GAIT complex,2.0
27317,SYNCRIP,GO:0106002,mCRD-mediated mRNA stability complex,2.0
27318,SYNCRIP,GO:1900152,"negative regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay",2.0
27319,SYNCRIP,GO:1990904,ribonucleoprotein complex,2.0
27321,SYNCRIP,GO:2000767,positive regulation of cytoplasmic translation,2.0
27322,SYNE1,GO:0000932,P-body,2.0
27323,SYNE1,GO:0003723,RNA binding,2.0
27324,SYNE1,GO:0003779,actin binding,2.0
27325,SYNE1,GO:0005515,protein binding,2.0
27326,SYNE1,GO:0005521,lamin binding,2.0
27327,SYNE1,GO:0005634,nucleus,2.0
27328,SYNE1,GO:0005635,nuclear envelope,2.0
27329,SYNE1,GO:0005640,nuclear outer membrane,2.0
27330,SYNE1,GO:0005654,nucleoplasm,2.0
27331,SYNE1,GO:0005730,nucleolus,2.0
27332,SYNE1,GO:0005737,cytoplasm,2.0
27333,SYNE1,GO:0005794,Golgi apparatus,2.0
27334,SYNE1,GO:0005856,cytoskeleton,2.0
27335,SYNE1,GO:0006997,nucleus organization,2.0
27336,SYNE1,GO:0007030,Golgi organization,2.0
27337,SYNE1,GO:0007283,spermatogenesis,2.0
27338,SYNE1,GO:0016020,membrane,2.0
27339,SYNE1,GO:0019899,enzyme binding,2.0
27340,SYNE1,GO:0030017,sarcomere,2.0
27341,SYNE1,GO:0031965,nuclear membrane,2.0
27342,SYNE1,GO:0034993,meiotic nuclear membrane microtubule tethering complex,2.0
27343,SYNE1,GO:0042692,muscle cell differentiation,2.0
27344,SYNE1,GO:0042803,protein homodimerization activity,2.0
27345,SYNE1,GO:0045211,postsynaptic membrane,2.0
27346,SYNE1,GO:0051015,actin filament binding,2.0
27347,SYNE1,GO:0090292,nuclear matrix anchoring at nuclear membrane,2.0
27348,SYNE1,GO:0140444,cytoskeleton-nuclear membrane anchor activity,2.0
27373,SYNJ1,GO:0003723,RNA binding,2.0
27374,SYNJ1,GO:0004438,phosphatidylinositol-3-phosphate phosphatase activity,2.0
27376,SYNJ1,GO:0004439,"phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity",2.0
27381,SYNJ1,GO:0005829,cytosol,2.0
27382,SYNJ1,GO:0005874,microtubule,2.0
27383,SYNJ1,GO:0006661,phosphatidylinositol biosynthetic process,2.0
27384,SYNJ1,GO:0006836,neurotransmitter transport,2.0
27385,SYNJ1,GO:0007420,brain development,2.0
27386,SYNJ1,GO:0007612,learning,2.0
27387,SYNJ1,GO:0008022,protein C-terminus binding,2.0
27388,SYNJ1,GO:0012506,vesicle membrane,2.0
27389,SYNJ1,GO:0014015,positive regulation of gliogenesis,2.0
27390,SYNJ1,GO:0016082,synaptic vesicle priming,2.0
27391,SYNJ1,GO:0016191,synaptic vesicle uncoating,2.0
27392,SYNJ1,GO:0017124,SH3 domain binding,2.0
27393,SYNJ1,GO:0030117,membrane coat,2.0
27394,SYNJ1,GO:0030132,clathrin coat of coated pit,2.0
27395,SYNJ1,GO:0032526,response to retinoic acid,2.0
27396,SYNJ1,GO:0034097,response to cytokine,2.0
27397,SYNJ1,GO:0034595,phosphatidylinositol phosphate 5-phosphatase activity,2.0
27398,SYNJ1,GO:0034596,phosphatidylinositol phosphate 4-phosphatase activity,2.0
27399,SYNJ1,GO:0036092,phosphatidylinositol-3-phosphate biosynthetic process,2.0
27400,SYNJ1,GO:0043195,terminal bouton,2.0
27401,SYNJ1,GO:0043647,inositol phosphate metabolic process,2.0
27402,SYNJ1,GO:0043812,phosphatidylinositol-4-phosphate phosphatase activity,2.0
27403,SYNJ1,GO:0043813,"phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity",2.0
27404,SYNJ1,GO:0044877,protein-containing complex binding,2.0
27405,SYNJ1,GO:0046488,phosphatidylinositol metabolic process,2.0
27406,SYNJ1,GO:0046855,inositol phosphate dephosphorylation,2.0
27407,SYNJ1,GO:0046856,phosphatidylinositol dephosphorylation,2.0
27411,SYNJ1,GO:0048260,positive regulation of receptor-mediated endocytosis,2.0
27412,SYNJ1,GO:0048471,perinuclear region of cytoplasm,2.0
27414,SYNJ1,GO:0048488,synaptic vesicle endocytosis,2.0
27417,SYNJ1,GO:0048489,synaptic vesicle transport,2.0
27418,SYNJ1,GO:0052629,"phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity",2.0
27419,SYNJ1,GO:0052658,"inositol-1,4,5-trisphosphate 5-phosphatase activity",2.0
27420,SYNJ1,GO:0061024,membrane organization,2.0
27421,SYNJ1,GO:0097060,synaptic membrane,2.0
27422,SYNJ1,GO:0098688,parallel fiber to Purkinje cell synapse,2.0
27423,SYNJ1,GO:0098793,presynapse,2.0
27425,SYNJ1,GO:1904980,positive regulation of endosome organization,2.0
27426,SYNJ1,GO:1990175,EH domain binding,2.0
27601,TAF1C,GO:0001164,RNA polymerase I core promoter sequence-specific DNA binding,2.0
27603,TAF1C,GO:0001181,RNA polymerase I general transcription initiation factor activity,2.0
27604,TAF1C,GO:0001188,RNA polymerase I preinitiation complex assembly,2.0
27605,TAF1C,GO:0001650,fibrillar center,2.0
27607,TAF1C,GO:0005515,protein binding,2.0
27608,TAF1C,GO:0005654,nucleoplasm,2.0
27610,TAF1C,GO:0005668,RNA polymerase transcription factor SL1 complex,2.0
27611,TAF1C,GO:0005730,nucleolus,2.0
27612,TAF1C,GO:0006360,transcription by RNA polymerase I,2.0
27613,TAF1C,GO:0006361,transcription initiation at RNA polymerase I promoter,2.0
27614,TAF1C,GO:0006366,transcription by RNA polymerase II,2.0
27650,TAF6,GO:0000124,SAGA complex,2.0
27651,TAF6,GO:0003677,DNA binding,2.0
27652,TAF6,GO:0003713,transcription coactivator activity,2.0
27653,TAF6,GO:0005515,protein binding,2.0
27654,TAF6,GO:0005634,nucleus,2.0
27656,TAF6,GO:0005654,nucleoplasm,2.0
27658,TAF6,GO:0005669,transcription factor TFIID complex,2.0
27662,TAF6,GO:0005829,cytosol,2.0
27663,TAF6,GO:0006282,regulation of DNA repair,2.0
27664,TAF6,GO:0006352,DNA-templated transcription initiation,2.0
27665,TAF6,GO:0006357,regulation of transcription by RNA polymerase II,2.0
27666,TAF6,GO:0006366,transcription by RNA polymerase II,2.0
27667,TAF6,GO:0006367,transcription initiation at RNA polymerase II promoter,2.0
27668,TAF6,GO:0006468,protein phosphorylation,2.0
27669,TAF6,GO:0006915,apoptotic process,2.0
27670,TAF6,GO:0016251,RNA polymerase II general transcription initiation factor activity,2.0
27673,TAF6,GO:0017162,aryl hydrocarbon receptor binding,2.0
27674,TAF6,GO:0032991,protein-containing complex,2.0
27675,TAF6,GO:0033276,transcription factor TFTC complex,2.0
27677,TAF6,GO:0035521,monoubiquitinated histone deubiquitination,2.0
27678,TAF6,GO:0035522,monoubiquitinated histone H2A deubiquitination,2.0
27679,TAF6,GO:0042789,mRNA transcription by RNA polymerase II,2.0
27680,TAF6,GO:0043966,histone H3 acetylation,2.0
27681,TAF6,GO:0045786,negative regulation of cell cycle,2.0
27682,TAF6,GO:0045893,positive regulation of DNA-templated transcription,2.0
27683,TAF6,GO:0046695,SLIK (SAGA-like) complex,2.0
27684,TAF6,GO:0046982,protein heterodimerization activity,2.0
27685,TAF6,GO:0051123,RNA polymerase II preinitiation complex assembly,2.0
27688,TAF6,GO:0060090,molecular adaptor activity,2.0
27689,TAF6,GO:0060261,positive regulation of transcription initiation by RNA polymerase II,2.0
27690,TAF6,GO:0071339,MLL1 complex,2.0
27744,TAOK2,GO:0000165,MAPK cascade,2.0
27745,TAOK2,GO:0001558,regulation of cell growth,2.0
27746,TAOK2,GO:0004674,protein serine/threonine kinase activity,2.0
27749,TAOK2,GO:0004709,MAP kinase kinase kinase activity,2.0
27750,TAOK2,GO:0005515,protein binding,2.0
27751,TAOK2,GO:0005524,ATP binding,2.0
27752,TAOK2,GO:0005654,nucleoplasm,2.0
27753,TAOK2,GO:0005730,nucleolus,2.0
27754,TAOK2,GO:0005737,cytoplasm,2.0
27755,TAOK2,GO:0005829,cytosol,2.0
27756,TAOK2,GO:0006468,protein phosphorylation,2.0
27757,TAOK2,GO:0006612,protein targeting to membrane,2.0
27758,TAOK2,GO:0006915,apoptotic process,2.0
27759,TAOK2,GO:0006974,cellular response to DNA damage stimulus,2.0
27760,TAOK2,GO:0007095,mitotic G2 DNA damage checkpoint signaling,2.0
27761,TAOK2,GO:0007409,axonogenesis,2.0
27763,TAOK2,GO:0008360,regulation of cell shape,2.0
27764,TAOK2,GO:0015629,actin cytoskeleton,2.0
27765,TAOK2,GO:0016477,cell migration,2.0
27766,TAOK2,GO:0030036,actin cytoskeleton organization,2.0
27767,TAOK2,GO:0030424,axon,2.0
27768,TAOK2,GO:0030659,cytoplasmic vesicle membrane,2.0
27769,TAOK2,GO:0031410,cytoplasmic vesicle,2.0
27770,TAOK2,GO:0031434,mitogen-activated protein kinase kinase binding,2.0
27771,TAOK2,GO:0031954,positive regulation of protein autophosphorylation,2.0
27772,TAOK2,GO:0032147,activation of protein kinase activity,2.0
27773,TAOK2,GO:0032874,positive regulation of stress-activated MAPK cascade,2.0
27774,TAOK2,GO:0032956,regulation of actin cytoskeleton organization,2.0
27775,TAOK2,GO:0035556,intracellular signal transduction,2.0
27776,TAOK2,GO:0038191,neuropilin binding,2.0
27777,TAOK2,GO:0043005,neuron projection,2.0
27778,TAOK2,GO:0043235,receptor complex,2.0
27779,TAOK2,GO:0043408,regulation of MAPK cascade,2.0
27780,TAOK2,GO:0043410,positive regulation of MAPK cascade,2.0
27781,TAOK2,GO:0043539,protein serine/threonine kinase activator activity,2.0
27782,TAOK2,GO:0044294,dendritic growth cone,2.0
27783,TAOK2,GO:0044295,axonal growth cone,2.0
27784,TAOK2,GO:0046330,positive regulation of JNK cascade,2.0
27786,TAOK2,GO:0046777,protein autophosphorylation,2.0
27787,TAOK2,GO:0048041,focal adhesion assembly,2.0
27788,TAOK2,GO:0048156,tau protein binding,2.0
27789,TAOK2,GO:0048812,neuron projection morphogenesis,2.0
27790,TAOK2,GO:0050321,tau-protein kinase activity,2.0
27791,TAOK2,GO:0051403,stress-activated MAPK cascade,2.0
27792,TAOK2,GO:0071902,positive regulation of protein serine/threonine kinase activity,2.0
27793,TAOK2,GO:0106310,protein serine kinase activity,2.0
27794,TAOK2,GO:0150019,basal dendrite morphogenesis,2.0
27795,TAOK2,GO:0150020,basal dendrite arborization,2.0
27811,TBC1D31,GO:0005515,protein binding,2.0
27812,TBC1D31,GO:0005813,centrosome,2.0
27814,TBC1D31,GO:0034451,centriolar satellite,2.0
27815,TBC1D31,GO:0036064,ciliary basal body,2.0
27816,TBC1D31,GO:0060090,molecular adaptor activity,2.0
27817,TBC1D31,GO:0060271,cilium assembly,2.0
27818,TBC1D5,GO:0002092,positive regulation of receptor internalization,2.0
27819,TBC1D5,GO:0005096,GTPase activator activity,2.0
27820,TBC1D5,GO:0005515,protein binding,2.0
27821,TBC1D5,GO:0005776,autophagosome,2.0
27822,TBC1D5,GO:0005794,Golgi apparatus,2.0
27823,TBC1D5,GO:0005829,cytosol,2.0
27824,TBC1D5,GO:0006914,autophagy,2.0
27825,TBC1D5,GO:0010008,endosome membrane,2.0
27826,TBC1D5,GO:0015031,protein transport,2.0
27827,TBC1D5,GO:0016236,macroautophagy,2.0
27828,TBC1D5,GO:0030904,retromer complex,2.0
27829,TBC1D5,GO:0035612,AP-2 adaptor complex binding,2.0
27830,TBC1D5,GO:0042147,"retrograde transport, endosome to Golgi",2.0
27831,TBC1D5,GO:0042594,response to starvation,2.0
27832,TBC1D5,GO:0043231,intracellular membrane-bounded organelle,2.0
27833,TBC1D5,GO:0044877,protein-containing complex binding,2.0
27834,TBC1D5,GO:0090630,activation of GTPase activity,2.0
27835,TBC1D5,GO:1902017,regulation of cilium assembly,2.0
27836,TBC1D5,GO:1905394,retromer complex binding,2.0
27996,STK39,GO:0002021,response to dietary excess,2.0
27997,STK39,GO:0004674,protein serine/threonine kinase activity,2.0
28001,STK39,GO:0005515,protein binding,2.0
28002,STK39,GO:0005524,ATP binding,2.0
28003,STK39,GO:0005654,nucleoplasm,2.0
28004,STK39,GO:0005737,cytoplasm,2.0
28005,STK39,GO:0005829,cytosol,2.0
28009,STK39,GO:0006468,protein phosphorylation,2.0
28011,STK39,GO:0006954,inflammatory response,2.0
28012,STK39,GO:0007165,signal transduction,2.0
28014,STK39,GO:0008217,regulation of blood pressure,2.0
28015,STK39,GO:0010820,positive regulation of T cell chemotaxis,2.0
28017,STK39,GO:0016301,kinase activity,2.0
28018,STK39,GO:0016323,basolateral plasma membrane,2.0
28019,STK39,GO:0016324,apical plasma membrane,2.0
28020,STK39,GO:0018105,peptidyl-serine phosphorylation,2.0
28022,STK39,GO:0018107,peptidyl-threonine phosphorylation,2.0
28026,STK39,GO:0019898,extrinsic component of membrane,2.0
28027,STK39,GO:0030644,cellular chloride ion homeostasis,2.0
28028,STK39,GO:0032414,positive regulation of ion transmembrane transporter activity,2.0
28029,STK39,GO:0035556,intracellular signal transduction,2.0
28031,STK39,GO:0035725,sodium ion transmembrane transport,2.0
28032,STK39,GO:0035865,cellular response to potassium ion,2.0
28033,STK39,GO:0036438,maintenance of lens transparency,2.0
28034,STK39,GO:0038146,chemokine (C-X-C motif) ligand 12 signaling pathway,2.0
28035,STK39,GO:0042116,macrophage activation,2.0
28036,STK39,GO:0043231,intracellular membrane-bounded organelle,2.0
28037,STK39,GO:0044297,cell body,2.0
28038,STK39,GO:0046777,protein autophosphorylation,2.0
28040,STK39,GO:0050727,regulation of inflammatory response,2.0
28041,STK39,GO:0071476,cellular hypotonic response,2.0
28042,STK39,GO:0090188,negative regulation of pancreatic juice secretion,2.0
28043,STK39,GO:0106310,protein serine kinase activity,2.0
28044,STK39,GO:1900745,positive regulation of p38MAPK cascade,2.0
28045,STK39,GO:1901017,negative regulation of potassium ion transmembrane transporter activity,2.0
28047,STK39,GO:1901380,negative regulation of potassium ion transmembrane transport,2.0
28048,STK39,GO:1904044,response to aldosterone,2.0
28049,STK39,GO:1905408,negative regulation of creatine transmembrane transporter activity,2.0
28050,STK39,GO:1990869,cellular response to chemokine,2.0
28051,STK39,GO:2000650,negative regulation of sodium ion transmembrane transporter activity,2.0
28052,SYT17,GO:0000149,SNARE binding,2.0
28053,SYT17,GO:0001786,phosphatidylserine binding,2.0
28054,SYT17,GO:0005509,calcium ion binding,2.0
28055,SYT17,GO:0005515,protein binding,2.0
28056,SYT17,GO:0005544,calcium-dependent phospholipid binding,2.0
28057,SYT17,GO:0005802,trans-Golgi network,2.0
28058,SYT17,GO:0005886,plasma membrane,2.0
28059,SYT17,GO:0014059,regulation of dopamine secretion,2.0
28060,SYT17,GO:0016192,vesicle-mediated transport,2.0
28061,SYT17,GO:0017156,calcium-ion regulated exocytosis,2.0
28062,SYT17,GO:0017158,regulation of calcium ion-dependent exocytosis,2.0
28063,SYT17,GO:0019905,syntaxin binding,2.0
28064,SYT17,GO:0030154,cell differentiation,2.0
28065,SYT17,GO:0030276,clathrin binding,2.0
28066,SYT17,GO:0070382,exocytic vesicle,2.0
28067,SYT17,GO:0071277,cellular response to calcium ion,2.0
28068,SYT17,GO:1903861,positive regulation of dendrite extension,2.0
28069,TBL1X,GO:0000118,histone deacetylase complex,2.0
28071,TBL1X,GO:0000122,negative regulation of transcription by RNA polymerase II,2.0
28072,TBL1X,GO:0000976,transcription cis-regulatory region binding,2.0
28073,TBL1X,GO:0003714,transcription corepressor activity,2.0
28076,TBL1X,GO:0005515,protein binding,2.0
28077,TBL1X,GO:0005634,nucleus,2.0
28078,TBL1X,GO:0005654,nucleoplasm,2.0
28079,TBL1X,GO:0006357,regulation of transcription by RNA polymerase II,2.0
28080,TBL1X,GO:0006508,proteolysis,2.0
28081,TBL1X,GO:0007605,sensory perception of sound,2.0
28082,TBL1X,GO:0008013,beta-catenin binding,2.0
28083,TBL1X,GO:0008022,protein C-terminus binding,2.0
28084,TBL1X,GO:0016575,histone deacetylation,2.0
28085,TBL1X,GO:0017053,transcription repressor complex,2.0
28086,TBL1X,GO:0019904,protein domain specific binding,2.0
28087,TBL1X,GO:0042393,histone binding,2.0
28088,TBL1X,GO:0043161,proteasome-mediated ubiquitin-dependent protein catabolic process,2.0
28089,TBL1X,GO:0045893,positive regulation of DNA-templated transcription,2.0
28090,TBL1X,GO:0045944,positive regulation of transcription by RNA polymerase II,2.0
28091,TBL1X,GO:0050821,protein stabilization,2.0
28092,TBL1X,GO:0072686,mitotic spindle,2.0
28093,TBL1X,GO:0090263,positive regulation of canonical Wnt signaling pathway,2.0
28094,TBL1X,GO:0140297,DNA-binding transcription factor binding,2.0
28180,TDO2,GO:0004833,"tryptophan 2,3-dioxygenase activity",2.0
28182,TDO2,GO:0005515,protein binding,2.0
28183,TDO2,GO:0005829,cytosol,2.0
28184,TDO2,GO:0016597,amino acid binding,2.0
28185,TDO2,GO:0019441,tryptophan catabolic process to kynurenine,2.0
28187,TDO2,GO:0019442,tryptophan catabolic process to acetyl-CoA,2.0
28188,TDO2,GO:0019825,oxygen binding,2.0
28189,TDO2,GO:0020037,heme binding,2.0
28191,TDO2,GO:0042802,identical protein binding,2.0
28192,TDO2,GO:0046872,metal ion binding,2.0
28193,TDO2,GO:0051289,protein homotetramerization,2.0
28194,TDO2,GO:1904842,response to nitroglycerin,2.0
28195,TECTA,GO:0005201,extracellular matrix structural constituent,2.0
28196,TECTA,GO:0005576,extracellular region,2.0
28197,TECTA,GO:0005886,plasma membrane,2.0
28198,TECTA,GO:0007160,cell-matrix adhesion,2.0
28199,TECTA,GO:0007605,sensory perception of sound,2.0
28200,TECTA,GO:0031012,extracellular matrix,2.0
28201,TECTA,GO:0062023,collagen-containing extracellular matrix,2.0
28202,TECTA,GO:0070062,extracellular exosome,2.0
28274,TERB2,GO:0000781,"chromosome, telomeric region",2.0
28275,TERB2,GO:0005515,protein binding,2.0
28276,TERB2,GO:0005637,nuclear inner membrane,2.0
28278,TERB2,GO:0007129,homologous chromosome pairing at meiosis,2.0
28280,TERB2,GO:0045141,meiotic telomere clustering,2.0
28281,TERB2,GO:0070197,meiotic attachment of telomere to nuclear envelope,2.0
28283,TERF2,GO:0000723,telomere maintenance,2.0
28284,TERF2,GO:0000781,"chromosome, telomeric region",2.0
28286,TERF2,GO:0000783,nuclear telomere cap complex,2.0
28287,TERF2,GO:0001673,male germ cell nucleus,2.0
28288,TERF2,GO:0001701,in utero embryonic development,2.0
28289,TERF2,GO:0003691,double-stranded telomeric DNA binding,2.0
28292,TERF2,GO:0003720,telomerase activity,2.0
28294,TERF2,GO:0005515,protein binding,2.0
28295,TERF2,GO:0005634,nucleus,2.0
28296,TERF2,GO:0005654,nucleoplasm,2.0
28298,TERF2,GO:0006278,RNA-templated DNA biosynthetic process,2.0
28299,TERF2,GO:0007049,cell cycle,2.0
28300,TERF2,GO:0008022,protein C-terminus binding,2.0
28301,TERF2,GO:0008089,anterograde axonal transport,2.0
28302,TERF2,GO:0010628,positive regulation of gene expression,2.0
28303,TERF2,GO:0010629,negative regulation of gene expression,2.0
28304,TERF2,GO:0016233,telomere capping,2.0
28308,TERF2,GO:0016604,nuclear body,2.0
28309,TERF2,GO:0019899,enzyme binding,2.0
28310,TERF2,GO:0031627,telomeric loop formation,2.0
28312,TERF2,GO:0031848,protection from non-homologous end joining at telomere,2.0
28315,TERF2,GO:0032204,regulation of telomere maintenance,2.0
28316,TERF2,GO:0032205,negative regulation of telomere maintenance,2.0
28317,TERF2,GO:0032206,positive regulation of telomere maintenance,2.0
28319,TERF2,GO:0032208,negative regulation of telomere maintenance via recombination,2.0
28322,TERF2,GO:0032210,regulation of telomere maintenance via telomerase,2.0
28325,TERF2,GO:0032211,negative regulation of telomere maintenance via telomerase,2.0
28328,TERF2,GO:0032214,negative regulation of telomere maintenance via semi-conservative replication,2.0
28329,TERF2,GO:0042162,telomeric DNA binding,2.0
28330,TERF2,GO:0042803,protein homodimerization activity,2.0
28331,TERF2,GO:0044877,protein-containing complex binding,2.0
28332,TERF2,GO:0051000,positive regulation of nitric-oxide synthase activity,2.0
28333,TERF2,GO:0061820,telomeric D-loop disassembly,2.0
28335,TERF2,GO:0070187,shelterin complex,2.0
28340,TERF2,GO:0070198,"protein localization to chromosome, telomeric region",2.0
28342,TERF2,GO:0090398,cellular senescence,2.0
28343,TERF2,GO:0098505,G-rich strand telomeric DNA binding,2.0
28345,TERF2,GO:0099088,axonal transport of messenger ribonucleoprotein complex,2.0
28346,TERF2,GO:1903770,negative regulation of beta-galactosidase activity,2.0
28347,TERF2,GO:1903824,negative regulation of telomere single strand break repair,2.0
28348,TERF2,GO:1904115,axon cytoplasm,2.0
28349,TERF2,GO:1904354,negative regulation of telomere capping,2.0
28350,TERF2,GO:1904357,negative regulation of telomere maintenance via telomere lengthening,2.0
28351,TERF2,GO:1904430,negative regulation of t-circle formation,2.0
28353,TERF2,GO:1905778,negative regulation of exonuclease activity,2.0
28354,TERF2,GO:1905839,negative regulation of telomeric D-loop disassembly,2.0
28356,TERF2,GO:2000773,negative regulation of cellular senescence,2.0
28357,TET2,GO:0002521,leukocyte differentiation,2.0
28358,TET2,GO:0003677,DNA binding,2.0
28359,TET2,GO:0005515,protein binding,2.0
28360,TET2,GO:0005634,nucleus,2.0
28361,TET2,GO:0006211,5-methylcytosine catabolic process,2.0
28362,TET2,GO:0006325,chromatin organization,2.0
28363,TET2,GO:0006493,protein O-linked glycosylation,2.0
28365,TET2,GO:0007049,cell cycle,2.0
28366,TET2,GO:0008198,ferrous iron binding,2.0
28367,TET2,GO:0008270,zinc ion binding,2.0
28368,TET2,GO:0014070,response to organic cyclic compound,2.0
28369,TET2,GO:0030099,myeloid cell differentiation,2.0
28371,TET2,GO:0035511,oxidative DNA demethylation,2.0
28372,TET2,GO:0045944,positive regulation of transcription by RNA polymerase II,2.0
28374,TET2,GO:0070579,methylcytosine dioxygenase activity,2.0
28378,TET2,GO:0070989,oxidative demethylation,2.0
28379,TET2,GO:0080111,DNA demethylation,2.0
28443,THBS1,GO:0001666,response to hypoxia,2.0
28444,THBS1,GO:0001786,phosphatidylserine binding,2.0
28445,THBS1,GO:0001937,negative regulation of endothelial cell proliferation,2.0
28448,THBS1,GO:0001953,negative regulation of cell-matrix adhesion,2.0
28450,THBS1,GO:0001968,fibronectin binding,2.0
28451,THBS1,GO:0002040,sprouting angiogenesis,2.0
28452,THBS1,GO:0002544,chronic inflammatory response,2.0
28453,THBS1,GO:0002581,negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II,2.0
28454,THBS1,GO:0002605,negative regulation of dendritic cell antigen processing and presentation,2.0
28455,THBS1,GO:0005178,integrin binding,2.0
28456,THBS1,GO:0005201,extracellular matrix structural constituent,2.0
28459,THBS1,GO:0005509,calcium ion binding,2.0
28460,THBS1,GO:0005515,protein binding,2.0
28461,THBS1,GO:0005576,extracellular region,2.0
28463,THBS1,GO:0005577,fibrinogen complex,2.0
28464,THBS1,GO:0005615,extracellular space,2.0
28466,THBS1,GO:0005783,endoplasmic reticulum,2.0
28467,THBS1,GO:0005788,endoplasmic reticulum lumen,2.0
28468,THBS1,GO:0006954,inflammatory response,2.0
28469,THBS1,GO:0006955,immune response,2.0
28470,THBS1,GO:0006986,response to unfolded protein,2.0
28471,THBS1,GO:0007155,cell adhesion,2.0
28472,THBS1,GO:0008201,heparin binding,2.0
28473,THBS1,GO:0008284,positive regulation of cell population proliferation,2.0
28474,THBS1,GO:0008285,negative regulation of cell population proliferation,2.0
28475,THBS1,GO:0009410,response to xenobiotic stimulus,2.0
28476,THBS1,GO:0009612,response to mechanical stimulus,2.0
28477,THBS1,GO:0009749,response to glucose,2.0
28478,THBS1,GO:0009897,external side of plasma membrane,2.0
28479,THBS1,GO:0009986,cell surface,2.0
28480,THBS1,GO:0010595,positive regulation of endothelial cell migration,2.0
28481,THBS1,GO:0010596,negative regulation of endothelial cell migration,2.0
28482,THBS1,GO:0010748,negative regulation of long-chain fatty acid import across plasma membrane,2.0
28483,THBS1,GO:0010751,negative regulation of nitric oxide mediated signal transduction,2.0
28485,THBS1,GO:0010754,negative regulation of cGMP-mediated signaling,2.0
28486,THBS1,GO:0010757,negative regulation of plasminogen activation,2.0
28487,THBS1,GO:0010759,positive regulation of macrophage chemotaxis,2.0
28488,THBS1,GO:0010763,positive regulation of fibroblast migration,2.0
28489,THBS1,GO:0016477,cell migration,2.0
28490,THBS1,GO:0016525,negative regulation of angiogenesis,2.0
28494,THBS1,GO:0016529,sarcoplasmic reticulum,2.0
28495,THBS1,GO:0017134,fibroblast growth factor binding,2.0
28496,THBS1,GO:0018149,peptide cross-linking,2.0
28497,THBS1,GO:0030141,secretory granule,2.0
28498,THBS1,GO:0030169,low-density lipoprotein particle binding,2.0
28499,THBS1,GO:0030194,positive regulation of blood coagulation,2.0
28500,THBS1,GO:0030335,positive regulation of cell migration,2.0
28502,THBS1,GO:0030511,positive regulation of transforming growth factor beta receptor signaling pathway,2.0
28503,THBS1,GO:0031012,extracellular matrix,2.0
28504,THBS1,GO:0031091,platelet alpha granule,2.0
28505,THBS1,GO:0031093,platelet alpha granule lumen,2.0
28506,THBS1,GO:0032026,response to magnesium ion,2.0
28507,THBS1,GO:0032570,response to progesterone,2.0
28508,THBS1,GO:0032695,negative regulation of interleukin-12 production,2.0
28509,THBS1,GO:0032760,positive regulation of tumor necrosis factor production,2.0
28510,THBS1,GO:0032914,positive regulation of transforming growth factor beta1 production,2.0
28511,THBS1,GO:0033574,response to testosterone,2.0
28512,THBS1,GO:0034605,cellular response to heat,2.0
28513,THBS1,GO:0034976,response to endoplasmic reticulum stress,2.0
28514,THBS1,GO:0040037,negative regulation of fibroblast growth factor receptor signaling pathway,2.0
28515,THBS1,GO:0042327,positive regulation of phosphorylation,2.0
28516,THBS1,GO:0042802,identical protein binding,2.0
28517,THBS1,GO:0043032,positive regulation of macrophage activation,2.0
28518,THBS1,GO:0043066,negative regulation of apoptotic process,2.0
28519,THBS1,GO:0043154,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process,2.0
28520,THBS1,GO:0043236,laminin binding,2.0
28521,THBS1,GO:0043394,proteoglycan binding,2.0
28522,THBS1,GO:0043406,positive regulation of MAP kinase activity,2.0
28523,THBS1,GO:0043536,positive regulation of blood vessel endothelial cell migration,2.0
28524,THBS1,GO:0043537,negative regulation of blood vessel endothelial cell migration,2.0
28525,THBS1,GO:0043652,engulfment of apoptotic cell,2.0
28526,THBS1,GO:0045727,positive regulation of translation,2.0
28527,THBS1,GO:0045766,positive regulation of angiogenesis,2.0
28528,THBS1,GO:0048266,behavioral response to pain,2.0
28529,THBS1,GO:0048661,positive regulation of smooth muscle cell proliferation,2.0
28530,THBS1,GO:0050431,transforming growth factor beta binding,2.0
28532,THBS1,GO:0050921,positive regulation of chemotaxis,2.0
28533,THBS1,GO:0051592,response to calcium ion,2.0
28534,THBS1,GO:0051895,negative regulation of focal adhesion assembly,2.0
28535,THBS1,GO:0051897,positive regulation of protein kinase B signaling,2.0
28536,THBS1,GO:0051918,negative regulation of fibrinolysis,2.0
28537,THBS1,GO:0062023,collagen-containing extracellular matrix,2.0
28542,THBS1,GO:0070051,fibrinogen binding,2.0
28543,THBS1,GO:0070052,collagen V binding,2.0
28544,THBS1,GO:0070062,extracellular exosome,2.0
28545,THBS1,GO:0071356,cellular response to tumor necrosis factor,2.0
28546,THBS1,GO:0071363,cellular response to growth factor stimulus,2.0
28547,THBS1,GO:0090051,negative regulation of cell migration involved in sprouting angiogenesis,2.0
28548,THBS1,GO:1902043,positive regulation of extrinsic apoptotic signaling pathway via death domain receptors,2.0
28549,THBS1,GO:1903588,negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis,2.0
28550,THBS1,GO:1903671,negative regulation of sprouting angiogenesis,2.0
28551,THBS1,GO:2000353,positive regulation of endothelial cell apoptotic process,2.0
28552,THBS1,GO:2000379,positive regulation of reactive oxygen species metabolic process,2.0
28553,THBS1,GO:2001027,negative regulation of endothelial cell chemotaxis,2.0
28554,THBS1,GO:2001237,negative regulation of extrinsic apoptotic signaling pathway,2.0
28555,THRA,GO:0000122,negative regulation of transcription by RNA polymerase II,2.0
28556,THRA,GO:0000785,chromatin,2.0
28557,THRA,GO:0000976,transcription cis-regulatory region binding,2.0
28558,THRA,GO:0000978,RNA polymerase II cis-regulatory region sequence-specific DNA binding,2.0
28559,THRA,GO:0000981,"DNA-binding transcription factor activity, RNA polymerase II-specific",2.0
28560,THRA,GO:0001502,cartilage condensation,2.0
28561,THRA,GO:0001503,ossification,2.0
28562,THRA,GO:0002154,thyroid hormone mediated signaling pathway,2.0
28563,THRA,GO:0002155,regulation of thyroid hormone mediated signaling pathway,2.0
28564,THRA,GO:0003700,DNA-binding transcription factor activity,2.0
28565,THRA,GO:0004879,nuclear receptor activity,2.0
28567,THRA,GO:0005515,protein binding,2.0
28568,THRA,GO:0005634,nucleus,2.0
28569,THRA,GO:0005654,nucleoplasm,2.0
28570,THRA,GO:0005829,cytosol,2.0
28571,THRA,GO:0006357,regulation of transcription by RNA polymerase II,2.0
28572,THRA,GO:0006366,transcription by RNA polymerase II,2.0
28573,THRA,GO:0007611,learning or memory,2.0
28574,THRA,GO:0008016,regulation of heart contraction,2.0
28575,THRA,GO:0008050,female courtship behavior,2.0
28576,THRA,GO:0008270,zinc ion binding,2.0
28577,THRA,GO:0009409,response to cold,2.0
28578,THRA,GO:0009755,hormone-mediated signaling pathway,2.0
28580,THRA,GO:0017025,TBP-class protein binding,2.0
28581,THRA,GO:0017055,negative regulation of RNA polymerase II transcription preinitiation complex assembly,2.0
28582,THRA,GO:0019904,protein domain specific binding,2.0
28583,THRA,GO:0030154,cell differentiation,2.0
28584,THRA,GO:0030218,erythrocyte differentiation,2.0
28585,THRA,GO:0030878,thyroid gland development,2.0
28586,THRA,GO:0031490,chromatin DNA binding,2.0
28587,THRA,GO:0033032,regulation of myeloid cell apoptotic process,2.0
28588,THRA,GO:0044877,protein-containing complex binding,2.0
28589,THRA,GO:0045892,negative regulation of DNA-templated transcription,2.0
28590,THRA,GO:0045925,positive regulation of female receptivity,2.0
28591,THRA,GO:0045944,positive regulation of transcription by RNA polymerase II,2.0
28592,THRA,GO:0050994,regulation of lipid catabolic process,2.0
28593,THRA,GO:0060509,type I pneumocyte differentiation,2.0
28594,THRA,GO:0070324,thyroid hormone binding,2.0
28596,THRA,GO:0120162,positive regulation of cold-induced thermogenesis,2.0
28597,THRA,GO:0140296,general transcription initiation factor binding,2.0
28598,THRA,GO:2000143,negative regulation of DNA-templated transcription initiation,2.0
28625,TM4SF19,GO:0005515,protein binding,2.0
28626,TM4SF19,GO:0016020,membrane,2.0
28649,TMEM39B,GO:0008150,biological_process,2.0
28650,TMEM39B,GO:0016020,membrane,2.0
28651,TMLHE,GO:0005506,iron ion binding,2.0
28652,TMLHE,GO:0005739,mitochondrion,2.0
28654,TMLHE,GO:0005759,mitochondrial matrix,2.0
28655,TMLHE,GO:0045329,carnitine biosynthetic process,2.0
28658,TMLHE,GO:0050353,trimethyllysine dioxygenase activity,2.0
28669,TNRC6B,GO:0000932,P-body,2.0
28670,TNRC6B,GO:0003723,RNA binding,2.0
28671,TNRC6B,GO:0005515,protein binding,2.0
28672,TNRC6B,GO:0005654,nucleoplasm,2.0
28673,TNRC6B,GO:0005829,cytosol,2.0
28674,TNRC6B,GO:0031047,RNA-mediated gene silencing,2.0
28675,TNRC6B,GO:0035195,miRNA-mediated gene silencing,2.0
28676,TNRC6B,GO:0035278,miRNA-mediated gene silencing by inhibition of translation,2.0
28677,TNRC6B,GO:0060213,positive regulation of nuclear-transcribed mRNA poly(A) tail shortening,2.0
28679,TNRC6B,GO:1900153,"positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay",2.0
28680,TNRC6C,GO:0000932,P-body,2.0
28681,TNRC6C,GO:0003723,RNA binding,2.0
28682,TNRC6C,GO:0005515,protein binding,2.0
28683,TNRC6C,GO:0005654,nucleoplasm,2.0
28684,TNRC6C,GO:0005829,cytosol,2.0
28685,TNRC6C,GO:0035195,miRNA-mediated gene silencing,2.0
28687,TNRC6C,GO:0035278,miRNA-mediated gene silencing by inhibition of translation,2.0
28688,TNRC6C,GO:0060213,positive regulation of nuclear-transcribed mRNA poly(A) tail shortening,2.0
28690,TNRC6C,GO:1900153,"positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay",2.0
28714,TOP2B,GO:0000712,resolution of meiotic recombination intermediates,2.0
28715,TOP2B,GO:0000792,heterochromatin,2.0
28716,TOP2B,GO:0000819,sister chromatid segregation,2.0
28717,TOP2B,GO:0001764,neuron migration,2.0
28718,TOP2B,GO:0003677,DNA binding,2.0
28719,TOP2B,GO:0003682,chromatin binding,2.0
28720,TOP2B,GO:0003918,"DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) activity",2.0
28722,TOP2B,GO:0005080,protein kinase C binding,2.0
28723,TOP2B,GO:0005524,ATP binding,2.0
28724,TOP2B,GO:0005634,nucleus,2.0
28726,TOP2B,GO:0005654,nucleoplasm,2.0
28728,TOP2B,GO:0005730,nucleolus,2.0
28730,TOP2B,GO:0005829,cytosol,2.0
28731,TOP2B,GO:0006265,DNA topological change,2.0
28732,TOP2B,GO:0007409,axonogenesis,2.0
28733,TOP2B,GO:0008022,protein C-terminus binding,2.0
28734,TOP2B,GO:0019899,enzyme binding,2.0
28735,TOP2B,GO:0030183,B cell differentiation,2.0
28736,TOP2B,GO:0030900,forebrain development,2.0
28737,TOP2B,GO:0042826,histone deacetylase binding,2.0
28738,TOP2B,GO:0045870,positive regulation of single stranded viral RNA replication via double stranded DNA intermediate,2.0
28739,TOP2B,GO:0046872,metal ion binding,2.0
28740,TOP2B,GO:0046982,protein heterodimerization activity,2.0
28741,TOP2B,GO:1990904,ribonucleoprotein complex,2.0
28742,TOP3B,GO:0000793,condensed chromosome,2.0
28743,TOP3B,GO:0003677,DNA binding,2.0
28744,TOP3B,GO:0003723,RNA binding,2.0
28745,TOP3B,GO:0003916,DNA topoisomerase activity,2.0
28746,TOP3B,GO:0003917,"DNA topoisomerase type I (single strand cut, ATP-independent) activity",2.0
28747,TOP3B,GO:0005515,protein binding,2.0
28748,TOP3B,GO:0005634,nucleus,2.0
28750,TOP3B,GO:0006265,DNA topological change,2.0
28752,TOP3B,GO:0007059,chromosome segregation,2.0
28753,TOP3B,GO:0140225,DNA topoisomerase III-beta-TDRD3 complex,2.0
28803,TRAPPC9,GO:0005515,protein binding,2.0
28804,TRAPPC9,GO:0005737,cytoplasm,2.0
28805,TRAPPC9,GO:0005783,endoplasmic reticulum,2.0
28806,TRAPPC9,GO:0005802,trans-Golgi network,2.0
28807,TRAPPC9,GO:0005829,cytosol,2.0
28808,TRAPPC9,GO:0006888,endoplasmic reticulum to Golgi vesicle-mediated transport,2.0
28809,TRAPPC9,GO:0006901,vesicle coating,2.0
28810,TRAPPC9,GO:0021987,cerebral cortex development,2.0
28811,TRAPPC9,GO:0030008,TRAPP complex,2.0
28812,TRAPPC9,GO:0030182,neuron differentiation,2.0
28813,TRAPPC9,GO:0051092,positive regulation of NF-kappaB transcription factor activity,2.0
28814,TRAPPC9,GO:0099022,vesicle tethering,2.0
28815,TRAPPC9,GO:1990071,TRAPPII protein complex,2.0
28940,TRPC6,GO:0005261,cation channel activity,2.0
28941,TRPC6,GO:0005262,calcium channel activity,2.0
28942,TRPC6,GO:0005515,protein binding,2.0
28943,TRPC6,GO:0005737,cytoplasm,2.0
28944,TRPC6,GO:0005886,plasma membrane,2.0
28947,TRPC6,GO:0006812,cation transport,2.0
28948,TRPC6,GO:0007204,positive regulation of cytosolic calcium ion concentration,2.0
28949,TRPC6,GO:0007338,single fertilization,2.0
28950,TRPC6,GO:0015279,store-operated calcium channel activity,2.0
28951,TRPC6,GO:0016020,membrane,2.0
28952,TRPC6,GO:0032414,positive regulation of ion transmembrane transporter activity,2.0
28953,TRPC6,GO:0034703,cation channel complex,2.0
28954,TRPC6,GO:0036057,slit diaphragm,2.0
28955,TRPC6,GO:0042803,protein homodimerization activity,2.0
28956,TRPC6,GO:0051480,regulation of cytosolic calcium ion concentration,2.0
28957,TRPC6,GO:0051928,positive regulation of calcium ion transport,2.0
28958,TRPC6,GO:0070588,calcium ion transmembrane transport,2.0
28960,TRPC6,GO:0070679,"inositol 1,4,5 trisphosphate binding",2.0
28962,TRPM1,GO:0005261,cation channel activity,2.0
28963,TRPM1,GO:0005262,calcium channel activity,2.0
28966,TRPM1,GO:0005789,endoplasmic reticulum membrane,2.0
28967,TRPM1,GO:0005886,plasma membrane,2.0
28969,TRPM1,GO:0007216,G protein-coupled glutamate receptor signaling pathway,2.0
28970,TRPM1,GO:0007601,visual perception,2.0
28971,TRPM1,GO:0030424,axon,2.0
28972,TRPM1,GO:0051262,protein tetramerization,2.0
28973,TRPM1,GO:0070588,calcium ion transmembrane transport,2.0
28974,TRPM1,GO:0071482,cellular response to light stimulus,2.0
28975,TRPM1,GO:0098655,cation transmembrane transport,2.0
28976,TRPM1,GO:0098703,calcium ion import across plasma membrane,2.0
28993,TRRAP,GO:0000124,SAGA complex,2.0
28997,TRRAP,GO:0000786,nucleosome,2.0
28998,TRRAP,GO:0000812,Swr1 complex,2.0
28999,TRRAP,GO:0003712,transcription coregulator activity,2.0
29000,TRRAP,GO:0005515,protein binding,2.0
29001,TRRAP,GO:0005634,nucleus,2.0
29003,TRRAP,GO:0005654,nucleoplasm,2.0
29005,TRRAP,GO:0005794,Golgi apparatus,2.0
29006,TRRAP,GO:0006281,DNA repair,2.0
29007,TRRAP,GO:0006282,regulation of DNA repair,2.0
29008,TRRAP,GO:0006325,chromatin organization,2.0
29009,TRRAP,GO:0006351,DNA-templated transcription,2.0
29010,TRRAP,GO:0006355,regulation of DNA-templated transcription,2.0
29012,TRRAP,GO:0006357,regulation of transcription by RNA polymerase II,2.0
29013,TRRAP,GO:0016301,kinase activity,2.0
29014,TRRAP,GO:0016573,histone acetylation,2.0
29015,TRRAP,GO:0033276,transcription factor TFTC complex,2.0
29017,TRRAP,GO:0035267,NuA4 histone acetyltransferase complex,2.0
29019,TRRAP,GO:0035521,monoubiquitinated histone deubiquitination,2.0
29021,TRRAP,GO:0035522,monoubiquitinated histone H2A deubiquitination,2.0
29023,TRRAP,GO:0042981,regulation of apoptotic process,2.0
29024,TRRAP,GO:0043484,regulation of RNA splicing,2.0
29025,TRRAP,GO:0043966,histone H3 acetylation,2.0
29027,TRRAP,GO:0043967,histone H4 acetylation,2.0
29028,TRRAP,GO:0043968,histone H2A acetylation,2.0
29029,TRRAP,GO:0045893,positive regulation of DNA-templated transcription,2.0
29030,TRRAP,GO:0051726,regulation of cell cycle,2.0
29031,TRRAP,GO:1905168,positive regulation of double-strand break repair via homologous recombination,2.0
29032,TRRAP,GO:2000779,regulation of double-strand break repair,2.0
29173,TSPAN17,GO:0000151,ubiquitin ligase complex,2.0
29174,TSPAN17,GO:0004842,ubiquitin-protein transferase activity,2.0
29175,TSPAN17,GO:0005886,plasma membrane,2.0
29176,TSPAN17,GO:0016567,protein ubiquitination,2.0
29177,TSPAN17,GO:0019899,enzyme binding,2.0
29178,TSPAN17,GO:0051604,protein maturation,2.0
29179,TSPAN17,GO:0072594,establishment of protein localization to organelle,2.0
29180,TSPAN17,GO:0072659,protein localization to plasma membrane,2.0
29181,TSPAN4,GO:0003823,antigen binding,2.0
29182,TSPAN4,GO:0005178,integrin binding,2.0
29183,TSPAN4,GO:0005515,protein binding,2.0
29184,TSPAN4,GO:0005886,plasma membrane,2.0
29186,TSPAN4,GO:0005925,focal adhesion,2.0
29187,TSPAN4,GO:0031982,vesicle,2.0
29188,TSPAN4,GO:0065003,protein-containing complex assembly,2.0
29189,TSPAN7,GO:0005515,protein binding,2.0
29190,TSPAN7,GO:0005886,plasma membrane,2.0
29191,TSPOAP1,GO:0005515,protein binding,2.0
29192,TSPOAP1,GO:0005737,cytoplasm,2.0
29193,TSPOAP1,GO:0005739,mitochondrion,2.0
29195,TSPOAP1,GO:0005829,cytosol,2.0
29196,TSPOAP1,GO:0007274,neuromuscular synaptic transmission,2.0
29197,TSPOAP1,GO:0008150,biological_process,2.0
29198,TSPOAP1,GO:0030156,benzodiazepine receptor binding,2.0
29200,TSPOAP1,GO:0044305,calyx of Held,2.0
29201,TSPOAP1,GO:0098978,glutamatergic synapse,2.0
29202,TSPOAP1,GO:0099509,regulation of presynaptic cytosolic calcium ion concentration,2.0
29203,TSPOAP1,GO:0099626,voltage-gated calcium channel activity involved in regulation of presynaptic cytosolic calcium levels,2.0
29215,TTN,GO:0000794,condensed nuclear chromosome,2.0
29216,TTN,GO:0002020,protease binding,2.0
29217,TTN,GO:0003300,cardiac muscle hypertrophy,2.0
29218,TTN,GO:0004674,protein serine/threonine kinase activity,2.0
29219,TTN,GO:0004713,protein tyrosine kinase activity,2.0
29220,TTN,GO:0005509,calcium ion binding,2.0
29221,TTN,GO:0005515,protein binding,2.0
29222,TTN,GO:0005516,calmodulin binding,2.0
29224,TTN,GO:0005524,ATP binding,2.0
29225,TTN,GO:0005576,extracellular region,2.0
29226,TTN,GO:0005829,cytosol,2.0
29227,TTN,GO:0006936,muscle contraction,2.0
29229,TTN,GO:0006941,striated muscle contraction,2.0
29230,TTN,GO:0007076,mitotic chromosome condensation,2.0
29231,TTN,GO:0008307,structural constituent of muscle,2.0
29233,TTN,GO:0010628,positive regulation of gene expression,2.0
29235,TTN,GO:0010737,protein kinase A signaling,2.0
29236,TTN,GO:0018108,peptidyl-tyrosine phosphorylation,2.0
29237,TTN,GO:0019899,enzyme binding,2.0
29238,TTN,GO:0019901,protein kinase binding,2.0
29239,TTN,GO:0030018,Z disc,2.0
29240,TTN,GO:0030240,skeletal muscle thin filament assembly,2.0
29241,TTN,GO:0030241,skeletal muscle myosin thick filament assembly,2.0
29242,TTN,GO:0031433,telethonin binding,2.0
29244,TTN,GO:0031674,I band,2.0
29245,TTN,GO:0035995,detection of muscle stretch,2.0
29247,TTN,GO:0042802,identical protein binding,2.0
29248,TTN,GO:0042805,actinin binding,2.0
29250,TTN,GO:0043621,protein self-association,2.0
29251,TTN,GO:0045214,sarcomere organization,2.0
29252,TTN,GO:0045859,regulation of protein kinase activity,2.0
29253,TTN,GO:0048769,sarcomerogenesis,2.0
29254,TTN,GO:0050714,positive regulation of protein secretion,2.0
29256,TTN,GO:0050790,regulation of catalytic activity,2.0
29257,TTN,GO:0051015,actin filament binding,2.0
29258,TTN,GO:0051371,muscle alpha-actinin binding,2.0
29259,TTN,GO:0051592,response to calcium ion,2.0
29260,TTN,GO:0055003,cardiac myofibril assembly,2.0
29261,TTN,GO:0055008,cardiac muscle tissue morphogenesis,2.0
29262,TTN,GO:0055013,cardiac muscle cell development,2.0
29263,TTN,GO:0060048,cardiac muscle contraction,2.0
29264,TTN,GO:0070062,extracellular exosome,2.0
29265,TTN,GO:0097493,structural molecule activity conferring elasticity,2.0
29267,TTN,GO:0106310,protein serine kinase activity,2.0
29268,TTN,GO:1990733,titin-telethonin complex,2.0
29269,TUBGCP5,GO:0000278,mitotic cell cycle,2.0
29270,TUBGCP5,GO:0000922,spindle pole,2.0
29271,TUBGCP5,GO:0000923,equatorial microtubule organizing center,2.0
29272,TUBGCP5,GO:0000930,gamma-tubulin complex,2.0
29273,TUBGCP5,GO:0000931,gamma-tubulin ring complex,2.0
29274,TUBGCP5,GO:0005515,protein binding,2.0
29275,TUBGCP5,GO:0005813,centrosome,2.0
29277,TUBGCP5,GO:0005829,cytosol,2.0
29279,TUBGCP5,GO:0005874,microtubule,2.0
29280,TUBGCP5,GO:0007020,microtubule nucleation,2.0
29282,TUBGCP5,GO:0008017,microtubule binding,2.0
29283,TUBGCP5,GO:0031122,cytoplasmic microtubule organization,2.0
29284,TUBGCP5,GO:0043015,gamma-tubulin binding,2.0
29285,TUBGCP5,GO:0051011,microtubule minus-end binding,2.0
29286,TUBGCP5,GO:0051225,spindle assembly,2.0
29287,TUBGCP5,GO:0051321,meiotic cell cycle,2.0
29319,UBE3C,GO:0000209,protein polyubiquitination,2.0
29321,UBE3C,GO:0000502,proteasome complex,2.0
29322,UBE3C,GO:0005515,protein binding,2.0
29323,UBE3C,GO:0006511,ubiquitin-dependent protein catabolic process,2.0
29324,UBE3C,GO:0035519,protein K29-linked ubiquitination,2.0
29325,UBE3C,GO:0061630,ubiquitin protein ligase activity,2.0
29327,UBE3C,GO:0070936,protein K48-linked ubiquitination,2.0
29328,UBN2,GO:0005615,extracellular space,2.0
29329,UBN2,GO:0005634,nucleus,2.0
29330,UBN2,GO:0005654,nucleoplasm,2.0
29331,UBR5,GO:0000209,protein polyubiquitination,2.0
29333,UBR5,GO:0003723,RNA binding,2.0
29334,UBR5,GO:0005515,protein binding,2.0
29335,UBR5,GO:0005634,nucleus,2.0
29337,UBR5,GO:0005654,nucleoplasm,2.0
29338,UBR5,GO:0005737,cytoplasm,2.0
29339,UBR5,GO:0005829,cytosol,2.0
29340,UBR5,GO:0006281,DNA repair,2.0
29341,UBR5,GO:0006974,cellular response to DNA damage stimulus,2.0
29343,UBR5,GO:0008270,zinc ion binding,2.0
29344,UBR5,GO:0010628,positive regulation of gene expression,2.0
29345,UBR5,GO:0016020,membrane,2.0
29346,UBR5,GO:0032991,protein-containing complex,2.0
29347,UBR5,GO:0034450,ubiquitin-ubiquitin ligase activity,2.0
29349,UBR5,GO:0042307,positive regulation of protein import into nucleus,2.0
29350,UBR5,GO:0043130,ubiquitin binding,2.0
29351,UBR5,GO:0048471,perinuclear region of cytoplasm,2.0
29352,UBR5,GO:0050847,progesterone receptor signaling pathway,2.0
29353,UBR5,GO:0061630,ubiquitin protein ligase activity,2.0
29354,UBR5,GO:0070936,protein K48-linked ubiquitination,2.0
29355,UBR5,GO:0090263,positive regulation of canonical Wnt signaling pathway,2.0
29357,UBR5,GO:1901315,negative regulation of histone H2A K63-linked ubiquitination,2.0
29359,UBR5,GO:2000779,regulation of double-strand break repair,2.0
29360,UBR5,GO:2000780,negative regulation of double-strand break repair,2.0
29361,UIMC1,GO:0003677,DNA binding,2.0
29362,UIMC1,GO:0005515,protein binding,2.0
29363,UIMC1,GO:0005634,nucleus,2.0
29365,UIMC1,GO:0005654,nucleoplasm,2.0
29367,UIMC1,GO:0006282,regulation of DNA repair,2.0
29368,UIMC1,GO:0006302,double-strand break repair,2.0
29370,UIMC1,GO:0006325,chromatin organization,2.0
29371,UIMC1,GO:0007095,mitotic G2 DNA damage checkpoint signaling,2.0
29372,UIMC1,GO:0010212,response to ionizing radiation,2.0
29373,UIMC1,GO:0016604,nuclear body,2.0
29374,UIMC1,GO:0042393,histone binding,2.0
29376,UIMC1,GO:0044818,mitotic G2/M transition checkpoint,2.0
29377,UIMC1,GO:0045739,positive regulation of DNA repair,2.0
29379,UIMC1,GO:0045892,negative regulation of DNA-templated transcription,2.0
29380,UIMC1,GO:0046872,metal ion binding,2.0
29381,UIMC1,GO:0070530,K63-linked polyubiquitin modification-dependent protein binding,2.0
29383,UIMC1,GO:0070531,BRCA1-A complex,2.0
29386,UIMC1,GO:0070537,histone H2A K63-linked deubiquitination,2.0
29389,UNC13A,GO:0005509,calcium ion binding,2.0
29390,UNC13A,GO:0005516,calmodulin binding,2.0
29392,UNC13A,GO:0005543,phospholipid binding,2.0
29393,UNC13A,GO:0005886,plasma membrane,2.0
29394,UNC13A,GO:0007269,neurotransmitter secretion,2.0
29395,UNC13A,GO:0007528,neuromuscular junction development,2.0
29396,UNC13A,GO:0016081,synaptic vesicle docking,2.0
29397,UNC13A,GO:0016082,synaptic vesicle priming,2.0
29398,UNC13A,GO:0016188,synaptic vesicle maturation,2.0
29399,UNC13A,GO:0017075,syntaxin-1 binding,2.0
29401,UNC13A,GO:0019992,diacylglycerol binding,2.0
29402,UNC13A,GO:0030154,cell differentiation,2.0
29403,UNC13A,GO:0030672,synaptic vesicle membrane,2.0
29404,UNC13A,GO:0031594,neuromuscular junction,2.0
29405,UNC13A,GO:0035249,"synaptic transmission, glutamatergic",2.0
29406,UNC13A,GO:0042734,presynaptic membrane,2.0
29408,UNC13A,GO:0043005,neuron projection,2.0
29409,UNC13A,GO:0043195,terminal bouton,2.0
29410,UNC13A,GO:0048786,presynaptic active zone,2.0
29411,UNC13A,GO:0051966,"regulation of synaptic transmission, glutamatergic",2.0
29412,UNC13A,GO:0061789,dense core granule priming,2.0
29413,UNC13A,GO:0098831,presynaptic active zone cytoplasmic component,2.0
29414,UNC13A,GO:0099011,neuronal dense core vesicle exocytosis,2.0
29415,UNC13A,GO:0099525,presynaptic dense core vesicle exocytosis,2.0
29416,UNC13A,GO:1903861,positive regulation of dendrite extension,2.0
29426,UNC79,GO:0005886,plasma membrane,2.0
29428,UNC80,GO:0005261,cation channel activity,2.0
29429,UNC80,GO:0005886,plasma membrane,2.0
29431,UNC80,GO:0030424,axon,2.0
29432,UNC80,GO:0034703,cation channel complex,2.0
29433,UNC80,GO:0055080,cation homeostasis,2.0
29434,UNC80,GO:0098655,cation transmembrane transport,2.0
29435,UPF2,GO:0000184,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay",2.0
29438,UPF2,GO:0001889,liver development,2.0
29439,UPF2,GO:0003723,RNA binding,2.0
29440,UPF2,GO:0005515,protein binding,2.0
29441,UPF2,GO:0005634,nucleus,2.0
29442,UPF2,GO:0005737,cytoplasm,2.0
29444,UPF2,GO:0005829,cytosol,2.0
29446,UPF2,GO:0005844,polysome,2.0
29447,UPF2,GO:0006406,mRNA export from nucleus,2.0
29448,UPF2,GO:0031100,animal organ regeneration,2.0
29449,UPF2,GO:0035145,exon-exon junction complex,2.0
29451,UPF2,GO:0036464,cytoplasmic ribonucleoprotein granule,2.0
29452,UPF2,GO:0042162,telomeric DNA binding,2.0
29453,UPF2,GO:0048471,perinuclear region of cytoplasm,2.0
29454,UPF2,GO:0060090,molecular adaptor activity,2.0
29481,USH2A,GO:0001917,photoreceptor inner segment,2.0
29482,USH2A,GO:0002141,stereocilia ankle link,2.0
29484,USH2A,GO:0002142,stereocilia ankle link complex,2.0
29485,USH2A,GO:0005515,protein binding,2.0
29486,USH2A,GO:0005518,collagen binding,2.0
29487,USH2A,GO:0005576,extracellular region,2.0
29488,USH2A,GO:0005604,basement membrane,2.0
29490,USH2A,GO:0005737,cytoplasm,2.0
29491,USH2A,GO:0007601,visual perception,2.0
29492,USH2A,GO:0007605,sensory perception of sound,2.0
29493,USH2A,GO:0009887,animal organ morphogenesis,2.0
29494,USH2A,GO:0009888,tissue development,2.0
29495,USH2A,GO:0016324,apical plasma membrane,2.0
29496,USH2A,GO:0016477,cell migration,2.0
29497,USH2A,GO:0017022,myosin binding,2.0
29498,USH2A,GO:0032391,photoreceptor connecting cilium,2.0
29499,USH2A,GO:0032421,stereocilium bundle,2.0
29500,USH2A,GO:0034446,substrate adhesion-dependent cell spreading,2.0
29501,USH2A,GO:0035315,hair cell differentiation,2.0
29502,USH2A,GO:0036064,ciliary basal body,2.0
29503,USH2A,GO:0042491,inner ear auditory receptor cell differentiation,2.0
29504,USH2A,GO:0042802,identical protein binding,2.0
29505,USH2A,GO:0043025,neuronal cell body,2.0
29506,USH2A,GO:0043195,terminal bouton,2.0
29507,USH2A,GO:0045184,establishment of protein localization,2.0
29508,USH2A,GO:0045494,photoreceptor cell maintenance,2.0
29509,USH2A,GO:0048496,maintenance of animal organ identity,2.0
29510,USH2A,GO:0050896,response to stimulus,2.0
29511,USH2A,GO:0050953,sensory perception of light stimulus,2.0
29512,USH2A,GO:0051649,establishment of localization in cell,2.0
29513,USH2A,GO:0060113,inner ear receptor cell differentiation,2.0
29515,USH2A,GO:0060171,stereocilium membrane,2.0
29516,USH2A,GO:1990075,periciliary membrane compartment,2.0
29517,USH2A,GO:1990696,USH2 complex,2.0
29519,USP15,GO:0004197,cysteine-type endopeptidase activity,2.0
29520,USP15,GO:0004843,cysteine-type deubiquitinase activity,2.0
29522,USP15,GO:0005160,transforming growth factor beta receptor binding,2.0
29523,USP15,GO:0005515,protein binding,2.0
29524,USP15,GO:0005634,nucleus,2.0
29526,USP15,GO:0005654,nucleoplasm,2.0
29527,USP15,GO:0005737,cytoplasm,2.0
29528,USP15,GO:0005739,mitochondrion,2.0
29529,USP15,GO:0005829,cytosol,2.0
29531,USP15,GO:0006511,ubiquitin-dependent protein catabolic process,2.0
29532,USP15,GO:0007179,transforming growth factor beta receptor signaling pathway,2.0
29534,USP15,GO:0016579,protein deubiquitination,2.0
29536,USP15,GO:0016604,nuclear body,2.0
29537,USP15,GO:0030509,BMP signaling pathway,2.0
29538,USP15,GO:0035520,monoubiquitinated protein deubiquitination,2.0
29539,USP15,GO:0035616,histone H2B conserved C-terminal lysine deubiquitination,2.0
29540,USP15,GO:0042802,identical protein binding,2.0
29541,USP15,GO:0046332,SMAD binding,2.0
29542,USP15,GO:0060389,pathway-restricted SMAD protein phosphorylation,2.0
29543,USP15,GO:0061649,ubiquitin modification-dependent histone binding,2.0
29544,USP15,GO:0071108,protein K48-linked deubiquitination,2.0
29545,USP15,GO:1900246,positive regulation of RIG-I signaling pathway,2.0
29546,USP15,GO:1905035,negative regulation of antifungal innate immune response,2.0
29547,USP15,GO:1990167,protein K27-linked deubiquitination,2.0
29548,USP15,GO:1990380,K48-linked deubiquitinase activity,2.0
29573,USP45,GO:0001917,photoreceptor inner segment,2.0
29574,USP45,GO:0003407,neural retina development,2.0
29575,USP45,GO:0004843,cysteine-type deubiquitinase activity,2.0
29578,USP45,GO:0005515,protein binding,2.0
29579,USP45,GO:0005634,nucleus,2.0
29580,USP45,GO:0005654,nucleoplasm,2.0
29581,USP45,GO:0005737,cytoplasm,2.0
29582,USP45,GO:0006281,DNA repair,2.0
29583,USP45,GO:0006511,ubiquitin-dependent protein catabolic process,2.0
29584,USP45,GO:0008270,zinc ion binding,2.0
29585,USP45,GO:0016477,cell migration,2.0
29586,USP45,GO:0016579,protein deubiquitination,2.0
29588,USP45,GO:0045494,photoreceptor cell maintenance,2.0
29589,USP45,GO:0070911,global genome nucleotide-excision repair,2.0
29590,USP7,GO:0002039,p53 binding,2.0
29591,USP7,GO:0004197,cysteine-type endopeptidase activity,2.0
29593,USP7,GO:0004843,cysteine-type deubiquitinase activity,2.0
29598,USP7,GO:0005515,protein binding,2.0
29599,USP7,GO:0005634,nucleus,2.0
29602,USP7,GO:0005654,nucleoplasm,2.0
29603,USP7,GO:0005694,chromosome,2.0
29604,USP7,GO:0005829,cytosol,2.0
29607,USP7,GO:0006111,regulation of gluconeogenesis,2.0
29608,USP7,GO:0006283,transcription-coupled nucleotide-excision repair,2.0
29609,USP7,GO:0006511,ubiquitin-dependent protein catabolic process,2.0
29610,USP7,GO:0008022,protein C-terminus binding,2.0
29611,USP7,GO:0010216,maintenance of DNA methylation,2.0
29612,USP7,GO:0016567,protein ubiquitination,2.0
29613,USP7,GO:0016579,protein deubiquitination,2.0
29617,USP7,GO:0016604,nuclear body,2.0
29618,USP7,GO:0016605,PML body,2.0
29619,USP7,GO:0031625,ubiquitin protein ligase binding,2.0
29620,USP7,GO:0031647,regulation of protein stability,2.0
29622,USP7,GO:0032088,negative regulation of NF-kappaB transcription factor activity,2.0
29623,USP7,GO:0032435,negative regulation of proteasomal ubiquitin-dependent protein catabolic process,2.0
29624,USP7,GO:0032991,protein-containing complex,2.0
29625,USP7,GO:0035520,monoubiquitinated protein deubiquitination,2.0
29626,USP7,GO:0035616,histone H2B conserved C-terminal lysine deubiquitination,2.0
29627,USP7,GO:0042752,regulation of circadian rhythm,2.0
29628,USP7,GO:0048511,rhythmic process,2.0
29629,USP7,GO:0050821,protein stabilization,2.0
29631,USP7,GO:0051090,regulation of DNA-binding transcription factor activity,2.0
29632,USP7,GO:0070536,protein K63-linked deubiquitination,2.0
29633,USP7,GO:0071108,protein K48-linked deubiquitination,2.0
29634,USP7,GO:0101005,deubiquitinase activity,2.0
29635,USP7,GO:1901537,positive regulation of DNA demethylation,2.0
29636,USP7,GO:1901796,regulation of signal transduction by p53 class mediator,2.0
29637,USP7,GO:1904353,regulation of telomere capping,2.0
29638,USP7,GO:1905279,"regulation of retrograde transport, endosome to Golgi",2.0
29639,USP7,GO:1990380,K48-linked deubiquitinase activity,2.0
29691,USP9Y,GO:0004197,cysteine-type endopeptidase activity,2.0
29692,USP9Y,GO:0004843,cysteine-type deubiquitinase activity,2.0
29693,USP9Y,GO:0005634,nucleus,2.0
29694,USP9Y,GO:0005737,cytoplasm,2.0
29695,USP9Y,GO:0005829,cytosol,2.0
29696,USP9Y,GO:0006511,ubiquitin-dependent protein catabolic process,2.0
29697,USP9Y,GO:0007179,transforming growth factor beta receptor signaling pathway,2.0
29698,USP9Y,GO:0007283,spermatogenesis,2.0
29699,USP9Y,GO:0008234,cysteine-type peptidase activity,2.0
29700,USP9Y,GO:0016477,cell migration,2.0
29701,USP9Y,GO:0016579,protein deubiquitination,2.0
29703,USP9Y,GO:0030509,BMP signaling pathway,2.0
29704,USP9Y,GO:0070410,co-SMAD binding,2.0
29788,VIL1,GO:0001726,ruffle,2.0
29789,VIL1,GO:0001951,intestinal D-glucose absorption,2.0
29790,VIL1,GO:0005509,calcium ion binding,2.0
29792,VIL1,GO:0005515,protein binding,2.0
29793,VIL1,GO:0005546,"phosphatidylinositol-4,5-bisphosphate binding",2.0
29795,VIL1,GO:0005737,cytoplasm,2.0
29796,VIL1,GO:0005886,plasma membrane,2.0
29797,VIL1,GO:0005902,microvillus,2.0
29798,VIL1,GO:0005903,brush border,2.0
29799,VIL1,GO:0006915,apoptotic process,2.0
29800,VIL1,GO:0007173,epidermal growth factor receptor signaling pathway,2.0
29801,VIL1,GO:0008154,actin polymerization or depolymerization,2.0
29802,VIL1,GO:0008360,regulation of cell shape,2.0
29803,VIL1,GO:0009617,response to bacterium,2.0
29804,VIL1,GO:0010634,positive regulation of epithelial cell migration,2.0
29807,VIL1,GO:0015629,actin cytoskeleton,2.0
29808,VIL1,GO:0030027,lamellipodium,2.0
29810,VIL1,GO:0030041,actin filament polymerization,2.0
29811,VIL1,GO:0030042,actin filament depolymerization,2.0
29812,VIL1,GO:0030175,filopodium,2.0
29813,VIL1,GO:0030335,positive regulation of cell migration,2.0
29814,VIL1,GO:0030836,positive regulation of actin filament depolymerization,2.0
29815,VIL1,GO:0030855,epithelial cell differentiation,2.0
29816,VIL1,GO:0032233,positive regulation of actin filament bundle assembly,2.0
29817,VIL1,GO:0032432,actin filament bundle,2.0
29818,VIL1,GO:0032433,filopodium tip,2.0
29819,VIL1,GO:0032532,regulation of microvillus length,2.0
29820,VIL1,GO:0035727,lysophosphatidic acid binding,2.0
29821,VIL1,GO:0035729,cellular response to hepatocyte growth factor stimulus,2.0
29822,VIL1,GO:0040018,positive regulation of multicellular organism growth,2.0
29823,VIL1,GO:0042802,identical protein binding,2.0
29824,VIL1,GO:0042803,protein homodimerization activity,2.0
29825,VIL1,GO:0043027,cysteine-type endopeptidase inhibitor activity involved in apoptotic process,2.0
29826,VIL1,GO:0043154,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process,2.0
29827,VIL1,GO:0045010,actin nucleation,2.0
29828,VIL1,GO:0051014,actin filament severing,2.0
29830,VIL1,GO:0051015,actin filament binding,2.0
29832,VIL1,GO:0051016,barbed-end actin filament capping,2.0
29834,VIL1,GO:0051125,regulation of actin nucleation,2.0
29835,VIL1,GO:0051693,actin filament capping,2.0
29836,VIL1,GO:0060327,cytoplasmic actin-based contraction involved in cell motility,2.0
29837,VIL1,GO:0061041,regulation of wound healing,2.0
29838,VIL1,GO:0065003,protein-containing complex assembly,2.0
29839,VIL1,GO:0070062,extracellular exosome,2.0
29840,VIL1,GO:0071364,cellular response to epidermal growth factor stimulus,2.0
29841,VIL1,GO:1902896,terminal web assembly,2.0
29842,VIL1,GO:1903078,positive regulation of protein localization to plasma membrane,2.0
29843,VIL1,GO:2000392,regulation of lamellipodium morphogenesis,2.0
29845,VIL1,GO:2000394,positive regulation of lamellipodium morphogenesis,2.0
29864,VSIG4,GO:0001851,complement component C3b binding,2.0
29866,VSIG4,GO:0005515,protein binding,2.0
29867,VSIG4,GO:0006957,"complement activation, alternative pathway",2.0
29868,VSIG4,GO:0016020,membrane,2.0
29869,VSIG4,GO:0032703,negative regulation of interleukin-2 production,2.0
29870,VSIG4,GO:0032991,protein-containing complex,2.0
29871,VSIG4,GO:0042130,negative regulation of T cell proliferation,2.0
29872,VSIG4,GO:0043031,negative regulation of macrophage activation,2.0
29873,VSIG4,GO:0045957,"negative regulation of complement activation, alternative pathway",2.0
29952,WDFY4,GO:0005769,early endosome,2.0
29953,WDFY4,GO:0005783,endoplasmic reticulum,2.0
29954,WDFY4,GO:0006914,autophagy,2.0
29955,WDFY4,GO:0019882,antigen processing and presentation,2.0
29956,WDFY4,GO:0036037,"CD8-positive, alpha-beta T cell activation",2.0
29957,WDFY4,GO:0098586,cellular response to virus,2.0
29967,WNK3,GO:0004672,protein kinase activity,2.0
29968,WNK3,GO:0004674,protein serine/threonine kinase activity,2.0
29971,WNK3,GO:0005515,protein binding,2.0
29972,WNK3,GO:0005524,ATP binding,2.0
29973,WNK3,GO:0005737,cytoplasm,2.0
29975,WNK3,GO:0005829,cytosol,2.0
29976,WNK3,GO:0005912,adherens junction,2.0
29977,WNK3,GO:0005923,bicellular tight junction,2.0
29978,WNK3,GO:0006468,protein phosphorylation,2.0
29980,WNK3,GO:0006884,cell volume homeostasis,2.0
29982,WNK3,GO:0007231,osmosensory signaling pathway,2.0
29983,WNK3,GO:0010765,positive regulation of sodium ion transport,2.0
29984,WNK3,GO:0010766,negative regulation of sodium ion transport,2.0
29985,WNK3,GO:0010800,positive regulation of peptidyl-threonine phosphorylation,2.0
29986,WNK3,GO:0018107,peptidyl-threonine phosphorylation,2.0
29987,WNK3,GO:0019869,chloride channel inhibitor activity,2.0
29989,WNK3,GO:0019870,potassium channel inhibitor activity,2.0
29990,WNK3,GO:0032414,positive regulation of ion transmembrane transporter activity,2.0
29991,WNK3,GO:0035556,intracellular signal transduction,2.0
29993,WNK3,GO:0035633,maintenance of blood-brain barrier,2.0
29994,WNK3,GO:0043066,negative regulation of apoptotic process,2.0
29995,WNK3,GO:0046777,protein autophosphorylation,2.0
29996,WNK3,GO:0050801,ion homeostasis,2.0
29998,WNK3,GO:0051928,positive regulation of calcium ion transport,2.0
30000,WNK3,GO:0072659,protein localization to plasma membrane,2.0
30001,WNK3,GO:0090279,regulation of calcium ion import,2.0
30002,WNK3,GO:0106310,protein serine kinase activity,2.0
30003,WNK3,GO:1903078,positive regulation of protein localization to plasma membrane,2.0
30004,WNK3,GO:1903288,positive regulation of potassium ion import across plasma membrane,2.0
30005,WNK3,GO:1904062,regulation of cation transmembrane transport,2.0
30007,WNK3,GO:2000651,positive regulation of sodium ion transmembrane transporter activity,2.0
30010,WNT1,GO:0000578,embryonic axis specification,2.0
30011,WNT1,GO:0001658,branching involved in ureteric bud morphogenesis,2.0
30012,WNT1,GO:0001934,positive regulation of protein phosphorylation,2.0
30013,WNT1,GO:0005109,frizzled binding,2.0
30016,WNT1,GO:0005125,cytokine activity,2.0
30018,WNT1,GO:0005576,extracellular region,2.0
30019,WNT1,GO:0005615,extracellular space,2.0
30020,WNT1,GO:0005737,cytoplasm,2.0
30021,WNT1,GO:0005788,endoplasmic reticulum lumen,2.0
30022,WNT1,GO:0005796,Golgi lumen,2.0
30023,WNT1,GO:0005886,plasma membrane,2.0
30024,WNT1,GO:0007267,cell-cell signaling,2.0
30025,WNT1,GO:0007520,myoblast fusion,2.0
30026,WNT1,GO:0008284,positive regulation of cell population proliferation,2.0
30028,WNT1,GO:0009611,response to wounding,2.0
30029,WNT1,GO:0009986,cell surface,2.0
30030,WNT1,GO:0010592,positive regulation of lamellipodium assembly,2.0
30031,WNT1,GO:0010812,negative regulation of cell-substrate adhesion,2.0
30032,WNT1,GO:0016015,morphogen activity,2.0
30033,WNT1,GO:0019904,protein domain specific binding,2.0
30034,WNT1,GO:0021527,spinal cord association neuron differentiation,2.0
30035,WNT1,GO:0021536,diencephalon development,2.0
30036,WNT1,GO:0021551,central nervous system morphogenesis,2.0
30037,WNT1,GO:0021588,cerebellum formation,2.0
30038,WNT1,GO:0021797,forebrain anterior/posterior pattern specification,2.0
30039,WNT1,GO:0022004,midbrain-hindbrain boundary maturation during brain development,2.0
30040,WNT1,GO:0022408,negative regulation of cell-cell adhesion,2.0
30041,WNT1,GO:0030182,neuron differentiation,2.0
30042,WNT1,GO:0030512,negative regulation of transforming growth factor beta receptor signaling pathway,2.0
30043,WNT1,GO:0030514,negative regulation of BMP signaling pathway,2.0
30044,WNT1,GO:0030579,ubiquitin-dependent SMAD protein catabolic process,2.0
30045,WNT1,GO:0030666,endocytic vesicle membrane,2.0
30046,WNT1,GO:0030901,midbrain development,2.0
30047,WNT1,GO:0031100,animal organ regeneration,2.0
30048,WNT1,GO:0033077,T cell differentiation in thymus,2.0
30049,WNT1,GO:0033278,cell proliferation in midbrain,2.0
30050,WNT1,GO:0036520,astrocyte-dopaminergic neuron signaling,2.0
30051,WNT1,GO:0042472,inner ear morphogenesis,2.0
30052,WNT1,GO:0042770,signal transduction in response to DNA damage,2.0
30053,WNT1,GO:0043066,negative regulation of apoptotic process,2.0
30054,WNT1,GO:0043568,positive regulation of insulin-like growth factor receptor signaling pathway,2.0
30055,WNT1,GO:0045165,cell fate commitment,2.0
30056,WNT1,GO:0045444,fat cell differentiation,2.0
30057,WNT1,GO:0045599,negative regulation of fat cell differentiation,2.0
30058,WNT1,GO:0045747,positive regulation of Notch signaling pathway,2.0
30059,WNT1,GO:0045893,positive regulation of DNA-templated transcription,2.0
30062,WNT1,GO:0045944,positive regulation of transcription by RNA polymerase II,2.0
30063,WNT1,GO:0048018,receptor ligand activity,2.0
30066,WNT1,GO:0048146,positive regulation of fibroblast proliferation,2.0
30067,WNT1,GO:0048664,neuron fate determination,2.0
30068,WNT1,GO:0051091,positive regulation of DNA-binding transcription factor activity,2.0
30069,WNT1,GO:0060061,Spemann organizer formation,2.0
30070,WNT1,GO:0060070,canonical Wnt signaling pathway,2.0
30075,WNT1,GO:0060348,bone development,2.0
30076,WNT1,GO:0061184,positive regulation of dermatome development,2.0
30077,WNT1,GO:0070062,extracellular exosome,2.0
30078,WNT1,GO:0070365,hepatocyte differentiation,2.0
30079,WNT1,GO:0071375,cellular response to peptide hormone stimulus,2.0
30080,WNT1,GO:0071425,hematopoietic stem cell proliferation,2.0
30081,WNT1,GO:1902035,positive regulation of hematopoietic stem cell proliferation,2.0
30082,WNT1,GO:1903204,negative regulation of oxidative stress-induced neuron death,2.0
30083,WNT1,GO:1904953,Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation,2.0
30085,WNT1,GO:1904954,canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation,2.0
30086,WNT1,GO:1990403,embryonic brain development,2.0
30087,WNT1,GO:2000059,negative regulation of ubiquitin-dependent protein catabolic process,2.0
30088,WNT1,GO:2000773,negative regulation of cellular senescence,2.0
30089,WWOX,GO:0001649,osteoblast differentiation,2.0
30090,WWOX,GO:0003713,transcription coactivator activity,2.0
30091,WWOX,GO:0005515,protein binding,2.0
30092,WWOX,GO:0005634,nucleus,2.0
30093,WWOX,GO:0005654,nucleoplasm,2.0
30094,WWOX,GO:0005737,cytoplasm,2.0
30095,WWOX,GO:0005739,mitochondrion,2.0
30096,WWOX,GO:0005794,Golgi apparatus,2.0
30097,WWOX,GO:0005829,cytosol,2.0
30099,WWOX,GO:0005886,plasma membrane,2.0
30100,WWOX,GO:0005902,microvillus,2.0
30101,WWOX,GO:0016055,Wnt signaling pathway,2.0
30102,WWOX,GO:0016491,oxidoreductase activity,2.0
30103,WWOX,GO:0019899,enzyme binding,2.0
30104,WWOX,GO:0030178,negative regulation of Wnt signaling pathway,2.0
30105,WWOX,GO:0045944,positive regulation of transcription by RNA polymerase II,2.0
30106,WWOX,GO:0048705,skeletal system morphogenesis,2.0
30107,WWOX,GO:0071560,cellular response to transforming growth factor beta stimulus,2.0
30108,WWOX,GO:0072332,intrinsic apoptotic signaling pathway by p53 class mediator,2.0
30109,WWOX,GO:0090575,RNA polymerase II transcription regulator complex,2.0
30110,WWOX,GO:0097191,extrinsic apoptotic signaling pathway,2.0
30111,WWOX,GO:2001238,positive regulation of extrinsic apoptotic signaling pathway,2.0
30112,WWOX,GO:2001241,positive regulation of extrinsic apoptotic signaling pathway in absence of ligand,2.0
30169,XPO1,GO:0000054,ribosomal subunit export from nucleus,2.0
30170,XPO1,GO:0000055,ribosomal large subunit export from nucleus,2.0
30172,XPO1,GO:0000056,ribosomal small subunit export from nucleus,2.0
30174,XPO1,GO:0000776,kinetochore,2.0
30175,XPO1,GO:0003723,RNA binding,2.0
30176,XPO1,GO:0005049,nuclear export signal receptor activity,2.0
30179,XPO1,GO:0005515,protein binding,2.0
30180,XPO1,GO:0005634,nucleus,2.0
30181,XPO1,GO:0005635,nuclear envelope,2.0
30182,XPO1,GO:0005642,annulate lamellae,2.0
30183,XPO1,GO:0005654,nucleoplasm,2.0
30185,XPO1,GO:0005730,nucleolus,2.0
30186,XPO1,GO:0005737,cytoplasm,2.0
30188,XPO1,GO:0005829,cytosol,2.0
30190,XPO1,GO:0006611,protein export from nucleus,2.0
30195,XPO1,GO:0006913,nucleocytoplasmic transport,2.0
30196,XPO1,GO:0010824,regulation of centrosome duplication,2.0
30197,XPO1,GO:0015030,Cajal body,2.0
30198,XPO1,GO:0016020,membrane,2.0
30199,XPO1,GO:0031267,small GTPase binding,2.0
30200,XPO1,GO:0031965,nuclear membrane,2.0
30201,XPO1,GO:0032434,regulation of proteasomal ubiquitin-dependent protein catabolic process,2.0
30202,XPO1,GO:0032991,protein-containing complex,2.0
30203,XPO1,GO:0034504,protein localization to nucleus,2.0
30204,XPO1,GO:0042254,ribosome biogenesis,2.0
30205,XPO1,GO:0043231,intracellular membrane-bounded organelle,2.0
30206,XPO1,GO:0046825,regulation of protein export from nucleus,2.0
30207,XPO1,GO:0051028,mRNA transport,2.0
30208,XPO1,GO:1990904,ribonucleoprotein complex,2.0
30268,YEATS2,GO:0000122,negative regulation of transcription by RNA polymerase II,2.0
30269,YEATS2,GO:0005515,protein binding,2.0
30270,YEATS2,GO:0005634,nucleus,2.0
30271,YEATS2,GO:0006338,chromatin remodeling,2.0
30272,YEATS2,GO:0006355,regulation of DNA-templated transcription,2.0
30274,YEATS2,GO:0006357,regulation of transcription by RNA polymerase II,2.0
30277,YEATS2,GO:0016573,histone acetylation,2.0
30278,YEATS2,GO:0017025,TBP-class protein binding,2.0
30279,YEATS2,GO:0031063,regulation of histone deacetylation,2.0
30281,YEATS2,GO:0035267,NuA4 histone acetyltransferase complex,2.0
30282,YEATS2,GO:0042393,histone binding,2.0
30284,YEATS2,GO:0043966,histone H3 acetylation,2.0
30285,YEATS2,GO:0044154,histone H3-K14 acetylation,2.0
30287,YEATS2,GO:0045892,negative regulation of DNA-templated transcription,2.0
30288,YEATS2,GO:0045995,regulation of embryonic development,2.0
30289,YEATS2,GO:0051302,regulation of cell division,2.0
30291,YEATS2,GO:0051726,regulation of cell cycle,2.0
30293,YEATS2,GO:0072686,mitotic spindle,2.0
30294,YEATS2,GO:0090043,regulation of tubulin deacetylation,2.0
30296,YEATS2,GO:0140030,modification-dependent protein binding,2.0
30297,YEATS2,GO:0140672,ATAC complex,2.0
30299,YTHDC2,GO:0003723,RNA binding,2.0
30301,YTHDC2,GO:0005515,protein binding,2.0
30302,YTHDC2,GO:0005524,ATP binding,2.0
30303,YTHDC2,GO:0005622,intracellular anatomical structure,2.0
30304,YTHDC2,GO:0005634,nucleus,2.0
30305,YTHDC2,GO:0005783,endoplasmic reticulum,2.0
30307,YTHDC2,GO:0007286,spermatid development,2.0
30308,YTHDC2,GO:0008186,"ATP-dependent activity, acting on RNA",2.0
30309,YTHDC2,GO:0016887,ATP hydrolysis activity,2.0
30310,YTHDC2,GO:0034458,3'-5' RNA helicase activity,2.0
30311,YTHDC2,GO:0034612,response to tumor necrosis factor,2.0
30312,YTHDC2,GO:0035770,ribonucleoprotein granule,2.0
30313,YTHDC2,GO:0044829,positive regulation by host of viral genome replication,2.0
30314,YTHDC2,GO:0048471,perinuclear region of cytoplasm,2.0
30315,YTHDC2,GO:0048599,oocyte development,2.0
30316,YTHDC2,GO:0051321,meiotic cell cycle,2.0
30317,YTHDC2,GO:0051729,"germline cell cycle switching, mitotic to meiotic cell cycle",2.0
30318,YTHDC2,GO:0070063,RNA polymerase binding,2.0
30319,YTHDC2,GO:0070555,response to interleukin-1,2.0
30320,YTHDC2,GO:1990247,N6-methyladenosine-containing RNA binding,2.0
30321,YWHAE,GO:0000165,MAPK cascade,2.0
30322,YWHAE,GO:0001764,neuron migration,2.0
30323,YWHAE,GO:0003064,regulation of heart rate by hormone,2.0
30324,YWHAE,GO:0003723,RNA binding,2.0
30325,YWHAE,GO:0005246,calcium channel regulator activity,2.0
30326,YWHAE,GO:0005515,protein binding,2.0
30327,YWHAE,GO:0005634,nucleus,2.0
30328,YWHAE,GO:0005737,cytoplasm,2.0
30330,YWHAE,GO:0005829,cytosol,2.0
30332,YWHAE,GO:0005886,plasma membrane,2.0
30333,YWHAE,GO:0005925,focal adhesion,2.0
30334,YWHAE,GO:0006605,protein targeting,2.0
30335,YWHAE,GO:0007165,signal transduction,2.0
30336,YWHAE,GO:0007346,regulation of mitotic cell cycle,2.0
30337,YWHAE,GO:0015459,potassium channel regulator activity,2.0
30338,YWHAE,GO:0016020,membrane,2.0
30339,YWHAE,GO:0019899,enzyme binding,2.0
30340,YWHAE,GO:0019903,protein phosphatase binding,2.0
30341,YWHAE,GO:0019904,protein domain specific binding,2.0
30342,YWHAE,GO:0021762,substantia nigra development,2.0
30343,YWHAE,GO:0021766,hippocampus development,2.0
30344,YWHAE,GO:0021987,cerebral cortex development,2.0
30345,YWHAE,GO:0023026,MHC class II protein complex binding,2.0
30346,YWHAE,GO:0031625,ubiquitin protein ligase binding,2.0
30347,YWHAE,GO:0034504,protein localization to nucleus,2.0
30348,YWHAE,GO:0034605,cellular response to heat,2.0
30349,YWHAE,GO:0035556,intracellular signal transduction,2.0
30350,YWHAE,GO:0042470,melanosome,2.0
30351,YWHAE,GO:0042802,identical protein binding,2.0
30352,YWHAE,GO:0042826,histone deacetylase binding,2.0
30353,YWHAE,GO:0044325,transmembrane transporter binding,2.0
30354,YWHAE,GO:0045296,cadherin binding,2.0
30355,YWHAE,GO:0046827,positive regulation of protein export from nucleus,2.0
30356,YWHAE,GO:0046982,protein heterodimerization activity,2.0
30357,YWHAE,GO:0050815,phosphoserine residue binding,2.0
30359,YWHAE,GO:0051219,phosphoprotein binding,2.0
30360,YWHAE,GO:0051480,regulation of cytosolic calcium ion concentration,2.0
30361,YWHAE,GO:0060306,regulation of membrane repolarization,2.0
30362,YWHAE,GO:0070062,extracellular exosome,2.0
30363,YWHAE,GO:0086013,membrane repolarization during cardiac muscle cell action potential,2.0
30364,YWHAE,GO:0086091,regulation of heart rate by cardiac conduction,2.0
30365,YWHAE,GO:0097110,scaffold protein binding,2.0
30366,YWHAE,GO:1901016,regulation of potassium ion transmembrane transporter activity,2.0
30367,YWHAE,GO:1901020,negative regulation of calcium ion transmembrane transporter activity,2.0
30368,YWHAE,GO:1902309,negative regulation of peptidyl-serine dephosphorylation,2.0
30369,YWHAE,GO:1905913,negative regulation of calcium ion export across plasma membrane,2.0
30493,TPO,GO:0004447,iodide peroxidase activity,2.0
30494,TPO,GO:0004601,peroxidase activity,2.0
30496,TPO,GO:0005509,calcium ion binding,2.0
30497,TPO,GO:0005615,extracellular space,2.0
30499,TPO,GO:0005886,plasma membrane,2.0
30500,TPO,GO:0006590,thyroid hormone generation,2.0
30502,TPO,GO:0006979,response to oxidative stress,2.0
30503,TPO,GO:0009986,cell surface,2.0
30504,TPO,GO:0020037,heme binding,2.0
30505,TPO,GO:0035162,embryonic hemopoiesis,2.0
30506,TPO,GO:0042446,hormone biosynthetic process,2.0
30507,TPO,GO:0042744,hydrogen peroxide catabolic process,2.0
30508,TPO,GO:0098869,cellular oxidant detoxification,2.0
30509,TRIM33,GO:0000122,negative regulation of transcription by RNA polymerase II,2.0
30510,TRIM33,GO:0003677,DNA binding,2.0
30511,TRIM33,GO:0004842,ubiquitin-protein transferase activity,2.0
30512,TRIM33,GO:0005515,protein binding,2.0
30513,TRIM33,GO:0005634,nucleus,2.0
30514,TRIM33,GO:0005654,nucleoplasm,2.0
30515,TRIM33,GO:0008270,zinc ion binding,2.0
30516,TRIM33,GO:0016567,protein ubiquitination,2.0
30518,TRIM33,GO:0017015,regulation of transforming growth factor beta receptor signaling pathway,2.0
30519,TRIM33,GO:0030514,negative regulation of BMP signaling pathway,2.0
30520,TRIM33,GO:0045892,negative regulation of DNA-templated transcription,2.0
30521,TRIM33,GO:0070410,co-SMAD binding,2.0
30522,TRIM33,GO:0070412,R-SMAD binding,2.0
30523,UBE2H,GO:0000209,protein polyubiquitination,2.0
30524,UBE2H,GO:0004842,ubiquitin-protein transferase activity,2.0
30525,UBE2H,GO:0005515,protein binding,2.0
30526,UBE2H,GO:0005524,ATP binding,2.0
30527,UBE2H,GO:0005634,nucleus,2.0
30528,UBE2H,GO:0005829,cytosol,2.0
30529,UBE2H,GO:0006511,ubiquitin-dependent protein catabolic process,2.0
30530,UBE2H,GO:0043161,proteasome-mediated ubiquitin-dependent protein catabolic process,2.0
30531,UBE2H,GO:0061631,ubiquitin conjugating enzyme activity,2.0
30532,UBE2H,GO:0070936,protein K48-linked ubiquitination,2.0
30533,UBE2H,GO:0070979,protein K11-linked ubiquitination,2.0
30547,VASH1,GO:0001525,angiogenesis,2.0
30548,VASH1,GO:0001937,negative regulation of endothelial cell proliferation,2.0
30550,VASH1,GO:0003779,actin binding,2.0
30551,VASH1,GO:0004181,metallocarboxypeptidase activity,2.0
30553,VASH1,GO:0005515,protein binding,2.0
30554,VASH1,GO:0005615,extracellular space,2.0
30555,VASH1,GO:0005737,cytoplasm,2.0
30557,VASH1,GO:0005783,endoplasmic reticulum,2.0
30558,VASH1,GO:0006508,proteolysis,2.0
30559,VASH1,GO:0007049,cell cycle,2.0
30560,VASH1,GO:0009611,response to wounding,2.0
30561,VASH1,GO:0016525,negative regulation of angiogenesis,2.0
30563,VASH1,GO:0043537,negative regulation of blood vessel endothelial cell migration,2.0
30564,VASH1,GO:0045177,apical part of cell,2.0
30565,VASH1,GO:0045765,regulation of angiogenesis,2.0
30566,VASH1,GO:0051726,regulation of cell cycle,2.0
30567,VASH1,GO:0060716,labyrinthine layer blood vessel development,2.0
30568,VASH1,GO:0106423,tubulin-tyrosine carboxypeptidase,2.0
30569,VASH1,GO:1901491,negative regulation of lymphangiogenesis,2.0
30570,VASH1,GO:2000772,regulation of cellular senescence,2.0
30571,VDR,GO:0000122,negative regulation of transcription by RNA polymerase II,2.0
30573,VDR,GO:0000785,chromatin,2.0
30574,VDR,GO:0000902,cell morphogenesis,2.0
30575,VDR,GO:0000978,RNA polymerase II cis-regulatory region sequence-specific DNA binding,2.0
30576,VDR,GO:0000981,"DNA-binding transcription factor activity, RNA polymerase II-specific",2.0
30577,VDR,GO:0001501,skeletal system development,2.0
30578,VDR,GO:0003676,nucleic acid binding,2.0
30579,VDR,GO:0003677,DNA binding,2.0
30580,VDR,GO:0003700,DNA-binding transcription factor activity,2.0
30581,VDR,GO:0004879,nuclear receptor activity,2.0
30584,VDR,GO:0005515,protein binding,2.0
30585,VDR,GO:0005634,nucleus,2.0
30587,VDR,GO:0005654,nucleoplasm,2.0
30589,VDR,GO:0005829,cytosol,2.0
30590,VDR,GO:0006816,calcium ion transport,2.0
30591,VDR,GO:0006874,cellular calcium ion homeostasis,2.0
30592,VDR,GO:0007275,multicellular organism development,2.0
30593,VDR,GO:0007595,lactation,2.0
30594,VDR,GO:0008270,zinc ion binding,2.0
30595,VDR,GO:0008285,negative regulation of cell population proliferation,2.0
30596,VDR,GO:0010628,positive regulation of gene expression,2.0
30597,VDR,GO:0010839,negative regulation of keratinocyte proliferation,2.0
30598,VDR,GO:0010980,positive regulation of vitamin D 24-hydroxylase activity,2.0
30599,VDR,GO:0030154,cell differentiation,2.0
30600,VDR,GO:0030501,positive regulation of bone mineralization,2.0
30601,VDR,GO:0036094,small molecule binding,2.0
30602,VDR,GO:0038183,bile acid signaling pathway,2.0
30603,VDR,GO:0038186,lithocholic acid receptor activity,2.0
30604,VDR,GO:0042789,mRNA transcription by RNA polymerase II,2.0
30606,VDR,GO:0043235,receptor complex,2.0
30607,VDR,GO:0045618,positive regulation of keratinocyte differentiation,2.0
30608,VDR,GO:0045892,negative regulation of DNA-templated transcription,2.0
30609,VDR,GO:0045944,positive regulation of transcription by RNA polymerase II,2.0
30613,VDR,GO:0046697,decidualization,2.0
30614,VDR,GO:0046965,nuclear retinoid X receptor binding,2.0
30616,VDR,GO:0050892,intestinal absorption,2.0
30617,VDR,GO:0060057,apoptotic process involved in mammary gland involution,2.0
30618,VDR,GO:0060058,positive regulation of apoptotic process involved in mammary gland involution,2.0
30619,VDR,GO:0060558,regulation of calcidiol 1-monooxygenase activity,2.0
30620,VDR,GO:0060745,mammary gland branching involved in pregnancy,2.0
30621,VDR,GO:0070561,vitamin D receptor signaling pathway,2.0
30623,VDR,GO:0070564,positive regulation of vitamin D receptor signaling pathway,2.0
30625,VDR,GO:0070644,vitamin D response element binding,2.0
30627,VDR,GO:0090575,RNA polymerase II transcription regulator complex,2.0
30630,VDR,GO:1902098,calcitriol binding,2.0
30632,VDR,GO:1902121,lithocholic acid binding,2.0
30633,ZBTB16,GO:0000122,negative regulation of transcription by RNA polymerase II,2.0
30634,ZBTB16,GO:0000978,RNA polymerase II cis-regulatory region sequence-specific DNA binding,2.0
30636,ZBTB16,GO:0001222,transcription corepressor binding,2.0
30637,ZBTB16,GO:0001227,"DNA-binding transcription repressor activity, RNA polymerase II-specific",2.0
30639,ZBTB16,GO:0001228,"DNA-binding transcription activator activity, RNA polymerase II-specific",2.0
30640,ZBTB16,GO:0001673,male germ cell nucleus,2.0
30641,ZBTB16,GO:0001823,mesonephros development,2.0
30642,ZBTB16,GO:0003677,DNA binding,2.0
30644,ZBTB16,GO:0005515,protein binding,2.0
30645,ZBTB16,GO:0005634,nucleus,2.0
30647,ZBTB16,GO:0005829,cytosol,2.0
30648,ZBTB16,GO:0005886,plasma membrane,2.0
30649,ZBTB16,GO:0006357,regulation of transcription by RNA polymerase II,2.0
30650,ZBTB16,GO:0006915,apoptotic process,2.0
30651,ZBTB16,GO:0007417,central nervous system development,2.0
30652,ZBTB16,GO:0008022,protein C-terminus binding,2.0
30653,ZBTB16,GO:0008283,cell population proliferation,2.0
30654,ZBTB16,GO:0008285,negative regulation of cell population proliferation,2.0
30655,ZBTB16,GO:0009880,embryonic pattern specification,2.0
30656,ZBTB16,GO:0009952,anterior/posterior pattern specification,2.0
30657,ZBTB16,GO:0016567,protein ubiquitination,2.0
30658,ZBTB16,GO:0016604,nuclear body,2.0
30659,ZBTB16,GO:0016605,PML body,2.0
30660,ZBTB16,GO:0016607,nuclear speck,2.0
30661,ZBTB16,GO:0017053,transcription repressor complex,2.0
30662,ZBTB16,GO:0019904,protein domain specific binding,2.0
30663,ZBTB16,GO:0030097,hemopoiesis,2.0
30665,ZBTB16,GO:0030099,myeloid cell differentiation,2.0
30666,ZBTB16,GO:0032332,positive regulation of chondrocyte differentiation,2.0
30667,ZBTB16,GO:0032991,protein-containing complex,2.0
30668,ZBTB16,GO:0034504,protein localization to nucleus,2.0
30669,ZBTB16,GO:0035116,embryonic hindlimb morphogenesis,2.0
30670,ZBTB16,GO:0035136,forelimb morphogenesis,2.0
30671,ZBTB16,GO:0042733,embryonic digit morphogenesis,2.0
30672,ZBTB16,GO:0042802,identical protein binding,2.0
30673,ZBTB16,GO:0042803,protein homodimerization activity,2.0
30674,ZBTB16,GO:0043065,positive regulation of apoptotic process,2.0
30675,ZBTB16,GO:0043931,ossification involved in bone maturation,2.0
30676,ZBTB16,GO:0045600,positive regulation of fat cell differentiation,2.0
30677,ZBTB16,GO:0045638,negative regulation of myeloid cell differentiation,2.0
30678,ZBTB16,GO:0045778,positive regulation of ossification,2.0
30679,ZBTB16,GO:0045892,negative regulation of DNA-templated transcription,2.0
30682,ZBTB16,GO:0045893,positive regulation of DNA-templated transcription,2.0
30683,ZBTB16,GO:0045944,positive regulation of transcription by RNA polymerase II,2.0
30684,ZBTB16,GO:0046872,metal ion binding,2.0
30685,ZBTB16,GO:0048133,male germ-line stem cell asymmetric division,2.0
30686,ZBTB16,GO:0051138,positive regulation of NK T cell differentiation,2.0
30687,ZBTB16,GO:0051216,cartilage development,2.0
30688,ZBTB16,GO:0061036,positive regulation of cartilage development,2.0
30755,ZC3H11A,GO:0003723,RNA binding,2.0
30756,ZC3H11A,GO:0003729,mRNA binding,2.0
30757,ZC3H11A,GO:0005515,protein binding,2.0
30758,ZC3H11A,GO:0005654,nucleoplasm,2.0
30759,ZC3H11A,GO:0016973,poly(A)+ mRNA export from nucleus,2.0
30761,ZC3H11A,GO:0046872,metal ion binding,2.0
30762,ZC3H4,GO:0003723,RNA binding,2.0
30764,ZC3H4,GO:0005515,protein binding,2.0
30765,ZC3H4,GO:0005634,nucleus,2.0
30766,ZC3H4,GO:0005654,nucleoplasm,2.0
30767,ZC3H4,GO:0005694,chromosome,2.0
30768,ZC3H4,GO:0005829,cytosol,2.0
30769,ZC3H4,GO:0006353,DNA-templated transcription termination,2.0
30770,ZC3H4,GO:0032785,"negative regulation of DNA-templated transcription, elongation",2.0
30771,ZC3H4,GO:0046872,metal ion binding,2.0
30772,ZC3H4,GO:0071027,nuclear RNA surveillance,2.0
30773,ZC3H4,GO:0110064,lncRNA catabolic process,2.0
30774,ZC3H4,GO:0140744,negative regulation of lncRNA transcription,2.0
30775,ZC3H4,GO:1990841,promoter-specific chromatin binding,2.0
30776,ZFYVE26,GO:0000281,mitotic cytokinesis,2.0
30777,ZFYVE26,GO:0000724,double-strand break repair via homologous recombination,2.0
30778,ZFYVE26,GO:0005515,protein binding,2.0
30779,ZFYVE26,GO:0005764,lysosome,2.0
30780,ZFYVE26,GO:0005765,lysosomal membrane,2.0
30781,ZFYVE26,GO:0005769,early endosome,2.0
30782,ZFYVE26,GO:0005770,late endosome,2.0
30783,ZFYVE26,GO:0005813,centrosome,2.0
30785,ZFYVE26,GO:0007040,lysosome organization,2.0
30786,ZFYVE26,GO:0019901,protein kinase binding,2.0
30787,ZFYVE26,GO:0030496,midbody,2.0
30789,ZFYVE26,GO:0032266,phosphatidylinositol-3-phosphate binding,2.0
30791,ZFYVE26,GO:0032465,regulation of cytokinesis,2.0
30793,ZFYVE26,GO:0046872,metal ion binding,2.0
30794,ZFYVE26,GO:1905037,autophagosome organization,2.0
30795,ZMIZ1,GO:0001570,vasculogenesis,2.0
30796,ZMIZ1,GO:0001701,in utero embryonic development,2.0
30797,ZMIZ1,GO:0003007,heart morphogenesis,2.0
30798,ZMIZ1,GO:0003713,transcription coactivator activity,2.0
30799,ZMIZ1,GO:0005634,nucleus,2.0
30800,ZMIZ1,GO:0005654,nucleoplasm,2.0
30801,ZMIZ1,GO:0005737,cytoplasm,2.0
30802,ZMIZ1,GO:0005829,cytosol,2.0
30803,ZMIZ1,GO:0006357,regulation of transcription by RNA polymerase II,2.0
30804,ZMIZ1,GO:0007179,transforming growth factor beta receptor signaling pathway,2.0
30805,ZMIZ1,GO:0007296,vitellogenesis,2.0
30806,ZMIZ1,GO:0008270,zinc ion binding,2.0
30807,ZMIZ1,GO:0021852,pyramidal neuron migration to cerebral cortex,2.0
30808,ZMIZ1,GO:0030374,nuclear receptor coactivator activity,2.0
30809,ZMIZ1,GO:0030521,androgen receptor signaling pathway,2.0
30810,ZMIZ1,GO:0033233,regulation of protein sumoylation,2.0
30811,ZMIZ1,GO:0045582,positive regulation of T cell differentiation,2.0
30812,ZMIZ1,GO:0045747,positive regulation of Notch signaling pathway,2.0
30813,ZMIZ1,GO:0045944,positive regulation of transcription by RNA polymerase II,2.0
30814,ZMIZ1,GO:0046332,SMAD binding,2.0
30815,ZMIZ1,GO:0048146,positive regulation of fibroblast proliferation,2.0
30816,ZMIZ1,GO:0048589,developmental growth,2.0
30817,ZMIZ1,GO:0048844,artery morphogenesis,2.0
30818,ZMIZ1,GO:0060395,SMAD protein signal transduction,2.0
30819,ZMIZ1,GO:0090398,cellular senescence,2.0
30820,ZMIZ1,GO:1903508,positive regulation of nucleic acid-templated transcription,2.0
30821,ZMYM2,GO:0005515,protein binding,2.0
30822,ZMYM2,GO:0005634,nucleus,2.0
30823,ZMYM2,GO:0005829,cytosol,2.0
30824,ZMYM2,GO:0008150,biological_process,2.0
30825,ZMYM2,GO:0008270,zinc ion binding,2.0
30826,ZMYM2,GO:0016605,PML body,2.0
30827,ZMYM2,GO:0031624,ubiquitin conjugating enzyme binding,2.0
30828,ZMYM2,GO:0045892,negative regulation of DNA-templated transcription,2.0
30829,ZMYND11,GO:0003690,double-stranded DNA binding,2.0
30830,ZMYND11,GO:0003714,transcription corepressor activity,2.0
30831,ZMYND11,GO:0005515,protein binding,2.0
30832,ZMYND11,GO:0005634,nucleus,2.0
30834,ZMYND11,GO:0005654,nucleoplasm,2.0
30835,ZMYND11,GO:0005694,chromosome,2.0
30836,ZMYND11,GO:0006325,chromatin organization,2.0
30837,ZMYND11,GO:0007049,cell cycle,2.0
30838,ZMYND11,GO:0008270,zinc ion binding,2.0
30840,ZMYND11,GO:0009966,regulation of signal transduction,2.0
30841,ZMYND11,GO:0034243,regulation of transcription elongation by RNA polymerase II,2.0
30843,ZMYND11,GO:0035064,methylated histone binding,2.0
30846,ZMYND11,GO:0043124,negative regulation of I-kappaB kinase/NF-kappaB signaling,2.0
30847,ZMYND11,GO:0045892,negative regulation of DNA-templated transcription,2.0
30848,ZMYND11,GO:0046329,negative regulation of JNK cascade,2.0
30849,ZMYND11,GO:0051607,defense response to virus,2.0
30850,ZMYND11,GO:2001237,negative regulation of extrinsic apoptotic signaling pathway,2.0
30869,ZNF18,GO:0000978,RNA polymerase II cis-regulatory region sequence-specific DNA binding,2.0
30870,ZNF18,GO:0000981,"DNA-binding transcription factor activity, RNA polymerase II-specific",2.0
30871,ZNF18,GO:0005515,protein binding,2.0
30872,ZNF18,GO:0005634,nucleus,2.0
30873,ZNF18,GO:0006357,regulation of transcription by RNA polymerase II,2.0
30874,ZNF18,GO:0046872,metal ion binding,2.0
30882,ZNF385B,GO:0002039,p53 binding,2.0
30883,ZNF385B,GO:0003676,nucleic acid binding,2.0
30884,ZNF385B,GO:0005634,nucleus,2.0
30886,ZNF385B,GO:0008270,zinc ion binding,2.0
30887,ZNF385B,GO:0072332,intrinsic apoptotic signaling pathway by p53 class mediator,2.0
30896,ZNF517,GO:0000977,RNA polymerase II transcription regulatory region sequence-specific DNA binding,2.0
30897,ZNF517,GO:0000981,"DNA-binding transcription factor activity, RNA polymerase II-specific",2.0
30898,ZNF517,GO:0005634,nucleus,2.0
30899,ZNF517,GO:0006357,regulation of transcription by RNA polymerase II,2.0
30900,ZNF517,GO:0046872,metal ion binding,2.0
30901,ZNF548,GO:0000978,RNA polymerase II cis-regulatory region sequence-specific DNA binding,2.0
30902,ZNF548,GO:0000981,"DNA-binding transcription factor activity, RNA polymerase II-specific",2.0
30903,ZNF548,GO:0005634,nucleus,2.0
30904,ZNF548,GO:0006357,regulation of transcription by RNA polymerase II,2.0
30905,ZNF548,GO:0046872,metal ion binding,2.0
30906,ZNF559,GO:0000122,negative regulation of transcription by RNA polymerase II,2.0
30907,ZNF559,GO:0000977,RNA polymerase II transcription regulatory region sequence-specific DNA binding,2.0
30908,ZNF559,GO:0000981,"DNA-binding transcription factor activity, RNA polymerase II-specific",2.0
30909,ZNF559,GO:0001227,"DNA-binding transcription repressor activity, RNA polymerase II-specific",2.0
30910,ZNF559,GO:0005515,protein binding,2.0
30911,ZNF559,GO:0005634,nucleus,2.0
30912,ZNF559,GO:0006357,regulation of transcription by RNA polymerase II,2.0
30913,ZNF559,GO:0046872,metal ion binding,2.0
30914,ZNF626,GO:0000978,RNA polymerase II cis-regulatory region sequence-specific DNA binding,2.0
30915,ZNF626,GO:0000981,"DNA-binding transcription factor activity, RNA polymerase II-specific",2.0
30916,ZNF626,GO:0005634,nucleus,2.0
30917,ZNF626,GO:0006355,regulation of DNA-templated transcription,2.0
30918,ZNF626,GO:0006357,regulation of transcription by RNA polymerase II,2.0
30919,ZNF626,GO:0046872,metal ion binding,2.0
30920,ZNF711,GO:0000785,chromatin,2.0
30921,ZNF711,GO:0000978,RNA polymerase II cis-regulatory region sequence-specific DNA binding,2.0
30922,ZNF711,GO:0000981,"DNA-binding transcription factor activity, RNA polymerase II-specific",2.0
30923,ZNF711,GO:0005515,protein binding,2.0
30924,ZNF711,GO:0005634,nucleus,2.0
30926,ZNF711,GO:0006357,regulation of transcription by RNA polymerase II,2.0
30927,ZNF711,GO:0010468,regulation of gene expression,2.0
30928,ZNF711,GO:0043565,sequence-specific DNA binding,2.0
30929,ZNF711,GO:0045893,positive regulation of DNA-templated transcription,2.0
30930,ZNF711,GO:0045944,positive regulation of transcription by RNA polymerase II,2.0
30931,ZNF711,GO:0046872,metal ion binding,2.0
30932,ZNF713,GO:0000978,RNA polymerase II cis-regulatory region sequence-specific DNA binding,2.0
30933,ZNF713,GO:0000981,"DNA-binding transcription factor activity, RNA polymerase II-specific",2.0
30934,ZNF713,GO:0005634,nucleus,2.0
30935,ZNF713,GO:0006355,regulation of DNA-templated transcription,2.0
30936,ZNF713,GO:0006357,regulation of transcription by RNA polymerase II,2.0
30937,ZNF713,GO:0046872,metal ion binding,2.0
30938,ZNF713,GO:1990837,sequence-specific double-stranded DNA binding,2.0
30939,ZNF774,GO:0000978,RNA polymerase II cis-regulatory region sequence-specific DNA binding,2.0
30940,ZNF774,GO:0000981,"DNA-binding transcription factor activity, RNA polymerase II-specific",2.0
30941,ZNF774,GO:0005515,protein binding,2.0
30942,ZNF774,GO:0005634,nucleus,2.0
30943,ZNF774,GO:0006357,regulation of transcription by RNA polymerase II,2.0
30944,ZNF774,GO:0046872,metal ion binding,2.0
30945,ZNF804A,GO:0003674,molecular_function,2.0
30946,ZNF804A,GO:0005634,nucleus,2.0
30948,ZNF804A,GO:0005737,cytoplasm,2.0
30949,ZNF804A,GO:0005886,plasma membrane,2.0
30950,ZNF804A,GO:0010628,positive regulation of gene expression,2.0
30951,ZNF804A,GO:0010975,regulation of neuron projection development,2.0
30952,ZNF804A,GO:0010976,positive regulation of neuron projection development,2.0
30953,ZNF804A,GO:0030426,growth cone,2.0
30954,ZNF804A,GO:0043025,neuronal cell body,2.0
30955,ZNF804A,GO:0043197,dendritic spine,2.0
30956,ZNF804A,GO:0043198,dendritic shaft,2.0
30957,ZNF804A,GO:0046872,metal ion binding,2.0
30958,ZNF804A,GO:0098793,presynapse,2.0
30959,ZNF804A,GO:0098794,postsynapse,2.0
30960,ZNF804A,GO:1901588,dendritic microtubule,2.0
30961,ZNF804A,GO:1902952,positive regulation of dendritic spine maintenance,2.0
30962,ZNF827,GO:0000723,telomere maintenance,2.0
30963,ZNF827,GO:0000781,"chromosome, telomeric region",2.0
30964,ZNF827,GO:0000785,chromatin,2.0
30965,ZNF827,GO:0003677,DNA binding,2.0
30966,ZNF827,GO:0005515,protein binding,2.0
30967,ZNF827,GO:0005634,nucleus,2.0
30968,ZNF827,GO:0006338,chromatin remodeling,2.0
30969,ZNF827,GO:0010468,regulation of gene expression,2.0
30970,ZNF827,GO:0045892,negative regulation of DNA-templated transcription,2.0
30971,ZNF827,GO:0045944,positive regulation of transcription by RNA polymerase II,2.0
30972,ZNF827,GO:0046872,metal ion binding,2.0
30973,ZNF827,GO:0070200,establishment of protein localization to telomere,2.0
30974,ZNF827,GO:0120325,NuRD complex binding,2.0
30975,ZNF827,GO:1904791,negative regulation of shelterin complex assembly,2.0
30976,ZNF827,GO:1990904,ribonucleoprotein complex,2.0
30980,ZWILCH,GO:0000776,kinetochore,2.0
30981,ZWILCH,GO:0005515,protein binding,2.0
30982,ZWILCH,GO:0005828,kinetochore microtubule,2.0
30983,ZWILCH,GO:0005829,cytosol,2.0
30984,ZWILCH,GO:0007094,mitotic spindle assembly checkpoint signaling,2.0
30986,ZWILCH,GO:0034501,protein localization to kinetochore,2.0
30988,ZWILCH,GO:0051301,cell division,2.0
30989,ZWILCH,GO:1990423,RZZ complex,2.0
